Psyllid ID: psy3253
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 251 | 2.2.26 [Sep-21-2011] | |||||||
| Q8T0S6 | 669 | Serine/threonine-protein | yes | N/A | 0.820 | 0.307 | 0.757 | 1e-105 | |
| Q13188 | 491 | Serine/threonine-protein | yes | N/A | 0.820 | 0.419 | 0.736 | 1e-103 | |
| Q6IP06 | 493 | Serine/threonine-protein | N/A | N/A | 0.820 | 0.417 | 0.740 | 1e-103 | |
| Q9JI10 | 497 | Serine/threonine-protein | yes | N/A | 0.820 | 0.414 | 0.732 | 1e-103 | |
| O54748 | 491 | Serine/threonine-protein | no | N/A | 0.820 | 0.419 | 0.732 | 1e-102 | |
| Q802A6 | 491 | Serine/threonine-protein | N/A | N/A | 0.820 | 0.419 | 0.723 | 1e-102 | |
| Q9JI11 | 487 | Serine/threonine-protein | no | N/A | 0.820 | 0.422 | 0.728 | 1e-102 | |
| Q5E9L6 | 487 | Serine/threonine-protein | no | N/A | 0.820 | 0.422 | 0.728 | 1e-102 | |
| Q7ZUQ3 | 492 | Serine/threonine-protein | yes | N/A | 0.816 | 0.416 | 0.735 | 1e-102 | |
| Q13043 | 487 | Serine/threonine-protein | no | N/A | 0.820 | 0.422 | 0.728 | 1e-102 |
| >sp|Q8T0S6|HIPPO_DROME Serine/threonine-protein kinase hippo OS=Drosophila melanogaster GN=hpo PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 380 bits (975), Expect = e-105, Method: Compositional matrix adjust.
Identities = 181/239 (75%), Positives = 195/239 (81%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVV+YYGSYFK DLWI MEYCGAGSVSDIMRLRKKTL+EDEIATIL DTL+G
Sbjct: 89 MQQCDSPYVVRYYGSYFKQYDLWICMEYCGAGSVSDIMRLRKKTLTEDEIATILSDTLQG 148
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLHLRRKIHRDIKA NILLNTEG+A
Sbjct: 149 LVYLHLRRKIHRDIKAA---------------------------------NILLNTEGYA 175
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI+EIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 176 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDCVADIWSLGITALEMAEGKPP 235
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
YG+IHPMRAIFMIP KPPPSFREPD W+ EFIDFVS+CLVK P++RATA+E+L HEFI+
Sbjct: 236 YGEIHPMRAIFMIPQKPPPSFREPDRWSTEFIDFVSKCLVKEPDDRATATELLEHEFIR 294
|
Plays a key role in the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein Hippo (Hpo), in complex with its regulatory protein Salvador (Sav), phosphorylates and activates Warts (Wts) in complex with its regulatory protein Mats, which in turn phosphorylates and inactivates the Yorkie (Yki) oncoprotein. The Hippo/SWH signaling pathway inhibits the activity of the transcriptional complex formed by Scalloped (sd) and Yki and the target genes of this pathway include cyclin-E (cycE), diap1 and bantam. Phosphorylates Sav, Wts and Th/DIAP1. Regulates the level of Th/DIAP1 apoptosis inhibitor. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q13188|STK3_HUMAN Serine/threonine-protein kinase 3 OS=Homo sapiens GN=STK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 373 bits (957), Expect = e-103, Method: Compositional matrix adjust.
Identities = 176/239 (73%), Positives = 193/239 (80%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL EDEIATIL TLKG
Sbjct: 74 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLIEDEIATILKSTLKG 133
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 134 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 160
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGIT++EMAEGKPP
Sbjct: 161 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPP 220
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+RATA+++L H FI+
Sbjct: 221 YADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQRATATQLLQHPFIK 279
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6IP06|STK3_XENLA Serine/threonine-protein kinase 3 OS=Xenopus laevis GN=stk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (957), Expect = e-103, Method: Compositional matrix adjust.
Identities = 177/239 (74%), Positives = 193/239 (80%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDS YVVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 73 MQQCDSHYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILRSTLKG 132
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 133 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 159
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGIT++EMAEGKPP
Sbjct: 160 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPP 219
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++WT EF DFV +CLVKNPE+RATA+++L H FI+
Sbjct: 220 YADIHPMRAIFMIPTNPPPTFRKPELWTDEFTDFVKKCLVKNPEQRATATQLLQHPFIK 278
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein stk3/mst2 and stk4/mst1, in complex with its regulatory protein sav1, phosphorylates and activates lats1/2 in complex with its regulatory protein mob1, which in turn phosphorylates and inactivates yap1 oncoprotein and wwtr1/taz. Phosphorylation of yap1 by lats2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JI10|STK3_MOUSE Serine/threonine-protein kinase 3 OS=Mus musculus GN=Stk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (957), Expect = e-103, Method: Compositional matrix adjust.
Identities = 175/239 (73%), Positives = 194/239 (81%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 74 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILKSTLKG 133
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 134 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 160
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGIT++EMAEGKPP
Sbjct: 161 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPP 220
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVK+PE+RATA+++L H FI+
Sbjct: 221 YADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKSPEQRATATQLLQHPFIK 279
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1. Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus GN=Stk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (955), Expect = e-102, Method: Compositional matrix adjust.
Identities = 175/239 (73%), Positives = 194/239 (81%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 74 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILKSTLKG 133
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 134 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 160
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGIT++EMAEGKPP
Sbjct: 161 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPP 220
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVK+PE+RATA+++L H FI+
Sbjct: 221 YADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKSPEQRATATQLLQHPFIK 279
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates NKX2-1. Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q802A6|STK4_SQUAC Serine/threonine-protein kinase 3/4 OS=Squalus acanthias GN=STK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 173/239 (72%), Positives = 192/239 (80%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSD++R+R KTL+EDEIATIL TLKG
Sbjct: 79 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDLIRIRNKTLTEDEIATILQSTLKG 138
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLN EGHA
Sbjct: 139 LEYLHFMRKIHRDIKAG---------------------------------NILLNNEGHA 165
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGI+A+EMAEGKPP
Sbjct: 166 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGISAIEMAEGKPP 225
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++WT EF DFV +CLVKNPE+RA A+++L H FI+
Sbjct: 226 YADIHPMRAIFMIPTNPPPTFRKPELWTDEFTDFVKQCLVKNPEQRAAATQLLQHPFIK 284
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein stk3/mst2 and stk4/mst1, in complex with its regulatory protein sav1, phosphorylates and activates lats1/2 in complex with its regulatory protein mob1, which in turn phosphorylates and inactivates yap1 oncoprotein and wwtr1/taz. Phosphorylation of yap1 by lats2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Squalus acanthias (taxid: 7797) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JI11|STK4_MOUSE Serine/threonine-protein kinase 4 OS=Mus musculus GN=Stk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (953), Expect = e-102, Method: Compositional matrix adjust.
Identities = 174/239 (72%), Positives = 194/239 (81%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 77 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 137 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGITA+EMAEGKPP
Sbjct: 164 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 223
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ F+DFV +CLVK+PE+RATA+++L H F++
Sbjct: 224 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFMDFVKQCLVKSPEQRATATQLLQHPFVK 282
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5E9L6|STK4_BOVIN Serine/threonine-protein kinase 4 OS=Bos taurus GN=STK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (953), Expect = e-102, Method: Compositional matrix adjust.
Identities = 174/239 (72%), Positives = 194/239 (81%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 77 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 137 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGITA+EMAEGKPP
Sbjct: 164 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 223
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ F+DFV +CLVK+PE+RATA+++L H F++
Sbjct: 224 YADIHPMRAIFMIPTNPPPTFRKPELWSDSFMDFVKQCLVKSPEQRATATQLLQHPFVK 282
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7ZUQ3|STK3_DANRE Serine/threonine-protein kinase 3 OS=Danio rerio GN=stk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (953), Expect = e-102, Method: Compositional matrix adjust.
Identities = 175/238 (73%), Positives = 192/238 (80%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIAT+L TLKG
Sbjct: 73 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATVLKSTLKG 132
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 133 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 159
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGIT++EMAEGKPP
Sbjct: 160 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPP 219
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
Y DIHPMRAIFMIPT PPP+FR+P+ W+ +F DFV +CLVKNPE+RATA+++L H FI
Sbjct: 220 YADIHPMRAIFMIPTNPPPTFRKPEHWSDDFTDFVKKCLVKNPEQRATATQLLQHPFI 277
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein stk3/mst2 and stk4/mst1, in complex with its regulatory protein sav1, phosphorylates and activates lats1/2 in complex with its regulatory protein mob1, which in turn phosphorylates and inactivates yap1 oncoprotein and wwtr1/taz. Phosphorylation of yap1 by lats2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q13043|STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-102, Method: Compositional matrix adjust.
Identities = 174/239 (72%), Positives = 193/239 (80%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 77 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 137 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGITA+EMAEGKPP
Sbjct: 164 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 223
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y DIHPMRAIFMIPT PPP+FR+P++W+ F DFV +CLVK+PE+RATA+++L H F++
Sbjct: 224 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 282
|
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 251 | ||||||
| 345480521 | 528 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.388 | 0.827 | 1e-113 | |
| 156551419 | 521 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.393 | 0.827 | 1e-113 | |
| 328706800 | 541 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.378 | 0.823 | 1e-112 | |
| 328786401 | 521 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.393 | 0.823 | 1e-112 | |
| 350421067 | 521 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.393 | 0.823 | 1e-112 | |
| 340719762 | 521 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.393 | 0.823 | 1e-112 | |
| 170027953 | 615 | serine/threonine-protein kinase 3 [Culex | 0.820 | 0.334 | 0.807 | 1e-111 | |
| 332017045 | 529 | Serine/threonine-protein kinase 3 [Acrom | 0.816 | 0.387 | 0.819 | 1e-111 | |
| 383847106 | 521 | PREDICTED: serine/threonine-protein kina | 0.816 | 0.393 | 0.819 | 1e-111 | |
| 158295227 | 676 | AGAP006044-PA [Anopheles gambiae str. PE | 0.820 | 0.304 | 0.807 | 1e-111 |
| >gi|345480521|ref|XP_003424164.1| PREDICTED: serine/threonine-protein kinase hippo-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-113, Method: Compositional matrix adjust.
Identities = 197/238 (82%), Positives = 201/238 (84%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATILCDTLKG
Sbjct: 77 MQQCDSPFVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILCDTLKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 137 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 164 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 223
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATASE+LNHEFI
Sbjct: 224 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSVCLVKNPEERATASELLNHEFI 281
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156551419|ref|XP_001604121.1| PREDICTED: serine/threonine-protein kinase hippo-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-113, Method: Compositional matrix adjust.
Identities = 197/238 (82%), Positives = 201/238 (84%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATILCDTLKG
Sbjct: 70 MQQCDSPFVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILCDTLKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 130 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 157 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 216
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATASE+LNHEFI
Sbjct: 217 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSVCLVKNPEERATASELLNHEFI 274
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328706800|ref|XP_001950941.2| PREDICTED: serine/threonine-protein kinase hippo-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1055), Expect = e-112, Method: Compositional matrix adjust.
Identities = 196/238 (82%), Positives = 203/238 (85%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL DTLKG
Sbjct: 91 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILSDTLKG 150
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN+EGHA
Sbjct: 151 LEYLHLRRKIHRDIKAG---------------------------------NILLNSEGHA 177
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP
Sbjct: 178 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 237
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS+CL+KNPEERATA++ML+HEFI
Sbjct: 238 YGDIHPMRAIFMIPTKPPPSFREPDKWSPEFIDFVSQCLIKNPEERATATKMLDHEFI 295
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328786401|ref|XP_393691.4| PREDICTED: serine/threonine-protein kinase 3-like isoform 1 [Apis mellifera] gi|380027210|ref|XP_003697322.1| PREDICTED: serine/threonine-protein kinase 3-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-112, Method: Compositional matrix adjust.
Identities = 196/238 (82%), Positives = 200/238 (84%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATIL DTLKG
Sbjct: 70 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILSDTLKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 130 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 157 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 216
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATA+E+LNHEFI
Sbjct: 217 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSGCLVKNPEERATATELLNHEFI 274
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350421067|ref|XP_003492721.1| PREDICTED: serine/threonine-protein kinase 3-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-112, Method: Compositional matrix adjust.
Identities = 196/238 (82%), Positives = 200/238 (84%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATIL DTLKG
Sbjct: 70 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILSDTLKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 130 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 157 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 216
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATA+E+LNHEFI
Sbjct: 217 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSGCLVKNPEERATATELLNHEFI 274
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340719762|ref|XP_003398316.1| PREDICTED: serine/threonine-protein kinase 3-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-112, Method: Compositional matrix adjust.
Identities = 196/238 (82%), Positives = 200/238 (84%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATIL DTLKG
Sbjct: 70 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILSDTLKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 130 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 157 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 216
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATA+E+LNHEFI
Sbjct: 217 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSGCLVKNPEERATATELLNHEFI 274
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170027953|ref|XP_001841861.1| serine/threonine-protein kinase 3 [Culex quinquefasciatus] gi|167868331|gb|EDS31714.1| serine/threonine-protein kinase 3 [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 193/239 (80%), Positives = 203/239 (84%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL DTLKG
Sbjct: 67 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILIDTLKG 126
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN+EGHA
Sbjct: 127 LEYLHLRRKIHRDIKAG---------------------------------NILLNSEGHA 153
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI+EIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 154 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDCVADIWSLGITALEMAEGKPP 213
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
YGDIHPMRAIFMIPTKPPPSFR+PD+W+PEFIDFVS CLVKNPEERATA+++L HEFI+
Sbjct: 214 YGDIHPMRAIFMIPTKPPPSFRDPDIWSPEFIDFVSLCLVKNPEERATATDLLTHEFIR 272
|
Source: Culex quinquefasciatus Species: Culex quinquefasciatus Genus: Culex Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332017045|gb|EGI57844.1| Serine/threonine-protein kinase 3 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/238 (81%), Positives = 199/238 (83%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATIL DTLKG
Sbjct: 77 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILSDTLKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 137 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 164 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 223
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+PEFIDFVS CLVKNPEERATA+E+L HEFI
Sbjct: 224 YGDIHPMRAIFMIPTKPPPSFREPDQWSPEFIDFVSGCLVKNPEERATATELLQHEFI 281
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383847106|ref|XP_003699196.1| PREDICTED: serine/threonine-protein kinase 3-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1045), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/238 (81%), Positives = 199/238 (83%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL EDEIATIL DTLKG
Sbjct: 70 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLQEDEIATILSDTLKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN EGHA
Sbjct: 130 LEYLHLRRKIHRDIKAG---------------------------------NILLNNEGHA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 157 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADIWSLGITALEMAEGKPP 216
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
YGDIHPMRAIFMIPTKPPPSFREPD W+ EFIDFVS CLVKNPEERATA+E+LNHEFI
Sbjct: 217 YGDIHPMRAIFMIPTKPPPSFREPDQWSSEFIDFVSGCLVKNPEERATATELLNHEFI 274
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|158295227|ref|XP_316092.4| AGAP006044-PA [Anopheles gambiae str. PEST] gi|157015934|gb|EAA11663.5| AGAP006044-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1044), Expect = e-111, Method: Compositional matrix adjust.
Identities = 193/239 (80%), Positives = 203/239 (84%), Gaps = 33/239 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL DTLKG
Sbjct: 78 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILIDTLKG 137
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHLRRKIHRDIKAG NILLN+EGHA
Sbjct: 138 LEYLHLRRKIHRDIKAG---------------------------------NILLNSEGHA 164
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI+EIGYDCVAD+WSLGITALEMAEGKPP
Sbjct: 165 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDCVADIWSLGITALEMAEGKPP 224
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
YGDIHPMRAIFMIPTKPPPSFR+PD+W+PEFIDFVS CLVKNPEERATA+++L HEFI+
Sbjct: 225 YGDIHPMRAIFMIPTKPPPSFRDPDIWSPEFIDFVSLCLVKNPEERATATDLLAHEFIR 283
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 251 | ||||||
| UNIPROTKB|F1P2Z4 | 379 | STK3 "Uncharacterized protein" | 0.529 | 0.350 | 0.827 | 6.8e-98 | |
| UNIPROTKB|A0JN96 | 491 | STK3 "Serine/threonine kinase | 0.529 | 0.270 | 0.819 | 1.4e-97 | |
| UNIPROTKB|E2QTV3 | 380 | STK3 "Uncharacterized protein" | 0.529 | 0.35 | 0.819 | 1.4e-97 | |
| UNIPROTKB|F6URD2 | 491 | STK3 "Uncharacterized protein" | 0.529 | 0.270 | 0.819 | 1.4e-97 | |
| UNIPROTKB|Q6IP06 | 493 | stk3 "Serine/threonine-protein | 0.529 | 0.269 | 0.834 | 2.3e-97 | |
| UNIPROTKB|B3KYA7 | 519 | STK3 "Serine/threonine-protein | 0.529 | 0.256 | 0.819 | 2.9e-97 | |
| UNIPROTKB|Q13188 | 491 | STK3 "Serine/threonine-protein | 0.529 | 0.270 | 0.819 | 2.9e-97 | |
| MGI|MGI:1928487 | 497 | Stk3 "serine/threonine kinase | 0.529 | 0.267 | 0.812 | 4.7e-97 | |
| RGD|68412 | 491 | Stk3 "serine/threonine kinase | 0.529 | 0.270 | 0.812 | 4.7e-97 | |
| UNIPROTKB|O54748 | 491 | Stk3 "Serine/threonine-protein | 0.529 | 0.270 | 0.812 | 4.7e-97 |
| UNIPROTKB|F1P2Z4 STK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 6.8e-98, Sum P(2) = 6.8e-98
Identities = 110/133 (82%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 146 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 205
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ EF DFV +CLVKNPE+R
Sbjct: 206 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDEFTDFVKKCLVKNPEQR 265
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 266 ATATQLLQHTFIK 278
|
|
| UNIPROTKB|A0JN96 STK3 "Serine/threonine kinase 3 (STE20 homolog, yeast)" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 1.4e-97, Sum P(2) = 1.4e-97
Identities = 109/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
| UNIPROTKB|E2QTV3 STK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 1.4e-97, Sum P(2) = 1.4e-97
Identities = 109/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 74 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 133
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+R
Sbjct: 134 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQR 193
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 194 ATATQLLQHPFIK 206
|
|
| UNIPROTKB|F6URD2 STK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 1.4e-97, Sum P(2) = 1.4e-97
Identities = 109/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
| UNIPROTKB|Q6IP06 stk3 "Serine/threonine-protein kinase 3" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 2.3e-97, Sum P(2) = 2.3e-97
Identities = 111/133 (83%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 146 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 205
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++WT EF DFV +CLVKNPE+R
Sbjct: 206 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWTDEFTDFVKKCLVKNPEQR 265
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 266 ATATQLLQHPFIK 278
|
|
| UNIPROTKB|B3KYA7 STK3 "Serine/threonine-protein kinase 3 36kDa subunit" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 109/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 175 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 234
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+R
Sbjct: 235 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQR 294
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 295 ATATQLLQHPFIK 307
|
|
| UNIPROTKB|Q13188 STK3 "Serine/threonine-protein kinase 3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 109/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVKNPE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKNPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
| MGI|MGI:1928487 Stk3 "serine/threonine kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 4.7e-97, Sum P(2) = 4.7e-97
Identities = 108/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVK+PE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKSPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
| RGD|68412 Stk3 "serine/threonine kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 4.7e-97, Sum P(2) = 4.7e-97
Identities = 108/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVK+PE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKSPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
| UNIPROTKB|O54748 Stk3 "Serine/threonine-protein kinase 3" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 4.7e-97, Sum P(2) = 4.7e-97
Identities = 108/133 (81%), Positives = 126/133 (94%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WS
Sbjct: 147 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 206
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
LGIT++EMAEGKPPY DIHPMRAIFMIPT PPP+FR+P++W+ +F DFV +CLVK+PE+R
Sbjct: 207 LGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDDFTDFVKKCLVKSPEQR 266
Query: 227 ATASEMLNHEFIQ 239
ATA+++L H FI+
Sbjct: 267 ATATQLLQHPFIK 279
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q7ZUQ3 | STK3_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7352 | 0.8167 | 0.4166 | yes | N/A |
| Q9NB31 | CST1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6652 | 0.8207 | 0.4144 | yes | N/A |
| Q8T0S6 | HIPPO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7573 | 0.8207 | 0.3079 | yes | N/A |
| Q13188 | STK3_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7364 | 0.8207 | 0.4195 | yes | N/A |
| O61125 | STK4_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.5578 | 0.8247 | 0.4490 | yes | N/A |
| Q9JI10 | STK3_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7322 | 0.8207 | 0.4144 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 251 | |||
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-148 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-115 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-113 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-110 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-94 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-93 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-84 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-83 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-82 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-81 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-79 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-79 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-73 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-70 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-70 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-68 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-67 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-65 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-65 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-65 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-65 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-65 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-62 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-62 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-61 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-61 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-60 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-55 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-54 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-54 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-54 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-54 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-53 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-51 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-51 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-51 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-48 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-48 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-47 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-47 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-45 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-43 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-42 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-39 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-39 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-39 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-39 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-38 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-38 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-37 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-35 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-30 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-30 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-16 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 414 bits (1067), Expect = e-148
Identities = 162/238 (68%), Positives = 183/238 (76%), Gaps = 33/238 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++QCDSPY+VKYYGSYFKNTDLWIVMEYCGAGSVSDIM++ KTL+E+EIA IL TLKG
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH +KIHRDI KAGNILLN EG A
Sbjct: 112 LEYLHSNKKIHRDI---------------------------------KAGNILLNEEGQA 138
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGV+GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+ AD+WSLGITA+EMAEGKPP
Sbjct: 139 KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
Y DIHPMRAIFMIP KPPP+ +P+ W+PEF DFV +CLVK+PEER +A ++L H FI
Sbjct: 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 331 bits (850), Expect = e-115
Identities = 124/242 (51%), Positives = 156/242 (64%), Gaps = 36/242 (14%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLE 62
QC SPY+ KYYGS+ K + LWI+MEYCG GS D+++ K L E IA IL + L GLE
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLE 112
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
YLH KIHRDIKA NILL+ EG KL
Sbjct: 113 YLHEEGKIHRDIKAA---------------------------------NILLSEEGDVKL 139
Query: 123 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYG 182
ADFGV+GQLT TM+KRNT +GTPFWMAPEVI++ GYD AD+WSLGITA+E+A+G+PP
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199
Query: 183 DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242
D+HPMR +F+IP PPS E + ++ F DFVS CL K+P+ER +A E+L H+FI++
Sbjct: 200 DLHPMRVLFLIPKNNPPSL-EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258
Query: 243 TD 244
Sbjct: 259 KT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 323 bits (831), Expect = e-113
Identities = 114/237 (48%), Positives = 151/237 (63%), Gaps = 34/237 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++C P +VKYYGSY K +LWIVME+C GS+ D+++ +TL+E +IA + + LKG
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH IHRDIKA NILL ++G
Sbjct: 111 LEYLHSNGIIHRDIKAA---------------------------------NILLTSDGEV 137
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG++ QL+DT A RNT++GTP+WMAPEVI YD AD+WSLGITA+E+AEGKPP
Sbjct: 138 KLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
Y ++ PM+A+F I T PP R P+ W+ EF DF+ +CL KNPE+R TA ++L H F
Sbjct: 197 YSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-110
Identities = 110/242 (45%), Positives = 148/242 (61%), Gaps = 38/242 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++C P +V Y+GSY + LWIVMEYCG GS+ DI ++ + LSE +IA + +TLKG
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH KIHRDIK NILL +G
Sbjct: 114 LAYLHETGKIHRDIKGA---------------------------------NILLTEDGDV 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE---IGYDCVADMWSLGITALEMAEG 177
KLADFGV+ QLT T+AKR + IGTP+WMAPEV GYD D+W+LGITA+E+AE
Sbjct: 141 KLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200
Query: 178 KPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+PP D+HPMRA+F+I PPP ++ + W+P F DF+ +CL K+P++R TA+++L H
Sbjct: 201 QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260
Query: 236 EF 237
F
Sbjct: 261 PF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 278 bits (713), Expect = 2e-94
Identities = 106/243 (43%), Positives = 147/243 (60%), Gaps = 33/243 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ C P +V YY SY +LW+VMEY GS++DI+ ++E +IA + + L+G
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH + IHRDIK+ D NILL+ +G
Sbjct: 129 LEYLHSQNVIHRDIKS----------D-----------------------NILLSKDGSV 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFG A QLT +KRN+V+GTP+WMAPEVI+ Y D+WSLGI +EMAEG+PP
Sbjct: 156 KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
Y P+RA+F+I TK P + P+ W+PEF DF+++CLVK+PE+R +A E+L H F+++
Sbjct: 216 YLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
Query: 241 HDT 243
Sbjct: 276 ACP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 3e-93
Identities = 108/249 (43%), Positives = 143/249 (57%), Gaps = 47/249 (18%)
Query: 4 CDSPYVVKYYGSYFKNTD------LWIVMEYCGAGSVSDI---MRLRKKTLSEDEIATIL 54
+ P + +YG++ K LW+VME CG GSV+D+ +R + K L E+ IA IL
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
+TL+GL YLH + IHRDIK NILL
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQ---------------------------------NILL 146
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGI 169
KL DFGV+ QL T+ +RNT IGTP+WMAPEVI + YD +D+WSLGI
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
Query: 170 TALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229
TA+E+A+GKPP D+HPMRA+F IP PPP+ + P+ W+ +F DF+S CL+KN E+R
Sbjct: 207 TAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM 266
Query: 230 SEMLNHEFI 238
E+L H FI
Sbjct: 267 EELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 4e-84
Identities = 123/246 (50%), Positives = 153/246 (62%), Gaps = 37/246 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ QCDSPY+ +YYGSY K T LWI+MEY G GS D+ L+ L E IATIL + LKG
Sbjct: 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDL--LKPGPLEETYIATILREILKG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+YLH RKIHRDIKA N+LL+ +G
Sbjct: 114 LDYLHSERKIHRDIKAA---------------------------------NVLLSEQGDV 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDT KRNT +GTPFWMAPEVI++ YD AD+WSLGITA+E+A+G+PP
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
D+HPMR +F+IP PP+ ++ F +FV CL K+P R TA E+L H+FI R
Sbjct: 201 NSDLHPMRVLFLIPKNSPPTLEGQ--YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258
Query: 241 HDTDPS 246
+ S
Sbjct: 259 YTKKTS 264
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 3e-83
Identities = 121/241 (50%), Positives = 152/241 (63%), Gaps = 37/241 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ QCDSPYV KYYGSY K T LWI+MEY G GS D+ LR E +IAT+L + LKG
Sbjct: 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDL--LRAGPFDEFQIATMLKEILKG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+YLH +KIHRDIKA N+LL+ +G
Sbjct: 114 LDYLHSEKKIHRDIKAA---------------------------------NVLLSEQGDV 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDT KRNT +GTPFWMAPEVIQ+ YD AD+WSLGITA+E+A+G+PP
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
D+HPMR +F+IP PP+ ++ F +F+ CL K+P R TA E+L H+FI +
Sbjct: 201 NSDMHPMRVLFLIPKNNPPTLTGE--FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258
Query: 241 H 241
+
Sbjct: 259 N 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 3e-82
Identities = 86/239 (35%), Positives = 119/239 (49%), Gaps = 36/239 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ P +V+ Y + L++VMEYC G + D+++ ++ LSEDE L L
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSA 109
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH + +HRD LK NILL+ +GH
Sbjct: 110 LEYLHSKGIVHRD---------------------------------LKPENILLDEDGHV 136
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFG+A QL K T +GTP +MAPEV+ GY D+WSLG+ E+ GKPP
Sbjct: 137 KLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
Query: 181 YGDIHPMRAIFMIPTKPPPSFREP-DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ + +F KP P F P +PE D + + LVK+PE+R TA E L H F
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 3e-81
Identities = 92/244 (37%), Positives = 136/244 (55%), Gaps = 38/244 (15%)
Query: 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEY 63
C P +V Y +YF LWI++E+C G++ IM ++ L+E +I + L+ L +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
LH + IHRD LKAGNILL +G KLA
Sbjct: 119 LHSHKVIHRD---------------------------------LKAGNILLTLDGDVKLA 145
Query: 124 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYDCVADMWSLGITALEMAEGK 178
DFGV+ + T+ KR+T IGTP+WMAPEV+ ++ YD AD+WSLGIT +E+A+ +
Sbjct: 146 DFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
PP+ +++PMR + I PP+ +P W+ F DF+ CLVK+P++R TA+E+L H F+
Sbjct: 206 PPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
Query: 239 QRHD 242
Sbjct: 266 SDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 1e-79
Identities = 100/248 (40%), Positives = 132/248 (53%), Gaps = 43/248 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR--LRKKTLSEDEIATILCDTL 58
M QC+ P VVKYY S+ +LW+VM Y GS+ DIM+ + L E IAT+L + L
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KGLEYLH +IHRDIKAG NILL +G
Sbjct: 113 KGLEYLHSNGQIHRDIKAG---------------------------------NILLGEDG 139
Query: 119 HAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALE 173
K+ADFGV+ L D R T +GTP WMAPEV++++ GYD AD+WS GITA+E
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSF---REPDVWTPEFIDFVSRCLVKNPEERATAS 230
+A G PY PM+ + + PPS + ++ F +S CL K+P +R TA
Sbjct: 200 LATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE 259
Query: 231 EMLNHEFI 238
E+L H+F
Sbjct: 260 ELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 7e-79
Identities = 120/241 (49%), Positives = 150/241 (62%), Gaps = 37/241 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ QCDSPYV KYYGSY K+T LWI+MEY G GS D+ L L E +IATIL + LKG
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+YLH +KIHRDIKA N+LL+ G
Sbjct: 114 LDYLHSEKKIHRDIKAA---------------------------------NVLLSEHGEV 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDT KRNT +GTPFWMAPEVI++ YD AD+WSLGITA+E+A+G+PP
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
+ ++HPM+ +F+IP PP+ ++ +FV CL K P R TA E+L H+FI R
Sbjct: 201 HSELHPMKVLFLIPKNNPPTLEGN--YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258
Query: 241 H 241
Sbjct: 259 F 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 6e-73
Identities = 110/247 (44%), Positives = 147/247 (59%), Gaps = 46/247 (18%)
Query: 5 DSPYVVKYYGSYFK----NTD-LWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCD 56
D P VVK+YG Y+K N D LW+V+E C GSV+D+++ R + + E IA IL +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
L GL++LH+ + IHRD+K NILL T
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGN---------------------------------NILLTT 159
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITA 171
EG KL DFGV+ QLT T +RNT +GTPFWMAPEVI + YD D+WSLGITA
Sbjct: 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219
Query: 172 LEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
+E+ +G PP D+HPMRA+F IP PPP+ +P++W+ EF DF+ +CL K+ E+R T S+
Sbjct: 220 IELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279
Query: 232 MLNHEFI 238
+L H FI
Sbjct: 280 LLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-70
Identities = 97/247 (39%), Positives = 132/247 (53%), Gaps = 37/247 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q P + KYYGSY K LWI+MEY GSV +M+ ++E I+ I+ + L
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVA 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+Y+H IHRDIKA NIL+ G+
Sbjct: 114 LKYIHKVGVIHRDIKAA---------------------------------NILVTNTGNV 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKP 179
KL DFGVA L +KR+T +GTP+WMAPEVI E YD AD+WSLGIT EMA G P
Sbjct: 141 KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
PY D+ RA+ +IP PP E + ++ +FV+ CL + P+ER +A E+L ++I+
Sbjct: 201 PYSDVDAFRAMMLIPKSKPPRL-EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259
Query: 240 RHDTDPS 246
H P
Sbjct: 260 AHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 9e-70
Identities = 86/232 (37%), Positives = 120/232 (51%), Gaps = 36/232 (15%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P +VKY GS + L+I++EY GS+ I++ + E +A + L+GL YLH
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+ IHRDI KA NIL +G KLADFG
Sbjct: 118 QGVIHRDI---------------------------------KAANILTTKDGVVKLADFG 144
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP 186
VA +L D +V+GTP+WMAPEVI+ G +D+WSLG T +E+ G PPY D++P
Sbjct: 145 VATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204
Query: 187 MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
M A+F I P P+ +PE DF+ +C K+P R TA ++L H +I
Sbjct: 205 MAALFRIVQDDHPPL--PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 9e-68
Identities = 96/243 (39%), Positives = 128/243 (52%), Gaps = 42/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+QQ P ++Y G Y + W+VMEYC GS SDI+ + KK L E EIA I L+G
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH +IHRDIKAG NILL G
Sbjct: 128 LAYLHSHERIHRDIKAG---------------------------------NILLTEPGTV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KLADFG A ++ N+ +GTP+WMAPEVI E YD D+WSLGIT +E+AE
Sbjct: 155 KLADFGSAS----LVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + W+ F +FV CL K P++R ++ E+L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269
Query: 238 IQR 240
+ R
Sbjct: 270 VLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-67
Identities = 84/238 (35%), Positives = 131/238 (55%), Gaps = 35/238 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ P +V+ Y SY +LW+VME+ G+++DI + ++E++IAT+ LK
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLAVLKA 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L +LH + IHRDIK+ S ILL ++G
Sbjct: 128 LSFLHAQGVIHRDIKSDS---------------------------------ILLTSDGRV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL+DFG Q++ + +R +++GTP+WMAPEVI + Y D+WSLGI +EM +G+PP
Sbjct: 155 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
Y + P++A+ I PP + +P F+ R LV++P +RATA+E+LNH F+
Sbjct: 215 YFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 2e-65
Identities = 92/250 (36%), Positives = 138/250 (55%), Gaps = 46/250 (18%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
+C+SPY+V +YG+++ N D+ I MEY GS+ I++ + + E + I LKGL
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113
Query: 62 EYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
YLH + KI HRD+K NIL+N+ G
Sbjct: 114 TYLHEKHKIIHRDVKPS---------------------------------NILVNSRGQI 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFGV+GQL +++AK T +GT +MAPE IQ Y +D+WSLG++ +E+A G+ P
Sbjct: 141 KLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
Query: 181 YG--DIHPMRAIF----MIPTKPPPSFREP-DVWTPEFIDFVSRCLVKNPEERATASEML 233
Y + P IF I +PPP R P ++P+F DFV+ CL+K+P ER + E+L
Sbjct: 199 YPPENDPPD-GIFELLQYIVNEPPP--RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255
Query: 234 NHEFIQRHDT 243
H FI+++++
Sbjct: 256 EHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 2e-65
Identities = 86/245 (35%), Positives = 124/245 (50%), Gaps = 44/245 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
+ P +V+YYGS L I +EY GS+S +++ + L E I L
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQIL 111
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+GL YLH +HRDIK NIL++++G
Sbjct: 112 EGLAYLHSNGIVHRDIKGA---------------------------------NILVDSDG 138
Query: 119 HAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
KLADFG A +L +T +V GTP+WMAPEVI+ Y AD+WSLG T +EMA
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198
Query: 177 GKPPYGDIH-PMRAIFMI--PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
GKPP+ ++ PM A++ I +PP P+ + E DF+ +CL ++P++R TA E+L
Sbjct: 199 GKPPWSELGNPMAALYKIGSSGEPPEI---PEHLSEEAKDFLRKCLRRDPKKRPTADELL 255
Query: 234 NHEFI 238
H F+
Sbjct: 256 QHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 2e-65
Identities = 104/242 (42%), Positives = 137/242 (56%), Gaps = 46/242 (19%)
Query: 9 VVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGL 61
+ YYG++ K + LW+VME+CGAGSV+D+++ K L ED IA I + L+GL
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+LH + IHRDIK N+LL K
Sbjct: 135 AHLHAHKVIHRDIKGQ---------------------------------NVLLTENAEVK 161
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITALEMAE 176
L DFGV+ QL T+ +RNT IGTP+WMAPEVI + YD +D+WSLGITA+EMAE
Sbjct: 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
G PP D+HPMRA+F+IP PPP + W+ +FIDF+ CLVKN R + ++L H
Sbjct: 222 GAPPLCDMHPMRALFLIPRNPPPKLKSKK-WSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280
Query: 237 FI 238
FI
Sbjct: 281 FI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 5e-65
Identities = 101/242 (41%), Positives = 140/242 (57%), Gaps = 39/242 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ C +V Y+GSY + LWI ME+CG GS+ DI + LSE +IA + +TL+G
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + K+HRDIK NILL GH
Sbjct: 119 LYYLHSKGKMHRDIKGA---------------------------------NILLTDNGHV 145
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KLADFGV+ Q+T T+AKR + IGTP+WMAPEV ++ GY+ + D+W++GITA+E+AE
Sbjct: 146 KLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205
Query: 178 KPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+PP D+HPMRA+F++ PP ++ W+ F FV L KNP++R TA ++L H
Sbjct: 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
Query: 236 EF 237
F
Sbjct: 266 PF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 7e-65
Identities = 99/248 (39%), Positives = 138/248 (55%), Gaps = 46/248 (18%)
Query: 5 DSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCD 56
+ P VVK+YG ++K LW+V+E C GSV+++++ + + L E I+ IL
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
L GL++LH R IHRD+K NILL T
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGN---------------------------------NILLTT 163
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITA 171
EG KL DFGV+ QLT T +RNT +GTPFWMAPEVI + YD D+WSLGITA
Sbjct: 164 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223
Query: 172 LEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
+E+ +G PP D+HP++ +F IP PPP+ P+ W F F+S+CL+K+ E R + +
Sbjct: 224 IELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283
Query: 232 MLNHEFIQ 239
+L H FI+
Sbjct: 284 LLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 7e-65
Identities = 100/242 (41%), Positives = 138/242 (57%), Gaps = 39/242 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++C +V Y+GSY LWI MEYCG GS+ DI + LSE +IA + +TL+G
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + K+HRDIK NILL G
Sbjct: 119 LAYLHSKGKMHRDIKGA---------------------------------NILLTDNGDV 145
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KLADFGVA ++T T+AKR + IGTP+WMAPEV + GY+ + D+W++GITA+E+AE
Sbjct: 146 KLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205
Query: 178 KPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+PP D+HPMRA+F++ PP ++ W+ F +FV L KNP++R TA +L H
Sbjct: 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
Query: 236 EF 237
F
Sbjct: 266 LF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 9e-65
Identities = 91/248 (36%), Positives = 138/248 (55%), Gaps = 45/248 (18%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
+ C+SPYVVK YG+++K ++ IV+EY GS++D+++ + + E +A I LKGL
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQILKGL 112
Query: 62 EYLHLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+YLH +R IHRDI K N+L+N++G
Sbjct: 113 DYLHTKRHIIHRDI---------------------------------KPSNLLINSKGEV 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ADFG++ L +T+ + NT +GT +M+PE IQ Y AD+WSLG+T LE A GK P
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
Query: 181 Y------GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
+ M+AI P P + ++PEF DF+S CL K+P++R +A+E+L
Sbjct: 200 FLPPGQPSFFELMQAICDGPPPSLP----AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
Query: 235 HEFIQRHD 242
H FI++ D
Sbjct: 256 HPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-62
Identities = 76/243 (31%), Positives = 114/243 (46%), Gaps = 39/243 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ P +V+ ++ L++VMEYC G + D + R LSEDE I L+G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRG 110
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH IHRD LK NILL+ G
Sbjct: 111 LEYLHSNGIIHRD---------------------------------LKPENILLDENGVV 137
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKP 179
K+ADFG+A +L + + T +GTP++MAPEV+ GY D+WSLG+ E+ GKP
Sbjct: 138 KIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
Query: 180 PYGDIHPMRAIFMI----PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
P+ + + + +I + + E D + +CL K+P +R TA E+L H
Sbjct: 198 PFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
Query: 236 EFI 238
+
Sbjct: 258 PWF 260
|
Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-62
Identities = 91/249 (36%), Positives = 141/249 (56%), Gaps = 38/249 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ C+ PY+VK G+++ + LWI++E+C G+V IM + L+E +I I L+
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+YLH + IHRD LKAGN+LL +G
Sbjct: 123 LQYLHSMKIIHRD---------------------------------LKAGNVLLTLDGDI 149
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYDCVADMWSLGITALEMA 175
KLADFGV+ + T+ +R++ IGTP+WMAPEV+ ++ YD AD+WSLGIT +EMA
Sbjct: 150 KLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ +PP+ +++PMR + I PP+ +P W+ EF DF+ L K+PE R +A+++L H
Sbjct: 210 QIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269
Query: 236 EFIQRHDTD 244
F+ ++
Sbjct: 270 PFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 5e-61
Identities = 91/250 (36%), Positives = 140/250 (56%), Gaps = 38/250 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ CD P +VK +++ +LWI++E+C G+V +M ++ L+E +I + TL+
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + IHRD LKAGNIL +G
Sbjct: 116 LNYLHENKIIHRD---------------------------------LKAGNILFTLDGDI 142
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYDCVADMWSLGITALEMA 175
KLADFGV+ + T T+ +R++ IGTP+WMAPEV+ ++ YD AD+WSLGIT +EMA
Sbjct: 143 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ +PP+ +++PMR + I PP+ +P W+ EF DF+ +CL KN + R T +++L H
Sbjct: 203 QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262
Query: 236 EFIQRHDTDP 245
F+ + P
Sbjct: 263 PFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 6e-61
Identities = 101/242 (41%), Positives = 136/242 (56%), Gaps = 46/242 (19%)
Query: 9 VVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGL 61
+ YYG++ K + LW+VME+CGAGSV+D+++ K TL E+ IA I + L+GL
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+LH + IHRDIK N+LL K
Sbjct: 125 SHLHQHKVIHRDIKGQ---------------------------------NVLLTENAEVK 151
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITALEMAE 176
L DFGV+ QL T+ +RNT IGTP+WMAPEVI + YD +D+WSLGITA+EMAE
Sbjct: 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
G PP D+HPMRA+F+IP P P + W+ +F F+ CLVKN +R T +++ H
Sbjct: 212 GAPPLCDMHPMRALFLIPRNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270
Query: 237 FI 238
FI
Sbjct: 271 FI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 3e-60
Identities = 88/239 (36%), Positives = 134/239 (56%), Gaps = 35/239 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ P +V Y SY +LW+VMEY GS++D+ + + + E +IA + + L+
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQA 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH + IHRDIK+ NILL +G
Sbjct: 128 LEFLHSNQVIHRDIKSD---------------------------------NILLGMDGSV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y + +P+RA+++I T P + P+ + F DF++RCL + E+R +A E+L H F++
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-55
Identities = 85/239 (35%), Positives = 136/239 (56%), Gaps = 35/239 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ +P +V + S+ +L++VMEY GS++D+ + + + E +IA + + L+
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQA 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH + IHRDIK+ N+LL +G
Sbjct: 128 LEFLHANQVIHRDIKSD---------------------------------NVLLGMDGSV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y + +P+RA+++I T P + P+ +P F DF++RCL + E+R +A E+L H F++
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-54
Identities = 88/239 (36%), Positives = 136/239 (56%), Gaps = 35/239 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ +P +V Y SY +LW+VMEY GS++D+ + + + E +IA + + L+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQA 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH + IHRDIK+ NILL +G
Sbjct: 129 LEFLHSNQVIHRDIKSD---------------------------------NILLGMDGSV 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y + +P+RA+++I T P + P+ + F DF++RCL + E+R +A E+L H+F++
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-54
Identities = 98/243 (40%), Positives = 129/243 (53%), Gaps = 42/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+QQ P ++Y G Y K W+VMEYC GS SD++ + KK L E EIA I L+G
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH IHRDIKAG NILL G
Sbjct: 134 LAYLHSHNMIHRDIKAG---------------------------------NILLTEPGQV 160
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KLADFG A + + N+ +GTP+WMAPEVI E YD D+WSLGIT +E+AE
Sbjct: 161 KLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + + WT F FV CL K P+ER ++E+L H+F
Sbjct: 217 KPPLFNMNAMSALYHIAQNDSPTLQSNE-WTDSFRGFVDYCLQKIPQERPASAELLRHDF 275
Query: 238 IQR 240
++R
Sbjct: 276 VRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-54
Identities = 70/241 (29%), Positives = 113/241 (46%), Gaps = 38/241 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDT 57
+++ + P ++KYY S+ + L IVMEY G +S ++ +KK E++I
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+YLH R+ +HRDIK NI L +
Sbjct: 113 CLALKYLHSRKILHRDIKPQ---------------------------------NIFLTSN 139
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
G KL DFG++ L+ T+ TV+GTP++++PE+ Q Y+ +D+WSLG E+
Sbjct: 140 GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
K P+ + + I P P ++ E + VS L K+PEER + +++L F
Sbjct: 200 KHPFEGENLLELALKILKGQYPPI--PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257
Query: 238 I 238
I
Sbjct: 258 I 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-54
Identities = 86/242 (35%), Positives = 126/242 (52%), Gaps = 43/242 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + P +V+Y G+ + +L+I +E GS++ +++ + + E I L G
Sbjct: 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLG 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH R +HRDIK NIL++T G
Sbjct: 115 LEYLHDRNTVHRDIKGA---------------------------------NILVDTNGVV 141
Query: 121 KLADFGVAGQLTD-TMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGK 178
KLADFG+A Q+ + + AK + G+P+WMAPEVI Q+ GY AD+WSLG T LEMA GK
Sbjct: 142 KLADFGMAKQVVEFSFAK--SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
Query: 179 PPYGDIHPMRAIFMIPTKP--PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
PP+ + + A+F I PP PD + E DF+ +CL ++P R TA+E+L H
Sbjct: 200 PPWSQLEGVAAVFKIGRSKELPPI---PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256
Query: 237 FI 238
F+
Sbjct: 257 FV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 3e-54
Identities = 86/239 (35%), Positives = 134/239 (56%), Gaps = 35/239 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ +P +V Y SY +LW+VMEY GS++D+ + + + E +IA + + L+
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQA 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L++LH + IHRDIK+ NILL +G
Sbjct: 128 LDFLHSNQVIHRDIKSD---------------------------------NILLGMDGSV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 155 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
Y + +P+RA+++I T P + P+ + F DF++RCL + + R +A E+L H F++
Sbjct: 215 YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-53
Identities = 94/255 (36%), Positives = 129/255 (50%), Gaps = 55/255 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIM-RLRKKT--LSEDEIATILC 55
+ C SPY+VKYYG++ + + I MEYC GS+ I +++K+ + E + I
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
LKGL YLH R+ IHRDIK NILL
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPS---------------------------------NILLT 139
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+G KL DFGV+G+L +++A T GT F+MAPE IQ Y +D+WSLG+T LE+A
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA 197
Query: 176 --------EGKPPYGDIHPMRAIFMIPTKPPPSFR-EPDV---WTPEFIDFVSRCLVKNP 223
EG+PP G P+ + I P P + EP W+ EF DF+ +CL K+P
Sbjct: 198 QNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP 254
Query: 224 EERATASEMLNHEFI 238
R T +ML H +I
Sbjct: 255 TRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-53
Identities = 76/237 (32%), Positives = 109/237 (45%), Gaps = 69/237 (29%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ + P +VK YG + L++VMEYC GS+ D+++ + LSEDEI IL L+G
Sbjct: 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEG 104
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEGH 119
LEYLH IHRD+ K NILL + G
Sbjct: 105 LEYLHSNGIIHRDL---------------------------------KPENILLDSDNGK 131
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDCVADMWSLGITALEMAEGK 178
KLADFG++ LT + T++GTP +MAPEV+ G Y +D+WSLG+ E+
Sbjct: 132 VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---- 187
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PE D + + L K+PE+R +A E+L H
Sbjct: 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-51
Identities = 84/230 (36%), Positives = 126/230 (54%), Gaps = 35/230 (15%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68
VV+ Y SY +LW++ME+ G+++DI + + L+E++IAT+ L+ L YLH +
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDI--VSQTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA 128
IHRDIK+ S ILL +G KL+DFG
Sbjct: 138 VIHRDIKSDS---------------------------------ILLTLDGRVKLSDFGFC 164
Query: 129 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMR 188
Q++ + KR +++GTP+WMAPEVI Y D+WSLGI +EM +G+PPY P++
Sbjct: 165 AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224
Query: 189 AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
A+ + PPP + +P DF+ R L + P+ERATA E+L+H F+
Sbjct: 225 AMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-51
Identities = 93/243 (38%), Positives = 125/243 (51%), Gaps = 42/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ P ++Y G Y + W+VMEYC GS SD++ + KK L E EIA + L+G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH IHRD+KAG NILL+ G
Sbjct: 128 LAYLHSHNMIHRDVKAG---------------------------------NILLSEPGLV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KL DFG A MA N +GTP+WMAPEVI E YD D+WSLGIT +E+AE
Sbjct: 155 KLGDFGSA----SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + W+ F +FV CL K P++R T+ +L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
Query: 238 IQR 240
+ R
Sbjct: 270 VLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 6e-51
Identities = 95/243 (39%), Positives = 127/243 (52%), Gaps = 42/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ P ++Y G Y + W+VMEYC GS SD++ + KK L E EIA I L+G
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH IHRDIKAG NILL G
Sbjct: 138 LAYLHSHNMIHRDIKAG---------------------------------NILLTEPGQV 164
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KLADFG A + N+ +GTP+WMAPEVI E YD D+WSLGIT +E+AE
Sbjct: 165 KLADFGSASIASPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + + W+ F +FV CL K P++R T+ E+L H F
Sbjct: 221 KPPLFNMNAMSALYHIAQNESPTLQSNE-WSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
Query: 238 IQR 240
+ R
Sbjct: 280 VLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-48
Identities = 72/240 (30%), Positives = 111/240 (46%), Gaps = 40/240 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + + P++VK + ++ L++V+EY G + + ++ SE+ + +
Sbjct: 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAEIVLA 105
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH I+RD LK NILL+ +GH
Sbjct: 106 LEYLHSLGIIYRD---------------------------------LKPENILLDADGHI 132
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG+A +L+ ++ NT GTP ++APEV+ GY D WSLG+ EM GKPP
Sbjct: 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER---ATASEMLNHEF 237
+ + I+ K P F P+ +PE D +S L K+P +R A E+ H F
Sbjct: 193 F-YAEDRKEIYEKILKDPLRF--PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-48
Identities = 81/232 (34%), Positives = 127/232 (54%), Gaps = 35/232 (15%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68
VV+ Y SY +LW+VME+ G+++DI+ + ++E++IA + LK L LH +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQG 136
Query: 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA 128
IHRDIK+ S ILL +G KL+DFG
Sbjct: 137 VIHRDIKSDS---------------------------------ILLTHDGRVKLSDFGFC 163
Query: 129 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMR 188
Q++ + +R +++GTP+WMAPE+I + Y D+WSLGI +EM +G+PPY + P++
Sbjct: 164 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 189 AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
A+ MI PP + +P F+ R LV++P +RATA+E+L H F+ +
Sbjct: 224 AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 88/282 (31%), Positives = 136/282 (48%), Gaps = 76/282 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +C+SPY+V +YG+++ + ++ I ME+ GS+ +++ + + E+ + I L+G
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRG 111
Query: 61 LEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL + KI HRD+K NIL+N+ G
Sbjct: 112 LTYLREKHKIMHRDVKPS---------------------------------NILVNSRGE 138
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK- 178
KL DFGV+GQL D+MA N+ +GT +M+PE +Q Y +D+WSLG++ +EMA G+
Sbjct: 139 IKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY 196
Query: 179 --PP-----YGDIH-------------------------PMRAIF----MIPTKPPPSFR 202
PP + PM AIF I +PPP
Sbjct: 197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM-AIFELLDYIVNEPPPKL- 254
Query: 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244
++ EF DFV +CL KNP+ERA E+ H FI+R + +
Sbjct: 255 PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 7e-47
Identities = 81/231 (35%), Positives = 125/231 (54%), Gaps = 35/231 (15%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68
VV Y SY +LW+VME+ G+++DI+ + ++E++IAT+ L+ L YLH +
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQG 138
Query: 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA 128
IHRDIK+ S ILL ++G KL+DFG
Sbjct: 139 VIHRDIKSDS---------------------------------ILLTSDGRIKLSDFGFC 165
Query: 129 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMR 188
Q++ + KR +++GTP+WMAPEVI + Y D+WSLGI +EM +G+PPY + P++
Sbjct: 166 AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225
Query: 189 AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
A+ I PP ++ + F+ LV+ P +RATA E+L H F++
Sbjct: 226 AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-46
Identities = 85/253 (33%), Positives = 125/253 (49%), Gaps = 47/253 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDT 57
M+ D PY V +YG+ F+ D+WI ME S+ + + T+ ED + I
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 58 LKGLEYLHLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+K LEYLH + IHRD+ K N+L+N
Sbjct: 113 VKALEYLHSKLSVIHRDV---------------------------------KPSNVLINR 139
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVI----QEIGYDCVADMWSLGITA 171
G KL DFG++G L D++AK T+ G +MAPE I + GYD +D+WSLGIT
Sbjct: 140 NGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 172 LEMAEGKPPYGDIH-PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
+E+A G+ PY P + + + +P P + ++PEF DFV++CL KN +ER
Sbjct: 198 IELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA-EKFSPEFQDFVNKCLKKNYKERPNYP 256
Query: 231 EMLNHEFIQRHDT 243
E+L H F + H +
Sbjct: 257 ELLQHPFFELHLS 269
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-45
Identities = 82/246 (33%), Positives = 115/246 (46%), Gaps = 42/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P +VKYYG ++I MEYC G++ +++ + L E I L+G
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEG 111
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH +HRDIK NI L+ G
Sbjct: 112 LAYLHSHGIVHRDIKPA---------------------------------NIFLDHNGVI 138
Query: 121 KLADFGVAGQL---TDTMAKR-NTVIGTPFWMAPEVIQE---IGYDCVADMWSLGITALE 173
KL DFG A +L T TM + ++ GTP +MAPEVI G+ AD+WSLG LE
Sbjct: 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE 198
Query: 174 MAEGKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
MA GK P+ ++ I F + P + +PE DF+ RCL +P++R TASE+
Sbjct: 199 MATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
Query: 233 LNHEFI 238
L H F+
Sbjct: 259 LQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-43
Identities = 78/235 (33%), Positives = 114/235 (48%), Gaps = 38/235 (16%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+V+YYG + L I MEY GSV D ++ L+E L+G+EYLH
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS 122
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+HRDI K NIL ++ G+ KL DFG
Sbjct: 123 NMIVHRDI---------------------------------KGANILRDSAGNVKLGDFG 149
Query: 127 VAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183
+ +L + +V GTP+WM+PEVI GY AD+WS+G T +EM KPP+ +
Sbjct: 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
M AIF I T+ P + + P +P+ +F+ R V+N ++R +A E+L H F+
Sbjct: 210 FEAMAAIFKIATQ-PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 80/253 (31%), Positives = 124/253 (49%), Gaps = 52/253 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +C SPY+V +YG++ ++ + ME+ GS+ I + + + + + I ++G
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEG 115
Query: 61 LEYLH-LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL+ + R +HRDIK NIL+N+ G
Sbjct: 116 LTYLYNVHRIMHRDIKPS---------------------------------NILVNSRGQ 142
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
KL DFGV+G+L +++A +T +GT +M+PE IQ Y +D+WSLGI+ +E+A GK
Sbjct: 143 IKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200
Query: 180 PY--------GDIHPMRAIF----MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
P+ G PM I I +PPP D + + DFV CL+K+P ER
Sbjct: 201 PFAFSNIDDDGQDDPM-GILDLLQQIVQEPPPRLPSSD-FPEDLRDFVDACLLKDPTERP 258
Query: 228 TASEML-NHEFIQ 239
T ++ FIQ
Sbjct: 259 TPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 74/246 (30%), Positives = 113/246 (45%), Gaps = 43/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ D +V+Y G L I +EY GS+ +R + E + L+G
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEG 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + +HRD LKA N+L++ +G
Sbjct: 121 LAYLHSKGILHRD---------------------------------LKADNLLVDADGIC 147
Query: 121 KLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMAE 176
K++DFG++ + D + ++ G+ FWMAPEVI GY D+WSLG LEM
Sbjct: 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 177 GKPPYGDIHPMRAIFMIPTK---PP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
G+ P+ D + A+F + K PP P ++ +P +DF++ C NP+ R TA E+
Sbjct: 208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL-SPVALDFLNACFTINPDNRPTAREL 266
Query: 233 LNHEFI 238
L H FI
Sbjct: 267 LQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-39
Identities = 76/248 (30%), Positives = 126/248 (50%), Gaps = 50/248 (20%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLE 62
+CDSPY++ +YG++F + I E+ GS+ D+ R + E + I +KGL
Sbjct: 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYR----KIPEHVLGRIAVAVVKGLT 109
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
YL + +HRD+K N+L+NT G KL
Sbjct: 110 YLWSLKILHRDVKPS---------------------------------NMLVNTRGQVKL 136
Query: 123 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY- 181
DFGV+ QL +++AK T +GT +MAPE I Y +D+WSLGI+ +E+A G+ PY
Sbjct: 137 CDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194
Query: 182 ------GDIHPMRAIFMIPTKPPPSFREPD-VWTPEFIDFVSRCLVKNPEERATASEMLN 234
G + P++ + I + PP P ++ +F+ F+++C+ K P+ER +++
Sbjct: 195 QIQKNQGSLMPLQLLQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
Query: 235 HEFIQRHD 242
H FI +++
Sbjct: 253 HPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-39
Identities = 92/293 (31%), Positives = 140/293 (47%), Gaps = 90/293 (30%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM----RLRKKTLSEDEIATILCD 56
+ +C+SPY+V +YG+++ + ++ I ME+ GS+ ++ R+ ++ L + IA I
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI--- 113
Query: 57 TLKGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
KGL YL + KI HRD+K NIL+N
Sbjct: 114 --KGLTYLREKHKIMHRDVKPS---------------------------------NILVN 138
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+ G KL DFGV+GQL D+MA N+ +GT +M+PE +Q Y +D+WS+G++ +EMA
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196
Query: 176 EGK---PP------------------------------------YG-DIHPMRAIF---- 191
G+ PP YG D P AIF
Sbjct: 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLD 256
Query: 192 MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244
I +PPP V+ EF DFV++CL+KNP ERA +++ H FI+R + +
Sbjct: 257 YIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-39
Identities = 87/291 (29%), Positives = 141/291 (48%), Gaps = 84/291 (28%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +C+SPY+V +YG+++ + ++ I ME+ GS+ +++ K + E+ + + L+G
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRG 115
Query: 61 LEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL + +I HRD+K NIL+N+ G
Sbjct: 116 LAYLREKHQIMHRDVKPS---------------------------------NILVNSRGE 142
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK- 178
KL DFGV+GQL D+MA N+ +GT +M+PE +Q Y +D+WS+G++ +E+A G+
Sbjct: 143 IKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200
Query: 179 --PP---------YG------------------------------DIHPMRAIF----MI 193
PP +G D P AIF I
Sbjct: 201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260
Query: 194 PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244
+PPP V+TP+F +FV++CL+KNP ERA ++NH FI+R + +
Sbjct: 261 VNEPPPKLPN-GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-39
Identities = 78/248 (31%), Positives = 121/248 (48%), Gaps = 47/248 (18%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D PY+VK YG + ++D++I ME + + +++ + + ED + + +K L YL
Sbjct: 72 DCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 65 HLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
+ IHRD+K NILL+ G+ KL
Sbjct: 131 KEKHGVIHRDVKPS---------------------------------NILLDASGNVKLC 157
Query: 124 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVI----QEIGYDCVADMWSLGITALEMAEGKP 179
DFG++G+L D+ AK + G +MAPE I YD AD+WSLGI+ +E+A G+
Sbjct: 158 DFGISGRLVDSKAKTRSA-GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216
Query: 180 PYGDIHPMRAIFMIPTK----PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY + F + TK PPS + ++P+F FV CL K+ +R E+L H
Sbjct: 217 PY---KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273
Query: 236 EFIQRHDT 243
FI+R++T
Sbjct: 274 PFIRRYET 281
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 138 bits (347), Expect = 1e-38
Identities = 76/255 (29%), Positives = 110/255 (43%), Gaps = 55/255 (21%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--KKTLSEDEIATILCDTLKGLEYL 64
P +VK Y + L++VMEY GS+ D+++ K LSE E IL L LEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-AKLA 123
H + IHRDI K NILL+ +G KL
Sbjct: 118 HSKGIIHRDI---------------------------------KPENILLDRDGRVVKLI 144
Query: 124 DFGVAGQLTDTMAKR------NTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEM 174
DFG+A L D + +T +GTP +MAPEV+ + +D+WSLGIT E+
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
Query: 175 AEGKPPYGDIHPMRAIFMI----------PTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
G PP+ A P S P++ + D + + L K+P+
Sbjct: 205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264
Query: 225 ERATASEMLNHEFIQ 239
R ++S L+H+ +
Sbjct: 265 NRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-38
Identities = 78/238 (32%), Positives = 110/238 (46%), Gaps = 44/238 (18%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68
+V+Y G+ + + I ME+ GS+S I+ R L E L G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA 128
+HRDIK N++L G KL DFG A
Sbjct: 123 VVHRDIKGN---------------------------------NVMLMPNGIIKLIDFGCA 149
Query: 129 GQLT--------DTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
+L M K ++ GTP+WMAPEVI E GY +D+WS+G T EMA GKPP
Sbjct: 150 RRLAWVGLHGTHSNMLK--SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ + A+F I R PD ++ IDFV+ CL ++ ER +A ++L H+F+
Sbjct: 208 LASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 80/260 (30%), Positives = 123/260 (47%), Gaps = 54/260 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--RLRKKTLSEDEIATILCDTL 58
+ + SPY+V +YG++F +++ MEY AGS+ + + + + ED + I +
Sbjct: 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVV 112
Query: 59 KGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
KGL++L I HRD+K N+L+N
Sbjct: 113 KGLKFLKEEHNIIHRDVKPT---------------------------------NVLVNGN 139
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG------YDCVADMWSLGITA 171
G KL DFGV+G L ++AK N IG +MAPE I+ G Y +D+WSLG++
Sbjct: 140 GQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 172 LEMAEGKPPYGDIHPMRAIF----MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
LEMA G+ PY IF I PP+ P ++ + DFV++CL K P R
Sbjct: 198 LEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTL--PSGYSDDAQDFVAKCLNKIPNRRP 254
Query: 228 TASEMLNHEFI---QRHDTD 244
T +++L H ++ + D D
Sbjct: 255 TYAQLLEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-37
Identities = 82/257 (31%), Positives = 121/257 (47%), Gaps = 52/257 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL----RKKTLSEDEIATILCD 56
M+ D PY+VK+YG+ F+ D WI ME S+ + K + E+ + I
Sbjct: 57 MRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 57 TLKGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
T+K L YL KI HRD+K NILL+
Sbjct: 116 TVKALNYLKEELKIIHRDVKPS---------------------------------NILLD 142
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITAL 172
G+ KL DFG++GQL D++AK P+ MAPE I GYD +D+WSLGIT
Sbjct: 143 RNGNIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPSARDGYDVRSDVWSLGITLY 201
Query: 173 EMAEGKPPYGDIHPMRAIF----MIPTKPPPSFREPD--VWTPEFIDFVSRCLVKNPEER 226
E+A GK PY + +F + PP + ++P F++F++ CL+K+ +R
Sbjct: 202 EVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258
Query: 227 ATASEMLNHEFIQRHDT 243
E+L H FI+ ++
Sbjct: 259 PKYKELLEHPFIKDYEE 275
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-36
Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 42/244 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ +V+Y GS L I +EY GSV+ ++ E + + LKG
Sbjct: 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH R IHRDIK NIL++ +G
Sbjct: 119 LNYLHNRGIIHRDIKGA---------------------------------NILVDNKGGI 145
Query: 121 KLADFGVAGQL------TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
K++DFG++ +L T T R ++ G+ FWMAPEV+++ Y AD+WSLG +EM
Sbjct: 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
GK P+ D ++AIF I P P + E IDF+ + + +R TA+E+L
Sbjct: 206 LTGKHPFPDCTQLQAIFKIGENASPEI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
Query: 235 HEFI 238
H F+
Sbjct: 264 HPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-36
Identities = 77/249 (30%), Positives = 108/249 (43%), Gaps = 46/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ Q SPYVVK Y S+ +L++VMEY G ++ ++ +L ED + + +
Sbjct: 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLA 105
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH IHRD LK NIL+++ GH
Sbjct: 106 LEYLHSNGIIHRD---------------------------------LKPDNILIDSNGHL 132
Query: 121 KLADFGV--------AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
KL DFG+ L D + ++GTP ++APEVI G+ D WSLG
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192
Query: 173 EMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA--- 229
E G PP+ P IF + E + E ID +S+ LV +PE+R A
Sbjct: 193 EFLVGIPPFHGETPE-EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSI 251
Query: 230 SEMLNHEFI 238
E+ NH F
Sbjct: 252 EEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-35
Identities = 62/236 (26%), Positives = 114/236 (48%), Gaps = 40/236 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLK 59
+ + DS Y+++YY S+ L IVMEY G + ++++ R + L ED++ L
Sbjct: 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GL +LH ++ +HRDI K+ N+ L+ +
Sbjct: 113 GLAHLHSKKILHRDI---------------------------------KSLNLFLDAYDN 139
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
K+ D GVA L+D NT++GTP++++PE+ ++ Y+ +D+W+LG+ E GK
Sbjct: 140 VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH 199
Query: 180 PYGDIHPMRAIF--MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
P+ D + A+ +I PP +++ + + +CL K+ +R ++L
Sbjct: 200 PF-DANNQGALILKIIRGVFPPV---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-34
Identities = 57/214 (26%), Positives = 82/214 (38%), Gaps = 53/214 (24%)
Query: 32 GSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSI 91
S++DI+ +R + L+E+EI + L L LH + K
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAK---------------------- 38
Query: 92 KCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151
+GNILL +G KL G T + P++MAPE
Sbjct: 39 -----------------SGNILLTWDGLLKL--DGSVAFKTPEQS-----RPDPYFMAPE 74
Query: 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPE- 210
VIQ Y AD++SLGIT E + + PY + + AI I P+ D E
Sbjct: 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEG 134
Query: 211 ------FIDFVSRCLVKNPEERATASEMLNHEFI 238
F DF+ C + P+ R A+ L H
Sbjct: 135 VSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-34
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++C+ P++VK Y ++ ++++MEYC G + I+R R E + +
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLA 105
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
EYLH R I+RD LK N+LL++ G+
Sbjct: 106 FEYLHNRGIIYRD---------------------------------LKPENLLLDSNGYV 132
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG A +L K T GTP ++APE+I GYD D WSLGI E+ G+PP
Sbjct: 133 KLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
Query: 181 YG--DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
+G D PM I+ K P+ D + + L +NPEER
Sbjct: 192 FGEDDEDPME-IYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-34
Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 51/247 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDT 57
+Q+ + P++V + S+ ++++V++ G +R +K SE+++ +C+
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEI 109
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
+ LEYLH + IHRDIK NILL+ +
Sbjct: 110 VLALEYLHSKGIIHRDIKPD---------------------------------NILLDEQ 136
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
GH + DF +A ++T + GTP +MAPEV+ GY D WSLG+TA E G
Sbjct: 137 GHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
Query: 178 KPPYGDIHPMRAI----FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER--ATASE 231
K PY H T P W+ E ID +++ L ++P++R +
Sbjct: 196 KRPY-RGHSRTIRDQIRAKQETADVLY---PATWSTEAIDAINKLLERDPQKRLGDNLKD 251
Query: 232 MLNHEFI 238
+ NH +
Sbjct: 252 LKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 45/242 (18%)
Query: 7 PYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDTLKGL 61
P +V+YY N L+IVMEYC G ++ +++ KK + E+ I IL L L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 62 EYLHLRRK-----IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
H R +HRD+K NI L+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPA---------------------------------NIFLDA 145
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
+ KL DFG+A L + T +GTP++M+PE + + YD +D+WSLG E+
Sbjct: 146 NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
PP+ + ++ I R P ++ E + + L +P++R + E+L
Sbjct: 206 LSPPFTARNQLQLASKIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
Query: 237 FI 238
I
Sbjct: 264 LI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-32
Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 45/242 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---RLRKKTLSEDEIATILCDT 57
++Q D P V+KY S+ +N +L IV+E AG +S ++ + +K+ + E I
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
LE++H +R +HRDIK N+ +
Sbjct: 116 CSALEHMHSKRIMHRDIKPA---------------------------------NVFITAT 142
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
G KL D G+ + ++++GTP++M+PE I E GY+ +D+WSLG EMA
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 178 KPP-YGDIHPMRAIFMIPTK----PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
+ P YGD + ++ K P P+ D ++ E D VSRC+ +PE+R S +
Sbjct: 203 QSPFYGDKMNLYSLCKKIEKCDYPPLPA----DHYSEELRDLVSRCINPDPEKRPDISYV 258
Query: 233 LN 234
L
Sbjct: 259 LQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-32
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 44/235 (18%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDTLKGLE 62
P ++ Y ++ L IVMEY G +S + RKK + E EI I L+GL+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
LH ++ +HRD LK+ NILL K+
Sbjct: 118 ALHEQKILHRD---------------------------------LKSANILLVANDLVKI 144
Query: 123 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYG 182
D G++ L MAK T IGTP +MAPEV + Y +D+WSLG EMA PP+
Sbjct: 145 GDLGISKVLKKNMAK--TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
Query: 183 --DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ +R PP P +++ + +F+ L P+ R ++L
Sbjct: 203 ARSMQDLRYKVQRGKYPPI----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 38/238 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ P +V+ G + L+IV EY G + D +R + L+ ++ + KG
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL + +HRD+ A R N L+
Sbjct: 115 MEYLESKNFVHRDLAA-----------------------------R----NCLVTENLVV 141
Query: 121 KLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-G 177
K++DFG++ D KR WMAPE +++ + +D+WS G+ E+ G
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ PY + + ++ P+ E + + +C +PE+R T SE++
Sbjct: 202 EQPYPGMSNEEVLELLEDGYRLPR--PENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-31
Identities = 80/238 (33%), Positives = 108/238 (45%), Gaps = 45/238 (18%)
Query: 9 VVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+V+YYG + L I MEY GSV D ++ L+E L+G+ YLH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS 124
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+HRDI K NIL ++ G+ KL DFG
Sbjct: 125 NMIVHRDI---------------------------------KGANILRDSAGNVKLGDFG 151
Query: 127 VAGQL-TDTMAKRN--TVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183
+ +L T M+ +V GTP+WM+PEVI GY AD+WSLG T +EM KPP+ +
Sbjct: 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
Query: 184 IHPMRAIFMIPTKP--PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
M AIF I T+P P P + DF+ C+ R +A E+L H F Q
Sbjct: 212 YEAMAAIFKIATQPTNPQL---PSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 79/240 (32%), Positives = 118/240 (49%), Gaps = 48/240 (20%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDT---LKGLEYLH 65
+V+Y GS +N I ME GS+S ++R + L ++E TI+ T L+GL+YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYTKQILEGLKYLH 125
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLAD 124
+ +HRDIK N+L+NT G K++D
Sbjct: 126 DNQIVHRDIKGD---------------------------------NVLVNTYSGVVKISD 152
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYDCVADMWSLGITALEMAEGKPPYG 182
FG + +L T GT +MAPEVI + GY AD+WSLG T +EMA GKPP+
Sbjct: 153 FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212
Query: 183 DI-HPMRAIF---MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
++ P A+F M P P+ + E +F+ RC +P++RA+A ++L F+
Sbjct: 213 ELGEPQAAMFKVGMFKIHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 80/275 (29%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLH 65
P ++ Y S+ +++L++V GS D+++ + L E IA IL D L L+Y+H
Sbjct: 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+ IHR + KA +ILL+ +G L+
Sbjct: 119 SKGFIHRSV---------------------------------KASHILLSGDGKVVLSGL 145
Query: 126 GVAGQLTDTMAKRNTVIGTP-------FWMAPEVIQE--IGYDCVADMWSLGITALEMAE 176
+ + ++ V P W++PEV+Q+ GY+ +D++S+GITA E+A
Sbjct: 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205
Query: 177 GKPPYGDIHPM------------------------------RAIFMIPTK----PPPSFR 202
G P+ D+ R+ P P R
Sbjct: 206 GHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265
Query: 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
++ F FV CL ++PE R +AS++LNH F
Sbjct: 266 ---TFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE-IATILCDTLKGLEYLH 65
P ++ YY + + L I MEY G++ D + +K L E+E + L + + Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+HRDIK TL NI L G KL DF
Sbjct: 119 KAGILHRDIK----TL-----------------------------NIFLTKAGLIKLGDF 145
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIH 185
G++ L + TV+GTP++M+PE+ Q + Y+ +D+W+LG E+ K + +
Sbjct: 146 GISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 186 PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
P+ + I V++ E I V L ++PE+R TA E+L+ +
Sbjct: 206 PLNLVVKIVQGNYTP--VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 75/257 (29%), Positives = 113/257 (43%), Gaps = 56/257 (21%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
+ P VVK + + N ++ +++E+ GS+ E +A + L G+ YL
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYL 184
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H R +HRDIK N+L+N+ + K+AD
Sbjct: 185 HRRHIVHRDIKPS---------------------------------NLLINSAKNVKIAD 211
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ----EIGYD-CVADMWSLGITALEMAEGKP 179
FGV+ L TM N+ +GT +M+PE I YD D+WSLG++ LE G+
Sbjct: 212 FGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271
Query: 180 PY-----GDIHP-MRAIFMI-PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
P+ GD M AI M P + P + + EF F+S CL + P +R +A ++
Sbjct: 272 PFGVGRQGDWASLMCAICMSQPPEAPATA------SREFRHFISCCLQREPAKRWSAMQL 325
Query: 233 LNHEFIQRHDTDPSQNG 249
L H FI R Q G
Sbjct: 326 LQHPFILRAQPGQGQGG 342
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-30
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 55/227 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEI----ATILCD 56
+Q P++V YGS+ +++L++VMEY G + +R + E A ++
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAAQVVL- 112
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
LEYLH ++RD LK N+LL++
Sbjct: 113 ---ALEYLHSLDIVYRD---------------------------------LKPENLLLDS 136
Query: 117 EGHAKLADFGVAGQLTD-TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+G+ K+ DFG A ++ T T+ GTP ++APE+I GY D W+LGI EM
Sbjct: 137 DGYIKITDFGFAKRVKGRTY----TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222
G PP+ D +P++ I E V P F ++ L++N
Sbjct: 193 AGYPPFFDDNPIQIYEKI--------LEGKVRFPSFFSPDAKDLIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-30
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 45/237 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ D P VVK G + L+IVMEY G + +R + LS ++ + +G
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL + IHRD+ A R N L+
Sbjct: 115 MEYLESKNFIHRDLAA-----------------------------R----NCLVGENLVV 141
Query: 121 KLADFGVAGQLTDT--MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALEMAE- 176
K++DFG++ L D KR + P WMAPE ++E + +D+WS G+ E+
Sbjct: 142 KISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL 199
Query: 177 GKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
G+ PY + + + P P PE D + +C ++PE+R T SE
Sbjct: 200 GEQPYPGMSNEEVLEYLKNGYRLPQ----PPNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 76/282 (26%), Positives = 110/282 (39%), Gaps = 94/282 (33%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--RKKTLSEDE----IATIL 54
+ DSP++VK Y S+ L++VMEY G D+M L RK E+ IA ++
Sbjct: 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELV 111
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
L+ +H IHRDIK NIL+
Sbjct: 112 L----ALDSVHKLGFIHRDIKPD---------------------------------NILI 134
Query: 115 NTEGHAKLADFGVAGQLTDT-----------------------------MAKRNTVIGTP 145
+ +GH KLADFG+ ++ + N+ +GTP
Sbjct: 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP---------YGDIHPMRAIFMIPTK 196
++APEV++ Y D WSLG+ EM G PP Y I + P
Sbjct: 195 DYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPD 254
Query: 197 PPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLNHEF 237
PP +PE ID + R L +PE+R + E+ +H F
Sbjct: 255 PP--------VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-29
Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 39/241 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDT 57
+ + D P +VK++ S+ + I+ EYC + + K KTLSE+++
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L G+ Y+H RR +HRD+KA K +F N+L
Sbjct: 116 LLGVHYMHQRRILHRDLKA-------------------------KNIFLKN--NLL---- 144
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
K+ DFGV+ L + T GTP++M+PE ++ GYD +D+WSLG EM
Sbjct: 145 ---KIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ + + + I P PS P+ ++ + + L K+P R +A+E+L + F
Sbjct: 202 AHAFEGQNFLSVVLRIVEGPTPSL--PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
Query: 238 I 238
I
Sbjct: 260 I 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-28
Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 49/246 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILC-DTLK 59
M + + P++++ G+ +++ + +E+ GSVS L K ++ + L+
Sbjct: 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS--HLLSKYGAFKEAVIINYTEQLLR 114
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GL YLH + IHRD+K N+L+++ G
Sbjct: 115 GLSYLHENQIIHRDVKGA---------------------------------NLLIDSTGQ 141
Query: 120 -AKLADFGVAGQLTDTMAK----RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
++ADFG A +L + ++GT +MAPEV++ Y D+WS+G +EM
Sbjct: 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
Query: 175 AEGKPPYG-DIHP--MRAIFMI--PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229
A KPP+ + H + IF I T P P+ +P D RCL PE+R +
Sbjct: 202 ATAKPPWNAEKHSNHLALIFKIASATTAPSI---PEHLSPGLRDVTLRCLELQPEDRPPS 258
Query: 230 SEMLNH 235
E+L H
Sbjct: 259 RELLKH 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-28
Identities = 77/237 (32%), Positives = 110/237 (46%), Gaps = 43/237 (18%)
Query: 9 VVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+V+YYG + L I ME+ GS+ D ++ L+E+ L+G+ YLH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHS 124
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+HRDI K NIL ++ G+ KL DFG
Sbjct: 125 NMIVHRDI---------------------------------KGANILRDSVGNVKLGDFG 151
Query: 127 VAGQLTDTMAKRNT----VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYG 182
+ +L T+ T V GTP+WM+PEVI GY AD+WS+G T +EM KPP+
Sbjct: 152 ASKRL-QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210
Query: 183 DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ M AIF I T+P P V + DF+ R V+ + R +A E+L H F+
Sbjct: 211 EFEAMAAIFKIATQPTNPVLPPHV-SDHCRDFLKRIFVE-AKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 59/260 (22%), Positives = 101/260 (38%), Gaps = 67/260 (25%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
P ++K Y ++ +L+ V+EY G + +R + +L E + L LEYL
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYL 118
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H + IHRD LK NILL+ + H K+ D
Sbjct: 119 HSKGIIHRD---------------------------------LKPENILLDKDMHIKITD 145
Query: 125 FGVAGQLTDT--------------------MAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164
FG A L + + +GT +++PE++ E +D+
Sbjct: 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDL 205
Query: 165 WSLGITALEMAEGKPPY---GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221
W+LG +M GKPP+ + + I + + P + P+ D + + LV
Sbjct: 206 WALGCIIYQMLTGKPPFRGSNEYLTFQKILKL------EYSFPPNFPPDAKDLIEKLLVL 259
Query: 222 NPEERATAS----EMLNHEF 237
+P++R + E+ H F
Sbjct: 260 DPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 65/273 (23%), Positives = 105/273 (38%), Gaps = 74/273 (27%)
Query: 2 QQCDSPYVVKYYGSYF--KNTDLWIVMEYCG---AGSVSDIMRLRKKTLSEDEIATILCD 56
Q+ P +V+ +++V EY G ++ + +E +I +
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKCYMKQ 108
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
L+GL+YLH +HRDIK NIL+N
Sbjct: 109 LLEGLQYLHSNGILHRDIKGS---------------------------------NILINN 135
Query: 117 EGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI-QEIGYDCVADMWSLGITALE 173
+G KLADFG+A T + T VI T ++ PE++ Y DMWS+G E
Sbjct: 136 DGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAE 194
Query: 174 MAEGKPPY---GDIHPMRAIFMI----------------------PTKPPPS-FRE--PD 205
+ GKP + ++ + IF + P KP RE
Sbjct: 195 LFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254
Query: 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ P +D + + L +P++R +A + L HE+
Sbjct: 255 LIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-27
Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLK 59
M++ D P +VK G + L IVMEY G + D +R R K LS ++ + +
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+EYL + IHRD+ A R N L+
Sbjct: 115 GMEYLESKNFIHRDLAA-----------------------------R----NCLVGENLV 141
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K++DFG++ L D V G WMAPE ++E + +D+WS G+ E+
Sbjct: 142 VKISDFGLSRDLYDD--DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
Query: 177 -GKPPYGDIHPMRAIFMIPT--KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
G+ PY + + + + P P PE + +C ++PE+R T SE
Sbjct: 200 LGEEPYPGMSNAEVLEYLKKGYRLPK----PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-27
Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 71/270 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q C PYVVK + + +VMEY +S+++R ++ L E ++ + + LKG
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKG 111
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ Y+H +HRD LK N+L++ +G
Sbjct: 112 VAYMHANGIMHRD---------------------------------LKPANLLISADGVL 138
Query: 121 KLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMA 175
K+ADFG+A +L R + T ++ APE++ ++ YD D+W++G E+
Sbjct: 139 KIADFGLA-RLFSEEEPRLYSHQVATRWYRAPELLYGARK--YDPGVDLWAVGCIFAELL 195
Query: 176 EGKPPY---GDIHPMRAIFMI-----------------------PTKPPPSFRE--PDVW 207
G P + DI + +F P P E PD
Sbjct: 196 NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA- 254
Query: 208 TPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+PE +D + LV +P +R +A+E L H +
Sbjct: 255 SPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 72/259 (27%), Positives = 103/259 (39%), Gaps = 61/259 (23%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P +VK L++V EYC + + R LS + I +I+ L+GL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
R +HRD LK NIL+N +G KLADFG
Sbjct: 117 HRILHRD---------------------------------LKPQNILINRDGVLKLADFG 143
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKPPY-GD- 183
+A + + T ++ APE++ Y D+WS+G EM GKP + GD
Sbjct: 144 LARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203
Query: 184 -IHPMRAIFMI---PT-KPPPSFREPDVWTPEF-------------------IDFVSRCL 219
I + IF I PT + P + + P F ID +S+ L
Sbjct: 204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKML 263
Query: 220 VKNPEERATASEMLNHEFI 238
NP +R +A E L H +
Sbjct: 264 QYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 74/235 (31%), Positives = 109/235 (46%), Gaps = 41/235 (17%)
Query: 9 VVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+V+YYG + L I +EY GS+ D ++ L+E+ L+G+ YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS 124
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+HRDI K NIL ++ G+ KL DFG
Sbjct: 125 NMIVHRDI---------------------------------KGANILRDSAGNVKLGDFG 151
Query: 127 VAGQL-TDTMAKR--NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183
+ ++ T M+ +V GTP+WM+PEVI GY AD+WS+ T +EM KPP+ +
Sbjct: 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
M AIF I T+P PD + DF+ + V+ + R TA +L H F+
Sbjct: 212 YEAMAAIFKIATQPTKP-MLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 75/251 (29%), Positives = 111/251 (44%), Gaps = 48/251 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTL 58
M Q +SPYV K Y S+ L++VMEY G D L K L ED + + +
Sbjct: 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG---DCASLIKTLGGLPEDWAKQYIAEVV 107
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
G+E LH R IHRDIK N+L++ G
Sbjct: 108 LGVEDLHQRGIIHRDIKPE---------------------------------NLLIDQTG 134
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
H KL DFG L+ + +GTP ++APE I +G D ++D WSLG E G
Sbjct: 135 HLKLTDFG----LSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190
Query: 179 PPYGDIHPMRAIF--MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS---EML 233
PP+ P A+F ++ + + +PE +D ++R L +P +R A+ E+
Sbjct: 191 PPFHAETP-DAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249
Query: 234 NHEFIQRHDTD 244
+H F + + D
Sbjct: 250 SHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-26
Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 58/252 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR--------LRKKTLSEDEIAT 52
M++ P VV+ G + L++V+EY G + D +R K TLS ++ +
Sbjct: 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
KG+EYL ++ +HRD+ A R N
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAA-----------------------------R----NC 136
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGIT 170
L+ + K++DFG++ + D R G P WMAPE +++ + +D+WS G+
Sbjct: 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL 196
Query: 171 ALEMAE-GKPPYGDIHPMRAIFMI-----PTKPPPSFREPDVWTPEFI-DFVSRCLVKNP 223
E+ G PY + + + KP + P+ + + + C +P
Sbjct: 197 LWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE--------YCPDELYELMLSCWQLDP 248
Query: 224 EERATASEMLNH 235
E+R T SE++
Sbjct: 249 EDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 35/183 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMRLRKKTLSEDEIATILCDTLK 59
+ + P +V ++ S+ +N L+IVMEYC G + I R R SED+I +
Sbjct: 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GL+++H R+ +HRDIK+ NI L+ G
Sbjct: 113 GLKHIHDRKILHRDIKSQ---------------------------------NIFLSKNGM 139
Query: 120 -AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
AKL DFG+A QL D+M T +GTP++++PE+ Q Y+ D+WSLG E+ K
Sbjct: 140 VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
Query: 179 PPY 181
P+
Sbjct: 200 HPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-25
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 45/234 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDT 57
++Q + P V+KYY S+ ++ +L IV+E AG +S +++ +K+ + E +
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
LE++H RR +HRDIK N+ +
Sbjct: 116 CSALEHMHSRRVMHRDIKPA---------------------------------NVFITAT 142
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
G KL D G+ + ++++GTP++M+PE I E GY+ +D+WSLG EMA
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 178 KPP-YGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
+ P YGD + + I P PS D ++ E V+ C+ +PE+R
Sbjct: 203 QSPFYGDKMNLYSLCKKIEQCDYPPLPS----DHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-25
Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 40/235 (17%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL-SEDEIATILCDTLKGLEYLH 65
P +V+Y S+ +N +L+IVM+YC G + + ++ L ED+I L+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
R+ +HRDI K+ NI L +G KL DF
Sbjct: 119 DRKILHRDI---------------------------------KSQNIFLTKDGTIKLGDF 145
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY--GD 183
G+A L T+ T IGTP++++PE+ + Y+ +D+W+LG EM K + G+
Sbjct: 146 GIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ + + + PP S ++ + + VS+ +NP +R + + +L FI
Sbjct: 206 MKNLVLKIIRGSYPPVSSH----YSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-24
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 65/267 (24%)
Query: 1 MQQCDSPYVVKYY----GSYFKN-TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILC 55
++ + P +V+ G L +V E+ + + + K L + I ++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L+G+++LH R +HRD LK NIL+
Sbjct: 115 QLLRGVDFLHSHRIVHRD---------------------------------LKPQNILVT 141
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
++G K+ADFG+A + MA +V+ T ++ APEV+ + Y DMWS+G E+
Sbjct: 142 SDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
Query: 176 EGKP---PYGDIHPMRAIFMI--------------------PTKPPPSFRE--PDVWTPE 210
+P + + IF + P+ P SF+ P++ E
Sbjct: 201 RRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI-CEE 259
Query: 211 FIDFVSRCLVKNPEERATASEMLNHEF 237
+D + + L NP +R +A E L H +
Sbjct: 260 GLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-24
Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 47/249 (18%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P++V + ++ +T L ++++Y G + + R+ +E E+ + + + L++LH
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVLALDHLH 122
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
I+RDIK L+ NILL++EGH L DF
Sbjct: 123 QLGIIYRDIK----------LE-----------------------NILLDSEGHVVLTDF 149
Query: 126 GVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMAEGKPPY- 181
G++ + L + + + GT +MAPEVI+ G+D D WSLG+ E+ G P+
Sbjct: 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
Query: 182 --GDIHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER---ATASEMLNH 235
G+ + I I PP P + E DF+ + L K+P++R A E+ NH
Sbjct: 210 VDGEQNSQSEISRRILKSKPPF---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266
Query: 236 EFIQRHDTD 244
F Q D D
Sbjct: 267 PFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-24
Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 43/183 (23%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK---TLSEDEIATILCDTLKGLEY 63
P++++ + + L+++MEY G + +R + + + I+C LEY
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEY 116
Query: 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
LH + ++RD LK NILL+ EGH KL
Sbjct: 117 LHSKEIVYRD---------------------------------LKPENILLDKEGHIKLT 143
Query: 124 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183
DFG A +L D + T+ GTP ++APEVIQ G++ D W+LGI EM G PP+ D
Sbjct: 144 DFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
Query: 184 IHP 186
+P
Sbjct: 201 DNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-23
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 45/234 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDT 57
++Q + P V+KY S+ ++ +L IV+E AG +S +++ +K+ + E +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
+E++H RR +HRDIK N+ +
Sbjct: 116 CSAVEHMHSRRVMHRDIKPA---------------------------------NVFITAT 142
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
G KL D G+ + ++++GTP++M+PE I E GY+ +D+WSLG EMA
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 178 KPP-YGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
+ P YGD + + I P P+ + ++ + + VS C+ +P++R
Sbjct: 203 QSPFYGDKMNLFSLCQKIEQCDYPPLPT----EHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 54/243 (22%)
Query: 7 PYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIM----RLRKKTLSEDEIATILCDTLKGL 61
P++ + + S F+ D L+ VMEY G D+M R + E + + GL
Sbjct: 56 PFLTQLH-SCFQTKDRLFFVMEYVNGG---DLMFHIQRSGR--FDEPRARFYAAEIVLGL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
++LH R I+RD+K LD N+LL++EGH K
Sbjct: 110 QFLHERGIIYRDLK----------LD-----------------------NVLLDSEGHIK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
+ADFG+ + +T GTP ++APE++ Y D W+LG+ EM G+ P+
Sbjct: 137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
Query: 182 ---GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ ++I + P + E + L KNPE+R + I
Sbjct: 197 EGDDEDELFQSILEDEVRYPRWLSK------EAKSILKSFLTKNPEKRLGCLPTGEQD-I 249
Query: 239 QRH 241
+ H
Sbjct: 250 KGH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 5e-22
Identities = 70/266 (26%), Positives = 103/266 (38%), Gaps = 90/266 (33%)
Query: 21 DLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78
D++IV E +D+ ++ + L++D I L L+GL+YLH IHRD
Sbjct: 78 DVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRD----- 128
Query: 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA---------- 128
LK NIL+N+ K+ DFG+A
Sbjct: 129 ----------------------------LKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 129 GQLTDTMAKRNTVIGTPFWM-APEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD- 183
G LT+ + R W APE++ Y D+WS+G E+ KP P D
Sbjct: 161 GFLTEYVVTR--------WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212
Query: 184 IHPMRAIF------------------------MIPTKPPPSFRE--PDVWTPEFIDFVSR 217
I + I +P KP + P +PE ID + +
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEK 271
Query: 218 CLVKNPEERATASEMLNHEFI-QRHD 242
LV +P++R TA E L H ++ Q HD
Sbjct: 272 MLVFDPKKRITADEALAHPYLAQLHD 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 7e-22
Identities = 65/267 (24%), Positives = 110/267 (41%), Gaps = 78/267 (29%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLH 65
P +VK + +N +L+ V EY G++ +M+ RK K SE I +I+ L+GL ++H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
HRD LK N+L++ K+ADF
Sbjct: 117 KHGFFHRD---------------------------------LKPENLLVSGPEVVKIADF 143
Query: 126 GVAGQL------TDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGK 178
G+A ++ TD + T ++ APE++ + Y D+W+LG E+ +
Sbjct: 144 GLAREIRSRPPYTD-------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 179 P--PYGD----IHPMRAI--------------------FMIPTKPPPSFRE--PDVWTPE 210
P P ++ + ++ F P P S + P+ +PE
Sbjct: 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA-SPE 255
Query: 211 FIDFVSRCLVKNPEERATASEMLNHEF 237
ID + L +P++R TAS+ L H +
Sbjct: 256 AIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 39/189 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILC-DTLK 59
+ + P++V S+ ++ ++E+ G + LRK +++A + +
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVL 129
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
EYLH + I+RD LK N+LL+ +GH
Sbjct: 130 AFEYLHSKDIIYRD---------------------------------LKPENLLLDNKGH 156
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
K+ DFG A ++ D + T+ GTP ++APEVIQ G+ D W++G+ E G P
Sbjct: 157 VKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
Query: 180 PYGDIHPMR 188
P+ D P R
Sbjct: 214 PFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-21
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLH 65
P +V + S+ + L+IVMEYC G + ++L++ K ED I G++++H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+R +HRDI K+ NI L G KL DF
Sbjct: 118 EKRVLHRDI---------------------------------KSKNIFLTQNGKVKLGDF 144
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIH 185
G A LT A T +GTP+++ PE+ + + Y+ +D+WSLG E+ K P+
Sbjct: 145 GSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204
Query: 186 PMRAIFMI---PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
I + KP PS ++ E + + +NP R +A+ +L
Sbjct: 205 WKNLILKVCQGSYKPLPSH-----YSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-21
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 74/288 (25%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLH 65
P +V Y ++ + +LW+V + GS D++ +SE IA IL LK L+Y+H
Sbjct: 59 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA-D 124
+HR +KA + D ++Y L L++ ++N ++ D
Sbjct: 119 HMGYVHRSVKASHILISVD-------------GKVY--LSGLRSNLSMINHGQRLRVVHD 163
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYDCVADMWSLGITALEMAEGKPPYG 182
F + +V P W++PEV+Q+ GYD +D++S+GITA E+A G P+
Sbjct: 164 F-----------PKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
Query: 183 DIH----------------------PMRAIFMIPTK---------------PPPSFREPD 205
D+ P + M P++ P PS E
Sbjct: 212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESS 271
Query: 206 V------WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247
++P F FV +CL +NP+ R +AS +LNH F ++ S+
Sbjct: 272 SHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 319
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-20
Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---MRLRKKTLSEDEIATILCDTL 58
+Q P +V+YY ++ +N L+IVM+ + + ++ +K+ +E+ I I +
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 59 KGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L YLH ++I HRD L NI+L +
Sbjct: 124 LALRYLHKEKRIVHRD---------------------------------LTPNNIMLGED 150
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
+ DFG+A Q +K +V+GT + PE+++ Y AD+W+ G +M
Sbjct: 151 DKVTITDFGLAKQKQPE-SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREP---DVWTPEFIDFVSRCLVKNPEER 226
+PP+ + + + TK + EP +++ + D ++ CL + E R
Sbjct: 210 QPPFYSTN----MLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 61/274 (22%), Positives = 108/274 (39%), Gaps = 78/274 (28%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ + P ++K + DL++V E+ + +++ R++ L E I + L L+G
Sbjct: 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQG 110
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L + H +HRD LK N+L+NTEG
Sbjct: 111 LAFCHSHGILHRD---------------------------------LKPENLLINTEGVL 137
Query: 121 KLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITAL 172
KLADFG+A T + R ++ APE++ + GY D+WS+G
Sbjct: 138 KLADFGLARSFGSPVRPYTHYVVTR-------WYRAPELLLGDKGYSTPVDIWSVGCIFA 190
Query: 173 EMAEGKPPYGDIHPMRAIFMI--------------------------PTKPPPSFRE--P 204
E+ +P + + +F I P K + P
Sbjct: 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250
Query: 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
+ +P+ +D +S+ L +P +R TA + L H +
Sbjct: 251 NA-SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-20
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 1 MQQCDSPYVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTL 58
+ Q P +V Y S+ ++ L+IVM +C G + ++ +K K L E+++
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIA 112
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
L+YLH + +HRD LK N+ L
Sbjct: 113 MALQYLHEKHILHRD---------------------------------LKTQNVFLTRTN 139
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ D G+A L + +T+IGTP++M+PE+ Y+ +D+W+LG EMA K
Sbjct: 140 IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
Query: 179 PPYGDIHPMRAIF--MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
+ + M ++ +I K PP P ++PE + ++ L K PE+R + +L
Sbjct: 200 HAF-NAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255
Query: 237 FI 238
+I
Sbjct: 256 YI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 76/219 (34%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKG 60
+ D+P+VVK Y S+ L+++MEY G D+M L +K T +E+E + +T+
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGG---DMMTLLMKKDTFTEEETRFYIAETILA 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++ +H IHRDI K N+LL+ +GH
Sbjct: 114 IDSIHKLGYIHRDI---------------------------------KPDNLLLDAKGHI 140
Query: 121 KLADFG----------------VAGQLTDTMA----------------KRN------TVI 142
KL+DFG ++ L KRN + +
Sbjct: 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200
Query: 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
GTP ++APEV + GY+ D WSLG+ EM G PP+
Sbjct: 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-20
Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 50/251 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ S ++VK ++ + L++ MEY G ++ LSED + + +
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEA 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++ LH IHRD LK N L++ GH
Sbjct: 114 VDALHELGYIHRD---------------------------------LKPENFLIDASGHI 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG++ + N+V+G+P +MAPEV++ GYD D WSLG E G PP
Sbjct: 141 KLTDFGLS---KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
Query: 181 Y-GD--------IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
+ G + + P P F + E D +++ + + +
Sbjct: 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFN----LSDEAWDLITKLINDPSRRFGSLED 253
Query: 232 MLNHEFIQRHD 242
+ NH F + D
Sbjct: 254 IKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-20
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLH 65
P++V + + + VMEY G D+M + SE + GL+YLH
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+ ++RD+K LD N+LL+TEG K+ADF
Sbjct: 119 ENKIVYRDLK----------LD-----------------------NLLLDTEGFVKIADF 145
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GDI 184
G+ + + +T GTP ++APEV+ E Y D W LG+ EM G+ P+ GD
Sbjct: 146 GLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
Query: 185 HPMRAIF-MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
+F I R P + E I + R L +NPE R + E
Sbjct: 206 E--EEVFDSIVNDEV---RYPRFLSREAISIMRRLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-20
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 69/256 (26%)
Query: 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D+++V GA +++I++ +K LS+D I ++ L+GL+Y+H IHRD
Sbjct: 93 QDVYLVTHLMGA-DLNNIVKCQK--LSDDHIQFLVYQILRGLKYIHSAGIIHRD------ 143
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK NI +N + K+ DFG+A D M
Sbjct: 144 ---------------------------LKPSNIAVNEDCELKILDFGLARHTDDEM---T 173
Query: 140 TVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAIF---- 191
+ T ++ APE++ + Y+ D+WS+G E+ GK P D I ++ I
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233
Query: 192 --------------------MIPTKPPPSFREPDVW-TPEFIDFVSRCLVKNPEERATAS 230
+P P F+E P ID + + LV +P++R TA+
Sbjct: 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293
Query: 231 EMLNHEFI-QRHDTDP 245
E L H ++ + HD +
Sbjct: 294 EALAHPYLAEYHDPED 309
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-19
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 44/234 (18%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P +++YY ++ ++ L IVMEY G++++ I + L ED I L L ++H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLAD 124
+ +HRD LK NILL+ K+ D
Sbjct: 119 TKLILHRD---------------------------------LKTQNILLDKHKMVVKIGD 145
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDI 184
FG++ L+ + +K TV+GTP +++PE+ + Y+ +D+W+LG E+A K + +
Sbjct: 146 FGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF-EA 203
Query: 185 HPMRAI---FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ A+ M T P S D ++P+ + L +P +R S+++
Sbjct: 204 ANLPALVLKIMSGTFAPIS----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-19
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 89 CSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM 148
C+++ N IY+ L K NILL+ +GH L DFG+ K NT GTP ++
Sbjct: 104 CALENLHKFNVIYRDL---KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160
Query: 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD--IHPM-RAIFMIPTKPPPSFREPD 205
APE++ GY D W+LG+ EM G PP+ D ++ M R I P + P F
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDR-- 218
Query: 206 VWTPEFIDFVSRCLVKNPEER---ATASEMLNHEFIQRHD 242
+ D + L ++P R A E+ NH F +
Sbjct: 219 ----DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 36/176 (20%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P++ + + L+ VMEY G + I R RK E + L +LH
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLH 113
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
I+RD+K LD NILL+ EGH KLADF
Sbjct: 114 RHGVIYRDLK----------LD-----------------------NILLDAEGHCKLADF 140
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
G+ + T GTP ++APE++QE+ Y D W+LG+ EM G+PP+
Sbjct: 141 GMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 61/253 (24%), Positives = 100/253 (39%), Gaps = 58/253 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +SP++ + ++ +L++VMEY G + ++ + ED L + +
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ +H +HRDIK N+L++ GH
Sbjct: 115 IHSVHQMGYVHRDIKPE---------------------------------NVLIDRTGHI 141
Query: 121 KLADFGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQEIG------YDCVADMWSLGITALE 173
KLADFG A +LT + M +GTP ++APEV+ + Y D WSLG+ A E
Sbjct: 142 KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201
Query: 174 MAEGKPP---------YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
M G+ P Y +I + P P S +F+D + L+ +
Sbjct: 202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS--------SDFLDLIQS-LLCGQK 252
Query: 225 ERATASEMLNHEF 237
ER + H F
Sbjct: 253 ERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 71/274 (25%), Positives = 107/274 (39%), Gaps = 95/274 (34%)
Query: 19 NTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77
+ D+++V EY +D+ +R L + I+ LK L+Y+H IHRD
Sbjct: 81 DKDIYLVFEYME----TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRD---- 132
Query: 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA--------- 128
LK NILLN++ KLADFG+A
Sbjct: 133 -----------------------------LKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 129 ---GQLTDTMAKRNTVIGTPFWM-APEVIQEIG---YDCVADMWSLGITALEMAEGKPPY 181
LTD +A R W APE++ +G Y DMWS+G EM GKP +
Sbjct: 164 PENPVLTDYVATR--------WYRAPEIL--LGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
Query: 182 ---------------------GDIHPMRAIF------MIPTKPPPSFRE--PDVWTPEFI 212
DI +++ F +P++P E P + + +
Sbjct: 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA-SDDAL 272
Query: 213 DFVSRCLVKNPEERATASEMLNHEFIQR-HDTDP 245
D + + LV NP +R TA E L H ++ + H+
Sbjct: 273 DLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL--CDTLKGLEYL 64
P++ + ++ L+ VMEY G D+M + + DE + + GL++L
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H + I+RD+K LD N+LL+ +GH K+AD
Sbjct: 113 HKKGIIYRDLK----------LD-----------------------NVLLDKDGHIKIAD 139
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GD 183
FG+ + + K +T GTP ++APE+++ Y+ D WS G+ EM G+ P+ G+
Sbjct: 140 FGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLNHEF 237
+F P F P + E D +S+ ++P +R ++ H F
Sbjct: 200 DE--DELFDSILNDRPHF--PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-18
Identities = 61/250 (24%), Positives = 112/250 (44%), Gaps = 47/250 (18%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
SP++V + ++ +T L ++++Y G + + R++ E E+ + + LE+LH
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLH 122
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
I+RDIK NILL++ GH L DF
Sbjct: 123 KLGIIYRDIKLE---------------------------------NILLDSNGHVVLTDF 149
Query: 126 GVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMAEGKPPY- 181
G++ + D + + + GT +MAP++++ + G+D D WS+G+ E+ G P+
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
Query: 182 --GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLN 234
G+ + I K P + P + D + R L+K+P++R + A E+
Sbjct: 210 VDGEKNSQAEISRRILKSEPPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 235 HEFIQRHDTD 244
H F Q+ + D
Sbjct: 268 HPFFQKINWD 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 46/248 (18%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
SP++V + ++ L ++++Y G + + R SEDE+ + + LE+L
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHL 121
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H ++RDIK NILL++EGH L D
Sbjct: 122 HKLGIVYRDIKLE---------------------------------NILLDSEGHVVLTD 148
Query: 125 FGVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDCVADMWSLGITALEMAEGKPPY- 181
FG++ + L++ + + GT +MAPE+I+ + G+ D WSLGI E+ G P+
Sbjct: 149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
Query: 182 --GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLN 234
G+ + + K P F P PE D + + L K+P++R ASE+
Sbjct: 209 LEGERNTQSEVSRRILKCDPPF--PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 235 HEFIQRHD 242
H F + D
Sbjct: 267 HPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 70/271 (25%), Positives = 103/271 (38%), Gaps = 76/271 (28%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT----LSEDEIATILCDTLKG 60
D P++ Y S+ T L +VM+YC G ++ RL ++ LSE+ + L
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLHL ++RD LK NILL+ GH
Sbjct: 116 LEYLHLLGIVYRD---------------------------------LKPENILLHESGHI 142
Query: 121 KLADF------------------------GVAGQLTDTM-----AKRNTVIGTPFWMAPE 151
L+DF V ++T + N+ +GT ++APE
Sbjct: 143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202
Query: 152 VIQEIGYDCVADMWSLGITALEMAEGKPPY-GDIHPMRAIFMIPTKPPPSFREPDVWTPE 210
VI G+ D W+LGI EM G P+ G F K +F +
Sbjct: 203 VISGDGHGSAVDWWTLGILLYEMLYGTTPFKG--SNRDETFSNILKKEVTFPGSPPVSSS 260
Query: 211 FIDFVSRCLVKNPEER----ATASEMLNHEF 237
D + + LVK+P +R A+E+ H F
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 40/236 (16%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL-SEDEIATILCDTLKGLEYLH 65
P++VK + ++ L++++++ G + RL K+ + +E+++ L + L++LH
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
I+RD LK NILL+ EGH KL DF
Sbjct: 116 SLGIIYRD---------------------------------LKPENILLDEEGHIKLTDF 142
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIH 185
G++ + D K + GT +MAPEV+ G+ AD WS G+ EM G P+
Sbjct: 143 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
Query: 186 PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
+ MI P +PE + +NP R + E I+RH
Sbjct: 203 RKETMTMILKA---KLGMPQFLSPEAQSLLRALFKRNPANR-LGAGPDGVEEIKRH 254
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-18
Identities = 69/255 (27%), Positives = 104/255 (40%), Gaps = 69/255 (27%)
Query: 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D ++VM + G + +M+ K LSED I ++ LKGL+Y+H IHRD
Sbjct: 93 HDFYLVMPFMGT-DLGKLMKHEK--LSEDRIQFLVYQMLKGLKYIHAAGIIHRD------ 143
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK GN+ +N + K+ DFG+A Q M
Sbjct: 144 ---------------------------LKPGNLAVNEDCELKILDFGLARQTDSEMTG-- 174
Query: 140 TVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPY-GDIH--PMRAIFMIPT 195
+ T ++ APEVI + Y D+WS+G EM GKP + G H + I +
Sbjct: 175 -YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233
Query: 196 KPP-------------------PSFREPDVWT------PEFIDFVSRCLVKNPEERATAS 230
P P FR+ D + P ++ + + LV + E R TA+
Sbjct: 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293
Query: 231 EMLNHEFIQR-HDTD 244
E L H + + HD +
Sbjct: 294 EALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-18
Identities = 69/263 (26%), Positives = 102/263 (38%), Gaps = 66/263 (25%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
++P+VV + S+ L +VMEY G + +++ L D +T+ LEYL
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVDMARMYFAETVLALEYL 117
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H +HRD LK N+L+ + GH KL D
Sbjct: 118 HNYGIVHRD---------------------------------LKPDNLLITSMGHIKLTD 144
Query: 125 FGVAG----QLTDTMAK----RNT-------VIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
FG++ LT + + ++T V GTP ++APEVI GY D W++GI
Sbjct: 145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 204
Query: 170 TALEMAEGKPP-YGDI------HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222
E G P +GD + P + + D +SR L +N
Sbjct: 205 ILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------EGDEALPADAQDLISRLLRQN 257
Query: 223 PEER---ATASEMLNHEFIQRHD 242
P ER A E+ H F D
Sbjct: 258 PLERLGTGGAFEVKQHRFFLGLD 280
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-17
Identities = 65/249 (26%), Positives = 98/249 (39%), Gaps = 61/249 (24%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEI----ATILCDTLKG 60
S ++V ++ DL +VM G + I + + E A I+C G
Sbjct: 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC----G 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH RR ++RD LK N+LL+ G+
Sbjct: 108 LEHLHQRRIVYRD---------------------------------LKPENVLLDDHGNV 134
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
+++D G+A +L K GTP +MAPEV+Q YD D ++LG T EM G+ P
Sbjct: 135 RISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
Query: 181 YGDIHPM-------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----AT 228
+ R + + P F +PE D L K+PE+R +
Sbjct: 194 FRQRKEKVEKEELKRRTLEMAVEYPDKF------SPEAKDLCEALLQKDPEKRLGCRGGS 247
Query: 229 ASEMLNHEF 237
A E+ H
Sbjct: 248 ADEVREHPL 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 65/247 (26%)
Query: 22 LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81
L++V EY ++ +++ L D + + + L+ + Y H IHRDIK
Sbjct: 75 LYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPE---- 129
Query: 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT- 140
NIL++ G KL DFG A L A T
Sbjct: 130 -----------------------------NILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 141 VIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIFMIPTK 196
+ T ++ APE+ + + Y D+W++G E+ +G+P + DI + I
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 197 PPPS-------------FREPDVWTPE-------------FIDFVSRCLVKNPEERATAS 230
PPS P+ PE +DF+ CL +P+ER T
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280
Query: 231 EMLNHEF 237
E+L H +
Sbjct: 281 ELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 66/242 (27%), Positives = 100/242 (41%), Gaps = 44/242 (18%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEI--ATILCDTLKGL 61
+ P++ Y ++ +L+ VMEY G + I K L A I+C GL
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC----GL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
++LH + ++RD+K LD NILL+T+GH K
Sbjct: 110 QFLHSKGIVYRDLK----------LD-----------------------NILLDTDGHIK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
+ADFG+ + AK T GTP ++APE++ Y+ D WS G+ EM G+ P+
Sbjct: 137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
Query: 182 GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLNHEFIQR 240
I P P T E D + + V+ PE R ++ H F +
Sbjct: 197 HGHDEEELFQSIRMDNP---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253
Query: 241 HD 242
D
Sbjct: 254 ID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 58/242 (23%), Positives = 90/242 (37%), Gaps = 64/242 (26%)
Query: 24 IVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83
+V E+ + +++ + L+ +I + + TL+GLEYLH +HRD
Sbjct: 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD---------- 127
Query: 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG 143
LK N+L+ ++G KLADFG+A K +
Sbjct: 128 -----------------------LKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 144 TPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIFMI---- 193
T ++ APE++ G Y DMWS+G E+ P DI + IF
Sbjct: 165 TRWYRAPELL--FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222
Query: 194 -PTKPPPSFREPDVWTPEF-----------------IDFVSRCLVKNPEERATASEMLNH 235
P PD + +D + R L NP +R TA + L H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 236 EF 237
+
Sbjct: 283 PY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 76/301 (25%), Positives = 112/301 (37%), Gaps = 110/301 (36%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--RKKTLSED----EIATILCD 56
+ D+ +VVK Y S+ +L+ VM+Y G D+M L R ED IA + C
Sbjct: 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGG---DMMSLLIRLGIFEEDLARFYIAELTC- 112
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+E +H IHRDIK NIL++
Sbjct: 113 ---AIESVHKMGFIHRDIKPD---------------------------------NILIDR 136
Query: 117 EGHAKLADFGVAGQL----------------TDTM--------------------AKR-- 138
+GH KL DFG+ D+M KR
Sbjct: 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH 196
Query: 139 -----NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP----MRA 189
++++GTP ++APEV+ GY + D WS+G+ EM G+PP+ P ++
Sbjct: 197 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256
Query: 190 I-----FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER---ATASEMLNHEFIQRH 241
I IP++ S E D + R L E+R A E+ H F +
Sbjct: 257 INWETTLHIPSQAKLS--------REASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGI 307
Query: 242 D 242
D
Sbjct: 308 D 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 78/248 (31%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLE 62
+ DS +VVK + S+ +L+++ME+ G + ++ ++K TL+E+E + +T+ ++
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-MKKDTLTEEETQFYIAETVLAID 115
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
+H IHRDIK N+LL+++GH KL
Sbjct: 116 SIHQLGFIHRDIKPD---------------------------------NLLLDSKGHVKL 142
Query: 123 ADFGVAGQLTDTMA-----------------------------KRN------TVIGTPFW 147
+DFG+ L KRN + +GTP +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202
Query: 148 MAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM---------RAIFMIPTKPP 198
+APEV + GY+ + D WSLG+ EM G PP+ P + + P + P
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
Query: 199 PSFREPDV 206
S + D+
Sbjct: 263 ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-17
Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 42/242 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q P++ ++ + L VMEY G + + R++ +E+ + +
Sbjct: 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSA 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH R ++RDIK N++L+ +GH
Sbjct: 108 LEYLHSRDVVYRDIKLE---------------------------------NLMLDKDGHI 134
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM G+ P
Sbjct: 135 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235
+ + R +I + R P +PE ++ L K+P++R + A E++ H
Sbjct: 195 FYNQDHERLFELILME---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251
Query: 236 EF 237
F
Sbjct: 252 RF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-17
Identities = 67/242 (27%), Positives = 101/242 (41%), Gaps = 45/242 (18%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYL 64
P++V ++ L++++EY G + M L R+ ED L + LE+L
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHL 116
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H + I+RD LK NILL+ +GH KL D
Sbjct: 117 HQQGIIYRD---------------------------------LKPENILLDAQGHVKLTD 143
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDI 184
FG+ + +T GT +MAPE++ G+ D WSLG +M G PP+
Sbjct: 144 FGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
Query: 185 HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNHEFIQ 239
+ + I I K + P TPE D + + L +NP R A+E+ +H F
Sbjct: 204 NRKKTIDKI-LKGKLNL--PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF- 259
Query: 240 RH 241
RH
Sbjct: 260 RH 261
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-17
Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 45/239 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +V+ YG K ++IV EY G + + +R RK L + + + D +
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL IHRD L A N L+ +
Sbjct: 113 MEYLESNGFIHRD---------------------------------LAARNCLVGEDNVV 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG+A + D + GT F W PEV + +D+WS G+ E+ +E
Sbjct: 140 KVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEML 233
GK PY + + +R P + E + C + PE+R ++L
Sbjct: 198 GKMPYERFSNSEVVESVSA----GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 43/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q P++ S+ + L VMEY G + + R++ SED + +
Sbjct: 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSA 107
Query: 61 LEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L+YLH + + +RD LK N++L+ +GH
Sbjct: 108 LDYLHSEKNVVYRD---------------------------------LKLENLMLDKDGH 134
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM G+
Sbjct: 135 IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLN 234
P+ + + +I + R P +PE +S L K+P++R A E++
Sbjct: 195 PFYNQDHEKLFELILME---EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251
Query: 235 HEF 237
H+F
Sbjct: 252 HKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 69/214 (32%)
Query: 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLE 62
+ D +VVK + S+ +L+++ME+ G + ++ ++K TLSE+ + +T+ ++
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-MKKDTLSEEATQFYIAETVLAID 115
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
+H IHRDIK N+LL+ +GH KL
Sbjct: 116 AIHQLGFIHRDIKPD---------------------------------NLLLDAKGHVKL 142
Query: 123 ADFGVAGQLT----------------------DTMAKRN-------------TVIGTPFW 147
+DFG+ L + +KR + +GTP +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202
Query: 148 MAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
+APEV + GY+ + D WSLG+ EM G PP+
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 42/242 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q P++ S+ + L VMEY G + + R++ SED + +
Sbjct: 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSA 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH ++RD LK N++L+ +GH
Sbjct: 108 LGYLHSCDVVYRD---------------------------------LKLENLMLDKDGHI 134
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM G+ P
Sbjct: 135 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235
+ + + +I + R P +PE ++ L K+P++R A E++ H
Sbjct: 195 FYNQDHEKLFELILME---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251
Query: 236 EF 237
F
Sbjct: 252 RF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 74/250 (29%), Positives = 106/250 (42%), Gaps = 51/250 (20%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEY 63
+SP++V S+ ++DL++V +Y G + L+K+ SED + + + LE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEH 111
Query: 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
LH ++RD LK NILL+ GH L
Sbjct: 112 LHKYDIVYRD---------------------------------LKPENILLDATGHIALC 138
Query: 124 DFGVA-GQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMAEGKPPY 181
DFG++ LTD NT GT ++APEV + E GY D WSLG+ EM G P+
Sbjct: 139 DFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
Query: 182 --GDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----ATASEMLN 234
D M R I + P +V + E FV L +NP+ R A E+
Sbjct: 198 YAEDTQQMYRNIAFGKVRFP-----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252
Query: 235 HEFIQRHDTD 244
H F D D
Sbjct: 253 HPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 24 IVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
+V++Y AG + ++ R KT E E + L + ++H + IHRDIK+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA--- 172
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-- 138
NILL + G KL DFG + T++
Sbjct: 173 ------------------------------NILLCSNGLVKLGDFGFSKMYAATVSDDVG 202
Query: 139 NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP 198
T GTP+++APE+ + Y ADM+SLG+ E+ K P+ D M + M T
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEV-MHKTLAG 260
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
P +PE + V+ L +P+ R ++S++LN
Sbjct: 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 52/247 (21%)
Query: 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDTLKG 60
CD +VK++ + + L ++MEY G ++ ++ R K E E+ + +
Sbjct: 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+ +H R+ +HRD LK+ NI L G
Sbjct: 182 LDEVHSRKMMHRD---------------------------------LKSANIFLMPTGII 208
Query: 121 KLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
KL DFG + Q +D+++ ++ GTP+++APE+ + Y ADMWSLG+ E+
Sbjct: 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268
Query: 179 PPYGDIHPMRAIFMI------PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
P+ + + P P S + P L KNP R T ++
Sbjct: 269 RPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDP--------LLSKNPALRPTTQQL 320
Query: 233 LNHEFIQ 239
L+ EF++
Sbjct: 321 LHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 89/288 (30%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLH 65
P ++ + + + LW++ + GS + +++ + +SE I IL L+GL YLH
Sbjct: 59 PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 66 LRRKIHRDIKA------GSGTLVYDRLD--YCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
IHR+IKA G G + L Y ++ N +
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR----------------------NGQ 156
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYDCVADMWSLGITALEMA 175
+ DF Q + ++ W++PE++++ GY+ +D++S+GITA E+A
Sbjct: 157 KAKVVYDFP---QFSTSVLP---------WLSPELLRQDLYGYNVKSDIYSVGITACELA 204
Query: 176 EGKPPYGDIH---------------------------PMR---------------AIFMI 193
G+ P+ D+ M+ A M
Sbjct: 205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMT 264
Query: 194 PTKPPPSFREPD--VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
T R P ++P F + V CL ++PE+R +AS +L+H F +
Sbjct: 265 QTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P++ S+ L VMEY G + + R++ SED + + L+YLH
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+ ++RD LK N++L+ +GH K+ DFG
Sbjct: 114 GKIVYRD---------------------------------LKLENLMLDKDGHIKITDFG 140
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP 186
+ + A T GTP ++APEV+++ Y D W LG+ EM G+ P+ +
Sbjct: 141 LCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 187 MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHEF 237
+ +I + + P + + +S L+K+P +R A E++ H F
Sbjct: 201 EKLFELILME---DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-15
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 45/239 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +V+ YG + + + +V E+ G +SD +R ++ S++ + + D +G
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL IHRD+ A + C V NQ+
Sbjct: 113 MAYLESSNVIHRDLAARN--------------CLVGENQV-------------------V 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG+ + D +T GT F W +PEV Y +D+WS G+ E+ +E
Sbjct: 140 KVSDFGMTRFVLDDQYTSST--GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEML 233
GK PY + + I FR +P + + + + C + PE+R + S +L
Sbjct: 198 GKTPYENRSNSEVVETINA----GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 54/249 (21%), Positives = 93/249 (37%), Gaps = 66/249 (26%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
+++VMEY + +M K+ + E+ ++ L G+ +LH +HRD
Sbjct: 80 KIYMVMEYV-EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD------- 131
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK N+LLN G K+ DFG+A + +
Sbjct: 132 --------------------------LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ 165
Query: 141 VIGTPFWMAPEVIQEIG-YDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIF----- 191
++ T ++ APE++ Y DMWS+G E+ KP + +I + IF
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 192 -----------------MIPTKPPPS-----FREPDVWTPEFIDFVSRCLVKNPEERATA 229
TK P + F + + D ++R L +P +R +A
Sbjct: 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSL-SDNGFDLLNRLLTYDPAKRISA 284
Query: 230 SEMLNHEFI 238
+ L H +
Sbjct: 285 EDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 48/255 (18%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
Q +P++V + + + L++V+EY G + M+ R++ L E+ + L
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARFYAAEICIAL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+LH R I+RD LK N+LL+ +GH K
Sbjct: 110 NFLHERGIIYRD---------------------------------LKLDNVLLDADGHIK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
L D+G+ + +T GTP ++APE+++ Y D W+LG+ EM G+ P+
Sbjct: 137 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 182 G------DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA------ 229
D++ +F + + P R P + + + L K+P+ER
Sbjct: 197 DIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGF 254
Query: 230 SEMLNHEFIQRHDTD 244
S++ +H F + D D
Sbjct: 255 SDIKSHTFFRSIDWD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 61/253 (24%), Positives = 99/253 (39%), Gaps = 57/253 (22%)
Query: 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ D +VKY G K L ++MEY +GS+ D ++ + ++ +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG++YL +R IHRD L A NIL+ +E
Sbjct: 120 KGMDYLGSQRYIHRD---------------------------------LAARNILVESED 146
Query: 119 HAKLADFGVAGQLTD------TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
K++DFG+A L + + I FW APE ++ + +D+WS G+T
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLY 203
Query: 173 EM-AEGKP---PYGDIHPMRAI---FMIPT------KPPPSFREPDVWTPEFIDFVSRCL 219
E+ G P P + M I MI T K P E D + C
Sbjct: 204 ELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCW 263
Query: 220 VKNPEERATASEM 232
P++R + +++
Sbjct: 264 EAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-15
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 52/187 (27%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE-----------IATIL 54
S ++V ++ TDL +VM G +R + E+ A I+
Sbjct: 52 SRFIVSLAYAFQTKTDLCLVMTIMNGGD----LRYHIYNVDEENPGFPEPRACFYTAQII 107
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
GLE+LH RR I+RD LK N+LL
Sbjct: 108 S----GLEHLHQRRIIYRD---------------------------------LKPENVLL 130
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ +G+ +++D G+A +L D +K GTP +MAPE++Q YD D ++LG+T EM
Sbjct: 131 DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190
Query: 175 AEGKPPY 181
+ P+
Sbjct: 191 IAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-15
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P+ V YGS+ + L++V+E+ G +R R K D + EYL
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
++RD LK N+LL+ +G K+ DFG
Sbjct: 150 LNIVYRD---------------------------------LKPENLLLDKDGFIKMTDFG 176
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP 186
A ++ DT + T+ GTP ++APE++ +G+ AD W+LGI E+ G PP+ P
Sbjct: 177 FA-KVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
Query: 187 MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
+ +I K E ++ P+F+D + L+K ++L+H+ +R+
Sbjct: 234 L----LIYQK----ILEGIIYFPKFLDNNCKHLMK---------KLLSHDLTKRY 271
|
Length = 340 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-15
Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 38/180 (21%)
Query: 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTLKGL 61
+ P++ + Y + L+ VME+ G D+M +K+ E + L
Sbjct: 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSAL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+LH + I+RD+K LD N+LL+ EGH K
Sbjct: 110 MFLHDKGIIYRDLK----------LD-----------------------NVLLDHEGHCK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
LADFG+ + +T GTP ++APE++QE+ Y D W++G+ EM G P+
Sbjct: 137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-15
Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 70/252 (27%)
Query: 22 LWIVMEYC--GAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
+++VMEYC S+ D M SE ++ ++ L+GL+YLH IHRD
Sbjct: 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRD------ 133
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK N+LL +G K+ADFG+A
Sbjct: 134 ---------------------------LKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 140 TVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEGKP----------------- 179
+ T ++ APE++ +G Y DMW++G E+ KP
Sbjct: 167 PKVVTLWYRAPELL--LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224
Query: 180 ---PYGDIHP-MRAI-----FMIPTKPPPSFREPDVWTPEF-IDFVSRCLVKNPEERATA 229
P I P + F +P +P + + W E + ++ L+ +P++RATA
Sbjct: 225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA 284
Query: 230 SEMLNHEFIQRH 241
E L + +
Sbjct: 285 EEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 34/180 (18%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
Q + P++V + + + L+ V+EY G + M+ R++ L E+ + L
Sbjct: 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLAL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
YLH R I+RD LK N+LL++EGH K
Sbjct: 110 NYLHERGIIYRD---------------------------------LKLDNVLLDSEGHIK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
L D+G+ + +T GTP ++APE+++ Y D W+LG+ EM G+ P+
Sbjct: 137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 77/268 (28%)
Query: 14 GSYFKNTDLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKGLEYLHLRRKIH 71
G+ FK D+++VM+ SD+ + + L+E+ I L L+GL+Y+H IH
Sbjct: 77 GADFK--DVYVVMDLME----SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIH 130
Query: 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131
RD LK N+L+N + ++ DFG+A L
Sbjct: 131 RD---------------------------------LKPSNLLVNEDCELRIGDFGMARGL 157
Query: 132 TDTMAKRNTV----IGTPFWMAPEVIQEIG-YDCVADMWSLGITALEM------------ 174
+ + + + T ++ APE++ + Y DMWS+G EM
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
Query: 175 ---------AEGKPPYGDIHPMRA------IFMIPTKPPPSFRE--PDVWTPEFIDFVSR 217
G P ++ + + I +P K P + + P +PE +D +S+
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA-SPEALDLLSQ 276
Query: 218 CLVKNPEERATASEMLNHEFI-QRHDTD 244
L +PEER T + L H F+ Q HD D
Sbjct: 277 MLQFDPEERITVEQALQHPFLAQYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P +++ G K+ + I+ EY GS+ +R + ++ +L G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 119 MKYLSEMNYVHRD---------------------------------LAARNILVNSNLVC 145
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K++DFG++ +L D+ A T G P W APE I + +D+WS GI E M+ G
Sbjct: 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYG 205
Query: 178 KPPYGD 183
+ PY D
Sbjct: 206 ERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 47/186 (25%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRKKTLSEDEIAT-----ILCDTL 58
++P++ Y ++ L+ VME+ G D+M ++ K + AT I+C
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVC--- 107
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GL++LH + I+RD+K LD N++L+ +G
Sbjct: 108 -GLQFLHSKGIIYRDLK----------LD-----------------------NVMLDRDG 133
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
H K+ADFG+ + + +T GTP ++APE++Q + Y D WS G+ EM G+
Sbjct: 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
Query: 179 PPY-GD 183
P+ GD
Sbjct: 194 SPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-14
Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 45/239 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +V+ YG + L+IV E+ G + + +R R+ LS+D + ++ D +G
Sbjct: 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL IHRD L A N L+++ G
Sbjct: 113 MEYLERNSFIHRD---------------------------------LAARNCLVSSTGVV 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG+ + D ++ G F W PEV Y +D+WS G+ E+ E
Sbjct: 140 KVSDFGMTRYVLDDEYTSSS--GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEML 233
GK P+ + MI FR P + + + + C + PE R T +E+L
Sbjct: 198 GKMPFEKKSNYEVVEMISR----GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 46/228 (20%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLEYLHLR 67
+V G+ + ++ EYC G + + +R ++++ L+ +++ + KG+ +L +
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-AKLADFG 126
IHRD L A N+LL T G K+ DFG
Sbjct: 161 NCIHRD---------------------------------LAARNVLL-THGKIVKICDFG 186
Query: 127 VAGQLTDTMAKRNTVI-GTPF----WMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPP 180
+A D M N V+ G WMAPE I Y +D+WS GI E+ + G P
Sbjct: 187 LA---RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
Y + P+ + F K +P+ E D + C +P +R T
Sbjct: 244 YPGM-PVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 67/256 (26%), Positives = 106/256 (41%), Gaps = 47/256 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVS-DIMRLRKKTLSEDEIATILCDTL 58
+ D P + S F+ D L+ VMEY G + I ++ K E + +
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEIS 111
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GL +LH R I+RD LK N++L++EG
Sbjct: 112 VGLFFLHRRGIIYRD---------------------------------LKLDNVMLDSEG 138
Query: 119 HAKLADFGVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
H K+ADFG+ + + D + R T GTP ++APE+I Y D W+ G+ EM G
Sbjct: 139 HIKIADFGMCKEHMVDGVTTR-TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS-----EM 232
+PP+ D +F + S+ P + E + + K+P +R ++
Sbjct: 198 QPPF-DGEDEDELFQSIMEHNVSY--PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI 254
Query: 233 LNHEFIQRHDTDPSQN 248
H F +R D D +N
Sbjct: 255 REHAFFRRIDWDKLEN 270
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-14
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 44/238 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILC-DTLK 59
M P +V+ G + L+IV EY GS+ D +R R + + D +
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+EYL + +HRD L A N+L++ +
Sbjct: 114 GMEYLEEKNFVHRD---------------------------------LAARNVLVSEDLV 140
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEGK 178
AK++DFG+A + + + W APE ++E + +D+WS GI E+ + G+
Sbjct: 141 AKVSDFGLAKEASQGQDSGKLPVK---WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
PY P + + +R P+ PE + C +P +R T ++
Sbjct: 198 VPY----PRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 76/229 (33%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
L E + L L+G+E+ H IHRDIK
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPE--------------------------- 129
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQL-------TDTMAKRNTVIGTPFWMAPE-VIQEI 156
NIL++ G KL DFG A L TD +A R ++ APE ++ +
Sbjct: 130 ------NILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-------WYRAPELLVGDT 176
Query: 157 GYDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIFM-----------IPTKPPP--S 200
Y D+W++G EM G+P + DI + I I K P
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 201 FREPDV------------WTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
R P+V + +D +CL +P++R ++S++L+HEF
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 56/233 (24%), Positives = 87/233 (37%), Gaps = 72/233 (30%)
Query: 44 TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKT 103
L+E +I + L+G+ YLH +HRDIKA
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAA-------------------------- 144
Query: 104 LFRLKAGNILLNTEGHAKLADFGVAGQLTD---------TMAKRN--TVIGTPFWMAPE- 151
NIL++ +G K+ADFG+A R ++ T ++ PE
Sbjct: 145 -------NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197
Query: 152 VIQEIGYDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIFMI---PTKPP------- 198
++ E Y D+W +G EM +P DI + IF + PT+
Sbjct: 198 LLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL 257
Query: 199 PSFREPDVWT--------------PEFIDFVSRCLVKNPEERATASEMLNHEF 237
P +T PE +D +S+ L +P +R TAS+ L H +
Sbjct: 258 PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-14
Identities = 64/268 (23%), Positives = 99/268 (36%), Gaps = 84/268 (31%)
Query: 14 GSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72
GS + ++IV EY D+ L + LSE+ + L+GL+Y+H +HR
Sbjct: 83 GSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHR 138
Query: 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLADFGVA--- 128
D LK N+ +NTE K+ DFG+A
Sbjct: 139 D---------------------------------LKPANVFINTEDLVLKIGDFGLARIV 165
Query: 129 -------GQLTDTMAKRNTVIGTPFWMAPE-VIQEIGYDCVADMWSLGITALEMAEGKPP 180
G L++ + T ++ +P ++ Y DMW+ G EM GKP
Sbjct: 166 DPHYSHKGYLSEGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
Query: 181 YGDIHPMRAIFMIPTKPP--------------PSFREPDVWTP-------------EFID 213
+ H + + +I P PSF D P E +D
Sbjct: 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALD 278
Query: 214 FVSRCLVKNPEERATASEMLNHEFIQRH 241
F+ + L NP +R TA E L H ++ +
Sbjct: 279 FLEQILTFNPMDRLTAEEALMHPYMSCY 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 70/264 (26%), Positives = 106/264 (40%), Gaps = 87/264 (32%)
Query: 21 DLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D++IV E +D+ +L + + LS D I L L+GL+Y+H +HRD
Sbjct: 82 DVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRD------ 131
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA----------G 129
LK N+LLNT K+ DFG+A G
Sbjct: 132 ---------------------------LKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 130 QLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMAEGKP--------- 179
LT+ +A R ++ APE+ + GY D+WS+G EM +P
Sbjct: 165 FLTEYVATR-------WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217
Query: 180 -----------PYGD----IHPMRA---IFMIPTKPPPSFRE--PDVWTPEFIDFVSRCL 219
P + I +RA I +P KP + + P+ P+ +D + + L
Sbjct: 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLDKML 276
Query: 220 VKNPEERATASEMLNHEFI-QRHD 242
NP +R T E L H ++ Q HD
Sbjct: 277 TFNPHKRITVEEALAHPYLEQYHD 300
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-14
Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 48/244 (19%)
Query: 7 PYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTLKGLEY 63
P++ + + S F+ D L+ VMEY G D+M ++ E + GL +
Sbjct: 61 PFLTQLH-SCFQTMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
LH + I+RD+K LD N++L+ EGH K+A
Sbjct: 117 LHSKGIIYRDLK----------LD-----------------------NVMLDAEGHIKIA 143
Query: 124 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183
DFG+ + T GTP ++APE+I Y D W+ G+ EM G+PP+ D
Sbjct: 144 DFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-D 202
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----ATAS-EMLNHEFI 238
+F + S+ P + E + L K+P +R T ++ H F
Sbjct: 203 GEDEDELFQSIMEHNVSY--PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
Query: 239 QRHD 242
+R D
Sbjct: 261 RRID 264
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 40/186 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +SP+VV+ + ++ + L++VMEY G + ++M + E + +
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLA 154
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+ +H IHRD+K N+LL+ GH
Sbjct: 155 LDAIHSMGLIHRDVKPD---------------------------------NMLLDKHGHL 181
Query: 121 KLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQEIG----YDCVADMWSLGITALEMA 175
KLADFG ++ +T M + +T +GTP +++PEV++ G Y D WS+G+ EM
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
Query: 176 EGKPPY 181
G P+
Sbjct: 242 VGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-14
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 36/189 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P++V + S+ L+ V+++ G + ++ R+++ E +
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASA 108
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH ++RD LK NILL+++GH
Sbjct: 109 LGYLHSINIVYRD---------------------------------LKPENILLDSQGHV 135
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
L DFG+ + T GTP ++APEVI++ YD D W LG EM G PP
Sbjct: 136 VLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
Query: 181 Y--GDIHPM 187
+ D+ M
Sbjct: 196 FYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 43/244 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P +V+ G K L +VME G + ++ +++ + ++ + G
Sbjct: 50 MAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMG 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL + +HRD L A N+LL A
Sbjct: 108 MAYLESKHFVHRD---------------------------------LAARNVLLVNRHQA 134
Query: 121 KLADFGVAGQL-TDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG++ L + R T G P W APE I + +D+WS G+T E +
Sbjct: 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
G PYG++ I M+ + P+ E + C PE+R T SE+
Sbjct: 195 GAKPYGEMKGAEVIAMLESG--ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL--ES 250
Query: 237 FIQR 240
+R
Sbjct: 251 TFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 34/175 (19%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P++V + S+ L+ V++Y G + ++ R++ E + + YLH
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHS 114
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
I+RD LK NILL+++GH L DFG
Sbjct: 115 LNIIYRD---------------------------------LKPENILLDSQGHVVLTDFG 141
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
+ + + +T GTP ++APEV+++ YD D W LG EM G PP+
Sbjct: 142 LCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 48/222 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D+PY+V+ G + L +VME G ++ + +K ++ + ++ G
Sbjct: 49 MHQLDNPYIVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL + +HRD L A N+LL + +A
Sbjct: 108 MKYLEGKNFVHRD---------------------------------LAARNVLLVNQHYA 134
Query: 121 KLADFGVAGQL--TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L D+ K + P W APE I + +D+WS GIT E +
Sbjct: 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSY 194
Query: 177 GKPPYGDIHPMRAIFMI--------PTKPPPSFRE--PDVWT 208
G+ PY + + I P + PP D W
Sbjct: 195 GQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWI 236
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 56/237 (23%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D ++ + ++ +L++VM+Y G + ++ + L ED L + + ++ +
Sbjct: 59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H +HRDIK N+LL+ GH +LAD
Sbjct: 119 HQLGYVHRDIKPD---------------------------------NVLLDKNGHIRLAD 145
Query: 125 FGVAGQL-TDTMAKRNTVIGTPFWMAPEVIQEIG-----YDCVADMWSLGITALEMAEGK 178
FG +L D + N +GTP +++PE++Q + Y D WSLG+ EM G+
Sbjct: 146 FGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
Query: 179 PP---------YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
P YG I + F P DV + E D + R L+ +PE R
Sbjct: 206 TPFYAESLVETYGKIMNHKEHFQFPPD------VTDV-SEEAKDLIRR-LICSPETR 254
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 62/246 (25%), Positives = 97/246 (39%), Gaps = 48/246 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD---- 56
M D +++ YG + L +V E GS+ D RLRK L I + LCD
Sbjct: 50 MHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLD--RLRKDALGHFLI-STLCDYAVQ 105
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
G+ YL +R IHRD L A NILL +
Sbjct: 106 IANGMRYLESKRFIHRD---------------------------------LAARNILLAS 132
Query: 117 EGHAKLADFGVAGQL--TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE 173
+ K+ DFG+ L + + PF W APE ++ + +D+W G+T E
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192
Query: 174 M-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
M G+ P+ + + + I K P+ + + + +C NP +R T + +
Sbjct: 193 MFTYGEEPWAGLSGSQILKKI-DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
Query: 233 LNHEFI 238
EF+
Sbjct: 252 --REFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 59/249 (23%), Positives = 95/249 (38%), Gaps = 63/249 (25%)
Query: 18 KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77
+ L +V EYC +V + + + + E I I+ TL+ + + H IHRD+K
Sbjct: 71 RKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129
Query: 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK 137
NIL+ +G KL DFG A LT
Sbjct: 130 ---------------------------------NILITKQGQIKLCDFGFARILTGPGDD 156
Query: 138 RNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKPPY--------------- 181
+ T ++ APE++ + Y D+W++G E+ G+P +
Sbjct: 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKT 216
Query: 182 -GDIHPM-RAIFMIP------TKPPPSFREP-----DVWTPEFIDFVSRCLVKNPEERAT 228
GD+ P + IF + P P REP + + F+ CL +P ER +
Sbjct: 217 LGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276
Query: 229 ASEMLNHEF 237
E+L H +
Sbjct: 277 CEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 58/254 (22%), Positives = 105/254 (41%), Gaps = 69/254 (27%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D+++V GA +++I++ +K L++D + ++ L+GL+Y+H IHRD
Sbjct: 96 DVYLVTHLMGA-DLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRD------- 145
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK N+ +N + K+ DFG+A D M
Sbjct: 146 --------------------------LKPSNLAVNEDCELKILDFGLARHTDDEMTG--- 176
Query: 141 VIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGK---PPYGDIHPMRAIFMIPTK 196
+ T ++ APE++ + Y+ D+WS+G E+ G+ P I ++ I +
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 197 PPPSFRE----------------------PDVW---TPEFIDFVSRCLVKNPEERATASE 231
P + +V+ P +D + + LV + ++R TA++
Sbjct: 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296
Query: 232 MLNHE-FIQRHDTD 244
L H F Q HD D
Sbjct: 297 ALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 85/270 (31%)
Query: 24 IVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81
+VM+ SD+ ++ RK L+E ++ IL L GL LH +HRD
Sbjct: 97 LVMDIMA----SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD-------- 144
Query: 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA-----GQLTDTMA 136
L NI +N++G K+ADFG+A +DT++
Sbjct: 145 -------------------------LSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 137 KRNTV---------IGTPFWMAPEVIQEIGYDC---VADMWSLGITALEMAEGKPPY--- 181
K T+ + T ++ APE++ +G + DMWS+G E+ GKP +
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELL--MGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 182 GDIHPMRAIFMI---------------PTKPPPSFREPDVWTPEF-------IDFVSRCL 219
+I + IF + P + R+P F ID + L
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 220 VKNPEERATASEMLNHEFIQRHDT--DPSQ 247
NP ER +A E L HE+ + DPSQ
Sbjct: 298 KLNPLERISAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-13
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 34/181 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P++V + S+ L+ V++Y G + ++ R++ E +
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASA 108
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH ++RD LK NILL+++GH
Sbjct: 109 LGYLHSLNIVYRD---------------------------------LKPENILLDSQGHI 135
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
L DFG+ + + +T GTP ++APEV+ + YD D W LG EM G PP
Sbjct: 136 VLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
Query: 181 Y 181
+
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 35/183 (19%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
+ P++V + + + L+ V+E+ G + M+ R++ L E+ + L
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLAL 109
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+LH R I+RD+K LD N+LL+ EGH K
Sbjct: 110 NFLHERGIIYRDLK----------LD-----------------------NVLLDAEGHIK 136
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
L D+G+ + +T GTP ++APE+++ Y D W+LG+ EM G+ P+
Sbjct: 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 182 GDI 184
DI
Sbjct: 197 -DI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 40/186 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +S ++V+ + ++ + L++VMEY G + ++M + E + +
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLA 154
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+ +H IHRD+K N+LL+ GH
Sbjct: 155 LDAIHSMGFIHRDVKPD---------------------------------NMLLDKSGHL 181
Query: 121 KLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVIQEIGYDCV----ADMWSLGITALEMA 175
KLADFG ++ + M + +T +GTP +++PEV++ G D D WS+G+ EM
Sbjct: 182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 176 EGKPPY 181
G P+
Sbjct: 242 VGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-13
Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 36/176 (20%)
Query: 7 PYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P++V + S F+ D L+ V++Y G + ++ R+++ E + L YLH
Sbjct: 56 PFLVGLHYS-FQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLH 113
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
I+RD LK NILL+++GH L DF
Sbjct: 114 SLNIIYRD---------------------------------LKPENILLDSQGHVVLTDF 140
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
G+ + + +T GTP ++APEV+++ YD D W LG EM G PP+
Sbjct: 141 GLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-13
Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQ D+PY+V+ G + +VME G ++ ++ + K ++E I ++ G
Sbjct: 50 MQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQ-KNKHVTEKNITELVHQVSMG 107
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A N+LL T+ +A
Sbjct: 108 MKYLEETNFVHRD---------------------------------LAARNVLLVTQHYA 134
Query: 121 KLADFGVAGQLT--DTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L + K T P W APE + + +D+WS G+ E +
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSY 194
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
G+ PY + MI + P PE D + C +ER
Sbjct: 195 GQKPYKGMKGNEVTQMIESG--ERMECPQRCPPEMYDLMKLCWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 9e-13
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 33/196 (16%)
Query: 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVS-DIMRLRKK--TLSEDEIATILC 55
M++ +V+Y + N L+I+ME+C AG +S +I + K + E I I
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 56 DTLKGLEYLHL-------RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLK 108
L L Y H R +HRD+K N+ + + + ++
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQ----------------NIFLSTGIRHIGKIT 169
Query: 109 AGNILLNTEGHAKLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVI--QEIGYDCVADMW 165
A LN AK+ DFG++ + ++MA ++ +GTP++ +PE++ + YD +DMW
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 166 SLGITALEMAEGKPPY 181
+LG E+ GK P+
Sbjct: 228 ALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 52/209 (24%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D+ ++ + ++ +L++VM+Y G + ++ + L ED L + + ++ +
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H +HRDIK NIL++ GH +LAD
Sbjct: 119 HQLHYVHRDIKPD---------------------------------NILMDMNGHIRLAD 145
Query: 125 FGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQEI-------GYDCVADMWSLGITALEMAE 176
FG +L D + + +GTP +++PE++Q + G +C D WSLG+ EM
Sbjct: 146 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPEC--DWWSLGVCMYEMLY 203
Query: 177 GKPP---------YGDIHPMRAIFMIPTK 196
G+ P YG I + F P +
Sbjct: 204 GETPFYAESLVETYGKIMNHKERFQFPAQ 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 73/250 (29%)
Query: 23 WIVMEYCGAGSVSDIMRLRKKTL---SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
++V EY D+M L + L SED I + + L+GL Y H + +HRDIK
Sbjct: 92 YLVFEYMD----HDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIK---- 143
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR- 138
CS NILLN +G KLADFG+A +L ++ R
Sbjct: 144 ---------CS--------------------NILLNNKGQIKLADFGLA-RLYNSEESRP 173
Query: 139 --NTVIGTPFWMAPE-VIQEIGYDCVADMWSLGITALEMAEGKP---------------- 179
N VI T ++ PE ++ E Y D+WS G E+ KP
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232
Query: 180 ----PYGDIHP--MRAIFMIPTKPPPSFR-----EPDVWTPEFIDFVSRCLVKNPEERAT 228
P + P ++ + KP +R E +D + L +P +R T
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292
Query: 229 ASEMLNHEFI 238
A E LN ++
Sbjct: 293 AEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 40/186 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +SP+VV+ + ++ + L++VMEY G + ++M + E + +
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLA 154
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+ +H IHRD+K N+LL+ GH
Sbjct: 155 LDAIHSMGFIHRDVKPD---------------------------------NMLLDKSGHL 181
Query: 121 KLADFGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQEIG----YDCVADMWSLGITALEMA 175
KLADFG ++ + M + +T +GTP +++PEV++ G Y D WS+G+ EM
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 176 EGKPPY 181
G P+
Sbjct: 242 VGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 58/218 (26%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
L + I ++ L+GL++LH +HRD
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRD------------------------------- 133
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164
LK NIL+ + G KLADFG+A + MA V+ T ++ APEV+ + Y DM
Sbjct: 134 --LKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEVLLQSTYATPVDM 190
Query: 165 WSLGITALEMAEGKPPY-GD-----IHPMRAIFMIPTK--------------PPPSFREP 204
WS+G EM KP + G+ + + + +P + P R
Sbjct: 191 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPV 250
Query: 205 DVWTPEFIDFVSRCLVK----NPEERATASEMLNHEFI 238
PE + ++ L++ NP +R +A L H F
Sbjct: 251 QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-12
Identities = 61/255 (23%), Positives = 97/255 (38%), Gaps = 72/255 (28%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D ++VM Y +D+ ++ LSED++ ++ L GL+Y+H IHRD
Sbjct: 94 DFYLVMPYM----QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD------- 142
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK GN+ +N + K+ DFG+A M
Sbjct: 143 --------------------------LKPGNLAVNEDCELKILDFGLARHADAEMTG--- 173
Query: 141 VIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPY------------------ 181
+ T ++ APEVI + Y+ D+WS+G EM GK +
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233
Query: 182 ---------GDIHPMRAIFMIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATAS 230
D I +P P F P +P+ +D + + L + ++R TA+
Sbjct: 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELDVDKRLTAT 292
Query: 231 EMLNHEFI-QRHDTD 244
E L H + D D
Sbjct: 293 EALEHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 51/188 (27%), Positives = 73/188 (38%), Gaps = 39/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D P+VV+ G + + ++ + G + D +R K + + KG
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +R +HRD L A N+L+ T H
Sbjct: 122 MSYLEEKRLVHRD---------------------------------LAARNVLVKTPQHV 148
Query: 121 KLADFGVAGQLTDTMAKRNTVIG--TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K+ DFG+A +L D K G P WMA E I Y +D+WS G+T E M
Sbjct: 149 KITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207
Query: 177 GKPPYGDI 184
G PY I
Sbjct: 208 GAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 100/300 (33%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---MRLRKKTLSEDEIATILCDT 57
+ + D+ +VV+ Y S+ +L+ VM+Y G + + M + + L+ IA + C
Sbjct: 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC-- 112
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
+E +H IHRDIK NIL++ +
Sbjct: 113 --AVESVHKMGFIHRDIKPD---------------------------------NILIDRD 137
Query: 118 GHAKLADFGVAGQL----------------TDTM------------------------AK 137
GH KL DFG+ D+M A
Sbjct: 138 GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA 197
Query: 138 R-------NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP---- 186
R ++++GTP ++APEV+ GY + D WS+G+ EM G+PP+ P
Sbjct: 198 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ 257
Query: 187 MRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFIQRHD 242
M+ I + PP + +PE D + + L + PE+R A E+ H F + D
Sbjct: 258 MKVINWQTSLHIPPQAK----LSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 73/299 (24%), Positives = 111/299 (37%), Gaps = 102/299 (34%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
DSP+VV Y S+ L+++ME+ G + M ++ T SED + + + +E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLM-TMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H IHRDI K NIL++ GH KL+D
Sbjct: 118 HKLGFIHRDI---------------------------------KPDNILIDRGGHIKLSD 144
Query: 125 FGVA-----------------------------GQLTD----TMAKRNTV---------- 141
FG++ D TM+ ++ +
Sbjct: 145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLM 204
Query: 142 ----IGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP---MRAIFMIP 194
+GTP ++APE+ + GY D WSLG E G PP+ + R I
Sbjct: 205 AYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII--- 261
Query: 195 TKPPPSFRE----PD--VWTPEFIDFVSRCLVKNPEE---RATASEMLNHEFIQRHDTD 244
++RE PD + E D + R L+ N E R A E+ +H F + D D
Sbjct: 262 -----NWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLGRGGAHEIKSHPFFRGVDWD 314
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-12
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 44/179 (24%)
Query: 3 QCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
Q D +VKY G + +L +VMEY GS+ D ++ ++ L ++ KG
Sbjct: 63 QHD--NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL +R +HRD L NIL+ +E
Sbjct: 121 MEYLGSKRYVHRD---------------------------------LATRNILVESENRV 147
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTP-----FWMAPEVIQEIGYDCVADMWSLGITALEM 174
K+ DFG+ L K + P FW APE + E + +D+WS G+ E+
Sbjct: 148 KIGDFGLTKVLP--QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 43/185 (23%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D ++ + ++ L++VM+Y G + ++ + L ED + + + + +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H +HRDIK N+LL+ GH +LAD
Sbjct: 119 HQLHYVHRDIKPD---------------------------------NVLLDMNGHIRLAD 145
Query: 125 FGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEI-------GYDCVADMWSLGITALEMAE 176
FG ++ +++V +GTP +++PE++Q + G +C D WSLG+ EM
Sbjct: 146 FGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC--DWWSLGVCMYEMLY 203
Query: 177 GKPPY 181
G+ P+
Sbjct: 204 GETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 42/236 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+Q D P++VK G +N +WIVME G + +++ K +L +
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YL +R +HRDI A N+L+++
Sbjct: 120 LAYLESKRFVHRDI---------------------------------AARNVLVSSPDCV 146
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEGK 178
KL DFG++ L D + + P WMAPE I + +D+W G+ E + G
Sbjct: 147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGV 206
Query: 179 PPYGDIHPMRAIFMIP--TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
P+ + I I + P P P +++C +P +R +E+
Sbjct: 207 KPFQGVKNNDVIGRIENGERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 58/244 (23%)
Query: 18 KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77
+ T L +V E+ + + ++ + + + I ++ L+GL++LH R +HRD
Sbjct: 80 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD---- 135
Query: 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK 137
LK NIL+ + G KLADFG+A ++
Sbjct: 136 -----------------------------LKPQNILVTSSGQIKLADFGLA-RIYSFQMA 165
Query: 138 RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY---GDIHPMRAIFMIP 194
+V+ T ++ APEV+ + Y D+WS+G EM KP + D+ + I +
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
Query: 195 TKPPPSFREPDVWTPE-------------FI--------DFVSRCLVKNPEERATASEML 233
P DV P F+ D + +CL NP +R +A L
Sbjct: 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
Query: 234 NHEF 237
+H +
Sbjct: 286 SHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-12
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 18 KNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76
+ L+IV EY GS+ D +R R ++ L D + D + +EYL +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD--- 127
Query: 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA 136
L A N+L++ + AK++DFG+ + + T
Sbjct: 128 ------------------------------LAARNVLVSEDNVAKVSDFGLTKEASST-- 155
Query: 137 KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIP- 194
++T W APE ++E + +D+WS GI E+ G+ PY I P++ + +P
Sbjct: 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDV--VPR 211
Query: 195 TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
+ PD P D + +C + R +
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPS 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-12
Identities = 58/260 (22%), Positives = 108/260 (41%), Gaps = 65/260 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---------------- 44
++Q + P+V+K YG+ ++ L +++EY GS+ +R +K
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 45 LSEDEIATILCDTL-------KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97
+ DE A + D + +G++YL + +HRD
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD------------------------ 152
Query: 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQE 155
L A N+L+ K++DFG++ + D+ KR+ WMA E + +
Sbjct: 153 ---------LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203
Query: 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFI 212
Y +D+WS G+ E+ G PY I P R ++ T +R P+ + E
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT----GYRMERPENCSEEMY 259
Query: 213 DFVSRCLVKNPEERATASEM 232
+ + C + P++R T +++
Sbjct: 260 NLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 57/199 (28%), Positives = 80/199 (40%), Gaps = 37/199 (18%)
Query: 40 LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99
L KK L+ +++ KG+E+L R+ IHRD
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRD-------------------------- 204
Query: 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIG 157
L A NILL+ K+ DFG+A + D R P WMAPE I +
Sbjct: 205 -------LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 158 YDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVS 216
Y +D+WS G+ E+ + G PY + + F K R PD TPE +
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316
Query: 217 RCLVKNPEERATASEMLNH 235
C P +R T SE++ H
Sbjct: 317 DCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 61/258 (23%), Positives = 107/258 (41%), Gaps = 75/258 (29%)
Query: 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
++++V GA +++I++ +K LS++ + ++ L+GL+Y+H IHRD
Sbjct: 93 NEVYLVTNLMGA-DLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIHSAGIIHRD------ 143
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK N+ +N + ++ DFG+A Q D M
Sbjct: 144 ---------------------------LKPSNVAVNEDCELRILDFGLARQADDEMTG-- 174
Query: 140 TVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGK---PPYGDIHPMRAIFMIPT 195
+ T ++ APE++ + Y+ D+WS+G E+ +GK P I ++ I +
Sbjct: 175 -YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
Query: 196 KPPPS----------------------------FREPDVWTPEFIDFVSRCLVKNPEERA 227
P P FR + P ID + + LV + ++R
Sbjct: 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGAN---PLAIDLLEKMLVLDSDKRI 290
Query: 228 TASEMLNHE-FIQRHDTD 244
+ASE L H F Q HD +
Sbjct: 291 SASEALAHPYFSQYHDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 92/296 (31%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + D+ +VVK Y S+ +L+ VM+Y G + ++ +R + E + +
Sbjct: 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFPEVLARFYIAELTLA 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+E +H IHRDIK NIL++ +GH
Sbjct: 114 IESVHKMGFIHRDIKPD---------------------------------NILIDLDGHI 140
Query: 121 KLADFGVA-------------------------------------GQLTDTMAKR----- 138
KL DFG+ G T+ +R
Sbjct: 141 KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH 200
Query: 139 -----NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI 193
++++GTP ++APEV+ GY + D WS+G+ EM G+PP+ P +
Sbjct: 201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260
Query: 194 -----PTKPPPSFREPDVWTPEFIDFVSR--CLVKNPEERATASEMLNHEFIQRHD 242
PP + +PE +D +++ C + R A ++ H F D
Sbjct: 261 INWENTLHIPPQVK----LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-11
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 39/185 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + +V+ YG K ++IV EY G + + +R K ++ + D +G
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL ++ IHRD L A N L++ +G
Sbjct: 113 MAYLESKQFIHRD---------------------------------LAARNCLVDDQGCV 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG++ + D + + +G+ F W PEV+ + +D+W+ G+ E+ +
Sbjct: 140 KVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197
Query: 177 GKPPY 181
GK PY
Sbjct: 198 GKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 52/249 (20%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D P++V ++ L +++ G + + + SE E+ + + GLE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHM 113
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H R ++RD LK NILL+ GH +++D
Sbjct: 114 HNRFVVYRD---------------------------------LKPANILLDEHGHVRISD 140
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPY-- 181
G+A + K + +GT +MAPEV+Q+ YD AD +SLG ++ G P+
Sbjct: 141 LGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
Query: 182 ---GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEML 233
D H + + + + PD ++PE + L ++ +R A E+
Sbjct: 199 HKTKDKHEIDRMTLT-----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVK 253
Query: 234 NHEFIQRHD 242
H F + D
Sbjct: 254 EHVFFKGID 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 65/255 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEI---------- 50
M++ + +VV+ G +VME G + +R R+ E E
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRR---PEAENNPGLGPPTLQ 119
Query: 51 -----ATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLF 105
A + D G+ YL ++ +HRD
Sbjct: 120 KFIQMAAEIAD---GMAYLAAKKFVHRD-------------------------------- 144
Query: 106 RLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVAD 163
L A N ++ + K+ DFG+ + +T R G P WMAPE +++ + +D
Sbjct: 145 -LAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 164 MWSLGITALEMAE-GKPPY-GDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCL 219
+WS G+ EMA + PY G + F+I P PD + + C
Sbjct: 204 VWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE-NCPDKLL----ELMRMCW 258
Query: 220 VKNPEERATASEMLN 234
NP+ R T E+++
Sbjct: 259 QYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 65/236 (27%)
Query: 43 KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYK 102
+TLS+D L L+GL+Y+H +HRD
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRD----------------------------- 133
Query: 103 TLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDCV 161
LK N+LLN K+ DFG+A ++ + T ++ APE++ Y
Sbjct: 134 ----LKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA 189
Query: 162 ADMWSLGITALEMAEGKP--PYGD-IHPMRAIFMI------------------------P 194
D+WS+G E+ KP P D +H ++ I + P
Sbjct: 190 IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP 249
Query: 195 TKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQN 248
P SF P P ID + + LV +P +R T E L H ++ DPS
Sbjct: 250 YTPRQSFARLFPHA-NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH-DPSDE 303
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 35/182 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEIATILCDTLK 59
+++ +S +VV +Y L +V+ G + I + E+ +
Sbjct: 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GLE LH R ++RD LK NILL+ GH
Sbjct: 114 GLEDLHRERIVYRD---------------------------------LKPENILLDDYGH 140
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
+++D G+A ++ + R V GT +MAPEV++ Y D W LG EM EGK
Sbjct: 141 IRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 180 PY 181
P+
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 69/259 (26%), Positives = 104/259 (40%), Gaps = 75/259 (28%)
Query: 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDE-IATILCDTLKGLEYLHLRRKIHRDIKAGS 78
D++ V E G +D+ RL E + I L L+GL+Y+H +HRD
Sbjct: 83 EDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD----- 133
Query: 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 138
LK NIL+N K+ DFG+A M
Sbjct: 134 ----------------------------LKPSNILINENCDLKICDFGLARIQDPQMTG- 164
Query: 139 NTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEGKPPY-GDIH--------- 185
+ T ++ APE++ Q+ YD D+WS G EM EGKP + G H
Sbjct: 165 --YVSTRYYRAPEIMLTWQK--YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
Query: 186 -----PMRAIFMIPTKPPPSF------REPDVWT-------PEFIDFVSRCLVKNPEERA 227
P I I ++ F REP ++ P ID + + LV +P++R
Sbjct: 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280
Query: 228 TASEMLNHEFIQRHDTDPS 246
+A+E L H ++ + DP+
Sbjct: 281 SAAEALAHPYLAPYH-DPT 298
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 64/209 (30%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+G+ Y H R +HRD LK N+L++ E
Sbjct: 109 LQGIAYCHSHRVLHRD---------------------------------LKPQNLLIDRE 135
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEM 174
G KLADFG+A + + T ++ APE++ +G Y D+WS+G EM
Sbjct: 136 GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL--LGSRQYSTPVDIWSIGCIFAEM 193
Query: 175 AEGKPPY-GD--IHPMRAIFMIPTKP-----P-----PSFR------EPDVWT------- 208
+P + GD I + IF P P P ++ +
Sbjct: 194 VNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLD 253
Query: 209 PEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ +D +S+ LV +P +R +A L H +
Sbjct: 254 EDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-11
Identities = 57/236 (24%), Positives = 88/236 (37%), Gaps = 41/236 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q D P +VK G + ++IVME G +R +K L ++ D G
Sbjct: 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAG 105
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL + IHRD L A N L+
Sbjct: 106 MAYLESKNCIHRD---------------------------------LAARNCLVGENNVL 132
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEGK 178
K++DFG++ Q D + + + P W APE + Y +D+WS GI E + G
Sbjct: 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGV 192
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEM 232
PY + +A + +R P + + RC PE R SE+
Sbjct: 193 CPYPGMTNQQAREQVEK----GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-11
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 59/241 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M+Q P +V+ Y + ++I+ EY GS+ D ++ + L+ +++ + +
Sbjct: 55 MKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ ++ + IHRD L+A NIL++
Sbjct: 114 GMAFIERKNYIHRD---------------------------------LRAANILVSETLC 140
Query: 120 AKLADFGVAGQLTDT--MAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEM 174
K+ADFG+A + D A+ G F W APE I + +D+WS GI E+
Sbjct: 141 CKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196
Query: 175 AE-GKPPY-GDIHP-----MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
G+ PY G +P + + +P PD E + + C + PEER
Sbjct: 197 VTYGRIPYPGMTNPEVIQNLERGYRMP--------RPDNCPEELYELMRLCWKEKPEERP 248
Query: 228 T 228
T
Sbjct: 249 T 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-11
Identities = 63/250 (25%), Positives = 98/250 (39%), Gaps = 41/250 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D+P+V + G +T + ++ + G + D +R K + + KG
Sbjct: 63 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL RR +HRD L A N+L+ T H
Sbjct: 122 MNYLEERRLVHRD---------------------------------LAARNVLVKTPQHV 148
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K+ DFG+A L + + G P WMA E I Y +D+WS G+T E M G
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 208
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
PY I P I I K +P + T + + +C + + + R E++ EF
Sbjct: 209 SKPYDGI-PASEISSILEK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII-EF 265
Query: 238 IQRHDTDPSQ 247
+ DP +
Sbjct: 266 SKMA-RDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-11
Identities = 64/248 (25%), Positives = 97/248 (39%), Gaps = 41/248 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D Y+V+ G L +V + GS+ D +R + +L + KG
Sbjct: 63 MGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL R +HR+ L A NILL ++
Sbjct: 122 MYYLEEHRMVHRN---------------------------------LAARNILLKSDSIV 148
Query: 121 KLADFGVAGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
++ADFGVA L D + TP WMA E I Y +D+WS G+T E M+ G
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
PY + P ++ + +P + T + + +C + + R T E+ N EF
Sbjct: 209 AEPYAGMRPHEVPDLL--EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN-EF 265
Query: 238 IQRHDTDP 245
R DP
Sbjct: 266 -TRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 35/182 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEIATILCDTLK 59
+++ +S +VV +Y L +V+ G + I + E+ + L
Sbjct: 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC 113
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GLE LH ++RD LK NILL+ GH
Sbjct: 114 GLEDLHRENTVYRD---------------------------------LKPENILLDDYGH 140
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
+++D G+A ++ + + R V GT +MAPEV+ Y D W LG EM EG+
Sbjct: 141 IRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 180 PY 181
P+
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-11
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTLKGLEYL 64
P++ + + + L+ VMEY G D+M ++ E + GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H + I+RD+K LD N++L++EGH K+AD
Sbjct: 118 HSKGIIYRDLK----------LD-----------------------NVMLDSEGHIKIAD 144
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
FG+ + T GTP ++APE+I Y D W+ G+ EM G+ P+
Sbjct: 145 FGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 61/262 (23%), Positives = 94/262 (35%), Gaps = 68/262 (25%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATI---LCDTLKGLEY 63
+V+ Y + L +V EYC D+ + + + + + LKGL +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA 123
H +HRD LK N+L+N G KLA
Sbjct: 115 CHSHNVLHRD---------------------------------LKPQNLLINKNGELKLA 141
Query: 124 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAE-GKP-- 179
DFG+A + + + T ++ P+V+ Y DMWS G E+A G+P
Sbjct: 142 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201
Query: 180 PYGDIH-PMRAIFMI---PT-------------KPPPSFREPDVW-------TPEFIDFV 215
P D+ ++ IF + PT KP P + D +
Sbjct: 202 PGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLL 261
Query: 216 SRCLVKNPEERATASEMLNHEF 237
LV NP +R +A E L H +
Sbjct: 262 QNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 31/75 (41%), Positives = 42/75 (56%), Gaps = 1/75 (1%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
LK NILL+ GH +++D G+A Q+ + R V GT +MAPEVI Y D W
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFSPDWWG 186
Query: 167 LGITALEMAEGKPPY 181
LG EM +G+ P+
Sbjct: 187 LGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 52/180 (28%), Positives = 73/180 (40%), Gaps = 37/180 (20%)
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+G+E+L R+ IHRD L A NILL+
Sbjct: 184 RGMEFLASRKCIHRD---------------------------------LAARNILLSENN 210
Query: 119 HAKLADFGVAGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEM-A 175
K+ DFG+A + D R P WMAPE I + Y +D+WS G+ E+ +
Sbjct: 211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
G PY + + F K R P+ TPE + C NPE+R T SE++
Sbjct: 271 LGASPYPGVQ-IDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 46/241 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q D P +VK G + ++IVME GS+ +R +K L+ ++ + D G
Sbjct: 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAG 105
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL + IHRD L A N L+
Sbjct: 106 MEYLESKNCIHRD---------------------------------LAARNCLVGENNVL 132
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALEM-AEG 177
K++DFG++ + + + + P W APE + Y +D+WS GI E + G
Sbjct: 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG 192
Query: 178 KPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVSRCLVKNPEERATASEML 233
PY + + I + P P PE I + +C +PE R + SE+
Sbjct: 193 DTPYPGMSNQQTRERIESGYRMPAPQL------CPEEIYRLMLQCWAYDPENRPSFSEIY 246
Query: 234 N 234
N
Sbjct: 247 N 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 68/213 (31%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+GL Y+H + +HRD LK N+L++
Sbjct: 113 LRGLAYIHGQHILHRD---------------------------------LKPQNLLISYL 139
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDCVADMWSLGITALEMAE 176
G KLADFG+A + ++ + T ++ P+V+ Y D+W G +EM +
Sbjct: 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199
Query: 177 GKPPYG-------DIHPMRAIFMIPTK--------------------PPPSFREPDVW-- 207
G+P + + + + +PT+ P R VW
Sbjct: 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLR--VVWKR 257
Query: 208 ---TPEFIDFVSRCLVKNPEERATASEMLNHEF 237
P+ D S+ L+ P++R +A + L H +
Sbjct: 258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 63/217 (29%)
Query: 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
I T L L+G+ Y H R +HRD+K + L+ DR TN +
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQN--LLIDRR----------TNAL--------- 142
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWS 166
KLADFG+A + + T ++ APE++ +G Y D+WS
Sbjct: 143 -----------KLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL--LGSRHYSTPVDIWS 189
Query: 167 LGITALEMAEGKPPY-GD--IHPMRAIFMIPTKPP-----------------PSFREPDV 206
+G EM KP + GD I + IF I P P + D+
Sbjct: 190 VGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDL 249
Query: 207 WT------PEFIDFVSRCLVKNPEERATASEMLNHEF 237
T P +D +S+ L +P +R TA L HE+
Sbjct: 250 ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 42/208 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P ++ G K+ + I+ E+ G++ +R + ++ +L G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 119 MKYLSEMNYVHRD---------------------------------LAARNILVNSNLVC 145
Query: 121 KLADFGVAGQLTDTMAK--RNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-M 174
K++DFG++ L D + + +G W APE I + +D+WS GI E M
Sbjct: 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
Query: 175 AEGKPPYGDIHPMRAIFMIPTK---PPP 199
+ G+ PY D+ I I PPP
Sbjct: 206 SYGERPYWDMSNQDVINAIEQDYRLPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 51/209 (24%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
SE E+ + + GLE++H R ++RD
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRD------------------------------- 122
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVAD 163
LK NILL+ GH +++D G+A + K + +GT +MAPEV+Q+ + YD AD
Sbjct: 123 --LKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 164 MWSLGITALEMAEGKPPY-----GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRC 218
+SLG ++ G P+ D H + M T PD ++PE +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTMAV---ELPDSFSPELRSLLEGL 233
Query: 219 LVKNPEER-----ATASEMLNHEFIQRHD 242
L ++ R A E+ H F + D
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 38/162 (23%)
Query: 22 LWIVMEYCGAGSVSDIMRLRKKTL-SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
L+IVME G++ + +R R + L S ++ D +G+EYL ++ +HRD
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD------- 125
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
L A NIL++ +G AK++DFG+A +M N+
Sbjct: 126 --------------------------LAARNILVSEDGVAKVSDFGLAR--VGSMGVDNS 157
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPPY 181
+ W APE ++ + +D+WS G+ E+ + G+ PY
Sbjct: 158 KLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 72/237 (30%)
Query: 33 SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIK 92
++ ++++ RK+ L E + + + LK L+++H HRDIK
Sbjct: 85 NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPE--------------- 129
Query: 93 CNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWM 148
NIL+ + KLADFG + + T I T ++
Sbjct: 130 ------------------NILIKDD-ILKLADFGSCRGIYSKPPYT-----EYISTRWYR 165
Query: 149 APEVIQEIG-YDCVADMWSLGITALEMAEGKP--PYGD-------IH-----PMRAI--- 190
APE + G Y D+W++G E+ P P + IH P +
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225
Query: 191 --------FMIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ P+K R+ P+ + E +D + + L +P+ER TA + L H +
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNA-SAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 35/182 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMRLRKKTLSEDEIATILCDTLK 59
+++ +S +VV +Y L +V+ G + I + + E +
Sbjct: 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GLE LH R ++RD LK NILL+ GH
Sbjct: 114 GLEDLHQERIVYRD---------------------------------LKPENILLDDHGH 140
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
+++D G+A + + + V GT +MAPEV++ Y D W+LG EM G+
Sbjct: 141 IRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 180 PY 181
P+
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 64/209 (30%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+G+ + H RR +HRD LK N+L++ +
Sbjct: 111 LQGILFCHSRRVLHRD---------------------------------LKPQNLLIDNK 137
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEM 174
G KLADFG+A + + T ++ APEV+ +G Y D+WS+G EM
Sbjct: 138 GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL--LGSPRYSTPVDIWSIGTIFAEM 195
Query: 175 AEGKPPY-GD--IHPMRAIFMIPTKP-----PPSFREPDV------WTPEF--------- 211
A KP + GD I + IF I P P PD W
Sbjct: 196 ATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD 255
Query: 212 ---IDFVSRCLVKNPEERATASEMLNHEF 237
+D + + L+ +P +R +A + LNH +
Sbjct: 256 EDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-10
Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 64/209 (30%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
LKG+ + H R +HRD LK N+L+N
Sbjct: 110 LKGIAFCHENRVLHRD---------------------------------LKPQNLLINKR 136
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEM 174
G KLADFG+A + + + T ++ AP+V+ +G Y D+WS+G EM
Sbjct: 137 GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL--LGSRTYSTSIDIWSVGCIMAEM 194
Query: 175 AEGKPPY---GDIHPMRAIFMI-------------------PTKPPPSFREPDVWTPEF- 211
G+P + + + IF I PT P ++ P
Sbjct: 195 ITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD 254
Query: 212 ---IDFVSRCLVKNPEERATASEMLNHEF 237
ID + R L NPE R +A + L H +
Sbjct: 255 PLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 64/260 (24%), Positives = 92/260 (35%), Gaps = 82/260 (31%)
Query: 21 DLWIVMEYCGAGSVSDI-MRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D+++VME A I M L + +S +L L G+++LH IHRD
Sbjct: 95 DVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAGIIHRD------ 143
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL-TDTMAKR 138
LK NI++ ++ K+ DFG+A T M
Sbjct: 144 ---------------------------LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176
Query: 139 NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK---PPYGDIHPMRAIFMIPT 195
V T ++ APEVI +GY D+WS+G EM G P I I
Sbjct: 177 YVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234
Query: 196 KPPPSFRE-------------------------PDVWTP------------EFIDFVSRC 218
P F PDV P + D +S+
Sbjct: 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294
Query: 219 LVKNPEERATASEMLNHEFI 238
LV +PE+R + + L H +I
Sbjct: 295 LVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 37/188 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P ++ G K+ + IV EY GS+ +R + ++ +L G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 119 MKYLSDMGYVHRD---------------------------------LAARNILVNSNLVC 145
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L D T G W APE I + +D+WS GI E M+
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 177 GKPPYGDI 184
G+ PY ++
Sbjct: 206 GERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 66/251 (26%), Positives = 99/251 (39%), Gaps = 43/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M SPYV + G +T + +V + G + D +R K + ++ KG
Sbjct: 63 MAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL R +HRD L A N+L+ + H
Sbjct: 122 MSYLEEVRLVHRD---------------------------------LAARNVLVKSPNHV 148
Query: 121 KLADFGVAGQLTDTMAKRNTVIG--TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K+ DFG+A +L D G P WMA E I + +D+WS G+T E M
Sbjct: 149 KITDFGLA-RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF 207
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
G PY I P R I + K +P + T + + +C + + E R E++ E
Sbjct: 208 GAKPYDGI-PAREIPDLLEK-GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV-DE 264
Query: 237 FIQRHDTDPSQ 247
F R DPS+
Sbjct: 265 F-SRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-10
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 22 LWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHL 66
L++V+EY G++ D +R R+ +TL++ ++ + +G+E+L
Sbjct: 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLADF 125
++ IHRD L A N+L+ TE H K+ADF
Sbjct: 151 KKCIHRD---------------------------------LAARNVLV-TEDHVMKIADF 176
Query: 126 GVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEGKPPYG 182
G+A + R T G P WMAPE + + Y +D+WS G+ E G PY
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 183 DIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
I P+ +F + K +P T E + C + P +R T +++
Sbjct: 237 GI-PVEELFKL-LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 91 IKCNVITNQIYKTLFR-LKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFW 147
I C ++ ++R +K N+LL+ +G+ +L+D G+A +L D T+ +R GT +
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGY 160
Query: 148 MAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTKPPPSFREP 204
MAPE+++E Y D +++G + EM G+ P+ D A + + F E
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EH 219
Query: 205 DVWTPEFIDFVSRCLVKNPEERATASEMLN----HEFIQ 239
+T E D L K PE+R + E + HEF +
Sbjct: 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/180 (27%), Positives = 75/180 (41%), Gaps = 41/180 (22%)
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+G+E+L R+ IHRD L A NILL+
Sbjct: 185 RGMEFLASRKCIHRD---------------------------------LAARNILLSENN 211
Query: 119 HAKLADFGVAGQL---TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEM 174
K+ DFG+A + D + K + + P WMAPE I + Y +D+WS G+ E+
Sbjct: 212 VVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
Query: 175 -AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ G PY + + F K R P+ TPE + C +P+ER T S ++
Sbjct: 270 FSLGASPYPGVQ-INEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 42/172 (24%)
Query: 9 VVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEI-ATILCDTLKGLEYLH 65
+VKY G + L ++MEY GS+ D + K L++ + A +C+ G+ YLH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICE---GMAYLH 124
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+ IHRD L A N+LL+ + K+ DF
Sbjct: 125 SQHYIHRD---------------------------------LAARNVLLDNDRLVKIGDF 151
Query: 126 GVAGQL-TDTMAKRNTVIG-TP-FWMAPEVIQEIGYDCVADMWSLGITALEM 174
G+A + R G +P FW A E ++E + +D+WS G+T E+
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 54/246 (21%), Positives = 93/246 (37%), Gaps = 57/246 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT------LSEDEIATIL 54
M + P +VK G N +I+ME G + +R + L+ E+ I
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
D KG YL IHRD L A N L+
Sbjct: 113 LDVAKGCVYLEQMHFIHRD---------------------------------LAARNCLV 139
Query: 115 NTEGHA-----KLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSL 167
+ +G+ K+ DFG+A + +D K + WMAPE + + + +D+WS
Sbjct: 140 SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199
Query: 168 GITALE-MAEGKPPYGDIHPMRAIFMIPT----KPPPSFREPDVWTPEFIDFVSRCLVKN 222
G+ E + G+ PY ++ + + + P + + ++ ++ C ++
Sbjct: 200 GVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD-KIY-----QLMTNCWAQD 253
Query: 223 PEERAT 228
P ER T
Sbjct: 254 PSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 56/232 (24%), Positives = 87/232 (37%), Gaps = 56/232 (24%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL--------KG 60
+V+ Y K ++I+ EY GS+ D ++ DE +L L +G
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-------SDEGGKVLLPKLIDFSAQIAEG 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ Y+ + IHRD L+A N+L++
Sbjct: 116 MAYIERKNYIHRD---------------------------------LRAANVLVSESLMC 142
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMAE-GK 178
K+ADFG+A + D P W APE I + +D+WS GI E+ GK
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWT--PEFIDFVSRCLVKNPEERAT 228
PY P + + + +R P + E D + C + EER T
Sbjct: 203 IPY----PGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 63/224 (28%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
+S + L L+GL Y H R+ +HRD
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRD------------------------------- 129
Query: 105 FRLKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVA 162
LK N+L+N G KLADFG+A + T N V+ T ++ P+V + Y
Sbjct: 130 --LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 163 DMWSLGITALEMAEGKPPY------GDIHPMRAIFMIPT--------------------- 195
DMW +G EMA G+P + ++H + + PT
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKY 246
Query: 196 KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
KP P E I+ +++ L ++R +A E + H + +
Sbjct: 247 KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 68/233 (29%)
Query: 40 LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99
+ + LS D + L L+GL+YLH +HRDIK G
Sbjct: 95 VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPG---------------------- 132
Query: 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQEIG- 157
N+L+N+ K+ DFG+A + D + T ++ APE++ +G
Sbjct: 133 -----------NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL--MGS 179
Query: 158 --YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------- 193
Y D+WS+G E+ + + P++ + +I
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239
Query: 194 ----PTKPPPSFREPDVWTP---EFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P KPP + + E + + R LV +P++R +A++ L H ++
Sbjct: 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 43/205 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q +++ G K I+ EY G++ +R S ++ +L G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 120 MKYLSDMNYVHRD---------------------------------LAARNILVNSNLEC 146
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L D T G W APE I + +D+WS GI E M+
Sbjct: 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206
Query: 177 GKPPYGDI---HPMRAI---FMIPT 195
G+ PY D+ M+AI F +P
Sbjct: 207 GERPYWDMSNHEVMKAINDGFRLPA 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 42/190 (22%), Positives = 76/190 (40%), Gaps = 43/190 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ Q D +V+ G + + IV EY G++ +R + L ++ +L G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +H+ L A +L+N++
Sbjct: 120 MKYLSEMGYVHK---------------------------------GLAAHKVLVNSDLVC 146
Query: 121 KLADFGVAGQ-----LTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE-M 174
K++ F + + TM+ ++ V+ W APE IQ + +D+WS GI E M
Sbjct: 147 KISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
Query: 175 AEGKPPYGDI 184
+ G+ PY D+
Sbjct: 203 SYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 54/243 (22%), Positives = 99/243 (40%), Gaps = 53/243 (21%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATI 53
++ G+ ++ L++++EY G++ + +R R+ + LS ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+G+EYL ++ IHRD L A N+L
Sbjct: 146 AYQVARGMEYLASKKCIHRD---------------------------------LAARNVL 172
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITA 171
+ + K+ADFG+A + + T G P WMAPE + + Y +D+WS G+
Sbjct: 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232
Query: 172 LEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ G PY + P+ +F + K +P T E + C P +R T
Sbjct: 233 WEIFTLGGSPYPGV-PVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290
Query: 231 EML 233
+++
Sbjct: 291 QLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 62/266 (23%), Positives = 96/266 (36%), Gaps = 64/266 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ + P +VK L++V E+ + + I + L L+G
Sbjct: 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L + H R +HRD LK N+L+NTEG
Sbjct: 113 LAFCHSHRVLHRD---------------------------------LKPQNLLINTEGAI 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEG 177
KLADFG+A + + T ++ APE++ +G Y D+WSLG EM
Sbjct: 140 KLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL--LGCKYYSTAVDIWSLGCIFAEMVTR 197
Query: 178 K---PPYGDIHPMRAIFMIPTKP-----PPSFREPDV------WTP------------EF 211
+ P +I + IF P P PD W +
Sbjct: 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDG 257
Query: 212 IDFVSRCLVKNPEERATASEMLNHEF 237
D +S+ L +P +R +A L H F
Sbjct: 258 RDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 53/249 (21%), Positives = 92/249 (36%), Gaps = 69/249 (27%)
Query: 22 LWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78
L++V EY + + + L I + + LKG+ + H +HRD
Sbjct: 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRD----- 135
Query: 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLADFGVAGQLTDTMAK 137
LK N+L++ + K+AD G+ + +
Sbjct: 136 ----------------------------LKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 138 RNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEGKPPY-GD--IHPMRAIF 191
I T ++ APEV+ +G Y D+WS+G EM+ +P + GD + + IF
Sbjct: 168 YTHEIVTLWYRAPEVL--LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225
Query: 192 MI---------------------PTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERAT 228
+ P P PD+ +PE +D + + L +P +R +
Sbjct: 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDL-SPEGLDLLQKMLRYDPAKRIS 284
Query: 229 ASEMLNHEF 237
A L H +
Sbjct: 285 AKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 53/229 (23%)
Query: 22 LWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHL 66
L++++EY G++ + +R R+ + LS ++ + +G+EYL
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
RR IHRD L A N+L+ + K+ADFG
Sbjct: 153 RRCIHRD---------------------------------LAARNVLVTEDNVMKIADFG 179
Query: 127 VAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPPYGD 183
+A + D + T G P WMAPE + + Y +D+WS GI E+ G PY
Sbjct: 180 LARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
Query: 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
I P+ +F + + +P T E + C P +R T ++
Sbjct: 240 I-PVEELFKL-LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 59/254 (23%), Positives = 91/254 (35%), Gaps = 74/254 (29%)
Query: 21 DLWIVMEYCG---AGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77
++V E+C AG +S+ + EI ++ L GL Y+H + +HRD
Sbjct: 93 SFYLVFEFCEHDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRD---- 144
Query: 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL-TDTMA 136
+KA NIL+ +G KLADFG+A +
Sbjct: 145 -----------------------------MKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 137 KRN---TVIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMAEGKPPY-GD--IHPMRA 189
K N + T ++ PE+ + E Y DMW G EM P G+ H +
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235
Query: 190 IFMIPTKPPPS---------------------FREPD-----VWTPEFIDFVSRCLVKNP 223
I + P + + V P +D + + LV +P
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295
Query: 224 EERATASEMLNHEF 237
+R A LNH+F
Sbjct: 296 AKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 61/254 (24%), Positives = 90/254 (35%), Gaps = 86/254 (33%)
Query: 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
TDL M+ CG G LS + L L+GL Y H RR +HRD
Sbjct: 87 TDLKQYMDDCGGG------------LSMHNVRLFLFQLLRGLAYCHQRRVLHRD------ 128
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA-GQLTDTMAKR 138
LK N+L++ G KLADFG+A + +
Sbjct: 129 ---------------------------LKPQNLLISERGELKLADFGLARAKSVPSKTYS 161
Query: 139 NTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEGKP---------------- 179
N V+ T ++ P+V+ +G Y DMW +G EMA G+P
Sbjct: 162 NEVV-TLWYRPPDVL--LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218
Query: 180 -----PYGDIHPMRAIFMIPTKPPPSFREP------DVWT-----PEFIDFVSRCLVKNP 223
P + P + P P SF + P + + L P
Sbjct: 219 RVLGTPTEETWP--GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEP 276
Query: 224 EERATASEMLNHEF 237
++R +A+E + H +
Sbjct: 277 KKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 50/237 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M++ +V+ Y + ++IV EY GS+ D ++ + K L ++ + +
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ YL R IHRD L A NIL+
Sbjct: 115 GMAYLESRNYIHRD---------------------------------LAARNILVGENLV 141
Query: 120 AKLADFGVAGQLTDT--MAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE- 173
K+ADFG+A + D A+ G F W APE + +D+WS GI E
Sbjct: 142 CKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
+ G+ PY + + + +R P E D + +C K+PEER T
Sbjct: 198 VTYGRVPYPGMTNREVLEQVER----GYRMPRPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 53/243 (21%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATI 53
++ G+ ++ L++++EY G++ + +R R+ + L+ ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+G+EYL ++ IHRD L A N+L
Sbjct: 140 AYQVARGMEYLASQKCIHRD---------------------------------LAARNVL 166
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITA 171
+ + K+ADFG+A + + + T G P WMAPE + + Y +D+WS G+
Sbjct: 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226
Query: 172 LEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ G PY I P+ +F + K +P T E + C P +R T
Sbjct: 227 WEIFTLGGSPYPGI-PVEELFKL-LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284
Query: 231 EML 233
+++
Sbjct: 285 QLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 42/235 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q P +V+ G + ++IVME G +R L E+ ++ + G
Sbjct: 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAG 106
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL + IHRD L A N L+ +
Sbjct: 107 MEYLESKHCIHRD---------------------------------LAARNCLVTEKNVL 133
Query: 121 KLADFGVAGQLTDTM-AKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K++DFG++ + D + A + P W APE + Y +D+WS GI E + G
Sbjct: 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
Query: 178 KPPYGDI--HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
PY ++ R + P P++ + RC +P +R + S
Sbjct: 194 AVPYANLSNQQTREAIEQGVRLPC----PELCPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 52/146 (35%), Positives = 69/146 (47%), Gaps = 24/146 (16%)
Query: 107 LKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNTVIG----TPF-WMAPEVIQEIGYDC 160
+ A N+LL T+G AK+ DFG+A D M N V+ P WMAPE I +DC
Sbjct: 238 VAARNVLL-TDGRVAKICDFGLA---RDIMNDSNYVVKGNARLPVKWMAPESI----FDC 289
Query: 161 V----ADMWSLGITALEM-AEGKPPYGDIHPMRAIF-MIPTKPPPSFREPDVWTPEFIDF 214
V +D+WS GI E+ + GK PY I + M+ K PD PE
Sbjct: 290 VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--KRGYQMSRPDFAPPEIYSI 347
Query: 215 VSRCLVKNPEERATASEMLNHEFIQR 240
+ C P ER T S++ + IQR
Sbjct: 348 MKMCWNLEPTERPTFSQI--SQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 38/134 (28%), Positives = 49/134 (36%), Gaps = 34/134 (25%)
Query: 41 RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100
R + L D+ I L+GL YLH +R IHRD+K
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTE----------------------- 186
Query: 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160
NI +N + D G A Q + GT APEV+ Y+
Sbjct: 187 ----------NIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNS 235
Query: 161 VADMWSLGITALEM 174
AD+WS GI EM
Sbjct: 236 KADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 77/257 (29%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D+++VME A ++ ++ L + ++ +L L G+++LH IHRD
Sbjct: 100 DVYLVMELMDA----NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRD------- 148
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK NI++ ++ K+ DFG+A
Sbjct: 149 --------------------------LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GDIH------------PM 187
V+ T ++ APEVI +GY D+WS+G E+ +G + G H
Sbjct: 183 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 188 RAIFMI-------------PTKPPPSFRE--PD-----------VWTPEFIDFVSRCLVK 221
A FM P P SF E PD + T + D +S+ LV
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 222 NPEERATASEMLNHEFI 238
+P++R + E L H +I
Sbjct: 302 DPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 37/133 (27%), Positives = 53/133 (39%), Gaps = 38/133 (28%)
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG+EYL ++ +HRD L A N +L+
Sbjct: 109 KGMEYLASKKFVHRD---------------------------------LAARNCMLDESF 135
Query: 119 HAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE- 173
K+ADFG+A + D +T P WMA E +Q + +D+WS G+ E
Sbjct: 136 TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
Query: 174 MAEGKPPYGDIHP 186
M G PPY D+
Sbjct: 196 MTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 38/126 (30%), Positives = 54/126 (42%), Gaps = 36/126 (28%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+GL Y H R+ +HRD LK N+L+N +
Sbjct: 113 LRGLSYCHKRKILHRD---------------------------------LKPQNLLINEK 139
Query: 118 GHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMA 175
G KLADFG+A + T N V+ T ++ P+V + Y DMW +G EMA
Sbjct: 140 GELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198
Query: 176 EGKPPY 181
G+P +
Sbjct: 199 TGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 40/133 (30%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPF----WMAPEVIQEIGYDCV 161
L A N+L+ K+ DFG+A D M N + G+ F WMAPE I Y +
Sbjct: 265 LAARNVLICEGKLVKICDFGLA---RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321
Query: 162 ADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220
+D+WS GI E+ G PY ++ PM F K +P + E + + +C
Sbjct: 322 SDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWE 380
Query: 221 KNPEERATASEML 233
+ E R S+++
Sbjct: 381 EKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 64/257 (24%), Positives = 95/257 (36%), Gaps = 55/257 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D P++V+ G T + +V + G + D + K + + KG
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL RR +HRD L A N+L+ + H
Sbjct: 122 MMYLEERRLVHRD---------------------------------LAARNVLVKSPNHV 148
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K+ DFG+A L + N G P WMA E I + +D+WS G+T E M G
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFRE-------PDVWTPEFIDFVSRCLVKNPEERATAS 230
PY IPT+ P E P + T + + +C + + + R
Sbjct: 209 GKPYDG---------IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFK 259
Query: 231 EMLNHEFIQRHDTDPSQ 247
E L EF R DP +
Sbjct: 260 E-LAAEF-SRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-08
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 40/172 (23%)
Query: 9 VVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+VKY G ++ + ++ME+ +GS+ + + K ++ + KG++YL
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
R+ +HRD L A N+L+ +E K+ DFG
Sbjct: 128 RQYVHRD---------------------------------LAARNVLVESEHQVKIGDFG 154
Query: 127 VAGQLTDTMAKRNTV---IGTP-FWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ + +T + TV + +P FW APE + + + +D+WS G+T E+
Sbjct: 155 LTKAI-ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATI 53
++ G+ ++ L++++EY G++ + +R R+ + ++ ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+G+EYL ++ IHRD L A N+L
Sbjct: 143 TYQVARGMEYLASQKCIHRD---------------------------------LAARNVL 169
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITA 171
+ K+ADFG+A + + + T G P WMAPE + + Y +D+WS G+
Sbjct: 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229
Query: 172 LEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ G PY I P+ +F + K +P T E + C P R T
Sbjct: 230 WEIFTLGGSPYPGI-PVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK 287
Query: 231 EML 233
+++
Sbjct: 288 QLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 52/242 (21%), Positives = 85/242 (35%), Gaps = 83/242 (34%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
L++ + + L GL+Y+H +HRD
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRD------------------------------- 130
Query: 105 FRLKAGNILLNTEGHAKLADFGVA-----------GQLTDTMAKRNTVIGTPFWMAPEVI 153
LK GN+L+N + K+ DFG+A G +T+ +A R ++ APE++
Sbjct: 131 --LKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR-------WYRAPEIM 181
Query: 154 QEI-GYDCVADMWSLGITALEMAEGKPPY---------------------------GDIH 185
Y D+WS+G E+ KP + G
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241
Query: 186 PMRAIFMIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR-HD 242
I +P P F P+ P +D + + L +P +R + E L H ++ HD
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNA-NPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300
Query: 243 TD 244
D
Sbjct: 301 PD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 57/187 (30%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATI---LCDTLKGL 61
D+P +K Y S ++M+Y G + D+++ ++ LSE E+ I L + L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVE---AL 122
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
LH IH DIK + ++YDR ++IY
Sbjct: 123 NDLHKHNIIHNDIKLEN--VLYDRA----------KDRIY-------------------- 150
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPF-------WMAPEVIQEIGYDCVADMWSLGITALEM 174
L D+G + K IGTP + +PE I+ YD D W++G+ E+
Sbjct: 151 LCDYG--------LCKI---IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 175 AEGKPPY 181
GK P+
Sbjct: 200 LTGKHPF 206
|
Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 54/257 (21%), Positives = 84/257 (32%), Gaps = 67/257 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL------RKKTLSEDEIATIL 54
M + + +V+ G F+ +I++E G + +R R +L+ ++
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
D KG +YL IHRDI A N LL
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAAR---------------------------------NCLL 149
Query: 115 NTEGH---AKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
+G AK+ADFG+A + K + WM PE + + D+WS G+
Sbjct: 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209
Query: 170 TALE-MAEGKPPYGDIHPMRAIFMIPT----KPPPSFREP------DVWTPEFIDFVSRC 218
E + G PY + + PP P D W
Sbjct: 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHT-------- 261
Query: 219 LVKNPEERATASEMLNH 235
PE+R + +L
Sbjct: 262 ----PEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 49/248 (19%), Positives = 94/248 (37%), Gaps = 64/248 (25%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--------LSEDEIATILCDTL 58
VV+ G + ++++EY G + +R K LS + +
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
G+++L R +HRD L A N L++++
Sbjct: 128 LGMDHLSNARFVHRD---------------------------------LAARNCLVSSQR 154
Query: 119 HAKLADFGVAGQLTDTMAK-----RNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITAL 172
K++ ++ D RN +I P W+APE +QE + +D+WS G+
Sbjct: 155 EVKVSLLSLS---KDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMW 209
Query: 173 EM-AEGKPPYGDIHPMRAIFMIPTK----PPPSFREPDVWTPEFI-DFVSRCLVKNPEER 226
E+ +G+ P+ + + + P P P + ++RC NP++R
Sbjct: 210 EVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE------GCPSRLYKLMTRCWAVNPKDR 263
Query: 227 ATASEMLN 234
+ SE+++
Sbjct: 264 PSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 53/200 (26%), Positives = 77/200 (38%), Gaps = 46/200 (23%)
Query: 45 LSEDEIATILCDTL-------KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97
L EDE+A D L KG+ +L + IHRD
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD------------------------ 239
Query: 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTVIGTPFWMAPEVIQ 154
L A NILL K+ DFG+A + + + K N + WMAPE I
Sbjct: 240 ---------LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK-WMAPESIF 289
Query: 155 EIGYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFID 213
Y +D+WS GI E+ + G PY + P+ + F K P+ E D
Sbjct: 290 NCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYKMIKEGYRMLSPECAPSEMYD 348
Query: 214 FVSRCLVKNPEERATASEML 233
+ C +P +R T +++
Sbjct: 349 IMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 60/247 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIA 51
P ++ G+ L++ +EY G++ D +R + TLS ++
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
D +G++YL ++ IHRD L A N
Sbjct: 128 HFAADVARGMDYLSQKQFIHRD---------------------------------LAARN 154
Query: 112 ILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGI 169
IL+ AK+ADFG++ GQ + + T+ P WMA E + Y +D+WS G+
Sbjct: 155 ILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211
Query: 170 TALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEER 226
E+ G PY + + K P +R +P E D + +C + P ER
Sbjct: 212 LLWEIVSLGGTPYCGM----TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 267
Query: 227 ATASEML 233
+ +++L
Sbjct: 268 PSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 30/159 (18%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTD-TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMW 165
+K N+L++ KL DFG A L++ + A + T ++ +PE++ Y DMW
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 166 SLGITALEMAEGKPPYGDIHPMRAIFMI-----PTKPP--------PSF---REPDVWTP 209
S+G E+++G+P + + +F I P P F R P V P
Sbjct: 186 SVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHP 245
Query: 210 E-------------FIDFVSRCLVKNPEERATASEMLNH 235
+ +D + L NP +R + LNH
Sbjct: 246 QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-07
Identities = 52/224 (23%), Positives = 80/224 (35%), Gaps = 64/224 (28%)
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
L + + L L+GL Y+H R +HRD
Sbjct: 100 LHPENVKLFLFQLLRGLSYIHQRYILHRD------------------------------- 128
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVAD 163
LK N+L++ G KLADFG+A + + + T ++ P+V + Y D
Sbjct: 129 --LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 164 MWSLGITALEMAEGK---PPYGDIH-PMRAIFMIPTKPP----PSFREPDVWTPEFI--- 212
MW +G +EM +G P DI + IF++ P P + PE
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246
Query: 213 -------------------DFVSRCLVKNPEERATASEMLNHEF 237
D S+ L P+ R +A L+HE+
Sbjct: 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 10/128 (7%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPF----WMAPEVIQEIGYDCV 161
L A N+LL K+ DFG+A D M N V G+ F WMAPE I + Y +
Sbjct: 263 LAARNVLLAQGKIVKICDFGLA---RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319
Query: 162 ADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220
+D+WS GI E+ + G PY + + + F K +PD T E D + +C
Sbjct: 320 SDVWSYGILLWEIFSLGGTPYPGMI-VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWN 378
Query: 221 KNPEERAT 228
PE+R +
Sbjct: 379 SEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 38/158 (24%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D++IVME A ++ ++ + L + ++ +L L G+++LH IHRD
Sbjct: 103 DVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD------- 151
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK NI++ ++ K+ DFG+A +
Sbjct: 152 --------------------------LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 185
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
V+ T ++ APEVI +GY D+WS+G EM +G
Sbjct: 186 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 36/124 (29%), Positives = 52/124 (41%), Gaps = 36/124 (29%)
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+GL Y H R+ +HRD LK N+L+N
Sbjct: 114 LRGLNYCHRRKVLHRD---------------------------------LKPQNLLINER 140
Query: 118 GHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEV-IQEIGYDCVADMWSLGITALEMA 175
G KLADFG+A + T N V+ T ++ P++ + Y DMW +G EM+
Sbjct: 141 GELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199
Query: 176 EGKP 179
G+P
Sbjct: 200 TGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 49/236 (20%), Positives = 87/236 (36%), Gaps = 48/236 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M++ P +++ Y ++IV E GS+ + ++ + L ++ +
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ YL + IHRD L A N+L+
Sbjct: 115 GMAYLEAQNYIHRD---------------------------------LAARNVLVGENNI 141
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MA 175
K+ADFG+A + + + + G F W APE + +D+WS GI E +
Sbjct: 142 CKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
Query: 176 EGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
G+ PY + + + P P E D + C ++P++R T
Sbjct: 200 YGRMPYPGMTNAEVLQQVDQGYRMPCPPGCP-----KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-07
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 42/212 (19%)
Query: 22 LWIVMEYCGAGSVSDIMRLRKKTLSE-DEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
++I+ E+ GS+ D ++ + + ++ +G+ ++ R IHRD
Sbjct: 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD------- 127
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
L+A NIL++ K+ADFG+A + D
Sbjct: 128 --------------------------LRAANILVSASLVCKIADFGLARVIEDNEYTARE 161
Query: 141 VIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPP 198
P W APE I + +D+WS GI +E+ G+ PY + I +
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER--- 218
Query: 199 PSFREP--DVWTPEFIDFVSRCLVKNPEERAT 228
+R P + E + + RC PEER T
Sbjct: 219 -GYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 55/251 (21%), Positives = 98/251 (39%), Gaps = 53/251 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDL------WIVMEYCGAGSV-SDIMRLRKKTLSE----DE 49
M+ D P V+K G F+ + L +++ + G + S ++ R L E
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
+ + D G+EYL R IHRD L A
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRD---------------------------------LAA 141
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSL 167
N +L + +ADFG++ ++ R I P W+A E + + Y +D+W+
Sbjct: 142 RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201
Query: 168 GITALEMA-EGKPPYGDI--HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
G+T E+A G+ PY + H + + ++P+ E D + C +P+
Sbjct: 202 GVTMWEIATRGQTPYPGVENHEIYDYLRHGNR----LKQPEDCLDELYDLMYSCWRADPK 257
Query: 225 ERATASEMLNH 235
+R T +++
Sbjct: 258 DRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-07
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 57/218 (26%)
Query: 23 WIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81
+I+ E GS+ +R + + L + + C +G+ YL + IHRD
Sbjct: 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD-------- 129
Query: 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNT 140
L A NIL+ + K+ADFG+A + + + +
Sbjct: 130 -------------------------LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164
Query: 141 VIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMI----- 193
I P+ W APE + +D+WS GI EM G+ PY ++ I
Sbjct: 165 KI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
Query: 194 ---PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
P K P E + C PE+R +
Sbjct: 223 MPCPAKCP----------QEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 40/138 (28%), Positives = 52/138 (37%), Gaps = 34/138 (24%)
Query: 42 KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIY 101
K+ ++ +I I L+ ++YLH R IHRDIKA
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE------------------------ 211
Query: 102 KTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVIQEIGYDC 160
NI +N G L DFG A D A + GT APE++ Y
Sbjct: 212 ---------NIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGP 262
Query: 161 VADMWSLGITALEMAEGK 178
D+WS GI EMA
Sbjct: 263 AVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 50/218 (22%), Positives = 80/218 (36%), Gaps = 54/218 (24%)
Query: 22 LWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
++IV EY GS+ D ++ + + L + + G+ Y+ IHRD
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD------- 127
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
L++ NIL+ K+ADFG+A + D
Sbjct: 128 --------------------------LRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 141 VIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMI----- 193
P W APE + +D+WS GI E+ +G+ PY ++ + +
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
Query: 194 ---PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
P P S E + +C K+PEER T
Sbjct: 222 MPCPQDCPISLHE----------LMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 58/245 (23%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIA 51
P ++ G+ L+I +EY G++ D +R + TL+ ++
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
D G++YL ++ IHRD L A N
Sbjct: 123 QFASDVATGMQYLSEKQFIHRD---------------------------------LAARN 149
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGIT 170
+L+ +K+ADFG++ + + + T+ P WMA E + Y +D+WS G+
Sbjct: 150 VLVGENLASKIADFGLS--RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL 207
Query: 171 ALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERA 227
E+ G PY + + K P +R +P E + + +C P ER
Sbjct: 208 LWEIVSLGGTPYCGM----TCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERP 263
Query: 228 TASEM 232
+++
Sbjct: 264 PFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 58/239 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIA 51
P ++ G+ L++ +EY G++ D +R + TLS ++
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
D +G++YL ++ IHRD L A N
Sbjct: 116 HFAADVARGMDYLSQKQFIHRD---------------------------------LAARN 142
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGIT 170
IL+ AK+ADFG++ + + T+ P WMA E + Y +D+WS G+
Sbjct: 143 ILVGENYVAKIADFGLS--RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 200
Query: 171 ALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEER 226
E+ G PY + + K P +R +P E D + +C + P ER
Sbjct: 201 LWEIVSLGGTPYCGM----TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 255
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 51/218 (23%), Positives = 79/218 (36%), Gaps = 54/218 (24%)
Query: 22 LWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
++IV EY GS+ D ++ K L ++ + G+ Y+ +HRD
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD------- 127
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
L+A NIL+ K+ADFG+A + D
Sbjct: 128 --------------------------LRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161
Query: 141 VIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EGKPPYGDIHPMRAIFMI----- 193
P W APE + +D+WS GI E+ +G+ PY + + +
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
Query: 194 ---PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
P + P S D + +C K PEER T
Sbjct: 222 MPCPPECPESLH----------DLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 49/243 (20%), Positives = 83/243 (34%), Gaps = 55/243 (22%)
Query: 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-------------KKTLSEDEIATILC 55
+VK+YG + +V EY G ++ +R L+ ++ I
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
G+ YL + +HRD L N L+
Sbjct: 130 QIASGMVYLASQHFVHRD---------------------------------LATRNCLVG 156
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQEIGYDCVADMWSLGITA 171
+ K+ DFG++ + T R V G WM PE I + +D+WS G+
Sbjct: 157 YDLVVKIGDFGMSRDVYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
Query: 172 LEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ GK P+ + I I + P E D + C ++P++R
Sbjct: 215 WEIFTYGKQPWYGLSNEEVIECI--TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIK 272
Query: 231 EML 233
++
Sbjct: 273 DIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 55/223 (24%), Positives = 86/223 (38%), Gaps = 48/223 (21%)
Query: 22 LWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
++IV E+ G GS+ D ++ K L ++ + G+ Y+ IHRD
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD------- 127
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
L+A NIL+ K+ADFG+A + D
Sbjct: 128 --------------------------LRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161
Query: 141 VIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPP 198
P W APE + +D+WS GI E+ +G+ PY P + +
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY----PGMVNREVLEQVE 217
Query: 199 PSFREP-DVWTPEFI-DFVSRCLVKNPEERATASEMLNHEFIQ 239
+R P PE + + + C K+P+ER T E+IQ
Sbjct: 218 RGYRMPCPQGCPESLHELMKLCWKKDPDERPT------FEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 58/257 (22%), Positives = 95/257 (36%), Gaps = 77/257 (29%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D+++VME A ++ ++ + L + ++ +L L G+++LH IHRD
Sbjct: 96 DVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD------- 144
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK NI++ ++ K+ DFG+A + T
Sbjct: 145 --------------------------LKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTP 177
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK---PPYGDIHPMRAIFMIPTKP 197
+ T ++ APEVI +GY D+WS+G EM K P I + P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 198 PPSFRE-------------------------PDVWTP-----------EFIDFVSRCLVK 221
P F + PD P + D +S+ LV
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 222 NPEERATASEMLNHEFI 238
+P +R + E L H +I
Sbjct: 298 DPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 27/108 (25%), Positives = 47/108 (43%)
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPS 200
++GTP ++APE++ + D W+LG+ E G PP+ D P + I + P
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 201 FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQN 248
+ + + + L +P +RA E+ H D + QN
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQN 647
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 9/96 (9%)
Query: 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHP--MRAIFMIPTKPPPSFRE 203
WMA E + Y +D+WS G+ E+ G+ PY +I P M A +
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC 244
Query: 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLN--HEF 237
PD E ++ C +PEER + S+++ +F
Sbjct: 245 PD----ELFAVMACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 47/195 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLW------IVMEYCGAGSVSDIM---RL--RKKTLSEDE 49
M++ D P V++ G + + +++ + G + + RL + L
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM 113
Query: 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
+ + D G+EYL + IHRD L A
Sbjct: 114 LVKFMTDIASGMEYLSSKSFIHRD---------------------------------LAA 140
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSL 167
N +LN + +ADFG++ ++ + R I P W+A E + + Y +D+WS
Sbjct: 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200
Query: 168 GITALEMA-EGKPPY 181
G+T E+A G+ PY
Sbjct: 201 GVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 57/266 (21%), Positives = 92/266 (34%), Gaps = 65/266 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR--------------------- 39
M + D P +VK G + ++ EY G +++ +R
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 40 LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99
L LS E I G+ YL R+ +HRD
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD-------------------------- 155
Query: 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQE 155
L N L+ K+ADFG++ + A N I P WM PE I
Sbjct: 156 -------LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI--PIRWMPPESIFY 206
Query: 156 IGYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214
Y +D+W+ G+ E+ + G PY + I+ + + PD E +
Sbjct: 207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLELYNL 264
Query: 215 VSRCLVKNPEERATASEMLNHEFIQR 240
+ C K P +R + + + + +QR
Sbjct: 265 MRLCWSKLPSDRPSFASI--NRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 40/158 (25%), Positives = 55/158 (34%), Gaps = 41/158 (25%)
Query: 41 RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100
R L ++ TI L+ L YLH R IHRD+K
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTE----------------------- 214
Query: 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEVIQEIGY 158
NI L+ +A L DFG A +L GT +PE++ Y
Sbjct: 215 ----------NIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 159 DCVADMWSLGITALEMAE------GKPPYGDIHPMRAI 190
D+WS G+ EM+ GK +R+I
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 38/134 (28%), Positives = 55/134 (41%), Gaps = 17/134 (12%)
Query: 109 AGNILL-------NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDC 160
A NILL T KL+D GV+ +++ V P W+APE +
Sbjct: 145 AKNILLARLGLAEGTSPFIKLSDPGVS---FTALSREERVERIP-WIAPECVPGGNSLST 200
Query: 161 VADMWSLGITALEMA-EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCL 219
AD WS G T LE+ +G+ P + P K R P+ E +S+CL
Sbjct: 201 AADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK----HRLPEPSCKELATLISQCL 256
Query: 220 VKNPEERATASEML 233
P +R + +L
Sbjct: 257 TYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 57/253 (22%), Positives = 98/253 (38%), Gaps = 61/253 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL----CDTLKGLE 62
P V++ G ++ +V+E+C G + + +R + +++ +L C+ GL
Sbjct: 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
+LH IH D L N L + K+
Sbjct: 115 WLHQADFIHSD---------------------------------LALRNCQLTADLSVKI 141
Query: 123 ADFGVA-GQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCV-------ADMWSLGITALE 173
D+G+A Q + P W+APE+++ G D + +++WSLG+T E
Sbjct: 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
Query: 174 MAE-GKPPYGDIHPMRAIFMI----PTK-PPPSFREP--DVWTPEFIDFVSRCLVKNPEE 225
+ PY D+ + + + K P P D W E + F C + +PE
Sbjct: 202 LFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWY-EVMQF---CWL-DPET 256
Query: 226 RATASEMLNHEFI 238
R TA E+ HE +
Sbjct: 257 RPTAEEV--HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 35/131 (26%), Positives = 52/131 (39%), Gaps = 50/131 (38%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--------RKKTLSEDEIATILCDT 57
SP++V Y S ++++VMEY G V ++ + K +SE +A
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------ 116
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+YLH IHRD LK N+L++ E
Sbjct: 117 ---LDYLHRHGIIHRD---------------------------------LKPDNMLISNE 140
Query: 118 GHAKLADFGVA 128
GH KL DFG++
Sbjct: 141 GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 50/251 (19%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSE--------DEIATILCDTL 58
+VV+ G K +VME G + +R LR + + E+ + +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
G+ YL+ ++ +HRD L A N ++ +
Sbjct: 130 DGMAYLNAKKFVHRD---------------------------------LAARNCMVAHDF 156
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K+ DFG+ + +T R G P WMAPE +++ + +DMWS G+ E+
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
Query: 177 -GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ PY + + + + +PD D + C NP+ R T E++N
Sbjct: 217 LAEQPYQGLSNEQVLKFV--MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN- 273
Query: 236 EFIQRHDTDPS 246
+ + D PS
Sbjct: 274 --LLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 33/123 (26%), Positives = 48/123 (39%), Gaps = 34/123 (27%)
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
I+ L +EY+H ++ IHRDIK NI
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLE---------------------------------NI 298
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171
LN +G L DFG A + +GT +PE++ GY + D+WS G+
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
Query: 172 LEM 174
L+M
Sbjct: 359 LDM 361
|
Length = 501 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 49/245 (20%), Positives = 92/245 (37%), Gaps = 45/245 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLK 59
M++ P +V+ G + +I+ E+ G++ D +R ++ ++ + +
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+EYL + IHRD L A N L+
Sbjct: 116 AMEYLEKKNFIHRD---------------------------------LAARNCLVGENHL 142
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMAE-G 177
K+ADFG++ +T + P W APE + + +D+W+ G+ E+A G
Sbjct: 143 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEM--- 232
PY P + + +R P+ P+ + + C NP +R + +E+
Sbjct: 203 MSPY----PGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258
Query: 233 LNHEF 237
F
Sbjct: 259 FETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 56/245 (22%), Positives = 88/245 (35%), Gaps = 57/245 (23%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIAT 52
++VK+YG L +V EY G ++ +R K L ++
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
I G+ YL + +HRD+ A LV G
Sbjct: 128 IASQIASGMVYLASQHFVHRDL-ATRNCLV---------------------------GAN 159
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPF-WMAPEVIQEIGYDCVADMWSLG 168
LL K+ DFG++ + T R +T++ P WM PE I + +D+WS G
Sbjct: 160 LL-----VKIGDFGMSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFG 212
Query: 169 ITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
+ E+ GK P+ + I I P V E D + C + P++R
Sbjct: 213 VILWEIFTYGKQPWFQLSNTEVIECITQG--RVLERPRVCPKEVYDIMLGCWQREPQQRL 270
Query: 228 TASEM 232
E+
Sbjct: 271 NIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 10/83 (12%)
Query: 107 LKAGNILLNTEG---HAKLADFGVAGQLTD-------TMAKRNTVIGTPFWMAPEVIQEI 156
LK NI+++ G HAK+ DFG+ L T+ + V+GTP + APE ++
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 157 GYDCVADMWSLGITALEMAEGKP 179
+D+++ G+ LE G+
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 42/190 (22%), Positives = 71/190 (37%), Gaps = 46/190 (24%)
Query: 44 TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKT 103
TL + + D G+EYL + IHRD
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRD------------------------------ 138
Query: 104 LFRLKAGNILLNTEGHAKLADFGVAGQL-TDTMAKRNTVIGTPF-WMAPEVIQEIGYDCV 161
L A N +LN +ADFG++ ++ + ++ P W+A E + + Y
Sbjct: 139 ---LAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH 195
Query: 162 ADMWSLGITALE-MAEGKPPYGDIHPMRAI-FMIP---TKPPPSFREPDVWTPEFIDFVS 216
+D+W+ G+T E M G+ PY + ++I K PP E + + +
Sbjct: 196 SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLE------DVYELMC 249
Query: 217 RCLVKNPEER 226
+C P+ R
Sbjct: 250 QCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 56/231 (24%), Positives = 86/231 (37%), Gaps = 61/231 (26%)
Query: 24 IVMEYCGAGSVSDIMRLRKKTLSEDEIATIL----CDTLKGLEYLHLRRKIHRDIKAGSG 79
+VME+C G + +R +K T L C+ GL +LH IH D
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSD------ 125
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA--GQLTDTMAK 137
L N LL + K+ D+G++ D
Sbjct: 126 ---------------------------LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 138 RNTVIGTPFWMAPEVIQEI-GYDCVAD------MWSLGITALEMAE-GKPPYGDIHPMRA 189
+ + W+APE++ E+ G V D +WSLG+T E+ E G PY
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQ 217
Query: 190 IFMIPTK------PPPSFREP--DVWTPEFIDFVSRCLVKNPEERATASEM 232
+ + P P + P D W E + F C ++ PE+R +A E+
Sbjct: 218 VLTYTVREQQLKLPKPRLKLPLSDRWY-EVMQF---CWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 43/161 (26%), Positives = 65/161 (40%), Gaps = 33/161 (20%)
Query: 107 LKAGNILLNTEGHA-KLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEV-IQEIGYDCVA 162
LK N+L++ H KL DFG A L +A + +V I + F+ APE+ + Y
Sbjct: 196 LKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVSYICSRFYRAPELMLGATNYTTHI 252
Query: 163 DMWSLGITALEMAEGKPPYG------------------------DIHPMRAIFMIPTKPP 198
D+WSLG EM G P + +++P A P P
Sbjct: 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKP 312
Query: 199 PSFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
++ P + I+F+S+ L P +R E L F
Sbjct: 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 57/255 (22%), Positives = 87/255 (34%), Gaps = 78/255 (30%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78
D+++V E SD+ ++ K L+ + L L+ L+Y+H HRD
Sbjct: 78 DIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRD----- 128
Query: 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG---VAGQLTDTM 135
LK NIL N + K+ DFG VA T T
Sbjct: 129 ----------------------------LKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 136 AKRNTVIGTPFWMAPEVIQEI--GYDCVADMWSLGITALEMAEGKPPY---GDIHPMRAI 190
+ T ++ APE+ Y D+WS+G E+ GKP + +H + I
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
Query: 191 FMIPTKPPP----------------------------SFREPDVWTPEFIDFVSRCLVKN 222
+ P P F D P + + R L +
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNAD---PLALRLLERLLAFD 277
Query: 223 PEERATASEMLNHEF 237
P++R TA E L +
Sbjct: 278 PKDRPTAEEALADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 47/246 (19%), Positives = 94/246 (38%), Gaps = 47/246 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIA-------- 51
M++ + +VV+ G + ++ME G + +R LR + + A
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
+ + G+ YL+ + +HRD L A N
Sbjct: 123 QMAGEIADGMAYLNANKFVHRD---------------------------------LAARN 149
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGI 169
++ + K+ DFG+ + +T R G P WM+PE +++ + +D+WS G+
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209
Query: 170 TALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
E+A + PY + + + + +PD + + C NP+ R +
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFV--MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 267
Query: 229 ASEMLN 234
E+++
Sbjct: 268 FLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 43/191 (22%), Positives = 72/191 (37%), Gaps = 52/191 (27%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR------------KKTLSEDEIATILC 55
++VK+YG + L +V EY G ++ +R L++ ++ I
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
G+ YL + +HRD L N L+
Sbjct: 128 QIAAGMVYLASQHFVHRD---------------------------------LATRNCLVG 154
Query: 116 TEGHAKLADFGVAGQLTDTMAKR---NTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITA 171
K+ DFG++ + T R +T++ P WM PE I + +D+WSLG+
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 172 LEM-AEGKPPY 181
E+ GK P+
Sbjct: 213 WEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 41/191 (21%), Positives = 69/191 (36%), Gaps = 47/191 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIA 51
P +V G K L ++ YC + + + +R K TL +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
I+ G+E+L +H+D+ A LV+D+L+ I + ++Y + GN
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDL-ATRNVLVFDKLN-VKISDLGLFREVYAADYYKLMGN 185
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171
LL WM+PE I + +D+WS G+
Sbjct: 186 SLLPIR-----------------------------WMSPEAIMYGKFSIDSDIWSYGVVL 216
Query: 172 LEM-AEGKPPY 181
E+ + G PY
Sbjct: 217 WEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPF-WMAPEVIQEIGYDCVA 162
L A NIL+ + H K++D G++ ++ R +++ P WM PE I + +
Sbjct: 150 LAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL--PIRWMPPEAIMYGKFSSDS 207
Query: 163 DMWSLGITALEM-AEGKPPY 181
D+WS G+ E+ + G PY
Sbjct: 208 DIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 45/222 (20%)
Query: 33 SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIH---RDIK--AGSGTLVYDRLD 87
V +++ L K +SED + +L G + H+ + ++ +K A + D L
Sbjct: 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH 102
Query: 88 YCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFW 147
I C L NILL+ GH +L F ++ D+ V +
Sbjct: 103 REGIVCR-----------DLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAV--ENMY 148
Query: 148 MAPEV--IQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPD 205
APEV I E C D WSLG E+ GK ++ P
Sbjct: 149 CAPEVGGISEETEAC--DWWSLGAILFELLTGKT------------LVECHPSGINTHTT 194
Query: 206 VWTPEFIDFVSRCLVK-----NPEER-----ATASEMLNHEF 237
+ PE++ +R L++ NP ER A ++ +H F
Sbjct: 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 54/252 (21%), Positives = 85/252 (33%), Gaps = 58/252 (23%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIAT-----------I 53
++V++YG + L +V EY G ++ +R K L+ E I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
G+ YL +HRD L N L
Sbjct: 128 ASQIASGMVYLASLHFVHRD---------------------------------LATRNCL 154
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQEIGYDCVADMWSLGI 169
+ K+ DFG++ + T R V G WM PE I + +D+WS G+
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212
Query: 170 TALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
E+ GK P+ + AI I P PE + C + P++R
Sbjct: 213 VLWEIFTYGKQPWYQLSNTEAIECITQG--RELERPRTCPPEVYAIMQGCWQREPQQRMV 270
Query: 229 ASEMLNHEFIQR 240
++ H +Q
Sbjct: 271 IKDI--HSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 251 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1290|consensus | 590 | 99.98 | ||
| KOG0200|consensus | 609 | 99.98 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0670|consensus | 752 | 99.97 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0576|consensus | 829 | 99.97 | ||
| KOG4250|consensus | 732 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| KOG0668|consensus | 338 | 99.97 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1035|consensus | 1351 | 99.96 | ||
| KOG1024|consensus | 563 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| KOG0664|consensus | 449 | 99.95 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0590|consensus | 601 | 99.94 | ||
| KOG3653|consensus | 534 | 99.94 | ||
| KOG2052|consensus | 513 | 99.94 | ||
| KOG1152|consensus | 772 | 99.94 | ||
| KOG1167|consensus | 418 | 99.93 | ||
| KOG1345|consensus | 378 | 99.91 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0603|consensus | 612 | 99.88 | ||
| KOG0195|consensus | 448 | 99.87 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG4158|consensus | 598 | 99.86 | ||
| KOG1023|consensus | 484 | 99.86 | ||
| KOG1164|consensus | 322 | 99.83 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1240|consensus | 1431 | 99.79 | ||
| KOG1033|consensus | 516 | 99.78 | ||
| KOG0606|consensus | 1205 | 99.78 | ||
| KOG1165|consensus | 449 | 99.76 | ||
| KOG1163|consensus | 341 | 99.72 | ||
| KOG0590|consensus | 601 | 99.7 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.63 | |
| KOG1266|consensus | 458 | 99.6 | ||
| KOG0606|consensus | 1205 | 99.59 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.58 | |
| KOG1166|consensus | 974 | 99.56 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.55 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.54 | |
| KOG0601|consensus | 524 | 99.44 | ||
| KOG1243|consensus | 690 | 99.42 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.41 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.39 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.35 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| KOG2137|consensus | 700 | 99.26 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.17 | |
| KOG0601|consensus | 524 | 99.02 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.0 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.97 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.85 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.83 | |
| KOG3741|consensus | 655 | 98.76 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| KOG3087|consensus | 229 | 98.6 | ||
| KOG0576|consensus | 829 | 98.53 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.47 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.45 | |
| KOG1035|consensus | 1351 | 98.41 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.97 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.7 | |
| KOG1235|consensus | 538 | 97.59 | ||
| KOG1826|consensus | 2724 | 97.56 | ||
| KOG1093|consensus | 725 | 97.42 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.39 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.59 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.29 | |
| KOG2268|consensus | 465 | 94.86 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.97 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.27 | |
| KOG1236|consensus | 565 | 91.19 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 90.64 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 90.01 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 89.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 89.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 88.26 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.65 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 87.4 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 85.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 85.69 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 85.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 84.83 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 83.74 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 82.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 82.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 81.92 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 81.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 81.84 | |
| KOG2270|consensus | 520 | 81.45 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=339.79 Aligned_cols=207 Identities=30% Similarity=0.432 Sum_probs=176.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++|+|||||+++++|...+..||||||++||+|.+++- .++.+.+...+.+++|++.|++|||++||+|||||
T Consensus 230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK----- 303 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK----- 303 (475)
T ss_pred HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCC-----
Confidence 678999999999999999999999999999999999996 66889999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCC---CCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||++..+ ..+||+|||+|+..+. .....+..||+.|.|||++.+..
T Consensus 304 ----------------------------PeNILl~~~~e~~llKItDFGlAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 304 ----------------------------PENILLSNDAEDCLLKITDFGLAKVSGE-GSFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred ----------------------------cceEEeccCCcceEEEecccchhhcccc-ceehhhhcCCccccChhheecCC
Confidence 555555444 5699999999987763 34566788999999999997654
Q ss_pred --CCc-chhHHHHHHHHHHHHhCCCCCCCCCcch-hhhhcCCCCCCCC-CCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 158 --YDC-VADMWSLGITALEMAEGKPPYGDIHPMR-AIFMIPTKPPPSF-REPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 158 --~~~-~~DvwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
+++ ++|+||+||++|-+++|.+||.+..... ....+..+.-... ..+..++.+..+||.+||..||++|||++|+
T Consensus 355 ~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 355 VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 333 7899999999999999999997665544 5555655533222 3467789999999999999999999999999
Q ss_pred hcChhhhhcc
Q psy3253 233 LNHEFIQRHD 242 (251)
Q Consensus 233 l~hp~~~~~~ 242 (251)
|+||||+..+
T Consensus 435 L~hpW~~~~~ 444 (475)
T KOG0615|consen 435 LNHPWFKDAP 444 (475)
T ss_pred hcChhhhccc
Confidence 9999999655
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=328.56 Aligned_cols=206 Identities=41% Similarity=0.820 Sum_probs=183.1
Q ss_pred CCCCCCCccceeeeeEeeCCe-EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~-~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~N 78 (251)
|++++|||||.+||+|..... ++++||||++|||..++. .-+.++|.....++.+++.||.|||+ .+|||||||
T Consensus 131 l~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIK--- 206 (364)
T KOG0581|consen 131 LRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIK--- 206 (364)
T ss_pred HhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCC---
Confidence 357899999999999999884 999999999999999987 44789999999999999999999995 899999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+|++++..|.+||+|||.++...+. ...+..||..|||||.+.+..|
T Consensus 207 ------------------------------PsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Y 254 (364)
T KOG0581|consen 207 ------------------------------PSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESY 254 (364)
T ss_pred ------------------------------HHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcC
Confidence 99999999999999999999876554 5567889999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCC-----CcchhhhhcCCCCCCCCCCCC-CCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDI-----HPMRAIFMIPTKPPPSFREPD-VWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
+.++||||||+.++|+.+|++||... +..+....+...+++.+ |. .+++++++|+..||++||.+|||++|+
T Consensus 255 s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l--P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL 332 (364)
T KOG0581|consen 255 SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL--PEGEFSPEFRSFVSCCLRKDPSERPSAKQL 332 (364)
T ss_pred CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC--CcccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 99999999999999999999999653 44455556666666665 44 499999999999999999999999999
Q ss_pred hcChhhhhccCC
Q psy3253 233 LNHEFIQRHDTD 244 (251)
Q Consensus 233 l~hp~~~~~~~~ 244 (251)
++|||+++....
T Consensus 333 l~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 333 LQHPFIKKFEDP 344 (364)
T ss_pred hcCHHHhhcccc
Confidence 999999976543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=341.81 Aligned_cols=207 Identities=32% Similarity=0.597 Sum_probs=190.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++|+|||||+++++|++..++|+|+|+|..++|.++++ ++..++|.+++.++.||+.||+|||+.+|+|||||
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK------ 145 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK------ 145 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc------
Confidence 47899999999999999999999999999999999997 78899999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
-.|++++.+.++||+|||+|.....+..+..+..|||.|.|||++.+...+..
T Consensus 146 ---------------------------LGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfE 198 (592)
T KOG0575|consen 146 ---------------------------LGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFE 198 (592)
T ss_pred ---------------------------hhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCc
Confidence 77999999999999999999988777678888999999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||+||++|-|+.|+|||...+..+....+... .+..|..++.+..+||.+||+.||.+|||+++||.|+||...
T Consensus 199 vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 199 VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999988777777666655 455677899999999999999999999999999999999665
Q ss_pred cCCC
Q psy3253 242 DTDP 245 (251)
Q Consensus 242 ~~~~ 245 (251)
..+.
T Consensus 276 ~~p~ 279 (592)
T KOG0575|consen 276 FTPA 279 (592)
T ss_pred CcCC
Confidence 5443
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=332.93 Aligned_cols=206 Identities=45% Similarity=0.884 Sum_probs=196.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+..+|||||++++.|.-++.++.||||++||+|.+.+. ...++|.++..++++++.||+|||.+||+|||||
T Consensus 324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIK----- 396 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIK----- 396 (550)
T ss_pred HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccc-----
Confidence 567899999999999999999999999999999999986 4569999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
.+||+++.+|.+||+|||+|.++.....+.....||+.|||||+.....|.+
T Consensus 397 ----------------------------SDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~ 448 (550)
T KOG0578|consen 397 ----------------------------SDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGP 448 (550)
T ss_pred ----------------------------cceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCc
Confidence 8999999999999999999999988877888899999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||||++++||+.|++||-..++....+.+..+..+.+..+..+++++++|+.+||+.|+++|++++|+|+||||+.
T Consensus 449 KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 449 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred cccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999964
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 529 a 529 (550)
T KOG0578|consen 529 A 529 (550)
T ss_pred c
Confidence 3
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=328.15 Aligned_cols=208 Identities=29% Similarity=0.559 Sum_probs=188.2
Q ss_pred CCCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|.+| +||.|++||..|++...+|+|+||+++|+|.++|+ +-+.|++..++.++.+|+.||+|||++||||||||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlK---- 201 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLK---- 201 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCC----
Confidence 3456 89999999999999999999999999999999997 56899999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-----------c--cccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-----------A--KRNTVIGTPF 146 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-----------~--~~~~~~~~~~ 146 (251)
|+||+++++++++|.|||.|+...... . ....++||..
T Consensus 202 -----------------------------PENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAe 252 (604)
T KOG0592|consen 202 -----------------------------PENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAE 252 (604)
T ss_pred -----------------------------hhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeec
Confidence 899999999999999999998664311 1 1245789999
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
|.+||++.....++.+|+|+|||++|+|+.|++||.+.+.......+... .+..+..+++.+.+|++++|..||++|
T Consensus 253 YVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 253 YVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred ccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh---cccCCCCCCHHHHHHHHHHHccCcccc
Confidence 99999999999999999999999999999999999988887777666554 555688899999999999999999999
Q ss_pred CCHHHHhcChhhhhccCCC
Q psy3253 227 ATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~~~ 245 (251)
+|++|+.+||||...+|+.
T Consensus 330 lt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 330 LTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred ccHHHHhhCcccccCChhh
Confidence 9999999999999999975
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=315.06 Aligned_cols=209 Identities=32% Similarity=0.532 Sum_probs=190.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||+||+++..|++..++|||+||+.||.|...++ +.+.|++..++.++.+|+.||.|||++||||||+|
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlK----- 152 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLK----- 152 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCC-----
Confidence 457899999999999999999999999999999999887 67899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.+|+++|+|||+++..........+..||+.|+|||++.+.+++.
T Consensus 153 ----------------------------PENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~ 204 (357)
T KOG0598|consen 153 ----------------------------PENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDK 204 (357)
T ss_pred ----------------------------HHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCc
Confidence 9999999999999999999987666656667789999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC----CHHHHhcCh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA----TASEMLNHE 236 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~evl~hp 236 (251)
++|-||+|+++|+|++|.+||.+.+.......+....... .+..++++.++++.++|+.||++|. +++++-+||
T Consensus 205 ~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~--~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 205 AVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL--PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred ccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 9999999999999999999999988888777776664222 3555899999999999999999994 899999999
Q ss_pred hhhhccCCC
Q psy3253 237 FIQRHDTDP 245 (251)
Q Consensus 237 ~~~~~~~~~ 245 (251)
||+..+|+.
T Consensus 283 fF~~inW~~ 291 (357)
T KOG0598|consen 283 FFKGINWEK 291 (357)
T ss_pred ccccCCHHH
Confidence 999999975
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=314.52 Aligned_cols=204 Identities=31% Similarity=0.565 Sum_probs=180.9
Q ss_pred CCCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.+. ||||+++++++.+..++|+|||||.||+|.+++.. .+.+.+.+++.++.|++.|+.|||++||+|||||
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK---- 147 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK---- 147 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC----
Confidence 35677 99999999999999999999999999999999985 7899999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccccccccccccccccccCC-
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 157 (251)
|+|++++.+ +.+||+|||++..............|++.|+|||++.+..
T Consensus 148 -----------------------------~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~ 198 (370)
T KOG0583|consen 148 -----------------------------PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGT 198 (370)
T ss_pred -----------------------------HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCC
Confidence 889999999 9999999999986632334556678999999999999877
Q ss_pred CC-cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCC-CHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YD-CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVW-TPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~-~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|+ .++||||+|+++|.|++|..||.+.+.......+... .+..+..+ ++++.+|+.+||..||.+|+|+.|+++|
T Consensus 199 Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~---~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 199 YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG---EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC---CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 86 5799999999999999999999987766666655444 44456667 9999999999999999999999999999
Q ss_pred hhhhhc
Q psy3253 236 EFIQRH 241 (251)
Q Consensus 236 p~~~~~ 241 (251)
|||+..
T Consensus 276 ~w~~~~ 281 (370)
T KOG0583|consen 276 PWFQKE 281 (370)
T ss_pred hhhccC
Confidence 999973
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=305.05 Aligned_cols=213 Identities=29% Similarity=0.505 Sum_probs=180.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++..++.+|||||||+||+|.+|++ +.+.+++..++.++.||+.||++||+++||||||||.|||
T Consensus 63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 578999999999999999999999999999999999998 5679999999999999999999999999999999955555
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
+..+. .+- ..-.+||+|||+|+...+. ....+..|++.|||||++....|+.
T Consensus 142 Ls~~~------------------------~~~---~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdA 193 (429)
T KOG0595|consen 142 LSTTA------------------------RND---TSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDA 193 (429)
T ss_pred eccCC------------------------CCC---CCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhccccc
Confidence 44320 000 0045899999999877643 3455678999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
|+|+||+|+++|++++|++||...+..+....+..+.......+...++...+++...+..+|..|.++.+-+.|++...
T Consensus 194 KADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 194 KADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 99999999999999999999998888887776655544333345667888889999999999999999999999999865
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 274 ~p 275 (429)
T KOG0595|consen 274 NP 275 (429)
T ss_pred Cc
Confidence 43
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=318.89 Aligned_cols=208 Identities=31% Similarity=0.533 Sum_probs=187.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+-++||||+++|+++.++.++|+|+||+.||-|++++. .++++.+.++.+++.||+.|+.|+|..+|+|||+|
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLK----- 139 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLK----- 139 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCC-----
Confidence 567899999999999999999999999999999999997 67899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+|++++.++.+||+|||+|..-.+. ....+-+|++.|.|||++.+.+|..
T Consensus 140 ----------------------------pENlLLd~~~nIKIADFGMAsLe~~g-klLeTSCGSPHYA~PEIV~G~pYdG 190 (786)
T KOG0588|consen 140 ----------------------------PENLLLDVKNNIKIADFGMASLEVPG-KLLETSCGSPHYAAPEIVSGRPYDG 190 (786)
T ss_pred ----------------------------chhhhhhcccCEeeeccceeecccCC-ccccccCCCcccCCchhhcCCCCCC
Confidence 88999999999999999999654333 2334567899999999999999865
Q ss_pred -chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 161 -VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 161 -~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
++||||.|+++|.|++|+.||.+.+.......+..+ .+..|..+++++.+||.+||+.||++|+|.+||++|||+.
T Consensus 191 ~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G---~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 191 RPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG---VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred CccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC---cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 799999999999999999999987777777666665 6677899999999999999999999999999999999999
Q ss_pred hccCCCC
Q psy3253 240 RHDTDPS 246 (251)
Q Consensus 240 ~~~~~~~ 246 (251)
.+...+.
T Consensus 268 g~~~~~~ 274 (786)
T KOG0588|consen 268 GYTSLPS 274 (786)
T ss_pred cCCCCCh
Confidence 8776653
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=305.69 Aligned_cols=208 Identities=38% Similarity=0.647 Sum_probs=173.3
Q ss_pred CCCCCCCccceeeeeEeeCC--eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++|||||+++|...... .+++.|||+.+|+|.+++...++.+++..++.++.||+.||+|||++|++|||||
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK--- 144 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIK--- 144 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcc---
Confidence 46889999999999755444 6999999999999999998555589999999999999999999999999999998
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCcc---cccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++. ++.+||+|||.++..... ........||+.|+|||++.
T Consensus 145 ------------------------------~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 145 ------------------------------PANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ------------------------------cceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhc
Confidence 88888888 789999999999866531 12234567999999999998
Q ss_pred cC-CCCcchhHHHHHHHHHHHHhCCCCCCC-CCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 155 EI-GYDCVADMWSLGITALEMAEGKPPYGD-IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 155 ~~-~~~~~~DvwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.. ...+++||||+||++.||+||++||.. .........+..... ....+..++++..+|+.+||..||++|||++|+
T Consensus 195 ~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~-~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL 273 (313)
T KOG0198|consen 195 NGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS-LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL 273 (313)
T ss_pred CCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC-CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 53 334589999999999999999999987 455554444444332 124577899999999999999999999999999
Q ss_pred hcChhhhhcc
Q psy3253 233 LNHEFIQRHD 242 (251)
Q Consensus 233 l~hp~~~~~~ 242 (251)
|+|||.+...
T Consensus 274 L~hpf~~~~~ 283 (313)
T KOG0198|consen 274 LEHPFLKQNS 283 (313)
T ss_pred hhChhhhccc
Confidence 9999997644
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=310.17 Aligned_cols=207 Identities=28% Similarity=0.476 Sum_probs=172.8
Q ss_pred CCCCC-CCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCD-SPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~-hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++ |||||++++++.+.+ .+|+|||||+. +|+++|+.++..|++..++.|+.||+.||+|+|++|+.|||+|
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlK--- 137 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLK--- 137 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCC---
Confidence 46788 999999999998777 99999999976 9999999888999999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||++..+..+||+|||+|+.+... ......+.|++|+|||++.. .-
T Consensus 138 ------------------------------PENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~ 186 (538)
T KOG0661|consen 138 ------------------------------PENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGY 186 (538)
T ss_pred ------------------------------hhheEecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccc
Confidence 66777776778999999999877543 23344567999999999964 66
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCCCC---------------CCC---------CCCCCHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPPPS---------------FRE---------PDVWTPE 210 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~---------------~~~---------~~~~~~~ 210 (251)
|+.+.||||+||+++|+.+-++.|.+.+..+.++.+.. .+... ++. ...++++
T Consensus 187 Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~ 266 (538)
T KOG0661|consen 187 YSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSE 266 (538)
T ss_pred cCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHH
Confidence 89999999999999999999999988776666554422 11100 000 1336889
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
+.++|.+|+.|||.+|||++|+++||||+...
T Consensus 267 ~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 267 AASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 99999999999999999999999999998643
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=302.24 Aligned_cols=210 Identities=44% Similarity=0.820 Sum_probs=180.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.++||||++++.+|..+..+|+||+||.+||+.+.++.. ...+.|..+..+++++++||.|||.+|.||||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvK---- 153 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVK---- 153 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccc----
Confidence 57889999999999999999999999999999999999733 4579999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc----ccccccccccccccc--
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR----NTVIGTPFWMAPEVI-- 153 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~-- 153 (251)
+.||+++.+|.+||+|||.+........+. ....||++|+|||++
T Consensus 154 -----------------------------AgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 154 -----------------------------AGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred -----------------------------cccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh
Confidence 889999999999999999886443222222 445799999999995
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCC-------CCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP-------SFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+...|+.|+||||||++..|+.+|..||....+......-..+.++ .......++..++.++..||+.||++|
T Consensus 205 ~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kR 284 (516)
T KOG0582|consen 205 QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKR 284 (516)
T ss_pred cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccC
Confidence 3467999999999999999999999999998888777665555544 222344567889999999999999999
Q ss_pred CCHHHHhcChhhhhccC
Q psy3253 227 ATASEMLNHEFIQRHDT 243 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~ 243 (251)
||++++++|+||+....
T Consensus 285 ptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 285 PTASKLLKHAFFKKAKS 301 (516)
T ss_pred CCHHHHhccHHHhhccc
Confidence 99999999999987543
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=285.00 Aligned_cols=207 Identities=28% Similarity=0.437 Sum_probs=179.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.|+||||+++.+.+......|||||+++|++|..-+-++ .-+++..+..++.||+.||.|+|.+||+|||+|
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvk------ 137 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLK------ 137 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCC------
Confidence 4689999999999999999999999999999998766533 567999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+|+++.... -+||+|||++.... ...-+....|||.|+|||++.+.++
T Consensus 138 ---------------------------P~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 138 ---------------------------PENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred ---------------------------hhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCC
Confidence 5555553322 38999999998887 4345667789999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|||+.|+++|-++.|.+||++.+....+..+..+. ...-+.+..++++.++|+.+||..||++|+|+.|+|+|||
T Consensus 190 ~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 190 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 999999999999999999999999988888877766542 2222357788999999999999999999999999999999
Q ss_pred hhhccC
Q psy3253 238 IQRHDT 243 (251)
Q Consensus 238 ~~~~~~ 243 (251)
+++.+.
T Consensus 270 i~~r~~ 275 (355)
T KOG0033|consen 270 ICNRER 275 (355)
T ss_pred hcchHH
Confidence 987653
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=290.83 Aligned_cols=205 Identities=31% Similarity=0.590 Sum_probs=188.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.+.||+++++++.|.+...+||||||.+||.|+.+++ +.+.|++..++.++.||+.||+|||+.+|++||+|
T Consensus 98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLK----- 171 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLK----- 171 (355)
T ss_pred HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCC-----
Confidence 467899999999999999999999999999999999998 56899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.+|++||.|||+|+.... ...+..|||.|+|||++...++..
T Consensus 172 ----------------------------PENiLlD~~G~iKitDFGFAK~v~~---rT~TlCGTPeYLAPEii~sk~ynk 220 (355)
T KOG0616|consen 172 ----------------------------PENLLLDQNGHIKITDFGFAKRVSG---RTWTLCGTPEYLAPEIIQSKGYNK 220 (355)
T ss_pred ----------------------------hHHeeeccCCcEEEEeccceEEecC---cEEEecCCccccChHHhhcCCCCc
Confidence 8899999999999999999987653 356778999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc-----CCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-----ps~~evl~h 235 (251)
++|=||||+++|||+.|.+||.+.++......+... ....|..+++++++|+.++|+.|-.+| ...++|.+|
T Consensus 221 avDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~---~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 221 AVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG---KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred chhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC---cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 999999999999999999999998888877777665 445588899999999999999999999 467899999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|++
T Consensus 298 ~wF~~v~W~~ 307 (355)
T KOG0616|consen 298 PWFKGVDWEA 307 (355)
T ss_pred cccccccHHH
Confidence 9999999976
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=291.95 Aligned_cols=207 Identities=24% Similarity=0.478 Sum_probs=172.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+||.|||+|.+.++|..+..++||||||+. ++-+-++....+++...++.+++|++.|+.|+|++++||||||
T Consensus 55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIK----- 128 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIK----- 128 (396)
T ss_pred HHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCC-----
Confidence 5799999999999999999999999999987 6666666567789999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.+|.+||||||+|+....+.......+.|.+|+|||.+.+ -+|.
T Consensus 129 ----------------------------PENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG 180 (396)
T KOG0593|consen 129 ----------------------------PENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYG 180 (396)
T ss_pred ----------------------------hhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCC
Confidence 88999999999999999999887754444444567999999999987 7799
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC------------------CCCC-------CCCCCCHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP------------------PSFR-------EPDVWTPEF 211 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~------------------~~~~-------~~~~~~~~~ 211 (251)
.++||||+||++.||++|++.|.+.......+.+.. ... +... .....+..+
T Consensus 181 ~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ 260 (396)
T KOG0593|consen 181 KPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVL 260 (396)
T ss_pred CcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHH
Confidence 999999999999999999999977655444433211 000 0000 123356778
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
.||+++||..||.+|++.+|++.||||+++
T Consensus 261 ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 261 LDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred HHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 999999999999999999999999999653
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=295.43 Aligned_cols=209 Identities=76% Similarity=1.293 Sum_probs=201.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+|+++|+||++||.|.....+++|||||..|+.++.++.++.++++.++..++...+.||+|||...-||||||
T Consensus 82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK----- 156 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK----- 156 (502)
T ss_pred HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc-----
Confidence 578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
..||+++.+|+.||+|||.+.+.++...+..+..||++|+|||++....|..
T Consensus 157 ----------------------------AGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~ 208 (502)
T KOG0574|consen 157 ----------------------------AGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDT 208 (502)
T ss_pred ----------------------------cccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccch
Confidence 8899999999999999999999988888899999999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||||++..+|..|++||.+..+...++++..++++.+..|..++.++.|++++||..+|++|.|+.++++|||+++
T Consensus 209 ~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 209 KADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred hhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 289 A~ 290 (502)
T KOG0574|consen 289 AP 290 (502)
T ss_pred CC
Confidence 43
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=301.48 Aligned_cols=199 Identities=32% Similarity=0.572 Sum_probs=171.6
Q ss_pred CCCCCCCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRR-KIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~-iiH~dik~~ 77 (251)
|++++|||||+++|++.+.. .+++||||+.+|+|.++++. +...++...++.++.+|+.|+.|||+++ |||||||
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK-- 170 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLK-- 170 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccC--
Confidence 45799999999999998877 79999999999999999986 3789999999999999999999999999 9999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccccccccccccccccccccc--
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-- 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-- 154 (251)
++|++++.++ ++||+|||+++.............||..|||||++.
T Consensus 171 -------------------------------~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~ 219 (362)
T KOG0192|consen 171 -------------------------------SDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE 219 (362)
T ss_pred -------------------------------hhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC
Confidence 8899999997 999999999976553322223357899999999998
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-CCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
...++.++||||||+++|+++||..||.+.........+. ....+ ..+..+++.+.++|++||..||++||++.|++
T Consensus 220 ~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp--~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 220 KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP--PIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 6689999999999999999999999998888755555443 33322 33566899999999999999999999999986
Q ss_pred c
Q psy3253 234 N 234 (251)
Q Consensus 234 ~ 234 (251)
.
T Consensus 298 ~ 298 (362)
T KOG0192|consen 298 S 298 (362)
T ss_pred H
Confidence 4
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.58 Aligned_cols=208 Identities=28% Similarity=0.495 Sum_probs=178.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+.+|+|.+++. ....+++..+..++.||+.||+|||++|++|||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlk----- 122 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK----- 122 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC-----
Confidence 357899999999999999999999999999999999987 45689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||+++.............|++.|+|||++.+..++.
T Consensus 123 ----------------------------p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05571 123 ----------------------------LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred ----------------------------HHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCc
Confidence 8899999999999999999875432222333456899999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||..||++|| +++|+++|
T Consensus 175 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999999997766555544443332 233567899999999999999999999 89999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|..
T Consensus 252 ~~f~~~~~~~ 261 (323)
T cd05571 252 RFFASINWQD 261 (323)
T ss_pred CCcCCCCHHH
Confidence 9998866543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=289.64 Aligned_cols=195 Identities=30% Similarity=0.607 Sum_probs=170.9
Q ss_pred CCCCCCCccceeee-eEeeCCe-EEEEEEccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccc
Q psy3253 1 MQQCDSPYVVKYYG-SYFKNTD-LWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLHL--RR--KIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~-~~~~~~~-~~lv~e~~~~gsL~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~LH~--~~--iiH 71 (251)
|+||+|||||++++ .|.+++. +++|||||++|+|++.++ +.+..+++..++.++.|++.||..+|. .. ++|
T Consensus 72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 57999999999998 7766655 999999999999999996 335679999999999999999999999 44 899
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 151 (251)
|||| |.||+++.+|.+||+|||+++............+|||.||+||
T Consensus 152 RDIK---------------------------------PaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE 198 (375)
T KOG0591|consen 152 RDIK---------------------------------PANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPE 198 (375)
T ss_pred ccCc---------------------------------chheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHH
Confidence 9999 9999999999999999999998887766677789999999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
++...+|+.++||||+||++|||+.-++||.+.+-.+....+..+..++.+ ...+|.++..+|..|+..||..||+.
T Consensus 199 ~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 199 RIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999999999999999999999999887666666666665433321 25678999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=296.39 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=176.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....|+||||+.+|+|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk----- 120 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTAELLCALENLHKFNVIYRDLK----- 120 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC-----
Confidence 357899999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||+++.............||+.|+|||++.+..++.
T Consensus 121 ----------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 172 (312)
T cd05585 121 ----------------------------PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172 (312)
T ss_pred ----------------------------HHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCC
Confidence 8899999999999999999875433323334456899999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC---CHHHHhcChh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEF 237 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~ 237 (251)
++||||+||++|+|++|..||.+.+.......+... ....+..+++++.+++.+||..||++|| +++|+++|||
T Consensus 173 ~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred ccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 999999999999999999999876655554444333 2233567899999999999999999997 5899999999
Q ss_pred hhhccC
Q psy3253 238 IQRHDT 243 (251)
Q Consensus 238 ~~~~~~ 243 (251)
|++.++
T Consensus 250 ~~~~~~ 255 (312)
T cd05585 250 FSQLSW 255 (312)
T ss_pred cCCCCH
Confidence 997654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=299.60 Aligned_cols=198 Identities=26% Similarity=0.451 Sum_probs=176.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++|+|+|||++++++..+..+|||||||..|+|.+|++. .+..+...+.+.++.||++|++||.++++|||||-
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA---- 330 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA---- 330 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhh----
Confidence 6789999999999999988899999999999999999985 45778999999999999999999999999999965
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-cccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~ 158 (251)
.+||+++.+..+||+|||+|+...+..... .....+..|.|||.+....+
T Consensus 331 -----------------------------ARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 331 -----------------------------ARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred -----------------------------hhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCc
Confidence 889999999999999999999554443322 22234567999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
+.+|||||||++|||++| |+.|+.+.+..+.+..+..+. .+..|..+|+++.++|..||..+|++|||++.+.
T Consensus 382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999998 999999999999888887775 4556899999999999999999999999999775
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=298.51 Aligned_cols=210 Identities=36% Similarity=0.571 Sum_probs=181.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|...++|.||++|.+|++...+||||||++||++..++. +.+.|++..++.++.+++.||..+|+.|+||||||
T Consensus 195 L~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIK----- 268 (550)
T KOG0605|consen 195 LAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIK----- 268 (550)
T ss_pred hhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCC-----
Confidence 345789999999999999999999999999999999997 67899999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCc------------------------cc-
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD------------------------TM- 135 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~------------------------~~- 135 (251)
|+|++++..|++||+|||++..... ..
T Consensus 269 ----------------------------PdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (550)
T KOG0605|consen 269 ----------------------------PDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPK 320 (550)
T ss_pred ----------------------------hhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccc
Confidence 9999999999999999999952211 00
Q ss_pred --ccc--------------------cccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc
Q psy3253 136 --AKR--------------------NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI 193 (251)
Q Consensus 136 --~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 193 (251)
... ...+|||-|+|||++.+.+|...+|-|||||++|||+.|.+||.+.++.+....+
T Consensus 321 ~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI 400 (550)
T KOG0605|consen 321 FNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI 400 (550)
T ss_pred cccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 000 1135899999999999999999999999999999999999999988887776655
Q ss_pred CCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccC---CHHHHhcChhhhhccCCC
Q psy3253 194 PTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 194 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~~~~~~~~~ 245 (251)
... ....++....++++..|||.+|+. ||++|. .++||-+||||+..+|+.
T Consensus 401 ~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 401 VNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 443 223444455678999999999999 999995 699999999999999975
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=282.50 Aligned_cols=203 Identities=33% Similarity=0.507 Sum_probs=179.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
.||+|+++.++|+.+..+++|+|.|..|.|++++. ..-.+++.+.+.+.+|+..|+.|||..+|+|||+|
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLK--------- 150 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLK--------- 150 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccC---------
Confidence 79999999999999999999999999999999996 55789999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc------cCCC
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ------EIGY 158 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~ 158 (251)
|+||+.+.+..++|+|||++++.... .+.....|||.|.|||.+. ...|
T Consensus 151 ------------------------pENILlddn~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGY 205 (411)
T KOG0599|consen 151 ------------------------PENILLDDNMNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGY 205 (411)
T ss_pred ------------------------hhheeeccccceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCc
Confidence 88999999999999999999887654 4556678999999999984 3457
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+..+|+|+.|+++|.++.|.+||+...+.-....+..+. .-.-+.+..++...+|||.+||+.||++|.|++|+|+|||
T Consensus 206 s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 206 SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 888999999999999999999999888777666665542 2233457788999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|.+..
T Consensus 286 f~q~~ 290 (411)
T KOG0599|consen 286 FIQIA 290 (411)
T ss_pred HHHHH
Confidence 96643
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=309.57 Aligned_cols=203 Identities=32% Similarity=0.541 Sum_probs=186.4
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||.++++++.|++++++|.||||+.||++.... +.+.|++..++.+++.++.||+|||++|||+||||
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK--------- 495 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLK--------- 495 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecc---------
Confidence 6999999999999999999999999999965443 45889999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
-+||+++..|++||+|||+++.........++..||+.|+|||++.+..|+.++|=
T Consensus 496 ------------------------LdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDW 551 (694)
T KOG0694|consen 496 ------------------------LDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDW 551 (694)
T ss_pred ------------------------hhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhH
Confidence 88999999999999999999987655567888999999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~hp~~~ 239 (251)
|||||++|+|+.|+.||.+.+..+....|..... ..|..++.+..++++++|..||++|.- +++|..||||+
T Consensus 552 W~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr 628 (694)
T KOG0694|consen 552 WGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR 628 (694)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence 9999999999999999999999999888877643 347788999999999999999999963 68999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|+.
T Consensus 629 ~i~w~~ 634 (694)
T KOG0694|consen 629 SIDWDD 634 (694)
T ss_pred cCCHHH
Confidence 999974
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=300.65 Aligned_cols=205 Identities=59% Similarity=1.087 Sum_probs=191.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|.++++|||.++|+.|..+..++++||||.||++.++++ .+..+.+..+..++.+++.||.|||.++.+|||||
T Consensus 65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIK----- 138 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIK----- 138 (467)
T ss_pred HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceeccccc-----
Confidence 467899999999999999999999999999999999997 45556999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
+.||++..+|.+|++|||.+.+......+..+..||+.|||||++....|+.
T Consensus 139 ----------------------------aanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~ 190 (467)
T KOG0201|consen 139 ----------------------------AANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDT 190 (467)
T ss_pred ----------------------------ccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccc
Confidence 8899998889999999999998888777778899999999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||||++++||.+|.+|+.+..++.....+....++.+.. .+++.+++|+..||++||+.|||+.++|+|+|+++
T Consensus 191 KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 191 KADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999999999999998888888887754 78999999999999999999999999999999988
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 269 a 269 (467)
T KOG0201|consen 269 A 269 (467)
T ss_pred c
Confidence 3
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=294.78 Aligned_cols=207 Identities=29% Similarity=0.513 Sum_probs=176.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|......|+||||+++|+|..++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk----- 122 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK----- 122 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC-----
Confidence 357899999999999999999999999999999998886 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.
T Consensus 123 ----------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05595 123 ----------------------------LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred ----------------------------HHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCc
Confidence 8899999999999999999865332222223346889999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++|+||+||++|+|++|..||...+.......+... ....+..+++++.++|.+||+.||++|+ +++++++|
T Consensus 175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 999999999999999999999776655544443332 2223567899999999999999999998 99999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||...+|.
T Consensus 252 ~~~~~~~~~ 260 (323)
T cd05595 252 RFFLSINWQ 260 (323)
T ss_pred CCcCCCCHH
Confidence 999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=292.86 Aligned_cols=205 Identities=32% Similarity=0.514 Sum_probs=176.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+.+|+|.++++ ....+++..+..++.|++.||.|||++|++|||||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk----- 128 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK----- 128 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC-----
Confidence 457899999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.
T Consensus 129 ----------------------------p~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 177 (291)
T cd05612 129 ----------------------------PENILLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNK 177 (291)
T ss_pred ----------------------------HHHeEECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCc
Confidence 88999998999999999998755322 22345788999999999888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++||||+||++|+|++|..||.+.+.......+.... ...+..+++.+.++|++||+.||++|++ ++|+++|
T Consensus 178 ~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9999999999999999999998766555444443332 2235567899999999999999999995 9999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|..
T Consensus 255 ~~~~~~~~~~ 264 (291)
T cd05612 255 RWFKSVDWDD 264 (291)
T ss_pred ccccCCCHHH
Confidence 9999877764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.68 Aligned_cols=204 Identities=27% Similarity=0.503 Sum_probs=176.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+++..|+||||+.+|+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk----- 145 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK----- 145 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC-----
Confidence 357899999999999999999999999999999999997 45688999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.
T Consensus 146 ----------------------------p~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 194 (329)
T PTZ00263 146 ----------------------------PENLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGK 194 (329)
T ss_pred ----------------------------HHHEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCC
Confidence 88999999999999999999765432 22346788999999999988999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|+|||||++|+|++|..||.+.........+.... ...+..++..+.+|+.+||+.||++|++ ++++++|
T Consensus 195 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999998766655544444332 2235567899999999999999999986 7999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|+
T Consensus 272 p~f~~~~~~ 280 (329)
T PTZ00263 272 PYFHGANWD 280 (329)
T ss_pred CccCCCCHH
Confidence 999987665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=295.17 Aligned_cols=207 Identities=27% Similarity=0.503 Sum_probs=176.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|+||||+.+|+|.+++. ....+++.+++.++.||+.||.|||++|++|||||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDik----- 122 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK----- 122 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC-----
Confidence 457899999999999999999999999999999998886 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++.............|++.|+|||.+.+..++.
T Consensus 123 ----------------------------p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (328)
T cd05593 123 ----------------------------LENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174 (328)
T ss_pred ----------------------------HHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCc
Confidence 8899999999999999999865332222233346889999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|..||.+.+.......+... ....+..+++++.+++.+||..||++|+ +++|+++|
T Consensus 175 ~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC---CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999999999776655544443332 2233567899999999999999999997 89999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||...+|.
T Consensus 252 ~~~~~~~~~ 260 (328)
T cd05593 252 SFFTGVNWQ 260 (328)
T ss_pred CCcCCCCHH
Confidence 999886664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.35 Aligned_cols=205 Identities=26% Similarity=0.453 Sum_probs=177.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++.++...|+||||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk----- 158 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK----- 158 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC-----
Confidence 356899999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..... ......||+.|+|||++.+..++.
T Consensus 159 ----------------------------p~NILl~~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ 207 (340)
T PTZ00426 159 ----------------------------PENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVGHGK 207 (340)
T ss_pred ----------------------------HHHEEECCCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhCCCCCc
Confidence 8899999999999999999975432 123456889999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++|+||+||++|+|++|..||.+.+.......+.... ...+..+++.+.++|.+||+.||++|+ +++|+++|
T Consensus 208 ~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999999999998776655444444332 223566789999999999999999995 89999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||++.+|..
T Consensus 285 p~f~~~~~~~ 294 (340)
T PTZ00426 285 PWFGNIDWVS 294 (340)
T ss_pred CCcCCCCHHH
Confidence 9999887764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=292.99 Aligned_cols=204 Identities=27% Similarity=0.469 Sum_probs=175.9
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++.+....|+||||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlk-------- 123 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLK-------- 123 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC--------
Confidence 379999999999999999999999999999999886 45679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|
T Consensus 124 -------------------------p~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (320)
T cd05590 124 -------------------------LDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVD 178 (320)
T ss_pred -------------------------HHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccc
Confidence 8899999999999999999865432222333456899999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH------HHHhcChh
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA------SEMLNHEF 237 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~evl~hp~ 237 (251)
+||+||++|+|++|..||...+.......+..... ..+..++.++.+++.+||+.||++|+++ +++++|||
T Consensus 179 iwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 99999999999999999987776665555544322 2345679999999999999999999998 99999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|+..+|+
T Consensus 256 f~~~~~~ 262 (320)
T cd05590 256 FKELDWE 262 (320)
T ss_pred cCCCCHH
Confidence 9987764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=293.54 Aligned_cols=206 Identities=30% Similarity=0.493 Sum_probs=176.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|..+...|+||||+.+++|.+++. ....+.+..+..++.|++.||.|||++|++|||||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk----- 127 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLK----- 127 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 457899999999999999999999999999999999986 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||+++.............|++.|+|||.+.+..++.
T Consensus 128 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 179 (323)
T cd05584 128 ----------------------------PENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179 (323)
T ss_pred ----------------------------HHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCC
Confidence 8899999999999999999865433222333446889999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|..||...+.......+... ....+..+++++.++|.+||+.||++|| +++++++|
T Consensus 180 ~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 999999999999999999999876655544444333 2233566899999999999999999999 89999999
Q ss_pred hhhhhccC
Q psy3253 236 EFIQRHDT 243 (251)
Q Consensus 236 p~~~~~~~ 243 (251)
|||+...|
T Consensus 257 ~~~~~~~~ 264 (323)
T cd05584 257 PFFRHVNW 264 (323)
T ss_pred CCcCCCCH
Confidence 99987655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=273.38 Aligned_cols=207 Identities=26% Similarity=0.464 Sum_probs=175.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+.+.++|.....+.+|+||++. +|+..++.+...++...++.++.+++.||+|||++.|+|||+|
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlK----- 128 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLK----- 128 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCC-----
Confidence 5789999999999999999999999999965 9999999888899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|.|++++.+|.+||+|||+++.++.........+-|.+|+|||.+.+ ..|+
T Consensus 129 ----------------------------PnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg 180 (318)
T KOG0659|consen 129 ----------------------------PNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYG 180 (318)
T ss_pred ----------------------------ccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcC
Confidence 88999999999999999999988766555555577999999999866 6689
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhhcCCCCCCC-CC---------------------CCCCCCHHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTKPPPS-FR---------------------EPDVWTPEFIDF 214 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~-~~---------------------~~~~~~~~~~~l 214 (251)
..+||||.||++.||+.|.+.|.+.+..+. +......+.+. ++ .....+++..||
T Consensus 181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldL 260 (318)
T KOG0659|consen 181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDL 260 (318)
T ss_pred CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHH
Confidence 999999999999999999999976544433 33333322111 10 112246778999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+.+||.+||.+|+|+.|+++|+||+..
T Consensus 261 l~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 261 LSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHhhhccCchhcccHHHHhcchhhhcC
Confidence 999999999999999999999999953
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=299.01 Aligned_cols=207 Identities=31% Similarity=0.597 Sum_probs=186.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++|||||.+++.|++..++++|+|||.| +|..++. .++.++|+.++.++++++.||.|||+.+|+|||+|
T Consensus 55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~k----- 127 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMK----- 127 (808)
T ss_pred HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCC-----
Confidence 3578999999999999999999999999976 9999997 57899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||++.+.+++|++|||+|+..+..........|||.|||||...+.+|+.
T Consensus 128 ----------------------------PqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~ 179 (808)
T KOG0597|consen 128 ----------------------------PQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDH 179 (808)
T ss_pred ----------------------------cceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccc
Confidence 9999999999999999999998776655566678999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.+|+||+||++||+++|++||...........|...+. ..|...+..+.+|++.+|.+||.+|.|..+++.|||.+.
T Consensus 180 ~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 180 TSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred hhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 99999999999999999999987776666766666533 235678999999999999999999999999999999987
Q ss_pred ccCCC
Q psy3253 241 HDTDP 245 (251)
Q Consensus 241 ~~~~~ 245 (251)
.-..+
T Consensus 257 ~~~~~ 261 (808)
T KOG0597|consen 257 KINIA 261 (808)
T ss_pred hhhhh
Confidence 55444
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=291.02 Aligned_cols=205 Identities=29% Similarity=0.495 Sum_probs=175.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+||||+.+++|..++. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlk------ 128 (324)
T cd05589 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLK------ 128 (324)
T ss_pred cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC------
Confidence 46789999999999999999999999999999998875 4679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||++..............|++.|+|||.+.+..++.+
T Consensus 129 ---------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (324)
T cd05589 129 ---------------------------LDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181 (324)
T ss_pred ---------------------------HHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcc
Confidence 88999999999999999998654332233344568899999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcCh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHE 236 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~hp 236 (251)
+|+|||||++|+|++|..||.+.+.......+..... ..+..+++.+.++|.+||+.||++|| +++++++||
T Consensus 182 ~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 9999999999999999999987766555544433322 23566899999999999999999999 799999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+..+|.
T Consensus 259 ~f~~~~~~ 266 (324)
T cd05589 259 FFRDINWD 266 (324)
T ss_pred CcCCCCHH
Confidence 99876554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=293.13 Aligned_cols=206 Identities=29% Similarity=0.453 Sum_probs=176.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++.+.++...|+||||+.+|+|..++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dik------ 123 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLK------ 123 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC------
Confidence 56899999999999999999999999999999999887 45689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||++..............|++.|+|||++.+..++.+
T Consensus 124 ---------------------------p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (323)
T cd05575 124 ---------------------------PENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176 (323)
T ss_pred ---------------------------HHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcc
Confidence 88999999999999999998654332223334568899999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH----HHHhcChh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA----SEMLNHEF 237 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~evl~hp~ 237 (251)
+|||||||++|+|++|..||...+.......+.... ...+..+++.+.++|.+||+.||++||++ .|+++|||
T Consensus 177 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred ccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 999999999999999999998776555544443332 22345679999999999999999999987 69999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|...+|+
T Consensus 254 ~~~~~~~ 260 (323)
T cd05575 254 FSSINWD 260 (323)
T ss_pred cCCCCHH
Confidence 9887664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=285.69 Aligned_cols=204 Identities=25% Similarity=0.438 Sum_probs=165.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+.+ +|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk----- 130 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK----- 130 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-----
Confidence 3578999999999999999999999999975 9999987666678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+||+|||++..............+++.|+|||.+.+ ..++
T Consensus 131 ----------------------------p~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (288)
T cd07871 131 ----------------------------PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182 (288)
T ss_pred ----------------------------HHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccC
Confidence 88889988999999999998754333222334467889999998865 5688
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCC------------------------CCCCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPP------------------------PSFREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~------------------------~~~~~~~~~~~~~~ 212 (251)
.++|+||+||++|+|++|++||.+.+.......+. .... +.......+++++.
T Consensus 183 ~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (288)
T cd07871 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGI 262 (288)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHH
Confidence 99999999999999999999997655433222110 0000 00001234678899
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+||.+||++||++|||++|+++||||
T Consensus 263 dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 263 DLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=294.34 Aligned_cols=206 Identities=29% Similarity=0.506 Sum_probs=175.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~ 80 (251)
+.++||||+++++++.+....|+||||+.+|+|..++. ....+++..+..++.||+.||.|||+ .|++|||||
T Consensus 50 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDik----- 123 (325)
T cd05594 50 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK----- 123 (325)
T ss_pred HhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC-----
Confidence 56799999999999999999999999999999998886 45679999999999999999999997 799999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.
T Consensus 124 ----------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05594 124 ----------------------------LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175 (325)
T ss_pred ----------------------------CCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCC
Confidence 8899999999999999999865332222223346889999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|..||.+.+.......+... ....+..+++++.+++.+||+.||++|+ +++++++|
T Consensus 176 ~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999999999999999776655544443332 2223566899999999999999999997 99999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+...|.
T Consensus 253 ~~~~~~~~~ 261 (325)
T cd05594 253 KFFAGIVWQ 261 (325)
T ss_pred CCcCCCCHH
Confidence 999986655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=291.09 Aligned_cols=205 Identities=28% Similarity=0.458 Sum_probs=176.8
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++.++...|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDik-------- 123 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLK-------- 123 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC--------
Confidence 389999999999999999999999999999999886 45679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|
T Consensus 124 -------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (321)
T cd05591 124 -------------------------LDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178 (321)
T ss_pred -------------------------HHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccc
Confidence 8899999999999999999875433323334456889999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-------CHHHHhcCh
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-------TASEMLNHE 236 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~evl~hp 236 (251)
|||+||++|+|++|+.||...+.......+.... ...+..++.++.+++.+||+.||++|+ +++++++||
T Consensus 179 vwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDD---VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred eechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 9999999999999999998776665555444432 223455789999999999999999999 999999999
Q ss_pred hhhhccCCC
Q psy3253 237 FIQRHDTDP 245 (251)
Q Consensus 237 ~~~~~~~~~ 245 (251)
||+..+|+.
T Consensus 256 ~~~~~~~~~ 264 (321)
T cd05591 256 FFKEIDWVL 264 (321)
T ss_pred ccCCCCHHH
Confidence 999877764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=284.31 Aligned_cols=209 Identities=28% Similarity=0.450 Sum_probs=174.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++||||+++.+++..+...|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk-- 124 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK-- 124 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC--
Confidence 3578999999999999999999999999999999988742 23568999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..
T Consensus 125 -------------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 173 (280)
T cd05608 125 -------------------------------PENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173 (280)
T ss_pred -------------------------------HHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC
Confidence 8899998889999999999976543333333446788999999999989
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchh----hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----C
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRA----IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----T 228 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 228 (251)
++.++|+||+||++|++++|+.||........ ...+... ....+..+++++.+++.+||+.||++|| +
T Consensus 174 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (280)
T cd05608 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGN 250 (280)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 99999999999999999999999965432211 1111111 2233456899999999999999999999 8
Q ss_pred HHHHhcChhhhhccCCC
Q psy3253 229 ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~~ 245 (251)
++|+++||||+...|..
T Consensus 251 ~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 251 CDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHHhcChhhhcCCHhH
Confidence 89999999999987764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=288.69 Aligned_cols=205 Identities=25% Similarity=0.448 Sum_probs=174.2
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
.++||||+++++++.++++.|+||||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk------- 123 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLK------- 123 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC-------
Confidence 3589999999999999999999999999999999886 45679999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.++
T Consensus 124 --------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 177 (316)
T cd05620 124 --------------------------LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177 (316)
T ss_pred --------------------------HHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCccc
Confidence 889999989999999999986432222233345688999999999988999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-HHHhcChhhhhc
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-SEMLNHEFIQRH 241 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~evl~hp~~~~~ 241 (251)
|+||+||++|+|++|..||.+.+.......+.... ...+..++.++.+++.+||+.||++|+++ +++++||||+..
T Consensus 178 DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 99999999999999999998766555444443322 12245578999999999999999999998 689999999887
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
+|.
T Consensus 255 ~~~ 257 (316)
T cd05620 255 NWT 257 (316)
T ss_pred CHH
Confidence 664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=291.48 Aligned_cols=206 Identities=26% Similarity=0.469 Sum_probs=172.6
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++|+||||+++.++.... ..+|||||||+. +|.-++....-.|++.+++.+++||+.||.|+|.+|++|||||
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK--- 245 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIK--- 245 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeecccc---
Confidence 5789999999999988766 689999999987 9999998556789999999999999999999999999999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-cccccccccccccccccc-C
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQE-I 156 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~ 156 (251)
.+||+++.+|.+||+|||+|+.+...... ....+-|.+|+|||.+.+ .
T Consensus 246 ------------------------------~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t 295 (560)
T KOG0600|consen 246 ------------------------------GSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT 295 (560)
T ss_pred ------------------------------ccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCc
Confidence 88999999999999999999866543322 344567899999999976 5
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh---cCCCCCCCCCC-----------------------CCCCCHH
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM---IPTKPPPSFRE-----------------------PDVWTPE 210 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~-----------------------~~~~~~~ 210 (251)
.|+.++|+||.|||+.||++|++.|++.+..+.... +...+....+. ...++..
T Consensus 296 ~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~ 375 (560)
T KOG0600|consen 296 SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPAS 375 (560)
T ss_pred ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHH
Confidence 699999999999999999999999988766554433 32222211111 1335788
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
..+|+..||..||.+|.|+.++|+|+||..
T Consensus 376 ~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 376 ALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHHHhccCccccccHHHHhcCccccc
Confidence 999999999999999999999999999943
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=293.72 Aligned_cols=207 Identities=28% Similarity=0.494 Sum_probs=177.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++|+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk----- 125 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK----- 125 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC-----
Confidence 457899999999999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.
T Consensus 126 ----------------------------p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 177 (318)
T cd05582 126 ----------------------------PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177 (318)
T ss_pred ----------------------------HHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCC
Confidence 8899999999999999999876543323334456888999999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|||||||++|+|++|+.||...+.......+... ....+..+++.+.+++.+||+.||++||+ ++++++|
T Consensus 178 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999999999999877665555444333 22335668999999999999999999999 7889999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|.
T Consensus 255 ~~~~~~~~~ 263 (318)
T cd05582 255 PFFSTIDWN 263 (318)
T ss_pred CCcCCCCHH
Confidence 999877654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.03 Aligned_cols=210 Identities=24% Similarity=0.423 Sum_probs=166.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+. ++|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk----- 130 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK----- 130 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 457899999999999999999999999995 68888887666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+||+|||++..............+++.|+|||++.+ ..++
T Consensus 131 ----------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (303)
T cd07869 131 ----------------------------PQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182 (303)
T ss_pred ----------------------------HHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCC
Confidence 88889988999999999998654332222334557889999999865 4578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchh-hhh---cCCCC---------------CCCCC-----------CCCCCCH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRA-IFM---IPTKP---------------PPSFR-----------EPDVWTP 209 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~---~~~~~---------------~~~~~-----------~~~~~~~ 209 (251)
.++|+||+||++|+|++|..||.+...... ... ..... +..+. .....++
T Consensus 183 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (303)
T cd07869 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN 262 (303)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCCh
Confidence 899999999999999999999976433211 100 00000 00000 0112457
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
++.+|+.+||+.||++|||++|+++||||+.....
T Consensus 263 ~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 263 HAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred HHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence 88999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=290.99 Aligned_cols=210 Identities=26% Similarity=0.500 Sum_probs=186.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+-++|||||++|++..+...+|||+|+-++|+|.+|+.+....+.+..++.++.||+.|+.|+|+..++|||+|
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLK----- 145 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLK----- 145 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCC-----
Confidence 567899999999999999999999999999999999998888999999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceec-CCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+|+++ .+-|-+||.|||++-.+... .+..+..|+..|.|||++.+..|+
T Consensus 146 ----------------------------PENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 146 ----------------------------PENVVFFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred ----------------------------cceeEEeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhhcCccC
Confidence 555543 45678999999999776544 445566788899999999998886
Q ss_pred c-chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 C-VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~-~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
. ++||||||+++|.|++|++||+..+..+...++... .+..|..++.++++||..||+.||++|+|.+||.+++|+
T Consensus 197 APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 197 APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 4 799999999999999999999988777777666654 667788899999999999999999999999999999999
Q ss_pred hhccCCCCC
Q psy3253 239 QRHDTDPSQ 247 (251)
Q Consensus 239 ~~~~~~~~~ 247 (251)
+..+...+.
T Consensus 274 q~~D~~~sT 282 (864)
T KOG4717|consen 274 QAGDRGLST 282 (864)
T ss_pred cCCCCCccc
Confidence 998876543
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=292.55 Aligned_cols=206 Identities=33% Similarity=0.581 Sum_probs=186.7
Q ss_pred CCCCCCCccceeeeeEeeCCe-EEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~-~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++.|||||.+.++|..++. +|++|+||+||+|.+.+...+ ..|+++.+..|+.|++.|+.|||+++|+|||||
T Consensus 57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK--- 133 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLK--- 133 (426)
T ss_pred HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccch---
Confidence 367999999999999998887 999999999999999997444 779999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
+.||++++++.++|+|||+|+.............||+.|++||++.+.+|
T Consensus 134 ------------------------------~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pY 183 (426)
T KOG0589|consen 134 ------------------------------CANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPY 183 (426)
T ss_pred ------------------------------hhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCC
Confidence 88999999999999999999988776556777889999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
..++|+|||||++|||++-+++|...+....+..+..... .+.+..++.+++.+|+.||..+|+.||++.++|.+|..
T Consensus 184 n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 184 NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 9999999999999999999999998888888777766542 33477889999999999999999999999999999988
Q ss_pred hhc
Q psy3253 239 QRH 241 (251)
Q Consensus 239 ~~~ 241 (251)
++.
T Consensus 262 ~~~ 264 (426)
T KOG0589|consen 262 LRY 264 (426)
T ss_pred hhH
Confidence 753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=284.48 Aligned_cols=211 Identities=24% Similarity=0.354 Sum_probs=173.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+++..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dik---- 129 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK---- 129 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC----
Confidence 35789999999999999999999999999999999887533 3468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... ......|+..|+|||++.+..++
T Consensus 130 -----------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05631 130 -----------------------------PENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYT 179 (285)
T ss_pred -----------------------------HHHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcCCCCC
Confidence 889999889999999999987643221 22334678999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEML 233 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl 233 (251)
.++||||+||++|+|++|+.||...........+.. ........+..+++++.+|+.+||+.||++||+ ++|++
T Consensus 180 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~ 259 (285)
T cd05631 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK 259 (285)
T ss_pred cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh
Confidence 999999999999999999999976543211111110 011122335668999999999999999999997 89999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+..+|..
T Consensus 260 ~h~~~~~~~~~~ 271 (285)
T cd05631 260 QHPIFKNINFKR 271 (285)
T ss_pred cCHhhcCCCHHH
Confidence 999999887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=287.32 Aligned_cols=204 Identities=28% Similarity=0.495 Sum_probs=174.3
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
++||||+++++++.+....++||||+.+|+|.+++. ....+++.++..++.|++.||.|||++|++|||||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdik-------- 123 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLK-------- 123 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC--------
Confidence 589999999999999999999999999999999987 44678999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............|+..|+|||++.+..++.++|
T Consensus 124 -------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (316)
T cd05619 124 -------------------------LDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178 (316)
T ss_pred -------------------------HHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhh
Confidence 8899999999999999999865332222333456789999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH-HHhcChhhhhcc
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS-EMLNHEFIQRHD 242 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~hp~~~~~~ 242 (251)
+||+||++|+|++|..||.+.+.......+....+ . .+..++.++.+++.+||+.||++||++. ++++||||+..+
T Consensus 179 vwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-C--YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C--CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 99999999999999999987766554444433221 1 2455789999999999999999999996 999999999877
Q ss_pred CC
Q psy3253 243 TD 244 (251)
Q Consensus 243 ~~ 244 (251)
|.
T Consensus 256 ~~ 257 (316)
T cd05619 256 WS 257 (316)
T ss_pred HH
Confidence 65
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=287.21 Aligned_cols=204 Identities=26% Similarity=0.472 Sum_probs=174.7
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++..+...|+||||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlk-------- 123 (316)
T cd05592 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLK-------- 123 (316)
T ss_pred cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC--------
Confidence 589999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............||+.|+|||.+.+..++.++|
T Consensus 124 -------------------------p~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (316)
T cd05592 124 -------------------------LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVD 178 (316)
T ss_pred -------------------------HHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCccc
Confidence 8899999999999999999975433323334456899999999999888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-HHHhcChhhhhcc
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-SEMLNHEFIQRHD 242 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~evl~hp~~~~~~ 242 (251)
|||+||++|+|++|..||.+.+.......+.... ...+..++.++.+++.+||+.||++||++ +++++||||+..+
T Consensus 179 vwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred chhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 9999999999999999998776655554443322 12355678999999999999999999986 5889999998876
Q ss_pred CC
Q psy3253 243 TD 244 (251)
Q Consensus 243 ~~ 244 (251)
|.
T Consensus 256 ~~ 257 (316)
T cd05592 256 WE 257 (316)
T ss_pred HH
Confidence 64
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=287.44 Aligned_cols=203 Identities=29% Similarity=0.485 Sum_probs=175.0
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++.+....|+||||+.+|+|.+++. +...+++..+..++.|++.||.|||++|++|||||
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk--------- 123 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK--------- 123 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCC---------
Confidence 79999999999999999999999999999999886 45689999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+
T Consensus 124 ------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 179 (318)
T cd05570 124 ------------------------LDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179 (318)
T ss_pred ------------------------HHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhh
Confidence 88999999999999999998653322223334457889999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp~~~ 239 (251)
||+||++|+|++|..||.+.+.......+.... ...+..++.++.++|.+||..||++|||+ .++++||||+
T Consensus 180 wslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~ 256 (318)
T cd05570 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDE---VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256 (318)
T ss_pred hhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 999999999999999998766555544443332 22355679999999999999999999999 9999999999
Q ss_pred hccCC
Q psy3253 240 RHDTD 244 (251)
Q Consensus 240 ~~~~~ 244 (251)
..+|.
T Consensus 257 ~~~~~ 261 (318)
T cd05570 257 EIDWD 261 (318)
T ss_pred CCCHH
Confidence 87774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.04 Aligned_cols=207 Identities=28% Similarity=0.475 Sum_probs=174.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++|+|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk----- 128 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK----- 128 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-----
Confidence 356789999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||++..... ......|++.|+|||++.+..++.
T Consensus 129 ----------------------------p~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ 177 (333)
T cd05600 129 ----------------------------PENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDF 177 (333)
T ss_pred ----------------------------HHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCC
Confidence 8899999999999999999975443 223456889999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-----CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-----PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++||||+||++|+|++|..||...+.......+.... +........+++++.+++.+||..+|++||+++|+++|
T Consensus 178 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999998766554433222111 10100112568999999999999999999999999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|+
T Consensus 258 ~~~~~~~~~ 266 (333)
T cd05600 258 PFFKEVDWN 266 (333)
T ss_pred cccCCCCHH
Confidence 999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=280.90 Aligned_cols=211 Identities=28% Similarity=0.463 Sum_probs=175.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.++||.+.+||..|+.+...|++||||.||+|..+.+. .+..|++..++.++.+++.||+|||-.|||+||||||||
T Consensus 131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENI 210 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENI 210 (459)
T ss_pred HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCccee
Confidence 4679999999999999999999999999999999988863 346799999999999999999999999999999995555
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccC---------------------------
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT--------------------------- 132 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~--------------------------- 132 (251)
||+ .+|++.|+||.++....
T Consensus 211 Lvr---------------------------------edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~ 257 (459)
T KOG0610|consen 211 LVR---------------------------------EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSC 257 (459)
T ss_pred EEe---------------------------------cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccc
Confidence 555 44444444444442110
Q ss_pred -----------------------------cccccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3253 133 -----------------------------DTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD 183 (251)
Q Consensus 133 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 183 (251)
....+....+||-.|.|||++.+..-+.++|=|+|||++|||+.|..||.+
T Consensus 258 f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 258 FSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred cccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 011233445688899999999999999999999999999999999999999
Q ss_pred CCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC----HHHHhcChhhhhccCCC
Q psy3253 184 IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT----ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~hp~~~~~~~~~ 245 (251)
.+.......+..... .+......+.+++|||.++|.+||++|.. ++||-+||||+..+|+.
T Consensus 338 ~~~~~Tl~NIv~~~l-~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 338 SNNKETLRNIVGQPL-KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred CCchhhHHHHhcCCC-cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence 888888877766644 33333467899999999999999999987 99999999999999974
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=289.26 Aligned_cols=203 Identities=28% Similarity=0.503 Sum_probs=169.6
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||++++++|.+....|+||||+++|+|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk--------- 123 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK--------- 123 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC---------
Confidence 79999999999999999999999999999998886 45789999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||+++.............||+.|+|||++.+..++.++|+
T Consensus 124 ------------------------p~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (329)
T cd05588 124 ------------------------LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179 (329)
T ss_pred ------------------------HHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccce
Confidence 88999988999999999998643222223334568899999999999889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcc--------h-hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC------H
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPM--------R-AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT------A 229 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~ 229 (251)
||+||++|++++|..||...... . ....+... ....+..++..+.+++.+||+.||++|++ +
T Consensus 180 wslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 256 (329)
T cd05588 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGF 256 (329)
T ss_pred echHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCH
Confidence 99999999999999999532111 1 11112221 22345678999999999999999999987 7
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
+++++||||+..+|.
T Consensus 257 ~~i~~hp~~~~~~~~ 271 (329)
T cd05588 257 RDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHhcCCCCCCCCHH
Confidence 899999999887664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.52 Aligned_cols=209 Identities=29% Similarity=0.493 Sum_probs=171.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++.+.++...|+||||+.||+|.+++. ....+++..++.++.|++.||.|||++||+|||||
T Consensus 56 ~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlK------ 128 (363)
T cd05628 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK------ 128 (363)
T ss_pred HhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC------
Confidence 56899999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-------------------------
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA------------------------- 136 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------- 136 (251)
|+||+++.++.++|+|||+++.......
T Consensus 129 ---------------------------p~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (363)
T cd05628 129 ---------------------------PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181 (363)
T ss_pred ---------------------------HHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccc
Confidence 8899999999999999999864321100
Q ss_pred ----------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCC
Q psy3253 137 ----------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPD 205 (251)
Q Consensus 137 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 205 (251)
......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+... ....+....
T Consensus 182 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 261 (363)
T cd05628 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEV 261 (363)
T ss_pred cchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcC
Confidence 011246899999999999889999999999999999999999999877665554444321 122222233
Q ss_pred CCCHHHHHHHHHhhhcCcC---ccCCHHHHhcChhhhhccCCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPE---ERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~---~Rps~~evl~hp~~~~~~~~~ 245 (251)
.+++++.+++.+|+. +|+ .||+++|+++||||+..+|+.
T Consensus 262 ~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 262 PISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 478999999999765 444 458999999999999888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=296.17 Aligned_cols=211 Identities=45% Similarity=0.896 Sum_probs=193.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|..++||+||++++.|...+.++++.|||.||-....+-.-+..+.+.++..+++|++.||.|||+++|||||+|
T Consensus 83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLK----- 157 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLK----- 157 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhcc-----
Confidence 467899999999999999999999999999999999887778899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 155 (251)
..||+++-+|.++|+|||.+-.......+...+.|||+|||||+.. .
T Consensus 158 ----------------------------AGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD 209 (1187)
T KOG0579|consen 158 ----------------------------AGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKD 209 (1187)
T ss_pred ----------------------------ccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccC
Confidence 7788888899999999999876555555677889999999999873 5
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.+|+.++||||||+++.+|..+.+|....+++..+..+....++.+..|..|+..|.||+++||..||..||+++++++|
T Consensus 210 ~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 210 QPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 77999999999999999999999999999999999889888888888999999999999999999999999999999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+..
T Consensus 290 pfv~~~~Sn 298 (1187)
T KOG0579|consen 290 PFVQNAPSN 298 (1187)
T ss_pred cccccCCcc
Confidence 999976543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.83 Aligned_cols=206 Identities=28% Similarity=0.444 Sum_probs=175.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++...+..|+||||+.+|+|.+++. ....+.+..++.++.||+.||.|||++|++|||||
T Consensus 51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlk------ 123 (325)
T cd05602 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK------ 123 (325)
T ss_pred HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC------
Confidence 46899999999999999999999999999999999987 45678999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.+
T Consensus 124 ---------------------------p~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05602 124 ---------------------------PENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176 (325)
T ss_pred ---------------------------HHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCc
Confidence 88999998999999999998754332233344568999999999999899999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH----HHhcChh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS----EMLNHEF 237 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----evl~hp~ 237 (251)
+||||+||++|+|++|.+||.+.+.......+.... ...+..+++.+.+++.+||+.||.+|+++. ++++|+|
T Consensus 177 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred cccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 999999999999999999998766655444443322 223456799999999999999999999876 8999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|...+|+
T Consensus 254 ~~~~~~~ 260 (325)
T cd05602 254 FSPINWD 260 (325)
T ss_pred cCCCCHH
Confidence 9887663
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=283.82 Aligned_cols=207 Identities=36% Similarity=0.746 Sum_probs=168.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni 79 (251)
|++++||||+++++++..++..++||||+++++|.+++. ....+++..+..++.|++.||.|||++ +++|||||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlk---- 131 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK---- 131 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCC----
Confidence 467899999999999999999999999999999999997 456799999999999999999999986 69999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++...... ......++..|+|||++.+..++
T Consensus 132 -----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 132 -----------------------------PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred -----------------------------hhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCC
Confidence 88888888999999999998755332 22334578899999999988899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC--------------------------------------------
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-------------------------------------------- 195 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------------------------------- 195 (251)
.++|+||+||++|++++|+.||...+.......+..
T Consensus 181 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T cd06649 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260 (331)
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH
Confidence 999999999999999999999965433222111100
Q ss_pred -CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 196 -KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 196 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
...........+++++.+||.+||++||++|||++|+++||||+....
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 261 VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred HhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 000000012246789999999999999999999999999999987544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=274.76 Aligned_cols=208 Identities=27% Similarity=0.478 Sum_probs=173.3
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|.+.+|||||.+.++... -+.+|||||||+. +|..++..-.++|...+++.+..|++.|++|||...|+|||+|
T Consensus 129 Ll~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK--- 204 (419)
T KOG0663|consen 129 LLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLK--- 204 (419)
T ss_pred HHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccc---
Confidence 346789999999998874 4579999999987 9999998777899999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
++|++++..|.+||+|||+|+.++.+.......+-|.+|+|||.+.+ ..
T Consensus 205 ------------------------------~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~t 254 (419)
T KOG0663|consen 205 ------------------------------TSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKT 254 (419)
T ss_pred ------------------------------hhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcc
Confidence 88999999999999999999999887666666677899999999976 55
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhhcCCCCCCC----CCC---------------------C-CCCC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTKPPPS----FRE---------------------P-DVWT 208 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~----~~~---------------------~-~~~~ 208 (251)
|+.+.||||+||++.+++++++.|.+...... +..+...+... +.. . ..++
T Consensus 255 yst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~ls 334 (419)
T KOG0663|consen 255 YSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLS 334 (419)
T ss_pred cCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccc
Confidence 89999999999999999999999976544333 33332221110 000 0 1135
Q ss_pred HHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 209 PEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 209 ~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
..-++|+..+|.+||.+|.|++|.|.|+||++..
T Consensus 335 e~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 335 EQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred hhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 7789999999999999999999999999999843
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=278.78 Aligned_cols=211 Identities=26% Similarity=0.449 Sum_probs=170.2
Q ss_pred CCCCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|+.++|+||+.+++++.- -..+|+|+|+|+ .+|.+.++ .+..+++.-++.+++||+.||+|+|+.|++|||+|
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK 152 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK 152 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence 356789999999999964 357999999995 59999987 45669999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--ccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~ 153 (251)
|.|++++.+..+||+|||+|+..... .......+-|.+|+|||++
T Consensus 153 ---------------------------------PsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 153 ---------------------------------PSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred ---------------------------------hhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHH
Confidence 88999999999999999999877532 1222344578999999998
Q ss_pred c-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCC------------------------CCC-CCCC
Q psy3253 154 Q-EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKP------------------------PPS-FREP 204 (251)
Q Consensus 154 ~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~------------------------~~~-~~~~ 204 (251)
. ...|+.+.||||+||++.||++|++.|.+.+.......+. ..+ +.. ....
T Consensus 200 l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f 279 (359)
T KOG0660|consen 200 LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF 279 (359)
T ss_pred hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc
Confidence 5 4779999999999999999999999997654443332221 110 000 0113
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
...++...+|+++||..||.+|+|++|+|+|||+...-....
T Consensus 280 p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 280 PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 456899999999999999999999999999999987655443
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=288.76 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=174.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++..++..|+||||+.+|+|..++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlk------ 123 (325)
T cd05604 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLK------ 123 (325)
T ss_pred HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC------
Confidence 46899999999999999999999999999999998886 55789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.+
T Consensus 124 ---------------------------p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (325)
T cd05604 124 ---------------------------PENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176 (325)
T ss_pred ---------------------------HHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCc
Confidence 88999999999999999998654322223344568899999999999889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH----HHHhcChh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA----SEMLNHEF 237 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~evl~hp~ 237 (251)
+||||+||++|+|++|..||...+.......+.... ...+...+..+.+++.+||..+|++||++ +++++|||
T Consensus 177 ~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~ 253 (325)
T cd05604 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF 253 (325)
T ss_pred CccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCC
Confidence 999999999999999999998766555544443332 12234578999999999999999999976 59999999
Q ss_pred hhhccC
Q psy3253 238 IQRHDT 243 (251)
Q Consensus 238 ~~~~~~ 243 (251)
|+...|
T Consensus 254 f~~~~~ 259 (325)
T cd05604 254 FESLSW 259 (325)
T ss_pred cCCCCH
Confidence 987655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=287.26 Aligned_cols=204 Identities=29% Similarity=0.520 Sum_probs=170.2
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++......|+||||+.+|+|..++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dik-------- 123 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK-------- 123 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC--------
Confidence 489999999999999999999999999999998886 45689999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............|+..|+|||++.+..++.++|
T Consensus 124 -------------------------p~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (329)
T cd05618 124 -------------------------LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178 (329)
T ss_pred -------------------------HHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccc
Confidence 8899999999999999999865332222334456889999999999989999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcc--------h-hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC------
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPM--------R-AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT------ 228 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------ 228 (251)
+||+||++|+|++|..||...... . ....+... ....+..++..+.++|.+||+.||++||+
T Consensus 179 iwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~ 255 (329)
T cd05618 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTG 255 (329)
T ss_pred eecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCC
Confidence 999999999999999999521111 1 11111111 22345678999999999999999999998
Q ss_pred HHHHhcChhhhhccCC
Q psy3253 229 ASEMLNHEFIQRHDTD 244 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~ 244 (251)
++++++||||+..+|.
T Consensus 256 ~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 256 FADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHhcCCCCCCCCHH
Confidence 5899999999988774
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=290.97 Aligned_cols=209 Identities=25% Similarity=0.424 Sum_probs=174.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++.++...|+||||+.+|+|.+++. +..+++..+..++.||+.||.|||++|++|||||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk----- 169 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVK----- 169 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC-----
Confidence 357899999999999999999999999999999999986 3468999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccC---
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEI--- 156 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--- 156 (251)
|+||+++.++.++|+|||++........ ......||+.|+|||++.+.
T Consensus 170 ----------------------------p~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 221 (370)
T cd05596 170 ----------------------------PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221 (370)
T ss_pred ----------------------------HHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCC
Confidence 8899999999999999999976543211 22345689999999998653
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCc--cCCHHHH
Q psy3253 157 -GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEE--RATASEM 232 (251)
Q Consensus 157 -~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ev 232 (251)
.++.++|+||+||++|+|++|..||.+.+.......+... ....+.....++.++.++|.+||+.+|++ |+|++|+
T Consensus 222 ~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 3788999999999999999999999876665544444332 22233333457999999999999999988 9999999
Q ss_pred hcChhhhhccCC
Q psy3253 233 LNHEFIQRHDTD 244 (251)
Q Consensus 233 l~hp~~~~~~~~ 244 (251)
++||||+..+|.
T Consensus 302 l~h~~~~~~~~~ 313 (370)
T cd05596 302 KSHPFFKNDQWT 313 (370)
T ss_pred hcCcccCCCChh
Confidence 999999987765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.34 Aligned_cols=210 Identities=32% Similarity=0.565 Sum_probs=174.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.++...|+||||+.+|+|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk----- 128 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK----- 128 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC-----
Confidence 356899999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA------------------------ 136 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------ 136 (251)
|+||+++.++.++|+|||++........
T Consensus 129 ----------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (364)
T cd05599 129 ----------------------------PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180 (364)
T ss_pred ----------------------------HHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccc
Confidence 8899999999999999999864321100
Q ss_pred --------------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCC
Q psy3253 137 --------------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSF 201 (251)
Q Consensus 137 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~ 201 (251)
......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+... .....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 260 (364)
T cd05599 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF 260 (364)
T ss_pred ccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 001235889999999999889999999999999999999999999877665544333221 11222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCccCC---HHHHhcChhhhhccCCC
Q psy3253 202 REPDVWTPEFIDFVSRCLVKNPEERAT---ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 202 ~~~~~~~~~~~~li~~~l~~~p~~Rps---~~evl~hp~~~~~~~~~ 245 (251)
.....+++++.++|.+|+. +|.+|++ ++|+++||||+..+|+.
T Consensus 261 ~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 261 PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 2234578999999999997 9999997 99999999999887743
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=285.85 Aligned_cols=206 Identities=29% Similarity=0.450 Sum_probs=174.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.+....|+||||+++|+|...+. ....+++..+..++.||+.||.|||+.|++|||||
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlk------ 123 (321)
T cd05603 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLK------ 123 (321)
T ss_pred HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC------
Confidence 56899999999999999999999999999999998886 45678999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||++..............+++.|+|||.+.+..++.+
T Consensus 124 ---------------------------p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (321)
T cd05603 124 ---------------------------PENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176 (321)
T ss_pred ---------------------------HHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCc
Confidence 88999999999999999998653322223334567899999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH----HHHhcChh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA----SEMLNHEF 237 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~evl~hp~ 237 (251)
+||||+||++|+|++|..||...+.......+.... ...+...+.++.+++.+||+.||++|+++ .|+++|+|
T Consensus 177 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred CcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 999999999999999999998776555544444332 23355678999999999999999999865 59999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|...+|.
T Consensus 254 ~~~~~~~ 260 (321)
T cd05603 254 FSPINWD 260 (321)
T ss_pred cCCCCHH
Confidence 9876653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.61 Aligned_cols=205 Identities=26% Similarity=0.449 Sum_probs=173.3
Q ss_pred CCCC-CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.++| ++|+++++++.+.+.+|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk------ 128 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK------ 128 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC------
Confidence 4544 568899999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.+
T Consensus 129 ---------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 181 (324)
T cd05587 129 ---------------------------LDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181 (324)
T ss_pred ---------------------------HHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcc
Confidence 88999999999999999998643222222334568899999999999889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcCh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHE 236 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp 236 (251)
+|+||+||++|+|++|+.||.+.+.......+.... ...+..+++++.+++.+||..||++|++. +++++||
T Consensus 182 ~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp 258 (324)
T cd05587 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA 258 (324)
T ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 999999999999999999998776655555444332 22356689999999999999999999976 8999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+..+|.
T Consensus 259 ~~~~~~~~ 266 (324)
T cd05587 259 FFRRIDWE 266 (324)
T ss_pred CcCCCCHH
Confidence 99987764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=290.62 Aligned_cols=210 Identities=32% Similarity=0.558 Sum_probs=176.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++.+.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlk----- 128 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIK----- 128 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC-----
Confidence 3567899999999999999999999999999999999974 4789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------------------------- 135 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------- 135 (251)
|+||+++.++.++|+|||++.......
T Consensus 129 ----------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (350)
T cd05573 129 ----------------------------PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180 (350)
T ss_pred ----------------------------HHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccc
Confidence 889999999999999999997654332
Q ss_pred ----ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHH
Q psy3253 136 ----AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPE 210 (251)
Q Consensus 136 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 210 (251)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ..........++++
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 260 (350)
T cd05573 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPE 260 (350)
T ss_pred ccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHH
Confidence 1223346889999999999989999999999999999999999999776655444333321 11122223347999
Q ss_pred HHHHHHHhhhcCcCccCC-HHHHhcChhhhhccCCC
Q psy3253 211 FIDFVSRCLVKNPEERAT-ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps-~~evl~hp~~~~~~~~~ 245 (251)
+.++|.+||. ||++|++ ++|+++||||+..+|+.
T Consensus 261 ~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 261 AIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 9999999998 9999999 99999999999887753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=279.67 Aligned_cols=204 Identities=22% Similarity=0.434 Sum_probs=163.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+.++++..+.. ....+++..++.++.|++.||.|||+.|++|||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk----- 127 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK----- 127 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 357899999999999999999999999998877665543 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||++.+..++
T Consensus 128 ----------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 128 ----------------------------PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred ----------------------------HHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCC
Confidence 8888998899999999999976543211 12234578899999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CC------------------CCCCC--------CCCCCCCHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TK------------------PPPSF--------REPDVWTPE 210 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~------------------~~~~~--------~~~~~~~~~ 210 (251)
.++|+||+||++|+|++|++||.+.+.......+. .. ..+.. .....++++
T Consensus 180 ~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 259 (287)
T cd07848 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGV 259 (287)
T ss_pred CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHH
Confidence 99999999999999999999997654322211100 00 00000 001236788
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.+|+++||+.||++|||++|+++||||
T Consensus 260 ~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 260 LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=275.98 Aligned_cols=209 Identities=44% Similarity=0.894 Sum_probs=178.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|+||||+++++|.+++......+++..++.++.|++.||.|||++|++|+|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~----- 130 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK----- 130 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 357899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+. .
T Consensus 131 ----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 182 (280)
T cd06611 131 ----------------------------AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182 (280)
T ss_pred ----------------------------hhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCC
Confidence 8888888889999999999865543333334456788899999874 3
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++|+||+|+++|++++|.+||...+.......+.....+....+..++.++.+++.+||+.+|++||+++++++|
T Consensus 183 ~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 45677899999999999999999999877665555445444444444566789999999999999999999999999999
Q ss_pred hhhhhcc
Q psy3253 236 EFIQRHD 242 (251)
Q Consensus 236 p~~~~~~ 242 (251)
|||....
T Consensus 263 ~~~~~~~ 269 (280)
T cd06611 263 PFVSDQS 269 (280)
T ss_pred hhhcccc
Confidence 9998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=291.74 Aligned_cols=210 Identities=30% Similarity=0.544 Sum_probs=172.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.++...|+||||+.+|+|.+++. +...+++..++.++.||+.||.|||++||+|||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlK----- 128 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK----- 128 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 357899999999999999999999999999999999986 44678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------------------------- 135 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------- 135 (251)
|+||+++.++.++|+|||++.......
T Consensus 129 ----------------------------p~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (382)
T cd05625 129 ----------------------------PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180 (382)
T ss_pred ----------------------------HHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccc
Confidence 889999999999999999975321000
Q ss_pred ----------------------ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc
Q psy3253 136 ----------------------AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI 193 (251)
Q Consensus 136 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 193 (251)
.......||+.|+|||++.+..++.++||||+||++|+|++|.+||...+.......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (382)
T cd05625 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260 (382)
T ss_pred ccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011235788999999999889999999999999999999999999876654443333
Q ss_pred CC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC---HHHHhcChhhhhccCCC
Q psy3253 194 PT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT---ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 194 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~evl~hp~~~~~~~~~ 245 (251)
.. ......+....+++++.++|.+|+ .+|++|++ ++|+++||||+..+|..
T Consensus 261 ~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 261 INWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 22 222233334567999999999987 49999987 99999999999877653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=275.83 Aligned_cols=210 Identities=42% Similarity=0.861 Sum_probs=175.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++..+...++|+||+.+++|..++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 57 ~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlk------ 130 (282)
T cd06643 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK------ 130 (282)
T ss_pred HHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC------
Confidence 46899999999999999999999999999999999887556789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----cC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EI 156 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~ 156 (251)
|+||+++.++.++++|||++..............++..|+|||.+. +.
T Consensus 131 ---------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (282)
T cd06643 131 ---------------------------AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183 (282)
T ss_pred ---------------------------cccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCC
Confidence 8888888889999999999876543333334456788999999983 34
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
.++.++|+||+||++|++++|.+||...+.......+..........+..++.++.++|.+||+.||++||+++++++||
T Consensus 184 ~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 57789999999999999999999997766555444443333333334556789999999999999999999999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+.....
T Consensus 264 ~~~~~~~~ 271 (282)
T cd06643 264 FVTVNSNK 271 (282)
T ss_pred CEeccCCC
Confidence 99875443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=295.75 Aligned_cols=205 Identities=27% Similarity=0.496 Sum_probs=174.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|+.++||||++++++|..+++.|+||||+.+|+|.+++... ...+++.++..++.|++.||.|||++||+|||||
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk-- 196 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK-- 196 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC--
Confidence 45789999999999999999999999999999999988532 4568999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 197 -------------------------------p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 197 -------------------------------SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred -------------------------------HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC
Confidence 8889999899999999999976543211 1233458999999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++||||+||++|+|++|..||.+.+.......+....... .+..+++++.++|.+||..||++||++++++.|
T Consensus 246 ~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 246 KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 899999999999999999999999998776655554443332222 245678999999999999999999999999999
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
||++.
T Consensus 324 ~~~~~ 328 (478)
T PTZ00267 324 EFLKY 328 (478)
T ss_pred HHHHH
Confidence 99874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=276.04 Aligned_cols=212 Identities=42% Similarity=0.861 Sum_probs=177.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++++||||+++++++..+...|+||||+.+++|..++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk----- 137 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK----- 137 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCC-----
Confidence 357899999999999999999999999999999998887666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+. .
T Consensus 138 ----------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (292)
T cd06644 138 ----------------------------AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189 (292)
T ss_pred ----------------------------cceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccC
Confidence 8888888889999999999865433323333445778899999984 3
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++|+||+||++|+|++|.+||...+.......+.....+....+..++.++.+++.+||+.+|++||+++|+++|
T Consensus 190 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 45678899999999999999999999776554444444333333334456678999999999999999999999999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+++.
T Consensus 270 ~~~~~~~~~~ 279 (292)
T cd06644 270 PFVSSVTSNR 279 (292)
T ss_pred ccccccccch
Confidence 9999877764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=270.68 Aligned_cols=204 Identities=79% Similarity=1.364 Sum_probs=176.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++.+.++...|+++||+.+++|.+++......+++..+..++.|++.||.|||+.|++||||+
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~------ 126 (256)
T cd06612 53 KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK------ 126 (256)
T ss_pred HhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC------
Confidence 56799999999999999999999999999999999997667789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+..++.+
T Consensus 127 ---------------------------~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 179 (256)
T cd06612 127 ---------------------------AGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179 (256)
T ss_pred ---------------------------cceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCch
Confidence 88899988999999999999766544333334457788999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+|+||+|+++|+|++|..||...........+..........+..++.++.+++.+||+.||++|||++|++.||||
T Consensus 180 ~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999776655544444433333444455678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.43 Aligned_cols=212 Identities=23% Similarity=0.401 Sum_probs=166.2
Q ss_pred CCCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++... ...|+||||+. ++|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 130 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK 130 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 3578999999999988643 35899999995 69999886 45679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEV 152 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.+||+|||+++....... ......+++.|+|||+
T Consensus 131 ---------------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 177 (338)
T cd07859 131 ---------------------------------PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177 (338)
T ss_pred ---------------------------------HHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHH
Confidence 8899999999999999999975432211 1223467889999999
Q ss_pred ccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh---------------------------cCCCCCCC-CC
Q psy3253 153 IQE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM---------------------------IPTKPPPS-FR 202 (251)
Q Consensus 153 ~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~---------------------------~~~~~~~~-~~ 202 (251)
+.+ ..++.++||||+||++|+|++|++||.+.+....... +....+.. ..
T Consensus 178 ~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 257 (338)
T cd07859 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQ 257 (338)
T ss_pred HhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHH
Confidence 865 6788999999999999999999999966543221110 00000000 01
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
.....++.+.+++.+||+.||++|||++|+++||||+.......+
T Consensus 258 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~ 302 (338)
T cd07859 258 KFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE 302 (338)
T ss_pred hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc
Confidence 123467889999999999999999999999999999887665543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=270.19 Aligned_cols=212 Identities=27% Similarity=0.374 Sum_probs=169.8
Q ss_pred CCCccceeeeeEeeC----CeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 5 DSPYVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 5 ~hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
.|||||.++++|.+. .-+.+|||.++||.|++.++.++ ..|+|+++..+..||..|+.|||+.+|.||||||||+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 699999999999753 34789999999999999997544 5799999999999999999999999999999997776
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|...+.+ +..+||+|||+|+..... ....+...|+.|.|||++...+|+
T Consensus 193 Lyt~t~~------------------------------na~lKLtDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 193 LYTTTSP------------------------------NAPLKLTDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred eeecCCC------------------------------CcceEecccccccccCCC-ccccCCcccccccCHHHhCchhcC
Confidence 6664432 335899999999876543 233345679999999999988999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcch----hhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMR----AIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..+|+||+|+++|-|++|.+||....... ....+..+ ..-+.+.+..+|.+.+++|.++|..+|++|.|++|+++
T Consensus 242 kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 99999999999999999999995332211 11112222 22233346778999999999999999999999999999
Q ss_pred ChhhhhccCCCCC
Q psy3253 235 HEFIQRHDTDPSQ 247 (251)
Q Consensus 235 hp~~~~~~~~~~~ 247 (251)
|||+....--++.
T Consensus 322 hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 322 HPWINQYEAVPQT 334 (400)
T ss_pred CchhcccccCCCC
Confidence 9999887655543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.16 Aligned_cols=204 Identities=25% Similarity=0.433 Sum_probs=175.1
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||+|+++++++...+..|+||||+.+|+|.+++. ....+++.++..++.||+.||.|||++|++|||||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk--------- 128 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK--------- 128 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCC---------
Confidence 68999999999999999999999999999999886 45679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||+++.............|++.|+|||++.+..++.++|+
T Consensus 129 ------------------------p~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 184 (323)
T cd05616 129 ------------------------LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184 (323)
T ss_pred ------------------------HHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccch
Confidence 88999999999999999998754322223334568899999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp~~~ 239 (251)
||+||++|+|++|..||.+.+.......+.... ...+..++.++.+++.+||+.||++|++. +++++||||+
T Consensus 185 wSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred hchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 999999999999999998776665555444332 22355689999999999999999999974 8999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|..
T Consensus 262 ~~~~~~ 267 (323)
T cd05616 262 YIDWEK 267 (323)
T ss_pred CCCHHH
Confidence 877654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=287.52 Aligned_cols=210 Identities=28% Similarity=0.473 Sum_probs=175.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+++|+|.++++.....+++..+..++.|++.||.|||+.|++|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlk------ 129 (330)
T cd05601 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK------ 129 (330)
T ss_pred HhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCc------
Confidence 46799999999999999999999999999999999998665789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccc------
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQ------ 154 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~------ 154 (251)
|+||+++.++.++|+|||++......... .....+++.|+|||++.
T Consensus 130 ---------------------------p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (330)
T cd05601 130 ---------------------------PENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182 (330)
T ss_pred ---------------------------hHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccc
Confidence 88999999999999999999765432221 22345788999999986
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
...++.++||||+||++|+|++|..||...........+... ....++....+++++.+++.+||. +|++|||+++++
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred cCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 455778999999999999999999999776655444433222 112233334578999999999998 999999999999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+..+|+.
T Consensus 262 ~h~~~~~~~~~~ 273 (330)
T cd05601 262 CHPFFSKIDWNN 273 (330)
T ss_pred CCCCcCCCCHHH
Confidence 999999877654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.21 Aligned_cols=211 Identities=28% Similarity=0.506 Sum_probs=170.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+...+|+||||+.+|+|.+++. +...+++..++.++.||+.||.|||+.||+|||||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlK----- 128 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK----- 128 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCc-----
Confidence 357899999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------------------------- 135 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------------------------- 135 (251)
|+||+++.+++++|+|||++.......
T Consensus 129 ----------------------------p~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (381)
T cd05626 129 ----------------------------PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180 (381)
T ss_pred ----------------------------HHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccc
Confidence 889999889999999999975321000
Q ss_pred ----------------------ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc
Q psy3253 136 ----------------------AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI 193 (251)
Q Consensus 136 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 193 (251)
.......||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred cccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 0001235889999999999888999999999999999999999999766554433332
Q ss_pred CC-CCCCCCCCCCCCCHHHHHHHHHhh--hcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 194 PT-KPPPSFREPDVWTPEFIDFVSRCL--VKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 194 ~~-~~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
.. ...........+++++.++|.+|+ ..+|..|++++|+++||||+..+|..
T Consensus 261 ~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 261 INWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 22 122233334457999999999955 44555699999999999999877643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=283.84 Aligned_cols=213 Identities=27% Similarity=0.447 Sum_probs=180.8
Q ss_pred CCCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+++. |||||+++++|.+....++|||+|+||.|.+.+... .+++..+..++.|++.|++|||+.|++|||+||||+
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~ 166 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENL 166 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHe
Confidence 45777 999999999999999999999999999999999754 499999999999999999999999999999996655
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+.... ..++.++++|||++..... ........||+.|+|||++...+++
T Consensus 167 L~~~~~-----------------------------~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~ 216 (382)
T KOG0032|consen 167 LLASKD-----------------------------EGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYG 216 (382)
T ss_pred eecccc-----------------------------CCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCC
Confidence 555221 0125799999999987765 3455667899999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
..+||||+|+++|.|++|.+||.+.+.......+.... ......+..++..+.++|.+||..||.+|+|+.++|+|||+
T Consensus 217 ~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 217 DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 99999999999999999999998887666655554442 23334467789999999999999999999999999999999
Q ss_pred hhccCCC
Q psy3253 239 QRHDTDP 245 (251)
Q Consensus 239 ~~~~~~~ 245 (251)
+.....+
T Consensus 297 ~~~~~~~ 303 (382)
T KOG0032|consen 297 KSIGEAT 303 (382)
T ss_pred cCCcccc
Confidence 9865444
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.92 Aligned_cols=209 Identities=31% Similarity=0.506 Sum_probs=170.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.++...|+||||+.+|+|.+++. ....+++..++.++.|++.||+|||+.|++|||||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlk----- 128 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK----- 128 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-----
Confidence 356899999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA------------------------ 136 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------ 136 (251)
|+||+++.++.++|+|||+++.......
T Consensus 129 ----------------------------p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (377)
T cd05629 129 ----------------------------PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180 (377)
T ss_pred ----------------------------HHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccc
Confidence 8889998899999999999853211000
Q ss_pred -----------------------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc
Q psy3253 137 -----------------------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI 193 (251)
Q Consensus 137 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 193 (251)
......||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+.......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (377)
T cd05629 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260 (377)
T ss_pred cccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 000135888999999999888999999999999999999999999776654443333
Q ss_pred CC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc---CCHHHHhcChhhhhccCC
Q psy3253 194 PT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEER---ATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 194 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~evl~hp~~~~~~~~ 244 (251)
.. .....++....++.++.++|.+||. +|.+| +|++|+++||||+..+|+
T Consensus 261 ~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 261 INWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred HccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 22 1112222233578999999999998 77775 599999999999977653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=276.59 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=162.3
Q ss_pred CCCCCCccceeeeeEe-----eCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
+.++||||+++++++. .....++||||+. ++|.+++... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 3568999999999985 2456899999996 5999998643 3458999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++...... .......+++.|+|||.+.+
T Consensus 138 ---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 138 ---------------------------------PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred ---------------------------------HHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhC
Confidence 88999998999999999999755432 22334567889999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC----CCCC--------------------CCCCCCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP----PPSF--------------------REPDVWTPEF 211 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~--------------------~~~~~~~~~~ 211 (251)
..++.++||||+||++|+|++|.+||.+.........+.... +..+ .....+++.+
T Consensus 184 ~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (290)
T cd07862 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 263 (290)
T ss_pred CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHH
Confidence 889999999999999999999999997655433322221100 0000 0013467888
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.||++|||+.|+++||||
T Consensus 264 ~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 264 KDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=284.30 Aligned_cols=206 Identities=30% Similarity=0.466 Sum_probs=169.0
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++ +||||+++++++..+..+++||||+.+|+|.+++. .+..+++..++.++.||+.||.|||++|++|||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk----- 132 (332)
T cd05614 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIK----- 132 (332)
T ss_pred HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC-----
Confidence 345 59999999999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEI-GY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~ 158 (251)
|+||+++.++.++|+|||+++...... .......||+.|+|||++.+. .+
T Consensus 133 ----------------------------p~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 184 (332)
T cd05614 133 ----------------------------LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184 (332)
T ss_pred ----------------------------HHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCC
Confidence 888999889999999999987543221 122334689999999999764 47
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TA 229 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~ 229 (251)
+.++|||||||++|+|++|..||...... .....+... ....+..+++.+.+++.+||+.||++|| ++
T Consensus 185 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 261 (332)
T cd05614 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGA 261 (332)
T ss_pred CCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCH
Confidence 88999999999999999999999643221 111112221 1123456799999999999999999999 88
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
+++++||||+..+|.
T Consensus 262 ~~~l~h~~~~~~~~~ 276 (332)
T cd05614 262 SEIKEHPFFKGLDWE 276 (332)
T ss_pred HHHHcCCCcCCCCHH
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.85 Aligned_cols=205 Identities=28% Similarity=0.514 Sum_probs=170.5
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++.+...+|+||||+.+|+|..++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk--------- 123 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK--------- 123 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC---------
Confidence 69999999999999999999999999999998886 45679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+
T Consensus 124 ------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (327)
T cd05617 124 ------------------------LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179 (327)
T ss_pred ------------------------HHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchhee
Confidence 88999999999999999998653322223344568999999999998899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCc------chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC------HHHH
Q psy3253 165 WSLGITALEMAEGKPPYGDIHP------MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT------ASEM 232 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~ev 232 (251)
||+||++|+|++|..||..... ........... ....+..++..+.+++.+||+.||++|++ ++++
T Consensus 180 wslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i 257 (327)
T cd05617 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDI 257 (327)
T ss_pred ehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHH
Confidence 9999999999999999953211 11111111111 22345668999999999999999999997 5799
Q ss_pred hcChhhhhccCCC
Q psy3253 233 LNHEFIQRHDTDP 245 (251)
Q Consensus 233 l~hp~~~~~~~~~ 245 (251)
++||||+..+|+.
T Consensus 258 ~~h~~f~~~~~~~ 270 (327)
T cd05617 258 KSHTFFRSIDWDL 270 (327)
T ss_pred HcCCCCCCCCHHH
Confidence 9999999887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.19 Aligned_cols=209 Identities=30% Similarity=0.518 Sum_probs=172.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.+++||||+++++.+.++...|+||||+.||+|.+++. +...+++..++.++.|++.||.|||++|++|||||
T Consensus 56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk------ 128 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK------ 128 (360)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC------
Confidence 46899999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-------------------------
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA------------------------- 136 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~------------------------- 136 (251)
|+||+++.++.++|+|||++........
T Consensus 129 ---------------------------p~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (360)
T cd05627 129 ---------------------------PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181 (360)
T ss_pred ---------------------------HHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccc
Confidence 8899999999999999999864321100
Q ss_pred ----------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCC
Q psy3253 137 ----------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPD 205 (251)
Q Consensus 137 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 205 (251)
......||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+.......+... ....+....
T Consensus 182 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 261 (360)
T cd05627 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEV 261 (360)
T ss_pred cccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCC
Confidence 011235889999999999999999999999999999999999999877665554433321 112222233
Q ss_pred CCCHHHHHHHHHhhhcCcCccC---CHHHHhcChhhhhccCCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~~~~~~~~~ 245 (251)
.+++++.++|.+|+. ||++|+ +++|+++||||+..+|..
T Consensus 262 ~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 262 PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 478999999999875 999998 589999999999987754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=286.91 Aligned_cols=207 Identities=27% Similarity=0.468 Sum_probs=170.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.++...|+||||+.+|+|.+++. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~--~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK------ 169 (370)
T cd05621 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK------ 169 (370)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC------
Confidence 46799999999999999999999999999999999986 3468999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCC---
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIG--- 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--- 157 (251)
|+||+++.++.+||+|||++........ ......||+.|+|||++.+..
T Consensus 170 ---------------------------p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 222 (370)
T cd05621 170 ---------------------------PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222 (370)
T ss_pred ---------------------------HHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCC
Confidence 8899999999999999999976543211 223456899999999996543
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCc--cCCHHHHh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEE--RATASEML 233 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~evl 233 (251)
++.++|+||+||++|+|++|..||...+.......+... ....++....+++.+.+++.+||..++.+ |+|++|++
T Consensus 223 ~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred CCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 778999999999999999999999776655444444332 22233333457899999999999865544 88999999
Q ss_pred cChhhhhccC
Q psy3253 234 NHEFIQRHDT 243 (251)
Q Consensus 234 ~hp~~~~~~~ 243 (251)
+||||+...|
T Consensus 303 ~hp~~~~~~~ 312 (370)
T cd05621 303 QHPFFKNDQW 312 (370)
T ss_pred cCcccCCCCc
Confidence 9999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=286.16 Aligned_cols=209 Identities=25% Similarity=0.362 Sum_probs=164.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|..+...+++||++. ++|..++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiK----- 209 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK----- 209 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-----
Confidence 467899999999999999999999999995 68988886 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++
T Consensus 210 ----------------------------P~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 210 ----------------------------AENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred ----------------------------hHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC
Confidence 888888888999999999986433211 122334689999999999988999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcc-------hhhhhc---CCCCC-----------------------------CC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPM-------RAIFMI---PTKPP-----------------------------PS 200 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~---~~~~~-----------------------------~~ 200 (251)
.++||||+||++|+|++|..||...+.. .....+ ....+ +.
T Consensus 262 ~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (391)
T PHA03212 262 PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPL 341 (391)
T ss_pred cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCC
Confidence 9999999999999999999876432110 000000 00000 00
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 201 FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 201 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
+......+.++.++|.+||++||++|||++|+|+||||+.....
T Consensus 342 ~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 342 WTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 00011346689999999999999999999999999999875433
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=276.24 Aligned_cols=200 Identities=29% Similarity=0.531 Sum_probs=179.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.|+||||+++|++|++++.+++||||..+|.|++|+. ..+.+++++++.+++||+.|+.|+|+++++|||+|
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLK----- 180 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLK----- 180 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccc-----
Confidence 678999999999999999999999999999999999997 56889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
.+||+++.++.+||+|||++-.+... ....++.|++-|.+||++.+.+|..
T Consensus 181 ----------------------------LENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~G 231 (668)
T KOG0611|consen 181 ----------------------------LENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKG 231 (668)
T ss_pred ----------------------------hhheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCC
Confidence 88999999999999999999766544 3445678999999999999999865
Q ss_pred -chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 161 -VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 161 -~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.+|.||||+++|-|+.|..||.+.+....+..+..+.- ..|. -+....-||.+||..||++|+|+++|-+|=|+.
T Consensus 232 PEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---rEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 232 PEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---REPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---cCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 69999999999999999999999999888888777633 2232 367889999999999999999999999998875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=275.04 Aligned_cols=210 Identities=25% Similarity=0.398 Sum_probs=170.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.++.+.|+||||+.|++|.+++... ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik---- 122 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK---- 122 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC----
Confidence 35789999999999999999999999999999999888533 3468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... ......++..|+|||++.+..++
T Consensus 123 -----------------------------p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 172 (277)
T cd05607 123 -----------------------------PENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYS 172 (277)
T ss_pred -----------------------------hHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCC
Confidence 888888888999999999987654321 22234578899999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH----HH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA----SE 231 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~e 231 (251)
.++|+||+||++|++++|..||...... .......... ... ....+++++.+++.+||+.||++||++ ++
T Consensus 173 ~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 9999999999999999999999654321 1111111111 111 124579999999999999999999999 67
Q ss_pred HhcChhhhhccCCCC
Q psy3253 232 MLNHEFIQRHDTDPS 246 (251)
Q Consensus 232 vl~hp~~~~~~~~~~ 246 (251)
++.||||+..+|+.-
T Consensus 251 ~~~h~~f~~~~~~~~ 265 (277)
T cd05607 251 PRKHEFFKTINFPRL 265 (277)
T ss_pred hhcChhhcCCCHHHH
Confidence 889999998877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=258.19 Aligned_cols=202 Identities=31% Similarity=0.548 Sum_probs=180.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+.|+||||+++|++|.+....||++||...|+|...++.. ...+++..+..++.|++.||.|+|.+++||||||
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiK----- 151 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIK----- 151 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCC-----
Confidence 3689999999999999999999999999999999888633 4569999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+|++++..+.+|++|||.+.... ..+..+..||.-|.|||...+...+.
T Consensus 152 ----------------------------penlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~ 201 (281)
T KOG0580|consen 152 ----------------------------PENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDK 201 (281)
T ss_pred ----------------------------HHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccc
Confidence 888888899999999999996544 34666778999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.+|+|++|++.|+++.|.+||......+.+..+... ....|..++.++.|+|.+|+..+|.+|.+..|++.|||+..
T Consensus 202 ~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 202 FVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999877766666655544 34457889999999999999999999999999999999975
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 279 ~ 279 (281)
T KOG0580|consen 279 N 279 (281)
T ss_pred c
Confidence 4
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.33 Aligned_cols=209 Identities=30% Similarity=0.498 Sum_probs=171.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++.|.+++.+|+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlk----- 128 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK----- 128 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC-----
Confidence 357899999999999999999999999999999999997 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--------------------------
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT-------------------------- 134 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~-------------------------- 134 (251)
|+||+++.++.++|+|||++......
T Consensus 129 ----------------------------p~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (376)
T cd05598 129 ----------------------------PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180 (376)
T ss_pred ----------------------------HHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccc
Confidence 88899998999999999997422100
Q ss_pred -----------------cccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-
Q psy3253 135 -----------------MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK- 196 (251)
Q Consensus 135 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 196 (251)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 260 (376)
T cd05598 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE 260 (376)
T ss_pred ccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC
Confidence 00001235889999999999989999999999999999999999999876655443332221
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCcCccC---CHHHHhcChhhhhccCC
Q psy3253 197 PPPSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFIQRHDTD 244 (251)
Q Consensus 197 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~~~~~~~~ 244 (251)
..........+++++.++|.+|+ .+|++|+ |++|+++||||+..++.
T Consensus 261 ~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 261 TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 12222234467899999999977 5999999 99999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=269.96 Aligned_cols=213 Identities=26% Similarity=0.467 Sum_probs=174.5
Q ss_pred CCCCCCCc-cceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPY-VVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpn-iv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|+.++|+| ||++++++.+.+ .++|||||++. +|..++.... ..++...++.+..||+.||.|||++||+
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~Il 142 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGIL 142 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46789999 999999998877 79999999965 9999998555 4688899999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
||||| |+|++++++|.+||+|||+|+..+-+.........|.+|+||
T Consensus 143 HRDLK---------------------------------PQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaP 189 (323)
T KOG0594|consen 143 HRDLK---------------------------------PQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAP 189 (323)
T ss_pred cccCC---------------------------------cceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCH
Confidence 99988 999999999999999999998776554555666789999999
Q ss_pred cccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh---hhcCCCCCCC--------------CCC---C-----
Q psy3253 151 EVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI---FMIPTKPPPS--------------FRE---P----- 204 (251)
Q Consensus 151 E~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~--------------~~~---~----- 204 (251)
|++.+. .|+...||||+||+++||+++++.|.+....... ..+...+... +.. +
T Consensus 190 EvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~ 269 (323)
T KOG0594|consen 190 EVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSS 269 (323)
T ss_pred HHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHH
Confidence 999775 6899999999999999999999999765443332 2222221100 000 1
Q ss_pred --CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 205 --DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 205 --~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
....++..+++.+||+++|.+|.|++.+|.||||+.......+
T Consensus 270 ~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 270 ILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred hccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 1123578999999999999999999999999999988665544
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.82 Aligned_cols=199 Identities=27% Similarity=0.553 Sum_probs=178.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++|+||||+.+.|+|....=+|+|||||..|.|.+.++ .+..+.......|..+|+.|+.|||.+.|||||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLK----- 239 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLK----- 239 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccC-----
Confidence 568999999999999988888999999999999999997 66788999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
.-||+++.+..+||+|||-++......+ .-.+.||..|||||++.+.+++.
T Consensus 240 ----------------------------SPNiLIs~~d~VKIsDFGTS~e~~~~ST-kMSFaGTVaWMAPEvIrnePcsE 290 (904)
T KOG4721|consen 240 ----------------------------SPNILISYDDVVKISDFGTSKELSDKST-KMSFAGTVAWMAPEVIRNEPCSE 290 (904)
T ss_pred ----------------------------CCceEeeccceEEeccccchHhhhhhhh-hhhhhhhHhhhCHHHhhcCCccc
Confidence 7788888889999999999876554422 23456899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|+||||||++||||+||..||.+.+...+++.+-. ....+..|..+|+.|.=||+.||+-.|.+||++.+++.|
T Consensus 291 KVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs-NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 291 KVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS-NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ccceehhHHHHHHHHhcCCCccccchheeEEeccC-CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 99999999999999999999999888887765544 345667789999999999999999999999999999999
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=273.51 Aligned_cols=207 Identities=41% Similarity=0.829 Sum_probs=176.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++++||||+++++++..+...|+|+||+.+++|..++. ...+++.++..++.|++.||.|||+.|++|||||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~----- 142 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK----- 142 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 357899999999999999999999999999999999886 3468999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+..++.
T Consensus 143 ----------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (296)
T cd06655 143 ----------------------------SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194 (296)
T ss_pred ----------------------------HHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCc
Confidence 8899998899999999999876544322233345778899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+|||||++|++++|..||...+.......+.....+....+..+++.+.++|.+||..||++|||+++++.||||+.
T Consensus 195 ~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 99999999999999999999977666544443333333344456678999999999999999999999999999999987
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 275 ~~ 276 (296)
T cd06655 275 AK 276 (296)
T ss_pred cc
Confidence 55
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.41 Aligned_cols=208 Identities=25% Similarity=0.439 Sum_probs=167.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..++..++||||+.+ +|.+++...+..+++..++.++.|++.||.|||++|++|||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlk----- 131 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK----- 131 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 3578999999999999999999999999965 8988887566678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++
T Consensus 132 ----------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (309)
T cd07872 132 ----------------------------PQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183 (309)
T ss_pred ----------------------------HHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCC
Confidence 88999998999999999998754433222333456888999998854 5678
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCC------------------CCC------CCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKP------------------PPS------FREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~------------------~~~------~~~~~~~~~~~~ 212 (251)
.++||||+||++|+|++|++||.+.+.......+. ... .+. ......+++++.
T Consensus 184 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T cd07872 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGI 263 (309)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHH
Confidence 89999999999999999999997654432221110 000 000 011234688999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
++|.+||+.||++|||++|+++||||+...
T Consensus 264 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 264 ELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.51 Aligned_cols=207 Identities=43% Similarity=0.844 Sum_probs=172.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++.+..+.+.|+||||+.+++|.+++. ...+++.++..++.|++.||.|||+.|++|||||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLk----- 143 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK----- 143 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 356799999999999999999999999999999999986 3468999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.
T Consensus 144 ----------------------------p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 195 (296)
T cd06654 144 ----------------------------SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195 (296)
T ss_pred ----------------------------HHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCc
Confidence 8888888889999999999875443322233346788899999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+|||||++|++++|..||...+.............+....+..++..+.+++.+||..+|++|||++|+++||||..
T Consensus 196 ~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999976655433322222222233335567889999999999999999999999999999986
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 276 ~~ 277 (296)
T cd06654 276 AK 277 (296)
T ss_pred cC
Confidence 54
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.75 Aligned_cols=204 Identities=31% Similarity=0.484 Sum_probs=170.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++.+....|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlk--------- 123 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLK--------- 123 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC---------
Confidence 79999999999999999999999999999999886 46789999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCCcchh
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDCVAD 163 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 163 (251)
|+||+++.++.++|+|||++..............||..|+|||++.+. .++.++|
T Consensus 124 ------------------------p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 179 (330)
T cd05586 124 ------------------------PENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179 (330)
T ss_pred ------------------------HHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccc
Confidence 889999989999999999986543322233345688999999998654 4789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC----CHHHHhcChhhh
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA----TASEMLNHEFIQ 239 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~evl~hp~~~ 239 (251)
|||+||++|+|++|..||...+.......+..... .+ ....+++++.+++.+||..||++|| +++|+++||||.
T Consensus 180 vwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-RF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred eeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-CC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 99999999999999999977665554444333221 11 1234789999999999999999998 799999999998
Q ss_pred hccCC
Q psy3253 240 RHDTD 244 (251)
Q Consensus 240 ~~~~~ 244 (251)
..+|.
T Consensus 258 ~~~~~ 262 (330)
T cd05586 258 DIDWD 262 (330)
T ss_pred CCCHH
Confidence 76644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.04 Aligned_cols=204 Identities=27% Similarity=0.470 Sum_probs=173.5
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||+|+++++++.+.+..|+||||+.+|+|.+++. ....+++.+++.++.|++.||.|||++|++|||||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDik--------- 128 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLK--------- 128 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC---------
Confidence 56888999999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+
T Consensus 129 ------------------------p~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 184 (323)
T cd05615 129 ------------------------LDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184 (323)
T ss_pred ------------------------HHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccch
Confidence 88999999999999999998754332222334458899999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~hp~~~ 239 (251)
||+||++|+|++|..||.+.+.......+.... ...+..++.++.+++.+||+.+|++|++ .+++++||||+
T Consensus 185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 999999999999999998776655554443332 2235567899999999999999999997 57999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|..
T Consensus 262 ~~~~~~ 267 (323)
T cd05615 262 RIDWDK 267 (323)
T ss_pred CCCHHH
Confidence 887743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=280.24 Aligned_cols=208 Identities=32% Similarity=0.541 Sum_probs=172.4
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|+++.|||||+|+++..+ .+.+|||+|||..|.+...- .... +++.+++.++..++.||.|||.+||||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK-- 237 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK-- 237 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc--
Confidence 689999999999999975 46799999999988874432 2334 9999999999999999999999999999999
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccC-----cccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT-----DTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~~~~y~aPE~ 152 (251)
|+|++++.+|++||+|||.+.... .....-....|||.|+|||.
T Consensus 238 -------------------------------PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 238 -------------------------------PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred -------------------------------hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 889999999999999999997552 11122233679999999999
Q ss_pred cccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 153 IQEIG----YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 153 ~~~~~----~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
..+.. .+.+.||||+|++||-++.|+.||.+....+....+.... ..++........+++||.+||.+||++|++
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP-LEFPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc-ccCCCcccccHHHHHHHHHHhhcChhheee
Confidence 97632 3457899999999999999999998887777776665543 344444457899999999999999999999
Q ss_pred HHHHhcChhhhhccCC
Q psy3253 229 ASEMLNHEFIQRHDTD 244 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~ 244 (251)
+.+|..|||..+.-..
T Consensus 366 l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 366 LPDIKLHPWVTRDGDS 381 (576)
T ss_pred hhhheecceeccCCCC
Confidence 9999999999876433
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.83 Aligned_cols=207 Identities=32% Similarity=0.536 Sum_probs=165.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++..+..+++||||+++|+|.+. ....+..+..++.||+.||.|||++|++|||||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk----- 195 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIK----- 195 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC-----
Confidence 3578999999999999999999999999999998542 345778888999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-----
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE----- 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----- 155 (251)
|+||+++.++.+||+|||++..............|+..|+|||.+..
T Consensus 196 ----------------------------p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 247 (353)
T PLN00034 196 ----------------------------PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247 (353)
T ss_pred ----------------------------HHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccC
Confidence 88999999999999999999765433222334568899999998843
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh---hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI---FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
...+.++|||||||++|+|++|+.||......... ..+.... ....+..++.++.+||.+||+.||++|||++|+
T Consensus 248 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el 325 (353)
T PLN00034 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWSAMQL 325 (353)
T ss_pred cCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 23456899999999999999999999643222211 1111111 122345678999999999999999999999999
Q ss_pred hcChhhhhccCCCCC
Q psy3253 233 LNHEFIQRHDTDPSQ 247 (251)
Q Consensus 233 l~hp~~~~~~~~~~~ 247 (251)
++||||.+.....++
T Consensus 326 l~hp~~~~~~~~~~~ 340 (353)
T PLN00034 326 LQHPFILRAQPGQGQ 340 (353)
T ss_pred hcCcccccCCccccc
Confidence 999999987555443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=274.96 Aligned_cols=214 Identities=24% Similarity=0.367 Sum_probs=175.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.++||||+++++.+.++...++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk---- 129 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK---- 129 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC----
Confidence 35689999999999999999999999999999999888643 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++
T Consensus 130 -----------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd05605 130 -----------------------------PENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred -----------------------------HHHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHhcCCCCC
Confidence 889999999999999999987543221 12234578899999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEML 233 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl 233 (251)
.++|+||+||++|++++|..||.+.........+... .......+..+++.+.+++.+||+.||++|| ++++++
T Consensus 180 ~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 9999999999999999999999765442221111110 0111223456799999999999999999999 999999
Q ss_pred cChhhhhccCCCCCC
Q psy3253 234 NHEFIQRHDTDPSQN 248 (251)
Q Consensus 234 ~hp~~~~~~~~~~~~ 248 (251)
+||||...+|..-++
T Consensus 260 ~~~~~~~~~~~~~~~ 274 (285)
T cd05605 260 AHPFFRTANFKRLEA 274 (285)
T ss_pred cCcCccCCCHHHHhh
Confidence 999999988775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=272.79 Aligned_cols=208 Identities=41% Similarity=0.823 Sum_probs=174.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...|+||||+++++|.+++. ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 71 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~------ 142 (297)
T cd06656 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK------ 142 (297)
T ss_pred HhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC------
Confidence 56899999999999999999999999999999999986 3568999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.+
T Consensus 143 ---------------------------p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (297)
T cd06656 143 ---------------------------SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195 (297)
T ss_pred ---------------------------HHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcH
Confidence 88999988999999999998755433222333457888999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+||++|++++|..||...+.............+....+..++..+.+++.+||..+|++||+++++++||||+..
T Consensus 196 ~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 99999999999999999999766554433333333333333456678899999999999999999999999999999865
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 276 ~~~ 278 (297)
T cd06656 276 KPL 278 (297)
T ss_pred ccc
Confidence 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=276.58 Aligned_cols=205 Identities=37% Similarity=0.772 Sum_probs=166.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni 79 (251)
|++++||||++++++|.++...++||||+.+|+|.+++. ....+++..+..++.|++.||.|||+. +++|||||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlk---- 131 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK---- 131 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC----
Confidence 357899999999999999999999999999999999997 456789999999999999999999985 79999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++
T Consensus 132 -----------------------------p~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 180 (333)
T cd06650 132 -----------------------------PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS 180 (333)
T ss_pred -----------------------------hhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCC
Confidence 88889988899999999998654322 12234578899999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc--------------------------------------------CC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI--------------------------------------------PT 195 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~--------------------------------------------~~ 195 (251)
.++|+||+||++|++++|..||...........+ ..
T Consensus 181 ~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (333)
T cd06650 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN 260 (333)
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhc
Confidence 9999999999999999999999654322211100 00
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 196 KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
...+.. ....++.++.+|+.+||++||++|||++|++.||||+...
T Consensus 261 ~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 261 EPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000000 0123578899999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=265.41 Aligned_cols=203 Identities=38% Similarity=0.686 Sum_probs=170.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++++||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|||||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~----- 131 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIK----- 131 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 357899999999999999999999999999999999987 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc---cccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..
T Consensus 132 ----------------------------p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 132 ----------------------------GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred ----------------------------HHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence 888999888999999999986543221111 2234677899999999888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++|+||+|+++|++++|+.||...+............. ....+..++..+.+++.+||..+|++|||+.|+++|||
T Consensus 184 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 99999999999999999999999976655444433322211 22345668999999999999999999999999999999
Q ss_pred h
Q psy3253 238 I 238 (251)
Q Consensus 238 ~ 238 (251)
|
T Consensus 263 ~ 263 (263)
T cd06625 263 V 263 (263)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.05 Aligned_cols=207 Identities=27% Similarity=0.461 Sum_probs=170.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.++...|+||||+.+|+|.+++. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk------ 169 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK------ 169 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC------
Confidence 46799999999999999999999999999999999986 3468999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccCC---
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIG--- 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--- 157 (251)
|+||+++.++.++|+|||++....... .......||+.|+|||++.+..
T Consensus 170 ---------------------------p~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 222 (371)
T cd05622 170 ---------------------------PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222 (371)
T ss_pred ---------------------------HHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCc
Confidence 889999999999999999997654321 1223456899999999996543
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCc--cCCHHHHh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEE--RATASEML 233 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~evl 233 (251)
++.++|+||+||++|+|++|..||...+.......+... ....+.....++..+.++|.+||+.++.+ |++++|++
T Consensus 223 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~ 302 (371)
T cd05622 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 302 (371)
T ss_pred cCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHh
Confidence 788999999999999999999999877665554444332 22233334568999999999999844433 78999999
Q ss_pred cChhhhhccC
Q psy3253 234 NHEFIQRHDT 243 (251)
Q Consensus 234 ~hp~~~~~~~ 243 (251)
+||||++.+|
T Consensus 303 ~h~~~~~~~~ 312 (371)
T cd05622 303 RHLFFKNDQW 312 (371)
T ss_pred cCcccCCCCh
Confidence 9999988655
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=267.39 Aligned_cols=207 Identities=59% Similarity=1.071 Sum_probs=175.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+|+||+.+++|.+++.. ..+++..+..++.|++.||.|||+++++||||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~------ 125 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIK------ 125 (274)
T ss_pred HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC------
Confidence 467899999999999999999999999999999999873 388999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++++|||++..............++..|+|||.+.+..++.+
T Consensus 126 ---------------------------p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 178 (274)
T cd06609 126 ---------------------------AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178 (274)
T ss_pred ---------------------------HHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCch
Confidence 88999999999999999999776544333344567788999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||||+++|++++|..||...+.......+.....+.... ..+++++.+++.+||..+|++|||++++++||||++.
T Consensus 179 sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 999999999999999999997666555444443333323221 2278999999999999999999999999999999875
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 258 ~~~ 260 (274)
T cd06609 258 KKT 260 (274)
T ss_pred Ccc
Confidence 543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=274.40 Aligned_cols=210 Identities=30% Similarity=0.581 Sum_probs=162.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+.++||||++++++|.+++..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 54 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk----- 128 (327)
T cd08227 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVK----- 128 (327)
T ss_pred HhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC-----
Confidence 4679999999999999999999999999999999999643 3568999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-------ccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++++||+.......... ......++..|+|||++
T Consensus 129 ----------------------------p~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 129 ----------------------------ASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred ----------------------------hhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHh
Confidence 8888888888899999986543321100 01122356679999999
Q ss_pred cc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCC--------------------------------
Q psy3253 154 QE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP-------------------------------- 199 (251)
Q Consensus 154 ~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------- 199 (251)
.+ ..++.++||||+||++|++++|..||.................+
T Consensus 181 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T cd08227 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV 260 (327)
T ss_pred hcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccccc
Confidence 65 45889999999999999999999999653322111110000000
Q ss_pred -----------CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 200 -----------SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 200 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.......+++++.+++.+||+.||++|||++|+++||||++....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 000112356789999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=265.68 Aligned_cols=204 Identities=54% Similarity=1.039 Sum_probs=170.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|++|||+.+++|.+++......+++..+..++.|++.||.|||+.|++|+|||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~----- 128 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK----- 128 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-----
Confidence 457899999999999999999999999999999999997655789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC---C
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI---G 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~ 157 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+. .
T Consensus 129 ----------------------------p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~ 180 (262)
T cd06613 129 ----------------------------GANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180 (262)
T ss_pred ----------------------------hhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCC
Confidence 889999999999999999987654432233344577889999999776 7
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++.++|+||+|+++|+|++|.+||...+........... .+........++.++.+++.+||..+|++|||+++++.|
T Consensus 181 ~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 181 YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 889999999999999999999999776554444333222 112222234567889999999999999999999999999
Q ss_pred hh
Q psy3253 236 EF 237 (251)
Q Consensus 236 p~ 237 (251)
+|
T Consensus 261 ~~ 262 (262)
T cd06613 261 PF 262 (262)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.25 Aligned_cols=210 Identities=21% Similarity=0.275 Sum_probs=169.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......|++||++. ++|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk----- 212 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK----- 212 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-----
Confidence 467899999999999999999999999995 68988884 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++........ ......||+.|+|||++.+..+
T Consensus 213 ----------------------------p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 213 ----------------------------TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred ----------------------------HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence 8889999999999999999976543211 1233468999999999998899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhh----c----------------------CCCCCCCCCC-----C
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRA---IFM----I----------------------PTKPPPSFRE-----P 204 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~----~----------------------~~~~~~~~~~-----~ 204 (251)
+.++||||+||++|+|++|..||.+...... ... + .....+.+.. .
T Consensus 265 ~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (392)
T PHA03207 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK 344 (392)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc
Confidence 9999999999999999999999965432110 000 0 0000000111 1
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
..++.++.++|.+||..||++|||++|+++||||+..+++.
T Consensus 345 ~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred cCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 23567889999999999999999999999999999877764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=264.06 Aligned_cols=203 Identities=29% Similarity=0.607 Sum_probs=172.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.++...|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+|||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~---- 128 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK---- 128 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC----
Confidence 35789999999999999999999999999999999999754 4678999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||++.+..++
T Consensus 129 -----------------------------~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd08529 129 -----------------------------SLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179 (256)
T ss_pred -----------------------------cceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCC
Confidence 889999988999999999987654433333334577889999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|+||||+++|++++|..||...+.......+.....+. .+..++.++.+++.+||+.+|++||++.|++.|||+
T Consensus 180 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP--VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999997766555444443332222 233678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=286.09 Aligned_cols=208 Identities=25% Similarity=0.392 Sum_probs=161.3
Q ss_pred CCCCCCCccceeeeeEeeC--------CeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||++++++|... ..+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~I 191 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI 191 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4678999999999887532 24779999996 478777752 34679999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccccccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWM 148 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 148 (251)
+||||| |+||+++.++ .+||+|||+++..... .......+++.|+
T Consensus 192 iHrDLK---------------------------------p~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~ 237 (440)
T PTZ00036 192 CHRDLK---------------------------------PQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYR 237 (440)
T ss_pred ecCCcC---------------------------------HHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCcc
Confidence 999988 7788887554 6999999999765432 2223346788999
Q ss_pred ccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC----------------C-------CC
Q psy3253 149 APEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP----------------P-------SF 201 (251)
Q Consensus 149 aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~----------------~-------~~ 201 (251)
|||++.+ ..++.++||||+||++|+|++|.+||.+.........+.. .+. + ..
T Consensus 238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~ 317 (440)
T PTZ00036 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKK 317 (440)
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHH
Confidence 9999865 4689999999999999999999999976544322221110 000 0 00
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 202 REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 202 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
..+...++++.+||.+||++||++|||++|+++||||+....
T Consensus 318 ~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 013346789999999999999999999999999999987654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=265.35 Aligned_cols=207 Identities=33% Similarity=0.609 Sum_probs=174.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++++||+.+++|.+++. +...+++..+..++.|++.||+|||++|++|+|||
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~------ 120 (262)
T cd05572 48 EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK------ 120 (262)
T ss_pred HhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC------
Confidence 56899999999999999999999999999999999997 34568999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.+
T Consensus 121 ---------------------------~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~ 172 (262)
T cd05572 121 ---------------------------PENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFS 172 (262)
T ss_pred ---------------------------HHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCCh
Confidence 889999889999999999997665432 2233456888999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCC--cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIH--PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLN 234 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~ 234 (251)
+|+||+|+++|++++|..||.... .......+... ......+...++++.++|.+||..+|++||+ ++|+++
T Consensus 173 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999997665 33333333321 1122334455899999999999999999999 999999
Q ss_pred ChhhhhccCC
Q psy3253 235 HEFIQRHDTD 244 (251)
Q Consensus 235 hp~~~~~~~~ 244 (251)
||||+..+|+
T Consensus 252 ~~~~~~~~~~ 261 (262)
T cd05572 252 HKWFNGFDWE 261 (262)
T ss_pred ChhhhCCCCC
Confidence 9999998886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.88 Aligned_cols=198 Identities=25% Similarity=0.450 Sum_probs=175.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------KTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
|..|+|||||+++|+|.+++..|||||||..|||.+|++.+. .+++..+.+.++.||+.|+.||-++
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 457999999999999999999999999999999999997432 1388999999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccc-cccccc
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN-TVIGTP 145 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~-~~~~~~ 145 (251)
.++||||- .+|++++.+..+||+|||+++..-.... +.. ...-+.
T Consensus 623 ~FVHRDLA---------------------------------TRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPI 669 (774)
T KOG1026|consen 623 HFVHRDLA---------------------------------TRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPI 669 (774)
T ss_pred cccccchh---------------------------------hhhceeccceEEEecccccchhhhhhhhhcccCCceeee
Confidence 99999965 8899999999999999999987643322 222 234577
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
+|||||.+...+|+.+|||||+||++||+++ |.-||.+....+.+..+..+.- ++.|..+|.++.+||..||+.+|+
T Consensus 670 RWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 670 RWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL--LSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred ecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc--ccCCCCCCHHHHHHHHHHhhcCcc
Confidence 8999999999999999999999999999998 9999999999999988877653 677999999999999999999999
Q ss_pred ccCCHHHHh
Q psy3253 225 ERATASEML 233 (251)
Q Consensus 225 ~Rps~~evl 233 (251)
+||+++||-
T Consensus 748 ~RPsF~eI~ 756 (774)
T KOG1026|consen 748 RRPSFKEIH 756 (774)
T ss_pred cCCCHHHHH
Confidence 999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=271.70 Aligned_cols=209 Identities=22% Similarity=0.415 Sum_probs=167.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+. ++|.+++......+++..+..++.|++.||.|||+.|++|+|||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlk----- 131 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK----- 131 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC-----
Confidence 357899999999999999999999999996 59999887666779999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+.+ ..++
T Consensus 132 ----------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 183 (301)
T cd07873 132 ----------------------------PQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183 (301)
T ss_pred ----------------------------HHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCc
Confidence 88899998999999999998754433222233456788999999865 4578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCC------------------CCCC------CCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKP------------------PPSF------REPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~------------------~~~~------~~~~~~~~~~~ 212 (251)
.++||||+||++|+|++|++||...+.......+. ... .+.. .....+++.+.
T Consensus 184 ~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (301)
T cd07873 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA 263 (301)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHH
Confidence 89999999999999999999997655432221100 000 0000 01234688899
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
++|.+||+.||.+|||++|+++||||+....
T Consensus 264 ~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 264 ELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 9999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=265.04 Aligned_cols=202 Identities=50% Similarity=0.950 Sum_probs=166.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...+++|||+++++|.+++. ..+.+++.+++.++.|++.||.|||+.|++|+|||
T Consensus 61 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk------ 133 (267)
T cd06645 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK------ 133 (267)
T ss_pred HhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC------
Confidence 56899999999999999999999999999999999986 45689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 158 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+. ...+
T Consensus 134 ---------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 186 (267)
T cd06645 134 ---------------------------GANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186 (267)
T ss_pred ---------------------------HHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCC
Confidence 8888888889999999999865543333334456788999999874 4557
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
+.++|+||+||++|++++|..||............... .+........++..+.+++.+||..+|++|||++++++||
T Consensus 187 ~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 88999999999999999999998655443333222111 1112222335788999999999999999999999999999
Q ss_pred h
Q psy3253 237 F 237 (251)
Q Consensus 237 ~ 237 (251)
|
T Consensus 267 ~ 267 (267)
T cd06645 267 F 267 (267)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=269.99 Aligned_cols=210 Identities=27% Similarity=0.456 Sum_probs=168.5
Q ss_pred CCCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|+.++|||||++.-+|... -...+||||+.. +|.++++. .+..++.-.++-+..||..||.|||+.||+||
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR 149 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR 149 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC
Confidence 5678999999998877532 246799999965 99999973 36788999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 151 (251)
||| |+|++++.+ |.+||||||.|+..-.. .....-.+|+.|+|||
T Consensus 150 DIK---------------------------------PqNlLvD~~tg~LKicDFGSAK~L~~~-epniSYicSRyYRaPE 195 (364)
T KOG0658|consen 150 DIK---------------------------------PQNLLVDPDTGVLKICDFGSAKVLVKG-EPNISYICSRYYRAPE 195 (364)
T ss_pred CCC---------------------------------hheEEEcCCCCeEEeccCCcceeeccC-CCceeEEEeccccCHH
Confidence 999 999999866 78999999999876543 2334456789999999
Q ss_pred cccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCC----------------CCCC-------CC
Q psy3253 152 VIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPP----------------PSFR-------EP 204 (251)
Q Consensus 152 ~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~----------------~~~~-------~~ 204 (251)
.+.+ ..|+.+.||||.||++.||+-|++.|.+.+.......+ .+.+. +... ..
T Consensus 196 Lifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~ 275 (364)
T KOG0658|consen 196 LIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFF 275 (364)
T ss_pred HHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecc
Confidence 9976 66999999999999999999999999765444333222 11110 0000 12
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
...+++..+|+.++|+++|++|.++.|++.||||+......
T Consensus 276 ~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 276 KRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred cCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 44689999999999999999999999999999999876654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=264.65 Aligned_cols=202 Identities=37% Similarity=0.671 Sum_probs=170.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....+++|||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~----- 133 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIK----- 133 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH-hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCC-----
Confidence 357899999999999999999999999999999999997 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc------cccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA------KRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.++.++|+|||.++....... ......++..|+|||.+.
T Consensus 134 ----------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 185 (267)
T cd06628 134 ----------------------------GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185 (267)
T ss_pred ----------------------------HHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc
Confidence 8899999999999999999876542111 112234677899999998
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+..++.++|+||+||++|++++|+.||...+.......+.....+ ..+..++..+.++|++||+.||++||+++|+++
T Consensus 186 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP--EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC--cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 888899999999999999999999999876554444333332222 234567899999999999999999999999999
Q ss_pred Chhh
Q psy3253 235 HEFI 238 (251)
Q Consensus 235 hp~~ 238 (251)
||||
T Consensus 264 ~~~~ 267 (267)
T cd06628 264 HPFL 267 (267)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=268.63 Aligned_cols=205 Identities=31% Similarity=0.552 Sum_probs=176.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~----- 128 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK----- 128 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC-----
Confidence 357899999999999999999999999999999999997 44789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... .....+++.|+|||.+.+...+.
T Consensus 129 ----------------------------p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 177 (290)
T cd05580 129 ----------------------------PENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGK 177 (290)
T ss_pred ----------------------------HHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCc
Confidence 88999999999999999999765433 23345788899999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++|+||||+++|+|++|..||...+.......+... ....+..+++.+.+++.+||..||++|+ +++|+++|
T Consensus 178 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 178 AVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 999999999999999999999776654444333322 1223556789999999999999999999 99999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|..
T Consensus 255 ~~~~~~~~~~ 264 (290)
T cd05580 255 PWFAGIDWIA 264 (290)
T ss_pred cccccCCHHH
Confidence 9999988754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=271.19 Aligned_cols=208 Identities=38% Similarity=0.756 Sum_probs=173.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++.+..++..|+||||+.+++|.+++. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 74 ~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk------ 145 (292)
T cd06658 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK------ 145 (292)
T ss_pred HhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC------
Confidence 56899999999999999999999999999999999875 3568999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+..++.+
T Consensus 146 ---------------------------p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (292)
T cd06658 146 ---------------------------SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198 (292)
T ss_pred ---------------------------HHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCch
Confidence 88999988999999999998654433222333457888999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+|+++|++++|..||...+.......+..............+..+.+++.+||..||++|||++|+++||||+..
T Consensus 199 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 99999999999999999999766554443333222222333344578899999999999999999999999999999865
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 279 ~~~ 281 (292)
T cd06658 279 GPP 281 (292)
T ss_pred CCc
Confidence 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=268.13 Aligned_cols=196 Identities=21% Similarity=0.343 Sum_probs=164.0
Q ss_pred CCCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik 75 (251)
|++++||||+++++++.+ ....++||||+.+|+|.+++. ....+++.....++.+++.||.|||+ .+++|||||
T Consensus 72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk 150 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150 (283)
T ss_pred HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh-hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence 468899999999999876 346899999999999999997 45678999999999999999999998 499999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||++...... .....++..|+|||.+.+
T Consensus 151 ---------------------------------p~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 151 ---------------------------------SVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred ---------------------------------hhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhh
Confidence 88999999999999999998754432 123456788999999976
Q ss_pred --CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 --IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 --~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.++|||||||++|+|++|..||.+.+.......+..... ....+..+++++.+++.+||+.||++|||++|++
T Consensus 195 ~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell 273 (283)
T PHA02988 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN-SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273 (283)
T ss_pred ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 6789999999999999999999999987766555444322211 2223446799999999999999999999999998
Q ss_pred c
Q psy3253 234 N 234 (251)
Q Consensus 234 ~ 234 (251)
+
T Consensus 274 ~ 274 (283)
T PHA02988 274 Y 274 (283)
T ss_pred H
Confidence 5
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=276.90 Aligned_cols=205 Identities=25% Similarity=0.338 Sum_probs=160.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++|||++. ++|.+++......+++..++.++.||+.||.|||++||+|||||
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk----- 184 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVK----- 184 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 467899999999999999999999999995 58999887667789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.++..... .......||..|+|||++.+..++.
T Consensus 185 ----------------------------p~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 235 (357)
T PHA03209 185 ----------------------------TENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNS 235 (357)
T ss_pred ----------------------------HHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCc
Confidence 88888888899999999998643222 1223345788999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCC-CCCCCCcc----------hhhhhc--CCCCCCCCC-------------------------
Q psy3253 161 VADMWSLGITALEMAEGKP-PYGDIHPM----------RAIFMI--PTKPPPSFR------------------------- 202 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~-p~~~~~~~----------~~~~~~--~~~~~~~~~------------------------- 202 (251)
++|||||||++|+|+++.. +|...... .....+ ....+..+.
T Consensus 236 ~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (357)
T PHA03209 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRY 315 (357)
T ss_pred hhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccccc
Confidence 9999999999999998544 44322111 000000 000000000
Q ss_pred ---CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 203 ---EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 203 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
....++.++.++|.+||+.||++|||++|+|+||||++
T Consensus 316 ~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 316 PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 01235667888999999999999999999999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=275.05 Aligned_cols=211 Identities=25% Similarity=0.407 Sum_probs=170.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||++++++|.++.+.|+||||+.+|+|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk------ 129 (331)
T cd05597 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK------ 129 (331)
T ss_pred HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCC------
Confidence 45789999999999999999999999999999999997656789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc-----
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE----- 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----- 155 (251)
|+||+++.++.++|+|||++........ ......|++.|+|||++..
T Consensus 130 ---------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05597 130 ---------------------------PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182 (331)
T ss_pred ---------------------------HHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccc
Confidence 8889998899999999999865443222 2223458999999999863
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCC-CCCCCCCCHHHHHHHHHhhhcCcCc--cCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPS-FREPDVWTPEFIDFVSRCLVKNPEE--RATASE 231 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~e 231 (251)
..++.++||||+||++|+|++|..||.+.........+.... ... ......+++++.+++.+||..++++ |+++++
T Consensus 183 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~ 262 (331)
T cd05597 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD 262 (331)
T ss_pred cCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 457789999999999999999999997765544433332211 111 1122347899999999988664443 789999
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
+++||||...+|..
T Consensus 263 ~l~hp~~~~~~~~~ 276 (331)
T cd05597 263 FKDHPFFEGIDWDN 276 (331)
T ss_pred HhcCCCCCCCCHHH
Confidence 99999998877644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=269.95 Aligned_cols=208 Identities=40% Similarity=0.792 Sum_probs=176.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|+++||+++++|.+++. ...+++..++.++.|++.||.|||++|++|||||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~----- 144 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK----- 144 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 356899999999999999999999999999999999875 3568999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+..++.
T Consensus 145 ----------------------------p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (297)
T cd06659 145 ----------------------------SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196 (297)
T ss_pred ----------------------------HHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCc
Confidence 8888898899999999999865543333334456788999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+||+||++|+|++|..||...+.......+.............++..+.+++.+||+.+|++||+++|+++||||..
T Consensus 197 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 99999999999999999999976655554444433333333345567889999999999999999999999999999987
Q ss_pred ccC
Q psy3253 241 HDT 243 (251)
Q Consensus 241 ~~~ 243 (251)
...
T Consensus 277 ~~~ 279 (297)
T cd06659 277 TGL 279 (297)
T ss_pred CCC
Confidence 654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=276.86 Aligned_cols=204 Identities=25% Similarity=0.452 Sum_probs=160.4
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|+.++||||+++++++.... ..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++|++||||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 149 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 149 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 35789999999999986443 47999999965 6777664 45889999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||++...... .......+|+.|+|||++.
T Consensus 150 k---------------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~ 195 (359)
T cd07876 150 K---------------------------------PSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVIL 195 (359)
T ss_pred C---------------------------------HHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhcc
Confidence 8 88999999999999999999754322 1223346788999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-----------------------CCCC-C-----------
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-----------------------TKPP-P----------- 199 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------------------~~~~-~----------- 199 (251)
+..++.++||||+||++|+|++|..||.+.+.......+. .... .
T Consensus 196 ~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
T cd07876 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW 275 (359)
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccc
Confidence 9899999999999999999999999997654322111000 0000 0
Q ss_pred ----CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 200 ----SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 200 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
........++++.+||.+||..||++|||++|+++||||+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 276 IFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred ccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 0001122467899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=275.55 Aligned_cols=211 Identities=24% Similarity=0.422 Sum_probs=172.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.+....|+||||+.+|+|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlk------ 129 (332)
T cd05623 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIK------ 129 (332)
T ss_pred hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC------
Confidence 46789999999999999999999999999999999998656789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccc-----c
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.++|+|||++........ ......||+.|+|||++. .
T Consensus 130 ---------------------------p~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (332)
T cd05623 130 ---------------------------PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182 (332)
T ss_pred ---------------------------HHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCC
Confidence 8899999999999999999865432211 223346899999999985 3
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCC-CCCCCCCHHHHHHHHHhhhcCcCc--cCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSF-REPDVWTPEFIDFVSRCLVKNPEE--RATASE 231 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~--Rps~~e 231 (251)
..++.++|+|||||++|+|++|..||...+.......+..... ..+ .....+++++.+++.+||..++++ |++++|
T Consensus 183 ~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~ 262 (332)
T cd05623 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIED 262 (332)
T ss_pred CCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHH
Confidence 4578899999999999999999999987766555544433211 111 123457999999999999765544 689999
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
+++||||+..+|+.
T Consensus 263 ~~~h~~f~~~~~~~ 276 (332)
T cd05623 263 FKQHPFFTGIDWDN 276 (332)
T ss_pred HhCCCCcCCCCHHH
Confidence 99999999877644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.66 Aligned_cols=204 Identities=49% Similarity=0.926 Sum_probs=167.7
Q ss_pred CC-CCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 3 QC-DSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
++ +|||++++++++.+. ...++||||+.+++|.++++. ....+++..++.++.|++.||.|||+.|++|||
T Consensus 74 ~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 153 (291)
T cd06639 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRD 153 (291)
T ss_pred HhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 34 799999999998753 358999999999999998853 345789999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|| |+||+++.++.++|+|||.+..............++..|+|||.+
T Consensus 154 lk---------------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 200 (291)
T cd06639 154 VK---------------------------------GNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200 (291)
T ss_pred CC---------------------------------HHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhh
Confidence 88 888899888999999999987654332233344577889999998
Q ss_pred ccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 154 QEI-----GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 154 ~~~-----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
... .++.++|+||+||++|++++|.+||...+.......+..........+..++..+.++|.+||+.+|++||+
T Consensus 201 ~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 280 (291)
T cd06639 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS 280 (291)
T ss_pred cCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC
Confidence 543 367899999999999999999999987665554444444433333345567889999999999999999999
Q ss_pred HHHHhcChhhh
Q psy3253 229 ASEMLNHEFIQ 239 (251)
Q Consensus 229 ~~evl~hp~~~ 239 (251)
++|+++||||+
T Consensus 281 ~~~il~~~~~~ 291 (291)
T cd06639 281 VTHLLEHPFIK 291 (291)
T ss_pred HHHHhcCcccC
Confidence 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.22 Aligned_cols=208 Identities=38% Similarity=0.745 Sum_probs=169.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni 79 (251)
|++++||||++++++|.+++..++||||+++++|.++++ ....+++..+..++.|++.||.|||+ .+++|+|||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~---- 127 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVK---- 127 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCC----
Confidence 357899999999999999999999999999999999997 44778999999999999999999998 599999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++
T Consensus 128 -----------------------------p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~ 176 (308)
T cd06615 128 -----------------------------PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYT 176 (308)
T ss_pred -----------------------------hHHEEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCC
Confidence 88999988999999999998654322 12334578889999999888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC------------------------------------CCCCCCC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK------------------------------------PPPSFRE 203 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------------------------~~~~~~~ 203 (251)
.++|+||+|+++|++++|..||...+........... ..+.. .
T Consensus 177 ~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 255 (308)
T cd06615 177 VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL-P 255 (308)
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccC-c
Confidence 9999999999999999999998644332222111100 00000 1
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
...++.++.+++.+||..+|++|||++|+++||||++.+.+.
T Consensus 256 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 297 (308)
T cd06615 256 SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297 (308)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccccc
Confidence 123678899999999999999999999999999999865553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.48 Aligned_cols=204 Identities=27% Similarity=0.474 Sum_probs=168.8
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+.+++++...+..++||||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|||||
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dik-------- 124 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLK-------- 124 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCC--------
Confidence 479999999999998899999999999999999887 45679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-cCCCCcch
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDCVA 162 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~ 162 (251)
|+||+++.++.++++|||++...... ......++..|+|||.+. +..++.++
T Consensus 125 -------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~ 177 (279)
T cd05633 125 -------------------------PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSA 177 (279)
T ss_pred -------------------------HHHEEECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchh
Confidence 88999998999999999998654332 122345788999999986 45678999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchh--hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRA--IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
|+||+||++|++++|..||........ ....... .....+..+++++.++|.+||+.||++|+ |++|+++|
T Consensus 178 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999999999999965432221 1111111 12233566899999999999999999999 69999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|..
T Consensus 256 ~~~~~~~~~~ 265 (279)
T cd05633 256 VFFKGIDWQQ 265 (279)
T ss_pred ccccCCCHhH
Confidence 9999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=267.41 Aligned_cols=208 Identities=58% Similarity=1.047 Sum_probs=174.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|+||||+.+++|.+++. ...+++..+..++.|++.|+.|||++|++|+||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~----- 128 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK----- 128 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCC-----
Confidence 357899999999999999999999999999999999885 4578999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++++|||++..............++..|+|||.+.+..++.
T Consensus 129 ----------------------------p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (277)
T cd06642 129 ----------------------------AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180 (277)
T ss_pred ----------------------------hheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCch
Confidence 8888888889999999999876543322333345678899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+|||||++|++++|..||...........+.....+. ....++.++.+++.+||+.+|++|||++|+++||||++
T Consensus 181 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT--LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC--CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 9999999999999999999997655544443333332222 23456889999999999999999999999999999997
Q ss_pred ccCCC
Q psy3253 241 HDTDP 245 (251)
Q Consensus 241 ~~~~~ 245 (251)
..+.+
T Consensus 259 ~~~~~ 263 (277)
T cd06642 259 YTKKT 263 (277)
T ss_pred HhhhH
Confidence 66543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.48 Aligned_cols=207 Identities=40% Similarity=0.808 Sum_probs=174.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..++..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||+
T Consensus 71 ~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~------ 142 (285)
T cd06648 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK------ 142 (285)
T ss_pred HHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC------
Confidence 467899999999999999999999999999999999874 678999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++++|||.+..............++..|+|||.+.+..++.+
T Consensus 143 ---------------------------p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (285)
T cd06648 143 ---------------------------SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195 (285)
T ss_pred ---------------------------hhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCc
Confidence 88888888899999999988654433222333457888999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+|+++|++++|..||...+.......+.....+....+..++..+.+++.+||+.+|++|||++++++||||+..
T Consensus 196 ~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 99999999999999999999776655544444433333333344578999999999999999999999999999999876
Q ss_pred cC
Q psy3253 242 DT 243 (251)
Q Consensus 242 ~~ 243 (251)
..
T Consensus 276 ~~ 277 (285)
T cd06648 276 GP 277 (285)
T ss_pred CC
Confidence 53
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=265.50 Aligned_cols=214 Identities=28% Similarity=0.415 Sum_probs=174.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++......|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~---- 122 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK---- 122 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC----
Confidence 457899999999999999999999999999999999987433 368999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++
T Consensus 123 -----------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~ 172 (277)
T cd05577 123 -----------------------------PENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEVYD 172 (277)
T ss_pred -----------------------------HHHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHHhcCCCCC
Confidence 88999999999999999998654332 222334567789999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEML 233 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl 233 (251)
.++|+||+|+++|++++|+.||...........+.. ........+..+++++.++|.+||+.||++|| ++++++
T Consensus 173 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 999999999999999999999965543111111111 11112223456799999999999999999999 888999
Q ss_pred cChhhhhccCCCCCC
Q psy3253 234 NHEFIQRHDTDPSQN 248 (251)
Q Consensus 234 ~hp~~~~~~~~~~~~ 248 (251)
+||||.+.+|...+.
T Consensus 253 ~h~~~~~~~~~~~~~ 267 (277)
T cd05577 253 EHPLFKDLNWRRLEA 267 (277)
T ss_pred hChhhhcCChhhhhc
Confidence 999999999966543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=261.99 Aligned_cols=204 Identities=33% Similarity=0.561 Sum_probs=171.5
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
+.+|||++++++++..+...|+|+||+.+++|.++++ ....+++..+..++.|++.||.|||+.|++||||+
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~------- 124 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK------- 124 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-------
Confidence 4689999999999999999999999999999999997 44678999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
|+||+++.++.++|+|||++..... .....++..|+|||.+.+..++.++
T Consensus 125 --------------------------p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~ 174 (260)
T cd05611 125 --------------------------PENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMS 174 (260)
T ss_pred --------------------------HHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchh
Confidence 8899998899999999999865432 2234567889999999887789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccC---CHHHHhcChhh
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFI 238 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~~ 238 (251)
|+||+|+++|++++|..||...+.......+.... .........+++++.+++.+||+.+|++|| +++|+++||||
T Consensus 175 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999999999999999997666554443332221 111122345789999999999999999999 55899999999
Q ss_pred hhccCC
Q psy3253 239 QRHDTD 244 (251)
Q Consensus 239 ~~~~~~ 244 (251)
++.+|+
T Consensus 255 ~~~~~~ 260 (260)
T cd05611 255 KSINWD 260 (260)
T ss_pred hcCCCC
Confidence 998885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=266.83 Aligned_cols=204 Identities=25% Similarity=0.442 Sum_probs=162.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.++...|+||||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~--- 128 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLK--- 128 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC---
Confidence 357899999999999999999999999996 58988886433 568999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+.+ ..
T Consensus 129 ------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (285)
T cd07861 129 ------------------------------PQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178 (285)
T ss_pred ------------------------------HHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCC
Confidence 88999999999999999998654433222233456788999998865 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC------------------------C--CCCCCCCCCCCCHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT------------------------K--PPPSFREPDVWTPEF 211 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------~--~~~~~~~~~~~~~~~ 211 (251)
++.++|+||+||++|++++|.+||.+............ . ..........+++++
T Consensus 179 ~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (285)
T cd07861 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDG 258 (285)
T ss_pred cCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHH
Confidence 78899999999999999999999975443221111000 0 000001123478899
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|.+||..||++|||++++++||||
T Consensus 259 ~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 259 LDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=268.37 Aligned_cols=208 Identities=25% Similarity=0.402 Sum_probs=171.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|+|++++++.+.++++.|+||||+.+++|.+++... ...+++..++.++.|++.||.|||+.|++|||||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dik---- 129 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK---- 129 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC----
Confidence 35789999999999999999999999999999999988633 3468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++
T Consensus 130 -----------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05630 130 -----------------------------PENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred -----------------------------HHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCC
Confidence 889999989999999999986543221 12234678899999999988899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcch---hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASE 231 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~e 231 (251)
.++|+||+||++|+|++|..||....... .......... ...+..+++++.+++.+||+.||++||| ++|
T Consensus 180 ~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~ 257 (285)
T cd05630 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257 (285)
T ss_pred CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHH
Confidence 99999999999999999999997543221 1111111111 1224567899999999999999999999 899
Q ss_pred HhcChhhhhccCC
Q psy3253 232 MLNHEFIQRHDTD 244 (251)
Q Consensus 232 vl~hp~~~~~~~~ 244 (251)
+++||||++.+|.
T Consensus 258 ~~~h~~~~~~~~~ 270 (285)
T cd05630 258 VKEHPLFKQINFK 270 (285)
T ss_pred HHcChhhhccCHH
Confidence 9999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=265.84 Aligned_cols=213 Identities=49% Similarity=0.942 Sum_probs=178.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++......|+++||+++++|.+++......+++..+..++.|++.||.|||+.|++|+|++
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~----- 143 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK----- 143 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC-----
Confidence 357899999999999999999999999999999999998544489999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.
T Consensus 144 ----------------------------p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 195 (286)
T cd06614 144 ----------------------------SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195 (286)
T ss_pred ----------------------------hhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCC
Confidence 8888998899999999998865443322223344677899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+||+|+++|++++|..||...........+.............++..+.+++.+||+.+|.+|||+++++.|+||++
T Consensus 196 ~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999977665544444433333333334457899999999999999999999999999999999
Q ss_pred ccCCCC
Q psy3253 241 HDTDPS 246 (251)
Q Consensus 241 ~~~~~~ 246 (251)
..+..+
T Consensus 276 ~~~~~~ 281 (286)
T cd06614 276 ACPKEE 281 (286)
T ss_pred cCchHh
Confidence 666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=263.78 Aligned_cols=206 Identities=58% Similarity=1.045 Sum_probs=173.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+||||+.+++|.+++. ...+++.++..++.|++.||.|||+.+++|+||+
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~------ 128 (277)
T cd06640 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK------ 128 (277)
T ss_pred HhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCC------
Confidence 56899999999999999999999999999999999986 3578999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++++|||++..............++..|.|||.+.+..++.+
T Consensus 129 ---------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 181 (277)
T cd06640 129 ---------------------------AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181 (277)
T ss_pred ---------------------------hhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccH
Confidence 88888888899999999999765443222333456778999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+|||||++|++++|.+||...........+.....+ ..+..++..+.+++.+||+.+|++||+++++++||||.+.
T Consensus 182 ~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP--TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC--CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 99999999999999999999776655544433333222 2244568899999999999999999999999999999876
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 260 ~~~ 262 (277)
T cd06640 260 AKK 262 (277)
T ss_pred chh
Confidence 554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=262.28 Aligned_cols=204 Identities=37% Similarity=0.673 Sum_probs=169.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......++++||+.+++|.+++. +...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~----- 129 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK----- 129 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC-----
Confidence 357899999999999999999999999999999999997 44678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc------cccccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT------MAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.++.++|+|||.+...... ........++..|+|||.+.
T Consensus 130 ----------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 181 (265)
T cd06631 130 ----------------------------GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181 (265)
T ss_pred ----------------------------HHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc
Confidence 88888888899999999998654211 01112234677899999998
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+..++.++|+||+|+++|++++|..||...+.......+..........+..++.++.+++.+||..+|++||+++|+++
T Consensus 182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 88899999999999999999999999976554443333222211222235568999999999999999999999999999
Q ss_pred Chhh
Q psy3253 235 HEFI 238 (251)
Q Consensus 235 hp~~ 238 (251)
||||
T Consensus 262 ~~~~ 265 (265)
T cd06631 262 HDFL 265 (265)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.94 Aligned_cols=208 Identities=42% Similarity=0.838 Sum_probs=174.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......|+|+||+++++|.+++. ...+++.++..++.|++.||.|||++|++|+|+|
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~----- 142 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK----- 142 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCC-----
Confidence 357899999999999999999999999999999999986 3468899999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............++..|+|||.+....++.
T Consensus 143 ----------------------------p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 194 (293)
T cd06647 143 ----------------------------SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194 (293)
T ss_pred ----------------------------HHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCc
Confidence 8888888889999999998865543333333445778899999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+||+|+++|++++|..||...+.......+.....+....+..++..+.+++.+||..+|++||++++++.||||+.
T Consensus 195 ~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999999999999999976655444333333333334445567889999999999999999999999999999987
Q ss_pred ccC
Q psy3253 241 HDT 243 (251)
Q Consensus 241 ~~~ 243 (251)
..-
T Consensus 275 ~~~ 277 (293)
T cd06647 275 AKP 277 (293)
T ss_pred Ccc
Confidence 663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=263.11 Aligned_cols=202 Identities=50% Similarity=0.949 Sum_probs=165.0
Q ss_pred CC-CCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 3 QC-DSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
++ +||||+++++++... ...|++|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+|+
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred HhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 44 799999999998753 4689999999999999998753 356899999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||++..............++..|+|||++.
T Consensus 138 ~---------------------------------~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 138 K---------------------------------GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred C---------------------------------HHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhc
Confidence 8 8899999999999999999876543323334456788899999985
Q ss_pred -----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 155 -----EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 155 -----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
...++.++|+||+||++|+|++|..||................... .....++.++.+++.+||..+|++|||+
T Consensus 185 ~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred cccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 3457889999999999999999999997655444443332222111 2234578999999999999999999999
Q ss_pred HHHhcChhh
Q psy3253 230 SEMLNHEFI 238 (251)
Q Consensus 230 ~evl~hp~~ 238 (251)
+|++.||||
T Consensus 264 ~~il~~~~~ 272 (272)
T cd06637 264 EQLMKHPFI 272 (272)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=261.90 Aligned_cols=203 Identities=49% Similarity=0.935 Sum_probs=165.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++||||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|||+|
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~----- 133 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK----- 133 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-----
Confidence 357899999999999999999999999999999999986 45678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
|+||+++.++.++|+|||++..............++..|+|||.+. ...
T Consensus 134 ----------------------------p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 185 (267)
T cd06646 134 ----------------------------GANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185 (267)
T ss_pred ----------------------------HHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCC
Confidence 8888888889999999999976543322333445778899999884 345
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++.++|+||+||++|+|++|..||...........+... ..+.......++..+.+++.+||..+|++|||++++++|
T Consensus 186 ~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 778999999999999999999999655433322222111 111222234578999999999999999999999999999
Q ss_pred hh
Q psy3253 236 EF 237 (251)
Q Consensus 236 p~ 237 (251)
+|
T Consensus 266 l~ 267 (267)
T cd06646 266 LF 267 (267)
T ss_pred CC
Confidence 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.00 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=160.0
Q ss_pred CCCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++.. ....+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 135 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 135 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 35689999999998864 345899999996 48988886433 458999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++...... .......++..|+|||++.+
T Consensus 136 ---------------------------------p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 136 ---------------------------------PENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred ---------------------------------HHHEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhC
Confidence 88999999999999999998755432 12223456888999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---C-----CC----------------CCCCCCCCCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---K-----PP----------------PSFREPDVWTPEF 211 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~-----~~----------------~~~~~~~~~~~~~ 211 (251)
..++.++|+||+||++|+|++|.+||.+.........+.. . .+ ........++..+
T Consensus 182 ~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (288)
T cd07863 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESG 261 (288)
T ss_pred CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHH
Confidence 8899999999999999999999999965443322111100 0 00 0000123467889
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.||++|||++|+++||||
T Consensus 262 ~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 262 AQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=260.71 Aligned_cols=202 Identities=29% Similarity=0.552 Sum_probs=168.4
Q ss_pred CCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++|||++++++.+.. +...|++|||+.+++|.+++... ...+++.+++.++.+++.||.+||+.|++|||||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~---- 129 (257)
T cd08223 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK---- 129 (257)
T ss_pred HhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC----
Confidence 57899999999998864 44689999999999999998753 3468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+.+..++
T Consensus 130 -----------------------------p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (257)
T cd08223 130 -----------------------------TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180 (257)
T ss_pred -----------------------------chhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCC
Confidence 888888888999999999987654333333344578889999999988899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|+||+|++++++++|..||...+.......+.....+. .+..+++++.+++.+||+.||++|||+.|+++||||
T Consensus 181 ~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999997665544433333322212 245678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=263.67 Aligned_cols=203 Identities=53% Similarity=1.005 Sum_probs=168.0
Q ss_pred CC-CCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 3 QC-DSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
++ +||||+++++++.... ..++||||+.+++|.++++.. +..+++..+..++.|++.||.|||+.|++|+
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 45 7999999999997544 489999999999999998643 4678999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
||+ |+||+++.++.++|+|||.+..............++..|+|||.
T Consensus 138 ~l~---------------------------------p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 184 (275)
T cd06608 138 DIK---------------------------------GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184 (275)
T ss_pred CCC---------------------------------HHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhH
Confidence 988 88999998999999999998755443333344567888999998
Q ss_pred ccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC
Q psy3253 153 IQE-----IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227 (251)
Q Consensus 153 ~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 227 (251)
+.. ..++.++||||+|+++|++++|..||...........+..........+..++.++.+++.+||..||++||
T Consensus 185 ~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 264 (275)
T cd06608 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP 264 (275)
T ss_pred hcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc
Confidence 753 346778999999999999999999997665555444444444434444455788999999999999999999
Q ss_pred CHHHHhcChhh
Q psy3253 228 TASEMLNHEFI 238 (251)
Q Consensus 228 s~~evl~hp~~ 238 (251)
|++|+++|||+
T Consensus 265 t~~~ll~~~~~ 275 (275)
T cd06608 265 FMEELLEHPFI 275 (275)
T ss_pred CHHHHhcCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=260.56 Aligned_cols=203 Identities=30% Similarity=0.567 Sum_probs=172.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
+++++||||+++++++....+.++|+||+.+++|.+++.... ..+++.+++.++.|++.||.|||++|++|+||+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~---- 128 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIK---- 128 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC----
Confidence 467899999999999999999999999999999999986433 468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||.+..............++..|+|||.+.+..++
T Consensus 129 -----------------------------~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 179 (256)
T cd08218 129 -----------------------------SQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179 (256)
T ss_pred -----------------------------HHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCC
Confidence 888888888899999999997654433223334567889999999888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|+||+||+++++++|..||...+.......+..+..+. .+..++.++.+++.+||+.+|++||+++|+++||||
T Consensus 180 ~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999997666555544443333222 355678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=261.61 Aligned_cols=204 Identities=35% Similarity=0.547 Sum_probs=162.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL--SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++++..+...++++||+.+++|.+++......+ ++..+..++.|++.||.|||++|++|||||
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~---- 135 (268)
T cd06624 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK---- 135 (268)
T ss_pred HhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCC----
Confidence 57899999999999999999999999999999999997554556 888999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCcccccccccccccccccccccccCC-
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 157 (251)
|+||+++. .+.++|+|||.+..............++..|+|||.+.+..
T Consensus 136 -----------------------------p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 186 (268)
T cd06624 136 -----------------------------GDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186 (268)
T ss_pred -----------------------------HHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccc
Confidence 77777765 56899999999865433222222334678899999986543
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++|+||+|+++|++++|..||......................+..+++++.+++.+||+.+|++|||++|++.||
T Consensus 187 ~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 7889999999999999999999996543322211111111111223556789999999999999999999999999999
Q ss_pred hh
Q psy3253 237 FI 238 (251)
Q Consensus 237 ~~ 238 (251)
||
T Consensus 267 ~~ 268 (268)
T cd06624 267 FL 268 (268)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.54 Aligned_cols=214 Identities=25% Similarity=0.423 Sum_probs=170.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|+|||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~----- 129 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLK----- 129 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC-----
Confidence 35789999999999999999999999999 889999997443479999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++
T Consensus 130 ----------------------------p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (298)
T cd07841 130 ----------------------------PNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181 (298)
T ss_pred ----------------------------hhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCC
Confidence 88889988999999999999766543233333445778999998854 4578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C----------------------CCCCCCCCCCCHHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P----------------------PPSFREPDVWTPEFIDF 214 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~----------------------~~~~~~~~~~~~~~~~l 214 (251)
.++|+||+||++|++++|.++|.+.+.......+... . ..........+..+.++
T Consensus 182 ~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T cd07841 182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDL 261 (298)
T ss_pred cHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHH
Confidence 8999999999999999998888655443222111000 0 00000123346889999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhhhhccCCCCCC
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFIQRHDTDPSQN 248 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~~ 248 (251)
|.+||+++|++|||++|++.||||++...+.+++
T Consensus 262 i~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~ 295 (298)
T cd07841 262 LQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295 (298)
T ss_pred HHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence 9999999999999999999999999877766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=266.48 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=171.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++.+.++.+.++||||++|++|.+++. ....+++..+..++.|++.||.|||+.|++|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 128 (305)
T cd05609 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK------ 128 (305)
T ss_pred HhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc------
Confidence 56899999999999999999999999999999999997 44679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---------------cccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---------------KRNTVIGTPF 146 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---------------~~~~~~~~~~ 146 (251)
|+||+++.++.++++|||+++....... ......++..
T Consensus 129 ---------------------------p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (305)
T cd05609 129 ---------------------------PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181 (305)
T ss_pred ---------------------------hHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCcc
Confidence 8888998899999999998863211000 0111245678
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
|+|||.+.+..++.++|+|||||++|++++|..||.+.+.....................++.++.++|.+||+.+|++|
T Consensus 182 y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 261 (305)
T cd05609 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261 (305)
T ss_pred ccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhc
Confidence 99999998888999999999999999999999999776555444433322211112233578999999999999999999
Q ss_pred CC---HHHHhcChhhhhccCCC
Q psy3253 227 AT---ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 227 ps---~~evl~hp~~~~~~~~~ 245 (251)
|+ +.|+++||||+..+|+.
T Consensus 262 ~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 262 LGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred cCccCHHHHHhCccccCCCHHH
Confidence 97 79999999998877754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=264.19 Aligned_cols=203 Identities=53% Similarity=1.007 Sum_probs=165.8
Q ss_pred CC-CCCccceeeeeEe-----eCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 3 QC-DSPYVVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
++ +||||+++++++. ++...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+++|||
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 149 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 45 7999999999884 34578999999999999998752 235688999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|| |+||+++.++.++|+|||.+..............++..|+|||.+
T Consensus 150 lk---------------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (286)
T cd06638 150 VK---------------------------------GNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196 (286)
T ss_pred CC---------------------------------HHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhh
Confidence 88 889999889999999999987654433333445678899999988
Q ss_pred cc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 154 QE-----IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 154 ~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
.. ..++.++|+||+||++|++++|..||......................+..++..+.+++.+||+.||++|||
T Consensus 197 ~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 276 (286)
T cd06638 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT 276 (286)
T ss_pred chhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC
Confidence 53 4478899999999999999999999976655444433333332333334556889999999999999999999
Q ss_pred HHHHhcChhh
Q psy3253 229 ASEMLNHEFI 238 (251)
Q Consensus 229 ~~evl~hp~~ 238 (251)
++|+++|+||
T Consensus 277 ~~ell~~~~~ 286 (286)
T cd06638 277 VSDLLQHVFI 286 (286)
T ss_pred HHHHhhcccC
Confidence 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=263.03 Aligned_cols=209 Identities=26% Similarity=0.445 Sum_probs=171.5
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
..+||||+++++++......++||||+.|++|.+++. ....+++..++.++.|++.||.|||+.+++|||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~------- 124 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLK------- 124 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCC-------
Confidence 3579999999999999999999999999999999886 45679999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCcc
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCV 161 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 161 (251)
|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.+
T Consensus 125 --------------------------p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 176 (278)
T cd05606 125 --------------------------PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSS 176 (278)
T ss_pred --------------------------HHHEEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcc
Confidence 88999988999999999998654332 1223457889999999975 368899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcCh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHE 236 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~hp 236 (251)
+|+||+|+++|++++|..||......................+..++.++.+++.+||..+|++|| +++|+++||
T Consensus 177 ~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred cchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 999999999999999999997653221111111111112233556799999999999999999999 999999999
Q ss_pred hhhhccCCCCC
Q psy3253 237 FIQRHDTDPSQ 247 (251)
Q Consensus 237 ~~~~~~~~~~~ 247 (251)
||+..+|....
T Consensus 257 ~~~~~~~~~~~ 267 (278)
T cd05606 257 FFRSLDWQMVF 267 (278)
T ss_pred cccCCCchHhh
Confidence 99999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.82 Aligned_cols=211 Identities=23% Similarity=0.404 Sum_probs=172.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.+++..|+||||+.||+|.+++......+++..++.++.|++.||+|||++|++|||||
T Consensus 56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlk------ 129 (331)
T cd05624 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK------ 129 (331)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCc------
Confidence 45789999999999999999999999999999999998656789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc-----
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE----- 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----- 155 (251)
|+||+++.++.++|+|||++........ ......|++.|+|||++.+
T Consensus 130 ---------------------------p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05624 130 ---------------------------PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182 (331)
T ss_pred ---------------------------hHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCC
Confidence 8889998899999999999876543222 1223468999999999865
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCC-CCCCCCCHHHHHHHHHhhhcCcCc--cCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSF-REPDVWTPEFIDFVSRCLVKNPEE--RATASE 231 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~--Rps~~e 231 (251)
..++.++|+||+||++|+|++|+.||...+.......+.... ...+ .....+++++.+++.+||...+++ |+++++
T Consensus 183 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~ 262 (331)
T cd05624 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIED 262 (331)
T ss_pred CCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHH
Confidence 457889999999999999999999997766554443333221 1111 112346899999999999876654 469999
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
+++||||+..+|+.
T Consensus 263 ~~~h~~f~~~~~~~ 276 (331)
T cd05624 263 FKKHAFFEGIDWEN 276 (331)
T ss_pred HhcCCCcCCCCHHH
Confidence 99999999877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=267.43 Aligned_cols=211 Identities=31% Similarity=0.500 Sum_probs=174.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.++||||+++++.+.+....|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+|||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk---- 130 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK---- 130 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCC----
Confidence 35688999999999999999999999999999999998743 3578999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-----------------------
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----------------------- 136 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----------------------- 136 (251)
|+||+++.++.++|+|||++........
T Consensus 131 -----------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (316)
T cd05574 131 -----------------------------PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181 (316)
T ss_pred -----------------------------hHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhh
Confidence 8888888889999999999865432110
Q ss_pred ------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHH
Q psy3253 137 ------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPE 210 (251)
Q Consensus 137 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (251)
......|+..|+|||.+.+..++.++|+||||+++|++++|..||.+.+.......+.... .........+..
T Consensus 182 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 260 (316)
T cd05574 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-VTFPGSPPVSSS 260 (316)
T ss_pred cccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC-ccCCCccccCHH
Confidence 1112356778999999988889999999999999999999999997766554444333222 122223337899
Q ss_pred HHHHHHHhhhcCcCccCC----HHHHhcChhhhhccCCC
Q psy3253 211 FIDFVSRCLVKNPEERAT----ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps----~~evl~hp~~~~~~~~~ 245 (251)
+.+++.+||..||++||| ++|+++||||+..+|..
T Consensus 261 ~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred HHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 999999999999999999 99999999999987754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=265.62 Aligned_cols=204 Identities=26% Similarity=0.443 Sum_probs=161.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++++||++ ++|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~----- 126 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK----- 126 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC-----
Confidence 356899999999999999999999999996 58888886556789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+. .++
T Consensus 127 ----------------------------~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 178 (284)
T cd07839 127 ----------------------------PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178 (284)
T ss_pred ----------------------------HHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccC
Confidence 888888889999999999997654332223334567889999998664 468
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCC-CCcchhhhhc------------------CC-CCCCCC-------CCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGD-IHPMRAIFMI------------------PT-KPPPSF-------REPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~-~~~~~~~~~~------------------~~-~~~~~~-------~~~~~~~~~~~ 212 (251)
.++|+||+||++|+|++|..|+.. .+.......+ .. ...... .....+++++.
T Consensus 179 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07839 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR 258 (284)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHH
Confidence 899999999999999998887633 2211111100 00 000000 01234688999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++|.+||+.||++|||++|+++||||
T Consensus 259 ~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 259 DLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=257.97 Aligned_cols=203 Identities=29% Similarity=0.562 Sum_probs=173.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....+++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~---- 128 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK---- 128 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC----
Confidence 45789999999999999999999999999999999999744 4568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||.+..............+++.|.|||.+.+..++
T Consensus 129 -----------------------------p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~ 179 (256)
T cd08221 129 -----------------------------TLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179 (256)
T ss_pred -----------------------------hHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCC
Confidence 888888889999999999997654433233445678899999999888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|+||+|+++|+|++|..||...+.......+....... .+..++.++.+++.+||..+|++||+++|+++|||+
T Consensus 180 ~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999999999999999999997766555554444332222 235678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=262.72 Aligned_cols=204 Identities=34% Similarity=0.696 Sum_probs=166.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++.+......++||||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk----- 122 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK----- 122 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCC-----
Confidence 3578999999999999999999999999999999654 357888999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.
T Consensus 123 ----------------------------p~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 172 (279)
T cd06619 123 ----------------------------PSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGI 172 (279)
T ss_pred ----------------------------HHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCC
Confidence 88888888999999999999754332 223346788999999999888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcc-------hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPM-------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
++|+||+||++|++++|..||...... .....+........ .....++++.+++.+||..+|++||+++|++
T Consensus 173 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil 251 (279)
T cd06619 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251 (279)
T ss_pred cchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 999999999999999999999543221 11111111111111 2344688999999999999999999999999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+..+..+
T Consensus 252 ~~~~~~~~~~~~ 263 (279)
T cd06619 252 DHPFIVQYNDGN 263 (279)
T ss_pred cCcccccccCcc
Confidence 999998775543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=264.11 Aligned_cols=208 Identities=38% Similarity=0.777 Sum_probs=175.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++.+...++.+++|||+++++|.+++. ...+++..+..++.|++.||+|||+.|++||||+
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~------ 143 (292)
T cd06657 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK------ 143 (292)
T ss_pred HhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC------
Confidence 46899999999999999999999999999999999875 4568999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.+
T Consensus 144 ---------------------------p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 196 (292)
T cd06657 144 ---------------------------SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196 (292)
T ss_pred ---------------------------HHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCch
Confidence 88999999999999999998655433222333457888999999988888999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+|+++|++++|..||...........+....+........+++.+.+++.+||+.+|.+||+++++++||||.+.
T Consensus 197 ~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 99999999999999999999766554444333333333333445678999999999999999999999999999999887
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
.-+
T Consensus 277 ~~~ 279 (292)
T cd06657 277 GPP 279 (292)
T ss_pred CCC
Confidence 643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=259.88 Aligned_cols=205 Identities=49% Similarity=0.897 Sum_probs=170.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|+.++||||+++++.+..+...+++||++.+++|.++++... ..+++..+..++.|++.||.+||+.|++|||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~--- 129 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK--- 129 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC---
Confidence 356899999999999999999999999999999999997432 468999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----ccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----RNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.
T Consensus 130 ------------------------------p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 130 ------------------------------AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred ------------------------------HHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc
Confidence 88999998999999999998765433221 12335678899999987
Q ss_pred cC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCC---CCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 155 EI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREP---DVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 155 ~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.. .++.++|+||+|+++|+|++|+.||................+...... ..+++++.+++.+||..||++|||++
T Consensus 180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 76 788999999999999999999999977655544443333333222222 35789999999999999999999999
Q ss_pred HHhcChhh
Q psy3253 231 EMLNHEFI 238 (251)
Q Consensus 231 evl~hp~~ 238 (251)
|+++||||
T Consensus 260 ~ll~~p~~ 267 (267)
T cd06610 260 ELLKHKFF 267 (267)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=263.89 Aligned_cols=204 Identities=26% Similarity=0.531 Sum_probs=164.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++||||+++++|..++. ....+++..++.++.|++.||.|||+.|++|||||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~----- 127 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK----- 127 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-----
Confidence 357899999999999999999999999999988887765 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++
T Consensus 128 ----------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (286)
T cd07847 128 ----------------------------PENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179 (286)
T ss_pred ----------------------------hhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcC
Confidence 88889988999999999999766543322333456778999999865 5578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-----------------------CCCCCC-----CCCCCCCHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-----------------------KPPPSF-----REPDVWTPEF 211 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~~~-----~~~~~~~~~~ 211 (251)
.++|+||+|+++|+|++|.+||.+.........+.. ...+.. .....++..+
T Consensus 180 ~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07847 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPA 259 (286)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHH
Confidence 899999999999999999999976554322211100 000000 0013457889
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.+|++|||+.|++.||||
T Consensus 260 ~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 260 LSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=269.76 Aligned_cols=198 Identities=28% Similarity=0.521 Sum_probs=158.5
Q ss_pred CCC-CCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhC-------------------------------------
Q psy3253 2 QQC-DSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRK------------------------------------- 42 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~------------------------------------- 42 (251)
+++ +||||+++++++... ..++++|||+++|+|.++++...
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (338)
T cd05102 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV 144 (338)
T ss_pred HHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence 345 899999999988754 46899999999999999996421
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 43 ------------------------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 43 ------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
..+++..+..++.||+.||.|||++|++|||||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiK----------------------- 201 (338)
T cd05102 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLA----------------------- 201 (338)
T ss_pred cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCc-----------------------
Confidence 247788899999999999999999999999988
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHh
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 176 (251)
|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++
T Consensus 202 ----------p~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 202 ----------ARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred ----------cceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 888888888999999999997543221 11223345677999999988889999999999999999997
Q ss_pred -CCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 177 -GKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 177 -g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
|..||.+....... ..+.... ....+..+++++.+++.+||+.||++|||++|+++
T Consensus 272 ~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 272 LGASPYPGVQINEEFCQRLKDGT--RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCCCccHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999765433222 2222222 22235667899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=260.49 Aligned_cols=198 Identities=26% Similarity=0.405 Sum_probs=164.2
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++.|...+..|+||||+.+++|.+++.. ...+++.++..++.|++.||.|||+.|++|||||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~--------- 136 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK--------- 136 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC---------
Confidence 799999999999999999999999999999999974 3589999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++ .++|+|||.+...... ....++..|+|||.+.+..++.++|
T Consensus 137 ------------------------p~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~D 188 (267)
T PHA03390 137 ------------------------LENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFD 188 (267)
T ss_pred ------------------------HHHEEEeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhh
Confidence 7788888777 8999999998654322 2234678899999998888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchh-hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-HHHHhcChhhhh
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRA-IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-ASEMLNHEFIQR 240 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~evl~hp~~~~ 240 (251)
+||+|+++|++++|..||........ ..............+..+++.+.++|.+||+.+|.+||+ ++|+++||||..
T Consensus 189 vwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 189 WWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999999975433221 111111111222334568999999999999999999996 699999999963
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=264.93 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=173.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|+||+++++.+..++..|++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik---- 129 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK---- 129 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC----
Confidence 45789999999999999999999999999999999888643 3469999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++
T Consensus 130 -----------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~ 179 (285)
T cd05632 130 -----------------------------PENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYT 179 (285)
T ss_pred -----------------------------HHHEEECCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCC
Confidence 88899988899999999998654322 122234578899999999888899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEML 233 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl 233 (251)
.++|+||+||++|++++|..||...........+... .......+..+++++.+|+.+||+.||++||+ +++++
T Consensus 180 ~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05632 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259 (285)
T ss_pred cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHH
Confidence 9999999999999999999999765443222111111 11111234567899999999999999999999 88999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+|+||+..++..
T Consensus 260 ~~~~~~~~~~~~ 271 (285)
T cd05632 260 RHPFFRNMNFKR 271 (285)
T ss_pred cChhhhcCCHHH
Confidence 999999887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.87 Aligned_cols=207 Identities=26% Similarity=0.458 Sum_probs=164.5
Q ss_pred CCCCCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|+.++||||+++++++.... ..|+||||+. ++|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk 130 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK 130 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 35689999999999998766 7999999996 58888875 45679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 131 ---------------------------------p~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (372)
T cd07853 131 ---------------------------------PGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177 (372)
T ss_pred ---------------------------------hHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHc
Confidence 8889999999999999999975432211 122335688899999987
Q ss_pred cC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-----------------------CC--CCCC----CCCC
Q psy3253 155 EI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-----------------------TK--PPPS----FREP 204 (251)
Q Consensus 155 ~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------------------~~--~~~~----~~~~ 204 (251)
+. .++.++||||+||++|+|++|+.||.+.+.......+. .. .++. ....
T Consensus 178 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (372)
T cd07853 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLS 257 (372)
T ss_pred CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccC
Confidence 64 47889999999999999999999997654432221110 00 0000 1122
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
...++++.+||.+||+.||++|||++|+++||||+...
T Consensus 258 ~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 258 SQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 34588999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.33 Aligned_cols=204 Identities=22% Similarity=0.472 Sum_probs=152.5
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLR--------KKTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|++++||||+++++++.. +...|++|||+. ++|.+++... ...+++..++.++.||+.||.|||++|++
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 130 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 457899999999999854 457899999995 5898887522 12589999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceec----CCCCCeEecccccccccCcccc---ccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL----NTEGHAKLADFGVAGQLTDTMA---KRNTVIG 143 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~----~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~ 143 (251)
||||| |+||++ +.++.+||+|||+++....... ......+
T Consensus 131 HrDlk---------------------------------p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 177 (317)
T cd07868 131 HRDLK---------------------------------PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177 (317)
T ss_pred cCCCC---------------------------------HHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccc
Confidence 99999 556665 3456799999999976543211 1233467
Q ss_pred cccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch------------hhhhcCCCCC----------C-
Q psy3253 144 TPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR------------AIFMIPTKPP----------P- 199 (251)
Q Consensus 144 ~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~------------~~~~~~~~~~----------~- 199 (251)
|+.|+|||++.+ ..++.++|+||+||++|+|++|.+||....... .......... +
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (317)
T cd07868 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE 257 (317)
T ss_pred cccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccc
Confidence 889999999876 458889999999999999999999995332110 0000000000 0
Q ss_pred -----------CC----------CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 200 -----------SF----------REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 200 -----------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.. ......+.++.++|.+||++||++|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 258 HSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0011234678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=278.56 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=158.9
Q ss_pred CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccc
Q psy3253 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDR 85 (251)
Q Consensus 7 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~ 85 (251)
=|+|+++++|...+|+|||+|.++ .+|++++++++ .+|+...++.++.||+.||.+||+.||||+||||||||+.-.
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~- 325 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP- 325 (586)
T ss_pred eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-
Confidence 389999999999999999999994 59999998554 679999999999999999999999999999999666666521
Q ss_pred cccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHH
Q psy3253 86 LDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMW 165 (251)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 165 (251)
....+||+|||+++....... ....+..|+|||++.+.+|+.+.|||
T Consensus 326 ------------------------------~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmW 372 (586)
T KOG0667|consen 326 ------------------------------KRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMW 372 (586)
T ss_pred ------------------------------CcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCcccee
Confidence 122599999999986654322 55678899999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC--------------------------------------------
Q psy3253 166 SLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP-------------------------------------------- 198 (251)
Q Consensus 166 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------------------------------------------- 198 (251)
||||++.||++|.+.|.+.+....+..+.. .++
T Consensus 373 SLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~ 452 (586)
T KOG0667|consen 373 SLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRK 452 (586)
T ss_pred ehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhh
Confidence 999999999999999976544433332210 000
Q ss_pred --CCCCCC-----------CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 199 --PSFREP-----------DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 199 --~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.....| ..-...+.|++++||.+||.+|+|+.|+|+||||+.
T Consensus 453 ~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 453 ARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred hcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 000001 011245899999999999999999999999999984
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=264.15 Aligned_cols=208 Identities=29% Similarity=0.530 Sum_probs=189.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+..+||.+..+..+|++.+++|.||||..||.|+-.+. +...|++..++.+..+|+.||.|||+++|++||+|
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK----- 295 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK----- 295 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech-----
Confidence 467799999999999999999999999999999988776 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
.+|.+++++|++||.|||+++.-........+..|||.|.|||++....|..
T Consensus 296 ----------------------------LENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgr 347 (516)
T KOG0690|consen 296 ----------------------------LENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGR 347 (516)
T ss_pred ----------------------------hhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccc
Confidence 7899999999999999999986655555667789999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++|-|.+|+++|+|++|+.||.+.+.......+... ....|..++++...|+..+|..||++|. .+.||.+|
T Consensus 348 aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 348 AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred eeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999999999999999998888887766655 3344788999999999999999999995 68999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
+||...+|+.
T Consensus 425 ~FF~~v~W~~ 434 (516)
T KOG0690|consen 425 RFFASVDWEA 434 (516)
T ss_pred hhhccCCHHH
Confidence 9999999975
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=259.51 Aligned_cols=199 Identities=22% Similarity=0.378 Sum_probs=165.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+.+.++||||+.+|+|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dik----- 134 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA----- 134 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc-----
Confidence 457899999999999999999999999999999999997556689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++
T Consensus 135 ----------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 135 ----------------------------AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred ----------------------------HhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc
Confidence 8888888899999999998754322111 11122345679999999888999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++||||+||++|++++ |..||.+.........+..... .+.+..++..+.+++.+||+.+|++|||++|+++
T Consensus 187 ~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999775 9999987665554444433322 2335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=261.43 Aligned_cols=205 Identities=42% Similarity=0.823 Sum_probs=169.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++..+...++++||+.+++|.+++......+++..+..++.|++.||.|||+ .|++|+|||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~----- 128 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK----- 128 (265)
T ss_pred HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCC-----
Confidence 46789999999999999999999999999999999997555789999999999999999999999 999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+......... ...++..|+|||.+.+..++.
T Consensus 129 ----------------------------~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~ 178 (265)
T cd06605 129 ----------------------------PSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSV 178 (265)
T ss_pred ----------------------------HHHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCc
Confidence 88999999999999999998655432211 155778899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC-----cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIH-----PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++|+||+|+++|++++|..||...+ .......+.....+... ...+++++.++|.+||..||++|||++|++.|
T Consensus 179 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999996542 11122222222222221 12278999999999999999999999999999
Q ss_pred hhhhhcc
Q psy3253 236 EFIQRHD 242 (251)
Q Consensus 236 p~~~~~~ 242 (251)
|||+++.
T Consensus 258 ~~~~~~~ 264 (265)
T cd06605 258 PFIKKYE 264 (265)
T ss_pred chhhccc
Confidence 9998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.87 Aligned_cols=206 Identities=22% Similarity=0.299 Sum_probs=161.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++..+...++|||++. ++|.+++......+++..++.++.|++.||.|||++||+|||||
T Consensus 214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLK----- 287 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIK----- 287 (461)
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCC-----
Confidence 467899999999999999999999999995 69999887555679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||+++....... ......||..|+|||++.+..+
T Consensus 288 ----------------------------P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 288 ----------------------------TENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred ----------------------------HHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence 8888888889999999999975432211 1223458999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCc--------chhhhhcCCC------CC-------------------------C
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHP--------MRAIFMIPTK------PP-------------------------P 199 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~------~~-------------------------~ 199 (251)
+.++|||||||++|+|++|..++..... ......+... .+ .
T Consensus 340 ~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 419 (461)
T PHA03211 340 TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRP 419 (461)
T ss_pred CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCc
Confidence 9999999999999999998755422110 0111100000 00 0
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 200 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.+.....++..+.+||.+||+.||++|||++|+|+||||+.
T Consensus 420 ~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 420 AWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00011134568999999999999999999999999999974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=272.03 Aligned_cols=202 Identities=25% Similarity=0.438 Sum_probs=159.2
Q ss_pred CCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
+.++||||+++++++... ...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++|++|||||
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDik 146 (355)
T cd07874 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146 (355)
T ss_pred HHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 467999999999998643 357999999965 7777765 358899999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||+++..... .......+++.|+|||++.+
T Consensus 147 ---------------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 147 ---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ---------------------------------hHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcC
Confidence 88889988999999999999764432 22233467889999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-----------------------CCC---------------
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-----------------------TKP--------------- 197 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------------------~~~--------------- 197 (251)
..++.++|+||+||++|+|++|+.||.+.+......... ...
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (355)
T cd07874 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272 (355)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccc
Confidence 889999999999999999999999997654322111000 000
Q ss_pred -CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 198 -PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 198 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+.........+.++.++|.+||+.||++|||++|+++||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00000112235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.58 Aligned_cols=203 Identities=47% Similarity=0.876 Sum_probs=185.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|.++.|||+|.+.|+|..+...+|||||| -||-++++.....++.+-++..++.+.+.||.|||+.+.||||||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiK----- 153 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIK----- 153 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhcc-----
Confidence 46899999999999999999999999999 569999998888999999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
..||+++..|.+||+|||.+.... ....++|||.|||||++. .+.
T Consensus 154 ----------------------------AGNILLse~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGq 201 (948)
T KOG0577|consen 154 ----------------------------AGNILLSEPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQ 201 (948)
T ss_pred ----------------------------ccceEecCCCeeeeccccchhhcC----chhcccCCccccchhHheeccccc
Confidence 889999999999999999996544 345688999999999994 577
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
|+.++||||||+++.++...++|+.+.+.+...+-|..+.++.+. ...|+..|++|+..||+.-|++|||.++++.|+|
T Consensus 202 YdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 202 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred cCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 999999999999999999999999999999999888888887775 5668999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
+.+..
T Consensus 281 v~R~R 285 (948)
T KOG0577|consen 281 VLRER 285 (948)
T ss_pred hccCC
Confidence 97643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=281.31 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=170.4
Q ss_pred CCCCCCccceeeeeEeeCC--------eEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 2 QQCDSPYVVKYYGSYFKNT--------DLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~--------~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
..++|+|++++++.+.... .+++||||+.+|+|.+++... ...+++..+..++.|++.||.|||++|++
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii 165 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 4678999999998875432 378999999999999998633 35689999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--cccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWM 148 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~ 148 (251)
||||| |+||+++.++.+||+|||+++..... ........||+.|+
T Consensus 166 HrDLK---------------------------------P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~ 212 (496)
T PTZ00283 166 HRDIK---------------------------------SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212 (496)
T ss_pred cCCCC---------------------------------HHHEEEeCCCCEEEEecccCeeccccccccccccccCCccee
Confidence 99988 88999998999999999998755422 11223456889999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
|||.+.+..++.++|||||||++|+|++|..||.+.+.......+...... ..+..+++++.+++.+||..||++||+
T Consensus 213 aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs 290 (496)
T PTZ00283 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS 290 (496)
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC
Confidence 999999989999999999999999999999999876655544444333222 235668999999999999999999999
Q ss_pred HHHHhcChhhhhc
Q psy3253 229 ASEMLNHEFIQRH 241 (251)
Q Consensus 229 ~~evl~hp~~~~~ 241 (251)
++++++|||++..
T Consensus 291 ~~ell~~p~~~~~ 303 (496)
T PTZ00283 291 SSKLLNMPICKLF 303 (496)
T ss_pred HHHHHhCHHHHHh
Confidence 9999999998753
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.88 Aligned_cols=199 Identities=24% Similarity=0.488 Sum_probs=175.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR------KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++|||||++.|++......++++|||+||+|..|++.. ...++.++.+.++.+|++|.+||+++++|||||
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 67899999999999999999999999999999999999866 567999999999999999999999999999997
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc-cccc-cccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT-MAKR-NTVIGTPFWMAPEV 152 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~-~~~~~~~~y~aPE~ 152 (251)
. .+|++++....+||+|||+|+.+... .... ........|||||.
T Consensus 829 A---------------------------------aRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEs 875 (1025)
T KOG1095|consen 829 A---------------------------------ARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPES 875 (1025)
T ss_pred h---------------------------------hhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHH
Confidence 7 77778888889999999999854322 2222 22345678999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 153 IQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 153 ~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
+....++.|+|||||||++||+++ |..||++.++.+.......+. .+..|..|+..+.++|..||+.+|++||++..
T Consensus 876 l~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~ 953 (1025)
T KOG1095|consen 876 LKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRT 953 (1025)
T ss_pred HhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHH
Confidence 999999999999999999999999 999999998888877444444 66779999999999999999999999999999
Q ss_pred Hhc
Q psy3253 232 MLN 234 (251)
Q Consensus 232 vl~ 234 (251)
+++
T Consensus 954 i~~ 956 (1025)
T KOG1095|consen 954 IVE 956 (1025)
T ss_pred HHh
Confidence 987
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=262.07 Aligned_cols=200 Identities=52% Similarity=0.982 Sum_probs=163.3
Q ss_pred CCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 5 DSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 5 ~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
+||||+++++++.. ....|++|||+.+|+|.+++... ...+++..+..++.|++.||.|||+.|++|+|+|
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~-- 148 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIK-- 148 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC--
Confidence 79999999999853 45789999999999999998743 3568899999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--- 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 154 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.
T Consensus 149 -------------------------------~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 197 (282)
T cd06636 149 -------------------------------GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197 (282)
T ss_pred -------------------------------HHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCccc
Confidence 8889998899999999999875543222333456788899999885
Q ss_pred --cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 155 --EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 155 --~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
...++.++|+||+||++|++++|..||....+......+........ ....++.++.++|.+||+.||.+|||++|+
T Consensus 198 ~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL-KSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC-cccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 34577899999999999999999999976554444433322222221 234578999999999999999999999999
Q ss_pred hcChhh
Q psy3253 233 LNHEFI 238 (251)
Q Consensus 233 l~hp~~ 238 (251)
+.||||
T Consensus 277 l~~~~~ 282 (282)
T cd06636 277 LKHPFI 282 (282)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=271.91 Aligned_cols=202 Identities=25% Similarity=0.426 Sum_probs=159.7
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|+.++||||+++++++... ...|+||||+.+ +|.+++. ..+++..+..++.|++.||.|||++|++||||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 152 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 3568999999999988543 357999999965 7877775 35889999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||+++..... .......++..|+|||++.
T Consensus 153 k---------------------------------p~NIll~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~ 198 (364)
T cd07875 153 K---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 198 (364)
T ss_pred C---------------------------------HHHEEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHh
Confidence 8 88999999999999999999754432 1223345788999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC---------------------CC-------------
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP---------------------PS------------- 200 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~~------------- 200 (251)
+..++.++|||||||++|+|++|+.||.+.+.......+..... +.
T Consensus 199 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (364)
T cd07875 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 278 (364)
T ss_pred CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccc
Confidence 98999999999999999999999999976544332221110000 00
Q ss_pred -----CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 201 -----FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 201 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.......+..+.++|.+||+.||++|||++|+|+||||..
T Consensus 279 ~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 279 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred cccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0001123567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=257.41 Aligned_cols=204 Identities=46% Similarity=0.867 Sum_probs=170.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
.|||++++++++..+...|++|||+.+++|.++++. ..+++..+..++.|++.||.|||+.|++|+||+
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~--------- 128 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIK--------- 128 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcC---------
Confidence 599999999999999999999999999999999863 478999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCcchh
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVAD 163 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 163 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|
T Consensus 129 ------------------------p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 184 (277)
T cd06917 129 ------------------------AANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184 (277)
T ss_pred ------------------------HHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchh
Confidence 88889988999999999998766544333344567888999998864 45688999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
+||+|+++|+|++|..||.+.........+.....+... ...++.++.+++.+||+.||++||+++|++.|+||++...
T Consensus 185 v~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999776655544433333222221 2237889999999999999999999999999999988664
Q ss_pred C
Q psy3253 244 D 244 (251)
Q Consensus 244 ~ 244 (251)
.
T Consensus 264 ~ 264 (277)
T cd06917 264 T 264 (277)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=270.89 Aligned_cols=205 Identities=24% Similarity=0.478 Sum_probs=162.6
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++... ...|++++++ +++|.+++. ...+++..+..++.||+.||.|||++|++||||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdi 144 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDL 144 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 4678999999999988543 3579999998 779988875 457999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.+||+|||++...... .....+++.|+|||++.
T Consensus 145 k---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~ 188 (343)
T cd07878 145 K---------------------------------PSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIML 188 (343)
T ss_pred C---------------------------------hhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhc
Confidence 8 88899988999999999999765432 23345788999999987
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC-------------------CCC------CCCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP-------------------PSF------REPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------------------~~~------~~~~ 205 (251)
+ ..++.++||||+||++|+|++|..||.+.+.......+.. ... +.. ....
T Consensus 189 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (343)
T cd07878 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFR 268 (343)
T ss_pred CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhcc
Confidence 6 5688899999999999999999999976443222111100 000 000 0012
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
..++.+.+|+.+||+.||++|||++|+++||||......
T Consensus 269 ~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 269 GANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 456788999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=259.02 Aligned_cols=207 Identities=36% Similarity=0.562 Sum_probs=173.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++.+..+...|+++||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 48 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~------ 120 (265)
T cd05579 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK------ 120 (265)
T ss_pred HhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC------
Confidence 467899999999999999999999999999999999973 4589999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--------ccccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--------KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++|+|||++........ ......++..|+|||..
T Consensus 121 ---------------------------~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 173 (265)
T cd05579 121 ---------------------------PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173 (265)
T ss_pred ---------------------------HHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHh
Confidence 8899999999999999999865432211 22234467789999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH---H
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA---S 230 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ 230 (251)
.....+.++|+||||+++|++++|..||...........+..... ........+..+.+++.+||+.+|++|||+ .
T Consensus 174 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~ 252 (265)
T cd05579 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIE 252 (265)
T ss_pred cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHH
Confidence 888889999999999999999999999977666555544433221 221122248999999999999999999999 9
Q ss_pred HHhcChhhhhccC
Q psy3253 231 EMLNHEFIQRHDT 243 (251)
Q Consensus 231 evl~hp~~~~~~~ 243 (251)
++++||||+..+|
T Consensus 253 ~~l~~~~~~~~~~ 265 (265)
T cd05579 253 EIKNHPFFKGIDW 265 (265)
T ss_pred HHhcCccccCCCC
Confidence 9999999998877
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=255.76 Aligned_cols=202 Identities=27% Similarity=0.509 Sum_probs=169.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++..+...++||||+.+++|.+++.... ..+++..+..++.+++.||+|||++|++|+|||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~---- 128 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLK---- 128 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC----
Confidence 467899999999999999999999999999999999997543 458999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.+ +.++++|||.+....... ......++..|+|||.+.+..+
T Consensus 129 -----------------------------~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08220 129 -----------------------------TQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPY 178 (256)
T ss_pred -----------------------------HHHEEEcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCC
Confidence 778888644 457999999997654332 2223456788999999988888
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|+||+|+++|++++|..||...+.......+...... ..+..+++++.+++.+||..+|++|||++|+++||||
T Consensus 179 ~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA--PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC--CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999776655555444433222 2345679999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=263.16 Aligned_cols=203 Identities=37% Similarity=0.651 Sum_probs=167.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++......+++|||+.+++|.+++. ....+++.++..++.|++.||.+||+.|++|+|||
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik------ 125 (260)
T PF00069_consen 53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK------ 125 (260)
T ss_dssp HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS------
T ss_pred cccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc------
Confidence 35689999999999999999999999999999999997 56789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-cCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ 160 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+. +..++.
T Consensus 126 ---------------------------p~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (260)
T PF00069_consen 126 ---------------------------PENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTR 178 (260)
T ss_dssp ---------------------------GGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBST
T ss_pred ---------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 8999999999999999999975433333344556788999999998 788999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC---cchhhhhcCC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIH---PMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++|+||+|+++|+|++|..||.... .......... ............+.++.+++.+||+.||++|||++++++||
T Consensus 179 ~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 179 KSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp HHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 9999999999999999999998762 2222211111 10011111122248999999999999999999999999999
Q ss_pred hh
Q psy3253 237 FI 238 (251)
Q Consensus 237 ~~ 238 (251)
||
T Consensus 259 ~~ 260 (260)
T PF00069_consen 259 WF 260 (260)
T ss_dssp GG
T ss_pred CC
Confidence 98
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.21 Aligned_cols=211 Identities=25% Similarity=0.420 Sum_probs=166.4
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+. ...++||||+. ++|.+++......+++.++..++.|++.||.|||+.|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~--- 135 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLK--- 135 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC---
Confidence 3578999999999999754 46899999996 48999887556789999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..
T Consensus 136 ------------------------------p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (309)
T cd07845 136 ------------------------------VSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185 (309)
T ss_pred ------------------------------HHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCC
Confidence 88999999999999999999765433222223345677999999865 55
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C---------------CCCCC---------CCCCCCHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P---------------PPSFR---------EPDVWTPE 210 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------~~~~~---------~~~~~~~~ 210 (251)
++.++|+||+||++|++++|.+||.+.+.......+... . ..... .....+++
T Consensus 186 ~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T cd07845 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEA 265 (309)
T ss_pred cCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHH
Confidence 788999999999999999999999765544332211110 0 00000 01225788
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+.++|.+||+.||++|||++|+++||||+......
T Consensus 266 ~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 266 GLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 99999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=265.18 Aligned_cols=204 Identities=22% Similarity=0.460 Sum_probs=152.3
Q ss_pred CCCCCCCccceeeeeEe--eCCeEEEEEEccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLR--------KKTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|++++||||+++++++. .+...++||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 130 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 45789999999999885 3567899999996 5888887522 13588999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceec----CCCCCeEecccccccccCcccc---ccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL----NTEGHAKLADFGVAGQLTDTMA---KRNTVIG 143 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~----~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~ 143 (251)
||||| |+||++ +.++.++|+|||+++....... ......+
T Consensus 131 H~Dlk---------------------------------p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 177 (317)
T cd07867 131 HRDLK---------------------------------PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177 (317)
T ss_pred cCCCC---------------------------------HHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCccee
Confidence 99999 666665 3456899999999976543211 1223457
Q ss_pred cccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh------------hhhcCCCCC----------CC
Q psy3253 144 TPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA------------IFMIPTKPP----------PS 200 (251)
Q Consensus 144 ~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~~~----------~~ 200 (251)
|+.|+|||.+.+ ..++.++||||+||++|+|++|.+||........ ......... +.
T Consensus 178 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (317)
T cd07867 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPE 257 (317)
T ss_pred cccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 889999999876 4578999999999999999999999954321100 000000000 00
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 201 ----------------------FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 201 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.......+..+.+++.+||+.||++|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 258 YPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred chhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.03 Aligned_cols=205 Identities=58% Similarity=1.040 Sum_probs=173.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...++||||+.+++|.+++. ...+++..+..++.|++.|+.+||+.|++|+|||
T Consensus 57 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~------ 128 (277)
T cd06641 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIK------ 128 (277)
T ss_pred HhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCC------
Confidence 57899999999999999999999999999999999986 4578999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++++|||++..............++..|+|||.+.+..++.+
T Consensus 129 ---------------------------p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 181 (277)
T cd06641 129 ---------------------------AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181 (277)
T ss_pred ---------------------------HHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCch
Confidence 88999988999999999998655433222333456788999999988888999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+||++|++++|..||...........+.....+. ....++.++.+++.+||+.+|++||+++++++||||.+.
T Consensus 182 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999997665544444433332222 245578999999999999999999999999999999875
Q ss_pred cC
Q psy3253 242 DT 243 (251)
Q Consensus 242 ~~ 243 (251)
..
T Consensus 260 ~~ 261 (277)
T cd06641 260 AK 261 (277)
T ss_pred hh
Confidence 43
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=255.39 Aligned_cols=205 Identities=45% Similarity=0.803 Sum_probs=172.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++..+...+++|||+.+++|.+++.. ...+++..+..++.|++.|+.|||+ .|++||||+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~----- 127 (264)
T cd06623 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK----- 127 (264)
T ss_pred HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCC-----
Confidence 467899999999999999999999999999999999973 4789999999999999999999999 999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+....++.
T Consensus 128 ----------------------------~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (264)
T cd06623 128 ----------------------------PSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179 (264)
T ss_pred ----------------------------HHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCc
Confidence 8889998999999999999976654333333445778899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC---cchhhhhcCCCCCCCCCCCCC-CCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIH---PMRAIFMIPTKPPPSFREPDV-WTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++|+||||+++|++++|..||...+ .......+....... .+.. ++..+.+++.+||..+|++|||++|+++||
T Consensus 180 ~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred hhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC--CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 9999999999999999999997664 222233333322222 2334 789999999999999999999999999999
Q ss_pred hhhhcc
Q psy3253 237 FIQRHD 242 (251)
Q Consensus 237 ~~~~~~ 242 (251)
||+..+
T Consensus 258 ~~~~~~ 263 (264)
T cd06623 258 FIKKAD 263 (264)
T ss_pred HHHhcc
Confidence 998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.53 Aligned_cols=208 Identities=23% Similarity=0.397 Sum_probs=169.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------KTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|+.++||||+++++++......|+||||+.+|+|.++++... ..++...+..++.|++.||.|||++|++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 356899999999999998889999999999999999997432 23466788999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 149 (251)
|||| |+||+++.++.++|+|||+++........ .....++..|+|
T Consensus 143 ~dik---------------------------------p~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~ 189 (288)
T cd05061 143 RDLA---------------------------------ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (288)
T ss_pred CCCC---------------------------------hheEEEcCCCcEEECcCCccccccccccccccCCCcccccccC
Confidence 9988 88888888899999999998754322111 112234567999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||.+.+..++.++|+||+||++|++++ |..||.+.+.......+...... ..+...++.+.+++.+||+.||++|||
T Consensus 190 pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred HHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 999988889999999999999999998 78899776655544443333222 224556899999999999999999999
Q ss_pred HHHHhc------ChhhhhccC
Q psy3253 229 ASEMLN------HEFIQRHDT 243 (251)
Q Consensus 229 ~~evl~------hp~~~~~~~ 243 (251)
+.++++ ||||+..+|
T Consensus 268 ~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 268 FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHHHhhcCCCCCCCCC
Confidence 999987 999998887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=257.10 Aligned_cols=203 Identities=38% Similarity=0.660 Sum_probs=165.3
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+ ....++++||+.+++|.+++. ....+++...+.++.|++.||.|||++|++|||||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~--- 133 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIK--- 133 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC---
Confidence 357899999999998875 357899999999999999987 44568999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---ccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 134 ------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 134 ------------------------------GANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred ------------------------------HHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC
Confidence 8888888889999999999865432111 1112346778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++|+||+||++|++++|+.||...+............ .....+..+++.+.+++ +||..+|++||+++|+++|
T Consensus 184 ~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 889999999999999999999999997765554444332221 12223455788899999 6777899999999999999
Q ss_pred hhhh
Q psy3253 236 EFIQ 239 (251)
Q Consensus 236 p~~~ 239 (251)
|||+
T Consensus 262 p~~~ 265 (266)
T cd06651 262 PFAQ 265 (266)
T ss_pred cccc
Confidence 9997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=270.13 Aligned_cols=206 Identities=26% Similarity=0.481 Sum_probs=160.9
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+| .|.+||+++++-..++.+||||||-+. +|...+++.......-.++.+..|++.|+++.|+.||||.|||
T Consensus 415 KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLK------ 487 (677)
T KOG0596|consen 415 KLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLK------ 487 (677)
T ss_pred HhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCC------
Confidence 44 589999999999999999999999865 9999998766666656899999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccC---
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI--- 156 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--- 156 (251)
|.|+++- .|.+||+|||+|..+....+ ......||+.|||||.+...
T Consensus 488 ---------------------------PANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 488 ---------------------------PANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred ---------------------------cccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 6666554 36699999999987654432 24456799999999999422
Q ss_pred --------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCC-HHHHHHHHHhhhcCcCcc
Q psy3253 157 --------GYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWT-PEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 157 --------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p~~R 226 (251)
+.++++||||+||++|+|+.|++||+..... ..+..+.. +.-..+.+..-+ .++.++++.||.+||++|
T Consensus 540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~-P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR 618 (677)
T KOG0596|consen 540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD-PNHEIEFPDIPENDELIDVMKCCLARDPKKR 618 (677)
T ss_pred ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC-CCccccccCCCCchHHHHHHHHHHhcCcccC
Confidence 2667899999999999999999999765432 22222222 211112222222 339999999999999999
Q ss_pred CCHHHHhcChhhhhccCC
Q psy3253 227 ATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~~ 244 (251)
||+.|+|+|||.+...-.
T Consensus 619 ~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 619 WSIPELLQHPFLQIQPIP 636 (677)
T ss_pred CCcHHHhcCccccccccc
Confidence 999999999999875443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.43 Aligned_cols=200 Identities=22% Similarity=0.387 Sum_probs=166.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
|++++||||+++++++.+....+++|||+++++|.+++.... ..+++..++.++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356899999999999998889999999999999999996431 45788999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~ 143 (251)
+.|++||||| |+||+++.++.++|+|||++....... .......+
T Consensus 142 ~~~i~H~dlk---------------------------------p~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05048 142 SHHFVHRDLA---------------------------------ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188 (283)
T ss_pred hCCeeccccc---------------------------------cceEEEcCCCcEEECCCcceeeccccccccccCCCcc
Confidence 9999999988 888899888999999999987543221 11223345
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
++.|+|||.+.+..++.++|+|||||++|++++ |..||.+.........+...... ..+..+++++.+++.+||+.|
T Consensus 189 ~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~l~~~c~~~~ 266 (283)
T cd05048 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL--PCPEDCPARVYALMIECWNEI 266 (283)
T ss_pred cccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCcccCCHHHHHHHHHHccCC
Confidence 678999999988889999999999999999998 99999877666655554443322 235678999999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|.+||+++|++++
T Consensus 267 p~~Rp~~~~i~~~ 279 (283)
T cd05048 267 PARRPRFKDIHTR 279 (283)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=253.75 Aligned_cols=199 Identities=28% Similarity=0.472 Sum_probs=166.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......+++|||+.+|+|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~----- 127 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA----- 127 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC-----
Confidence 457899999999999999999999999999999999997555678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-cccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||.+.......... ....++..|+|||.+.+..++
T Consensus 128 ----------------------------p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd05114 128 ----------------------------ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179 (256)
T ss_pred ----------------------------cceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc
Confidence 888888888999999999987543322111 122244579999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+|+++|++++ |+.||...+.......+...... ..+...+.++.+++.+||..+|++|||++|+++
T Consensus 180 ~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999 89999777665555554443322 234557889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=275.54 Aligned_cols=199 Identities=32% Similarity=0.522 Sum_probs=171.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++||+......+++|||+|.||+|.++++.....++..+...++.+.+.||+|||++++|||||-
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIA----- 289 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIA----- 289 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHh-----
Confidence 568999999999999999999999999999999999999776679999999999999999999999999999966
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
.+|++++.++.+||+|||+++.............-+..|+|||.+....++.
T Consensus 290 ----------------------------ARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 290 ----------------------------ARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred ----------------------------HHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCcccc
Confidence 7788888888899999999976542222222333467899999999999999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhc-CCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMI-PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++|||||||++||+++ |..||.+.........+ ..+.+ ...+...+.++..++.+||..+|++|||+.++.+
T Consensus 342 kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r--~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 342 KTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR--MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc--CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 9999999999999998 88899988887777666 33332 2345677899999999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.87 Aligned_cols=220 Identities=19% Similarity=0.312 Sum_probs=160.0
Q ss_pred CCCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCc
Q psy3253 4 CDSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTL 81 (251)
Q Consensus 4 l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~ 81 (251)
.+|+++++++++|..+ .+.|+|||++ +++|.+++. ..+.+++..+..++.||+.||.|||+ .||+||||||+|||+
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl 265 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM 265 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 3567799999988764 5799999999 778998886 45689999999999999999999998 599999999888888
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
.......... ....+-...+.+||+|||.+..... ......+|+.|+|||++.+..++.+
T Consensus 266 ~~~~~~~~~~-----------------~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~ 325 (467)
T PTZ00284 266 ETSDTVVDPV-----------------TNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYS 325 (467)
T ss_pred ecCCcccccc-----------------cccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcH
Confidence 6322100000 0001112234699999998854322 2234568999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCC-----------------------CCCC-------------
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPP-----------------------PSFR------------- 202 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~-----------------------~~~~------------- 202 (251)
+|||||||++|+|++|++||.+.+.......+ ....+ +...
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 99999999999999999999765543322111 00000 0000
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
.....++.+.+||.+||++||++|||++|+|+||||++...+.
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence 0001145678999999999999999999999999999865443
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.26 Aligned_cols=211 Identities=33% Similarity=0.556 Sum_probs=178.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL--SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++|.|.|||++.|.+-+++++-+.||-+.||||+.+++..=+++ .+.++-.+.+||++||+|||++.|+|||||
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIK---- 702 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIK---- 702 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeecccc----
Confidence 36899999999999999999999999999999999998666777 788999999999999999999999999999
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCccccccccccccccccccccccc--C
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--I 156 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~ 156 (251)
-+|++++ ..|.+||+|||-++..........++.||..|||||++.. .
T Consensus 703 -----------------------------GDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~R 753 (1226)
T KOG4279|consen 703 -----------------------------GDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPR 753 (1226)
T ss_pred -----------------------------CCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCc
Confidence 7888884 6788999999999887766566677889999999999965 4
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
.|..++|||||||++.||.||++||..........-...-.....+.|..++.++++||.+|+.+||.+||+++++|.+|
T Consensus 754 GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 754 GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 58899999999999999999999996654443332111111223345677889999999999999999999999999999
Q ss_pred hhhhccCCC
Q psy3253 237 FIQRHDTDP 245 (251)
Q Consensus 237 ~~~~~~~~~ 245 (251)
|++..+..+
T Consensus 834 Flq~~~kk~ 842 (1226)
T KOG4279|consen 834 FLQHNNKKP 842 (1226)
T ss_pred ccccCCCCC
Confidence 998774433
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=259.64 Aligned_cols=207 Identities=35% Similarity=0.646 Sum_probs=168.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--KKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~ 77 (251)
|++++||||+++++++......++||||+.+++|..++... ...+++..+..++.|++.||.|||+ .|++|+|||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~-- 130 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK-- 130 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCC--
Confidence 35689999999999999999999999999999999998743 2478999999999999999999997 599999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI- 156 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 156 (251)
|+||+++.++.++|+|||.+...... ......++..|+|||.+.+.
T Consensus 131 -------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 177 (286)
T cd06622 131 -------------------------------PTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGG 177 (286)
T ss_pred -------------------------------HHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCC
Confidence 88889888899999999998654322 12223467789999998543
Q ss_pred -----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh---hcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 157 -----GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF---MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 157 -----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
.++.++|+||+||++|++++|..||.......... .+...... ..+..+++++.++|.+||..+|++||+
T Consensus 178 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (286)
T cd06622 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPT 255 (286)
T ss_pred CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC--CCCcccCHHHHHHHHHHcccCcccCCC
Confidence 35789999999999999999999996544333222 12222222 234558999999999999999999999
Q ss_pred HHHHhcChhhhhccCC
Q psy3253 229 ASEMLNHEFIQRHDTD 244 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~ 244 (251)
++++++||||......
T Consensus 256 ~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 256 YAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHhcChhhhhccCC
Confidence 9999999999876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=254.49 Aligned_cols=199 Identities=30% Similarity=0.548 Sum_probs=167.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++..+...|++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+|||
T Consensus 53 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~----- 127 (255)
T cd08219 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK----- 127 (255)
T ss_pred HhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC-----
Confidence 5689999999999999999999999999999999988643 3568999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++++|||.+..............++..|+|||++.+..++.
T Consensus 128 ----------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (255)
T cd08219 128 ----------------------------SKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179 (255)
T ss_pred ----------------------------cceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCc
Confidence 8888888889999999999876543333333455788899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++|+||+|+++|+|++|..||...+.......+....... .+..++..+.+++.+||+.||++|||++|+++-
T Consensus 180 ~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC--CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999998766554444443332222 245678999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=258.98 Aligned_cols=204 Identities=26% Similarity=0.436 Sum_probs=160.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+.+ +|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~----- 130 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLK----- 130 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC-----
Confidence 4578999999999999999999999999974 9999987656688999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++
T Consensus 131 ----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 182 (291)
T cd07844 131 ----------------------------PQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182 (291)
T ss_pred ----------------------------HHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccC
Confidence 88999998999999999998654322222222345778999999865 5578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCc-chhhh---hcCCCCC---------------CCC---------CCCCCCC--H
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHP-MRAIF---MIPTKPP---------------PSF---------REPDVWT--P 209 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~---~~~~~~~---------------~~~---------~~~~~~~--~ 209 (251)
.++|+||+|+++|+|++|..||.+... ..... ....... ... .....++ .
T Consensus 183 ~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (291)
T cd07844 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIP 262 (291)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCch
Confidence 899999999999999999999965441 11110 0000000 000 0011233 7
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+.+++.+||..+|++|||++|+++||||
T Consensus 263 ~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 263 HGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=254.14 Aligned_cols=203 Identities=31% Similarity=0.567 Sum_probs=170.6
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLH-----LRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH-----~~~ii 70 (251)
|++++||||+++++.+.. +...+++|||+.+++|.+++... ...+++..++.++.|++.||.||| +.+++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence 357899999999997753 45689999999999999999643 467899999999999999999999 89999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|+||| |+||+++.++.++++|||++..............++..|+||
T Consensus 133 h~dl~---------------------------------p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~p 179 (265)
T cd08217 133 HRDLK---------------------------------PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179 (265)
T ss_pred ecCCC---------------------------------HHHEEEecCCCEEEecccccccccCCcccccccccCCCccCh
Confidence 99988 888999889999999999997665443323345678899999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
|.+.+..++.++|+||||+++|++++|..||...+.......+...... ..+..++..+.+++.+||+.+|++|||++
T Consensus 180 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 257 (265)
T cd08217 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKRPSTE 257 (265)
T ss_pred hhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHH
Confidence 9998888999999999999999999999999776654444444443322 23556789999999999999999999999
Q ss_pred HHhcChhh
Q psy3253 231 EMLNHEFI 238 (251)
Q Consensus 231 evl~hp~~ 238 (251)
|+++|||+
T Consensus 258 ~il~~~~~ 265 (265)
T cd08217 258 ELLQLPLI 265 (265)
T ss_pred HHhhCCCC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=258.62 Aligned_cols=204 Identities=28% Similarity=0.535 Sum_probs=164.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...++|+||+ +++|.+++......+++..++.++.||+.||.|||+.|++|+|||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 126 (286)
T cd07832 54 QACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK------ 126 (286)
T ss_pred HhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC------
Confidence 5788999999999999999999999999 999999997666789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc-CCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++++|||.+........ ......++..|+|||.+.+ ..++
T Consensus 127 ---------------------------p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 179 (286)
T cd07832 127 ---------------------------PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179 (286)
T ss_pred ---------------------------HHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCC
Confidence 8899998899999999999876543321 1233457888999999865 3468
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C---------------------CC--C-CCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P---------------------PP--S-FREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------------~~--~-~~~~~~~~~~~~ 212 (251)
.++||||+||++|++++|.++|.+.........+... . .. . .......+.++.
T Consensus 180 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07832 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL 259 (286)
T ss_pred chhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHH
Confidence 8999999999999999998888655433222111000 0 00 0 001134578899
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
+++++||+.+|++|||++++++||||.
T Consensus 260 ~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 260 DLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=256.14 Aligned_cols=204 Identities=30% Similarity=0.573 Sum_probs=166.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++.+.++.++||||+.+++|.+++. ....+++..+..++.|++.||.|||++|++|+|||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~----- 130 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK----- 130 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 356899999999999999999999999999999999997 44678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCccccc----cccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAK----RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++ .++|+|||.+......... .....++..|+|||.+.+
T Consensus 131 ----------------------------~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 182 (268)
T cd06630 131 ----------------------------GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182 (268)
T ss_pred ----------------------------HHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc
Confidence 7788887665 5899999998765432111 122356778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh---hcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF---MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
..++.++|+||+|+++|++++|..||.......... ...... .....+..+++++.+++.+||+.+|++|||+.|+
T Consensus 183 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 888999999999999999999999996443222111 111111 1122345678999999999999999999999999
Q ss_pred hcChhhh
Q psy3253 233 LNHEFIQ 239 (251)
Q Consensus 233 l~hp~~~ 239 (251)
++||||+
T Consensus 262 l~~~~~~ 268 (268)
T cd06630 262 LKHPVFR 268 (268)
T ss_pred hcCcccC
Confidence 9999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.48 Aligned_cols=209 Identities=30% Similarity=0.565 Sum_probs=163.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....+++|||+.+|+|.+++... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk---- 128 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK---- 128 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC----
Confidence 35789999999999999999999999999999999999743 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-------cccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEV 152 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.++++|||.+........ ......++..|+|||.
T Consensus 129 -----------------------------~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 129 -----------------------------ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred -----------------------------cceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 8888988889999999998864432111 1112235667999999
Q ss_pred ccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh-hcCCCCC------------------------------C
Q psy3253 153 IQE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF-MIPTKPP------------------------------P 199 (251)
Q Consensus 153 ~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~------------------------------~ 199 (251)
+.. ..++.++|+||+||++|++++|..||.......... .+....+ .
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhh
Confidence 865 457889999999999999999999997543322111 1100000 0
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 200 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
.......++.++.+++.+||.+||++|||++|+++||||+...
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000122346789999999999999999999999999999775
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=256.92 Aligned_cols=201 Identities=32% Similarity=0.603 Sum_probs=170.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++|+||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~----- 127 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK----- 127 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-----
Confidence 3578999999999999999999999999999999999874 3689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.
T Consensus 128 ----------------------------~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~ 178 (258)
T cd05578 128 ----------------------------PDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSV 178 (258)
T ss_pred ----------------------------HHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCC
Confidence 889999999999999999987654332 223345778899999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCc--chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH--HHHhcCh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA--SEMLNHE 236 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~evl~hp 236 (251)
++|+||+|+++|++++|..||..... .......... .....+..++..+.++|.+||+.||.+||++ +|+++||
T Consensus 179 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred cccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 99999999999999999999976653 1211111111 2233456678999999999999999999999 9999999
Q ss_pred hh
Q psy3253 237 FI 238 (251)
Q Consensus 237 ~~ 238 (251)
||
T Consensus 257 ~~ 258 (258)
T cd05578 257 YF 258 (258)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=258.99 Aligned_cols=198 Identities=29% Similarity=0.556 Sum_probs=161.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||++++|++.+....++|+||+.+|+|.+++... ...+++..+..++.||+.||.|||+++++|++|+
T Consensus 56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~----- 130 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLS----- 130 (259)
T ss_dssp HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-S-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 4679999999999999888899999999999999999865 5789999999999999999999999999999987
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--cccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
++||+++.++.+||+|||++...... ............|+|||.+.+..+
T Consensus 131 ----------------------------~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 182 (259)
T PF07714_consen 131 ----------------------------PSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY 182 (259)
T ss_dssp ----------------------------GGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE
T ss_pred ----------------------------cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999999999999999765221 112233345667999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++||||||+++|++++ |..||.+.+.......+..... ...+..++..+.+++.+||..+|++|||++|+++
T Consensus 183 ~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 183 TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999 7899988776665555533332 2346678999999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=252.41 Aligned_cols=202 Identities=40% Similarity=0.721 Sum_probs=168.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++++||+++++|.+++. +...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~----- 129 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIK----- 129 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 356899999999999999999999999999999999997 44578999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~ 159 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.... ++
T Consensus 130 ----------------------------~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~ 180 (258)
T cd06632 130 ----------------------------GANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYG 180 (258)
T ss_pred ----------------------------HHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCC
Confidence 888999889999999999987654332 223345788899999987666 88
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|+||+|+++|++++|..||...........+..... ....+..+++.+.+++.+||+.+|++||++++++.|||+
T Consensus 181 ~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999976654443333322111 112345678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=272.52 Aligned_cols=202 Identities=30% Similarity=0.570 Sum_probs=169.3
Q ss_pred CCCCCCCccceeeeeEeeCCe--EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~--~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~dik~ 76 (251)
|+.|+|||||++|++|.+... +.+|+|.+.+|+|..|.+ +.+..+.+.++.|++||+.||.|||++. |||||||
T Consensus 95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLK- 172 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLK- 172 (632)
T ss_pred HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccc-
Confidence 678999999999999986544 889999999999999997 6688999999999999999999999986 9999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
.+||+++. .|.+||+|+|+|........+. ..|||.|||||...
T Consensus 173 --------------------------------CDNIFinG~~G~VKIGDLGLAtl~r~s~aks--vIGTPEFMAPEmYE- 217 (632)
T KOG0584|consen 173 --------------------------------CDNIFVNGNLGEVKIGDLGLATLLRKSHAKS--VIGTPEFMAPEMYE- 217 (632)
T ss_pred --------------------------------cceEEEcCCcCceeecchhHHHHhhccccce--eccCccccChHHHh-
Confidence 67777754 4789999999997665443332 67999999999996
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..|...+||||||+++.||+|+..||........+ ..+..+..+. .....-.+++++||.+||.. .+.|+|+.|+|.
T Consensus 218 E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 218 ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 68999999999999999999999999766554444 4444443322 11233479999999999999 999999999999
Q ss_pred Chhhhhc
Q psy3253 235 HEFIQRH 241 (251)
Q Consensus 235 hp~~~~~ 241 (251)
||||+..
T Consensus 296 d~Ff~~d 302 (632)
T KOG0584|consen 296 DPFFDED 302 (632)
T ss_pred Chhhccc
Confidence 9999875
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=258.98 Aligned_cols=204 Identities=27% Similarity=0.442 Sum_probs=161.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.++...++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~---- 127 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK---- 127 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC----
Confidence 357899999999999999999999999995 5899888643 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-C
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-Y 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~ 158 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+.. +
T Consensus 128 -----------------------------p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 178 (284)
T cd07860 128 -----------------------------PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178 (284)
T ss_pred -----------------------------HHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCC
Confidence 8899999999999999999875543322223334577899999886544 5
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CC----------------------C-CCCCCCCCCCHHHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KP----------------------P-PSFREPDVWTPEFI 212 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~----------------------~-~~~~~~~~~~~~~~ 212 (251)
+.++|+||||+++|++++|..||...+.......+.. .. . ........+++++.
T Consensus 179 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07860 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGR 258 (284)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHH
Confidence 8889999999999999999999965443222111100 00 0 00001234678899
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++|.+||+.||++|||++|+++||||
T Consensus 259 ~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 259 DLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=252.28 Aligned_cols=204 Identities=38% Similarity=0.693 Sum_probs=167.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++.+....++|+||+.+++|.+++. ....+++..+..++.+++.||.|||+.|++|+||+
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~----- 126 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK----- 126 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh-hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 357899999999999999999999999999999999987 44568999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccc----ccccccccccccccccC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN----TVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++.++|+|||.+........... ...++..|+|||.+.+.
T Consensus 127 ----------------------------~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 127 ----------------------------PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred ----------------------------HHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCC
Confidence 8889998899999999999876543322211 23467789999999776
Q ss_pred C---CCcchhHHHHHHHHHHHHhCCCCCCCCCc-chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 157 G---YDCVADMWSLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 157 ~---~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
. .+.++||||+|+++|++++|..||...+. ......+.....+..+....++..+.+++.+||+.+|++|||++|+
T Consensus 179 ~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred CCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 5 78899999999999999999999965532 2222223333333333334458999999999999999999999999
Q ss_pred hcChhh
Q psy3253 233 LNHEFI 238 (251)
Q Consensus 233 l~hp~~ 238 (251)
+.|||+
T Consensus 259 ~~~~~~ 264 (264)
T cd06626 259 LQHPFV 264 (264)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=250.22 Aligned_cols=203 Identities=56% Similarity=1.072 Sum_probs=171.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++++||+.+++|.+++......+++..+..++.|++.||.+||+.|++||||+
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~----- 125 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK----- 125 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCC-----
Confidence 357889999999999999999999999999999999997554689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.
T Consensus 126 ----------------------------p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~ 176 (253)
T cd05122 126 ----------------------------AANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176 (253)
T ss_pred ----------------------------HHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCc
Confidence 8888998899999999999876554321 23445778899999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++|+||+|+++|++++|..||...+.....................++..+.+++.+||+.||++|||++|+++|||
T Consensus 177 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999977644444433333333333334445899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=252.24 Aligned_cols=200 Identities=24% Similarity=0.431 Sum_probs=165.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......+++|||+.+|+|.+++......+++..+..++.|++.||.|||+.|++|+|||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~----- 127 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA----- 127 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC-----
Confidence 467899999999999998888999999999999999997555678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++
T Consensus 128 ----------------------------p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 179 (256)
T cd05113 128 ----------------------------ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179 (256)
T ss_pred ----------------------------cceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCccc
Confidence 88888888899999999998654332111 1122345679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+||||+++|++++ |..||...........+...... ..+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus 180 ~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999998 99999766554444434333222 2245568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=251.06 Aligned_cols=199 Identities=25% Similarity=0.428 Sum_probs=162.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......++||||+.+++|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~----- 121 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA----- 121 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc-----
Confidence 457899999999999999999999999999999999997555678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+......... ......+..|+|||.+.+..+
T Consensus 122 ----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 122 ----------------------------ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred ----------------------------hheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC
Confidence 88888888889999999998653321111 011122346999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||+||++|++++ |..||...........+...... ..+..++..+.+++.+||+.+|++|||++|+++
T Consensus 174 ~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999997 88999765554433333332222 235567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=256.76 Aligned_cols=207 Identities=39% Similarity=0.743 Sum_probs=165.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~ 77 (251)
+.++||||+++++++..+...|++|||++ |+|.+++... ...+++..+..++.|++.||.|||++ +++|||||
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk-- 131 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK-- 131 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC--
Confidence 45689999999999999999999999996 6898887632 35689999999999999999999997 99999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc--
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-- 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 155 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 132 -------------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 179 (283)
T cd06617 132 -------------------------------PSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPEL 179 (283)
T ss_pred -------------------------------HHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcc
Confidence 888899889999999999987654321 1222456778999998854
Q ss_pred --CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 --IGYDCVADMWSLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 --~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
..++.++|+||+||++|++++|+.||..... ............... ....++.++.+++.+||..+|++||+++++
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 258 (283)
T cd06617 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258 (283)
T ss_pred cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4568899999999999999999999965332 122222222222222 123478999999999999999999999999
Q ss_pred hcChhhhhccCC
Q psy3253 233 LNHEFIQRHDTD 244 (251)
Q Consensus 233 l~hp~~~~~~~~ 244 (251)
++||||+.....
T Consensus 259 l~~~~~~~~~~~ 270 (283)
T cd06617 259 LQHPFFELHLSK 270 (283)
T ss_pred hcCchhhhcccc
Confidence 999999986644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=256.20 Aligned_cols=198 Identities=24% Similarity=0.427 Sum_probs=164.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------------KTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
|++++||||+++++++......+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999999999999999999999999996332 24899999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPF 146 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~ 146 (251)
++||||| |+||+++.++.++|+|||++........ ......++..
T Consensus 141 i~H~dlk---------------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 187 (288)
T cd05093 141 FVHRDLA---------------------------------TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187 (288)
T ss_pred eeecccC---------------------------------cceEEEccCCcEEeccCCccccccCCceeecCCCCCcccc
Confidence 9999988 8888888899999999999975432211 1222334667
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
|+|||.+.+..++.++|+|||||++|+|++ |.+||...........+...... ..+..+++++.+++.+||+.||.+
T Consensus 188 y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~ 265 (288)
T cd05093 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHM 265 (288)
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999998 99999776655544444433222 234567899999999999999999
Q ss_pred cCCHHHHh
Q psy3253 226 RATASEML 233 (251)
Q Consensus 226 Rps~~evl 233 (251)
|||++|++
T Consensus 266 Rpt~~~v~ 273 (288)
T cd05093 266 RLNIKEIH 273 (288)
T ss_pred CCCHHHHH
Confidence 99999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=250.30 Aligned_cols=208 Identities=35% Similarity=0.641 Sum_probs=175.5
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~ 81 (251)
..++|+||++||+|..+....+.||.|. .-+..+++.-.++++|..+-.+...++.||.||-+ +||+|||+|
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvK------ 219 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK------ 219 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccC------
Confidence 4568999999999999999999999994 46777777667889999999999999999999997 589999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 158 (251)
|+||+++..|.+|+||||++....+.... ....|.+.|||||.+. +..|
T Consensus 220 ---------------------------PSNILlDe~GniKlCDFGIsGrlvdSkAh-trsAGC~~YMaPERidp~~~~kY 271 (391)
T KOG0983|consen 220 ---------------------------PSNILLDERGNIKLCDFGISGRLVDSKAH-TRSAGCAAYMAPERIDPPDKPKY 271 (391)
T ss_pred ---------------------------ccceEEccCCCEEeecccccceeeccccc-ccccCCccccCccccCCCCCCcc
Confidence 89999999999999999999776554333 2334677899999994 4568
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+..+||||||+.+++|.||+.||.+.+.. +....+....++.+..-..+++.+.+|+..||+.|+.+||...++|+|||
T Consensus 272 DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 272 DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 88999999999999999999999775443 34445555666666666669999999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
+..++...
T Consensus 352 i~~ye~a~ 359 (391)
T KOG0983|consen 352 IKRYETAE 359 (391)
T ss_pred eeecchhh
Confidence 98876543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=253.28 Aligned_cols=204 Identities=34% Similarity=0.621 Sum_probs=166.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++......++||||+.+++|.++++. ...+++..++.++.|++.||.|||++|++|||||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~----- 135 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK----- 135 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCC-----
Confidence 4578999999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCC-
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIG- 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~- 157 (251)
|+||+++.++.++++|||.+....... .......++..|+|||.+....
T Consensus 136 ----------------------------~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 187 (272)
T cd06629 136 ----------------------------ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187 (272)
T ss_pred ----------------------------hhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccC
Confidence 888888889999999999987543211 1122234677899999987654
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-C--CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-P--PSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
++.++|+||+|+++|++++|..||...........+.... . ........++..+.+++.+||..+|++|||++|++
T Consensus 188 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 188 GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 7889999999999999999999997655443332222111 1 11112235689999999999999999999999999
Q ss_pred cChhh
Q psy3253 234 NHEFI 238 (251)
Q Consensus 234 ~hp~~ 238 (251)
+||||
T Consensus 268 ~~~~~ 272 (272)
T cd06629 268 QHPFI 272 (272)
T ss_pred hCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=250.84 Aligned_cols=202 Identities=34% Similarity=0.630 Sum_probs=173.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++|||++++.+.+..+...++++||+++++|.+++... ...+++..+..++.+++.||.+||+.|++|+||+
T Consensus 54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~--- 130 (258)
T cd08215 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK--- 130 (258)
T ss_pred HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC---
Confidence 5678999999999999999999999999999999999754 3789999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+..............+++.|+|||...+..+
T Consensus 131 ------------------------------~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 131 ------------------------------PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred ------------------------------hHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCC
Confidence 88888888899999999999766544323344567888999999988889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|+||+|++++++++|..||...+............... .+..++.++.+++.+||..+|++|||++|+++||||
T Consensus 181 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997766555554444333222 244678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=252.42 Aligned_cols=203 Identities=31% Similarity=0.578 Sum_probs=168.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
+++++||||+++++.+......++++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+|||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~---- 128 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIK---- 128 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC----
Confidence 356899999999999999999999999999999999986433 358999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCC-eEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++. ++++|||.+..............++..|+|||.+.+..+
T Consensus 129 -----------------------------~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~ 179 (257)
T cd08225 129 -----------------------------SQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179 (257)
T ss_pred -----------------------------HHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCC
Confidence 78888877754 699999998765543322333457888999999988889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|+||+|+++|++++|..||...+.......+...... ......+.++.+++.+||..+|++|||++|+++||||
T Consensus 180 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA--PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999766554444433332211 2234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=251.42 Aligned_cols=200 Identities=26% Similarity=0.460 Sum_probs=165.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......|+||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~----- 127 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA----- 127 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc-----
Confidence 357899999999999999999999999999999999997656678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-cccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..++
T Consensus 128 ----------------------------p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 128 ----------------------------ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred ----------------------------HhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCC
Confidence 888999889999999999986543221111 111223469999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+||+|+++|++++ |..||...+.......+..... ...+..++.++.+++.+||..+|++|||++|+++.
T Consensus 180 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999998 8999976655554444433322 22345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.76 Aligned_cols=202 Identities=48% Similarity=0.871 Sum_probs=168.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++..+...|+||||+. |+|.+++......+++..+..++.|++.||.|||+.|++||||+
T Consensus 70 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~------ 142 (307)
T cd06607 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIK------ 142 (307)
T ss_pred HhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC------
Confidence 56899999999999999999999999996 58888876556779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 158 (251)
|+||+++.++.++|+|||++...... ....++..|+|||.+. ...+
T Consensus 143 ---------------------------p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ 191 (307)
T cd06607 143 ---------------------------AGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQY 191 (307)
T ss_pred ---------------------------cccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCC
Confidence 88999999999999999998654322 2345677899999884 3568
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++||||||+++|++++|.+||.+.+.......+.....+.. ....++..+.+++.+||..+|++||++.+++.||||
T Consensus 192 ~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred CcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 8899999999999999999999977665554444433322222 234578899999999999999999999999999999
Q ss_pred hhcc
Q psy3253 239 QRHD 242 (251)
Q Consensus 239 ~~~~ 242 (251)
.+..
T Consensus 271 ~~~~ 274 (307)
T cd06607 271 LRER 274 (307)
T ss_pred cccC
Confidence 8754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.12 Aligned_cols=200 Identities=20% Similarity=0.374 Sum_probs=159.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------------------KTLSEDEIATILCDTLKGLE 62 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------------------~~l~~~~~~~~~~~i~~~l~ 62 (251)
|++++||||+++++++.+....++||||+.+|+|.+++.... ..+++..+..++.||+.||.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 457899999999999999899999999999999999986321 23677889999999999999
Q ss_pred HHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccc
Q psy3253 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNT 140 (251)
Q Consensus 63 ~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~ 140 (251)
|||+.|++||||| |+||+++.++.+||+|||++........ ....
T Consensus 153 ~lH~~~ivH~dlk---------------------------------p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~ 199 (304)
T cd05096 153 YLSSLNFVHRDLA---------------------------------TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGR 199 (304)
T ss_pred HHHHCCccccCcc---------------------------------hhheEEcCCccEEECCCccceecccCceeEecCc
Confidence 9999999999988 8888998899999999999975432211 1222
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcchhhhhcC----C-CCCCCCCCCCCCCHHHHH
Q psy3253 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE--GKPPYGDIHPMRAIFMIP----T-KPPPSFREPDVWTPEFID 213 (251)
Q Consensus 141 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~ 213 (251)
..++..|+|||.+....++.++|||||||++|+|++ +..||............. . ........+..++..+.+
T Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (304)
T cd05096 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE 279 (304)
T ss_pred CCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHH
Confidence 344678999999988889999999999999999986 567886654433322110 0 111112234567899999
Q ss_pred HHHHhhhcCcCccCCHHHHh
Q psy3253 214 FVSRCLVKNPEERATASEML 233 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl 233 (251)
++.+||+.||++|||++|+.
T Consensus 280 li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHccCCchhCcCHHHHH
Confidence 99999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.95 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=155.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++||||+++|+|..++......+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nil 149 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNIL 149 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEE
Confidence 45789999999999999999999999999999999999755678999999999999999999999999999999955555
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
+.. ....-.....++++|||.+...... ....++..|+|||.+.+ ..++
T Consensus 150 l~~--------------------------~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~ 199 (274)
T cd05076 150 LAR--------------------------LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLS 199 (274)
T ss_pred Eec--------------------------cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCC
Confidence 441 1111112234899999987543221 12345777999998865 5688
Q ss_pred cchhHHHHHHHHHHHH-hCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMA-EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+|||||++|+++ +|..||............... ...+...++.+.++|.+||+.+|++|||+++++++
T Consensus 200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK----HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc----cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 9999999999999985 699999765443332221111 11233456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=258.76 Aligned_cols=203 Identities=25% Similarity=0.438 Sum_probs=162.6
Q ss_pred CCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++++... ...|+||||+. ++|.+++......+++..++.++.|++.||.|||++|++|+|||
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~---- 133 (293)
T cd07843 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLK---- 133 (293)
T ss_pred HhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC----
Confidence 468899999999999877 88999999996 59999987555679999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~ 158 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+. .+
T Consensus 134 -----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 184 (293)
T cd07843 134 -----------------------------TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184 (293)
T ss_pred -----------------------------HHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccc
Confidence 889999999999999999997665432333334567889999998654 46
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC------------------C----------CCCCCCCCC-CCH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK------------------P----------PPSFREPDV-WTP 209 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~-~~~ 209 (251)
+.++|+||+|+++|+|++|.+||...........+... . ......+.. +++
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (293)
T cd07843 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSD 264 (293)
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCCh
Confidence 88999999999999999999999755433222111000 0 000001122 588
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+.++|.+||+.+|++|||++|++.||||
T Consensus 265 ~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 265 NGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=251.26 Aligned_cols=198 Identities=26% Similarity=0.459 Sum_probs=163.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++. ....++||||+.+++|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk----- 122 (257)
T cd05115 49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA----- 122 (257)
T ss_pred HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccc-----
Confidence 46789999999999885 457899999999999999997656789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+..
T Consensus 123 ----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 123 ----------------------------ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred ----------------------------hheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence 88888888899999999998754322111 11112246799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+|||||++|++++ |..||.+.........+...... ..+..+++++.+++.+||..+|++||+++++.+
T Consensus 175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999996 99999877665555444443322 235667999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=255.12 Aligned_cols=199 Identities=24% Similarity=0.421 Sum_probs=165.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
|++++||||+++++++.+....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997432 34789999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 143 (251)
++|++||||| |+||+++.++.++|+|||++........ ......+
T Consensus 141 ~~~i~H~dlk---------------------------------p~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~ 187 (291)
T cd05094 141 SQHFVHRDLA---------------------------------TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187 (291)
T ss_pred hCCeeecccC---------------------------------cceEEEccCCcEEECCCCcccccCCCceeecCCCCCc
Confidence 9999999988 8899999999999999999975433211 1223345
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+...... ..+..++..+.+++.+||+.+
T Consensus 188 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~ 265 (291)
T cd05094 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQRE 265 (291)
T ss_pred ceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccC
Confidence 678999999988889999999999999999998 99999776655544443333222 224557899999999999999
Q ss_pred cCccCCHHHHhc
Q psy3253 223 PEERATASEMLN 234 (251)
Q Consensus 223 p~~Rps~~evl~ 234 (251)
|++|||++++++
T Consensus 266 P~~Rpt~~~v~~ 277 (291)
T cd05094 266 PQQRLNIKEIYK 277 (291)
T ss_pred hhhCcCHHHHHH
Confidence 999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.83 Aligned_cols=200 Identities=21% Similarity=0.395 Sum_probs=162.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------KTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|+.++||||+++++++..+...++||||+.+++|.+++.... ..++...+..++.|++.||.|||+.|++|
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH 142 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH 142 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 356899999999999998899999999999999999996432 23577888999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 149 (251)
|||| |+||+++.++.++++|||++......... .....++..|+|
T Consensus 143 ~dlk---------------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05062 143 RDLA---------------------------------ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189 (277)
T ss_pred CCcc---------------------------------hheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcC
Confidence 9988 88889988999999999998654322111 112234667999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||.+.+..++.++|+|||||++|++++ |..||.+.........+...... ..+..++..+.+++.+||+.||++|||
T Consensus 190 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (277)
T cd05062 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPS 267 (277)
T ss_pred hhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999988889999999999999999998 78899776655444433333221 234567899999999999999999999
Q ss_pred HHHHhcC
Q psy3253 229 ASEMLNH 235 (251)
Q Consensus 229 ~~evl~h 235 (251)
+.|++++
T Consensus 268 ~~e~l~~ 274 (277)
T cd05062 268 FLEIISS 274 (277)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=249.75 Aligned_cols=199 Identities=27% Similarity=0.497 Sum_probs=169.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--------KKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
+.++||||+++++++.++...+++|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+|
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130 (262)
T ss_pred hhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence 5678999999999999999999999999999999999854 47899999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPE 151 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 151 (251)
|| |+||+++.++.++|+|||.+....... .......++..|+|||
T Consensus 131 i~---------------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (262)
T cd00192 131 LA---------------------------------ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177 (262)
T ss_pred cC---------------------------------cceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHH
Confidence 88 889999999999999999997654322 1223344677899999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.+....++.++|+||+|+++|++++ |..||...........+.... ....+..+++++.+++.+||..+|++|||++
T Consensus 178 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 255 (262)
T cd00192 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFS 255 (262)
T ss_pred HhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCcCHH
Confidence 9988889999999999999999999 699998776555554444432 2334566799999999999999999999999
Q ss_pred HHhcC
Q psy3253 231 EMLNH 235 (251)
Q Consensus 231 evl~h 235 (251)
|++++
T Consensus 256 ~l~~~ 260 (262)
T cd00192 256 ELVER 260 (262)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=251.28 Aligned_cols=200 Identities=27% Similarity=0.454 Sum_probs=167.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....+++|||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~----- 133 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA----- 133 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-----
Confidence 357899999999999999999999999999999999997666689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 134 ----------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 134 ----------------------------ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred ----------------------------cceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC
Confidence 8899999999999999999976642111 1111223567999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|+||||+++|++++ |..||...........+..... ...+..++..+.+++.+||+.+|++||+++|++++
T Consensus 186 ~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR--LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999998 9999977665555444433322 12345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=254.43 Aligned_cols=204 Identities=24% Similarity=0.415 Sum_probs=159.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+. ++|.+++......+.+..+..++.|++.||.|||+.|++|+|||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk----- 130 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK----- 130 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-----
Confidence 357899999999999999999999999995 68877776555678889999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++
T Consensus 131 ----------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (291)
T cd07870 131 ----------------------------PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182 (291)
T ss_pred ----------------------------hHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCC
Confidence 88888888899999999998754332222233456788999999865 4578
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchh-hhhc------------------CC-------CC-CCCC---CCCCCCCH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRA-IFMI------------------PT-------KP-PPSF---REPDVWTP 209 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~------------------~~-------~~-~~~~---~~~~~~~~ 209 (251)
.++|+||+|+++|++++|..||........ .... .. .. +... ......++
T Consensus 183 ~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (291)
T cd07870 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP 262 (291)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCCh
Confidence 899999999999999999999965432111 0000 00 00 0000 00011367
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++.+++.+|+..||++|||++|++.||||
T Consensus 263 ~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 263 KAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=261.36 Aligned_cols=211 Identities=28% Similarity=0.555 Sum_probs=162.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+.++||||++++++|..+...++||||+.+++|.+++.+. ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlk----- 128 (328)
T cd08226 54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK----- 128 (328)
T ss_pred HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 4589999999999999999999999999999999998743 2468999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-------cccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVI 153 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++++||+.+......... .....++..|+|||.+
T Consensus 129 ----------------------------p~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 129 ----------------------------ASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred ----------------------------HHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhh
Confidence 88888888889999999765322111000 0111234569999999
Q ss_pred cc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC---------------------------------
Q psy3253 154 QE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP--------------------------------- 198 (251)
Q Consensus 154 ~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------- 198 (251)
.+ ..++.++||||+||++|++++|..||.................
T Consensus 181 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (328)
T cd08226 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVA 260 (328)
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhc
Confidence 65 4478899999999999999999999976543222211111000
Q ss_pred -----------CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 199 -----------PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 199 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
........+++.+.+|+.+||..||++|||++|+++||||+......
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 261 AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 00011233567899999999999999999999999999998876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=251.12 Aligned_cols=199 Identities=23% Similarity=0.421 Sum_probs=165.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++..+...+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk---- 131 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA---- 131 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC----
Confidence 357899999999999999999999999999999999986433 468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..+
T Consensus 132 -----------------------------p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 132 -----------------------------ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred -----------------------------cceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCC
Confidence 88888888999999999998765432111 112223557999999988899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.+.......+..... ...+..+++++.+++.+||+.||++|||++|+++
T Consensus 183 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR--MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999998 9999977665554444433322 2335668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=253.22 Aligned_cols=199 Identities=23% Similarity=0.411 Sum_probs=165.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------KTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
|+.++||||+++++++......+++|||+.+++|.++++..+ ..+++..+..++.|++.||.+||++
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 357899999999999999999999999999999999997432 3478889999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccc
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTP 145 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~ 145 (251)
|++||||| |+||+++.++.++|+|||++........ ......++.
T Consensus 142 ~i~h~dlk---------------------------------p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~ 188 (280)
T cd05049 142 HFVHRDLA---------------------------------TRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188 (280)
T ss_pred Ceeccccc---------------------------------cceEEEcCCCeEEECCcccceecccCcceecCCCCcccc
Confidence 99999988 8888998899999999999865432211 112233467
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
.|+|||.+.+..++.++||||+||++|++++ |..||...+.......+....... .+..++..+.+++.+||+.||+
T Consensus 189 ~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~ 266 (280)
T cd05049 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQ 266 (280)
T ss_pred eecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcc
Confidence 7999999999899999999999999999998 999997766666555544333222 2456789999999999999999
Q ss_pred ccCCHHHHhc
Q psy3253 225 ERATASEMLN 234 (251)
Q Consensus 225 ~Rps~~evl~ 234 (251)
+||+++|+++
T Consensus 267 ~Rp~~~eil~ 276 (280)
T cd05049 267 QRINIKDIHE 276 (280)
T ss_pred cCCCHHHHHH
Confidence 9999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=259.55 Aligned_cols=217 Identities=24% Similarity=0.300 Sum_probs=165.4
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccc
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLD 87 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~ 87 (251)
+|++.+.|.-.++.|+|+|.+ |.|+++++..+ ..+++...++.++.|++.+++|||+.+++|.|+|||||+|+-+...
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 567777888899999999999 66999999753 3679999999999999999999999999999999999999954332
Q ss_pred cccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHHHH
Q psy3253 88 YCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSL 167 (251)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 167 (251)
--... +.. ..-+-..++..++++|||.|.... ......+.|..|+|||++.+.+|+.++||||+
T Consensus 232 ~~~~~-------k~~------~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 232 KTYNP-------KKK------VCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EEecc-------CCc------cceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceee
Confidence 10000 000 011233456679999999995433 23466778999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcchhhh---hcCCCCCCCCCC---------------C-------------------------
Q psy3253 168 GITALEMAEGKPPYGDIHPMRAIF---MIPTKPPPSFRE---------------P------------------------- 204 (251)
Q Consensus 168 G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~---------------~------------------------- 204 (251)
||+|+|+++|...|++.++.+... .+.+..+..... +
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 999999999999998766555332 232211110000 0
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
+.-..+++||+++||.+||.+|+|+.|+|.||||.+..
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 00024489999999999999999999999999998754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=284.34 Aligned_cols=225 Identities=25% Similarity=0.423 Sum_probs=169.0
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-------C
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLR-------R 68 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~-------~ 68 (251)
|++++|||||+++++|.+. ..+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 4578999999999998653 5699999999999999999632 35799999999999999999999984 4
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM 148 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 148 (251)
|+||||||+||||........ .+.......+..+.+||+|||++....... ......+|+.|+
T Consensus 146 IVHRDLKPeNILL~s~~~~lg----------------~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~Ym 208 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIG----------------KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYW 208 (1021)
T ss_pred ceeccCcHHHeEeecCccccc----------------cccccccccCCCCceEEccCCccccccccc-cccccCCCcccc
Confidence 999999999888863210000 000011112344569999999997654321 223346899999
Q ss_pred ccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 149 APEVIQE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 149 aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
|||++.+ ..++.++|||||||++|+|++|..||................+ .. .....+.++.+||.+||..+|.+|
T Consensus 209 APEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~l-pi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 209 SPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DL-PIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred CHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CC-CcCCCCHHHHHHHHHHhcCChhHC
Confidence 9999854 4578899999999999999999999976544333322222211 11 124568999999999999999999
Q ss_pred CCHHHHhcChhhhhccCC
Q psy3253 227 ATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~~ 244 (251)
|++.|+|.|||++.....
T Consensus 287 PSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 287 PSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred cCHHHHhccHHHhhcCCC
Confidence 999999999999876554
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=263.74 Aligned_cols=209 Identities=26% Similarity=0.403 Sum_probs=178.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++.|.||.+-.+|++++.+|+||..|+||+|.-.+.+. +..|++..++.++.+|+.||.+||..+|++||+|
T Consensus 239 L~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLK---- 314 (591)
T KOG0986|consen 239 LEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLK---- 314 (591)
T ss_pred HHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCC----
Confidence 45788999999999999999999999999999998766532 3589999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.+|+++|+|+|+|..+..... .....||..|||||++.+..|+
T Consensus 315 -----------------------------PeNILLDd~GhvRISDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~ne~Y~ 364 (591)
T KOG0986|consen 315 -----------------------------PENILLDDHGHVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQNEVYD 364 (591)
T ss_pred -----------------------------hhheeeccCCCeEeeccceEEecCCCCc-cccccCcccccCHHHHcCCccc
Confidence 9999999999999999999988765533 3345899999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASE 231 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e 231 (251)
...|-||+||++|+|+.|+.||...........+ .... ....+..++++++++...+|..||++|. .+++
T Consensus 365 ~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e 442 (591)
T KOG0986|consen 365 FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE 442 (591)
T ss_pred CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcch
Confidence 9999999999999999999999654333222111 1122 2233578899999999999999999996 6789
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
|-+||||+..+|.-
T Consensus 443 vk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 443 VKEHPFFKDLNWRR 456 (591)
T ss_pred hhhCcccccCCHhH
Confidence 99999999998853
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=257.89 Aligned_cols=204 Identities=26% Similarity=0.502 Sum_probs=163.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++..+...|+||||+++++|..+.. ....+++..++.++.|++.||.|||+.|++|+|++
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~----- 127 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK----- 127 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-----
Confidence 356899999999999999999999999999989888765 44569999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++
T Consensus 128 ----------------------------p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 179 (286)
T cd07846 128 ----------------------------PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179 (286)
T ss_pred ----------------------------HHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccC
Confidence 88999999999999999998765433222233456788999999865 4467
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---------------------CCCCC-------CCCCCCCCHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---------------------KPPPS-------FREPDVWTPEF 211 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~-------~~~~~~~~~~~ 211 (251)
.++||||+|+++|++++|.+||...........+.. ...+. ......++..+
T Consensus 180 ~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07846 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259 (286)
T ss_pred chHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHH
Confidence 889999999999999999999965443221111000 00000 01123568889
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.+|++||+++|+++||||
T Consensus 260 ~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 260 LDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=266.51 Aligned_cols=199 Identities=27% Similarity=0.484 Sum_probs=160.1
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------------------------------------
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------------------------------- 42 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------------------------------- 42 (251)
+.+ +||||+++++++......++||||+.+|+|.++++...
T Consensus 96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 456 89999999999999999999999999999999986321
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccc
Q psy3253 43 -------------------------------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSI 91 (251)
Q Consensus 43 -------------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~ 91 (251)
..+++..++.++.||+.||.|||++|++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLk---------------- 239 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVA---------------- 239 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCc----------------
Confidence 246788899999999999999999999999988
Q ss_pred cccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCCCcchhHHHHHH
Q psy3253 92 KCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169 (251)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 169 (251)
|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||+||
T Consensus 240 -----------------p~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 240 -----------------ARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred -----------------hheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 8888888888999999999975433211 112223456799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 170 TALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 170 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++|+|++ |..||................ .....+...++++.+++.+||+.||++|||++|+++
T Consensus 303 il~ellt~G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 303 LLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHhCCCCCCccccccHHHHHHHHcc-cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999997 999997654433332222211 122234556899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.80 Aligned_cols=197 Identities=27% Similarity=0.466 Sum_probs=162.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++||||+++++++. ....++||||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlk----- 122 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLA----- 122 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc-----
Confidence 35689999999999885 456799999999999999996 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+..
T Consensus 123 ----------------------------p~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 123 ----------------------------ARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred ----------------------------hhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC
Confidence 88888888889999999999765432211 11122346799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+|||||++|++++ |..||...........+..... ...+..+++++.++|.+||+.||++||++++|..
T Consensus 175 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8999999999999999998 9999987666555555544332 2345678999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=251.16 Aligned_cols=203 Identities=36% Similarity=0.623 Sum_probs=164.9
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+. ..++++|||+.+++|.+++. +...+++..++.++.|++.||.|||++|++|+|||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~--- 133 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIK--- 133 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC---
Confidence 3578999999999998763 46889999999999999987 44678999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---ccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+
T Consensus 134 ------------------------------p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 134 ------------------------------GANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred ------------------------------HHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC
Confidence 8888888889999999999875432111 1122346778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++|+|||||++|++++|+.||................ .....+...+..+.+++.+|+. +|++||+++|+++|
T Consensus 184 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 889999999999999999999999997655444443333221 1222355678889999999995 99999999999999
Q ss_pred hhhh
Q psy3253 236 EFIQ 239 (251)
Q Consensus 236 p~~~ 239 (251)
||++
T Consensus 262 ~~~~ 265 (265)
T cd06652 262 TFVH 265 (265)
T ss_pred cccC
Confidence 9984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=253.10 Aligned_cols=200 Identities=25% Similarity=0.420 Sum_probs=161.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++.+....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|++||||
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 357899999999999998889999999999999999997443 25899999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCccccc--cccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA 149 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 149 (251)
| |+||+++.++ .++|+|||+++........ ......+..|+|
T Consensus 143 k---------------------------------p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05036 143 A---------------------------------ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189 (277)
T ss_pred c---------------------------------hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCC
Confidence 8 6666665443 5899999999765322111 112223457999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||++.+..++.++|||||||++|+|++ |..||.+.+.......+...... ..+..++..+.+++.+||+.+|++|||
T Consensus 190 PE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rps 267 (277)
T cd05036 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPN 267 (277)
T ss_pred HHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 999988889999999999999999997 99999876655554444333222 235667899999999999999999999
Q ss_pred HHHHhcC
Q psy3253 229 ASEMLNH 235 (251)
Q Consensus 229 ~~evl~h 235 (251)
++++++|
T Consensus 268 ~~~vl~~ 274 (277)
T cd05036 268 FATILER 274 (277)
T ss_pred HHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=253.93 Aligned_cols=208 Identities=41% Similarity=0.783 Sum_probs=164.4
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||++++++|... ..+|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~ 132 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 4578999999999998643 468999999999999988752 34568999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++....... .....++..|+|||.+.+
T Consensus 133 ---------------------------------~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 133 ---------------------------------PSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQG 177 (287)
T ss_pred ---------------------------------HHHEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcC
Confidence 888888888899999999986543221 122346778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-----chhhhhcCCCCCCCCCC----CCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHP-----MRAIFMIPTKPPPSFRE----PDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R 226 (251)
..++.++|+||+||++|+|++|..||..... ......+.....+.... ...+++++.+++.+||..+|++|
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (287)
T cd06621 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257 (287)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccC
Confidence 8899999999999999999999999965421 12222222211111111 12356789999999999999999
Q ss_pred CCHHHHhcChhhhhccC
Q psy3253 227 ATASEMLNHEFIQRHDT 243 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~ 243 (251)
||+.|++.||||+....
T Consensus 258 pt~~eil~~~~~~~~~~ 274 (287)
T cd06621 258 PTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCHHHHHhCcccccccc
Confidence 99999999999965543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=253.03 Aligned_cols=206 Identities=34% Similarity=0.656 Sum_probs=167.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~ 80 (251)
+.++||||+++++++......++||||+.+++|.+++. ..+.+++..+..++.+++.||.|||+ .|++|||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~----- 131 (284)
T cd06620 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK----- 131 (284)
T ss_pred HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCC-----
Confidence 46899999999999999999999999999999999886 45679999999999999999999997 689999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.
T Consensus 132 ----------------------------p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~ 181 (284)
T cd06620 132 ----------------------------PSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTV 181 (284)
T ss_pred ----------------------------HHHEEECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCc
Confidence 88889988999999999998654322 122346788999999998888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcc-----------hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPM-----------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
++|+||+||++|++++|..||...... .....+.....+... ...++.++.+++.+||+.||++|||+
T Consensus 182 ~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~ 260 (284)
T cd06620 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-SSDFPEDLRDFVDACLLKDPTERPTP 260 (284)
T ss_pred cchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC-chhcCHHHHHHHHHHhcCCcccCcCH
Confidence 999999999999999999999654331 111112112111211 22368899999999999999999999
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
+|+++|+||.+...+
T Consensus 261 ~e~~~~~~~~~~~~~ 275 (284)
T cd06620 261 QQLCAMPPFIQALRA 275 (284)
T ss_pred HHHhcCccccccccc
Confidence 999999999765433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=252.49 Aligned_cols=201 Identities=32% Similarity=0.600 Sum_probs=167.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++||||+++++.+.+....++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+.|++|+|+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~--- 133 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK--- 133 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC---
Confidence 567999999999999988899999999999999998863 34578999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++. +.++++|||.+..............++..|+|||.+.+..+
T Consensus 134 ------------------------------~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 182 (260)
T cd08222 134 ------------------------------AKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182 (260)
T ss_pred ------------------------------hhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCC
Confidence 66777654 45999999998765433333334456788999999988888
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|+||+|+++|++++|..||...........+.....+. .+..++.++.++|.+||+.+|++||+++|+++||||
T Consensus 183 ~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS--LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC--CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997655544444433332222 245678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=250.00 Aligned_cols=199 Identities=23% Similarity=0.405 Sum_probs=166.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+|||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~---- 131 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA---- 131 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC----
Confidence 46789999999999999999999999999999999999743 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+....++
T Consensus 132 -----------------------------~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 182 (261)
T cd05148 132 -----------------------------ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182 (261)
T ss_pred -----------------------------cceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCC
Confidence 888888889999999999997654332222233345679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||||+++|++++ |..||...........+.... ....+..+++.+.+++.+||+.||++|||++++++
T Consensus 183 ~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999998 899997766555444443332 22335677899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.78 Aligned_cols=210 Identities=26% Similarity=0.433 Sum_probs=162.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.++...|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~---- 129 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK---- 129 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC----
Confidence 357899999999999999999999999995 58888775333 236888899999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++. ++.+||+|||++..............++..|+|||.+.+ ..
T Consensus 130 -----------------------------p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (294)
T PLN00009 130 -----------------------------PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180 (294)
T ss_pred -----------------------------cceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCC
Confidence 77888764 456899999999654332222223345778999998865 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCC-----------------CCC------CCCCCCCHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPP-----------------PSF------REPDVWTPEF 211 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~-----------------~~~------~~~~~~~~~~ 211 (251)
++.++|+||+|+++|++++|.+||...+.......+. .... +.+ ......++++
T Consensus 181 ~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (294)
T PLN00009 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAG 260 (294)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHH
Confidence 7889999999999999999999997654432222110 0000 000 0123467889
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.+++.+||+.+|++||+++++++||||++.+..
T Consensus 261 ~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~ 293 (294)
T PLN00009 261 VDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293 (294)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence 999999999999999999999999999987654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=265.11 Aligned_cols=199 Identities=25% Similarity=0.460 Sum_probs=159.4
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------------------------------------
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------------------------------- 42 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------------------------------- 42 (251)
+++ +||||+++++++..+...++||||+.+|+|.++++...
T Consensus 93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 346 89999999999999999999999999999999986432
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccccc
Q psy3253 43 ------------------------------------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRL 86 (251)
Q Consensus 43 ------------------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~ 86 (251)
..+++..+..++.||+.||.|||+.|++|||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk----------- 241 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA----------- 241 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc-----------
Confidence 146788899999999999999999999999988
Q ss_pred ccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCCCcchhH
Q psy3253 87 DYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||
T Consensus 242 ----------------------p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 242 ----------------------ARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred ----------------------hhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 8888888888899999999975543211 1122234567999999998899999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcchhhh-hcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 165 WSLGITALEMAE-GKPPYGDIHPMRAIF-MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 165 wslG~~l~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|||||++|++++ |..||.......... .+.... ....+...+.++.+++.+||+.||++|||++|+++.
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999998 889997654333222 222221 112245568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=253.23 Aligned_cols=201 Identities=25% Similarity=0.396 Sum_probs=159.1
Q ss_pred CCC-CCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+++ +|||++++++++.++ ...++||||+. ++|.+++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~--- 127 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIK--- 127 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC---
Confidence 345 599999999999877 88999999996 58888887555679999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++. +.++|+|||.+........ .....++..|+|||.+.. ..
T Consensus 128 ------------------------------p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 175 (282)
T cd07831 128 ------------------------------PENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGY 175 (282)
T ss_pred ------------------------------HHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCC
Confidence 88888888 8999999999976543221 122346788999997744 55
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---C------------CCCCCCCC-----------CCCCCHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---T------------KPPPSFRE-----------PDVWTPEF 211 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~------------~~~~~~~~-----------~~~~~~~~ 211 (251)
++.++|+||+||++|+|++|.+||.+.+.......+. . .....+.. ...++.++
T Consensus 176 ~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd07831 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEG 255 (282)
T ss_pred CCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHH
Confidence 7889999999999999999999997654432221110 0 00000000 12457899
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++|.+||+.+|++|||++++++||||
T Consensus 256 ~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 256 LDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHhccCcccccCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=261.85 Aligned_cols=213 Identities=25% Similarity=0.423 Sum_probs=170.3
Q ss_pred CCCCCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++.... ..|++|||+. ++|.+++. +...+++..++.++.|++.||.+||+.|++|||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlk 130 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLK 130 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 35789999999999997765 7999999996 58999886 44589999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc---ccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.++|+|||.+....... .......++..|+|||.
T Consensus 131 ---------------------------------p~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 177 (330)
T cd07834 131 ---------------------------------PSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177 (330)
T ss_pred ---------------------------------HHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCcee
Confidence 889999999999999999997655432 12233456788999999
Q ss_pred cccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC---C------------------------CC-CCC
Q psy3253 153 IQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP---P------------------------PS-FRE 203 (251)
Q Consensus 153 ~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~------------------------~~-~~~ 203 (251)
+.+. .++.++|+||+|+++|++++|.+||.+.+.......+.... . .. ...
T Consensus 178 ~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
T cd07834 178 LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL 257 (330)
T ss_pred eecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHh
Confidence 9877 78999999999999999999999997654432221111100 0 00 001
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQN 248 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~~ 248 (251)
....+.++.+++.+||+.+|++|||++++++||||++...++.+.
T Consensus 258 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 258 FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 233678899999999999999999999999999999877765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=246.94 Aligned_cols=202 Identities=42% Similarity=0.739 Sum_probs=169.5
Q ss_pred CCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++.+... ...++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~---- 128 (260)
T cd06606 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIK---- 128 (260)
T ss_pred HHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC----
Confidence 578999999999999888 8899999999999999999743 489999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||.+........ ......++..|.|||.+....
T Consensus 129 -----------------------------p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 179 (260)
T cd06606 129 -----------------------------GANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179 (260)
T ss_pred -----------------------------HHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC
Confidence 8888988899999999999976654422 123345778899999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCC-cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIH-PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
.+.++|+||+|++++++++|..||...+ .......+.. .......+...+..+.+++.+||..+|++||++.|++.||
T Consensus 180 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 9999999999999999999999997665 2222222222 1122234566789999999999999999999999999999
Q ss_pred hh
Q psy3253 237 FI 238 (251)
Q Consensus 237 ~~ 238 (251)
||
T Consensus 259 ~~ 260 (260)
T cd06606 259 FL 260 (260)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=251.91 Aligned_cols=199 Identities=23% Similarity=0.433 Sum_probs=164.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--------------KTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--------------~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
|+.++||||+++++++.++...+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997432 247899999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~ 144 (251)
.|++||||| |+||+++.++.++|+|||++........ ......++
T Consensus 141 ~~i~H~dlk---------------------------------p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 187 (280)
T cd05092 141 LHFVHRDLA---------------------------------TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187 (280)
T ss_pred CCeeccccc---------------------------------HhhEEEcCCCCEEECCCCceeEcCCCceeecCCCcccc
Confidence 999999988 8888888889999999999865432211 11222346
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
..|+|||.+.+..++.++|||||||++|++++ |.+||...........+..... ...+..+++.+.+++.+||+.||
T Consensus 188 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P 265 (280)
T cd05092 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREP 265 (280)
T ss_pred ccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCCh
Confidence 67999999988889999999999999999998 9999976655554444433322 23356789999999999999999
Q ss_pred CccCCHHHHhc
Q psy3253 224 EERATASEMLN 234 (251)
Q Consensus 224 ~~Rps~~evl~ 234 (251)
++||+++|+++
T Consensus 266 ~~Rp~~~~l~~ 276 (280)
T cd05092 266 QQRMVIKDIHS 276 (280)
T ss_pred hhCCCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=246.67 Aligned_cols=201 Identities=43% Similarity=0.783 Sum_probs=171.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++|||++++++++.++...+++|||+++++|.+++. ....+++..+..++.|++.||.+||+.|++|||||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 126 (254)
T cd06627 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK------ 126 (254)
T ss_pred HhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC------
Confidence 57899999999999999999999999999999999987 34789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............++..|+|||...+..++.+
T Consensus 127 ---------------------------p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~ 179 (254)
T cd06627 127 ---------------------------AANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179 (254)
T ss_pred ---------------------------HHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcc
Confidence 88888888899999999999766543332333456788999999988778899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+|+||+|+++|++++|..||.................. ..+..++..+.+++.+||+.+|++|||++|++.||||
T Consensus 180 ~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP--PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999766554444333322222 2355678999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=248.29 Aligned_cols=192 Identities=22% Similarity=0.308 Sum_probs=159.8
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
...||||+++++++.+....+++|||+.+|+|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk------- 112 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN------- 112 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-------
Confidence 3469999999999999999999999999999999986 34569999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
|+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++
T Consensus 113 --------------------------p~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 163 (237)
T cd05576 113 --------------------------PNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEAC 163 (237)
T ss_pred --------------------------HHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCCCCCCchh
Confidence 88999998999999999987654332 1223346679999999888889999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcChh
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHEF 237 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp~ 237 (251)
|+||+|+++|++++|..|+...... +.. ......+..+++.+.+++.+||+.||++|+++ +|+++|||
T Consensus 164 DvwslG~il~el~~g~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 164 DWWSLGAILFELLTGKTLVECHPSG-----INT--HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred hHHHHHHHHHHHHHCcchhhcCchh-----ccc--ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 9999999999999999887532111 000 01122345678999999999999999999986 99999999
Q ss_pred h
Q psy3253 238 I 238 (251)
Q Consensus 238 ~ 238 (251)
|
T Consensus 237 ~ 237 (237)
T cd05576 237 F 237 (237)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=252.04 Aligned_cols=200 Identities=22% Similarity=0.431 Sum_probs=164.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----------------KTLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~L 64 (251)
|++++||||+++++++..+...|++|||+.+++|.+++.... ..+++..+..++.|++.||.||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999985321 2478889999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVI 142 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 142 (251)
|++|++||||| |+||+++.++.++|+|||++........ ......
T Consensus 141 H~~~i~H~dlk---------------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 187 (283)
T cd05090 141 SSHFFVHKDLA---------------------------------ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187 (283)
T ss_pred HhcCeehhccc---------------------------------cceEEEcCCCcEEeccccccccccCCcceecccCCC
Confidence 99999999988 8888888888999999999976532211 122233
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 143 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+..... ...+..+++.+.+++.+||+.
T Consensus 188 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~ 265 (283)
T cd05090 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQE 265 (283)
T ss_pred ccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHccc
Confidence 4567999999988889999999999999999998 9999977655444444433322 223566899999999999999
Q ss_pred CcCccCCHHHHhcC
Q psy3253 222 NPEERATASEMLNH 235 (251)
Q Consensus 222 ~p~~Rps~~evl~h 235 (251)
||++||++++++++
T Consensus 266 ~p~~Rp~~~~i~~~ 279 (283)
T cd05090 266 GPSRRPRFKDIHTR 279 (283)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=250.02 Aligned_cols=200 Identities=19% Similarity=0.281 Sum_probs=153.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...+++|||+++|+|..++......+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 59 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 138 (262)
T cd05077 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILL 138 (262)
T ss_pred HhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEE
Confidence 57899999999999999889999999999999999987556779999999999999999999999999999999555554
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-cCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ 160 (251)
. ..+.-......++++|||.+...... ....++..|+|||.+. +..++.
T Consensus 139 ~--------------------------~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~ 188 (262)
T cd05077 139 A--------------------------REGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSI 188 (262)
T ss_pred e--------------------------cCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCc
Confidence 3 11111111223899999998654322 2234677899999986 466888
Q ss_pred chhHHHHHHHHHHHH-hCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMA-EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++|||||||++|+++ +|..||........... ... ........+.++.+++.+||+.||++||++++++++
T Consensus 189 ~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 189 AADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEG---QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-Hhc---CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 999999999999997 58888865543322211 111 111123346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=266.61 Aligned_cols=197 Identities=29% Similarity=0.454 Sum_probs=165.2
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
-+||||+++++++.++.+.|+|||.+.|+-|.+-+. ....+. .++..|+.+|+.|+.|||++|++|||+|
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~-~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLk-------- 442 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIR-SKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLK-------- 442 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHH-hcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCC--------
Confidence 479999999999999999999999999998887776 233444 8888999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceec-CCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
|+||++ +..++++|+|||.++..... .....-|..|.|||++...++++++
T Consensus 443 -------------------------p~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~ac 494 (612)
T KOG0603|consen 443 -------------------------PGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEAC 494 (612)
T ss_pred -------------------------hhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcch
Confidence 888888 58889999999999765543 2233457789999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
|+||||+++|+|++|..||...... .....+... .+ ...+|.++++|+.+||+.||.+|++++|+..||||-..
T Consensus 495 D~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~--s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 495 DWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KF--SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred hhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---cc--ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 9999999999999999999665544 333333222 22 26789999999999999999999999999999999444
Q ss_pred cC
Q psy3253 242 DT 243 (251)
Q Consensus 242 ~~ 243 (251)
+.
T Consensus 570 ~t 571 (612)
T KOG0603|consen 570 PT 571 (612)
T ss_pred CC
Confidence 44
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=250.64 Aligned_cols=198 Identities=28% Similarity=0.441 Sum_probs=162.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++++||||+++++++. +...++++||+.+|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk----- 136 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLA----- 136 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccC-----
Confidence 35789999999999885 455789999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.++....... ......++..|+|||.+.+..+
T Consensus 137 ----------------------------p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 188 (279)
T cd05111 137 ----------------------------ARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188 (279)
T ss_pred ----------------------------cceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc
Confidence 8888998889999999999975532211 1122345667999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|++++ |..||.+.........+.... ....+..++.++.+++.+||..||++|||++|+++
T Consensus 189 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE--RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999998 999997765544333333222 22234557889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=253.43 Aligned_cols=204 Identities=27% Similarity=0.492 Sum_probs=162.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...+++|||+.++.+..+.. +...+++..+..++.|++.||.|||++|++|+|++
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~----- 127 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK----- 127 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 357889999999999999999999999998866665554 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEI-GY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~ 158 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .+
T Consensus 128 ----------------------------~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 179 (288)
T cd07833 128 ----------------------------PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179 (288)
T ss_pred ----------------------------HHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCc
Confidence 8899999999999999999876544322 22234567789999999877 78
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC--------------------C-CCCC--------CCCCCCCCH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT--------------------K-PPPS--------FREPDVWTP 209 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------------------~-~~~~--------~~~~~~~~~ 209 (251)
+.++|+||+|+++|++++|.+||.+.........+.. . .... ...+..++.
T Consensus 180 ~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07833 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSS 259 (288)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccch
Confidence 8999999999999999999999965433221111000 0 0000 001233588
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++.++|.+||..+|++|||++++++||||
T Consensus 260 ~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=272.69 Aligned_cols=209 Identities=21% Similarity=0.269 Sum_probs=158.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
|++++||||+++++++...+..|++++++. ++|.+++.... .......++.++.||+.||.|||++||+|||||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK- 294 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK- 294 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC-
Confidence 357899999999999999999999999995 57877775221 223466788899999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++....... ......|+..|+|||++.+
T Consensus 295 --------------------------------P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 295 --------------------------------LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred --------------------------------HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 8899999999999999999976543221 2233568999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcc--hhhhh-cC--CCCCCC--------------------------CCC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPP-YGDIHPM--RAIFM-IP--TKPPPS--------------------------FRE 203 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p-~~~~~~~--~~~~~-~~--~~~~~~--------------------------~~~ 203 (251)
..++.++|||||||++|+|++|..+ +...... ..... +. ...... ...
T Consensus 343 ~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~ 422 (501)
T PHA03210 343 DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR 422 (501)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH
Confidence 8999999999999999999998754 4322111 11100 00 000000 000
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
...++.++.++|.+||++||++|||++|+|+||||.....
T Consensus 423 ~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 423 NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 1234677889999999999999999999999999987543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.57 Aligned_cols=206 Identities=25% Similarity=0.452 Sum_probs=161.2
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||++++++|... .+.|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dl 144 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 144 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 3578999999999988643 35799999995 588888752 3899999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||.+...... .......++..|+|||.+.
T Consensus 145 k---------------------------------p~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 190 (353)
T cd07850 145 K---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 190 (353)
T ss_pred C---------------------------------HHHEEECCCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHh
Confidence 8 88999999999999999999765432 1222345678899999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-----------------------CCC---CCC-------
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-----------------------KPP---PSF------- 201 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------------~~~---~~~------- 201 (251)
+..++.++|+||+||++|+|++|..||...+.......+.. ... ..+
T Consensus 191 ~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T cd07850 191 GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDV 270 (353)
T ss_pred CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccc
Confidence 98999999999999999999999999965543221111100 000 000
Q ss_pred -------CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 202 -------REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 202 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
......++++.++|.+||+.||++|||++|+|.||||+...++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred ccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0012346678999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=254.33 Aligned_cols=203 Identities=48% Similarity=0.878 Sum_probs=168.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++.+....|+||||+. |+|.+++......+++.++..++.|++.||.|||++|++|+||+
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~----- 148 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK----- 148 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 357899999999999999999999999995 58888887666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
|+||+++.++.++|+|||++..... .....++..|+|||.+. ...
T Consensus 149 ----------------------------p~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~ 196 (313)
T cd06633 149 ----------------------------AGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQ 196 (313)
T ss_pred ----------------------------hhhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCC
Confidence 8888888889999999999854322 22345788899999984 356
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++|+||+|+++|++++|..||...+.......+.....+.. ....++..+.+++.+||+.+|++||+++++++|||
T Consensus 197 ~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 78899999999999999999999977665444443333222222 23456788999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|+..+
T Consensus 276 ~~~~~ 280 (313)
T cd06633 276 VRRDR 280 (313)
T ss_pred cCCCc
Confidence 98754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=248.20 Aligned_cols=200 Identities=34% Similarity=0.582 Sum_probs=170.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++.+..+...|++|||+.+++|.+++. ....+++..+..++.|++.||.|||+.+++|+||+
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~------ 120 (250)
T cd05123 48 SRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK------ 120 (250)
T ss_pred HHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC------
Confidence 56889999999999999999999999999999999997 34578999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............++..|+|||...+...+.+
T Consensus 121 ---------------------------p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 173 (250)
T cd05123 121 ---------------------------PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173 (250)
T ss_pred ---------------------------cceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCch
Confidence 88888888899999999998765433223334456778999999988888999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH---HHHhcChhh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA---SEMLNHEFI 238 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~evl~hp~~ 238 (251)
+|+||||+++|++++|..||...+.......+... ....+...+..+.+++.+||..||++||++ +++++||||
T Consensus 174 ~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999999999999766654433333332 333456678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=246.11 Aligned_cols=199 Identities=27% Similarity=0.437 Sum_probs=164.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......++||||+.+++|.+++......+++..+..++.+++.||.|+|++|++|||||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~----- 120 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA----- 120 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC-----
Confidence 356899999999999999999999999999999999997556678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-cccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||++.......... ....++..|+|||.+.+..++
T Consensus 121 ----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 172 (250)
T cd05085 121 ----------------------------ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172 (250)
T ss_pred ----------------------------hheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCC
Confidence 888888888899999999986543221111 112234569999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+|+++|++++ |..||...........+..... ...+..++..+.+++.+||..+|++||+++|+++
T Consensus 173 ~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999998 9999976655444443333322 2235567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=254.63 Aligned_cols=203 Identities=25% Similarity=0.459 Sum_probs=157.6
Q ss_pred CC-CCCccceeeeeEeeCCe-----EEEEEEccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 3 QC-DSPYVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
++ +||||+++++++..... .|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 134 (295)
T cd07837 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR 134 (295)
T ss_pred HccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 45 57999999999987665 8999999975 8988886432 358999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 151 (251)
||| |+||+++. ++.++|+|||.+..............+++.|+|||
T Consensus 135 dl~---------------------------------~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE 181 (295)
T cd07837 135 DLK---------------------------------PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181 (295)
T ss_pred CCC---------------------------------hHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChH
Confidence 988 77888887 78899999999875543222222334577899999
Q ss_pred cccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC----CCC---------------CCC------CCCC
Q psy3253 152 VIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT----KPP---------------PSF------REPD 205 (251)
Q Consensus 152 ~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~---------------~~~------~~~~ 205 (251)
.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.. ... +.. ....
T Consensus 182 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (295)
T cd07837 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP 261 (295)
T ss_pred HhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhcc
Confidence 8854 4578899999999999999999999976544332211100 000 000 0013
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.++.++.++|.+||+.||++||+++|++.||||+
T Consensus 262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 262 DLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 4688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=252.73 Aligned_cols=208 Identities=38% Similarity=0.723 Sum_probs=163.0
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR----LRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKA 76 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~ 76 (251)
++ +||||+++++++..+...+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. |++|||||
T Consensus 58 ~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk- 135 (288)
T cd06616 58 RSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK- 135 (288)
T ss_pred HhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC-
Confidence 44 49999999999999889999999995 46665442 1246799999999999999999999974 99999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+.
T Consensus 136 --------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 136 --------------------------------PSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred --------------------------------HHHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccc
Confidence 888888888899999999986544321 12233567889999999765
Q ss_pred ---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCC--CCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 157 ---GYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSF--REPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 157 ---~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.++.++|+||+||++|++++|+.||...... ...........+.. ..+..++.++.+|+.+||+.+|++|||++
T Consensus 183 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 262 (288)
T cd06616 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK 262 (288)
T ss_pred cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 6889999999999999999999999655421 11122222211111 12235789999999999999999999999
Q ss_pred HHhcChhhhhccCCC
Q psy3253 231 EMLNHEFIQRHDTDP 245 (251)
Q Consensus 231 evl~hp~~~~~~~~~ 245 (251)
|+++||||+...+..
T Consensus 263 ~i~~~~~~~~~~~~~ 277 (288)
T cd06616 263 ELLEHPFIKDYEERN 277 (288)
T ss_pred HHhcChhhhchhhcc
Confidence 999999998866543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=253.23 Aligned_cols=203 Identities=26% Similarity=0.442 Sum_probs=161.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++|||++++++++.++...|++|||++ ++|.+++.... ..+++..++.++.|++.||.|||+++++||||+
T Consensus 53 ~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~----- 126 (283)
T cd07835 53 KELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK----- 126 (283)
T ss_pred HhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC-----
Confidence 56799999999999999999999999995 69999986433 368999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 159 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++
T Consensus 127 ----------------------------p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 178 (283)
T cd07835 127 ----------------------------PQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS 178 (283)
T ss_pred ----------------------------HHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccC
Confidence 889999889999999999997554322222233457789999988653 568
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-------------------------CCC-CCCCCCCCCCCHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-------------------------TKP-PPSFREPDVWTPEFID 213 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------------------~~~-~~~~~~~~~~~~~~~~ 213 (251)
.++|+||+|+++|++++|.+||...+.......+. ... .........++.++.+
T Consensus 179 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (283)
T cd07835 179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLD 258 (283)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHH
Confidence 89999999999999999999996554322111100 000 0001113456789999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++.+||+.+|++|||++|++.||||
T Consensus 259 li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 259 LLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHhcCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=277.40 Aligned_cols=200 Identities=27% Similarity=0.451 Sum_probs=178.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|-|++||||++|.|+.......++|.|||++|+|+.|++++.+.|+.-+...+++-|+.|++||-++|++||||-
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA----- 758 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA----- 758 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhh-----
Confidence 679999999999999999999999999999999999999999999999999999999999999999999999966
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-ccccc--ccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIG--TPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~--~~~y~aPE~~~~~~ 157 (251)
.+||+++.+..+|++|||+++...++.... ....| +.+|.|||.+...+
T Consensus 759 ----------------------------ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK 810 (996)
T KOG0196|consen 759 ----------------------------ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK 810 (996)
T ss_pred ----------------------------hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc
Confidence 889999999999999999998665443211 11212 46799999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++.++||||+|+++||.++ |..||++..+-+.+..+..+. .++.|..+|..+.+|+..||++|..+||.++|++++
T Consensus 811 FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy--RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 811 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY--RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999876 999999999988888877765 445688899999999999999999999999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=246.40 Aligned_cols=199 Identities=25% Similarity=0.448 Sum_probs=159.8
Q ss_pred CCCCCCCccceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.++||||+++++++. .+...+++|||+.+|+|.++++.....+.+..+..++.|++.||.|||+.|++|||||
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk---- 125 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLA---- 125 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC----
Confidence 46789999999999775 4556899999999999999997555667888889999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||+++....... ......++..|+|||.+.+
T Consensus 126 -----------------------------~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 126 -----------------------------ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred -----------------------------cceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 8888888889999999999875432111 1112234567999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++|||||||++|++++ |.+||...+.......+...... ..+..+++.+.+++.+||..+|++||+++|++.
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL--LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 889999999999999999999 56777665554444333333222 224556889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=252.77 Aligned_cols=204 Identities=28% Similarity=0.468 Sum_probs=162.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++...+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++|||||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~--- 127 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK--- 127 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC---
Confidence 3578999999999999999999999999975 8988886443 468999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++.++.++++|||.+..............++..|+|||.+.+ ..
T Consensus 128 ------------------------------p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 177 (284)
T cd07836 128 ------------------------------PQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177 (284)
T ss_pred ------------------------------HHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCC
Confidence 88999998999999999999754433222233456788999998865 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---------------CC--CCCC---------CCCCCCCHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---------------KP--PPSF---------REPDVWTPEF 211 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------~~--~~~~---------~~~~~~~~~~ 211 (251)
++.++|+||+|+++|++++|.+||.+.+.......+.. .. .... ......+..+
T Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (284)
T cd07836 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLG 257 (284)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHH
Confidence 68899999999999999999999976544322211100 00 0000 0012357889
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.||.+||+++|+++||||
T Consensus 258 ~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 258 IDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=264.26 Aligned_cols=197 Identities=27% Similarity=0.485 Sum_probs=172.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++|+|.+. ..++|||++..|.|.+|++++...++......++.||+.||.|||+.+++||||-
T Consensus 445 MrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIA----- 518 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIA----- 518 (974)
T ss_pred HHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhh-----
Confidence 6899999999999999654 5899999999999999999888999999999999999999999999999999977
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccc-cccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~ 159 (251)
.+||++.....+|++|||+++-......-... ...+.-|+|||.+....++
T Consensus 519 ----------------------------aRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFT 570 (974)
T KOG4257|consen 519 ----------------------------ARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFT 570 (974)
T ss_pred ----------------------------hhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhccc
Confidence 77788877788999999999877654333322 2335569999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
.++|||.||+++||+++ |..||.+-.+...+..+..+. .++.|+.||+.+..|+.+||.++|.+||++.|+.
T Consensus 571 tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--RlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 571 TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 99999999999999876 999999888888777776665 4456899999999999999999999999998874
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=252.38 Aligned_cols=198 Identities=24% Similarity=0.427 Sum_probs=161.7
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++......+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||
T Consensus 57 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 136 (297)
T cd05089 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136 (297)
T ss_pred HhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 355 79999999999998889999999999999999996432 24888999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 145 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 145 (251)
++|++||||| |+||+++.++.++|+|||++...... ........+.
T Consensus 137 ~~~ivH~dlk---------------------------------p~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 182 (297)
T cd05089 137 EKQFIHRDLA---------------------------------ARNVLVGENLASKIADFGLSRGEEVY-VKKTMGRLPV 182 (297)
T ss_pred HCCcccCcCC---------------------------------cceEEECCCCeEEECCcCCCccccce-eccCCCCcCc
Confidence 9999999988 88888888899999999998543211 1111122245
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
.|+|||...+..++.++|||||||++|+|++ |..||.+.........+..... ...+..++.++.+++.+||+.+|.
T Consensus 183 ~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~ 260 (297)
T cd05089 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--MEKPRNCDDEVYELMRQCWRDRPY 260 (297)
T ss_pred cccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChh
Confidence 6999999988889999999999999999997 9999977666555444433322 223456889999999999999999
Q ss_pred ccCCHHHHhcC
Q psy3253 225 ERATASEMLNH 235 (251)
Q Consensus 225 ~Rps~~evl~h 235 (251)
+|||++++++.
T Consensus 261 ~Rp~~~~i~~~ 271 (297)
T cd05089 261 ERPPFAQISVQ 271 (297)
T ss_pred hCcCHHHHHHH
Confidence 99999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.14 Aligned_cols=198 Identities=26% Similarity=0.448 Sum_probs=161.7
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++..+...|+||||+.+++|.++++... ..+++..++.++.|++.||+|||
T Consensus 62 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 141 (303)
T cd05088 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141 (303)
T ss_pred HHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence 456 89999999999999999999999999999999996432 25789999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 145 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 145 (251)
++|++||||| |+||+++.++.++|+|||++...... ........+.
T Consensus 142 ~~gi~H~dlk---------------------------------p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 187 (303)
T cd05088 142 QKQFIHRDLA---------------------------------ARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPV 187 (303)
T ss_pred hCCccccccc---------------------------------hheEEecCCCcEEeCccccCcccchh-hhcccCCCcc
Confidence 9999999988 88888888899999999998533211 1111122355
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
.|+|||.+.+..++.++|||||||++|++++ |..||...+.......+.... ....+..+++++.+++.+||+.+|+
T Consensus 188 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~ 265 (303)
T cd05088 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVYDLMRQCWREKPY 265 (303)
T ss_pred cccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--cCCCCCCCCHHHHHHHHHHcCCChh
Confidence 6999999988888999999999999999998 999997665555444443322 2223455789999999999999999
Q ss_pred ccCCHHHHhcC
Q psy3253 225 ERATASEMLNH 235 (251)
Q Consensus 225 ~Rps~~evl~h 235 (251)
+||++++++.+
T Consensus 266 ~Rp~~~~il~~ 276 (303)
T cd05088 266 ERPSFAQILVS 276 (303)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=255.61 Aligned_cols=199 Identities=25% Similarity=0.434 Sum_probs=163.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++... ..++++||+.+|+|.+++......++...+..++.||+.||+|||++|++|||||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlk----- 136 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLA----- 136 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccc-----
Confidence 4678999999999999765 4789999999999999998666678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||+++........ ......+..|+|||.+.+..+
T Consensus 137 ----------------------------p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (316)
T cd05108 137 ----------------------------ARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188 (316)
T ss_pred ----------------------------hhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCC
Confidence 88888888899999999999765432211 111223567999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|||||||++|++++ |..||.+.........+.... ....+..++.++.+++.+||..+|++|||+.+++.+
T Consensus 189 ~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999997 999997765444333222222 223345678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=249.64 Aligned_cols=199 Identities=23% Similarity=0.432 Sum_probs=164.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------KTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|+.++||||+++++++......++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.|++|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 356899999999999999999999999999999999996322 24678899999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 149 (251)
|||| |+||+++.++.++|+|||+++....... ......++..|+|
T Consensus 143 ~di~---------------------------------p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05032 143 RDLA---------------------------------ARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (277)
T ss_pred cccC---------------------------------hheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccC
Confidence 9988 8889999999999999999875433211 1222345678999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||.+.+..++.++|+|||||++|++++ |..||...+.......+.... ....+..++.++.+++.+||+.+|++|||
T Consensus 190 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 267 (277)
T cd05032 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPT 267 (277)
T ss_pred HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 999988889999999999999999998 999997766655554444332 22335667999999999999999999999
Q ss_pred HHHHhc
Q psy3253 229 ASEMLN 234 (251)
Q Consensus 229 ~~evl~ 234 (251)
++|+++
T Consensus 268 ~~~l~~ 273 (277)
T cd05032 268 FLEIVS 273 (277)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=249.86 Aligned_cols=199 Identities=22% Similarity=0.391 Sum_probs=164.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
++++||||+++++++......++++||+.+++|.+++... ...+++..+..++.|++.||.|||+
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred hcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999998522 1347888899999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~ 144 (251)
+|++||||| |+||+++.++.+||+|||+++....... ......++
T Consensus 143 ~gi~H~dlk---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 189 (283)
T cd05091 143 HHVVHKDLA---------------------------------TRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189 (283)
T ss_pred cCccccccc---------------------------------hhheEecCCCceEecccccccccccchheeeccCccCC
Confidence 999999988 8888888888999999999875432211 11223346
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.........+...... ..+..++..+.+++.+||+.+|
T Consensus 190 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05091 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFP 267 (283)
T ss_pred ccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCc
Confidence 78999999988889999999999999999998 88899777666555554444322 2356789999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++||+++|+++.
T Consensus 268 ~~RP~~~~i~~~ 279 (283)
T cd05091 268 SRRPRFKDIHSR 279 (283)
T ss_pred ccCCCHHHHHHH
Confidence 999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=246.67 Aligned_cols=199 Identities=23% Similarity=0.419 Sum_probs=164.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++......|++|||+.+++|.+++.... ..+++..+..++.|++.||.+||+.|++|||||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~---- 130 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA---- 130 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC----
Confidence 357899999999999999999999999999999999997443 468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++......... ......+..|+|||.+.+..+
T Consensus 131 -----------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 181 (261)
T cd05068 131 -----------------------------ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181 (261)
T ss_pred -----------------------------cceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCC
Confidence 88888888999999999999765432111 111122346999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||||+++|++++ |+.||.+.........+..... ...+..++..+.+++.+||+.+|++||++++++.
T Consensus 182 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999 9999987666555544433322 2234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=256.71 Aligned_cols=209 Identities=27% Similarity=0.422 Sum_probs=165.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...+++|||+. |+|.+++. ....+++..+..++.|++.||.|||+.|++|||||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~----- 146 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS----- 146 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc-----
Confidence 357899999999999999999999999996 59999886 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--------------cccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--------------MAKRNTVIGTPF 146 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--------------~~~~~~~~~~~~ 146 (251)
|+||+++.++.++|+|||.+...... ........++..
T Consensus 147 ----------------------------~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (335)
T PTZ00024 147 ----------------------------PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLW 198 (335)
T ss_pred ----------------------------HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccC
Confidence 88889988999999999998754411 111112235678
Q ss_pred cccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCCCC----------------------
Q psy3253 147 WMAPEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPPPS---------------------- 200 (251)
Q Consensus 147 y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~---------------------- 200 (251)
|+|||.+.+. .++.++|+||+||++|++++|.+||.+.+.......+. ......
T Consensus 199 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
T PTZ00024 199 YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL 278 (335)
T ss_pred CCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH
Confidence 9999998653 46889999999999999999999997665433222110 000000
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 201 FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 201 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.......+.++.+++.+||+.+|++|||++|++.||||+...-.
T Consensus 279 ~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 00113457889999999999999999999999999999865443
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=246.25 Aligned_cols=197 Identities=27% Similarity=0.471 Sum_probs=162.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++. ....+++|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~----- 122 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLA----- 122 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcc-----
Confidence 45789999999999875 4568999999999999999973 4579999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc---cccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||.++......... ....++..|+|||.+.+..
T Consensus 123 ----------------------------p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 123 ----------------------------ARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174 (257)
T ss_pred ----------------------------cceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC
Confidence 888888889999999999997654322111 1112235699999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+||||+++|++++ |.+||...+.......+.... ....+..+++.+.+++.+||..+|++|||+.++++
T Consensus 175 ~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999998 999997766555444443332 22345678899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=252.07 Aligned_cols=200 Identities=29% Similarity=0.537 Sum_probs=168.8
Q ss_pred CCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++ ||||+++++++.++...+++|||+.+++|.+++. ....+++..+..++.|++.||.+||+.|++|+|||
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~----- 129 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK----- 129 (280)
T ss_pred HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC-----
Confidence 3566 9999999999999999999999999999999997 44589999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--------------------ccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--------------------AKRNT 140 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--------------------~~~~~ 140 (251)
|+||+++.++.++++|||.+....... .....
T Consensus 130 ----------------------------~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (280)
T cd05581 130 ----------------------------PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181 (280)
T ss_pred ----------------------------HHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccccccc
Confidence 888899888999999999987654322 11222
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 141 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
..++..|+|||......++.++|+||+|++++++++|..||...+.......+... ....+..+++.+.+++.+||+
T Consensus 182 ~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~ 258 (280)
T cd05581 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL---EYSFPPNFPPDAKDLIEKLLV 258 (280)
T ss_pred ccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc---CCCCCCccCHHHHHHHHHHhc
Confidence 34677899999998888899999999999999999999999776544433332221 223356679999999999999
Q ss_pred cCcCccCCH----HHHhcChhh
Q psy3253 221 KNPEERATA----SEMLNHEFI 238 (251)
Q Consensus 221 ~~p~~Rps~----~evl~hp~~ 238 (251)
.+|++|||+ +++++||||
T Consensus 259 ~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 259 LDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCHhhCCCcccCHHHHhcCCCC
Confidence 999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=246.77 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=165.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++......++||||+.+++|.+++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlk----- 134 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA----- 134 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc-----
Confidence 457899999999999999999999999999999999997666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccc---ccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++++|||++........... ....+..|+|||.+.+..
T Consensus 135 ----------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (268)
T cd05063 135 ----------------------------ARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186 (268)
T ss_pred ----------------------------hhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC
Confidence 8888888888999999999875543211111 111234699999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+||+||++|++++ |..||...........+.... ....+..++.++.+++.+||+.+|++||+++++++
T Consensus 187 ~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999987 999997666555554444332 22234567899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=247.87 Aligned_cols=200 Identities=28% Similarity=0.560 Sum_probs=162.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|+.++||||+++++++......++++||+.+++|.+++.. ....+++..+..++.|++.||.|||++|++|+|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~-- 133 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIK-- 133 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC--
Confidence 3578999999999999999999999999999999988852 23458999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+..
T Consensus 134 -------------------------------~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 182 (267)
T cd08228 134 -------------------------------PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred -------------------------------HHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC
Confidence 8888888889999999999876543322223345778899999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCc--chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+||+|+++|++++|..||..... ......+.....+.. .....+..+.+++.+||..+|++||+++|+++
T Consensus 183 ~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 89999999999999999999999854432 222222222222121 12356789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=256.61 Aligned_cols=204 Identities=27% Similarity=0.459 Sum_probs=182.4
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccc
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDR 85 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~ 85 (251)
-|.+++++..|++-+++|.||||+.||+|.-.++ .-+.|.+..+..++.+|+.||-|||++|||+||+|
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK---------- 477 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK---------- 477 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeecc----------
Confidence 4789999999999999999999999999988886 56789999999999999999999999999999988
Q ss_pred cccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHH
Q psy3253 86 LDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMW 165 (251)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 165 (251)
.+|++++..|++||.|||+++.-.-......+..|||.|+|||++...+|+.++|-|
T Consensus 478 -----------------------LDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWW 534 (683)
T KOG0696|consen 478 -----------------------LDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 534 (683)
T ss_pred -----------------------ccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHH
Confidence 889999999999999999998654444445667899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcChhhhh
Q psy3253 166 SLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHEFIQR 240 (251)
Q Consensus 166 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp~~~~ 240 (251)
|+|+++|||+.|++||.+.+..+....+.... ...|..+|.+..++.+..|...|.+|... .+|-.|||||+
T Consensus 535 a~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 535 AFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999999999999888887766542 23467789999999999999999999643 67999999999
Q ss_pred ccCCCC
Q psy3253 241 HDTDPS 246 (251)
Q Consensus 241 ~~~~~~ 246 (251)
.+|+.-
T Consensus 612 iDWek~ 617 (683)
T KOG0696|consen 612 IDWEKL 617 (683)
T ss_pred ccHHHH
Confidence 999863
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=253.22 Aligned_cols=207 Identities=36% Similarity=0.685 Sum_probs=165.8
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCcc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTLV 82 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~ 82 (251)
.+||||+++++++.++...|++|||+. ++|.+++......+++..+..++.|++.||.|||+ .|++||||+
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~------- 142 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK------- 142 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc-------
Confidence 369999999999999999999999994 58888877556789999999999999999999997 599999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC----C
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG----Y 158 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~ 158 (251)
|+||+++.++.++|+|||.+........ .....++..|+|||.+.+.. +
T Consensus 143 --------------------------p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (296)
T cd06618 143 --------------------------PSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKY 195 (296)
T ss_pred --------------------------HHHEEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCcccc
Confidence 8899999899999999999875543221 12234567899999986543 7
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|+||||+++|+|++|+.||...... .....+.............++.++.+++.+||..||++||+++++++|||
T Consensus 196 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 196 DIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 88999999999999999999999653322 22222222222222223357899999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|+......
T Consensus 276 ~~~~~~~~ 283 (296)
T cd06618 276 IRRYETAE 283 (296)
T ss_pred hhccchhH
Confidence 99765443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=245.45 Aligned_cols=199 Identities=24% Similarity=0.465 Sum_probs=164.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.. ...+++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+|||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~---- 124 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLA---- 124 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccC----
Confidence 467899999999999988 88999999999999999997554 578999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.
T Consensus 125 -----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 175 (257)
T cd05040 125 -----------------------------ARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175 (257)
T ss_pred -----------------------------cccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhccc
Confidence 8888888889999999999976543211 11123356679999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 157 GYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++.++|+||+||++|+|++ |..||...........+... ......+...+..+.+++.+||..+|++|||++|+++
T Consensus 176 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 89999999999999999998 99999766555444333321 1223335567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=247.42 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=164.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++++|.+++......+++.++..++.|++.||.+||+.|++|||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlk----- 133 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA----- 133 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhc-----
Confidence 357899999999999999999999999999999999998656678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc---cccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++++|||.+.......... ....++..|+|||.+.+..
T Consensus 134 ----------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 134 ----------------------------ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred ----------------------------hhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc
Confidence 888888888999999999997654321111 1112245799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+||+||++|++++ |..||.+.........+.... ....+..+++.+.+++.+||+.+|++||+++++++
T Consensus 186 ~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY--RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC--cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999886 999997765544444443332 22234567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=253.63 Aligned_cols=204 Identities=26% Similarity=0.461 Sum_probs=157.5
Q ss_pred CCCCCCCccceeeeeEeeCC--------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT--------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~--------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||+++++++.... ..++||||+. ++|.+++......+++.+++.++.|++.||.|||++|++|+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~ 143 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHR 143 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 35789999999999986543 4699999995 58988887555679999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----ccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----RNTVIGTPFWM 148 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~ 148 (251)
||| |+||+++.++.++|+|||.+......... .....++..|+
T Consensus 144 dl~---------------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~ 190 (310)
T cd07865 144 DMK---------------------------------AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190 (310)
T ss_pred CCC---------------------------------HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcccc
Confidence 988 88999998999999999999755322111 12234577899
Q ss_pred cccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh---cCCCCCCC---------------C--------
Q psy3253 149 APEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM---IPTKPPPS---------------F-------- 201 (251)
Q Consensus 149 aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~---------------~-------- 201 (251)
|||.+.+. .++.++|+||+|+++|+|++|.+||.+.+....... +....+.. .
T Consensus 191 aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (310)
T cd07865 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKV 270 (310)
T ss_pred CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhh
Confidence 99988654 468899999999999999999999966543221111 00000000 0
Q ss_pred ---CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 202 ---REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 202 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
......++.+.++|.+||..||++|||++|+++||||
T Consensus 271 ~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 271 KERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=246.46 Aligned_cols=202 Identities=19% Similarity=0.308 Sum_probs=155.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++||||+.+|+|.++++.....+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nil 132 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVL 132 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 35789999999999999989999999999999999999865667899999999999999999999999999999955554
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
+.-+. .......+.++++|||.+...... ....++..|+|||.+.+ ..++
T Consensus 133 i~~~~-------------------------~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~ 183 (258)
T cd05078 133 LIREE-------------------------DRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLS 183 (258)
T ss_pred Eeccc-------------------------ccccCCCceEEecccccccccCCc----hhccccCCccCchhccCCCCCC
Confidence 44110 000112223799999998654322 22346778999999976 4578
Q ss_pred cchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+||+|+++|++++| .+||...+.......... ....+...+.++.+++.+||+.||++|||++++++.
T Consensus 184 ~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 184 LAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred chhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 899999999999999998 466655544333222111 112244567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=252.97 Aligned_cols=204 Identities=27% Similarity=0.497 Sum_probs=164.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...++|+||+.+ +|.+++......+++..+..++.|++.||.|||+.|++|+|||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~----- 125 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK----- 125 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcC-----
Confidence 3567899999999999999999999999965 8998887656789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 159 (251)
|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++
T Consensus 126 ----------------------------p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 177 (283)
T cd05118 126 ----------------------------PENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177 (283)
T ss_pred ----------------------------HHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCC
Confidence 889999999999999999997665443222234467789999998776 788
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC----C----------------------CCC-CCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK----P----------------------PPS-FREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~----------------------~~~-~~~~~~~~~~~~ 212 (251)
.++|+||+|+++|++++|+.||...+.......+... . ... ......++.++.
T Consensus 178 ~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (283)
T cd05118 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQAL 257 (283)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHH
Confidence 9999999999999999999999655443222111000 0 000 001234678899
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++|.+||+.||.+||+++|+++||||
T Consensus 258 ~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 258 DLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHhccCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.37 Aligned_cols=197 Identities=27% Similarity=0.457 Sum_probs=160.1
Q ss_pred CCCCC-CCccceeeeeE-ee------CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q psy3253 1 MQQCD-SPYVVKYYGSY-FK------NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRR--K 69 (251)
Q Consensus 1 l~~l~-hpniv~l~~~~-~~------~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~--i 69 (251)
||+|. |||||.+++.. .. ...+.|+||||.||+|-++|+++ ...|++.++++|+.+++.|+.+||... |
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi 167 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI 167 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence 56775 99999999933 21 13488999999999999999743 245999999999999999999999987 9
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---------cccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---------KRNT 140 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---------~~~~ 140 (251)
|||||| .+|+|+..++++||||||.+.......+ ....
T Consensus 168 IHRDLK---------------------------------iENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~ 214 (738)
T KOG1989|consen 168 IHRDLK---------------------------------IENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIE 214 (738)
T ss_pred chhhhh---------------------------------hhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHH
Confidence 999988 7788999999999999999975433221 1122
Q ss_pred ccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHH
Q psy3253 141 VIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSR 217 (251)
Q Consensus 141 ~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 217 (251)
..-|+.|+|||.+ .+.+.+.|+|||+|||+||.|+....||.+.....+.... -.++....++..+.+||..
T Consensus 215 k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~-----Y~~P~~p~ys~~l~~LI~~ 289 (738)
T KOG1989|consen 215 KYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN-----YSFPPFPNYSDRLKDLIRT 289 (738)
T ss_pred hhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc-----ccCCCCccHHHHHHHHHHH
Confidence 3468899999988 4678999999999999999999999999876554443221 1223345789999999999
Q ss_pred hhhcCcCccCCHHHHhcC
Q psy3253 218 CLVKNPEERATASEMLNH 235 (251)
Q Consensus 218 ~l~~~p~~Rps~~evl~h 235 (251)
||+.||.+||++-|++.+
T Consensus 290 mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 290 MLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HhccCcccCCCHHHHHHH
Confidence 999999999999999865
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=251.96 Aligned_cols=199 Identities=25% Similarity=0.481 Sum_probs=163.5
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++..+...+++|||+.+|+|.++++.. ...+++..++.++.|++.||.|||
T Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 356 7999999999999999999999999999999999632 246889999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 143 (251)
+.|++||||| |+||+++.++.++|+|||.++........ .....+
T Consensus 150 ~~~ivH~dlk---------------------------------p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 196 (293)
T cd05053 150 SKKCIHRDLA---------------------------------ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196 (293)
T ss_pred HCCccccccc---------------------------------eeeEEEcCCCeEEeCccccccccccccceeccCCCCC
Confidence 9999999988 88888888999999999999755432111 111223
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
+..|+|||.+.+..++.++|||||||++|++++ |..||.+.........+..... ...+...+..+.+++.+||+.|
T Consensus 197 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~ 274 (293)
T cd05053 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEV 274 (293)
T ss_pred CccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccC
Confidence 456999999988889999999999999999997 9999977665554444433322 2235567899999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||++|++++
T Consensus 275 p~~Rps~~eil~~ 287 (293)
T cd05053 275 PSQRPTFKQLVED 287 (293)
T ss_pred cccCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=247.93 Aligned_cols=197 Identities=26% Similarity=0.449 Sum_probs=160.1
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++......+++|||+.+|+|.+++.... ..+++..++.++.|++.||+|||
T Consensus 50 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH 129 (270)
T cd05047 50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129 (270)
T ss_pred HhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456 79999999999999889999999999999999996432 24789999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 145 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 145 (251)
+.|++||||| |+||+++.++.++++|||++...... ........+.
T Consensus 130 ~~~i~H~dik---------------------------------p~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~ 175 (270)
T cd05047 130 QKQFIHRDLA---------------------------------ARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPV 175 (270)
T ss_pred HCCEeecccc---------------------------------cceEEEcCCCeEEECCCCCccccchh-hhccCCCCcc
Confidence 9999999988 88888888999999999998532211 1111122345
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
.|+|||++....++.++|+|||||++|+|++ |..||.+.+.......+..... ...+..++.++.+++.+||..||.
T Consensus 176 ~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~ 253 (270)
T cd05047 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPY 253 (270)
T ss_pred ccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChh
Confidence 6999999988889999999999999999997 9999976655444444433322 223455788999999999999999
Q ss_pred ccCCHHHHhc
Q psy3253 225 ERATASEMLN 234 (251)
Q Consensus 225 ~Rps~~evl~ 234 (251)
+|||++|++.
T Consensus 254 ~Rps~~~il~ 263 (270)
T cd05047 254 ERPSFAQILV 263 (270)
T ss_pred hCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=246.01 Aligned_cols=199 Identities=25% Similarity=0.423 Sum_probs=164.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++......+++|||+.+++|.+++... ...++...+..++.|++.||.|||+.|++|||||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~---- 130 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR---- 130 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc----
Confidence 35789999999999999999999999999999999999643 4568899999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..+
T Consensus 131 -----------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 181 (261)
T cd05072 131 -----------------------------AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181 (261)
T ss_pred -----------------------------hhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCC
Confidence 88888888899999999999765432111 112234567999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||+||++|++++ |..||...........+..... ......++.++.+++.+||..+|++|||++++++
T Consensus 182 ~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 182 TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999998 9999977655554444433322 2234567899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=243.74 Aligned_cols=199 Identities=28% Similarity=0.469 Sum_probs=164.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++++||||+++++++.+....++||||+.+++|.+++......+++..+..++.+++.||.|||++|++|||||
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~----- 120 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA----- 120 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcC-----
Confidence 357899999999999999999999999999999999997656678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc--cccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+.......... .....+..|+|||.+.+..+
T Consensus 121 ----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 121 ----------------------------ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred ----------------------------cceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC
Confidence 888899889999999999987543211111 11223456999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||+|+++|++++ |..||...........+.... ....+..++.++.+++.+||..+|++|||++|+++
T Consensus 173 ~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999998 889997766544444433322 22235667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=264.25 Aligned_cols=209 Identities=30% Similarity=0.546 Sum_probs=190.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|.++.+|.||++|..|.+....||+||-|-||.|+..++ .++.|++..++.++.-+++|+.|||.+|||+||+|
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK----- 547 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK----- 547 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCC-----
Confidence 346789999999999999999999999999999999998 67899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+|.+++.+|-+||.|||+|+.+... .+..++.||+.|.|||++.+...+.
T Consensus 548 ----------------------------PENllLd~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILnKGHD~ 598 (732)
T KOG0614|consen 548 ----------------------------PENLLLDNRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILNKGHDR 598 (732)
T ss_pred ----------------------------hhheeeccCCceEEeehhhHHHhccC-CceeeecCCcccccchhhhccCcch
Confidence 88999999999999999999988765 4566788999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|.||||+++|||++|.+||.+.+++..+..+..+.. .+..|..++....++|.++...+|.+|.. +.++-+|
T Consensus 599 avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 599 AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 99999999999999999999999999988887776643 34457788999999999999999999974 8999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
.||...+|+-
T Consensus 678 ~Wf~gfdweg 687 (732)
T KOG0614|consen 678 RWFEGFDWEG 687 (732)
T ss_pred hhhhcCChhh
Confidence 9999999974
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.76 Aligned_cols=199 Identities=24% Similarity=0.455 Sum_probs=161.2
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
+++ +||||+++++++...+..+++|||+.+|+|.++++... ..+++.++..++.|++.||.|||++|++|+|||
T Consensus 93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk---- 168 (302)
T cd05055 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLA---- 168 (302)
T ss_pred HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhc----
Confidence 467 79999999999999999999999999999999997433 348999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++++|||++........ ......++..|+|||.+.+..
T Consensus 169 -----------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 169 -----------------------------ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred -----------------------------cceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 8888888888899999999975543211 112223466799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++||||+||++|++++ |..||................ .....+...++++.+++.+||+.+|++|||++|+++
T Consensus 220 ~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999998 999997655443332222111 111224456899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=244.08 Aligned_cols=196 Identities=28% Similarity=0.463 Sum_probs=161.4
Q ss_pred CCCCCCCccceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++|||++++++++. ++...+++|||+.+++|.++++.... .+++..+..++.|++.||.|||++|++|||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk--- 129 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLA--- 129 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccc---
Confidence 35789999999999764 55679999999999999999975443 48899999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++++|||++....... .....+..|+|||.+.+..+
T Consensus 130 ------------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 130 ------------------------------ARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred ------------------------------hheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCC
Confidence 888899889999999999986543221 12233557999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++||||+||++|++++ |..||...+.......+...... ..+..+++.+.+++.+||+.+|++|||++++++
T Consensus 177 ~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999997 99999766555444444333222 235667999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.67 Aligned_cols=199 Identities=26% Similarity=0.516 Sum_probs=163.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------------------KTLSEDEIATILCDT 57 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------------------~~l~~~~~~~~~~~i 57 (251)
|+.++||||+++++.+......++++||+.+++|.+++.... ..+++..+..++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 357899999999999999999999999999999999986321 247888999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA- 136 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~- 136 (251)
+.||.|||+.|++||||| |+||+++.++.++|+|||+++.......
T Consensus 137 ~~~l~~LH~~~ivH~dik---------------------------------p~nill~~~~~~kl~dfg~~~~~~~~~~~ 183 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLA---------------------------------ARNVLVAEGRKMKISDFGLSRDVYEEDSY 183 (290)
T ss_pred HHHHHHHHHCCeehhhhh---------------------------------hheEEEcCCCcEEeccccccccccCccch
Confidence 999999999999999988 8888888888999999999875432211
Q ss_pred -cccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHH
Q psy3253 137 -KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214 (251)
Q Consensus 137 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 214 (251)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.... ....+..++.++.++
T Consensus 184 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 261 (290)
T cd05045 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY--RMERPENCSEEMYNL 261 (290)
T ss_pred hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHHHH
Confidence 1122234567999999988889999999999999999998 999997766555444333322 223356678999999
Q ss_pred HHHhhhcCcCccCCHHHHhc
Q psy3253 215 VSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~ 234 (251)
+.+||+.+|++||+++|+++
T Consensus 262 i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 262 MLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=251.54 Aligned_cols=198 Identities=26% Similarity=0.479 Sum_probs=161.8
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++......+++|||+.+|+|.+++.... ..+++.++..++.|++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 69999999999998889999999999999999997432 34788999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 143 (251)
++|++||||| |+||+++.++.++|+|||.++........ .....+
T Consensus 152 ~~gi~H~dlk---------------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 198 (314)
T cd05099 152 SRRCIHRDLA---------------------------------ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198 (314)
T ss_pred HCCeeecccc---------------------------------ceeEEEcCCCcEEEccccccccccccccccccccCCC
Confidence 9999999988 88888888899999999999755422111 111123
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
+..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+..... ...+..++.++.+++.+||+.+
T Consensus 199 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~ 276 (314)
T cd05099 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAV 276 (314)
T ss_pred CccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCC
Confidence 456999999988889999999999999999998 8899977665554444433322 2235667889999999999999
Q ss_pred cCccCCHHHHhc
Q psy3253 223 PEERATASEMLN 234 (251)
Q Consensus 223 p~~Rps~~evl~ 234 (251)
|++|||++|+++
T Consensus 277 p~~Rps~~~ll~ 288 (314)
T cd05099 277 PTQRPTFKQLVE 288 (314)
T ss_pred cccCcCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.71 Aligned_cols=199 Identities=30% Similarity=0.573 Sum_probs=161.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++||||+++++++..+...+++|||+.+++|.+++.. ....+++..+..++.|++.||.|||++|++|+|||
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~--- 133 (267)
T cd08229 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK--- 133 (267)
T ss_pred HHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC---
Confidence 568999999999999999999999999999999998863 23568999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++++|||.+..............++..|+|||.+.+..+
T Consensus 134 ------------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~ 183 (267)
T cd08229 134 ------------------------------PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred ------------------------------HHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCc
Confidence 88888888899999999998755433222233457788999999988889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcc--hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPM--RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||+|+++|++++|..||.+.... .....+.....+.. .+..++.++.+++.+||+.||++|||+++|++
T Consensus 184 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC-CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999999999644322 11122222111111 23457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.99 Aligned_cols=200 Identities=22% Similarity=0.423 Sum_probs=160.5
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLR-----KKTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||+++++++... ...+++|||+.+|+|.+++... ...+++..+..++.|++.||.|||++|+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 133 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF 133 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3578999999999977432 2578999999999999987422 2357899999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
+||||| |+||+++.++.++|+|||+++....... ......+++.|
T Consensus 134 ~H~dlk---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T cd05075 134 IHRDLA---------------------------------ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180 (272)
T ss_pred eccccc---------------------------------hhheEEcCCCCEEECCCCcccccCcccceecCCcccCCccc
Confidence 999988 8888888889999999999976543211 11222346679
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+|||...+..++.++|+|||||++|++++ |..||.+.........+...... ..+..++..+.+++.+||..||++|
T Consensus 181 ~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 258 (272)
T cd05075 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDR 258 (272)
T ss_pred CCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccC
Confidence 99999988889999999999999999999 88999776655544444333222 2345678999999999999999999
Q ss_pred CCHHHHhcC
Q psy3253 227 ATASEMLNH 235 (251)
Q Consensus 227 ps~~evl~h 235 (251)
||++|++++
T Consensus 259 ps~~~l~~~ 267 (272)
T cd05075 259 PSFETLRCE 267 (272)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.39 Aligned_cols=199 Identities=26% Similarity=0.478 Sum_probs=161.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR------KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++......+++|||+.+++|.+++... ...+++.+++.++.|++.||.|||+.+++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 46789999999999999888999999999999999999632 234788999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC-----CeEecccccccccCcccc--ccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-----HAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-----~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
| |+||+++.++ .++++|||++........ ......++..|
T Consensus 133 ~---------------------------------p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y 179 (269)
T cd05044 133 A---------------------------------ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179 (269)
T ss_pred C---------------------------------hheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccc
Confidence 8 6666666555 799999999865432211 11223446779
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+|||.+.+..++.++|||||||++|++++ |..||...+.......+.... ....+..++..+.+++.+||..+|++|
T Consensus 180 ~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (269)
T cd05044 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--RLQKPENCPDKIYQLMTNCWAQDPSER 257 (269)
T ss_pred cCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--ccCCcccchHHHHHHHHHHcCCCcccC
Confidence 99999988889999999999999999998 999997665554444333322 223355678999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
|+++++++
T Consensus 258 p~~~~i~~ 265 (269)
T cd05044 258 PTFDRIQE 265 (269)
T ss_pred CCHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=249.96 Aligned_cols=204 Identities=47% Similarity=0.856 Sum_probs=168.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++.++...++||||+. |+|.+++......+++.++..++.|++.||.|||+.|++||||+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~----- 152 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK----- 152 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 356899999999999999999999999996 58888876566789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
|+||+++.++.++|+|||++...... ....++..|+|||.+. ...
T Consensus 153 ----------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~ 200 (317)
T cd06635 153 ----------------------------AGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAMDEGQ 200 (317)
T ss_pred ----------------------------cccEEECCCCCEEEecCCCccccCCc----ccccCCccccChhhhhcCCCCC
Confidence 88888888899999999988643322 2345678899999974 356
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++|+||+||++|+|++|..||...+.......+........ ....+++.+.+++.+||+.+|++||+++++++|+|
T Consensus 201 ~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 78899999999999999999999977655444443333322222 23457889999999999999999999999999999
Q ss_pred hhhccC
Q psy3253 238 IQRHDT 243 (251)
Q Consensus 238 ~~~~~~ 243 (251)
+....-
T Consensus 280 ~~~~~~ 285 (317)
T cd06635 280 VLRERP 285 (317)
T ss_pred hhccCc
Confidence 965443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=243.33 Aligned_cols=200 Identities=25% Similarity=0.457 Sum_probs=165.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++......+++|||+.+++|.+++......+++..+..++.|++.||.+||+.|++|+|||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~----- 127 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA----- 127 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc-----
Confidence 357899999999999999999999999999999999997656678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++
T Consensus 128 ----------------------------p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~ 179 (256)
T cd05112 128 ----------------------------ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179 (256)
T ss_pred ----------------------------cceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcC
Confidence 88888888889999999998654322111 1122245679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+||+|+++|++++ |..||...........+...... ..+...+.++.+++.+||..+|++|||++|++++
T Consensus 180 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999998 99999776655555444333221 2245568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=257.97 Aligned_cols=210 Identities=25% Similarity=0.454 Sum_probs=163.9
Q ss_pred CCCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
|++++||||+++++++.. ....++||||+. ++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk- 134 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLK- 134 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-
Confidence 457899999999998863 356899999995 58999886 45669999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----ccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----RNTVIGTPFWMAPEV 152 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.
T Consensus 135 --------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~ 182 (334)
T cd07855 135 --------------------------------PSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182 (334)
T ss_pred --------------------------------HHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHH
Confidence 88999999999999999998654332111 123357788999999
Q ss_pred ccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCC--------------------CC--CCC---CC
Q psy3253 153 IQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTK--------------------PP--PSF---RE 203 (251)
Q Consensus 153 ~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~--------------------~~--~~~---~~ 203 (251)
+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+ ... .+ ... ..
T Consensus 183 ~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (334)
T cd07855 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKI 262 (334)
T ss_pred hcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHH
Confidence 865 45788999999999999999999999655432211100 000 00 000 01
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
....+.++.++|++||+.+|++|||+++++.||||++.....
T Consensus 263 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 263 FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 134688999999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=246.78 Aligned_cols=197 Identities=25% Similarity=0.427 Sum_probs=161.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||+++++++.+. ..++++||+.+|+|.++++.....+++..++.++.|++.||.|||++|++|||||
T Consensus 64 ~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlk------ 136 (279)
T cd05109 64 AGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA------ 136 (279)
T ss_pred HhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc------
Confidence 467899999999999754 4789999999999999997656679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||+++........ .....++..|+|||...+..++
T Consensus 137 ---------------------------p~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (279)
T cd05109 137 ---------------------------ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189 (279)
T ss_pred ---------------------------cceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCC
Confidence 88888888888999999999765422111 1112235679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|||||||++|++++ |..||...........+...... ..+..++.++.+++.+||..||++||++.|++.
T Consensus 190 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL--PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999998 99999766554444333332222 224567899999999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.35 Aligned_cols=201 Identities=30% Similarity=0.553 Sum_probs=169.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++||||+++++++.++...++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~-- 130 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK-- 130 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC--
Confidence 35789999999999999999999999999999999998642 3568999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|.||+++.++.++++|||++...... ......++..|+|||.+.+..
T Consensus 131 -------------------------------~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~ 177 (256)
T cd08530 131 -------------------------------SANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRP 177 (256)
T ss_pred -------------------------------cceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCC
Confidence 88888888889999999999765543 222245678899999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++|+||+|+++|++++|..||...+.......+....... .+..++.++.+++.+||..+|++|||++|+++||+
T Consensus 178 ~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 9999999999999999999999998776654444443333222 23467899999999999999999999999999997
Q ss_pred h
Q psy3253 238 I 238 (251)
Q Consensus 238 ~ 238 (251)
+
T Consensus 256 ~ 256 (256)
T cd08530 256 V 256 (256)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.82 Aligned_cols=198 Identities=24% Similarity=0.467 Sum_probs=161.8
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
.+ +||||+++++++......|+||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 45 79999999999999999999999999999999997432 247889999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc--cccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~ 144 (251)
.|++||||| |+||+++.++.++|+|||.+.......... ....++
T Consensus 159 ~gi~H~dlk---------------------------------p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~ 205 (307)
T cd05098 159 KKCIHRDLA---------------------------------ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205 (307)
T ss_pred CCccccccc---------------------------------HHheEEcCCCcEEECCCcccccccccchhhccccCCCc
Confidence 999999988 888888888999999999986543221111 112234
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
..|+|||.+.+..++.++|+||+||++|+|++ |..||.+.........+..... ...+..++.++.+++.+||..+|
T Consensus 206 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred cceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccCh
Confidence 57999999988889999999999999999998 8889876655444443333322 22355678999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++|++++
T Consensus 284 ~~Rps~~evl~~ 295 (307)
T cd05098 284 SQRPTFKQLVED 295 (307)
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=256.82 Aligned_cols=209 Identities=28% Similarity=0.452 Sum_probs=163.4
Q ss_pred CCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
+.++||||+++++++... ...|+++||+. ++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk- 135 (337)
T cd07858 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK- 135 (337)
T ss_pred HhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC-
Confidence 467999999999988643 35899999995 68998886 45679999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 155 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 155 (251)
|+||+++.++.++|+|||++..............++..|+|||.+..
T Consensus 136 --------------------------------p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (337)
T cd07858 136 --------------------------------PSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183 (337)
T ss_pred --------------------------------HHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcC
Confidence 88888888899999999999765433222233456788999998864
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---------------------------CCCCCCC-CCCCCCC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------------PTKPPPS-FREPDVW 207 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------~~~~~~~-~~~~~~~ 207 (251)
..++.++|+||+||++|+|++|.+||.+.+.......+ ....... ......+
T Consensus 184 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (337)
T cd07858 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA 263 (337)
T ss_pred CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccC
Confidence 46889999999999999999999999654321111000 0000000 0112357
Q ss_pred CHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 208 TPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 208 ~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
++++.++|.+||+.+|++|||++|+++||||.......
T Consensus 264 ~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred CHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 88999999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=253.12 Aligned_cols=204 Identities=21% Similarity=0.420 Sum_probs=156.7
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLR----KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++.+. ...++||||+++ +|.+++... ...+++..++.++.|++.||.|||+.|++||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dl 134 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDL 134 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 3578999999999999887 789999999965 777776422 136899999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCC----CCCeEecccccccccCcccc---ccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT----EGHAKLADFGVAGQLTDTMA---KRNTVIGTPFW 147 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~----~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y 147 (251)
| |+||+++. ++.++|+|||++........ ......++..|
T Consensus 135 k---------------------------------p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 181 (316)
T cd07842 135 K---------------------------------PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181 (316)
T ss_pred C---------------------------------HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence 8 77777777 88899999999876543221 12233467889
Q ss_pred cccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh-------------hhhcC-------------------
Q psy3253 148 MAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA-------------IFMIP------------------- 194 (251)
Q Consensus 148 ~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-------------~~~~~------------------- 194 (251)
+|||.+.+ ..++.++|+|||||++|+|++|.+||.+...... ...+.
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence 99998865 4578899999999999999999999965433220 00000
Q ss_pred --CCCCCCCC---------CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 195 --TKPPPSFR---------EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 195 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
........ .....+.++.+++.+||++||++|||++|+++||||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000000 011456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=245.14 Aligned_cols=199 Identities=22% Similarity=0.441 Sum_probs=155.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
+.++||||+++++.+.+....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++|++|||||
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk-- 127 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA-- 127 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEeccccc--
Confidence 46799999999999999999999999999999999997433 234677889999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......++..|+|||++..
T Consensus 128 -------------------------------p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 128 -------------------------------LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred -------------------------------HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhh
Confidence 8899999999999999999864322111 1122234567999998742
Q ss_pred -------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCC---CCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 156 -------IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPP---PSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 156 -------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
..++.++||||+||++|+|++ |..||................. +....+..++..+.+++..|+ .||+
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~ 255 (269)
T cd05042 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPE 255 (269)
T ss_pred ccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcc
Confidence 346789999999999999999 7888876654443332222211 111224467889999999998 5999
Q ss_pred ccCCHHHHhc
Q psy3253 225 ERATASEMLN 234 (251)
Q Consensus 225 ~Rps~~evl~ 234 (251)
+|||++||++
T Consensus 256 ~Rpt~~~v~~ 265 (269)
T cd05042 256 TRPTAEEVHE 265 (269)
T ss_pred cccCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=242.98 Aligned_cols=192 Identities=24% Similarity=0.392 Sum_probs=153.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.. ...++||||+.+|+|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlk----- 128 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVC----- 128 (259)
T ss_pred HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCc-----
Confidence 467899999999999988 77899999999999999998555579999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC-------CeEecccccccccCccccccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-------HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++ .++++|||.+..... .....++..|+|||.+
T Consensus 129 ----------------------------p~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~ 176 (259)
T cd05037 129 ----------------------------GKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECI 176 (259)
T ss_pred ----------------------------cceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhh
Confidence 5666665555 699999999875433 1223456679999999
Q ss_pred ccC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 154 QEI--GYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 154 ~~~--~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.+. .++.++|+||+|+++|++++ |..||...+............ . .+.....++.+++.+||..+|++|||+.
T Consensus 177 ~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 252 (259)
T cd05037 177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--R--LPMPDCAELANLINQCWTYDPTKRPSFR 252 (259)
T ss_pred cCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--C--CCCCCchHHHHHHHHHhccChhhCCCHH
Confidence 776 78899999999999999999 578886654332222111111 1 1222348899999999999999999999
Q ss_pred HHhc
Q psy3253 231 EMLN 234 (251)
Q Consensus 231 evl~ 234 (251)
|+++
T Consensus 253 ~il~ 256 (259)
T cd05037 253 AILR 256 (259)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=245.29 Aligned_cols=200 Identities=23% Similarity=0.439 Sum_probs=162.5
Q ss_pred CCCCCCCccceeeeeEeeCCe------EEEEEEccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIMRLR-----KKTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||+++++++..... .+++|||+.+|+|..++... ...+++..+..++.|++.||.|||++|+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i 134 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356899999999998865443 79999999999999988532 2368999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y 147 (251)
+||||| |+||+++.++.++|+|||.++........ .....++..|
T Consensus 135 ~H~dlk---------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 181 (273)
T cd05035 135 IHRDLA---------------------------------ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181 (273)
T ss_pred eccccc---------------------------------hheEEECCCCeEEECCccceeeccccccccccccccCCccc
Confidence 999988 88888888899999999998755332211 1112245679
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+|||.+.+..++.++||||+||++|++++ |.+||.+.........+..... ...+..++..+.+++.+||+.||++|
T Consensus 182 ~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 259 (273)
T cd05035 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDR 259 (273)
T ss_pred cCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhC
Confidence 99999988889999999999999999999 8999977665555544443332 23356789999999999999999999
Q ss_pred CCHHHHhcC
Q psy3253 227 ATASEMLNH 235 (251)
Q Consensus 227 ps~~evl~h 235 (251)
||+.|++.+
T Consensus 260 p~~~e~~~~ 268 (273)
T cd05035 260 PTFTKLREV 268 (273)
T ss_pred cCHHHHHHH
Confidence 999999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=242.05 Aligned_cols=196 Identities=27% Similarity=0.476 Sum_probs=163.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~---- 129 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA---- 129 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcc----
Confidence 357899999999999998889999999999999999997443 368999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+........ ....+..|+|||.+....++
T Consensus 130 -----------------------------p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~ 177 (256)
T cd05039 130 -----------------------------ARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFS 177 (256)
T ss_pred -----------------------------cceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCC
Confidence 8889998899999999999976532211 22345569999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+|+++|++++ |..||...........+..... ...+..+++++.+++.+||..+|++|||++|+++
T Consensus 178 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999997 9999976655544433333322 2234567899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=244.02 Aligned_cols=200 Identities=23% Similarity=0.403 Sum_probs=154.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
|++++||||+++++++.+....++||||+.+|+|.++++... ..+++..++.++.|++.||.|||+.|++|+|||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlk- 127 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLA- 127 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccC-
Confidence 357899999999999998889999999999999999996432 245677888999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.+++++|+|||.+........ ......++..|+|||++.
T Consensus 128 --------------------------------p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 128 --------------------------------LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred --------------------------------cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhc
Confidence 7888888888999999999864332211 112234567799999985
Q ss_pred cC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCC---CCCCCCCHHHHHHHHHhhhcCc
Q psy3253 155 EI-------GYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSF---REPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 155 ~~-------~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p 223 (251)
+. .++.++|+||+|+++|++++ |..||.................... ......++.+.+++++|+ .+|
T Consensus 176 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P 254 (269)
T cd05087 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQP 254 (269)
T ss_pred cccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCc
Confidence 42 35789999999999999996 9999976554443322111111111 112346788999999998 689
Q ss_pred CccCCHHHHhc
Q psy3253 224 EERATASEMLN 234 (251)
Q Consensus 224 ~~Rps~~evl~ 234 (251)
++|||++|++.
T Consensus 255 ~~Rpt~~~l~~ 265 (269)
T cd05087 255 EQRPSAEEVHL 265 (269)
T ss_pred ccCCCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=249.04 Aligned_cols=199 Identities=23% Similarity=0.457 Sum_probs=163.6
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+.+ +||||+++++++......+++|||+.+|+|.+++.... ..++...+..++.||+.||.|||
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 356 79999999999999999999999999999999997432 24678889999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 143 (251)
++|++||||| |+||+++.++.++|+|||.++........ .....+
T Consensus 155 ~~givH~dlk---------------------------------p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~ 201 (304)
T cd05101 155 SQKCIHRDLA---------------------------------ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201 (304)
T ss_pred HCCeeecccc---------------------------------cceEEEcCCCcEEECCCccceecccccccccccCCCC
Confidence 9999999988 88888888899999999999765432211 122234
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
+..|+|||.+.+..++.++||||||+++|++++ |..||.+.........+..... ...+..++.++.+++.+||..+
T Consensus 202 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~ 279 (304)
T cd05101 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAI 279 (304)
T ss_pred CceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccC
Confidence 567999999988889999999999999999998 7888877666555544433322 2235567899999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||+.|+++.
T Consensus 280 p~~Rps~~e~l~~ 292 (304)
T cd05101 280 PSHRPTFKQLVED 292 (304)
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=277.71 Aligned_cols=206 Identities=29% Similarity=0.448 Sum_probs=177.2
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+++=|++++.+|++..++||||||+.||+|-.++.... .+++..++.++..|+.||..+|+.|+||||||
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiK--------- 202 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIK--------- 202 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCC---------
Confidence 56779999999999999999999999999999998444 89999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccC-cccccccccccccccccccccc----c-CCC
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQ----E-IGY 158 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~----~-~~~ 158 (251)
|+||+++..|++||+|||.|.... +........+|||-|.|||++. + +.|
T Consensus 203 ------------------------PDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~y 258 (1317)
T KOG0612|consen 203 ------------------------PDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEY 258 (1317)
T ss_pred ------------------------cceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCcccc
Confidence 999999999999999999998776 4445567789999999999994 2 568
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC---HHHHhc
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERAT---ASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~evl~ 234 (251)
++.+|-||+||++|+|+.|..||....-...+..|..- ....++....+|.+..+||.+++. +|+.|.. ++++-+
T Consensus 259 G~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 259 GRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 88999999999999999999999766555555544432 233333335589999999999876 4889988 999999
Q ss_pred ChhhhhccCCC
Q psy3253 235 HEFIQRHDTDP 245 (251)
Q Consensus 235 hp~~~~~~~~~ 245 (251)
||||.+.+|+.
T Consensus 338 HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 338 HPFFEGIDWDN 348 (1317)
T ss_pred CccccCCChhh
Confidence 99999999954
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.20 Aligned_cols=202 Identities=45% Similarity=0.843 Sum_probs=166.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||++++++++......++||||+. |+|.+++......+++.++..++.|++.||.|||+.|++|||||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~----- 142 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK----- 142 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-----
Confidence 356899999999999999999999999996 58888876556779999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
|+||+++.++.++++|||++...... ....++..|+|||.+. ...
T Consensus 143 ----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~ 190 (308)
T cd06634 143 ----------------------------AGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQ 190 (308)
T ss_pred ----------------------------HHhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCC
Confidence 88889888899999999998654322 2235678899999974 345
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++||||+||++|++++|..||...+.......+.....+.. ....++..+.++|.+||..+|++||+++++++|||
T Consensus 191 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 78899999999999999999999976654443333333322221 23457889999999999999999999999999999
Q ss_pred hhhc
Q psy3253 238 IQRH 241 (251)
Q Consensus 238 ~~~~ 241 (251)
+...
T Consensus 270 ~~~~ 273 (308)
T cd06634 270 VLRE 273 (308)
T ss_pred cccc
Confidence 9764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=262.50 Aligned_cols=205 Identities=26% Similarity=0.461 Sum_probs=177.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++|||||+++++......+|+||||+.+|.+++++. +.+...+..+..++.|++.|++|||+++|+|||||
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk----- 182 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLK----- 182 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccc-----
Confidence 578999999999999999999999999999999999998 56677779999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC-
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD- 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~- 159 (251)
.+|++++.+..+||+|||++..+... .......|++.|.|||++.+.++.
T Consensus 183 ----------------------------~eNilL~~~mnikIaDfgfS~~~~~~-~~lqt~cgsppyAaPEl~~g~~y~g 233 (596)
T KOG0586|consen 183 ----------------------------AENILLDENMNIKIADFGFSTFFDYG-LMLQTFCGSPPYAAPELFNGKKYDG 233 (596)
T ss_pred ----------------------------hhhcccccccceeeeccccceeeccc-ccccccCCCCCccChHhhcCcccCC
Confidence 77889999999999999999766533 344566789999999999987764
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
+.+|+||+|+++|.++.|..||.+.+-.......... .+..+..++.++.++|.++|.++|.+|+++++++.|.|..
T Consensus 234 pe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g---k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 234 PEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG---KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred cceehhhhhhhheeeeecccccCCcccccccchheee---eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 5799999999999999999999876555444333332 4455777899999999999999999999999999999986
Q ss_pred hccC
Q psy3253 240 RHDT 243 (251)
Q Consensus 240 ~~~~ 243 (251)
....
T Consensus 311 ~~~~ 314 (596)
T KOG0586|consen 311 DLLE 314 (596)
T ss_pred hhhh
Confidence 5433
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=269.09 Aligned_cols=206 Identities=50% Similarity=0.964 Sum_probs=190.0
Q ss_pred CCCCCccceeeeeEe-----eCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 3 QCDSPYVVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 3 ~l~hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
..+|||++.+|++|. .++.++||||||.|||..++++.. +..+.|..+.-++..++.|+.+||...++|||||
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDik- 150 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIK- 150 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeeccc-
Confidence 348999999999996 456799999999999999999733 4678899999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
-.||+++.++.+|+.|||.+.+.+....+..+..||++|||||++...
T Consensus 151 --------------------------------G~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 151 --------------------------------GQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred --------------------------------CceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecc
Confidence 889999999999999999999988887888999999999999999643
Q ss_pred -----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 157 -----GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 157 -----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
.|+..+|+||||++..+|..|.+|+.+.-+....+.+..++++.+..+..++.+|.++|..||..|.++||+..+
T Consensus 199 e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ 278 (953)
T KOG0587|consen 199 ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE 278 (953)
T ss_pred cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhh
Confidence 367789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcChhhhhc
Q psy3253 232 MLNHEFIQRH 241 (251)
Q Consensus 232 vl~hp~~~~~ 241 (251)
+|.|||.++.
T Consensus 279 ll~hpFi~e~ 288 (953)
T KOG0587|consen 279 LLKHPFITEQ 288 (953)
T ss_pred hccCCccccc
Confidence 9999999843
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.67 Aligned_cols=208 Identities=27% Similarity=0.469 Sum_probs=168.5
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++ +||||+++++.+..+...|+||||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~----- 132 (290)
T cd05613 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIK----- 132 (290)
T ss_pred HhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-----
Confidence 355 69999999999999999999999999999999997 34678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc--CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE--IG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~ 157 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..
T Consensus 133 ----------------------------p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 184 (290)
T cd05613 133 ----------------------------LENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184 (290)
T ss_pred ----------------------------HHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCC
Confidence 8899998899999999999875433211 1223446788999999865 34
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----C
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----T 228 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s 228 (251)
++.++|+||+|+++|++++|..||...... .....+.... . ..+..+++.+.+++.+||+.||++|| +
T Consensus 185 ~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~ 261 (290)
T cd05613 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-P--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSD 261 (290)
T ss_pred CCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-C--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 678899999999999999999999643221 1111121221 1 22455789999999999999999997 8
Q ss_pred HHHHhcChhhhhccCCCC
Q psy3253 229 ASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~~~ 246 (251)
+++++.||||++.+|+..
T Consensus 262 ~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 262 ADEIKKHPFFQKINWDDL 279 (290)
T ss_pred HHHHHcCcccccCCHHHH
Confidence 999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=249.14 Aligned_cols=203 Identities=33% Similarity=0.550 Sum_probs=163.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++|||++++++++......++|+||+. ++|.+++......+++..+..++.|++.||.+||++|++||||+
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~------ 125 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK------ 125 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC------
Confidence 56789999999999999999999999997 59999998554689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 160 (251)
|+||+++.++.++|+|||.+...............+..|+|||.+.+. .++.
T Consensus 126 ---------------------------~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 178 (282)
T cd07829 126 ---------------------------PQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178 (282)
T ss_pred ---------------------------hheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCc
Confidence 889999999999999999987654332222233456779999998765 7889
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC--------------------CCCCCC------CCCCCCCHHHHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT--------------------KPPPSF------REPDVWTPEFIDF 214 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~------~~~~~~~~~~~~l 214 (251)
++|+||+|+++|++++|.+||...........+.. ...+.. ......+..+.++
T Consensus 179 ~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (282)
T cd07829 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDL 258 (282)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHH
Confidence 99999999999999999999966543222111100 000000 0112347889999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhh
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.+||..||++||+++++++||||
T Consensus 259 i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 259 LSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHhhccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=244.30 Aligned_cols=199 Identities=25% Similarity=0.428 Sum_probs=163.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+.+++|.+++....+.+++.+++.++.|++.||.|||++|++|+|||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~----- 133 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA----- 133 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC-----
Confidence 357899999999999999999999999999999999998666779999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccc--ccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVI--GTPFWMAPEVIQE 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~--~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++++|||.+......... ..... .+..|+|||.+.+
T Consensus 134 ----------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 134 ----------------------------ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred ----------------------------hheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc
Confidence 88999988899999999998654322111 11111 1346999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+||++|++++ |..||...+.......+.... ....+..++..+.+++.+||..+|++||++++++.
T Consensus 186 ~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 889999999999999999886 999997765554444443322 22234567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=242.68 Aligned_cols=200 Identities=33% Similarity=0.585 Sum_probs=161.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++|+|++++++++..+...+++|||+.+++|.+++... ...+++..+..++.+++.||.|||+.|++|||||
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~-- 133 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIK-- 133 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcC--
Confidence 35789999999999999999999999999999999998632 3568999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++++|||.+..............++..|.|||.+.+..
T Consensus 134 -------------------------------p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 182 (267)
T cd08224 134 -------------------------------PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred -------------------------------hhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC
Confidence 8899998899999999999865443322233345778899999998888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCc--chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|+||+|+++|++++|..||..... ......+........ ....++..+.++|.+||..+|++|||+.++++
T Consensus 183 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL-PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC-ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999954322 112222222211111 12256889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=247.21 Aligned_cols=201 Identities=21% Similarity=0.360 Sum_probs=160.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----------KTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|++++||||+++++++..+...+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 357899999999999999999999999999999999997433 2689999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWM 148 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~ 148 (251)
||||| |+||+++.++.++|+|||.+....... .......++..|+
T Consensus 153 H~dlk---------------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 199 (296)
T cd05051 153 HRDLA---------------------------------TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWM 199 (296)
T ss_pred ccccc---------------------------------hhceeecCCCceEEccccceeecccCcceeecCcCCCCceec
Confidence 99988 888888888999999999986543221 1122334566799
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcchhhhhcCC-----CCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAE--GKPPYGDIHPMRAIFMIPT-----KPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
|||.+.+..++.++|||||||++|++++ +..||.............. ........+..++.++.+++.+||+.
T Consensus 200 aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 200 AWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279 (296)
T ss_pred CHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhcc
Confidence 9999988889999999999999999998 7788865544333222211 11112223455688999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
||++|||++|+++
T Consensus 280 ~p~~Rpt~~el~~ 292 (296)
T cd05051 280 DEEDRPTFREIHL 292 (296)
T ss_pred ChhcCCCHHHHHH
Confidence 9999999999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=249.99 Aligned_cols=207 Identities=29% Similarity=0.474 Sum_probs=167.8
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++ +||||+++++.+..+...|+||||+.+|+|.+++. ....+++..++.++.|++.||.|||+.|++|||||
T Consensus 59 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~----- 132 (288)
T cd05583 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIK----- 132 (288)
T ss_pred HhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCC-----
Confidence 356 69999999999999999999999999999999986 34678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCC--
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIG-- 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-- 157 (251)
|+||+++.++.++++|||++........ ......++..|+|||.+.+..
T Consensus 133 ----------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 184 (288)
T cd05583 133 ----------------------------LENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184 (288)
T ss_pred ----------------------------HHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCC
Confidence 8899998889999999999876443221 122234678899999987654
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC---HH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT---AS 230 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ 230 (251)
.+.++|+||+|+++|+|++|..||...... .....+... ....+..++..+.+++.+||+.||++||| +.
T Consensus 185 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~ 261 (288)
T cd05583 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGAD 261 (288)
T ss_pred CcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHH
Confidence 788999999999999999999999543221 111111122 12234567899999999999999999998 56
Q ss_pred HHhcChhhhhccCCC
Q psy3253 231 EMLNHEFIQRHDTDP 245 (251)
Q Consensus 231 evl~hp~~~~~~~~~ 245 (251)
++++||||+..+|+.
T Consensus 262 ~~l~~~~~~~~~~~~ 276 (288)
T cd05583 262 EIKNHPFFQGIDWDD 276 (288)
T ss_pred HHhcCcccccCCHHH
Confidence 779999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.50 Aligned_cols=210 Identities=26% Similarity=0.485 Sum_probs=162.0
Q ss_pred CCCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++... .+.|+++||+. ++|.+++. ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlk 133 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLK 133 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 3578999999999987543 35899999996 58888775 4679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEV 152 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.
T Consensus 134 ---------------------------------p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (336)
T cd07849 134 ---------------------------------PSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180 (336)
T ss_pred ---------------------------------HHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHH
Confidence 88999999999999999998765432111 122356888999998
Q ss_pred ccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCC--------------------C--CCC---CC
Q psy3253 153 IQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKP--------------------P--PSF---RE 203 (251)
Q Consensus 153 ~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~--------------------~--~~~---~~ 203 (251)
+.+ ..++.++|+||+||++|+|++|++||.+.+.......+ .... + ... ..
T Consensus 181 ~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T cd07849 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL 260 (336)
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH
Confidence 754 56888999999999999999999999654322211100 0000 0 000 00
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
....++++.+++.+||+.+|++|||++|+++||||+....+..
T Consensus 261 ~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 261 FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 1235788999999999999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=245.84 Aligned_cols=202 Identities=27% Similarity=0.435 Sum_probs=160.7
Q ss_pred CCCCCCccceeeeeEeeCCe-----EEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++..... .+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 35679999999999987766 999999996 48999886433 368999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 135 ---------------------------------~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 135 ---------------------------------PQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred ---------------------------------hhhEEEccCCCEEEeccCcceeccCCc-ccccccccccccChHHhcc
Confidence 889999999999999999987654332 2223346778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-----------------------CCCC-CCCCCCCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-----------------------PPPS-FREPDVWTPEF 211 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------~~~~-~~~~~~~~~~~ 211 (251)
..++.++|+||+||++|+|++|.+||.+.........+... .... .......++.+
T Consensus 181 ~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (287)
T cd07838 181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG 260 (287)
T ss_pred CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHH
Confidence 88999999999999999999999999765443322111100 0000 00012345778
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.||++||+++|+++||||
T Consensus 261 ~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 261 LDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=242.29 Aligned_cols=198 Identities=28% Similarity=0.456 Sum_probs=164.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++......+++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+|||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~---- 130 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA---- 130 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc----
Confidence 357899999999999998889999999999999999997433 468999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++++|||.+......... .....++..|+|||.+.+..+
T Consensus 131 -----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 181 (261)
T cd05034 131 -----------------------------ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181 (261)
T ss_pred -----------------------------hheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCc
Confidence 88889988999999999998765432111 111223557999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
+.++|+||+|+++|++++ |+.||.+.+.......+..... ...+...+.++.+++.+||+.+|++||+++|++
T Consensus 182 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR--MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 999999999999999998 9999977665554444433322 223455689999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=246.08 Aligned_cols=199 Identities=25% Similarity=0.420 Sum_probs=161.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------------CCCCHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------------KTLSEDEIATILCDTLK 59 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------------~~l~~~~~~~~~~~i~~ 59 (251)
|++++||||+++++++..+.+.+++|||+.+|+|.+++.... ..+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 356899999999999999999999999999999999996322 24678889999999999
Q ss_pred HHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--c
Q psy3253 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--K 137 (251)
Q Consensus 60 ~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 137 (251)
||.|||++|++||||| |+||+++.++.++|+|||.+........ .
T Consensus 142 aL~~lH~~~i~H~dl~---------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 188 (288)
T cd05050 142 GMAYLSERKFVHRDLA---------------------------------TRNCLVGENMVVKIADFGLSRNIYSADYYKA 188 (288)
T ss_pred HHHHHHhCCeeccccc---------------------------------HhheEecCCCceEECccccceecccCccccc
Confidence 9999999999999988 8888888889999999999865432211 1
Q ss_pred ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHH
Q psy3253 138 RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVS 216 (251)
Q Consensus 138 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 216 (251)
......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...... ..+..++.++.+++.
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 266 (288)
T cd05050 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMR 266 (288)
T ss_pred cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHH
Confidence 112234567999999988889999999999999999997 88888766555544444333221 234567899999999
Q ss_pred HhhhcCcCccCCHHHHhc
Q psy3253 217 RCLVKNPEERATASEMLN 234 (251)
Q Consensus 217 ~~l~~~p~~Rps~~evl~ 234 (251)
+||+.+|++|||++|+++
T Consensus 267 ~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 267 LCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=243.51 Aligned_cols=199 Identities=27% Similarity=0.452 Sum_probs=162.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+ ...++||||+.+++|.+++......+++..+..++.|++.||+|||+.|++|||||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~----- 134 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA----- 134 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC-----
Confidence 357899999999999865 45789999999999999997555678999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||++......... .....++..|+|||.+.+..++
T Consensus 135 ----------------------------p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (270)
T cd05056 135 ----------------------------ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186 (270)
T ss_pred ----------------------------hheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCC
Confidence 88888888889999999998755432111 1112234569999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++||||||+++|++++ |..||...........+...... ..+..++.++.+++.+||..+|++|||+++++..
T Consensus 187 ~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999986 99999776655544444333222 2356778999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=257.72 Aligned_cols=198 Identities=25% Similarity=0.479 Sum_probs=159.2
Q ss_pred CCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------------------------------------
Q psy3253 2 QQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------------------------------- 42 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------------------------------- 42 (251)
+++. ||||+++++++......|+|||||.+|+|.+++..+.
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 4564 9999999999999999999999999999999986431
Q ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 43 ---------------------------------------------------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 43 ---------------------------------------------------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
..+++..+..++.|++.||.|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 24677888999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 143 (251)
+.|++||||| |+||+++.++.++|+|||++........ ......+
T Consensus 255 ~~~ivH~dik---------------------------------p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 301 (400)
T cd05105 255 SKNCVHRDLA---------------------------------ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301 (400)
T ss_pred hCCeeCCCCC---------------------------------hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCC
Confidence 9999999988 8888888888999999999875432211 1222345
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhh-hcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIF-MIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
+..|+|||.+.+..++.++|||||||++|++++ |..||.......... .+.... ....+..++.++.+++.+||+.
T Consensus 302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHCcc
Confidence 677999999988889999999999999999997 889987654332222 222221 2233566789999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
||++|||+.++.+
T Consensus 380 dP~~RPt~~~l~~ 392 (400)
T cd05105 380 EPEKRPSFLHLSD 392 (400)
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=241.53 Aligned_cols=197 Identities=25% Similarity=0.418 Sum_probs=161.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||++++++++. ....+++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.|++|||||
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~---- 129 (260)
T cd05070 55 MKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR---- 129 (260)
T ss_pred HHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc----
Confidence 45789999999999885 45689999999999999998743 3458999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||...+..+
T Consensus 130 -----------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 180 (260)
T cd05070 130 -----------------------------SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180 (260)
T ss_pred -----------------------------cceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCC
Confidence 88888888889999999999654322111 112234556999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
+.++|+||||+++|++++ |.+||.+.+.......+..... ...+...+..+.+++.+||..+|++|||++++.
T Consensus 181 ~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 999999999999999999 8999977666555554443322 223556789999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=235.36 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=158.0
Q ss_pred CCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q psy3253 2 QQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRR--KIH 71 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH 71 (251)
++++||||+++++....+ ...|++++|...|||.+.++.. +..+++.+++.++.+++.||++||+.. +.|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 478999999998877533 3499999999999999999633 346899999999999999999999998 999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc---------cccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT---------MAKRNTVI 142 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~ 142 (251)
|||| |.||+++..+.+++.|||.+....-. -..+....
T Consensus 153 ~DiK---------------------------------P~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~ 199 (302)
T KOG2345|consen 153 RDIK---------------------------------PANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEER 199 (302)
T ss_pred cCCC---------------------------------cceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHh
Confidence 9988 88899988999999999999765321 11233456
Q ss_pred ccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc--chhhhhcCCCCCCCCCCCCCCCHHHHHHHHH
Q psy3253 143 GTPFWMAPEVIQE---IGYDCVADMWSLGITALEMAEGKPPYGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSR 217 (251)
Q Consensus 143 ~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 217 (251)
+|..|+|||.+.- ...+.++|||||||++|.|+.|..||..... ......+. +....++....++..+.++|++
T Consensus 200 Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~-n~q~s~P~~~~yse~l~~lik~ 278 (302)
T KOG2345|consen 200 CTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ-NAQISIPNSSRYSEALHQLIKS 278 (302)
T ss_pred CCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee-ccccccCCCCCccHHHHHHHHH
Confidence 7899999999953 4578899999999999999999999943221 11111111 1122233334489999999999
Q ss_pred hhhcCcCccCCHHHHhcC
Q psy3253 218 CLVKNPEERATASEMLNH 235 (251)
Q Consensus 218 ~l~~~p~~Rps~~evl~h 235 (251)
||+.||.+||++.|++.+
T Consensus 279 mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 279 MLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HhcCCcccCCCHHHHHHH
Confidence 999999999999999864
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=240.41 Aligned_cols=198 Identities=28% Similarity=0.503 Sum_probs=164.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++.+....+++|||+.+++|.+++...... +++..+..++.|++.||.+||+.|++|+|||
T Consensus 56 ~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~----- 130 (258)
T smart00219 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLA----- 130 (258)
T ss_pred HhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccc-----
Confidence 5679999999999999989999999999999999999744444 9999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccc-ccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++++|||.+........... ...++..|+|||.+.+..++
T Consensus 131 ----------------------------~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 131 ----------------------------ARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred ----------------------------cceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCC
Confidence 8888998899999999999976543311111 12356789999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+|+++|++++ |.+||...+.......+...... ..+..++.++.+++.+||+.+|++|||++|+++
T Consensus 183 ~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 183 SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999998 88998766555544444333322 234557999999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.33 Aligned_cols=207 Identities=35% Similarity=0.642 Sum_probs=175.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.-++|||+|++||+=.+.+..++.||||++|+|.++++ .+...++...+.+..|++.|+.|||++||||||||
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK------ 1361 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK------ 1361 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC------
Confidence 45799999999999999999999999999999999997 56778999999999999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc----cccccccccccccccccccc--
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQE-- 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-- 155 (251)
|.||+++.+|.+|++|||.|..+.... ..-....||+.|||||++.+
T Consensus 1362 ---------------------------~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1362 ---------------------------PANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred ---------------------------ccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 889999999999999999998765432 12234579999999999965
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
.+-..++||||+||++.||+||+.||...+.. ..++.+..+..++. |..++++-++||..||..||++|-++.|++
T Consensus 1415 ~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~--P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1415 GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI--PERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC--chhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 34556899999999999999999999766554 33444444444444 566999999999999999999999999999
Q ss_pred cChhhhhccCC
Q psy3253 234 NHEFIQRHDTD 244 (251)
Q Consensus 234 ~hp~~~~~~~~ 244 (251)
+|-|-+....+
T Consensus 1493 e~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1493 EHAFGKSCTDE 1503 (1509)
T ss_pred Hhhcccccccc
Confidence 99998755443
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=241.30 Aligned_cols=202 Identities=36% Similarity=0.624 Sum_probs=166.0
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++.+.+. ..+++++||+.+++|.+++. ....+++..++.++.|++.||.|||++|++|+|||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~--- 133 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIK--- 133 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC---
Confidence 3578999999999998754 46899999999999999987 44568999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc---cccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 134 ------------------------------p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 134 ------------------------------GANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred ------------------------------HHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC
Confidence 888898888999999999997543211 11122346788999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++|+|||||++|++++|..||...........+.... .....+..+++.+.+++.+||+. |.+||++.+++.|
T Consensus 184 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP-TKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC-CCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 888999999999999999999999997765555444333222 22234677899999999999994 7999999999999
Q ss_pred hhh
Q psy3253 236 EFI 238 (251)
Q Consensus 236 p~~ 238 (251)
||.
T Consensus 262 ~~~ 264 (264)
T cd06653 262 PFV 264 (264)
T ss_pred CCC
Confidence 984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=240.77 Aligned_cols=197 Identities=25% Similarity=0.413 Sum_probs=160.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||++++++++. ....+++|||+.+++|.++++... ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~---- 129 (260)
T cd05069 55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR---- 129 (260)
T ss_pred HHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC----
Confidence 35789999999999885 456899999999999999997433 358899999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||...+..+
T Consensus 130 -----------------------------~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 180 (260)
T cd05069 130 -----------------------------AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180 (260)
T ss_pred -----------------------------cceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCc
Confidence 8888998899999999999965432211 1112234567999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
+.++|+||+|+++|++++ |..||.+.........+...... ..+...+..+.+++.+||..||++||++++++
T Consensus 181 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 254 (260)
T cd05069 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--PCPQGCPESLHELMKLCWKKDPDERPTFEYIQ 254 (260)
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 999999999999999999 99999776655544444333222 23456789999999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=245.21 Aligned_cols=201 Identities=20% Similarity=0.366 Sum_probs=159.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----------KTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|++++||||+++++++..+...+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 357899999999999999999999999999999999997432 2367788999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWM 148 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 148 (251)
||||| |+||+++.++.++|+|||++........ .......+..|+
T Consensus 153 H~dlk---------------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 199 (296)
T cd05095 153 HRDLA---------------------------------TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWM 199 (296)
T ss_pred cccCC---------------------------------hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccC
Confidence 99988 8888888889999999999875432211 112223356799
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcchhhhhc-----CCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAE--GKPPYGDIHPMRAIFMI-----PTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
|||...+..++.++|+|||||++|++++ |..||............ ..........+..+++.+.+++.+||+.
T Consensus 200 ~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 279 (296)
T cd05095 200 SWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279 (296)
T ss_pred CHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCC
Confidence 9999888889999999999999999998 77888655443332211 0111112233456789999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
||++|||++|+++
T Consensus 280 ~p~~Rp~~~~i~~ 292 (296)
T cd05095 280 NAKERPSFQEIHA 292 (296)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=245.64 Aligned_cols=201 Identities=20% Similarity=0.369 Sum_probs=159.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------KTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||+++++++......++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 150 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 457899999999999999999999999999999999986332 236788999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
+||||| |+||+++.++.++|+|||++........ ......++..|
T Consensus 151 ~H~dlk---------------------------------p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 197 (295)
T cd05097 151 VHRDLA---------------------------------TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197 (295)
T ss_pred eccccC---------------------------------hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceee
Confidence 999988 8888888888999999999865432211 11222345679
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcchhhhhcCC-----CCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE--GKPPYGDIHPMRAIFMIPT-----KPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
+|||.+.+..++.++|+|||||++|+|++ +..||.............. ........+..+++.+.+++.+||+
T Consensus 198 ~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 277 (295)
T cd05097 198 MAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWS 277 (295)
T ss_pred cChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcC
Confidence 99999988889999999999999999988 6678866554443322110 1111122345578999999999999
Q ss_pred cCcCccCCHHHHhc
Q psy3253 221 KNPEERATASEMLN 234 (251)
Q Consensus 221 ~~p~~Rps~~evl~ 234 (251)
.||++|||++++++
T Consensus 278 ~~p~~RPs~~~i~~ 291 (295)
T cd05097 278 RDIKDRPTFNKIHH 291 (295)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999973
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=241.53 Aligned_cols=199 Identities=19% Similarity=0.384 Sum_probs=154.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+.++||||+++++.+.+....|+||||+.+|+|.++++... ..+++..++.++.||+.||.|||+++++|||||
T Consensus 50 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dik--- 126 (268)
T cd05086 50 RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLA--- 126 (268)
T ss_pred hccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCc---
Confidence 46899999999999999999999999999999999997432 346777888999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccccccccccccc-
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQE- 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~- 155 (251)
|+||+++.++.++|+|||++....... .......++..|+|||++..
T Consensus 127 ------------------------------p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (268)
T cd05086 127 ------------------------------LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176 (268)
T ss_pred ------------------------------cceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence 888888888999999999985422111 11223456778999998743
Q ss_pred ------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCC---CCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 156 ------IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPP---SFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 156 ------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
..++.++|+||||+++|+|++ |..||...........+...... ....+..+++.+.+++..|| .+|++
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~ 255 (268)
T cd05086 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEK 255 (268)
T ss_pred cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCccc
Confidence 245778999999999999997 57788665554433332222111 11223457889999999999 67999
Q ss_pred cCCHHHHhc
Q psy3253 226 RATASEMLN 234 (251)
Q Consensus 226 Rps~~evl~ 234 (251)
||+++|+++
T Consensus 256 Rp~~~~i~~ 264 (268)
T cd05086 256 RATAEEVHR 264 (268)
T ss_pred CCCHHHHHH
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=243.06 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=156.1
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++... ...+++|||+.+++|.+++.. ..+++.++..++.|++.||.|||++|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlk--- 134 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLA--- 134 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC---
Confidence 4578999999999988653 468999999999999999863 469999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---cccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+
T Consensus 135 ------------------------------p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 135 ------------------------------ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred ------------------------------hheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc
Confidence 88888888899999999998765432111 111234556999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh--hhhcC-----------CCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA--IFMIP-----------TKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
..++.++|+||||+++|+|++|..||........ ..... .........+..++.++.+++.+||+.+
T Consensus 185 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (283)
T cd05080 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264 (283)
T ss_pred cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 8899999999999999999999999854321100 00000 0001112234567899999999999999
Q ss_pred cCccCCHHHHhc
Q psy3253 223 PEERATASEMLN 234 (251)
Q Consensus 223 p~~Rps~~evl~ 234 (251)
|++|||++++++
T Consensus 265 p~~Rps~~~i~~ 276 (283)
T cd05080 265 AKFRPTFRSLIP 276 (283)
T ss_pred hhhCCCHHHHHH
Confidence 999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=240.91 Aligned_cols=198 Identities=27% Similarity=0.476 Sum_probs=161.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++ .....+++|||+.+++|.+++... +..+++.++..++.|++.||+|||+.|++|||||
T Consensus 55 l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~---- 129 (260)
T cd05067 55 MKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR---- 129 (260)
T ss_pred HHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc----
Confidence 4578999999999987 455789999999999999998643 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++++|||.+........ ......++..|+|||.+....+
T Consensus 130 -----------------------------p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 180 (260)
T cd05067 130 -----------------------------AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180 (260)
T ss_pred -----------------------------HHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCc
Confidence 8888998899999999999865542211 1122234567999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||||+++|++++ |.+||.+.+.......+..... ...+...+.++.+++.+||..+|++|||++++++
T Consensus 181 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999998 9999977665554444333322 2234567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=250.70 Aligned_cols=199 Identities=29% Similarity=0.530 Sum_probs=158.7
Q ss_pred CCC-CCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhC-------------------------------------
Q psy3253 2 QQC-DSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRK------------------------------------- 42 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~------------------------------------- 42 (251)
+++ +||||+++++++.. +..++++|||+.+++|.+++....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 355 79999999998864 457899999999999999986321
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 43 -----------------------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 43 -----------------------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
..+++..+..++.||+.||.|||++||+|||||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDik------------------------ 200 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLA------------------------ 200 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC------------------------
Confidence 257889999999999999999999999999988
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE- 176 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~- 176 (251)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||+||++|++++
T Consensus 201 ---------p~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~ 271 (337)
T cd05054 201 ---------ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271 (337)
T ss_pred ---------cceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHc
Confidence 888888888899999999997653221 11222344567999999999999999999999999999997
Q ss_pred CCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 177 GKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 177 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|..||.+....... ..+.... ....+...++++.+++.+||+.+|++||+++|+++|
T Consensus 272 g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 272 GASPYPGVQIDEEFCRRLKEGT--RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCCCCCCCccHHHHHHHhccC--CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999664332222 2222221 222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=250.74 Aligned_cols=208 Identities=31% Similarity=0.519 Sum_probs=162.5
Q ss_pred CCC-CCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+++ +||||+++++++... ...|+||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.|++|||||
T Consensus 61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~--- 134 (337)
T cd07852 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLK--- 134 (337)
T ss_pred HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC---
Confidence 467 999999999998643 46899999996 599998863 378899999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-----ccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-----KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+
T Consensus 135 ------------------------------p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 135 ------------------------------PSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred ------------------------------HHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceee
Confidence 8899999999999999999975543211 11223467889999987
Q ss_pred cc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---------------------------CCCC-CCCCCCC
Q psy3253 154 QE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------------PTKP-PPSFREP 204 (251)
Q Consensus 154 ~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------~~~~-~~~~~~~ 204 (251)
.+ ..++.++|+||+|+++|++++|++||.+.........+ .... .......
T Consensus 185 ~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (337)
T cd07852 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL 264 (337)
T ss_pred eccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc
Confidence 54 55788999999999999999999999654433221110 0000 0001112
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
..++.++.+++.+||+.||++|||++++++|||++......
T Consensus 265 ~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~ 305 (337)
T cd07852 265 PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS 305 (337)
T ss_pred cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence 33688999999999999999999999999999998875543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=260.15 Aligned_cols=200 Identities=24% Similarity=0.444 Sum_probs=168.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++-+|.||+-+.|++.++.. .+|+.+|+|.+|+.+++..+..|+....+.|+.||+.|+.|||.++|||||+|
T Consensus 442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK----- 515 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK----- 515 (678)
T ss_pred HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc-----
Confidence 467789999999999988876 99999999999999999888999999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccc---c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQ---E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~---~ 155 (251)
..||++.+++++||+|||++...+..... .....+...|+|||++. .
T Consensus 516 ----------------------------SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~ 567 (678)
T KOG0193|consen 516 ----------------------------SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD 567 (678)
T ss_pred ----------------------------ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc
Confidence 88999999999999999999643322111 12233567799999994 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC--CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP--PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
.+|++.+|||||||++|||++|..||........++++..+. +........++.++++|+..||.+++++||.+.++|
T Consensus 568 nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 568 NPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred CCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 779999999999999999999999999666666666665552 222223456788999999999999999999999998
Q ss_pred c
Q psy3253 234 N 234 (251)
Q Consensus 234 ~ 234 (251)
.
T Consensus 648 ~ 648 (678)
T KOG0193|consen 648 S 648 (678)
T ss_pred H
Confidence 6
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=247.56 Aligned_cols=203 Identities=28% Similarity=0.444 Sum_probs=158.8
Q ss_pred CCCCCCccceeeeeEeeCC----------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 2 QQCDSPYVVKYYGSYFKNT----------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~----------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
++++||||+++++++.... .+++|+||+++ +|.+++......+++..+..++.|++.||.|||+.|++|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H 139 (302)
T cd07864 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139 (302)
T ss_pred HhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5689999999999987654 79999999975 787777645567999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAP 150 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aP 150 (251)
+||| |+||+++.++.++|+|||.+......... .....++..|+||
T Consensus 140 ~dl~---------------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~P 186 (302)
T cd07864 140 RDIK---------------------------------CSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186 (302)
T ss_pred CCCC---------------------------------HHHEEECCCCcEEeCcccccccccCCcccccccceeccCccCh
Confidence 9988 88999999999999999998755432211 1222456779999
Q ss_pred ccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCCC------------------------CCC
Q psy3253 151 EVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPPP------------------------SFR 202 (251)
Q Consensus 151 E~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~------------------------~~~ 202 (251)
|.+.+ ..++.++|+||+||++|++++|++||...+.......+. ....+ ...
T Consensus 187 E~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd07864 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE 266 (302)
T ss_pred HHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhh
Confidence 98854 457889999999999999999999996543322211110 00000 001
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
....++..+.+++.+||+.+|++|||+++++.||||
T Consensus 267 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 267 EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.66 Aligned_cols=205 Identities=26% Similarity=0.475 Sum_probs=163.1
Q ss_pred CCCCCCCccceeeeeEeeCCe------EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++|||++++.+++..... .++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+.|++||||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dl 144 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDL 144 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 357899999999998865544 89999999 679999886 357999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||.+...... .....++..|+|||.+.
T Consensus 145 k---------------------------------p~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 188 (343)
T cd07851 145 K---------------------------------PSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIML 188 (343)
T ss_pred C---------------------------------HHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHh
Confidence 8 88899988999999999999765432 22335677899999985
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC---------------------------CCC-CCCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP---------------------------PSF-REPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~-~~~~ 205 (251)
+ ..++.++|+||+|+++|++++|..||.+.+.......+..... ..+ ....
T Consensus 189 ~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (343)
T cd07851 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFS 268 (343)
T ss_pred CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhc
Confidence 5 4678899999999999999999999976544332222111000 000 0012
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
..+.++.+++.+||+.+|++|||++|+++||||++....
T Consensus 269 ~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 269 GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred cCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 358899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.14 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=159.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+.++||||+++++.+. ....++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~----- 129 (262)
T cd05071 56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR----- 129 (262)
T ss_pred HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC-----
Confidence 5689999999999875 45689999999999999999743 3458899999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||...+..++
T Consensus 130 ----------------------------p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 181 (262)
T cd05071 130 ----------------------------AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181 (262)
T ss_pred ----------------------------cccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCC
Confidence 88888888899999999998654332111 1122345679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+||++|++++ |..||.+.........+..... ......++..+.+++.+||+.+|++||+++++++
T Consensus 182 ~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999 8889977655554444333322 2224567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.01 Aligned_cols=198 Identities=27% Similarity=0.451 Sum_probs=163.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.. ...+++|||+.+|+|.+++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~----- 136 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLA----- 136 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccC-----
Confidence 357899999999999987 68999999999999999998666779999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+....+
T Consensus 137 ----------------------------p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05057 137 ----------------------------ARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188 (279)
T ss_pred ----------------------------cceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCc
Confidence 88888888889999999999765422111 111223457999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+||+|+++|++++ |..||.+.........+.... ....+..++..+.+++.+||..+|++||++.++++
T Consensus 189 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999998 999997766555444444332 22335567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=270.83 Aligned_cols=201 Identities=21% Similarity=0.316 Sum_probs=159.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR----------KKTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
++++||||+++++++.+++..|++|||++||+|.+++... ...++...++.++.||+.||.|||++|++|
T Consensus 57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIH 136 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH 136 (932)
T ss_pred HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5789999999999999999999999999999999998632 123556778899999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc-----------------
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT----------------- 134 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~----------------- 134 (251)
|||| |+||+++.++.++|+|||+++.....
T Consensus 137 RDLK---------------------------------PeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s 183 (932)
T PRK13184 137 RDLK---------------------------------PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183 (932)
T ss_pred cCCc---------------------------------hheEEEcCCCCEEEEecCcceeccccccccccccccccccccc
Confidence 9988 88899988999999999999755211
Q ss_pred -cccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHH
Q psy3253 135 -MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFID 213 (251)
Q Consensus 135 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (251)
........||+.|+|||.+.+..++.++||||+||++|+|++|..||...+............+........+++.+.+
T Consensus 184 ~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~ 263 (932)
T PRK13184 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQ 263 (932)
T ss_pred ccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHH
Confidence 0111224589999999999998999999999999999999999999976544333222111122222223567899999
Q ss_pred HHHHhhhcCcCccCCHHHHhcC
Q psy3253 214 FVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~h 235 (251)
++.+||..||++|++..+.+.+
T Consensus 264 LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 264 IAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999876665544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=249.20 Aligned_cols=199 Identities=24% Similarity=0.461 Sum_probs=163.4
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++..+...+++|||+.+|+|.+++.... ..++..+++.++.|++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 456 79999999999999889999999999999999997432 24778889999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--cccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 143 (251)
++|++||||| |+||+++.++.++|+|||+++........ .....+
T Consensus 152 ~~givH~dlk---------------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 198 (334)
T cd05100 152 SQKCIHRDLA---------------------------------ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198 (334)
T ss_pred HCCeeccccc---------------------------------cceEEEcCCCcEEECCcccceecccccccccccCCCc
Confidence 9999999988 88888888899999999998755432111 111223
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+..... ...+..++.++.+++.+||+.+
T Consensus 199 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~ 276 (334)
T cd05100 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAV 276 (334)
T ss_pred CceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccC
Confidence 456999999988889999999999999999998 8899987766555544433322 2234567899999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||++|++++
T Consensus 277 p~~Rps~~ell~~ 289 (334)
T cd05100 277 PSQRPTFKQLVED 289 (334)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=242.38 Aligned_cols=199 Identities=21% Similarity=0.391 Sum_probs=162.3
Q ss_pred CCCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRK-------KTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||+++++++.. +...++++||+.+++|.+++.... ..+++.++..++.|++.||.|||+.+++||
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 357899999999998765 467899999999999999986432 458999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAP 150 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 150 (251)
||| |+||+++.++.++++|||+++........ .....++..|+||
T Consensus 142 di~---------------------------------p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 142 DIA---------------------------------ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred ccC---------------------------------HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence 988 88888888899999999999755322111 1122345679999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
|.+.+..++.++||||+||++|++++ |..||...+.......+..... ...+..+++++.+++.+||..||++|||+
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR--LAQPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 99988889999999999999999998 9999977666555444433322 22345578999999999999999999999
Q ss_pred HHHhc
Q psy3253 230 SEMLN 234 (251)
Q Consensus 230 ~evl~ 234 (251)
.|+++
T Consensus 267 ~~~~~ 271 (280)
T cd05043 267 SQLVQ 271 (280)
T ss_pred HHHHH
Confidence 99984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.45 Aligned_cols=201 Identities=21% Similarity=0.416 Sum_probs=163.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--------KTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||+++++++.+....|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.|++||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 141 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR 141 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence 357899999999999998889999999999999999997433 168999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc-ccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE 151 (251)
||| |+||+++.++.++++|||.+...... ........++..|+|||
T Consensus 142 dlk---------------------------------p~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 188 (275)
T cd05046 142 DLA---------------------------------ARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188 (275)
T ss_pred cCc---------------------------------cceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChh
Confidence 988 88888888899999999998643221 11122234566799999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.+.+..++.++|+||+|+++|++++ |..||................ ..+..+..++..+.+++.+||+.+|++|||++
T Consensus 189 ~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 267 (275)
T cd05046 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFS 267 (275)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 9988888999999999999999998 888997655544443333222 22333556889999999999999999999999
Q ss_pred HHhcC
Q psy3253 231 EMLNH 235 (251)
Q Consensus 231 evl~h 235 (251)
|+++.
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.19 Aligned_cols=211 Identities=25% Similarity=0.527 Sum_probs=164.5
Q ss_pred CCCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++.||||+.+..+|.+ +..++|++||.+. +|.+.++..+ ..++...++.++.||+.|+.|||++=++|||+|
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK 159 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK 159 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence 357899999999999987 7789999999987 9999996322 458889999999999999999999999999999
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCC----CCeEecccccccccCcccc---cccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE----GHAKLADFGVAGQLTDTMA---KRNTVIGTPFWM 148 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~----~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~ 148 (251)
|.||++..+ |.+||+|||+++.+.+.-. .....+-|.+|+
T Consensus 160 ---------------------------------PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYR 206 (438)
T KOG0666|consen 160 ---------------------------------PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYR 206 (438)
T ss_pred ---------------------------------cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEec
Confidence 555555544 8899999999998765422 223345688999
Q ss_pred ccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC------------CcchhhhhcCCCCCCC-CCC-----------
Q psy3253 149 APEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDI------------HPMRAIFMIPTKPPPS-FRE----------- 203 (251)
Q Consensus 149 aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~------------~~~~~~~~~~~~~~~~-~~~----------- 203 (251)
|||.+.+ ..|+++.||||+||++.||++-++.|.+. ++...+..+...+... ++.
T Consensus 207 APELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~l 286 (438)
T KOG0666|consen 207 APELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLL 286 (438)
T ss_pred ChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHH
Confidence 9999977 56899999999999999999999988542 2222333333322111 000
Q ss_pred -------------------CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 204 -------------------PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 204 -------------------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
...-++...+|+.+||++||.+|+|++++|+|+||+..+..+
T Consensus 287 s~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 287 SDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred HHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 011245589999999999999999999999999999876654
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=243.97 Aligned_cols=203 Identities=28% Similarity=0.483 Sum_probs=161.3
Q ss_pred CCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++|||++++++++... ...++|+||+.+ +|.+++......+++..++.++.|++.||.|||++|++|+|||
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~---- 127 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIK---- 127 (287)
T ss_pred HhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc----
Confidence 567899999999999887 789999999964 9999887554689999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccccc-CC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..
T Consensus 128 -----------------------------p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 178 (287)
T cd07840 128 -----------------------------GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178 (287)
T ss_pred -----------------------------HHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcccc
Confidence 8899999999999999999976543321 1222345778999998754 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CC-CCCC-----------------------CCCCC-CCH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KP-PPSF-----------------------REPDV-WTP 209 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-~~~~-----------------------~~~~~-~~~ 209 (251)
++.++||||||+++|++++|..||...+.......+.. .. ...+ ..... +++
T Consensus 179 ~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T cd07840 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258 (287)
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCH
Confidence 78999999999999999999999976554322221110 00 0000 00111 388
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
++.+++.+||+.+|++||++++++.||||
T Consensus 259 ~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 259 SALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=247.47 Aligned_cols=204 Identities=27% Similarity=0.477 Sum_probs=156.8
Q ss_pred CCCCCCCccceeeeeEeeC--------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||+++++++... ..+++|+||+.+ +|...+......+++..++.++.|++.||.|||++|++|+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~ 139 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHR 139 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3578999999999987543 347999999964 7877776555689999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-----------cccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-----------RNTV 141 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~ 141 (251)
||| |+||+++.++.++|+|||++......... ....
T Consensus 140 dl~---------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (311)
T cd07866 140 DIK---------------------------------AANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186 (311)
T ss_pred CCC---------------------------------HHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccc
Confidence 988 88999999999999999999754322111 1122
Q ss_pred cccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCC--------------------
Q psy3253 142 IGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKP-------------------- 197 (251)
Q Consensus 142 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~-------------------- 197 (251)
.+++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+.......+. ...
T Consensus 187 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (311)
T cd07866 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSF 266 (311)
T ss_pred eeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccC
Confidence 45677999998765 457889999999999999999999996554432211110 000
Q ss_pred ---CCC-CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 198 ---PPS-FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 198 ---~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.. .......++.+.+++.+||..||++|||+.|+++||||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 267 TNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 00012345778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.89 Aligned_cols=208 Identities=23% Similarity=0.419 Sum_probs=160.8
Q ss_pred CC-CCCccceeeeeEeeC----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QC-DSPYVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++ +||||+++++.+... ...++++||+. ++|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 57 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlk-- 132 (332)
T cd07857 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLK-- 132 (332)
T ss_pred HhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC--
Confidence 45 699999999875432 45789999995 69998886 45789999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+
T Consensus 133 -------------------------------p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 133 -------------------------------PGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred -------------------------------HHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence 8888888889999999999976543211 11223578889999987
Q ss_pred cc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---------------------------CCCCCCC-CCC
Q psy3253 154 QE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---------------------------TKPPPSF-REP 204 (251)
Q Consensus 154 ~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------------------~~~~~~~-~~~ 204 (251)
.+ ..++.++|+||+|+++|++++|.+||...+.......+. ......+ ...
T Consensus 182 ~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (332)
T cd07857 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF 261 (332)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence 55 568899999999999999999999997654322111100 0000000 112
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
...+..+.+++.+||+.||++|||++|++.|||++......
T Consensus 262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~ 302 (332)
T cd07857 262 PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD 302 (332)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcc
Confidence 33578999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=249.65 Aligned_cols=207 Identities=28% Similarity=0.482 Sum_probs=163.8
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++..+. ..++||||+ +++|.+++. ...+++..++.++.|++.||.|||+.|++||||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dl 144 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDL 144 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 45789999999999987543 469999999 779998875 457999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++++|||++...... .....+++.|+|||.+.
T Consensus 145 k---------------------------------p~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 188 (343)
T cd07880 145 K---------------------------------PGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVIL 188 (343)
T ss_pred C---------------------------------HHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHh
Confidence 8 88889988999999999998754322 22335678899999986
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---C------------------------CCCC-CCCCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---K------------------------PPPS-FREPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~------------------------~~~~-~~~~~ 205 (251)
+ ..++.++|+||+|+++|++++|..||.+.+.......+.. . .... .....
T Consensus 189 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (343)
T cd07880 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLP 268 (343)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhcc
Confidence 5 4578899999999999999999999976543222111100 0 0000 01124
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
.+++.+.++|.+||..||++|||+.+++.||||+.......
T Consensus 269 ~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 269 NANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred CCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 56888999999999999999999999999999998755443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=241.91 Aligned_cols=200 Identities=22% Similarity=0.430 Sum_probs=157.4
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++... ...++||||+++++|.+++......+++..+..++.|++.||+|||++|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlk--- 136 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA--- 136 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccc---
Confidence 3578999999999998764 56899999999999999997555578999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---ccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 137 ------------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 137 ------------------------------ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred ------------------------------hheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc
Confidence 8888888889999999999975543211 1122345667999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc---------------chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHP---------------MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
..++.++|+||+|+++|+++++..|...... ......+... ...+.+..++..+.+|+.+||+
T Consensus 187 ~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 264 (284)
T cd05079 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG--KRLPRPPNCPEEVYQLMRKCWE 264 (284)
T ss_pred CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC--ccCCCCCCCCHHHHHHHHHHcc
Confidence 8899999999999999999997765422100 0000001111 1222345678999999999999
Q ss_pred cCcCccCCHHHHhcC
Q psy3253 221 KNPEERATASEMLNH 235 (251)
Q Consensus 221 ~~p~~Rps~~evl~h 235 (251)
.+|++|||++++++.
T Consensus 265 ~~p~~Rpt~~~il~~ 279 (284)
T cd05079 265 FQPSKRTTFQNLIEG 279 (284)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=250.86 Aligned_cols=208 Identities=27% Similarity=0.470 Sum_probs=157.8
Q ss_pred CCCCCCCccceeeeeEeeC--------------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--------------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--------------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
|++++||||+++++++... ...|+||||+. ++|.+++. ...+++..++.++.||+.||.|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~ 132 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS 132 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999877543 35799999996 59988875 4579999999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCccccc---ccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAK---RNTVI 142 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~---~~~~~ 142 (251)
.|++||||| |+||+++. ++.++++|||.+......... .....
T Consensus 133 ~givH~dik---------------------------------p~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (342)
T cd07854 133 ANVLHRDLK---------------------------------PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179 (342)
T ss_pred CCcccCCCC---------------------------------HHHEEEcCCCceEEECCcccceecCCcccccccccccc
Confidence 999999988 77777763 456899999998654321111 11224
Q ss_pred ccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC------------------------C
Q psy3253 143 GTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK------------------------P 197 (251)
Q Consensus 143 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------------~ 197 (251)
++..|+|||.+.+ ..++.++|+|||||++|++++|..||...+........... .
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07854 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259 (342)
T ss_pred ccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc
Confidence 6778999998754 55788999999999999999999999654432222111100 0
Q ss_pred CCC---CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 198 PPS---FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 198 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
... ......++.++.+++.+||+.||++|||++|+++||||+...+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 000 00123467889999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=242.97 Aligned_cols=202 Identities=30% Similarity=0.536 Sum_probs=159.7
Q ss_pred CCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++ ||||+++++++..+...++||||+ +|+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+
T Consensus 52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~---- 126 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK---- 126 (283)
T ss_pred HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC----
Confidence 3566 999999999999999999999999 779999887443 478999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-cCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~ 158 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+. ...+
T Consensus 127 -----------------------------~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~ 176 (283)
T cd07830 127 -----------------------------PENLLVSGPEVVKIADFGLAREIRSRP-PYTDYVSTRWYRAPEILLRSTSY 176 (283)
T ss_pred -----------------------------hhhEEEcCCCCEEEeecccceeccCCC-CcCCCCCcccccCceeeecCcCc
Confidence 889999999999999999997554321 222345677899999884 4557
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCC-----------------------CCCC-CCCCCCCHHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKP-----------------------PPSF-REPDVWTPEF 211 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~-----------------------~~~~-~~~~~~~~~~ 211 (251)
+.++|+||||++++++++|.+||............. ... .... ......+..+
T Consensus 177 ~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd07830 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEA 256 (283)
T ss_pred CCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHH
Confidence 889999999999999999999996544322211100 000 0000 0011236789
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.+++.+||+.+|++|||++|++.||||
T Consensus 257 ~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 257 IDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=240.47 Aligned_cols=199 Identities=26% Similarity=0.463 Sum_probs=154.9
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.. ....++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlk--- 135 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLA--- 135 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC---
Confidence 357899999999998753 346899999999999999997555678999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---cccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+
T Consensus 136 ------------------------------p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 136 ------------------------------TRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred ------------------------------HhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 88889988999999999999755322111 011112345999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh----------------hhhcCCCCCCCCCCCCCCCHHHHHHHHHhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA----------------IFMIPTKPPPSFREPDVWTPEFIDFVSRCL 219 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 219 (251)
..++.++|+||+|+++|++++|..++........ ...+... .....+..++.++.+++.+||
T Consensus 186 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl 263 (284)
T cd05081 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN--GRLPAPPGCPAEIYAIMKECW 263 (284)
T ss_pred CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC--CcCCCCCCCCHHHHHHHHHHc
Confidence 8899999999999999999998766532211100 0001111 122234567899999999999
Q ss_pred hcCcCccCCHHHHhc
Q psy3253 220 VKNPEERATASEMLN 234 (251)
Q Consensus 220 ~~~p~~Rps~~evl~ 234 (251)
..+|++|||++|+++
T Consensus 264 ~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 264 NNDPSQRPSFSELAL 278 (284)
T ss_pred cCChhhCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=244.20 Aligned_cols=198 Identities=24% Similarity=0.414 Sum_probs=160.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++... ..++++||+.+|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 64 ~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dik------ 136 (303)
T cd05110 64 ASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA------ 136 (303)
T ss_pred HhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccc------
Confidence 578999999999998654 4789999999999999997656678999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++
T Consensus 137 ---------------------------p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (303)
T cd05110 137 ---------------------------ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189 (303)
T ss_pred ---------------------------cceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCC
Confidence 8888888888899999999975542211 11122345679999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++||||||+++|++++ |..||.+.........+..... ...+..++..+.+++.+||..+|++||+++++++.
T Consensus 190 ~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER--LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999997 8999976554443333333222 22345578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=236.70 Aligned_cols=195 Identities=25% Similarity=0.456 Sum_probs=160.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||++++++++..+ ..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|||||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~---- 127 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA---- 127 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC----
Confidence 3578999999999998654 4799999999999999997443 358999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+...... ......+..|+|||.+.+..++
T Consensus 128 -----------------------------p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~ 175 (254)
T cd05083 128 -----------------------------ARNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFS 175 (254)
T ss_pred -----------------------------cceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcC
Confidence 88888888899999999998654321 1122335579999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++|+||+|+++|++++ |..||...........+..... ...+..+++.+.+++.+||+.+|++||++++++.
T Consensus 176 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR--MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999997 9999977665554444433322 2234567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=246.80 Aligned_cols=206 Identities=26% Similarity=0.491 Sum_probs=161.4
Q ss_pred CCCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||++++++|.. ....|+++||+ +++|.++++ ...+++..+..++.|++.||.|||+.|++||||+
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~---- 135 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK---- 135 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC----
Confidence 357899999999999865 56789999999 569988875 4568889999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 158 (251)
|+||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..+
T Consensus 136 -----------------------------p~Nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 183 (328)
T cd07856 136 -----------------------------PSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKY 183 (328)
T ss_pred -----------------------------HHHEeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCc
Confidence 8888888889999999999865432 1122345778999998765 568
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh---------------------------cCCCCC-CCCCCCCCCCHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM---------------------------IPTKPP-PSFREPDVWTPE 210 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~---------------------------~~~~~~-~~~~~~~~~~~~ 210 (251)
+.++|+||+||++|++++|.+||...+....... ...... +.......++.+
T Consensus 184 ~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (328)
T cd07856 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPS 263 (328)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHH
Confidence 8999999999999999999999965443111100 000000 000112346789
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+.++|.+||+.+|++|||++|++.||||+....+.
T Consensus 264 ~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 264 AIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 99999999999999999999999999997665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=237.27 Aligned_cols=198 Identities=26% Similarity=0.437 Sum_probs=161.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|+||+++++++.. ...+++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+|||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~---- 129 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR---- 129 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccC----
Confidence 457899999999999877 6789999999999999999743 3457888999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+....+
T Consensus 130 -----------------------------p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 180 (260)
T cd05073 130 -----------------------------AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180 (260)
T ss_pred -----------------------------cceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCc
Confidence 8888888889999999999865432211 1122234566999999988888
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|+|||||++|++++ |..||.+.+.......+..... ...+...+.++.+++.+||+.+|++||+++++++
T Consensus 181 ~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998 9999987665544444333322 2234567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=238.15 Aligned_cols=209 Identities=23% Similarity=0.380 Sum_probs=162.3
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
.|+||++++++|+++..+|||||-+.||+|...++ .+..|++.++.++.++|+.||.|||.+||.|||+||+||+-..+
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p 212 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP 212 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC
Confidence 59999999999999999999999999999999987 56789999999999999999999999999999999666544422
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------ccccccccccccccccccc---
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-------AKRNTVIGTPFWMAPEVIQ--- 154 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~--- 154 (251)
. .-.-+||+||.+........ ....+..|+..|||||+..
T Consensus 213 n------------------------------~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv 262 (463)
T KOG0607|consen 213 N------------------------------KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV 262 (463)
T ss_pred C------------------------------CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc
Confidence 1 01128999998875332110 1123345777899999873
Q ss_pred --cCCCCcchhHHHHHHHHHHHHhCCCCCCC-------CCcc--------hhhhhcCCCCC-CCCCCCCCCCHHHHHHHH
Q psy3253 155 --EIGYDCVADMWSLGITALEMAEGKPPYGD-------IHPM--------RAIFMIPTKPP-PSFREPDVWTPEFIDFVS 216 (251)
Q Consensus 155 --~~~~~~~~DvwslG~~l~~l~~g~~p~~~-------~~~~--------~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 216 (251)
...|+.++|.||||+++|-|++|.+||.+ ++.. .....+..+.- -+...+.-++.+..++++
T Consensus 263 ~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis 342 (463)
T KOG0607|consen 263 DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS 342 (463)
T ss_pred cccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH
Confidence 34578899999999999999999999943 2221 12222333311 122235667899999999
Q ss_pred HhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 217 RCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 217 ~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.+|..++.+|.++.++++|||+++...+
T Consensus 343 nLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 343 NLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHhccHHhhhhhhhccCCccccccchh
Confidence 9999999999999999999999987655
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=237.22 Aligned_cols=198 Identities=25% Similarity=0.517 Sum_probs=163.8
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGS 78 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~N 78 (251)
.++||||+++++++..+.+.+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .|++|+|||
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~--- 141 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLT--- 141 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCC---
Confidence 47899999999999999999999999999999998742 34578999999999999999999996 789999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..+
T Consensus 142 ------------------------------~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 142 ------------------------------PNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred ------------------------------HHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCC
Confidence 889999999999999999997654432 2334457788999999988889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|+||||+++|++++|.+||...+.......+........ ....+++.+.+++.+||+.||++||++.|+.++
T Consensus 191 ~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 9999999999999999999999976655444433333221111 123568999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=249.55 Aligned_cols=205 Identities=27% Similarity=0.485 Sum_probs=160.3
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++... ...++|+||+. .+|.++. +..+++..+..++.|++.||.|||+.|++||||
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl 143 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDL 143 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3568999999999998754 24699999995 4777654 357899999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||++...... .....++..|+|||.+.
T Consensus 144 k---------------------------------p~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 187 (342)
T cd07879 144 K---------------------------------PGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVIL 187 (342)
T ss_pred C---------------------------------HHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhc
Confidence 8 88999999999999999998654321 22335677899999986
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C-------------------CCCCC------CCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P-------------------PPSFR------EPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------------~~~~~------~~~ 205 (251)
+ ..++.++|+||+||++|+|++|+.||.+.+.......+... . .+... ...
T Consensus 188 ~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (342)
T cd07879 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP 267 (342)
T ss_pred CccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhc
Confidence 5 45788999999999999999999999765433222111100 0 00000 012
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
..++.+.++|.+||+.||++||+++|++.||||+......
T Consensus 268 ~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 268 KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 4578899999999999999999999999999999876644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=245.74 Aligned_cols=204 Identities=23% Similarity=0.475 Sum_probs=159.8
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++||||+++++++... ...|++++++ +++|.++++ ...+++..+..++.|++.||.|||++|++||||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 146 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 146 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 3568999999999988643 3478899988 779988875 346999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++|+|||++...... .....++..|+|||.+.
T Consensus 147 k---------------------------------p~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 147 K---------------------------------PSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIML 190 (345)
T ss_pred C---------------------------------hHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHh
Confidence 8 88889988999999999998654322 22345678899999986
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---------------------------CCCCCCC-CCCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---------------------------TKPPPSF-REPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------------------~~~~~~~-~~~~ 205 (251)
+ ..++.++|+||+||++|++++|.+||...+.......+. ......+ ....
T Consensus 191 ~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (345)
T cd07877 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 270 (345)
T ss_pred CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcC
Confidence 5 568889999999999999999999996544322211100 0000000 0112
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
..++++.++|.+||+.||++|||+.++++||||++...
T Consensus 271 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 271 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred CCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 45888999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=250.55 Aligned_cols=199 Identities=25% Similarity=0.450 Sum_probs=159.7
Q ss_pred CCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--------------------------------------
Q psy3253 2 QQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-------------------------------------- 42 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-------------------------------------- 42 (251)
.+++ ||||+++++++....+.++||||+.+|+|.++++..+
T Consensus 95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 4566 9999999999999999999999999999999996432
Q ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q psy3253 43 -----------------------------------------------------------KTLSEDEIATILCDTLKGLEY 63 (251)
Q Consensus 43 -----------------------------------------------------------~~l~~~~~~~~~~~i~~~l~~ 63 (251)
..+++..++.++.|++.||.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 135667788899999999999
Q ss_pred HHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccc
Q psy3253 64 LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTV 141 (251)
Q Consensus 64 LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 141 (251)
||+.|++||||| |+||+++.++.++|+|||+++....... .....
T Consensus 255 LH~~~ivHrdlk---------------------------------p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 255 LASKNCVHRDLA---------------------------------ARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred HhcCCcCcccCC---------------------------------cceEEEeCCCEEEEEecCcceecccccccccCCCc
Confidence 999999999988 8888888888999999999975432211 11223
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhh-cCCCCCCCCCCCCCCCHHHHHHHHHhh
Q psy3253 142 IGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCL 219 (251)
Q Consensus 142 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l 219 (251)
.++..|+|||.+.+..++.++|+||+|+++|++++ |..||........... +.... ....+..++.++.+++.+||
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl 379 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIYEIMQKCW 379 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHc
Confidence 45678999999988889999999999999999998 8899866544333222 22222 22235567899999999999
Q ss_pred hcCcCccCCHHHHhcC
Q psy3253 220 VKNPEERATASEMLNH 235 (251)
Q Consensus 220 ~~~p~~Rps~~evl~h 235 (251)
..+|++||+++|+++.
T Consensus 380 ~~~P~~RPs~~ell~~ 395 (401)
T cd05107 380 EEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=246.50 Aligned_cols=200 Identities=29% Similarity=0.445 Sum_probs=157.0
Q ss_pred CCCCCCCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEYLHLRR---KIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~---iiH~dik 75 (251)
|.+++|||+|+++|+|.+.. +.+||+||+..|+|.+.+..... .++|.....|+..++.||.|||+.. |||||||
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 46789999999999999888 59999999999999999985555 8999999999999999999999854 9999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccc-ccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQ 154 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~-~~~~~y~aPE~~~ 154 (251)
++||+++.+...||+|||+|+............ .||..|+|||+..
T Consensus 205 ---------------------------------ssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 205 ---------------------------------SSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred ---------------------------------HHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhc
Confidence 999999999999999999996544311222222 7899999999998
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---cchhhhh----cCC-----CCCCCCCCCCCCC-----HHHHHHHHH
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIH---PMRAIFM----IPT-----KPPPSFREPDVWT-----PEFIDFVSR 217 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~---~~~~~~~----~~~-----~~~~~~~~~~~~~-----~~~~~li~~ 217 (251)
....+.++||||||+++.|+++|+.+..... ......+ +.. ...+.+.. ...+ ..+..+..+
T Consensus 252 ~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~ 330 (361)
T KOG1187|consen 252 TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALR 330 (361)
T ss_pred cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHH
Confidence 8899999999999999999999998775321 1111111 111 11111110 2223 225678889
Q ss_pred hhhcCcCccCCHHHHhc
Q psy3253 218 CLVKNPEERATASEMLN 234 (251)
Q Consensus 218 ~l~~~p~~Rps~~evl~ 234 (251)
|++.+|++||++.||++
T Consensus 331 C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 331 CLRPDPKERPTMSQVVK 347 (361)
T ss_pred HcCcCCCcCcCHHHHHH
Confidence 99999999999999854
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.03 Aligned_cols=199 Identities=22% Similarity=0.402 Sum_probs=171.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+.+.|||+|+++|+|..+..+|+|+|||..|+|.+|++..+ ..++.-..+.++-||..|+.||..+++|||||-
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA---- 392 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA---- 392 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh----
Confidence 688999999999999999999999999999999999998554 456667778889999999999999999999966
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
.+|+++.++..+|++|||+++....+.. -+.......-|.|||.+....+
T Consensus 393 -----------------------------ARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtF 443 (1157)
T KOG4278|consen 393 -----------------------------ARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 443 (1157)
T ss_pred -----------------------------hhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccccccc
Confidence 7788888888999999999987765432 2333445667999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||+||+++|++.| |-.||.+.+....+..+..+. ....+.+|++.+.+||..||+|+|.+||++.|+-+
T Consensus 444 SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 444 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc--cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 999999999999999987 999999988777766555554 44568999999999999999999999999999853
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=220.04 Aligned_cols=208 Identities=23% Similarity=0.424 Sum_probs=172.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+++.|.|||+++++...+..+-+|+|||. .+|..|....++.++.+.++.++.|++.||.|+|++++.|||+|
T Consensus 55 lkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlk----- 128 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLK----- 128 (292)
T ss_pred HHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCC-----
Confidence 468899999999999999999999999995 59999998788999999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~ 159 (251)
|+|.+++.+|.+|++|||+++.++-+....+...-|.+|++|.++.+.+ |+
T Consensus 129 ----------------------------pqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~ 180 (292)
T KOG0662|consen 129 ----------------------------PQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_pred ----------------------------cceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhc
Confidence 9999999999999999999998876655555666788999999998754 78
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhh---cCCCCCC-CCCC-------------C---------CCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFM---IPTKPPP-SFRE-------------P---------DVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~---~~~~~~~-~~~~-------------~---------~~~~~~~~ 212 (251)
...|+||.||++.|+.. |.+.|.+.+....... +...+.. .++. + +.++..-+
T Consensus 181 tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~gr 260 (292)
T KOG0662|consen 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGR 260 (292)
T ss_pred cchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhH
Confidence 89999999999999986 8888887765544332 2222110 0000 0 11233458
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
++++++|.-+|.+|++++++++||||....
T Consensus 261 dllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 261 DLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred HHHHHHhccCcccccCHHHHhcCccccccC
Confidence 999999999999999999999999998653
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=244.87 Aligned_cols=199 Identities=30% Similarity=0.521 Sum_probs=156.3
Q ss_pred CCC-CCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhC-------------------------------------
Q psy3253 2 QQC-DSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRK------------------------------------- 42 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~------------------------------------- 42 (251)
.++ +||||+++++++... ...+++|||+++|+|.++++...
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 355 689999999988654 46899999999999999986432
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccc
Q psy3253 43 -----------------------------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKC 93 (251)
Q Consensus 43 -----------------------------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~ 93 (251)
..++...+..++.|++.||.|||++|++|||||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik------------------ 206 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLA------------------ 206 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCc------------------
Confidence 236777888999999999999999999999988
Q ss_pred cccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCCCcchhHHHHHHHH
Q psy3253 94 NVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171 (251)
Q Consensus 94 ~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 171 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++
T Consensus 207 ---------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 207 ---------------ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred ---------------cCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 8888888889999999999875432211 12223345679999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 172 LEMAE-GKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 172 ~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|++++ |..||......... ..+.... ....+...++++.+++.+||..||++|||++|+++|
T Consensus 272 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 272 WEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHCCCCCCCCccccHHHHHHHhccC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99997 99999665433222 2222221 122344568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=237.82 Aligned_cols=201 Identities=26% Similarity=0.443 Sum_probs=159.3
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|..++|+|+++++.+|.-. ...|+|||+|. .+|.+.+. ..++...+..++.|++.|+++||+.||+|||+
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdL 144 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDL 144 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeeccc
Confidence 3567999999999999522 35899999995 59999886 67889999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||++..++.+||.|||+++..... ........+..|.|||++.
T Consensus 145 k---------------------------------Psnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil 190 (369)
T KOG0665|consen 145 K---------------------------------PSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVIL 190 (369)
T ss_pred C---------------------------------cccceecchhheeeccchhhcccCcc-cccCchhheeeccCchhee
Confidence 8 88889999999999999999765443 2233345677899999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCC------------------CC-------------
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPP------------------PS------------- 200 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------------------~~------------- 200 (251)
+..+...+||||+||++.+|++|+..|.+.+.......+ ...+. +.
T Consensus 191 ~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~ 270 (369)
T KOG0665|consen 191 GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDS 270 (369)
T ss_pred ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcc
Confidence 988999999999999999999999998654333222211 00000 00
Q ss_pred -----CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 201 -----FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 201 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
......-...+++++.+||..||++|.|++++|+|||++
T Consensus 271 ~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 271 LFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000111235579999999999999999999999999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=263.52 Aligned_cols=106 Identities=25% Similarity=0.404 Sum_probs=86.1
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 142 IGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 142 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
.||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+.............++..+.+++.+||..
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~ 620 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTM 620 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 57899999999999889999999999999999999999998766655544443322111112335788899999999999
Q ss_pred CcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 222 NPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 222 ~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
||.+||+++|+++||||...+|++.+
T Consensus 621 dP~~R~ta~e~l~h~~~~~~~~~~~~ 646 (669)
T cd05610 621 DPTKRAGLKELKQHPLFHGVDWENLQ 646 (669)
T ss_pred ChhHCcCHHHHHhCHhhcCCCHHHhc
Confidence 99999999999999999988776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=236.59 Aligned_cols=200 Identities=26% Similarity=0.474 Sum_probs=158.7
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.. +...+++|||+.+++|.+++......+++..+..++.|++.||.|||+.|++|+|||
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~--- 136 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLA--- 136 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCC---
Confidence 357899999999999876 567999999999999999997555579999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---cccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+
T Consensus 137 ------------------------------p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 137 ------------------------------ARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred ------------------------------HHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc
Confidence 88899988999999999999765422111 111223456999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh--------------hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA--------------IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
..++.++|+||||+++|+|++|..|+........ ....... ......+..++.++.+++.+||+.
T Consensus 187 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~ 265 (284)
T cd05038 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE-GERLPRPPSCPDEVYDLMKLCWEA 265 (284)
T ss_pred CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc-CCcCCCCccCCHHHHHHHHHHhcc
Confidence 8899999999999999999999998854321110 0011111 112223456788999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
+|++|||++|+++
T Consensus 266 ~p~~Rpt~~ei~~ 278 (284)
T cd05038 266 EPQDRPSFADLIL 278 (284)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=228.15 Aligned_cols=202 Identities=41% Similarity=0.663 Sum_probs=166.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++|+|++++++++......++++||+.+++|.+++... ..++...+..++.+++.++.+||+.|++|+||+
T Consensus 42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~------ 114 (244)
T smart00220 42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLK------ 114 (244)
T ss_pred HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcC------
Confidence 4679999999999999989999999999999999998733 348999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++++|||.+....... ......++..|+|||.+.+..++.+
T Consensus 115 ---------------------------~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~ 166 (244)
T smart00220 115 ---------------------------PENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKA 166 (244)
T ss_pred ---------------------------HHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCch
Confidence 888999888999999999997654431 2233456778999999988888999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCC-CCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGD-IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+|+||+|++++++++|..||.. .+.......+.............++.++.+++.+||..+|++||++.++++||||
T Consensus 167 ~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 167 VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999976 3333333333222222111112278999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=248.52 Aligned_cols=201 Identities=20% Similarity=0.355 Sum_probs=167.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL-SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l-~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|.+|+|||||+++|+|..++.+|||+||++.|+|.+|+.....+. ......+++.||+.|++||.+.+++|||+-
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a---- 664 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLA---- 664 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccc----
Confidence 568999999999999999999999999999999999998554333 566777899999999999999999999966
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 157 (251)
+.|+++++++++||+|||+++....... ..+....+.+|+|+|.+.-++
T Consensus 665 -----------------------------~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk 715 (807)
T KOG1094|consen 665 -----------------------------TRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK 715 (807)
T ss_pred -----------------------------ccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc
Confidence 9999999999999999999985432222 233445678899999999999
Q ss_pred CCcchhHHHHHHHHHHHHh--CCCCCCCCCcchhhhhc---C-CC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 158 YDCVADMWSLGITALEMAE--GKPPYGDIHPMRAIFMI---P-TK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~---~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
++.++|+|+||+++||+++ .+.||.....+...... . .. ....+..|..++..+.++|-+||..+-++|||++
T Consensus 716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe 795 (807)
T KOG1094|consen 716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFE 795 (807)
T ss_pred ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHH
Confidence 9999999999999999765 78899776665554332 1 11 2233456788999999999999999999999999
Q ss_pred HHhc
Q psy3253 231 EMLN 234 (251)
Q Consensus 231 evl~ 234 (251)
++..
T Consensus 796 ~lh~ 799 (807)
T KOG1094|consen 796 QLHL 799 (807)
T ss_pred HHHH
Confidence 9863
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=228.33 Aligned_cols=210 Identities=24% Similarity=0.427 Sum_probs=165.1
Q ss_pred CCCCCCCccceeeeeEeeC--------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|+.+.|+|++.+.++|... ..+||||.+|+. +|.-++......++..+++.+..+++.||.|+|...|+||
T Consensus 70 L~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHR 148 (376)
T KOG0669|consen 70 LQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHR 148 (376)
T ss_pred HHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence 3568999999999988632 359999999987 9999997666789999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----cccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWM 148 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~ 148 (251)
|+| +.|+++++++.++|+|||+++.++.... ......-|.+|+
T Consensus 149 DmK---------------------------------aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYr 195 (376)
T KOG0669|consen 149 DMK---------------------------------AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYR 195 (376)
T ss_pred ccc---------------------------------HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecC
Confidence 988 8899999999999999999976543211 112233478899
Q ss_pred ccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh---cCCCCCCC------------------------
Q psy3253 149 APEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM---IPTKPPPS------------------------ 200 (251)
Q Consensus 149 aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~------------------------ 200 (251)
+||.+.+ ..++++.|+|+.||++.+|++|.+.+++.+....... +.....+.
T Consensus 196 ppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~ 275 (376)
T KOG0669|consen 196 PPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQK 275 (376)
T ss_pred CHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchh
Confidence 9999876 5689999999999999999999998865443322221 11111000
Q ss_pred -----CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 201 -----FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 201 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
...+-.-.++..+|+.++|.+||.+|++++++++|.||-....+
T Consensus 276 rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 276 RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 00012224678999999999999999999999999999776554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=231.13 Aligned_cols=200 Identities=21% Similarity=0.420 Sum_probs=158.3
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRK-----KTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||+++++++.... ..++++||+.+|+|.+++.... ..++...++.++.|++.||+|||+.|+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 134 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF 134 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 46789999999999886432 2478999999999998875221 257889999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
+||||| |+||+++.++.++++|||.++....... ......++..|
T Consensus 135 ~H~dik---------------------------------p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 181 (273)
T cd05074 135 IHRDLA---------------------------------ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181 (273)
T ss_pred eecccc---------------------------------hhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhh
Confidence 999988 8888888889999999999876532211 11122345679
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
++||.+.+..++.++||||+||++|++++ |.+||.+.+.......+..... ...+...+..+.+++.+||+.+|++|
T Consensus 182 ~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~R 259 (273)
T cd05074 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCR 259 (273)
T ss_pred cCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 99999988888999999999999999999 8899976655444433333222 22244578999999999999999999
Q ss_pred CCHHHHhcC
Q psy3253 227 ATASEMLNH 235 (251)
Q Consensus 227 ps~~evl~h 235 (251)
||++|++..
T Consensus 260 ps~~~~~~~ 268 (273)
T cd05074 260 PSFQHLRDQ 268 (273)
T ss_pred cCHHHHHHH
Confidence 999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=249.64 Aligned_cols=204 Identities=24% Similarity=0.430 Sum_probs=172.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|.+|+|||+++|||+..+ ....||||++.+|||-+.++. ....|.....-.++.||+.|+.||-.+++||||+-
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLA---- 239 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLA---- 239 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhh----
Confidence 568999999999999987 568999999999999999986 45678888999999999999999999999999976
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccc--c-cccccccccccccccC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--T-VIGTPFWMAPEVIQEI 156 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~-~~~~~~y~aPE~~~~~ 156 (251)
.+|+++..-..+||+|||+.+.......... . ..-..-|+|||.+...
T Consensus 240 -----------------------------ARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~ 290 (1039)
T KOG0199|consen 240 -----------------------------ARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR 290 (1039)
T ss_pred -----------------------------hhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc
Confidence 6777777777899999999987765432211 1 1123359999999999
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 157 GYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++.++|||+||+++|||++ |+-||.+.....+...+.. ...+..+..++.++.++++.||..+|++|||+..+.+.
T Consensus 291 kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 291 KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 99999999999999999998 8999998887777766663 34666788999999999999999999999999999765
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
-+.++
T Consensus 369 ~~l~e 373 (1039)
T KOG0199|consen 369 LVLAE 373 (1039)
T ss_pred HHHHh
Confidence 54443
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.50 Aligned_cols=209 Identities=25% Similarity=0.381 Sum_probs=169.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+++.||.||.+-..|++.+..+.|||-+.|.-|+-.+....+.++++..+.++.||+.||+|||.+||+|+|+|||||+
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVL 696 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVL 696 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchhee
Confidence 56899999999999999999999999999664444444556789999999999999999999999999999999955554
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
+.-. +.-.++||||||.|+.+++.. ......||+.|.|||++.++.|..
T Consensus 697 Las~------------------------------~~FPQvKlCDFGfARiIgEks-FRrsVVGTPAYLaPEVLrnkGyNr 745 (888)
T KOG4236|consen 697 LASA------------------------------SPFPQVKLCDFGFARIIGEKS-FRRSVVGTPAYLAPEVLRNKGYNR 745 (888)
T ss_pred eccC------------------------------CCCCceeeccccceeecchhh-hhhhhcCCccccCHHHHhhccccc
Confidence 4411 122368999999999887654 345568999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCc-chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.-||||+|+++|--++|.+||..... .+.+....--. +...+..++++..|||..+|+..-.+|.|++..+.|||++
T Consensus 746 SLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy--Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 746 SLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY--PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred cccceeeeEEEEEEecccccCCCccchhHHhhcccccc--CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 99999999999999999999954322 22221111111 1123677899999999999999999999999999999999
Q ss_pred hcc
Q psy3253 240 RHD 242 (251)
Q Consensus 240 ~~~ 242 (251)
++.
T Consensus 824 ~yq 826 (888)
T KOG4236|consen 824 DYQ 826 (888)
T ss_pred cch
Confidence 754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=232.05 Aligned_cols=194 Identities=22% Similarity=0.270 Sum_probs=151.7
Q ss_pred CCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
+.++|+|++++++.+.... ..++++|++. .++.+++. .....++..++.++.|++.||.|||+++++|||||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiK-- 153 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIK-- 153 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC--
Confidence 4578999999998765443 4578888884 47777765 33456888899999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------ccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-------AKRNTVIGTPFWMAP 150 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aP 150 (251)
|+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 154 -------------------------------p~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 154 -------------------------------PENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred -------------------------------HHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 888888888899999999997553211 111224589999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh-h--------hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA-I--------FMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
|+..+..++.++||||+||++|++++|..||.+...... . ..+... .. ....+++++.+++..|++.
T Consensus 203 e~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~ 278 (294)
T PHA02882 203 DAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG---KI-KIKNANKFIYDFIECVTKL 278 (294)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhh---hh-ccCCCCHHHHHHHHHHHhC
Confidence 999999999999999999999999999999976532211 1 111111 11 2345689999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
+|++||+++++++
T Consensus 279 ~~~~rp~~~~l~~ 291 (294)
T PHA02882 279 SYEEKPDYDALIK 291 (294)
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999874
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=242.77 Aligned_cols=209 Identities=28% Similarity=0.520 Sum_probs=171.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.+-+++-||+||..|++++.+|.||+|+.||++..++- +-+.|.|..++.++.++.+|+++.|..|+||||||
T Consensus 684 AEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiK------ 756 (1034)
T KOG0608|consen 684 AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK------ 756 (1034)
T ss_pred hhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhccceecccC------
Confidence 45578899999999999999999999999999999986 56789999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccC---cc-------------c---------c
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT---DT-------------M---------A 136 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~---~~-------------~---------~ 136 (251)
|+||+++.+|++||.|||+|.-+. +. . .
T Consensus 757 ---------------------------PDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~ 809 (1034)
T KOG0608|consen 757 ---------------------------PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADIS 809 (1034)
T ss_pred ---------------------------ccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcccc
Confidence 999999999999999999995321 00 0 0
Q ss_pred -----------------cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc-CCCCC
Q psy3253 137 -----------------KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI-PTKPP 198 (251)
Q Consensus 137 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~ 198 (251)
..-..+||+.|+|||++....++..+|-||.|++||+|+.|++||-...+...-..+ .....
T Consensus 810 ~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 810 KCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred ccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 001145899999999999999999999999999999999999999655544433222 22233
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCcCccC---CHHHHhcChhhhhccCCC
Q psy3253 199 PSFREPDVWTPEFIDFVSRCLVKNPEERA---TASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 199 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~hp~~~~~~~~~ 245 (251)
..+.....+++++.++|.++.- ++++|. -++||-+||||+..||..
T Consensus 890 l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 890 LHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred cccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence 3445567889999999998654 467775 567899999999998865
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=230.46 Aligned_cols=205 Identities=29% Similarity=0.515 Sum_probs=178.4
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
-+||.+|-++..|+++..++.|.||++||+|.-.++ +...++++.++.+..+|..||.|||++|||+||+|
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlk-------- 378 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLK-------- 378 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc--------
Confidence 489999999999999999999999999999988776 56789999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
.+|++++..|++|+.|+|+++..-.+....++..|||.|.|||++.+..|...+|
T Consensus 379 -------------------------ldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvd 433 (593)
T KOG0695|consen 379 -------------------------LDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 433 (593)
T ss_pred -------------------------ccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceeh
Confidence 8899999999999999999987666666678889999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCC--C-----CCcchh-hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC------CH
Q psy3253 164 MWSLGITALEMAEGKPPYG--D-----IHPMRA-IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA------TA 229 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~--~-----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~ 229 (251)
-|++|+++++|+.|+.||. + .+.+.- ...+... +...|..++-....+++..|++||.+|. .+
T Consensus 434 wwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek---qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~ 510 (593)
T KOG0695|consen 434 WWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK---QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGF 510 (593)
T ss_pred HHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---cccccceeehhhHHHHHHhhcCCcHHhcCCCcccch
Confidence 9999999999999999993 1 111111 2222222 4445777888899999999999999995 56
Q ss_pred HHHhcChhhhhccCCC
Q psy3253 230 SEMLNHEFIQRHDTDP 245 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~ 245 (251)
.++-.|+||+..+|+.
T Consensus 511 ~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 511 SDIKSHAFFRSIDWDL 526 (593)
T ss_pred hhhhcchhhhhCCHHH
Confidence 8999999999999986
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.47 Aligned_cols=198 Identities=30% Similarity=0.459 Sum_probs=151.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTL---SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l---~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+||||||+|+.=.+..+.|+..|.|.. +|.+++......+ ..-.....+.|++.||++||+.+|+|||+|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLk------ 633 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLK------ 633 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCC------
Confidence 699999999999999999999999976 9999998531111 113457789999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCC---C--CCeEecccccccccCccc---cccccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---E--GHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~--~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 153 (251)
|+||++.. + ..++|+|||++++..... ....+..||-.|.|||.+
T Consensus 634 ---------------------------PQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L 686 (903)
T KOG1027|consen 634 ---------------------------PQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL 686 (903)
T ss_pred ---------------------------CceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence 55555543 2 358999999999875432 224556789999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
....-+.++||+|+||++|..++| ..||++....... +..+...-......-..+..+||.+|+.++|..||++.+|
T Consensus 687 ~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 687 REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred hccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHH
Confidence 888888899999999999999885 8999765433222 2222111110011111288999999999999999999999
Q ss_pred hcChhh
Q psy3253 233 LNHEFI 238 (251)
Q Consensus 233 l~hp~~ 238 (251)
|.||+|
T Consensus 765 L~HPlF 770 (903)
T KOG1027|consen 765 LNHPLF 770 (903)
T ss_pred hCCCcc
Confidence 999998
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=227.51 Aligned_cols=209 Identities=33% Similarity=0.642 Sum_probs=169.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR----LRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik 75 (251)
|+.-+.||||++||+...++.+++.||+|+ .||..+.. .....++|...-.+..-.+.||.||-+ ..|||||||
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK 195 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK 195 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence 345578999999999999999999999995 48876653 334678999999999999999999997 589999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ- 154 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 154 (251)
|+||+++..|.+||||||.+.+.-+...+. ...|...|+|||.+.
T Consensus 196 ---------------------------------PSNILldr~G~vKLCDFGIcGqLv~SiAkT-~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 196 ---------------------------------PSNILLDRHGDVKLCDFGICGQLVDSIAKT-VDAGCRPYMAPERIDP 241 (361)
T ss_pred ---------------------------------hhheEEecCCCEeeecccchHhHHHHHHhh-hccCCccccChhccCC
Confidence 899999999999999999997654433322 234677899999994
Q ss_pred -cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCC---CCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 155 -EIGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPD---VWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 155 -~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
...|+.++||||||+++||+.||.+|+..++.. +....+..+.++.+..+. .++..+..+|..||.+|-+.||..
T Consensus 242 ~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 242 SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcch
Confidence 345899999999999999999999999877652 223334444444443333 378899999999999999999999
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
++++.+||++.+..+
T Consensus 322 ~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 322 DDLKKFPFYRMYAVE 336 (361)
T ss_pred hhhhcCchhhhhhhc
Confidence 999999999877654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=264.28 Aligned_cols=220 Identities=14% Similarity=0.164 Sum_probs=155.0
Q ss_pred CCCCC-CccceeeeeEe-------eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 2 QQCDS-PYVVKYYGSYF-------KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 2 ~~l~h-pniv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
+.++| +||++++++|. ....++.+||++ +++|.+++......+++.+++.++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 56778 79999999883 334678889988 5699999975556799999999999999999999999999999
Q ss_pred CCCCCCCcccccc-ccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc----------------c
Q psy3253 74 IKAGSGTLVYDRL-DYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM----------------A 136 (251)
Q Consensus 74 ik~~Ni~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~----------------~ 136 (251)
|||+||||...-. -+. .+.. ....--+.++.+|++|||+++...... .
T Consensus 106 lKP~NiLl~~~~~~k~~--------------d~~~-~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 170 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFI--------------ESAS-CSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPM 170 (793)
T ss_pred CCchhEEEcccCcEEEe--------------eccc-cCcccccccCcccccccccccccccccccchhhhhccccCCCcc
Confidence 9988888752100 000 0000 000001234568999999986432100 0
Q ss_pred cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHH
Q psy3253 137 KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVS 216 (251)
Q Consensus 137 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 216 (251)
......+|+.|+|||++.+..++.++|||||||++|||++|.+|+..... ....+.....+. ......+...+++.
T Consensus 171 ~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~ 246 (793)
T PLN00181 171 KQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPP--QILLNWPKEASFCL 246 (793)
T ss_pred cccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcCh--hhhhcCHHHHHHHH
Confidence 01123578889999999998999999999999999999999888753221 111111111111 01112456779999
Q ss_pred HhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 217 RCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 217 ~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||..+|.+||+++|+++||||...
T Consensus 247 ~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HhCCCChhhCcChHHHhhchhhhhh
Confidence 9999999999999999999999763
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=232.14 Aligned_cols=210 Identities=26% Similarity=0.474 Sum_probs=169.4
Q ss_pred CCCCCCccceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~dik~~N 78 (251)
+.|+||.||++|++|. +.+.+|.|+|||+|.+|..|++ ....+++.+++.|+.||+.||.||.+.. |||-|+|
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK--- 597 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK--- 597 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC---
Confidence 5789999999999996 4567999999999999999997 4678999999999999999999999864 9999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccc-------cccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWM 148 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~ 148 (251)
|.||++ +..|.+||.|||+++....... ......||-+|.
T Consensus 598 ------------------------------PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL 647 (775)
T KOG1151|consen 598 ------------------------------PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 647 (775)
T ss_pred ------------------------------CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence 555554 3446799999999987754322 234456899999
Q ss_pred cccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh---hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 149 APEVIQEI----GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI---FMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 149 aPE~~~~~----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
+||.+.-. +.+.++||||+|+++|.++.|+.||+....-..+ ..+.......++..+.++++..+||.+||.+
T Consensus 648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaY 727 (775)
T KOG1151|consen 648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAY 727 (775)
T ss_pred CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHh
Confidence 99998543 3678999999999999999999999764332222 2233334445566677899999999999999
Q ss_pred CcCccCCHHHHhcChhhhhccCCC
Q psy3253 222 NPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 222 ~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
--++|..+.|+-.||||...--.+
T Consensus 728 RKeDR~DV~qLA~dpyllPh~rrs 751 (775)
T KOG1151|consen 728 RKEDRIDVQQLACDPYLLPHIRRS 751 (775)
T ss_pred hhhhhhhHHHHccCccccchhhhc
Confidence 999999999999999998754433
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=234.27 Aligned_cols=235 Identities=25% Similarity=0.325 Sum_probs=160.2
Q ss_pred CCCccceeeeeEe----eCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q psy3253 5 DSPYVVKYYGSYF----KNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGS 78 (251)
Q Consensus 5 ~hpniv~l~~~~~----~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~N 78 (251)
+-.+||+|++.|. ++.|+|||+|++ |.+|..+|... ...++...++.|++||+.||.|||. .||||.||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 3468999999996 577999999999 66888888644 4789999999999999999999997 599999999999
Q ss_pred CCcccccccc---------------------cc-----------------------------------------------
Q psy3253 79 GTLVYDRLDY---------------------CS----------------------------------------------- 90 (251)
Q Consensus 79 i~~~~~~~~~---------------------~~----------------------------------------------- 90 (251)
||+..+..+. .+
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 9998441111 00
Q ss_pred ---ccccccc-hhh----hh-------------------h------------------------hhhccc-------Cce
Q psy3253 91 ---IKCNVIT-NQI----YK-------------------T------------------------LFRLKA-------GNI 112 (251)
Q Consensus 91 ---~~~~~~~-~~~----~~-------------------~------------------------~~~~~~-------~ni 112 (251)
+.++++. +.. +. . .+..+| .|-
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence 0000000 000 00 0 001111 001
Q ss_pred ec-------CCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC--
Q psy3253 113 LL-------NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGD-- 183 (251)
Q Consensus 113 l~-------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~-- 183 (251)
++ ..+-.+||+|||-|+-+....+ ....|..|+|||++.+.+|++.+||||++|++|||+||...|..
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~~khFT---~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWVHKHFT---EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhhhhhhc---hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 11 1112489999999987553322 23468899999999999999999999999999999999998831
Q ss_pred -----CCcc--hhhhhcCCCCCCC-----------------------CC-------------CCCCCCHHHHHHHHHhhh
Q psy3253 184 -----IHPM--RAIFMIPTKPPPS-----------------------FR-------------EPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 184 -----~~~~--~~~~~~~~~~~~~-----------------------~~-------------~~~~~~~~~~~li~~~l~ 220 (251)
.+.. ..+..+....+.. +. .+..-..++.+|+.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 1111 1111221111100 00 011113568999999999
Q ss_pred cCcCccCCHHHHhcChhhhhccC
Q psy3253 221 KNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 221 ~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
.+|++|||+.++|+|||+....-
T Consensus 536 f~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred cCccccccHHHHhcCccccCCCC
Confidence 99999999999999999985443
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=247.14 Aligned_cols=199 Identities=27% Similarity=0.525 Sum_probs=166.1
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
.||||+.+.|.+.++...++|+||+..|+|.+|++.++ ..++..+...++.||+.|++||++..+
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~ 439 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC 439 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 69999999999999899999999999999999998666 358999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-cccc--cccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVI--GTPF 146 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~--~~~~ 146 (251)
+|||+- .+||++..+..+||+|||+++.......-. .... -...
T Consensus 440 vHRDLA---------------------------------aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~k 486 (609)
T KOG0200|consen 440 VHRDLA---------------------------------ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVK 486 (609)
T ss_pred cchhhh---------------------------------hhhEEecCCCEEEEccccceeccCCCCceEecCCCCcccee
Confidence 999965 889999999999999999998544321111 1111 2445
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC-cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIH-PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
|+|||.+....|+.++||||||+++||+++ |..||.+.. .......+..+. ....|..+++++.++|+.||+.+|+
T Consensus 487 WmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~--r~~~P~~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 487 WMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN--RMEQPEHCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred ecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 999999999999999999999999999998 899998754 333333344433 4456888899999999999999999
Q ss_pred ccCCHHHHhcChhhhh
Q psy3253 225 ERATASEMLNHEFIQR 240 (251)
Q Consensus 225 ~Rps~~evl~hp~~~~ 240 (251)
+||++.|+. .+|..
T Consensus 565 ~RP~F~~~~--~~~~~ 578 (609)
T KOG0200|consen 565 DRPTFSECV--EFFEK 578 (609)
T ss_pred cCCCHHHHH--HHHHH
Confidence 999999987 45544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=254.09 Aligned_cols=193 Identities=19% Similarity=0.347 Sum_probs=145.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH---LRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH---~~~iiH~dik~~ 77 (251)
|++++|||||++++++.++...|+||||+++|+|.++++ .+++..+..++.|++.|+.||| +.+++|||+|
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk-- 810 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS-- 810 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC--
Confidence 467899999999999999999999999999999999986 3889999999999999999999 6699999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++..++. ||....... .....+++.|+|||++.+..
T Consensus 811 -------------------------------p~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 811 -------------------------------PEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKD 854 (968)
T ss_pred -------------------------------HHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCC
Confidence 777777777766654 554432211 11235678899999999889
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc--hhh---hhcCCCC------CCCC----CCCCCCCHHHHHHHHHhhhcC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPM--RAI---FMIPTKP------PPSF----REPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~---~~~~~~~------~~~~----~~~~~~~~~~~~li~~~l~~~ 222 (251)
++.++|||||||++||+++|+.||...... ... ....... .+.. ........++.+++.+||+.|
T Consensus 855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~ 934 (968)
T PLN00113 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934 (968)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence 999999999999999999999998432111 000 0000000 0000 001111235778999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||++|+++.
T Consensus 935 P~~RPt~~evl~~ 947 (968)
T PLN00113 935 PTARPCANDVLKT 947 (968)
T ss_pred chhCcCHHHHHHH
Confidence 9999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=237.95 Aligned_cols=194 Identities=23% Similarity=0.303 Sum_probs=136.0
Q ss_pred eCCeEEEEEEccCCCCHHHHHHHhCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 18 KNTDLWIVMEYCGAGSVSDIMRLRKKT-------------------LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 18 ~~~~~~lv~e~~~~gsL~~~~~~~~~~-------------------l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++...++|+||+.+++|.+++...... .....+..++.||+.||.|||++||+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK--- 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK--- 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC---
Confidence 456799999999999999998643211 1234566799999999999999999999998
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCcc-cccccccccccccccccccccC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++. ++.+||+|||+++..... ........+++.|+|||.+...
T Consensus 283 ------------------------------P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 283 ------------------------------PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred ------------------------------HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhcc
Confidence 77888874 578999999999754322 1223345678899999976322
Q ss_pred ----------------------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-------------hhhhhcCCCCCC--
Q psy3253 157 ----------------------GYDCVADMWSLGITALEMAEGKPPYGDIHPM-------------RAIFMIPTKPPP-- 199 (251)
Q Consensus 157 ----------------------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~-- 199 (251)
.+..++||||+||++|+|+++..++...... .....+......
T Consensus 333 ~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 412 (566)
T PLN03225 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDL 412 (566)
T ss_pred CCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhh
Confidence 2334569999999999999977665321000 000000000000
Q ss_pred --CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 200 --SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 200 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.+...........+||.+||+.||++|||++|+|+||||++..+.
T Consensus 413 ~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 413 RRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred hhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 011112223456799999999999999999999999999987664
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=234.66 Aligned_cols=198 Identities=24% Similarity=0.397 Sum_probs=156.8
Q ss_pred CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 7 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
-|+++++..|...+|+|||||-+ ..+|.+.+..-+ -+|....++.++.|+..||+.|-..|++|.|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK--------- 563 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK--------- 563 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccC---------
Confidence 37899999999999999999999 569999997443 468899999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.. ..+||||||.|...+....-. ..-+.+|.|||++.+.+|+..-|
T Consensus 564 ------------------------PDNiLVNE~k~iLKLCDfGSA~~~~eneitP--YLVSRFYRaPEIiLG~~yd~~iD 617 (752)
T KOG0670|consen 564 ------------------------PDNILVNESKNILKLCDFGSASFASENEITP--YLVSRFYRAPEIILGLPYDYPID 617 (752)
T ss_pred ------------------------ccceEeccCcceeeeccCccccccccccccH--HHHHHhccCcceeecCcccCCcc
Confidence 889999765 458999999997766542211 12356799999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhc--CCCCCCC------------C-------------------------CCC
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMI--PTKPPPS------------F-------------------------REP 204 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~------------~-------------------------~~~ 204 (251)
+||+||+||+|+||+..|.+.+........ ..+..+. + -.|
T Consensus 618 ~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkP 697 (752)
T KOG0670|consen 618 TWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKP 697 (752)
T ss_pred ceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCc
Confidence 999999999999999999766554332211 1110000 0 000
Q ss_pred -----------CCCC-------HHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 205 -----------DVWT-------PEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 205 -----------~~~~-------~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
+.++ .++.+|+.+||.+||++|.|+.|+|.||||+.
T Consensus 698 tkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 698 TKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred chhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0111 45899999999999999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=204.42 Aligned_cols=163 Identities=33% Similarity=0.468 Sum_probs=128.1
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCc
Q psy3253 32 GSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111 (251)
Q Consensus 32 gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~n 111 (251)
|||.++++.++..+++.+++.++.|++.||.|||+++ | |+|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------k---------------------------------p~N 41 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------K---------------------------------SGN 41 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------C---------------------------------ccc
Confidence 6999999866778999999999999999999999998 6 888
Q ss_pred eecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh-h
Q psy3253 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA-I 190 (251)
Q Consensus 112 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~ 190 (251)
|+++.++.+++ ||.+...... ...+++.|+|||++.+..++.++||||+||++|+|++|..||........ .
T Consensus 42 il~~~~~~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 114 (176)
T smart00750 42 ILLTWDGLLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL 114 (176)
T ss_pred EeEcCccceee--ccceEeeccc-----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH
Confidence 88888888888 9998654332 12578899999999999999999999999999999999999965433221 1
Q ss_pred hhcCCCCCCC----CCCCCCCCH--HHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 191 FMIPTKPPPS----FREPDVWTP--EFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 191 ~~~~~~~~~~----~~~~~~~~~--~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
..+....... ...+..++. ++.+++.+||..+|++||++.|+++|+|+..
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 115 EILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1111111101 011222333 6999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=234.46 Aligned_cols=207 Identities=50% Similarity=0.955 Sum_probs=183.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+..+|||||.+++.+.....++++||||.||+|.+..+ -.+++++.++...+++.+.||+|||++|-+|||||
T Consensus 66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiK----- 139 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIK----- 139 (829)
T ss_pred eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCccccccc-----
Confidence 467899999999999999999999999999999988765 56899999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 157 (251)
-.||+++..|.+|+.|||.+.+++....+...+.||+.|+|||+.. ...
T Consensus 140 ----------------------------Ganilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkgg 191 (829)
T KOG0576|consen 140 ----------------------------GANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 191 (829)
T ss_pred ----------------------------ccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccc
Confidence 8899999999999999999998887777788889999999999883 566
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|...+|+|++|+...++-.-++|-.+.-+....+..... .++.+..+..+++.+.+|++.+|..+|++|||++.+|.|
T Consensus 192 ynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 192 YNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 888999999999999999999998777777766554433 344566678899999999999999999999999999999
Q ss_pred hhhhhc
Q psy3253 236 EFIQRH 241 (251)
Q Consensus 236 p~~~~~ 241 (251)
||....
T Consensus 272 ~fvs~~ 277 (829)
T KOG0576|consen 272 PFVSQT 277 (829)
T ss_pred eeeccc
Confidence 998653
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=233.45 Aligned_cols=197 Identities=28% Similarity=0.496 Sum_probs=148.9
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++|+|||||+++++=.+.. .-.++||||.||||...++. +..++++.+.+.++..++.||.|||++||+||
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHR 144 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHR 144 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceec
Confidence 57899999999999876544 46899999999999999972 33689999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
||||+|||+... .+.....||+|||.|+...+.. .....+||..|.+||.
T Consensus 145 DlKP~NIvl~~G-----------------------------edgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel 194 (732)
T KOG4250|consen 145 DLKPGNIVLQIG-----------------------------EDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPEL 194 (732)
T ss_pred cCCCCcEEEeec-----------------------------CCCceEEeeecccccccCCCCC-eeeeecCchhhcChHH
Confidence 999666655411 0122237999999999877654 5566789999999999
Q ss_pred ccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC-Ccc---hhhhhcCCCCC------------------CCCCCCCCCC-
Q psy3253 153 IQE-IGYDCVADMWSLGITALEMAEGKPPYGDI-HPM---RAIFMIPTKPP------------------PSFREPDVWT- 208 (251)
Q Consensus 153 ~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~-~~~---~~~~~~~~~~~------------------~~~~~~~~~~- 208 (251)
... ..|+..+|.|||||++|+++||..||... .+. +....+....+ ..++.+...+
T Consensus 195 ~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~ 274 (732)
T KOG4250|consen 195 YERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSR 274 (732)
T ss_pred HhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccH
Confidence 985 77888999999999999999999999322 221 12222221111 0111122222
Q ss_pred ---HHHHHHHHHhhhcCcCccC
Q psy3253 209 ---PEFIDFVSRCLVKNPEERA 227 (251)
Q Consensus 209 ---~~~~~li~~~l~~~p~~Rp 227 (251)
..+-.++..+|..+|++|-
T Consensus 275 ~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 275 GLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred HHHhhhhHHHHHHHhhhHHHhC
Confidence 2356788889999999997
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=235.51 Aligned_cols=198 Identities=25% Similarity=0.455 Sum_probs=172.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|.+|+|||++|+++++.... +.||++|+.+|+|.+|++..+..+..+..+.|+.||++|++|||+++++||||-
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLa----- 825 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLA----- 825 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhh-----
Confidence 57899999999999998776 889999999999999999888999999999999999999999999999999977
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccc--ccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~--~~~~~y~aPE~~~~~~~ 158 (251)
.+|+++.+-.++|+.|||+++............ ...+.|+|-|.+....+
T Consensus 826 ----------------------------aRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 826 ----------------------------ARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred ----------------------------hhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC
Confidence 677777777789999999998765443332222 22456999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++||||||+++||++| |..|+.+....++...+..+. .+..|..++-++.-++.+||..|+..||+++|+..
T Consensus 878 thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 878 THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999998 999998887777766555554 36778999999999999999999999999999863
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=204.24 Aligned_cols=208 Identities=24% Similarity=0.410 Sum_probs=157.2
Q ss_pred CCCC-CCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCD-SPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+.|. ||||++++++..+. ....||+||.++.+...+. +.++.-+++.++.+++.||.|+|++||+|||+|
T Consensus 87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVK--- 159 (338)
T KOG0668|consen 87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVK--- 159 (338)
T ss_pred HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCC---
Confidence 3454 99999999999754 3578999999988876654 578999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCccccccccccccccccccccccc-C
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 156 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 156 (251)
|.|++++.. -.++|+|+|+|.-.... ...+....+..|--||.+.. .
T Consensus 160 ------------------------------PhNvmIdh~~rkLrlIDWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 160 ------------------------------PHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDYQ 208 (338)
T ss_pred ------------------------------cceeeechhhceeeeeecchHhhcCCC-ceeeeeeehhhcCCchheeech
Confidence 667776633 45899999999766544 34455667788999999965 4
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCC-CCC---cchhhhhcCC------------------------CCCC-CC------
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYG-DIH---PMRAIFMIPT------------------------KPPP-SF------ 201 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~-~~~---~~~~~~~~~~------------------------~~~~-~~------ 201 (251)
-|+.+-|+|||||++..|+..+-||. +.+ +...+..+.. .... .+
T Consensus 209 ~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~ 288 (338)
T KOG0668|consen 209 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINS 288 (338)
T ss_pred hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCc
Confidence 47788999999999999999888883 222 1111111111 0000 00
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 202 REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 202 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
....-.++++.||+.++|.+|.++|+|++|++.||||.....+.++
T Consensus 289 ~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~ 334 (338)
T KOG0668|consen 289 ENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS 334 (338)
T ss_pred cccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence 0012246999999999999999999999999999999876554433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=223.42 Aligned_cols=201 Identities=20% Similarity=0.312 Sum_probs=145.2
Q ss_pred ccceeeeeEee--------CCeEEEEEEccCCCCHHHHHHHhCC-----------------------CCCHHHHHHHHHH
Q psy3253 8 YVVKYYGSYFK--------NTDLWIVMEYCGAGSVSDIMRLRKK-----------------------TLSEDEIATILCD 56 (251)
Q Consensus 8 niv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~~~~~~~-----------------------~l~~~~~~~~~~~ 56 (251)
++++++++|.. +...++|+||+.+++|.++++.... .+++..++.++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34666666642 3468999999999999999863211 2356678889999
Q ss_pred HHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc
Q psy3253 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA 136 (251)
Q Consensus 57 i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 136 (251)
++.||.|||+.+++||||| |+||+++.++.++|+|||++........
T Consensus 318 l~~aL~~lH~~~ivHrDLK---------------------------------p~NILl~~~~~~kL~DFGla~~~~~~~~ 364 (507)
T PLN03224 318 VLTGLRKLHRIGIVHRDIK---------------------------------PENLLVTVDGQVKIIDFGAAVDMCTGIN 364 (507)
T ss_pred HHHHHHHHHHCCeecCCCc---------------------------------hHhEEECCCCcEEEEeCcCccccccCCc
Confidence 9999999999999999988 8888888889999999999965432211
Q ss_pred -cccccccccccccccccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCcc-----
Q psy3253 137 -KRNTVIGTPFWMAPEVIQEIGY----------------------DCVADMWSLGITALEMAEGKP-PYGDIHPM----- 187 (251)
Q Consensus 137 -~~~~~~~~~~y~aPE~~~~~~~----------------------~~~~DvwslG~~l~~l~~g~~-p~~~~~~~----- 187 (251)
......+++.|+|||.+..... ..+.|+||+||++++|++|.. ||.+....
T Consensus 365 ~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~ 444 (507)
T PLN03224 365 FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR 444 (507)
T ss_pred cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh
Confidence 1112234788999998853221 124699999999999999875 66432110
Q ss_pred -----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc---CccCCHHHHhcChhhhhc
Q psy3253 188 -----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP---EERATASEMLNHEFIQRH 241 (251)
Q Consensus 188 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~evl~hp~~~~~ 241 (251)
.............+......++...||+.+||..+| .+|+|++|+|+||||.+.
T Consensus 445 ~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 445 QYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred hccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 000111112223344456678999999999999876 689999999999999764
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=231.44 Aligned_cols=185 Identities=32% Similarity=0.537 Sum_probs=139.2
Q ss_pred CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 20 ~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
..+|+-||||+..+|.++++.+...-......+++++|++||.|+|++|+||||||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLK------------------------ 724 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLK------------------------ 724 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCC------------------------
Confidence 35899999999877878776332222578899999999999999999999999988
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccC------c------------ccccccccccccccccccccccC---CC
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT------D------------TMAKRNTVIGTPFWMAPEVIQEI---GY 158 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~------~------------~~~~~~~~~~~~~y~aPE~~~~~---~~ 158 (251)
|.||+++.+..+||+|||++...- . .........||.-|+|||++.+. +|
T Consensus 725 ---------P~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 725 ---------PRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred ---------cceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 889999999999999999997611 0 01122345689999999999764 49
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCC-CcchhhhhcCCCCCCCC-CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDI-HPMRAIFMIPTKPPPSF-REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
+.|+||||+|++++||+. ||+.. ........+..+..+.. ..+..--+.-..+|.+|++.||++|||+.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 999999999999999976 36433 22222333332221111 01222345568999999999999999999999999
Q ss_pred hhhh
Q psy3253 237 FIQR 240 (251)
Q Consensus 237 ~~~~ 240 (251)
||-.
T Consensus 873 llpp 876 (1351)
T KOG1035|consen 873 LLPP 876 (1351)
T ss_pred CCCc
Confidence 9975
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=204.54 Aligned_cols=198 Identities=21% Similarity=0.384 Sum_probs=167.9
Q ss_pred CCCCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 3 QCDSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRK-------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
...|||+..+.++..++ ...+.++.++.-|+|..|++..+ +.++..+...++.|++.|+.|||..|+||.||
T Consensus 343 ~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi 422 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI 422 (563)
T ss_pred cCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence 45799999999988654 56788899999999999997443 24666788889999999999999999999997
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccc--ccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVIGTPFWMAPEV 152 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~ 152 (251)
- .+|.++++.-.+||+|=.+++..-......- ....+..||+||.
T Consensus 423 A---------------------------------aRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEa 469 (563)
T KOG1024|consen 423 A---------------------------------ARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEA 469 (563)
T ss_pred h---------------------------------hhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHH
Confidence 7 7888888888999999998876644333221 1223556999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 153 IQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 153 ~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
+.+..|+.++|+||||+++|||+| |+.|+.+.++.+...++..+. .+..|.++|++++.++..||...|++||+++|
T Consensus 470 l~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy--RlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 470 LQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY--RLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred HhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc--eecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 999999999999999999999998 999999999999988887775 44568999999999999999999999999999
Q ss_pred HhcC
Q psy3253 232 MLNH 235 (251)
Q Consensus 232 vl~h 235 (251)
+...
T Consensus 548 lv~c 551 (563)
T KOG1024|consen 548 LVIC 551 (563)
T ss_pred HHHH
Confidence 9754
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=191.54 Aligned_cols=165 Identities=38% Similarity=0.720 Sum_probs=134.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~ 77 (251)
+...+|.+|++||.+......++.||.|+. ||+.|.+ ..++..+|...-+++..++.||.|||++ .+||||+|
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvK-- 176 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVK-- 176 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCC--
Confidence 456899999999999888899999999965 9987775 3467899999999999999999999986 79999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--- 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 154 (251)
|+||+++.+|++|+||||.+....+...+. ...|...|+|||.+.
T Consensus 177 -------------------------------PsNiLIn~~GqVKiCDFGIsG~L~dSiAkt-~daGCkpYmaPEri~~e~ 224 (282)
T KOG0984|consen 177 -------------------------------PSNILINYDGQVKICDFGISGYLVDSIAKT-MDAGCKPYMAPERINPEL 224 (282)
T ss_pred -------------------------------cceEEEccCCcEEEcccccceeehhhhHHH-HhcCCCccCChhhcCccc
Confidence 889999999999999999997665443332 234667799999984
Q ss_pred -cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc-chhhhhcCCCCCCCC
Q psy3253 155 -EIGYDCVADMWSLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSF 201 (251)
Q Consensus 155 -~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 201 (251)
...|+.++||||||+++.||.+++.||..+.. -.....+...+++.+
T Consensus 225 n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 225 NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred CcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 34789999999999999999999999966533 333444444444444
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-30 Score=205.38 Aligned_cols=205 Identities=25% Similarity=0.468 Sum_probs=156.9
Q ss_pred CCCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
.++|.||+...++.+-.. .+|.++|.+. .+|-..+- ....++..-++.+++||+.||+|||+.||.|||||
T Consensus 108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIK-- 183 (449)
T KOG0664|consen 108 SFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIK-- 183 (449)
T ss_pred hhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCC--
Confidence 468999999988876332 2678888884 47766554 56789999999999999999999999999999999
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-ccccccccccccccccc-
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQE- 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~- 155 (251)
|.|.+++.+..+||+|||+++.......+. ....-|..|+|||++.+
T Consensus 184 -------------------------------PGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGa 232 (449)
T KOG0664|consen 184 -------------------------------PGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGA 232 (449)
T ss_pred -------------------------------CccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcc
Confidence 889999999999999999997654332221 22345778999999976
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCC----------------------CCCC------CCC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKP----------------------PPSF------REP 204 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~----------------------~~~~------~~~ 204 (251)
..|+.+.||||+||++.|++.++..|+...+......+ ...+ .+.+ ..+
T Consensus 233 RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~ 312 (449)
T KOG0664|consen 233 RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASP 312 (449)
T ss_pred hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCC
Confidence 56899999999999999999999998655443322221 1111 1111 112
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
..-..+..+++.++|..||.+|++.++++.|++..+..
T Consensus 313 ~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 313 DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred cccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 23346678999999999999999999999999987643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=185.04 Aligned_cols=169 Identities=44% Similarity=0.790 Sum_probs=147.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++.+.|++++++++++......++++|++.+++|.+++......++...+..++.+++.++.+||+.|++|+||+
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~----- 119 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK----- 119 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-----
Confidence 356789999999999999899999999999899999997443578999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCcccccccccccccccccccccccC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~ 158 (251)
|.||+++. .+.++|+|||.+..............+...|.+||.+... ..
T Consensus 120 ----------------------------~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 171 (215)
T cd00180 120 ----------------------------PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171 (215)
T ss_pred ----------------------------HhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCC
Confidence 77888887 7889999999997654332122334467789999999776 77
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
+.++|+|++|++++++ ..+.+++.+|+..+|++||+++++++++
T Consensus 172 ~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 172 SEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred CchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8899999999999998 7899999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=216.49 Aligned_cols=208 Identities=24% Similarity=0.354 Sum_probs=165.4
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
.+.|||++.....+++.....-.||||.+ +|+.++. ..+.+...++-.+++|++.|++|+|+.|+.|||+|
T Consensus 377 ~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK------- 447 (601)
T KOG0590|consen 377 SLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLK------- 447 (601)
T ss_pred cccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh-cccccchhhhhHHHHHHHHHHHHHHhcCceeccCc-------
Confidence 57899998888877766555555999998 9999986 44689999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc----ccccccccccccccccccccCCC
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
++|+++..++.+||+|||.+....... .......|+..|.|||++.+..|
T Consensus 448 --------------------------~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y 501 (601)
T KOG0590|consen 448 --------------------------LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY 501 (601)
T ss_pred --------------------------cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc
Confidence 889999999999999999997554322 23455678889999999999999
Q ss_pred Cc-chhHHHHHHHHHHHHhCCCCCCCCCcchhh--hhcCCC----CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 159 DC-VADMWSLGITALEMAEGKPPYGDIHPMRAI--FMIPTK----PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 159 ~~-~~DvwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
.+ ..||||.|+++..|.+|+.||.-....... ...... ..........++.+.+.+|.+||++||.+|+|+++
T Consensus 502 dpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 502 DPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred CcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence 88 599999999999999999999533222111 111010 00111223456788999999999999999999999
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
|++.+||+..+...
T Consensus 582 i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 582 ILNDEWIRSIECCH 595 (601)
T ss_pred HhhChHhhhcceEE
Confidence 99999999877654
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=195.64 Aligned_cols=195 Identities=24% Similarity=0.387 Sum_probs=145.2
Q ss_pred CCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------Cc
Q psy3253 3 QCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR---------RK 69 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~---------~i 69 (251)
.++|+||++++++-..+. .++||++|.+.|+|.+|+. ....++.+..+++..++.||+|||+. .|
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~I 337 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPI 337 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcc
Confidence 478999999998876555 7899999999999999996 45799999999999999999999973 48
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--ccccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y 147 (251)
+||||| ..||++..++++-|+|||+|..+... ........||.+|
T Consensus 338 aHRDlk---------------------------------SkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RY 384 (534)
T KOG3653|consen 338 AHRDLK---------------------------------SKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRY 384 (534)
T ss_pred cccccc---------------------------------ccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhh
Confidence 999988 88999999999999999999877532 2233446899999
Q ss_pred cccccccc-CCCC-----cchhHHHHHHHHHHHHhCCCCCC-CC----------------Ccchhhhh-cCCCCCCCCC-
Q psy3253 148 MAPEVIQE-IGYD-----CVADMWSLGITALEMAEGKPPYG-DI----------------HPMRAIFM-IPTKPPPSFR- 202 (251)
Q Consensus 148 ~aPE~~~~-~~~~-----~~~DvwslG~~l~~l~~g~~p~~-~~----------------~~~~~~~~-~~~~~~~~~~- 202 (251)
||||++.+ .++. .+.||||+|.++||++++..-+. +. .-++.... +..+..+.+.
T Consensus 385 MAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~ 464 (534)
T KOG3653|consen 385 MAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD 464 (534)
T ss_pred cCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh
Confidence 99999965 2233 25899999999999998653321 10 00011111 1111111111
Q ss_pred --CCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 203 --EPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 203 --~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
....-..-+++.+..||+.||+.|.|+.=+
T Consensus 465 ~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 465 AWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 111223558999999999999999998544
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=192.69 Aligned_cols=194 Identities=26% Similarity=0.465 Sum_probs=143.9
Q ss_pred CCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cccc
Q psy3253 4 CDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR--------RKIH 71 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~iiH 71 (251)
|+|+||+.++++-..++ .++||++|.+.|||+||+. ...++....+.++..++.||.+||.. .|.|
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 69999999998886543 5899999999999999996 47899999999999999999999963 3899
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc----ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT----MAKRNTVIGTPFW 147 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~y 147 (251)
|||| ..||++.+++++-|+|+|+|...... ........||.+|
T Consensus 340 RDlK---------------------------------SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY 386 (513)
T KOG2052|consen 340 RDLK---------------------------------SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY 386 (513)
T ss_pred cccc---------------------------------cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeec
Confidence 9988 77999999999999999999765433 1234567899999
Q ss_pred ccccccccCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCCCCcc----hhhhhcCCCCCCCCCCCCCC
Q psy3253 148 MAPEVIQEIG----Y--DCVADMWSLGITALEMAEG----------KPPYGDIHPM----RAIFMIPTKPPPSFREPDVW 207 (251)
Q Consensus 148 ~aPE~~~~~~----~--~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 207 (251)
||||++...- + -..+||||||.++||+.-+ ++||.+..+. +.+..+.-........+..+
T Consensus 387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW 466 (513)
T KOG2052|consen 387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW 466 (513)
T ss_pred cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc
Confidence 9999995421 2 1248999999999998753 3577433221 11111111111111112222
Q ss_pred -----CHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 208 -----TPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 208 -----~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
-..+..+|+.||..||..|.|+-.+
T Consensus 467 ~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 467 KSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 1346789999999999999987554
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=205.11 Aligned_cols=143 Identities=26% Similarity=0.420 Sum_probs=127.5
Q ss_pred CCCccceeeeeEeeCCeEEEEEEcc-CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYC-GAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~-~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.|+||+++.++|++++.+|++||.. +|-+|++++. ....++|.+++.+++|++.|+++||++||+|||||
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdik-------- 697 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIK-------- 697 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccc--------
Confidence 4999999999999999999999987 4669999997 67889999999999999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc-ch
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC-VA 162 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~ 162 (251)
-+|++++.+|-+||+|||.+...-. ..-...+||..|.|||++.+.+|-. .-
T Consensus 698 -------------------------denvivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~q 750 (772)
T KOG1152|consen 698 -------------------------DENVIVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQ 750 (772)
T ss_pred -------------------------cccEEEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcc
Confidence 8999999999999999999854322 2334578999999999999988765 48
Q ss_pred hHHHHHHHHHHHHhCCCCCCC
Q psy3253 163 DMWSLGITALEMAEGKPPYGD 183 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~ 183 (251)
|||++|+++|.++....||.+
T Consensus 751 diwalgillytivykenpyyn 771 (772)
T KOG1152|consen 751 DIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhhhheeeEEEeccCCCcC
Confidence 999999999999999988854
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=191.88 Aligned_cols=201 Identities=31% Similarity=0.492 Sum_probs=146.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
-+.||+.+.+.+.++++.++|+||++..+..++.. .++..+++.++..++.||.++|.+|||||||||+
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKps------- 161 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPS------- 161 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcc-------
Confidence 47799999999999999999999999988888875 6779999999999999999999999999999955
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccC-------------------------------
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLT------------------------------- 132 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~------------------------------- 132 (251)
|++.+.. +.-.|.|||++....
T Consensus 162 --------------------------NFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~ 215 (418)
T KOG1167|consen 162 --------------------------NFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVAT 215 (418)
T ss_pred --------------------------ccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccccc
Confidence 5554432 234566666664100
Q ss_pred -------------cccccccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC-cchhhhh-----
Q psy3253 133 -------------DTMAKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIH-PMRAIFM----- 192 (251)
Q Consensus 133 -------------~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~----- 192 (251)
..........||+.|+|||++.+. ..+++.||||.|+++..++++..||.... .......
T Consensus 216 ~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 216 ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHh
Confidence 000112224589999999999764 46889999999999999999999983110 0000000
Q ss_pred ----------cCCC------------------------------CC---CCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 193 ----------IPTK------------------------------PP---PSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 193 ----------~~~~------------------------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
.... .. .........+..+.+++.+||..||.+|+|+
T Consensus 296 G~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitA 375 (418)
T KOG1167|consen 296 GSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITA 375 (418)
T ss_pred ChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccH
Confidence 0000 00 0001122345578999999999999999999
Q ss_pred HHHhcChhhhhcc
Q psy3253 230 SEMLNHEFIQRHD 242 (251)
Q Consensus 230 ~evl~hp~~~~~~ 242 (251)
+|+|+||||...+
T Consensus 376 EeALkHpFF~~~~ 388 (418)
T KOG1167|consen 376 EDALKHPFFDEAD 388 (418)
T ss_pred HHHhcCcCCcchh
Confidence 9999999998543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=177.35 Aligned_cols=199 Identities=19% Similarity=0.303 Sum_probs=146.3
Q ss_pred CCCccceeee-eEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~-~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.|.||+.-|+ .|++.+..+.++||+..|+|..-+. ..++.|.-.+.++.|++.||.|||+++++|||||.+||||.-
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 5889998877 6788888999999999999988764 467899999999999999999999999999999955443331
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-----CCC
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-----IGY 158 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~ 158 (251)
.....+|++|||..+..+....... -+..|.+||.... ...
T Consensus 157 -------------------------------~df~rvKlcDFG~t~k~g~tV~~~~---~~~~y~~pe~~~~~~ne~~~~ 202 (378)
T KOG1345|consen 157 -------------------------------ADFYRVKLCDFGLTRKVGTTVKYLE---YVNNYHAPELCDTVVNEKLVV 202 (378)
T ss_pred -------------------------------CCccEEEeeecccccccCceehhhh---hhcccCCcHHHhhccccceEe
Confidence 1223699999999977654322211 2445889987732 335
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcch---hh--hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc---CCHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMR---AI--FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER---ATAS 230 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~ 230 (251)
.+.+|+|.||+++|.++||.+||+...... .. .+.....+........+++.+..+.++-|..+|++| -+++
T Consensus 203 ~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 203 NPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 678999999999999999999996432221 11 112222222222345678999999999999999999 4555
Q ss_pred HHhcChhhh
Q psy3253 231 EMLNHEFIQ 239 (251)
Q Consensus 231 evl~hp~~~ 239 (251)
....+.|..
T Consensus 283 k~rk~~w~E 291 (378)
T KOG1345|consen 283 KMRKCLWKE 291 (378)
T ss_pred HHHHHHHHH
Confidence 566666664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=171.39 Aligned_cols=162 Identities=38% Similarity=0.620 Sum_probs=132.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++|+|++++++++......++++|++.+++|.+++......+++..+..++.+++.++.+||+.+++|+|++
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~------ 125 (225)
T smart00221 52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLK------ 125 (225)
T ss_pred HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC------
Confidence 46789999999999998889999999999999999997433338999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-cccccccccccccccccc-ccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI-QEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~ 159 (251)
+.|++++.++.++|+|||.+....... .......++..|++||.+ ....++
T Consensus 126 ---------------------------~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 178 (225)
T smart00221 126 ---------------------------PENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYG 178 (225)
T ss_pred ---------------------------HHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCC
Confidence 888888888999999999987654432 112233466779999998 667788
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCC-CCcc-hhhhhcCCC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGD-IHPM-RAIFMIPTK 196 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~-~~~~-~~~~~~~~~ 196 (251)
.++|+|++|++++++++|+.||.. .... .....+..+
T Consensus 179 ~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 179 EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 899999999999999999999966 3333 333444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=185.06 Aligned_cols=194 Identities=28% Similarity=0.478 Sum_probs=168.0
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||.+|+++..|+.+...++++++..||.|...+. ....+++.....+...++.|+.++|+.|++|||+|
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k--------- 124 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYK--------- 124 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccc---------
Confidence 49999999999999999999999999999987765 45678999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
++||+++.+|++++.|||+++..-..... .||..|+|||++. ....++|-
T Consensus 125 ------------------------~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ 174 (612)
T KOG0603|consen 125 ------------------------LENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADW 174 (612)
T ss_pred ------------------------ccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccc
Confidence 88999999999999999999765433222 6789999999997 46788999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~hp~~~ 239 (251)
||+|++++++++|..||.. +....+... .+..|..++..+.+++..++..+|.+|. -++|+.+|+||+
T Consensus 175 ws~gvl~felltg~~pf~~----~~~~~Il~~---~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~ 247 (612)
T KOG0603|consen 175 WSFGVLAFELLTGTLPFGG----DTMKRILKA---ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ 247 (612)
T ss_pred hhhhhhHHHHhhCCCCCch----HHHHHHhhh---ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe
Confidence 9999999999999999987 333333332 4445778899999999999999999995 458999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|..
T Consensus 248 ~i~~~~ 253 (612)
T KOG0603|consen 248 SIDWNE 253 (612)
T ss_pred eeeHhh
Confidence 999984
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=161.02 Aligned_cols=197 Identities=20% Similarity=0.381 Sum_probs=153.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRR-KIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~-iiH~dik~~Ni 79 (251)
+-+.||||+.+.+.|+...++.++..||..|||++.++... -..+..++.+++.+++.|+.|||+.. ++-|--
T Consensus 242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~----- 316 (448)
T KOG0195|consen 242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFY----- 316 (448)
T ss_pred eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhh-----
Confidence 45689999999999999999999999999999999997332 23578899999999999999999964 332210
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEec--ccccccccCcccccccccccccccccccccccCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA--DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
+....++++++.+.+|+ |-.++. ........+.|++||.++..+
T Consensus 317 ---------------------------lns~hvmidedltarismad~kfsf-------qe~gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 317 ---------------------------LNSKHVMIDEDLTARISMADTKFSF-------QEVGRAYSPAWMSPEALQRKP 362 (448)
T ss_pred ---------------------------cccceEEecchhhhheecccceeee-------eccccccCcccCCHHHHhcCc
Confidence 22668899988887764 332221 122234567899999998766
Q ss_pred CC---cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YD---CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~---~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
-+ .++|+|||++++||+.|+..||.+..+.+.-..+.- .......|++.+..+..|+.-|++.||.+||.++.++
T Consensus 363 ed~n~raadmwsfaillwel~trevpfadlspmecgmkial-eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv- 440 (448)
T KOG0195|consen 363 EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV- 440 (448)
T ss_pred hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh-
Confidence 43 369999999999999999999998877765433322 2335556888999999999999999999999999987
Q ss_pred Chhhhh
Q psy3253 235 HEFIQR 240 (251)
Q Consensus 235 hp~~~~ 240 (251)
|.+.+
T Consensus 441 -pilek 445 (448)
T KOG0195|consen 441 -PILEK 445 (448)
T ss_pred -hhHHH
Confidence 55543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=158.26 Aligned_cols=209 Identities=35% Similarity=0.569 Sum_probs=161.9
Q ss_pred CCCCCC-ccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSP-YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hp-niv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+.+.|+ +++++++.+......+++++++.+++|.+++.... ..+.......++.|++.++.++|+.|++|||+|
T Consensus 52 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~k--- 128 (384)
T COG0515 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK--- 128 (384)
T ss_pred HHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC---
Confidence 356777 79999999987777899999999999997776333 279999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccc------ccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMA------KRNTVIGTPFWMAPE 151 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE 151 (251)
|+|++++..+ .++++|||.+........ ......++..|++||
T Consensus 129 ------------------------------p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 129 ------------------------------PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred ------------------------------HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHH
Confidence 7788888777 699999999975443321 235567899999999
Q ss_pred cccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----chhhhhcCCCCCC--CCCCCCCC----CHHHHHHHHHh
Q psy3253 152 VIQE---IGYDCVADMWSLGITALEMAEGKPPYGDIHP----MRAIFMIPTKPPP--SFREPDVW----TPEFIDFVSRC 218 (251)
Q Consensus 152 ~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~--~~~~~~~~----~~~~~~li~~~ 218 (251)
.+.+ ...+...|+||+|++++++++|..||..... ......+...... ........ ...+.+++.++
T Consensus 179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (384)
T COG0515 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKL 258 (384)
T ss_pred HhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHH
Confidence 9987 5788899999999999999999999865543 2222222222211 11111111 25789999999
Q ss_pred hhcCcCccCCHHHHhcChhhhhccC
Q psy3253 219 LVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 219 l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
+..+|..|.+..+...+++......
T Consensus 259 ~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 259 LAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred HhcCchhcCCHHHHhhchHhhCccc
Confidence 9999999999999998877765443
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=162.41 Aligned_cols=193 Identities=21% Similarity=0.256 Sum_probs=138.8
Q ss_pred CCCccceeeeeEee---------------------------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHH
Q psy3253 5 DSPYVVKYYGSYFK---------------------------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDT 57 (251)
Q Consensus 5 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i 57 (251)
.|||||+++.+|.+ +..+|+||.-+.. +|.+|+- ....+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~--~~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW--TRHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh--cCCCchHHHHHHHHHH
Confidence 79999999998852 2358999999965 9999985 4567888888999999
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc---
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--- 134 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--- 134 (251)
++|+.|||++|+.|||+|..||++-+++ +.-..+.++|||.+---...
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------------D~~P~LVvaDFGCcLAd~~hGlq 401 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------------DEIPQLVVADFGCCLADDNHGLQ 401 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecC-----------------------------CCCcEEEEcccceeeeccccccc
Confidence 9999999999999999994444333221 11124788999987422110
Q ss_pred ---cccccccccccccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCC
Q psy3253 135 ---MAKRNTVIGTPFWMAPEVIQEIG------YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPD 205 (251)
Q Consensus 135 ---~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (251)
........|+..-+|||+....+ -..++|.|+.|.+.||+++...||........-..-... ..-...+.
T Consensus 402 lpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-~qLPalp~ 480 (598)
T KOG4158|consen 402 LPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-SQLPALPS 480 (598)
T ss_pred cccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-hhCCCCcc
Confidence 01112234677799999986433 234799999999999999999999764433222111111 11122367
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
.+++.+++++..+|+.||++|++++
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 7899999999999999999998764
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=168.53 Aligned_cols=200 Identities=26% Similarity=0.450 Sum_probs=155.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK-IHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~i-iH~dik~~Ni 79 (251)
|+++.|.|+.+++|.+.++...+.|-+||..|+|.+.+......++......++++|+.||.|+|..-+ .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~---- 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK---- 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec----
Confidence 789999999999999999999999999999999999998667889999999999999999999998765 999977
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCc--ccccccccccccccccccccccC-
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEI- 156 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~- 156 (251)
..|.+++....+|+.|||+...... ............-|.|||.+...
T Consensus 77 -----------------------------s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 77 -----------------------------SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred -----------------------------cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccc
Confidence 7888889999999999999865431 11111111223459999999652
Q ss_pred --C----CCcchhHHHHHHHHHHHHhCCCCCCCC----CcchhhhhcCC-CCC---CCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 157 --G----YDCVADMWSLGITALEMAEGKPPYGDI----HPMRAIFMIPT-KPP---PSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 157 --~----~~~~~DvwslG~~l~~l~~g~~p~~~~----~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
. .+.+.|+||+|++++++++.+.||... ++.+.+..+.. ... +........++++..++..||..+
T Consensus 128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~ 207 (484)
T KOG1023|consen 128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEI 207 (484)
T ss_pred cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccC
Confidence 1 466799999999999999999999543 22234444333 111 111111245668999999999999
Q ss_pred cCccCCHHHHh
Q psy3253 223 PEERATASEML 233 (251)
Q Consensus 223 p~~Rps~~evl 233 (251)
|++||+++++-
T Consensus 208 P~~rPs~~~i~ 218 (484)
T KOG1023|consen 208 PEKRPSIEQIR 218 (484)
T ss_pred hhhCccHHHHH
Confidence 99999999873
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-20 Score=155.51 Aligned_cols=194 Identities=21% Similarity=0.222 Sum_probs=148.0
Q ss_pred CccceeeeeE-eeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 7 PYVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 7 pniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+++.++++.+ ..+...++||+.+ |.+|.++..... ..|+..++..++.|++.+|+++|+.|++|||||
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiK--------- 149 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIK--------- 149 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcC---------
Confidence 5888888888 4777899999999 889999886454 789999999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCC-----CCeEeccccccc--ccCcccc-------c-cccccccccccc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-----GHAKLADFGVAG--QLTDTMA-------K-RNTVIGTPFWMA 149 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-----~~~kl~dfg~~~--~~~~~~~-------~-~~~~~~~~~y~a 149 (251)
|+|+.+... ..+.+.|||+++ ....... . .....||.+|++
T Consensus 150 ------------------------p~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S 205 (322)
T KOG1164|consen 150 ------------------------PENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYAS 205 (322)
T ss_pred ------------------------HHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcccccc
Confidence 555555433 358999999998 4321110 1 233559999999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCC--CCCCCCHHHHHHHHHhhhcCcCccC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERA 227 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp 227 (251)
+....+...+.+.|+||++.++.++..|..||..................... .....+.++.++...+-..+...+|
T Consensus 206 ~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 206 INVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred HHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence 99999999999999999999999999999999665533222221111111111 2334567888888888889999999
Q ss_pred CHHHHhc
Q psy3253 228 TASEMLN 234 (251)
Q Consensus 228 s~~evl~ 234 (251)
..+.+..
T Consensus 286 dy~~~~~ 292 (322)
T KOG1164|consen 286 DYEKLAE 292 (322)
T ss_pred CHHHHHH
Confidence 8877754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=148.92 Aligned_cols=161 Identities=24% Similarity=0.328 Sum_probs=109.4
Q ss_pred EEEEEEccCCCCHHHHHH---HhCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccc
Q psy3253 22 LWIVMEYCGAGSVSDIMR---LRKKT---LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNV 95 (251)
Q Consensus 22 ~~lv~e~~~~gsL~~~~~---~~~~~---l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~ 95 (251)
.+++|+-+. ++|.+++. ..... +.....+.+..|++..+++||..|++|+|||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~-------------------- 172 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK-------------------- 172 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S--------------------
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc--------------------
Confidence 478899884 59988864 12222 2334445667899999999999999999988
Q ss_pred cchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc--------CCCCcchhHHHH
Q psy3253 96 ITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYDCVADMWSL 167 (251)
Q Consensus 96 ~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dvwsl 167 (251)
|+|++++.+|.+.|+||+.....+..... ...+..|.|||.... ..++.+.|.|++
T Consensus 173 -------------~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 173 -------------PENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp -------------GGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred -------------eeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 99999999999999999988665432211 233566899997743 247888999999
Q ss_pred HHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 168 GITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 168 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
|+++|.++++..||........... .+.....+|..+.+||..+|+.||++|
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~~~-------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADPEW-------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTSGG-------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCCCCCCccccccc-------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999999976544433321 223344789999999999999999988
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-20 Score=173.48 Aligned_cols=195 Identities=19% Similarity=0.232 Sum_probs=139.8
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
..+|||++.+..+-.++...|||=+|... +|.|.+. .+.-+...+.+.++.|++.||+.+|..||+|||||
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIK------- 147 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIK------- 147 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccc-------
Confidence 35789999988887778888999999966 9999886 45667888999999999999999999999999999
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc-------ccccccccccccccccc
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-------NTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~ 155 (251)
.+||+++.=.-+.|+||..-+..--+.... .+.....+|.|||.+..
T Consensus 148 --------------------------sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 148 --------------------------SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred --------------------------cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence 556666655557888987765442221111 11223456999999843
Q ss_pred ----------CC-CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCC-CCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 156 ----------IG-YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 156 ----------~~-~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
.+ .+++.||||+||+++|+++ |+++|.- .+.-.+..-.. .....+ -.--+..+++++..|++.|
T Consensus 202 ~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-SQL~aYr~~~~~~~e~~L--e~Ied~~~Rnlil~Mi~rd 278 (1431)
T KOG1240|consen 202 ALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-SQLLAYRSGNADDPEQLL--EKIEDVSLRNLILSMIQRD 278 (1431)
T ss_pred cccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-HHHHhHhccCccCHHHHH--HhCcCccHHHHHHHHHccC
Confidence 12 6788999999999999987 7888831 11111100000 000000 0111347899999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|.++++.|+.
T Consensus 279 Ps~RlSAedyL~~ 291 (1431)
T KOG1240|consen 279 PSKRLSAEDYLQK 291 (1431)
T ss_pred chhccCHHHHHHh
Confidence 9999999999987
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.2e-20 Score=159.11 Aligned_cols=177 Identities=27% Similarity=0.423 Sum_probs=133.0
Q ss_pred eEEEEEEccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLR--KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
++|+.|++|+-.+|.+++..+ ....+....+.++.|++.|++| +|.+|+|+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlk----------------------- 383 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLK----------------------- 383 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcc-----------------------
Confidence 589999999999999999622 2456778899999999999999 999999988
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccCccc------ccccccccccccccccccccCCCCcchhHHHHHHHHH
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 172 (251)
|.||+...+..+||+|||+........ .......||..|++||.+.+..|+.++||||||++++
T Consensus 384 ----------p~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~ 453 (516)
T KOG1033|consen 384 ----------PSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILA 453 (516)
T ss_pred ----------ccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHH
Confidence 556666666789999999997654332 2445567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 173 EMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 173 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+++. -...+.. ......+..+..++. .... .+.-..|+++|+.+.|.+||++.+.-.|+|.
T Consensus 454 EL~~~f~T~~er---~~t~~d~r~g~ip~~-~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 454 ELLIQFSTQFER---IATLTDIRDGIIPPE-FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHHhccHHHH---HHhhhhhhcCCCChH-Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 9987 2222211 111112222211110 1121 3445799999999999999998888877775
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-19 Score=165.50 Aligned_cols=154 Identities=32% Similarity=0.485 Sum_probs=130.5
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-- 135 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 135 (251)
+.+++|||.-||+|||+| |+|.+++.-|++|+.|||+.+......
T Consensus 153 vla~Eylh~ygivhrdlk---------------------------------pdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLK---------------------------------PDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred hHHhHhhccCCeecCCCC---------------------------------CCcceeeecccccccchhhhhhhhhhccc
Confidence 788999999999999988 888899999999999999997542210
Q ss_pred -------------ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCC
Q psy3253 136 -------------AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFR 202 (251)
Q Consensus 136 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 202 (251)
.......||+.|.|||++....|...+|=|++|+++|+.+-|..||.+.++++.+..+......-.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0112246899999999999999999999999999999999999999999888888766555433333
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCcc---CCHHHHhcChhhhhccCC
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEER---ATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~R---ps~~evl~hp~~~~~~~~ 244 (251)
.....+++..+++.++|+.+|..| +.+-||.+|+||+..||.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 356679999999999999999999 577889999999999998
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.1e-18 Score=138.59 Aligned_cols=193 Identities=20% Similarity=0.230 Sum_probs=152.4
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
..+.|.++|.+.+++.+-.||+|++ |.||+++..-.+..|+..++.-++.|++.-++++|++.+|.||||
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIK--------- 151 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIK--------- 151 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccC---------
Confidence 3578888998889999999999999 899999999889999999999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCC-----CeEecccccccccCccccc-------ccccccccccccccc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-----HAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEV 152 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-----~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~ 152 (251)
|+|+++..-+ .+.++|||+|+.+.+..++ .....||.+||+-..
T Consensus 152 ------------------------PdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINT 207 (449)
T KOG1165|consen 152 ------------------------PDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINT 207 (449)
T ss_pred ------------------------ccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeec
Confidence 6666664333 3789999999988765443 233568999999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc---hhhhhcCCCCC--CCCCCCCCCCHHHHHHHHHhhhcCcCccC
Q psy3253 153 IQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM---RAIFMIPTKPP--PSFREPDVWTPEFIDFVSRCLVKNPEERA 227 (251)
Q Consensus 153 ~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 227 (251)
..+...+...|+=|+|-+++..+-|..||++.... .....|-.... +-.....++|.++..-+...-..+-.+-|
T Consensus 208 HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 208 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 99999999999999999999999999999765332 22333322211 11112456788888777777777777777
Q ss_pred CHHH
Q psy3253 228 TASE 231 (251)
Q Consensus 228 s~~e 231 (251)
..+-
T Consensus 288 DYdy 291 (449)
T KOG1165|consen 288 DYDY 291 (449)
T ss_pred CHHH
Confidence 6544
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=131.24 Aligned_cols=187 Identities=22% Similarity=0.283 Sum_probs=144.0
Q ss_pred ceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccc
Q psy3253 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYC 89 (251)
Q Consensus 10 v~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~ 89 (251)
.++..++.++.+-.|||+.+ |+||+++.+-....|+..+++-++-|++.-++|+|.+++||||||
T Consensus 74 P~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIK-------------- 138 (341)
T KOG1163|consen 74 PHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIK-------------- 138 (341)
T ss_pred chhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCC--------------
Confidence 44555666778889999999 899999998888999999999999999999999999999999999
Q ss_pred cccccccchhhhhhhhhcccCceecCCC---CCeEecccccccccCcccc-------cccccccccccccccccccCCCC
Q psy3253 90 SIKCNVITNQIYKTLFRLKAGNILLNTE---GHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~nil~~~~---~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+|++..-. ..+.++|||+++.+.+..+ ......||.+|.+-....+...+
T Consensus 139 -------------------PdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS 199 (341)
T KOG1163|consen 139 -------------------PDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS 199 (341)
T ss_pred -------------------ccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhh
Confidence 777776433 3478999999987754322 22335689999998888888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
...|+=|+|.++..+--|..||++...... ...+... ..+......++|.++.-.+..|-..--++-|...
T Consensus 200 RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 200 RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 999999999999999999999987643221 2222111 0111122567889999999988887777777653
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-18 Score=156.12 Aligned_cols=202 Identities=24% Similarity=0.305 Sum_probs=163.3
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCCCccc
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEYLH-LRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~LH-~~~iiH~dik~~Ni~~~~ 83 (251)
|+|++++++...+....+++++|..|+++.+-+..... ..+...+..++.|+..++.|+| ..++.|+|+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ik-------- 151 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIK-------- 151 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCC--------
Confidence 99999999999999999999999999999988832333 7788899999999999999999 9999999998
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCc-ccc--ccccccc-ccccccccccccCC-
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTD-TMA--KRNTVIG-TPFWMAPEVIQEIG- 157 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~-~~~--~~~~~~~-~~~y~aPE~~~~~~- 157 (251)
|+|.+++..+ .+++.|||+|..... ... ......| ++.|.|||...+..
T Consensus 152 -------------------------P~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 152 -------------------------PSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred -------------------------CccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 7788888888 899999999987665 211 1223346 88999999998854
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh--hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAI--FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..+..|+||.|+++.-+++|..|+......... .............+..++....+++.+++..+|.+|.+.+++-.+
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 456799999999999999999999554333322 111121122334467778899999999999999999999999999
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
||+..
T Consensus 287 ~~~~~ 291 (601)
T KOG0590|consen 287 NWLSS 291 (601)
T ss_pred ccccc
Confidence 99988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.1e-17 Score=139.58 Aligned_cols=109 Identities=18% Similarity=0.198 Sum_probs=81.8
Q ss_pred CCCCCCCccce-eeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCC
Q psy3253 1 MQQCDSPYVVK-YYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI-KAGS 78 (251)
Q Consensus 1 l~~l~hpniv~-l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di-k~~N 78 (251)
|++++|+|++. +++. ...|+||||++|++|.. +. ... ...++.+++.||.|||++||+|||| |
T Consensus 75 L~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~K--- 139 (365)
T PRK09188 75 LKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAK--- 139 (365)
T ss_pred HHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCC---
Confidence 46789999985 4432 35799999999999963 21 111 1467889999999999999999998 8
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccc--------cccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--------NTVIGTPFWMAP 150 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~y~aP 150 (251)
|+||+++.++.++|+|||+++......... ....+++.|.||
T Consensus 140 ------------------------------P~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p 189 (365)
T PRK09188 140 ------------------------------PQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAP 189 (365)
T ss_pred ------------------------------cceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCc
Confidence 888888888899999999998654321110 233467779999
Q ss_pred cccc
Q psy3253 151 EVIQ 154 (251)
Q Consensus 151 E~~~ 154 (251)
|.+.
T Consensus 190 e~~~ 193 (365)
T PRK09188 190 DALT 193 (365)
T ss_pred ccCC
Confidence 9884
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=122.78 Aligned_cols=139 Identities=13% Similarity=0.111 Sum_probs=98.8
Q ss_pred CCCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCC
Q psy3253 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI-KAGS 78 (251)
Q Consensus 1 l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di-k~~N 78 (251)
|++| .|+++.+++++ ...+++|||+.|.+|.+... . ....++.|++.+|+++|++|++|||| |
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~--~------~~~~~~~qi~~~L~~lH~~GIvHrDL~k--- 119 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP--R------GDLAYFRAARRLLQQLHRCGVAHNDLAK--- 119 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh--h------hhHHHHHHHHHHHHHHHHCcCccCCCCC---
Confidence 3567 45889998875 34699999999999865432 1 11357789999999999999999998 6
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-----c--------cccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-----K--------RNTVIGTP 145 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~--------~~~~~~~~ 145 (251)
|+||+++.++.++|+|||++........ . ......++
T Consensus 120 ------------------------------p~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~ 169 (218)
T PRK12274 120 ------------------------------EANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCP 169 (218)
T ss_pred ------------------------------cceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence 7888988888999999999975443221 0 11122455
Q ss_pred ccccccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q psy3253 146 FWMAPEVIQEI-GYD-CVADMWSLGITALEMAEGKPPYGDI 184 (251)
Q Consensus 146 ~y~aPE~~~~~-~~~-~~~DvwslG~~l~~l~~g~~p~~~~ 184 (251)
.|++|+...-. ..+ ...+-++.|+-+|.++|+..++.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 170 AALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 56666544321 233 3456678899999999998887543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-16 Score=128.69 Aligned_cols=118 Identities=19% Similarity=0.263 Sum_probs=88.2
Q ss_pred CCCCCCccceeeeeEeeC--------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 2 QQCDSPYVVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
.+++||+|..+.+++... ...+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~D 160 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGD 160 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCC
Confidence 457899999998886533 35799999999999988732 333 2456999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
+| |+|++++.++ ++++|||............ ...
T Consensus 161 ik---------------------------------p~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~v 194 (232)
T PRK10359 161 PH---------------------------------KGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RID 194 (232)
T ss_pred CC---------------------------------hHHEEEeCCC-EEEEECCCcccccchhhHH------------HHH
Confidence 88 7888888778 9999999886543221111 122
Q ss_pred ccCCCCcchhHHHHHHHHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEM 174 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l 174 (251)
....+..++|+|+||+++...
T Consensus 195 ler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 195 LERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HHhHhcccccccceeEeehHH
Confidence 334456789999999987654
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.9e-16 Score=126.04 Aligned_cols=198 Identities=19% Similarity=0.258 Sum_probs=138.0
Q ss_pred CCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccc
Q psy3253 3 QCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRR--KIHR 72 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~ 72 (251)
++.|.|||+++.++.+ ......+.||+..|+|.++++. +...+......+|+-||+.||.|||+.. ++|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 4679999999999864 3458899999999999999962 3456888899999999999999999874 8999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEeccc--cccccc--Ccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF--GVAGQL--TDTMAKRNTVIGTPFWM 148 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~df--g~~~~~--~~~~~~~~~~~~~~~y~ 148 (251)
++. .+.+++..+|-+|+..- ...... ...........+.+.|.
T Consensus 203 nlT---------------------------------c~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~ 249 (458)
T KOG1266|consen 203 NLT---------------------------------CDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS 249 (458)
T ss_pred Ccc---------------------------------hhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccc
Confidence 966 67777777776776421 111000 00111222334567799
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
+||.=..-+.+.++|||++|....+|..+..--..............+.... --.+.-++++.+|++-.|+.||+
T Consensus 250 a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~-----len~lqr~~i~kcl~~eP~~rp~ 324 (458)
T KOG1266|consen 250 APESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG-----LENGLQRGSITKCLEGEPNGRPD 324 (458)
T ss_pred cCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee-----ccCccccCcCcccccCCCCCCcc
Confidence 9998766677889999999999999988765432222211111111110000 01223367899999999999999
Q ss_pred HHHHhcChhh
Q psy3253 229 ASEMLNHEFI 238 (251)
Q Consensus 229 ~~evl~hp~~ 238 (251)
+.+++.||..
T Consensus 325 ar~llfHpll 334 (458)
T KOG1266|consen 325 ARLLLFHPLL 334 (458)
T ss_pred hhhhhcCcee
Confidence 9999999854
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-15 Score=139.63 Aligned_cols=210 Identities=28% Similarity=0.458 Sum_probs=165.5
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
.||-+++.+..+......+|+++|+.+++|...++ +.+..+...++.++..+..++++||...+.|+|++
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~-~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~--------- 931 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLH-NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLK--------- 931 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhh-cCCCcccccccchhHHHHhhhhccccchhhccccc---------
Confidence 45777777666666778999999999999999987 45578888888999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccccc---------------------------Cccc--
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL---------------------------TDTM-- 135 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~---------------------------~~~~-- 135 (251)
|.+.+...+++.++.+||..... ....
T Consensus 932 ------------------------p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~ 987 (1205)
T KOG0606|consen 932 ------------------------PDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSAD 987 (1205)
T ss_pred ------------------------ccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccc
Confidence 55555555555555555422111 0000
Q ss_pred --ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHH
Q psy3253 136 --AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFID 213 (251)
Q Consensus 136 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (251)
.......+|+.|.+||...+......+|.|++|+++++.++|.+||...........+.....+-..-+...+.+..+
T Consensus 988 ~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~ 1067 (1205)
T KOG0606|consen 988 EARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQD 1067 (1205)
T ss_pred hhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhh
Confidence 112334578899999999999999999999999999999999999988888777766666544444446667899999
Q ss_pred HHHHhhhcCcCccCCHH---HHhcChhhhhccCCCCCC
Q psy3253 214 FVSRCLVKNPEERATAS---EMLNHEFIQRHDTDPSQN 248 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~---evl~hp~~~~~~~~~~~~ 248 (251)
++.+.+..+|.+|..+. ++-.|+||+..+|++-+.
T Consensus 1068 ~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1068 LINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred hhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence 99999999999998887 999999999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-15 Score=118.63 Aligned_cols=75 Identities=20% Similarity=0.298 Sum_probs=63.6
Q ss_pred EEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCCCccccccccccccccccchhhh
Q psy3253 23 WIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL-HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIY 101 (251)
Q Consensus 23 ~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~ 101 (251)
++||||++|++|..... ....++...+..++.|++.+|.++ |+.|++|||||
T Consensus 93 ~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlk-------------------------- 145 (190)
T cd05147 93 VLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLS-------------------------- 145 (190)
T ss_pred EEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCC--------------------------
Confidence 89999998877765533 356899999999999999999999 79999999988
Q ss_pred hhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 102 KTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 102 ~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
|+||+++ ++.++|+|||++....
T Consensus 146 -------P~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 146 -------EYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -------HHHEEEE-CCcEEEEEccccccCC
Confidence 7788887 4679999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.1e-15 Score=138.61 Aligned_cols=145 Identities=22% Similarity=0.215 Sum_probs=115.9
Q ss_pred ccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccc
Q psy3253 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLD 87 (251)
Q Consensus 8 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~ 87 (251)
.|..+...+.-.+..++|+||.+.|||-++++ ....+++-.+..+..|++.-++.||.++||||||||.|.|++.....
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 44555555555666899999999999999997 67889999999999999999999999999999999998888843211
Q ss_pred cccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCc--ccccccccccccccccccccccCCCCcchhHH
Q psy3253 88 YCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMW 165 (251)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 165 (251)
.. ....++|+|||.+..... +..+-.....|-.+-.+|...+.+|+...|.|
T Consensus 834 ---------------------~~-----~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~Dyf 887 (974)
T KOG1166|consen 834 ---------------------DS-----DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYF 887 (974)
T ss_pred ---------------------CC-----cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhH
Confidence 11 134599999999975542 22223334566678899999999999999999
Q ss_pred HHHHHHHHHHhCCC
Q psy3253 166 SLGITALEMAEGKP 179 (251)
Q Consensus 166 slG~~l~~l~~g~~ 179 (251)
.++-+++-|+.|+.
T Consensus 888 GlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 888 GLAATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=114.90 Aligned_cols=92 Identities=21% Similarity=0.217 Sum_probs=70.0
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCcc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTLV 82 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~ 82 (251)
+.|+++.....+.... .++||||++|+++..... ....++...+..++.|++.++.++|+ .|++|||||
T Consensus 76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk------- 145 (190)
T cd05145 76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS------- 145 (190)
T ss_pred HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC-------
Confidence 4455554333333222 489999998876544322 34568889999999999999999999 999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
|+||+++ ++.++|+|||++....
T Consensus 146 --------------------------P~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 --------------------------EYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred --------------------------hhhEEEE-CCCEEEEEcccceecC
Confidence 7888887 7889999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.6e-14 Score=115.41 Aligned_cols=67 Identities=21% Similarity=0.306 Sum_probs=54.5
Q ss_pred CCCccceeeeeEeeCC---e-EEEEEEc--cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCC
Q psy3253 5 DSPYVVKYYGSYFKNT---D-LWIVMEY--CGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL-EYLHLRRKIHRDIK 75 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~---~-~~lv~e~--~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l-~~LH~~~iiH~dik 75 (251)
+||||++++|++.++. . +.+|+|| +.+|+|.+++.+ ..+++. ..++.+++.++ +|||+++|+|||||
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlK 132 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELK 132 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 7899999999999874 3 3378999 447999999963 346655 35677888777 89999999999999
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-13 Score=120.22 Aligned_cols=196 Identities=21% Similarity=0.213 Sum_probs=153.3
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCCCC
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK----GLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~----~l~~LH~~~iiH~dik~~Ni~ 80 (251)
.|+|.++.+..+...+..++-+|+| +.+|..+.......++....+..+.+... ||.++|..+++|-|+|
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~k----- 249 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLK----- 249 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccc-----
Confidence 5899999999999999999999999 46888888744455888899999999999 9999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccc-----cccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNT-----VIGTPFWMAPEVIQ 154 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~-----~~~~~~y~aPE~~~ 154 (251)
|.|++..++ ..+++.|||+...++........ ..+...|++||...
T Consensus 250 ----------------------------p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 250 ----------------------------PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred ----------------------------hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 888888888 78899999999877654322211 24666799999985
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDI--HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
+ -++...|++++|.++.+..++..+.... +......... .+.+.....+.++...+..|++.+|-.|++++.+
T Consensus 302 ~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~ 376 (524)
T KOG0601|consen 302 G-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQIL 376 (524)
T ss_pred c-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHH
Confidence 5 5688999999999999998887665333 2222111111 1222344456777789999999999999999999
Q ss_pred hcChhhh
Q psy3253 233 LNHEFIQ 239 (251)
Q Consensus 233 l~hp~~~ 239 (251)
++|+++.
T Consensus 377 ~~l~~i~ 383 (524)
T KOG0601|consen 377 TALNVIH 383 (524)
T ss_pred hcccccc
Confidence 9998876
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.7e-13 Score=118.12 Aligned_cols=136 Identities=18% Similarity=0.324 Sum_probs=105.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH-LRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~iiH~dik~~Ni 79 (251)
|+.++||||+++++.+..++..|+|+|-+ -.|..++... ....+.--+.||+.||.||| +.+++|++|.
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~---- 132 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEVCLGLFQILAALSFLNDDCNLVHGNVC---- 132 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCCeeeccEe----
Confidence 57899999999999999999999999998 4788787632 26666677899999999998 5789999977
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
.+.++++..|..||++|..+................-.|..|+.+....
T Consensus 133 -----------------------------~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 133 -----------------------------KDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred -----------------------------eeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 8899999999999999999866543322111111122355666543322
Q ss_pred cchhHHHHHHHHHHHHhC
Q psy3253 160 CVADMWSLGITALEMAEG 177 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g 177 (251)
...|.|.|||++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 347999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.1e-13 Score=106.97 Aligned_cols=89 Identities=24% Similarity=0.291 Sum_probs=74.4
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
.+.|+++.....++......+++|||++|++|.+++.... . ....++.+++.+|.++|+.|++|||++
T Consensus 55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~------- 122 (211)
T PRK14879 55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLT------- 122 (211)
T ss_pred HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCC-------
Confidence 4567788777777767778899999999999999986321 1 788899999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccc
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~ 130 (251)
|.||+++ ++.++++|||.+..
T Consensus 123 --------------------------p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 123 --------------------------TSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --------------------------cccEEEE-CCCEEEEECCcccC
Confidence 7788887 67799999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.1e-13 Score=120.22 Aligned_cols=87 Identities=20% Similarity=0.252 Sum_probs=74.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++|++++....++......++||||++|++|.+++. ....++.+++.+|.+||+.|++|||+|
T Consensus 391 ~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlk------ 455 (535)
T PRK09605 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLT------ 455 (535)
T ss_pred HhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCC------
Confidence 46789999888777777777899999999999999875 346789999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
|+||++ .++.++|+|||+++..
T Consensus 456 ---------------------------p~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 456 ---------------------------TSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ---------------------------hHHEEE-ECCcEEEEeCcccccC
Confidence 778888 5677999999999653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-12 Score=103.70 Aligned_cols=85 Identities=21% Similarity=0.263 Sum_probs=67.8
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
+.|+++....-++......+++|||++|++|.+++.... . .++.+++.+|.+||+.|++|||++
T Consensus 54 l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~-------- 117 (199)
T TIGR03724 54 ARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLT-------- 117 (199)
T ss_pred HHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCC--------
Confidence 455655544444555666799999999999998875221 1 788999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~ 130 (251)
|.||+++ ++.++++|||.+..
T Consensus 118 -------------------------~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 118 -------------------------TSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred -------------------------cceEEEE-CCcEEEEECCCCcC
Confidence 7788887 67899999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=106.67 Aligned_cols=76 Identities=22% Similarity=0.308 Sum_probs=63.5
Q ss_pred EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCCCccccccccccccccccchhh
Q psy3253 22 LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR-KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100 (251)
Q Consensus 22 ~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~-iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~ 100 (251)
.++||||++|++|..... ....+...++..++.|++.++.+||+.| ++|||+|
T Consensus 123 ~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik------------------------- 176 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS------------------------- 176 (237)
T ss_pred ceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC-------------------------
Confidence 489999999988876543 2345667778899999999999999999 9999988
Q ss_pred hhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 101 ~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
|+||+++ ++.++++|||.+....
T Consensus 177 --------p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 --------EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred --------hhhEEEE-CCCEEEEEChhhhccC
Confidence 7788887 6789999999986443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.8e-12 Score=104.07 Aligned_cols=90 Identities=20% Similarity=0.193 Sum_probs=68.2
Q ss_pred CCCCCcc--ceeeeeEeeCC----eEEEEEEccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 3 QCDSPYV--VKYYGSYFKNT----DLWIVMEYCGA-GSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 3 ~l~hpni--v~l~~~~~~~~----~~~lv~e~~~~-gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
+++|+++ ++.+++..... ..++|||+++| .+|.+++. ...+++.. +.+++.+|.+||++||+|||||
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~--~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlk 169 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQ--EAPLSEEQ----WQAIGQLIARFHDAGVYHADLN 169 (239)
T ss_pred HHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHh--cCCCCHHH----HHHHHHHHHHHHHCCCCCCCCC
Confidence 4566664 66666644322 23599999987 69999885 34555543 5689999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
|.||+++.++.++|+|||.+...
T Consensus 170 ---------------------------------p~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 170 ---------------------------------AHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred ---------------------------------chhEEEcCCCCEEEEECCCcccC
Confidence 77888877788999999998653
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.2e-12 Score=114.62 Aligned_cols=156 Identities=20% Similarity=0.253 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHh-CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 53 ILCDTLKGLEYLHL-RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 53 ~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
=+.+++.|+.|+|. .++||++|. |++|+++.++.+||+.|+.+...
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~---------------------------------p~~i~~na~~~wkl~Gf~f~v~~ 150 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQ---------------------------------PEAIVVNANGDWKLAGFSFCVNA 150 (700)
T ss_pred hhhcccchhhhhccCcceeecccc---------------------------------hhheeeccCcceeeccchhhhcc
Confidence 35567799999997 589999977 99999999999999999998654
Q ss_pred Cccccc----c-----cccccccccccccccccCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcchh-hhhcCCCCCCC
Q psy3253 132 TDTMAK----R-----NTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA-EGKPPYGDIHPMRA-IFMIPTKPPPS 200 (251)
Q Consensus 132 ~~~~~~----~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~-~~~~~~~~~~~ 200 (251)
...... + ........|.|||++.+...+.++|++|+|+++|.+. .|+..+........ ...........
T Consensus 151 ~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~ 230 (700)
T KOG2137|consen 151 NGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA 230 (700)
T ss_pred CCCCccccccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc
Confidence 431110 0 0111234599999999888899999999999999998 56665533211111 11111222223
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 201 FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 201 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
......+++++++=+.+++..++..||++.+++..|||++.
T Consensus 231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred ccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 33457789999999999999999999999999999999863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.4e-11 Score=94.50 Aligned_cols=72 Identities=18% Similarity=0.195 Sum_probs=60.7
Q ss_pred eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhh
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~ 100 (251)
..++||||++|++|..... ......++.+++.++.++|+.|++|||||
T Consensus 105 ~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~------------------------- 152 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLS------------------------- 152 (198)
T ss_pred CceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCC-------------------------
Confidence 4589999999999876532 13456788899999999999999999988
Q ss_pred hhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 101 ~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
|.||+++.++.++|+|||.+....
T Consensus 153 --------p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 --------EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --------cccEEEcCCCcEEEEECCccccCC
Confidence 888999888999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-10 Score=101.90 Aligned_cols=193 Identities=21% Similarity=0.253 Sum_probs=141.7
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
-|.++++++..|....+.|+-.|||+++++..... ....+++...+++..|++.++.++|+..++|+|+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~--------- 393 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK--------- 393 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhccccc---------
Confidence 48889999999988888899999999998877663 45678999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCccccccccccc-cccc-ccccccccCCCCcc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIG-TPFW-MAPEVIQEIGYDCV 161 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~y-~aPE~~~~~~~~~~ 161 (251)
|+||++..+ +..+++|||...... ........ +..| .++......++..+
T Consensus 394 ------------------------psni~i~~~~~~~~~~~~~~~t~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~ 446 (524)
T KOG0601|consen 394 ------------------------PSNILISNDGFFSKLGDFGCWTRLA---FSSGVFHHIDRLYPIAEILLEDYPHLSK 446 (524)
T ss_pred ------------------------ccceeeccchhhhhccccccccccc---eecccccccccccccchhhccccccccc
Confidence 666666654 556888888875421 11111122 2334 35555566778889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.|++|||.-+.+.+++.+.-........ +..+.. ........++..+.+.+...++..|+.+.++..|+-|.+
T Consensus 447 ~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~~~~---p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 447 ADIFSLGLSVDEAITGSPLSESGVQSLT---IRSGDT---PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cccccccccccccccCcccCccccccee---eecccc---cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999998765433332222 222211 112333477888999999999999999999988876644
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.1e-10 Score=85.09 Aligned_cols=82 Identities=26% Similarity=0.285 Sum_probs=68.7
Q ss_pred CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCCCccc
Q psy3253 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR---RKIHRDIKAGSGTLVY 83 (251)
Q Consensus 7 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~---~iiH~dik~~Ni~~~~ 83 (251)
.++.++++++...+..+++|||+.++++..+ +......++.+++.++..+|.. +++|+|++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~-------- 116 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH-------- 116 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCC--------
Confidence 5788888888777889999999988777543 5566677889999999999985 69999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
|.|+++++.+.++++|||.+.
T Consensus 117 -------------------------~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 117 -------------------------PGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred -------------------------cceEEEECCcEEEEEeccccc
Confidence 778888777889999999884
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-09 Score=85.52 Aligned_cols=75 Identities=20% Similarity=0.296 Sum_probs=57.6
Q ss_pred eEEEEEEccCCCCHHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCccccccccccccccccch
Q psy3253 21 DLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
..+++|||+.++++.. .+.. .... ..+..++.+++.++.++|. .|++|||+|
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~--~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~----------------------- 142 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKD--VRLL-EDPEELYDQILELMRKLYREAGLVHGDLS----------------------- 142 (187)
T ss_pred CCEEEEEEeCCCCccChhhhh--hhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC-----------------------
Confidence 3589999998854321 1110 1111 6778899999999999999 999999988
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
|+||+++ ++.++++|||.+....
T Consensus 143 ----------p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 ----------EYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ----------hhhEEEE-CCcEEEEECccccccc
Confidence 8888888 7889999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.5e-09 Score=81.62 Aligned_cols=77 Identities=19% Similarity=0.329 Sum_probs=58.4
Q ss_pred eEEEEEEccCCCCHHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 21 DLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYL-HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~L-H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
.-++||||++++.+.. .+ ....+++.+...+..+++.++..| |+.|++|||++
T Consensus 98 ~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs----------------------- 152 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS----------------------- 152 (197)
T ss_pred CCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----------------------
Confidence 4579999997654422 22 234566667778889999999998 89999999988
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
+.||++. ++.+.++|||.+.....
T Consensus 153 ----------~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 ----------EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred ----------HHHEEEE-CCcEEEEECCCceeCCC
Confidence 7777775 35699999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.7e-09 Score=91.73 Aligned_cols=78 Identities=24% Similarity=0.391 Sum_probs=59.6
Q ss_pred CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK-GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 20 ~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~-~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
...++||||++|++|.++........+ ...++.+++. .+..+|..|++|+|+|
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~h----------------------- 284 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLH----------------------- 284 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCC-----------------------
Confidence 346899999999999988753322332 2345555555 4788999999999988
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
|.||++..++.++++|||++...+.
T Consensus 285 ----------PgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 285 ----------PGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ----------cccEEECCCCcEEEEeCCCeeECCH
Confidence 7788888888999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.7e-08 Score=84.84 Aligned_cols=173 Identities=15% Similarity=0.224 Sum_probs=122.1
Q ss_pred CCCCCCccceeeeeEee----CCeEEEEEEccC-CCCHHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHH
Q psy3253 2 QQCDSPYVVKYYGSYFK----NTDLWIVMEYCG-AGSVSDIMRLR--------------KKTLSEDEIATILCDTLKGLE 62 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~----~~~~~lv~e~~~-~gsL~~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~ 62 (251)
+++.|+|||.+.++|.+ +..+++|++|.. .++|.++.-.+ +...+++..+.++.|+..||.
T Consensus 328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 57899999999999974 346999999985 56888766311 235788999999999999999
Q ss_pred HHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccc
Q psy3253 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 142 (251)
Q Consensus 63 ~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 142 (251)
++|+.|..-+-+. +.+|+++.+..++|+.-|.--....+.
T Consensus 408 sIHssGLAck~L~---------------------------------~~kIlv~G~~RIriS~C~i~Dvl~~d~------- 447 (655)
T KOG3741|consen 408 SIHSSGLACKTLD---------------------------------LKKILVTGKMRIRISGCGIMDVLQEDP------- 447 (655)
T ss_pred HHHhcCceeeccc---------------------------------HhHeEeeCcceEEEecccceeeecCCC-------
Confidence 9999998777755 778888888778877655542222111
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC-C-CCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP-Y-GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 143 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
. +.+. -..+-|.=.||.++..|.||..- + .+.+.......+ -..++.++++++..+..
T Consensus 448 -----~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----------~~~yS~D~rn~v~yl~s 507 (655)
T KOG3741|consen 448 -----T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----------TTTYSTDLRNVVEYLES 507 (655)
T ss_pred -----C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh----------hhhhhHHHHHHHHHHHh
Confidence 0 1111 12357999999999999998532 1 111222212222 24468899999999999
Q ss_pred cCcCccCCHHHHhcC
Q psy3253 221 KNPEERATASEMLNH 235 (251)
Q Consensus 221 ~~p~~Rps~~evl~h 235 (251)
.++.+ -++.+++.+
T Consensus 508 ~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 508 LNFRE-KSIQDLLPM 521 (655)
T ss_pred cCccc-ccHHHHHHH
Confidence 99986 578887754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.3e-08 Score=79.31 Aligned_cols=63 Identities=14% Similarity=0.020 Sum_probs=50.9
Q ss_pred CeEEEEEEccCCC-CHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 20 TDLWIVMEYCGAG-SVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 20 ~~~~lv~e~~~~g-sL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
...++|+|++++. +|.+++... ....+......++.+++..+.-||+.|++|+|++++|||+.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~ 172 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLH 172 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEe
Confidence 3578999999875 899998532 34566778889999999999999999999999995555554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.2e-07 Score=78.97 Aligned_cols=176 Identities=15% Similarity=0.237 Sum_probs=115.1
Q ss_pred EEEEEEccCCCC-HHHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccc
Q psy3253 22 LWIVMEYCGAGS-VSDIMR-----LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNV 95 (251)
Q Consensus 22 ~~lv~e~~~~gs-L~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~ 95 (251)
+-++|+.+.|.. .-.+++ +.-..+.+.-.++.++.++.+...||..|..-||+.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn-------------------- 144 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVN-------------------- 144 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccC--------------------
Confidence 667888876541 212221 222457889999999999999999999999999988
Q ss_pred cchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----cCCCCcchhHHHHHHH
Q psy3253 96 ITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGIT 170 (251)
Q Consensus 96 ~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~ 170 (251)
++|++++.++.+.|.|=..-. +...........|...|.+||.-. +..-+...|.|.||++
T Consensus 145 -------------~~~~lVsd~~~V~LVdsDsfq-i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavL 210 (637)
T COG4248 145 -------------QNSFLVSDDSKVVLVDSDSFQ-INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVL 210 (637)
T ss_pred -------------ccceeeecCceEEEEccccee-eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHH
Confidence 777777777777776532211 112223334456788899999764 3445667999999999
Q ss_pred HHHHHhC-CCCCCCCCcc-------h-hhh-----hcCC-----CCCCCCCCCCCCCHHHHHHHHHhhhcC--cCccCCH
Q psy3253 171 ALEMAEG-KPPYGDIHPM-------R-AIF-----MIPT-----KPPPSFREPDVWTPEFIDFVSRCLVKN--PEERATA 229 (251)
Q Consensus 171 l~~l~~g-~~p~~~~~~~-------~-~~~-----~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~--p~~Rps~ 229 (251)
+++++.| ..||.+.... + .+. .-.. ..++.-..+.-+++++..+..+|+..- +.-|||+
T Consensus 211 iF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 211 IFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred HHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 9998875 8999643211 1 000 0000 111112223446789999999999764 5679987
Q ss_pred HH
Q psy3253 230 SE 231 (251)
Q Consensus 230 ~e 231 (251)
+.
T Consensus 291 ~a 292 (637)
T COG4248 291 KA 292 (637)
T ss_pred HH
Confidence 54
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.3e-08 Score=73.74 Aligned_cols=71 Identities=24% Similarity=0.321 Sum_probs=56.0
Q ss_pred eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccc
Q psy3253 18 KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97 (251)
Q Consensus 18 ~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~ 97 (251)
+.....++|||.+|..|.+++... ...++..+-.-+.-||..||+|+|+.
T Consensus 70 D~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLT---------------------- 119 (204)
T COG3642 70 DPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLT---------------------- 119 (204)
T ss_pred cCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCc----------------------
Confidence 344457999999999999888633 24566777778889999999999977
Q ss_pred hhhhhhhhhcccCceecCCCCCeEecccccccc
Q psy3253 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 98 ~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~ 130 (251)
++|+++.... +.++|||++..
T Consensus 120 -----------tsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 120 -----------TSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred -----------cceEEEeCCc-EEEEECCcccc
Confidence 7777776655 89999999853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=74.53 Aligned_cols=76 Identities=17% Similarity=0.249 Sum_probs=61.6
Q ss_pred eEEEEEEccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 21 DLWIVMEYCGAG-SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 21 ~~~lv~e~~~~g-sL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
..++|+|++++. +|.+++... ...+......++.+++..+.-||+.|++|+|++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~------------------------ 145 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLHDAGIYHGDLN------------------------ 145 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCC------------------------
Confidence 468999999874 899998742 237777888999999999999999999999988
Q ss_pred hhhhhhhcccCceecCCCC---CeEecccccccc
Q psy3253 100 IYKTLFRLKAGNILLNTEG---HAKLADFGVAGQ 130 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~ 130 (251)
+.||++..++ .+.++||+.+..
T Consensus 146 ---------~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 146 ---------PSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred ---------cccEEEeCCCCceeEEEEcchhcee
Confidence 5555555554 789999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-07 Score=71.12 Aligned_cols=80 Identities=30% Similarity=0.359 Sum_probs=58.9
Q ss_pred eCCeEEEEEEccCC-CCHHHHHHHhCCCCCHHHH-HHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccc
Q psy3253 18 KNTDLWIVMEYCGA-GSVSDIMRLRKKTLSEDEI-ATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNV 95 (251)
Q Consensus 18 ~~~~~~lv~e~~~~-gsL~~~~~~~~~~l~~~~~-~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~ 95 (251)
+...-.+.|||.+| .++.+++...-..-.+... ..++.+|-..+.-||..+++|||+.
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLT-------------------- 140 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLT-------------------- 140 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeeccccc--------------------
Confidence 44445788999976 4888888744433333333 6788899999999999999999977
Q ss_pred cchhhhhhhhhcccCceecCCCC---CeEecccccccc
Q psy3253 96 ITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQ 130 (251)
Q Consensus 96 ~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~ 130 (251)
.+||++..++ .+.++|||++..
T Consensus 141 -------------TSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 141 -------------TSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred -------------ccceEEecCCCcCceEEEeecchhc
Confidence 6676665444 357899999854
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-08 Score=91.07 Aligned_cols=203 Identities=35% Similarity=0.514 Sum_probs=139.0
Q ss_pred CCCCCCCc-cceeeeeEeeCCeEEEEEEccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPY-VVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|.+++||| .++.++.++.+....+.++++.++ +-...+......+.+-+...+++.-..+++++|+.--+|+|
T Consensus 287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----- 361 (829)
T KOG0576|consen 287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----- 361 (829)
T ss_pred HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc-----
Confidence 46889999 888888888888999999999877 33222222223444555555666677789999987666776
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
||+..+ +..+..+|+......... ......+++.++|||+.....+
T Consensus 362 --------------------------------~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 362 --------------------------------NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred --------------------------------cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhccccc
Confidence 444433 457889999887665432 4556678999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHH-HHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFI-DFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~li~~~l~~~p~~Rps~~evl~hp 236 (251)
..+.|+|++|.-..++.-|.+|-.. +......+.... .+.+.....+++... ++...|+...|..|+...+++-|.
T Consensus 408 ~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsK 485 (829)
T KOG0576|consen 408 DGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSK 485 (829)
T ss_pred ccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHH
Confidence 9999999999877777777766533 222222222111 111111122333333 477889999999999999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
+|.+...-
T Consensus 486 vfngCpl~ 493 (829)
T KOG0576|consen 486 VFNGCPLR 493 (829)
T ss_pred HhccCccc
Confidence 99886653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-07 Score=72.02 Aligned_cols=75 Identities=25% Similarity=0.240 Sum_probs=55.1
Q ss_pred ceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCCCcccc
Q psy3253 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK-----IHRDIKAGSGTLVYD 84 (251)
Q Consensus 10 v~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~i-----iH~dik~~Ni~~~~~ 84 (251)
.+++.... ...++||||++|.++.+. .......+.+++.+|..||+.++ +|+|++
T Consensus 56 P~~~~~~~--~~~~lv~e~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~--------- 115 (170)
T cd05151 56 PKLYYFDP--ETGVLITEFIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLL--------- 115 (170)
T ss_pred CceEEEeC--CCCeEEEEecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCC---------
Confidence 34454432 335799999999887542 11123456789999999999885 999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
|.||+++ ++.++++|||.+.
T Consensus 116 ------------------------~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 116 ------------------------PGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ------------------------cCcEEEE-CCeEEEEeccccc
Confidence 7788887 5679999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-07 Score=84.38 Aligned_cols=87 Identities=24% Similarity=0.357 Sum_probs=56.5
Q ss_pred CccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 7 PYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRKKT-----LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 7 pniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~~~-----l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
.+.+.+-.++.+ ....+|||||++|+.+.++-...... +.+..+..++.|+ ...|++|+|+|
T Consensus 220 ~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpH----- 287 (537)
T PRK04750 220 SDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMH----- 287 (537)
T ss_pred CCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCC-----
Confidence 333444444432 34568999999999998753222222 3334444444444 46999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTD 133 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~ 133 (251)
|.||+++.++ .++++|||++...+.
T Consensus 288 ----------------------------PGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 288 ----------------------------PGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----------------------------hHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 6666666555 899999999976654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.6e-07 Score=73.72 Aligned_cols=74 Identities=30% Similarity=0.392 Sum_probs=49.5
Q ss_pred EEEEEEccC--CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 22 LWIVMEYCG--AGSVSDIMRLRKKTLSEDEIATILCDTLKGLEY-LHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 22 ~~lv~e~~~--~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~-LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
-++||||++ |..+..+.. ..++......++.+++..+.. +|..|++|||++
T Consensus 81 ~~ivME~I~~~G~~~~~l~~---~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs----------------------- 134 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKD---VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLS----------------------- 134 (188)
T ss_dssp TEEEEE--EETTEEGGCHHH---CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-S-----------------------
T ss_pred CEEEEEecCCCccchhhHHh---ccccchhHHHHHHHHHHHHHHHHHhcCceecCCC-----------------------
Confidence 379999998 656655433 222245566677788775555 679999999977
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
+.||+++.+ .+.++|||.+....
T Consensus 135 ----------~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 135 ----------EYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ----------TTSEEEETT-CEEE--GTTEEETT
T ss_pred ----------hhhEEeecc-eEEEEecCcceecC
Confidence 778888777 79999999986544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.5e-06 Score=83.04 Aligned_cols=197 Identities=22% Similarity=0.328 Sum_probs=132.9
Q ss_pred CCCCCCccceeeeeEeeCCe----EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~----~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
.+..|+|++.++.+-..... ..+..++|..-++...++ .-...+..+.+.+..++.+||.++|+....|.-+..+
T Consensus 237 ~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s 315 (1351)
T KOG1035|consen 237 SKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSAS 315 (1351)
T ss_pred HhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecc
Confidence 46789999999988765432 335567888888888776 5578899999999999999999999985444432200
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEec--ccccccccCccccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLA--DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
.....-.+..+.+.++ ||+..+...... ..........+.++|....
T Consensus 316 ------------------------------~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~ 364 (1351)
T KOG1035|consen 316 ------------------------------SSKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKE 364 (1351)
T ss_pred ------------------------------cccccccCccceeecchhhhcccccCCCcc-cchhhcCcccccccccccc
Confidence 0112333444556655 888876655432 2222334455778888876
Q ss_pred CCCCcc--hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IGYDCV--ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~~~~~--~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.+ .|+|.+|.+...+..|..+-.... . ...+ .+........+...+|+.-++++|+++.+++
T Consensus 365 ~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~----------~-~~~~-l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 365 NTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA----------V-PVSL-LDVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred ccchhhhhhHHHHHHHHHhhhhhcCccccccc----------c-hhhh-hccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 655554 799999999999888764421100 0 0011 0111222778999999999999999999999
Q ss_pred cChhhhhcc
Q psy3253 234 NHEFIQRHD 242 (251)
Q Consensus 234 ~hp~~~~~~ 242 (251)
.|+|.+...
T Consensus 433 ~~~f~~~~~ 441 (1351)
T KOG1035|consen 433 THPFLRFPT 441 (1351)
T ss_pred hchhccccc
Confidence 999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.3e-06 Score=66.23 Aligned_cols=66 Identities=23% Similarity=0.366 Sum_probs=50.8
Q ss_pred eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhh
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~ 100 (251)
..+|+|||++|..|.++.. +++ .+...++.++.-+|+.|+.|||.+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~h------------------------- 162 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPH------------------------- 162 (229)
T ss_pred EEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCC-------------------------
Confidence 4579999999988866532 222 244567788999999999999988
Q ss_pred hhhhhhcccCceecCCCCCeEeccccccc
Q psy3253 101 YKTLFRLKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 101 ~~~~~~~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
|.|++++.++ ++++||+..+
T Consensus 163 --------pgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 163 --------PGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred --------cCcEEEECCc-EEEEECcccc
Confidence 7788887655 8999997653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.3e-05 Score=64.14 Aligned_cols=59 Identities=20% Similarity=0.122 Sum_probs=44.8
Q ss_pred ccceeeeeEeeC---CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 8 YVVKYYGSYFKN---TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 8 niv~l~~~~~~~---~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
++.+++.+.... +..++||||++|.++.+.+. ...+++.....++.+++.+|..||+..
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ 119 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL--RPELSPEERRALARALADTLAALHSVD 119 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 355666666543 25689999999988876542 146788888899999999999999865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.6e-05 Score=59.11 Aligned_cols=77 Identities=18% Similarity=0.185 Sum_probs=61.0
Q ss_pred eEEEEEEccC-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 21 DLWIVMEYCG-AGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 21 ~~~lv~e~~~-~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
..+||+|-++ ..||.+++.... ...+......++.+++..+.-||+.|+.|+|+.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly----------------------- 155 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCY----------------------- 155 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCC-----------------------
Confidence 4789999664 358999885322 345778888999999999999999999999977
Q ss_pred hhhhhhhhcccCceecCCCCC--eEecccccccc
Q psy3253 99 QIYKTLFRLKAGNILLNTEGH--AKLADFGVAGQ 130 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~--~kl~dfg~~~~ 130 (251)
+.||+++..+. ++++||.-++.
T Consensus 156 ----------~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 156 ----------VRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred ----------HhheeecCCCCeeEEEEEhhccch
Confidence 67777765555 89999987753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=8.4e-05 Score=60.99 Aligned_cols=73 Identities=23% Similarity=0.292 Sum_probs=56.9
Q ss_pred eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhh
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~ 100 (251)
.-.+||||.+|-.|... .++......++..|+.-+.-.-..|++|||++
T Consensus 181 RHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlS------------------------- 229 (304)
T COG0478 181 RHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLS------------------------- 229 (304)
T ss_pred cceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCc-------------------------
Confidence 45799999998665332 23455566667777777777779999999977
Q ss_pred hhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 101 ~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
+-||+++.+|.+.++||-.+...+
T Consensus 230 --------efNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 230 --------EFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred --------hheEEEecCCCEEEEeCcccccCC
Confidence 999999999999999998875544
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00021 Score=64.51 Aligned_cols=83 Identities=20% Similarity=0.298 Sum_probs=57.2
Q ss_pred CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 20 ~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
...+|+||||+|..+.+.-......++...+..-+.+.. +..+-..|++|+|-+|.||+++
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~----------------- 335 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVR----------------- 335 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEe-----------------
Confidence 357999999999988766554556676665544443332 3344567899999997777666
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
+.+ ..++.+.+.|||+......
T Consensus 336 ---------~~~---~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 336 ---------PNP---EGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---------cCC---CCCccEEEEcccccccccH
Confidence 322 3456789999999876554
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.56 E-value=7.6e-06 Score=80.34 Aligned_cols=202 Identities=11% Similarity=0.026 Sum_probs=130.5
Q ss_pred CCCCCccceeeeeEe--eCCeEEEEEEccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC-C----cccc
Q psy3253 3 QCDSPYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDTLKGLEYLHLR-R----KIHR 72 (251)
Q Consensus 3 ~l~hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~LH~~-~----iiH~ 72 (251)
+..|+++.+.+.=.. +....+..++|+.+|.+++.+-+.- ..+.+.-+...-.+.+.+..-.|.. + .+|+
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 346777666554332 2334688999999999999886332 2333333333333435666666653 2 3677
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
++| +.|.++..+..++++++|+.+.........+...+++.|++|++
T Consensus 1365 ~Lk---------------------------------f~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1365 SLK---------------------------------FTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred hhh---------------------------------hhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHH
Confidence 766 77777777788999999999844444445566678888999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 153 IQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 153 ~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+...++.++|+|..|+.+|....|..+|..-.+......+... .....+.-.|.+.-.....+|-+....||.-..+
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~--tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNH--TFFSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccc--ccccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence 99888898999999999999998888777322221111111111 1222233334455555555666666788988888
Q ss_pred hcChhhh
Q psy3253 233 LNHEFIQ 239 (251)
Q Consensus 233 l~hp~~~ 239 (251)
+..+.|-
T Consensus 1490 ls~d~~a 1496 (2724)
T KOG1826|consen 1490 LSRDHFA 1496 (2724)
T ss_pred ccccccc
Confidence 8777664
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00015 Score=64.55 Aligned_cols=81 Identities=16% Similarity=0.198 Sum_probs=54.1
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC--CCCC-------CCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP--PPSF-------REPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
+|+||||+|.++.++..|...+......+....+..-. +... ...-.++..+.++..+|+...|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 49999999999999999887764332222221111100 0000 00112456678999999999999999999
Q ss_pred HHhcChhhhh
Q psy3253 231 EMLNHEFIQR 240 (251)
Q Consensus 231 evl~hp~~~~ 240 (251)
+..+++-|..
T Consensus 190 ~~~k~~i~~e 199 (725)
T KOG1093|consen 190 ELSKRCSFTE 199 (725)
T ss_pred HHhcCccHHH
Confidence 9999988764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00026 Score=57.45 Aligned_cols=78 Identities=23% Similarity=0.338 Sum_probs=56.1
Q ss_pred eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCccccccccccccccccchh
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
+-.|||||+....+ -.=..+.-.+...++..+..+++..+.-|-. .|++|+|++
T Consensus 140 ~nVLvMEfIg~~g~-pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLS------------------------ 194 (268)
T COG1718 140 NNVLVMEFIGDDGL-PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLS------------------------ 194 (268)
T ss_pred CCeEEEEeccCCCC-CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccch------------------------
Confidence 35799999944211 0000112233444788888999999998887 899999977
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
.-||++. ++.+.++|+|.+.....
T Consensus 195 ---------EyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 195 ---------EYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ---------hhheEEE-CCeEEEEECccccccCC
Confidence 8899998 77799999999976553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00032 Score=55.15 Aligned_cols=90 Identities=27% Similarity=0.220 Sum_probs=69.2
Q ss_pred CCCC-CccceeeeeEeeCCeEEEEEEccCCCCHHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCC
Q psy3253 3 QCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---MRLRKKTLSEDEIATILCDTLKGLEYLHL---RRKIHRDIK 75 (251)
Q Consensus 3 ~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~---~~~~~~~l~~~~~~~~~~~i~~~l~~LH~---~~iiH~dik 75 (251)
.+++ +++.+++|+|- .+++.||...+++... +. .-...++..+..++.+++..+.+|+. ..+.-.|++
T Consensus 15 ~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~ 89 (188)
T PF12260_consen 15 LLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVS 89 (188)
T ss_pred HcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 3443 69999999992 3679999976655421 11 11346889999999999999999997 347788977
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~ 130 (251)
++|+.++.++.+|++|...+..
T Consensus 90 ---------------------------------~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 90 ---------------------------------PDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred ---------------------------------hHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999987743
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00082 Score=60.78 Aligned_cols=80 Identities=31% Similarity=0.472 Sum_probs=58.8
Q ss_pred CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccch
Q psy3253 19 NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98 (251)
Q Consensus 19 ~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~ 98 (251)
....+|+|||++|-.+.+........++.+.+...+.++ -+..+-..|+.|+|.+
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpH----------------------- 292 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPH----------------------- 292 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCC-----------------------
Confidence 345799999999999998865445666644443333322 2444556899999998
Q ss_pred hhhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 99 ~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
|.|+++..++.+.+.|||+......
T Consensus 293 ----------pGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 293 ----------PGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ----------ccceEEecCCcEEEEcCcceecCCH
Confidence 7788888889999999999976654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.021 Score=45.32 Aligned_cols=74 Identities=22% Similarity=0.275 Sum_probs=54.7
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccC------CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCG------AGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~------~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
...+.+|.+++|+.+++...-+|+|... ..+|.+++. .+.++. .....+ -.-.++|-+.+|+.+|++|
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQAL---DEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHH---HHHHHHHHHcCCeecCCCc
Confidence 3467899999999999999999999863 237888885 455666 433333 3447788999999999995
Q ss_pred CCCCcc
Q psy3253 77 GSGTLV 82 (251)
Q Consensus 77 ~Ni~~~ 82 (251)
+||++.
T Consensus 147 ~NIv~~ 152 (199)
T PF10707_consen 147 HNIVVQ 152 (199)
T ss_pred ccEEEE
Confidence 555554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.015 Score=47.43 Aligned_cols=52 Identities=13% Similarity=0.116 Sum_probs=32.2
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
+.+++++....+..++|||+++|.+|.+... ......++.+++..+.-||+.
T Consensus 54 vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~l~~~l~~lH~i 105 (244)
T cd05150 54 VPEVIDYGSDDGRAWLLTSAVPGVPAAALWE-------ELEPERLVDALAEALRRLHAL 105 (244)
T ss_pred CCeEEEEEecCCccEEEEEeeCCccHhHhhc-------ccCHHHHHHHHHHHHHHHhcC
Confidence 4456666666566789999999988764321 111224455666666666654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.029 Score=45.45 Aligned_cols=22 Identities=27% Similarity=0.557 Sum_probs=18.0
Q ss_pred cccCceecCCCCCeEeccccccc
Q psy3253 107 LKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 107 ~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
+.|.|++++.++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 338899988877 8999999884
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.029 Score=47.75 Aligned_cols=74 Identities=18% Similarity=0.178 Sum_probs=54.9
Q ss_pred CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 20 TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 20 ~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
+.-|+|||++.|-.|.+..+ ..+ +-.+...++.-+.-|..+|+||||..
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~----v~d---~~~ly~~lm~~Iv~la~~GlIHgDFN------------------------ 229 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRH----VED---PPTLYDDLMGLIVRLANHGLIHGDFN------------------------ 229 (465)
T ss_pred cceeeHHHhhcccceeeeee----cCC---hHHHHHHHHHHHHHHHHcCceecccc------------------------
Confidence 34588999999888765432 112 22344556666778889999999977
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccCc
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD 133 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~ 133 (251)
--||++..++.++++||-.....+.
T Consensus 230 ---------EFNimv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 230 ---------EFNIMVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred ---------hheeEEecCCCEEEeechHhhccCC
Confidence 7899999999999999987765544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.34 Score=42.06 Aligned_cols=73 Identities=23% Similarity=0.333 Sum_probs=53.0
Q ss_pred CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCCCccccccccccccccccc
Q psy3253 19 NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97 (251)
Q Consensus 19 ~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~ 97 (251)
....|++|++. |++|.-. ..-..+++..++.+.+.-+.-+... ..-|||+.
T Consensus 298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt---------------------- 349 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLT---------------------- 349 (488)
T ss_pred ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCccccccc----------------------
Confidence 34578888987 5566321 3345677888887776655555543 46899977
Q ss_pred hhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 98 ~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
-.||+++ +|.+.|+||.+++..
T Consensus 350 -----------~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 350 -----------LDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred -----------ccceeee-cCceEEEEeeeeecc
Confidence 8899999 899999999999743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.43 E-value=0.46 Score=37.75 Aligned_cols=64 Identities=20% Similarity=0.263 Sum_probs=41.7
Q ss_pred CCCCCCCcc--ceeeeeEe-e-----------------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYV--VKYYGSYF-K-----------------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60 (251)
Q Consensus 1 l~~l~hpni--v~l~~~~~-~-----------------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~ 60 (251)
|++..+.++ |+++|+.. + .....+|.||..... .+..+. +.+|..-
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~d 176 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRD 176 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHH
Confidence 345666677 88888773 1 112467888775532 233333 4466677
Q ss_pred HHHHHhCCccccCCCCCC
Q psy3253 61 LEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 61 l~~LH~~~iiH~dik~~N 78 (251)
+..+|..||+-+|+++.|
T Consensus 177 l~~~~k~gI~~~Dv~~~n 194 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRN 194 (207)
T ss_pred HHHHHHCCeeeccCcccc
Confidence 899999999999988444
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.27 E-value=0.34 Score=41.03 Aligned_cols=21 Identities=24% Similarity=0.370 Sum_probs=16.9
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
+.|++++.++...++||+.+.
T Consensus 196 ~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 196 PDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCcEEEECCceEEEeeccccc
Confidence 778888777766899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=91.19 E-value=0.48 Score=41.82 Aligned_cols=64 Identities=19% Similarity=0.246 Sum_probs=48.5
Q ss_pred eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCCCcccccc
Q psy3253 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH-LRRKIHRDIKAGSGTLVYDRL 86 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~iiH~dik~~Ni~~~~~~~ 86 (251)
...|+-+|..|-++..++. ....+++....++.--+.|+..+- -.+++|.|++|.||+++...-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~--~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK--WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred cceeeeeccccccHHhhhh--cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 3578888999999999986 345566666677766677755544 578999999999999996544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.64 E-value=0.66 Score=39.37 Aligned_cols=22 Identities=23% Similarity=0.336 Sum_probs=16.2
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.||+++.+...-++||+.+..
T Consensus 196 ~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 196 RDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcEEEECCceEEEEecccccC
Confidence 7788777555457999998843
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.53 E-value=0.53 Score=39.69 Aligned_cols=20 Identities=30% Similarity=0.383 Sum_probs=15.2
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
+.|++++. +.+.++||+.+.
T Consensus 196 ~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 196 YHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cccEEEeC-CcEEEEECcccc
Confidence 77887776 557899998763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=90.01 E-value=0.5 Score=39.60 Aligned_cols=21 Identities=24% Similarity=0.362 Sum_probs=16.5
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
|.|++++.++...|+||+.+.
T Consensus 184 ~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 184 RDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cccEEEeCCceEEEeehhhhc
Confidence 778888776666899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=89.83 E-value=0.39 Score=38.87 Aligned_cols=21 Identities=33% Similarity=0.662 Sum_probs=15.7
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
+.|++++.....-|+||+.+.
T Consensus 173 ~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 173 PGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CCcEEEECCCEEEEEeCcccC
Confidence 778887765545799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.42 E-value=0.41 Score=38.57 Aligned_cols=21 Identities=38% Similarity=0.711 Sum_probs=16.9
Q ss_pred cCceecCC-CCCeEeccccccc
Q psy3253 109 AGNILLNT-EGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~-~~~~kl~dfg~~~ 129 (251)
+.||+++. ++.+.++||..|.
T Consensus 179 ~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 179 SGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred cCcEEEeCCCCCEEEEEcccCC
Confidence 77888876 4679999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=88.26 E-value=0.75 Score=38.70 Aligned_cols=21 Identities=43% Similarity=0.506 Sum_probs=16.9
Q ss_pred cCceecCCC----CCeEeccccccc
Q psy3253 109 AGNILLNTE----GHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~----~~~kl~dfg~~~ 129 (251)
+.||+++.+ +.+.++||..+.
T Consensus 188 ~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 188 EGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred cCeEEecCCCCCCCcEEEEeeCCCC
Confidence 778888764 779999999883
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.65 E-value=0.37 Score=41.29 Aligned_cols=94 Identities=14% Similarity=0.046 Sum_probs=49.9
Q ss_pred eEEEEEEccCCC----CHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh----CCccccCCCCCCCCccccccccccc
Q psy3253 21 DLWIVMEYCGAG----SVSDIMRLRKKTL-SEDEIATILCDTLKGLEYLHL----RRKIHRDIKAGSGTLVYDRLDYCSI 91 (251)
Q Consensus 21 ~~~lv~e~~~~g----sL~~~~~~~~~~l-~~~~~~~~~~~i~~~l~~LH~----~~iiH~dik~~Ni~~~~~~~~~~~~ 91 (251)
...+|++.+.+. ++....+ .+-. -.+-++.++.||+.-.-...+ .+.+|-||||.|||+.=++.
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e--~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~----- 321 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAE--LGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDE----- 321 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHH--cCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCC-----
Confidence 357888886442 2212211 1211 234456677788665433322 46899999999998872210
Q ss_pred cccccchhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 92 KCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
+.....+-.++...+--.++|-||.++...
T Consensus 322 ----------~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 322 ----------PISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred ----------cEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 000001122344444445788899888543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=87.40 E-value=0.59 Score=40.26 Aligned_cols=95 Identities=12% Similarity=0.085 Sum_probs=47.6
Q ss_pred EEEEEEccCCC--CHHHHHHHhCCCC--CHHHHHHHHHHHHHHHH---HHH-hCCccccCCCCCCCCccccccccccccc
Q psy3253 22 LWIVMEYCGAG--SVSDIMRLRKKTL--SEDEIATILCDTLKGLE---YLH-LRRKIHRDIKAGSGTLVYDRLDYCSIKC 93 (251)
Q Consensus 22 ~~lv~e~~~~g--sL~~~~~~~~~~l--~~~~~~~~~~~i~~~l~---~LH-~~~iiH~dik~~Ni~~~~~~~~~~~~~~ 93 (251)
..+|++.+.+. .+..-.. ..-++ -.+-++.++.|++.-.- .|- ..+.+|-||||.|||+.=+.-
T Consensus 246 nIIIfPLA~~Sadkv~~~~~-~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~------- 317 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNA-AELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKE------- 317 (434)
T ss_pred cEEEEehhhcchhhcCHHHH-HhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCC-------
Confidence 46888886442 1111111 11122 22344556666654321 122 346899999999998872210
Q ss_pred cccchhhhhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 94 NVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 94 ~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
+.....+-.++...+--.++|-||.++...+
T Consensus 318 --------~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 318 --------PIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred --------ceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 0000011223344444457888999886443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.83 E-value=0.55 Score=36.82 Aligned_cols=21 Identities=38% Similarity=0.711 Sum_probs=17.2
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
|.|++++.++ ++++||+.+..
T Consensus 86 ~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 86 AGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred CccEEEECCC-EEEEeCCcccC
Confidence 7888887777 89999998854
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=85.69 E-value=0.42 Score=37.97 Aligned_cols=21 Identities=43% Similarity=0.813 Sum_probs=14.0
Q ss_pred cCceecC-CCCCeEeccccccc
Q psy3253 109 AGNILLN-TEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~-~~~~~kl~dfg~~~ 129 (251)
+.||+++ .++.+.++||+.+.
T Consensus 175 ~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 175 PGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp GGGEEEESSTTEEEE--GTT-E
T ss_pred cccceeeeccceeEEEecccce
Confidence 8899998 55656799998873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=85.56 E-value=1.3 Score=36.81 Aligned_cols=22 Identities=41% Similarity=0.620 Sum_probs=19.1
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
|.|++.+..+.+.|+||..|..
T Consensus 162 ~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 162 PGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred ccceEEcCCCcEEEEecccCCC
Confidence 8888998888999999988853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=84.83 E-value=1.5 Score=37.19 Aligned_cols=22 Identities=14% Similarity=0.176 Sum_probs=18.9
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
++|++++.++.+.++||..++.
T Consensus 205 ~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 205 LSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred HHhEEEcCCCCEEEEEhhhccc
Confidence 8899998888899999988843
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=83.74 E-value=1.5 Score=37.65 Aligned_cols=21 Identities=29% Similarity=0.582 Sum_probs=16.2
Q ss_pred cCceecCCCCC-eEeccccccc
Q psy3253 109 AGNILLNTEGH-AKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~-~kl~dfg~~~ 129 (251)
|.||+++.+.. ..++||+-+.
T Consensus 206 ~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 206 PDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeEcCCCCeeeEEEccccc
Confidence 77778777664 7899999874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=82.66 E-value=0.84 Score=36.26 Aligned_cols=21 Identities=57% Similarity=0.958 Sum_probs=15.7
Q ss_pred cCceec-CCCCCeEeccccccc
Q psy3253 109 AGNILL-NTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~-~~~~~~kl~dfg~~~ 129 (251)
+.||++ ..++.++++||..|.
T Consensus 152 ~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 152 PGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp GGGEEETSSSSCEEE--GTT-E
T ss_pred cccEEeccCCCeEEEecHHHHh
Confidence 889999 788899999999883
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=82.65 E-value=0.83 Score=37.46 Aligned_cols=21 Identities=33% Similarity=0.521 Sum_probs=16.8
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
|.|++++.++ +.++||+.+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 7888887766 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=81.92 E-value=3.3 Score=32.41 Aligned_cols=67 Identities=21% Similarity=0.211 Sum_probs=43.5
Q ss_pred EEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhh
Q psy3253 23 WIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYK 102 (251)
Q Consensus 23 ~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~ 102 (251)
.+.|||.+|..|...-. . .+.. -+..++..-.-|-..||-|+.++
T Consensus 88 ~i~me~i~G~~L~~~~~---~-~~rk----~l~~vlE~a~~LD~~GI~H~El~--------------------------- 132 (201)
T COG2112 88 FIRMEYIDGRPLGKLEI---G-GDRK----HLLRVLEKAYKLDRLGIEHGELS--------------------------- 132 (201)
T ss_pred hhhhhhhcCcchhhhhh---c-ccHH----HHHHHHHHHHHHHHhccchhhhc---------------------------
Confidence 35599999888866542 1 1222 23345565555777899999976
Q ss_pred hhhhcccCceecCCCCCeEeccccccc
Q psy3253 103 TLFRLKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 103 ~~~~~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
--..|+++... .+.|+||..|.
T Consensus 133 ----~~~k~vlv~~~-~~~iIDFd~At 154 (201)
T COG2112 133 ----RPWKNVLVNDR-DVYIIDFDSAT 154 (201)
T ss_pred ----CCceeEEecCC-cEEEEEccchh
Confidence 21345555544 79999999885
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=81.86 E-value=3 Score=32.76 Aligned_cols=16 Identities=19% Similarity=0.030 Sum_probs=11.4
Q ss_pred CCccccCCCCCCCCcc
Q psy3253 67 RRKIHRDIKAGSGTLV 82 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~ 82 (251)
..++|||+.+.|+|+.
T Consensus 120 ~vl~HgD~~~~N~~~~ 135 (196)
T smart00587 120 NVLNHGDLWANNIMFK 135 (196)
T ss_pred eEEeeCCCCccceeec
Confidence 3579999996655555
|
subfamily of choline kinases |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=81.84 E-value=1.4 Score=35.76 Aligned_cols=38 Identities=29% Similarity=0.330 Sum_probs=30.9
Q ss_pred HHHHHHHHh--CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccc
Q psy3253 58 LKGLEYLHL--RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA 128 (251)
Q Consensus 58 ~~~l~~LH~--~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~ 128 (251)
+.+|.-.|+ .+.+|||-. |+||+-++.|.+||.|-+.-
T Consensus 151 i~~L~~fH~~~~~~lHGD~n---------------------------------p~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCN---------------------------------PDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCC---------------------------------hhheeecCCCCEEecChhhh
Confidence 355777884 468999965 99999999999999997654
|
The function of this family is unknown. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=81.45 E-value=2.8 Score=36.73 Aligned_cols=76 Identities=20% Similarity=0.275 Sum_probs=51.8
Q ss_pred EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCCCccccccccccccccccchhh
Q psy3253 22 LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQI 100 (251)
Q Consensus 22 ~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~ 100 (251)
-+|||+|+.. +=+-.-......++...+..+-.+++.-+.-|.+ .+++|.||+
T Consensus 239 hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS------------------------- 292 (520)
T KOG2270|consen 239 HVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS------------------------- 292 (520)
T ss_pred ceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchh-------------------------
Confidence 4799999943 2221112234567777788877777777776654 699999977
Q ss_pred hhhhhhcccCceecCCCCCeEecccccccccC
Q psy3253 101 YKTLFRLKAGNILLNTEGHAKLADFGVAGQLT 132 (251)
Q Consensus 101 ~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~ 132 (251)
--|++.- +|.+.++|-+.+....
T Consensus 293 --------EfN~Lyh-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 293 --------EFNLLYH-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred --------hhhheEE-CCEEEEEEccccccCC
Confidence 6676654 4668999988875443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 251 | ||||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-101 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-64 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-64 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-64 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-63 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-63 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-63 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-49 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-48 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-48 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-47 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-46 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-46 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-46 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-45 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-45 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-44 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-44 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-44 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-41 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-41 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-41 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-40 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-40 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-38 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-38 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-38 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-38 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-38 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-38 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-38 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-37 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-36 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-36 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-33 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-33 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-33 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-33 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-33 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-33 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-33 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-28 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-28 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-26 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-23 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-18 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-04 |
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 251 | |||
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-139 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-136 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-133 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-132 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-132 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-127 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-127 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-124 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-114 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-113 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-111 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-110 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-109 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-108 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-100 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-87 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-84 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-82 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-75 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-74 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-70 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-68 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-64 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-64 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-62 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-62 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-61 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-54 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-47 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-46 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-45 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-44 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-44 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-43 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-43 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-42 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-40 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-40 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-38 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-38 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-38 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-38 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-38 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-38 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-37 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-37 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-37 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-37 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-36 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-36 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-36 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-36 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-36 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-36 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-36 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-36 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-36 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-35 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-35 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-35 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-35 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-35 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-35 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-35 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-35 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-35 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-35 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-35 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-35 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-35 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-35 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-35 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-34 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-34 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-34 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-34 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-34 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-34 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-34 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-34 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-33 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-33 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-33 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-33 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-33 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-33 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-33 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-33 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-33 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-33 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-33 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-32 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-32 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-32 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-31 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-31 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-31 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-31 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 7e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-30 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-30 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-30 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-30 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 8e-30 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-29 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-29 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-29 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-29 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-29 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-29 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-29 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-29 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-29 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-29 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-28 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-28 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-28 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-28 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-28 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-27 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-27 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-27 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-27 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-27 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-26 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-26 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-26 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-25 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-25 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-25 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-25 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-25 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-25 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-25 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-25 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-25 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-24 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-24 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-24 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-24 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-24 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-24 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-24 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-24 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-24 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-24 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-23 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-23 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-23 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-23 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-23 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-23 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-22 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-22 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-22 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-22 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-21 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-21 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-21 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-21 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-20 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-20 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-20 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-20 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-20 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 9e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-19 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-19 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-19 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-19 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-19 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-19 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-18 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-18 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-18 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-17 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-17 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-17 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-17 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-17 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-17 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-17 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-16 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-15 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 8e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-12 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-11 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 8e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-10 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-09 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-09 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-05 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-04 |
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-139
Identities = 174/240 (72%), Positives = 193/240 (80%), Gaps = 33/240 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQCDSP+VVKYYGSYFKNTDLWIVMEYCGAGSVSDI+RLR KTL+EDEIATIL TLKG
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH RKIHRDIKAG NILLNTEGHA
Sbjct: 138 LEYLHFMRKIHRDIKAG---------------------------------NILLNTEGHA 164
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY+CVAD+WSLGITA+EMAEGKPP
Sbjct: 165 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
Y DIHPMRAIFMIPT PPP+FR+P++W+ F DFV +CLVK+PE+RATA+++L H F++
Sbjct: 225 YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-136
Identities = 92/245 (37%), Positives = 138/245 (56%), Gaps = 38/245 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ CD PY+VK G+Y+ + LWI++E+C G+V IM + L+E +I + L+
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L +LH +R IHRD+KAG N+L+ EG
Sbjct: 130 LNFLHSKRIIHRDLKAG---------------------------------NVLMTLEGDI 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEIGYDCVADMWSLGITALEMA 175
+LADFGV+ + T+ KR++ IGTP+WMAPEV+ ++ YD AD+WSLGIT +EMA
Sbjct: 157 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ +PP+ +++PMR + I PP+ P W+ EF DF+ L KNPE R +A+++L H
Sbjct: 217 QIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276
Query: 236 EFIQR 240
F+
Sbjct: 277 PFVSS 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-133
Identities = 120/246 (48%), Positives = 151/246 (61%), Gaps = 37/246 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ QCDSPYV KYYGSY K+T LWI+MEY G GS D++ L E +IATIL + LKG
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKG 131
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+YLH +KIHRDIKA N+LL+ G
Sbjct: 132 LDYLHSEKKIHRDIKAA---------------------------------NVLLSEHGEV 158
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KLADFGVAGQLTDT KRNT +GTPFWMAPEVI++ YD AD+WSLGITA+E+A G+PP
Sbjct: 159 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
+ ++HPM+ +F+IP PP+ ++ +FV CL K P R TA E+L H+FI R
Sbjct: 219 HSELHPMKVLFLIPKNNPPTLEGN--YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276
Query: 241 HDTDPS 246
+ S
Sbjct: 277 NAKKTS 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-132
Identities = 88/240 (36%), Positives = 136/240 (56%), Gaps = 35/240 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ +P +V Y SY +LW+VMEY GS++D++ + + E +IA + + L+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQA 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH + IHRDIK+ NILL +G
Sbjct: 129 LEFLHSNQVIHRDIKSD---------------------------------NILLGMDGSV 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
Y + +P+RA+++I T P + P+ + F DF++RCL + E+R +A E+L H+F++
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 374 bits (961), Expect = e-132
Identities = 85/240 (35%), Positives = 131/240 (54%), Gaps = 35/240 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ VV+ Y SY +LW++ME+ G+++DI+ + L+E++IAT+ L+
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQA 153
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + IHRDIK+ +ILL +G
Sbjct: 154 LAYLHAQGVIHRDIKSD---------------------------------SILLTLDGRV 180
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL+DFG Q++ + KR +++GTP+WMAPEVI Y D+WSLGI +EM +G+PP
Sbjct: 181 KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
Y P++A+ + PPP + +P DF+ R LV++P+ERATA E+L+H F+ +
Sbjct: 241 YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-127
Identities = 91/243 (37%), Positives = 125/243 (51%), Gaps = 42/243 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ P ++Y G Y + W+VMEYC GS SD++ + KK L E EIA + L+G
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH IHRD+KAG NILL+ G
Sbjct: 167 LAYLHSHNMIHRDVKAG---------------------------------NILLSEPGLV 193
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEG 177
KL DFG A + N+ +GTP+WMAPEVI E YD D+WSLGIT +E+AE
Sbjct: 194 KLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + W+ F +FV CL K P++R T+ +L H F
Sbjct: 250 KPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308
Query: 238 IQR 240
+ R
Sbjct: 309 VLR 311
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-127
Identities = 99/252 (39%), Positives = 137/252 (54%), Gaps = 46/252 (18%)
Query: 1 MQQCDSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATI 53
+ + YYG++ K + LW+VME+CGAGSV+D+++ + TL E+ IA I
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+ L+GL +LH + IHRDIK N+L
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQ---------------------------------NVL 161
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLG 168
L KL DFGV+ QL T+ +RNT IGTP+WMAPEVI + YD +D+WSLG
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 169 ITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
ITA+EMAEG PP D+HPMRA+F+IP P P + W+ +F F+ CLVKN +R
Sbjct: 222 ITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPA 280
Query: 229 ASEMLNHEFIQR 240
+++ H FI+
Sbjct: 281 TEQLMKHPFIRD 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-124
Identities = 96/260 (36%), Positives = 131/260 (50%), Gaps = 53/260 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-------LRKKTLSEDEIATI 53
M QC P +V YY S+ +LW+VM+ GSV DI++ + L E IATI
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
L + L+GLEYLH +IHRD+KAG NIL
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAG---------------------------------NIL 153
Query: 114 LNTEGHAKLADFGVAGQLTDT-----MAKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSL 167
L +G ++ADFGV+ L R T +GTP WMAPEV++++ GYD AD+WS
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 168 GITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDV-------WTPEFIDFVSRCLV 220
GITA+E+A G PY PM+ + + PPS + F +S CL
Sbjct: 214 GITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273
Query: 221 KNPEERATASEMLNHEFIQR 240
K+PE+R TA+E+L H+F Q+
Sbjct: 274 KDPEKRPTAAELLRHKFFQK 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-114
Identities = 80/256 (31%), Positives = 117/256 (45%), Gaps = 45/256 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGS---VSDIMRLRKKTLSEDEIATILCDT 57
M+ D PY+V++YG+ F+ D WI ME + + + E+ + I T
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 58 LKGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+K L +L KI HRDIK NILL+
Sbjct: 135 VKALNHLKENLKIIHRDIKPS---------------------------------NILLDR 161
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ----EIGYDCVADMWSLGITAL 172
G+ KL DFG++GQL D++AK G +MAPE I GYD +D+WSLGIT
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 173 EMAEGKPPYGDIHPM-RAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATA 229
E+A G+ PY + + + + PP E ++P FI+FV+ CL K+ +R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280
Query: 230 SEMLNHEFIQRHDTDP 245
E+L H FI ++
Sbjct: 281 KELLKHPFILMYEERA 296
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-113
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 86/300 (28%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
+ + P +V Y ++ + +LW+V + GS D++ ++E IA IL LK
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L+Y+H +HR +KA +IL++ +G
Sbjct: 140 ALDYIHHMGYVHRSVKAS---------------------------------HILISVDGK 166
Query: 120 AKLADFGVAGQLTDTMAKRNTV-------IGTPFWMAPEVIQE--IGYDCVADMWSLGIT 170
L+ + ++ V + W++PEV+Q+ GYD +D++S+GIT
Sbjct: 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226
Query: 171 ALEMAEGKPPYGDIHPMRAIFMIPTKPPPS------------------------------ 200
A E+A G P+ D+ + + P
Sbjct: 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 286
Query: 201 -------------FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247
++P F FV +CL +NP+ R +AS +LNH F ++ S+
Sbjct: 287 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-111
Identities = 72/252 (28%), Positives = 118/252 (46%), Gaps = 42/252 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ D PY+V+ +G++ NTD++I ME G + + + + + E + + +K
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 61 LEYLHLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL + IHRD+ K NILL+ G
Sbjct: 137 LYYLKEKHGVIHRDV---------------------------------KPSNILLDERGQ 163
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITALEM 174
KL DFG++G+L D AK + G +MAPE I + YD AD+WSLGI+ +E+
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 175 AEGKPPYGDIHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
A G+ PY + + + + PP ++ +F FV CL K+ +R +++L
Sbjct: 223 ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
Query: 234 NHEFIQRHDTDP 245
H FI+R++T
Sbjct: 283 EHSFIKRYETLE 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-110
Identities = 79/254 (31%), Positives = 122/254 (48%), Gaps = 45/254 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDT 57
M+ D P+ V +YG+ F+ D+WI ME S+ + + +T+ ED + I
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 58 LKGLEYLHLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+K LE+LH + IHRD+K N+L+N
Sbjct: 119 VKALEHLHSKLSVIHRDVKPS---------------------------------NVLINA 145
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI----QEIGYDCVADMWSLGITAL 172
G K+ DFG++G L D +AK + G +MAPE I + GY +D+WSLGIT +
Sbjct: 146 LGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 173 EMAEGKPPYGDI-HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
E+A + PY P + + + +P P D ++ EF+DF S+CL KN +ER T E
Sbjct: 205 ELAILRFPYDSWGTPFQQLKQVVEEPSPQL-PADKFSAEFVDFTSQCLKKNSKERPTYPE 263
Query: 232 MLNHEFIQRHDTDP 245
++ H F H++
Sbjct: 264 LMQHPFFTLHESKG 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-109
Identities = 66/249 (26%), Positives = 95/249 (38%), Gaps = 40/249 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
SP +V YG+ + + I ME GS+ +++ + L ED L L+G
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEG 162
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-H 119
LEYLH RR +H D+KA N+LL+++G
Sbjct: 163 LEYLHTRRILHGDVKAD---------------------------------NVLLSSDGSR 189
Query: 120 AKLADFGVAGQLTD-----TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
A L DFG A L ++ + + GT MAPEV+ D D+WS L M
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G P+ I ++PPP P P + L K P RA+A E+
Sbjct: 250 LNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309
Query: 235 HEFIQRHDT 243
+
Sbjct: 310 KVGKALQEV 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = e-100
Identities = 86/288 (29%), Positives = 136/288 (47%), Gaps = 80/288 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +C+SPY+V +YG+++ + ++ I ME+ GS+ +++ + + E + + +KG
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKG 143
Query: 61 LEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL + KI HRD+K NIL+N+ G
Sbjct: 144 LTYLREKHKIMHRDVKPS---------------------------------NILVNSRGE 170
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
KL DFGV+GQL D+MA N+ +GT +M+PE +Q Y +D+WS+G++ +EMA G+
Sbjct: 171 IKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 180 PY--------------------------------------GDIHPMRAIF----MIPTKP 197
P D P AIF I +P
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 198 PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
PP V++ EF DFV++CL+KNP ERA +++ H FI+R D +
Sbjct: 289 PPKL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-97
Identities = 76/247 (30%), Positives = 119/247 (48%), Gaps = 42/247 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE--IATILCDTL 58
+ +V+Y GS+ +N + I ME GS+S ++R + L ++E I L
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-E 117
+GL+YLH + +HRDIK N+L+NT
Sbjct: 133 EGLKYLHDNQIVHRDIKGD---------------------------------NVLINTYS 159
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMA 175
G K++DFG + +L T GT +MAPE+I GY AD+WSLG T +EMA
Sbjct: 160 GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219
Query: 176 EGKPPYGDI-HPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
GKPP+ ++ P A+F + K P P+ + E F+ +C +P++RA A+++L
Sbjct: 220 TGKPPFYELGEPQAAMFKVGMFKVHPEI--PESMSAEAKAFILKCFEPDPDKRACANDLL 277
Query: 234 NHEFIQR 240
EF++
Sbjct: 278 VDEFLKV 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-87
Identities = 50/246 (20%), Positives = 96/246 (39%), Gaps = 31/246 (12%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDT 57
+VV+Y+ ++ ++ + I EYC GS++D + + E E+ +L
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNV-IT-NQIYKTLFRLKAGNILLN 115
+GL Y+H +H DIK N+ I+ I + +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPS----------------NIFISRTSIPNAASEEGDEDDWAS 168
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEM 174
+ K+ D G +++ G ++A EV+QE + AD+++L +T +
Sbjct: 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
A +P + I P P V + EF + + + +PE R +A ++
Sbjct: 225 AGAEPLPRNGDQW---HEIRQGRLPRI--PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
Query: 235 HEFIQR 240
H +
Sbjct: 280 HSVLLS 285
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 7e-84
Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 40/240 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ P V+ ++ + L++ E CG S+ +L E ++ L DTL
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L +LH + +H D+K NI L G
Sbjct: 170 LAHLHSQGLVHLDVKPA---------------------------------NIFLGPRGRC 196
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG+ +L T G P +MAPE++Q Y AD++SLG+T LE+A
Sbjct: 197 KLGDFGLLVELG-TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
+ + PP F + E + L +P+ RATA +L +++
Sbjct: 255 PHGGEGWQQLRQG--YLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 4e-82
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 44/248 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ P +V++Y S+ + +V E +G++ ++ R K + + +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQ 137
Query: 57 TLKGLEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
LKGL++LH R IHRD+K NI +
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCD---------------------------------NIFI 164
Query: 115 NTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE 173
G K+ D G+A + AK VIGTP +MAPE+ +E YD D+++ G+ LE
Sbjct: 165 TGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLE 221
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
MA + PY + I+ T V PE + + C+ +N +ER + ++L
Sbjct: 222 MATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
Query: 234 NHEFIQRH 241
NH F Q
Sbjct: 282 NHAFFQEE 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-75
Identities = 58/242 (23%), Positives = 103/242 (42%), Gaps = 36/242 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLK 59
+ P +V+Y S+ +N L+IVM+YC G + + +K ED+I
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L+++H R+ +HRDI K+ NI L +G
Sbjct: 137 ALKHVHDRKILHRDI---------------------------------KSQNIFLTKDGT 163
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
+L DFG+A L T+ IGTP++++PE+ + Y+ +D+W+LG E+ K
Sbjct: 164 VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ + I + P ++ + VS+ +NP +R + + +L FI
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPV--SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281
Query: 240 RH 241
+
Sbjct: 282 KR 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-74
Identities = 65/251 (25%), Positives = 111/251 (44%), Gaps = 39/251 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILCDT 57
++Q + P V+KYY S+ ++ +L IV+E AG +S +++ KK + E +
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
LE++H RR +HRDI K N+ +
Sbjct: 146 CSALEHMHSRRVMHRDI---------------------------------KPANVFITAT 172
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
G KL D G+ + ++++GTP++M+PE I E GY+ +D+WSLG EMA
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 178 KPPY-GDIHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ P+ GD + ++ I P D ++ E V+ C+ +PE+R + + +
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 236 EFIQRHDTDPS 246
T S
Sbjct: 292 AKRMHACTASS 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-70
Identities = 60/275 (21%), Positives = 103/275 (37%), Gaps = 66/275 (24%)
Query: 1 MQQCDSPYVVKYYGSYF-------------KNTDLWIVMEYCGAGSVSDIMRLRKKTLSE 47
+ + YVV+YY ++ K + L+I MEYC G++ D++
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 48 DEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRL 107
DE + L+ L Y+H + IHRD L
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRD---------------------------------L 142
Query: 108 KAGNILLNTEGHAKLADFGVAGQLTDTMA--------------KRNTVIGTPFWMAPEVI 153
K NI ++ + K+ DFG+A + ++ + IGT ++A EV+
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 154 QEIG-YDCVADMWSLGITALEMAEGKPPYG--DIHPMRAIFMIPTKPPPSFREPDVWTPE 210
G Y+ DM+SLGI EM G ++ ++ + + + PP F D
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP-FSTGMERVNILKKLRSVSIEFPPDF--DDNKMKV 259
Query: 211 FIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
+ + +P +R A +LN ++ D
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-68
Identities = 52/264 (19%), Positives = 94/264 (35%), Gaps = 58/264 (21%)
Query: 1 MQQCDSPYVVKYYGSY----------------FKNTDLWIVMEYCGAGSVSDIMRLRK-K 43
+ + D +V Y G + K L+I ME+C G++ + R+ +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 44 TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKT 103
L + + KG++Y+H ++ I+RD+K
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPS-------------------------- 151
Query: 104 LFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163
NI L K+ DFG+ L + KR GT +M+PE I Y D
Sbjct: 152 -------NIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVD 203
Query: 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223
+++LG+ E+ F D++ + + + L K P
Sbjct: 204 LYALGLILAELLHVCDTA---FETSKFFTDLRDGII----SDIFDKKEKTLLQKLLSKKP 256
Query: 224 EERATASEMLNHEFIQRHDTDPSQ 247
E+R SE+L + + + ++
Sbjct: 257 EDRPNTSEILRTLTVWKKSPEKNE 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-64
Identities = 55/256 (21%), Positives = 105/256 (41%), Gaps = 51/256 (19%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
S +++ Y + +++VME ++ ++ +KK++ E + + L+ + +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+H D LK N L+ +G KL DF
Sbjct: 126 QHGIVHSD---------------------------------LKPANFLI-VDGMLKLIDF 151
Query: 126 GVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCV-----------ADMWSLGITAL 172
G+A Q+ T +++ +GT +M PE I+++ +D+WSLG
Sbjct: 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211
Query: 173 EMAEGKPPYGDI-HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
M GK P+ I + + + I P PD+ + D + CL ++P++R + E
Sbjct: 212 YMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 232 MLNHEFIQRHDTDPSQ 247
+L H ++Q +Q
Sbjct: 271 LLAHPYVQIQTHPVNQ 286
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 6e-64
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 47/254 (18%)
Query: 1 MQQCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
+++ D P V++Y+ + +I +E C ++ + + + E T+L T
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GL +LH +HRD LK NIL++
Sbjct: 130 GLAHLHSLNIVHRD---------------------------------LKPHNILISMPNA 156
Query: 120 -----AKLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVIQEI---GYDCVADMWSLG 168
A ++DFG+ +L + ++R+ V GT W+APE++ E D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 169 ITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
+ +EG P+G +A ++ + + + + +P++R
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
Query: 228 TASEMLNHEFIQRH 241
+A +L H F
Sbjct: 277 SAKHVLKHPFFWSL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-62
Identities = 54/256 (21%), Positives = 104/256 (40%), Gaps = 51/256 (19%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
S +++ Y + +++VME ++ ++ +KK++ E + + L+ + +H
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+H D LK N L+ +G KL DF
Sbjct: 173 QHGIVHSD---------------------------------LKPANFLI-VDGMLKLIDF 198
Query: 126 GVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCV-----------ADMWSLGITAL 172
G+A Q+ T +++ +G +M PE I+++ +D+WSLG
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 173 EMAEGKPPYGDI-HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
M GK P+ I + + + I P PD+ + D + CL ++P++R + E
Sbjct: 259 YMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 317
Query: 232 MLNHEFIQRHDTDPSQ 247
+L H ++Q +Q
Sbjct: 318 LLAHPYVQIQTHPVNQ 333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 6e-62
Identities = 55/260 (21%), Positives = 105/260 (40%), Gaps = 51/260 (19%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
S +++ Y + +++VME ++ ++ +KK++ E + + L+ + +H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+H D LK N L+ +G KL DF
Sbjct: 145 QHGIVHSD---------------------------------LKPANFLI-VDGMLKLIDF 170
Query: 126 GVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCV-----------ADMWSLGITAL 172
G+A Q+ T +++ +GT +M PE I+++ +D+WSLG
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 173 EMAEGKPPYGDI-HPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
M GK P+ I + + + I P PD+ + D + CL ++P++R + E
Sbjct: 231 YMTYGKTPFQQIINQISKLHAI-IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 232 MLNHEFIQRHDTDPSQNGGK 251
+L H ++Q +Q
Sbjct: 290 LLAHPYVQIQTHPVNQMAKG 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-61
Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 45/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATILC 55
+++ P +V+YY NT L+IVMEYC G ++ ++ K L E+ + ++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56 DTLKGLEYLHLRRK-----IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAG 110
L+ H R +HRD+K
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPA--------------------------------- 145
Query: 111 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGIT 170
N+ L+ + + KL DFG+A L + T +GTP++M+PE + + Y+ +D+WSLG
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 171 ALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ PP+ I P ++ E + ++R L R +
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 231 EMLNHEFIQRH 241
E+L + I H
Sbjct: 264 EILENPLILEH 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-54
Identities = 48/272 (17%), Positives = 89/272 (32%), Gaps = 63/272 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD------------LWIVMEYCGAGSVSDIMRLRKKT--LS 46
+ + + P +V+Y+ ++ + L+I M+ C ++ D M R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 47 EDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFR 106
I + +E+LH + +HRD
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRD--------------------------------- 143
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV------------IGTPFWMAPEVIQ 154
LK NI + K+ DFG+ + ++ + +GT +M+PE I
Sbjct: 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203
Query: 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214
Y D++SLG+ E+ P + +R + + P P
Sbjct: 204 GNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDVRNLKFP--PLFTQKYPCEYVM 259
Query: 215 VSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246
V L +P ER A ++ + + D
Sbjct: 260 VQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-47
Identities = 44/260 (16%), Positives = 86/260 (33%), Gaps = 52/260 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKT---LSEDEIATI 53
+ + P +++ + W+++ + G++ + + K L+ED+I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
L +GLE +H + HRD+K NIL
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPT---------------------------------NIL 166
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVI---------GTPFWMAPEVIQEIGYDCV--- 161
L EG L D G Q + + T + APE+ + +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221
D+WSLG M G+ PY + + + S + + ++ +
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286
Query: 222 NPEERATASEMLNHEFIQRH 241
+P +R +L+ +
Sbjct: 287 DPHQRPHIPLLLSQLEALQP 306
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-46
Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 45/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
P +++ YG + T +++++EY G+V ++ + E AT + +
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANA 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L Y H +R IHRD +K N+LL + G
Sbjct: 122 LSYCHSKRVIHRD---------------------------------IKPENLLLGSAGEL 148
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ADFG + + +R + GT ++ PE+I+ +D D+WSLG+ E GKPP
Sbjct: 149 KIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
Query: 181 YGDIHPM---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ + I + P T D +SR L NP +R E+L H +
Sbjct: 207 FEANTYQETYKRISRVEFTFPDFV------TEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 238 IQRHDTDPS 246
I + + PS
Sbjct: 261 ITANSSKPS 269
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-45
Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 42/247 (17%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
P +++ Y + + +++V+E C G ++ ++ R K SE+E + + G+ YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+HRD L N+LL + K+ADFG
Sbjct: 131 HGILHRD---------------------------------LTLSNLLLTRNMNIKIADFG 157
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP 186
+A QL K T+ GTP +++PE+ + +D+WSLG + G+PP+
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217
Query: 187 M---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243
+ + + P + E D + + L +NP +R + S +L+H F+ R+ +
Sbjct: 218 KNTLNKVVLADYEMPSFL------SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
Query: 244 DPSQNGG 250
S++ G
Sbjct: 272 TKSKDEG 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-44
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+VV ++G + N +++V+E C S+ ++ + R+K L+E E L + G +YLH
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
R IHRD LK GN+ LN + K+ DFG
Sbjct: 134 NRVIHRD---------------------------------LKLGNLFLNEDLEVKIGDFG 160
Query: 127 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHP 186
+A ++ ++ + GTP ++APEV+ + G+ D+WS+G + GKPP+
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
Query: 187 M---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
I + P P + + L +P R T +E+LN EF
Sbjct: 221 KETYLRIKKN------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-44
Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 51/248 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +VV ++G + N +++V+E C S+ ++ + R+K L+E E L + G
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLG 153
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+YLH R IHRD LK GN+ LN +
Sbjct: 154 CQYLHRNRVIHRD---------------------------------LKLGNLFLNEDLEV 180
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ DFG+A ++ ++ + GTP ++APEV+ + G+ D+WS+G + GKPP
Sbjct: 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 181 YGDIHPM-------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ + + IP P + + L +P R T +E+L
Sbjct: 241 FETSCLKETYLRIKKNEYSIPKHINPVAA----------SLIQKMLQTDPTARPTINELL 290
Query: 234 NHEFIQRH 241
N EF
Sbjct: 291 NDEFFTSG 298
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 46/261 (17%), Positives = 82/261 (31%), Gaps = 67/261 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--RLRKKTLSEDEIATILCDTL 58
M + V L+I M+ C ++ D M R + I
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+ +E+LH + +HRD LK NI +
Sbjct: 175 EAVEFLHSKGLMHRD---------------------------------LKPSNIFFTMDD 201
Query: 119 HAKLADFGVAGQLTDTMAKRNTV------------IGTPFWMAPEVIQEIGYDCVADMWS 166
K+ DFG+ + ++ + +GT +M+PE I Y D++S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPT--------KPPPSFREPDVWTPEFIDFVSRC 218
LG+ E+ ++ K P F + P+ V
Sbjct: 262 LGLILFEL---------LYSFSTQMERVRIITDVRNLKFPLLFTQ---KYPQEHMMVQDM 309
Query: 219 LVKNPEERATASEMLNHEFIQ 239
L +P ER A++++ + +
Sbjct: 310 LSPSPTERPEATDIIENAIFE 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-43
Identities = 55/255 (21%), Positives = 108/255 (42%), Gaps = 45/255 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR--LRKKTLSEDEIATILCDTL 58
M++ P +V + G+ + +L IV EY GS+ ++ ++ L E ++ D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 59 KGLEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
KG+ YLH R +HR+ LK+ N+L++
Sbjct: 148 KGMNYLHNRNPPIVHRN---------------------------------LKSPNLLVDK 174
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
+ K+ DFG++ T + GTP WMAPEV+++ + +D++S G+ E+A
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 177 GKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ P+G+++P + + + K P P+ + C P +R + + ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 234 NH-EFIQRHDTDPSQ 247
+ + + P
Sbjct: 291 DLLRPLIKSAVPPPN 305
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-42
Identities = 50/244 (20%), Positives = 95/244 (38%), Gaps = 45/244 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
P +++ Y + +++++E+ G + ++ + E AT + +
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADA 126
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L Y H R+ IHRD +K N+L+ +G
Sbjct: 127 LHYCHERKVIHRD---------------------------------IKPENLLMGYKGEL 153
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ADFG + +R T+ GT ++ PE+I+ +D D+W G+ E G PP
Sbjct: 154 KIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 181 YGDIHPM---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ R I + K PP + D +S+ L +P +R ++ H +
Sbjct: 212 FDSPSHTETHRRIVNVDLKFPPFL------SDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
Query: 238 IQRH 241
++ +
Sbjct: 266 VKAN 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 57/267 (21%), Positives = 97/267 (36%), Gaps = 42/267 (15%)
Query: 1 MQQCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM------RLRKKTLSEDEIATI 53
+ + D P V++YY S + L+I +E C ++ D++ K E ++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
L G+ +LH + IHRD+K N + T R A
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQ--------------------NILVSTSSRFTADQQT 160
Query: 114 LNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQEI-------GYDCVA 162
++DFG+ +L N GT W APE+++E
Sbjct: 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 163 DMWSLGITALEM-AEGKPPYGD-IHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCL 219
D++S+G + ++GK P+GD I I + E D +S+ +
Sbjct: 221 DIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMI 280
Query: 220 VKNPEERATASEMLNHEFIQRHDTDPS 246
+P +R TA ++L H
Sbjct: 281 DHDPLKRPTAMKVLRHPLFWPKSKKLE 307
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 50/263 (19%), Positives = 90/263 (34%), Gaps = 70/263 (26%)
Query: 2 QQCDSPYVVKYYGSYF--------KNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIAT 52
+ P +V++ + + ++ E C V + ++ + LS D +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 53 ILCDTLKGLEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAG 110
I T + ++++H ++ IHRD LK
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRD---------------------------------LKVE 167
Query: 111 NILLNTEGHAKLADFGVAGQLTDTMAKRN------------TVIGTPFWMAPEVI---QE 155
N+LL+ +G KL DFG A ++ T TP + PE+I
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVWTPEFI 212
D+W+LG + + P+ D +R + IP F
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQY--------TVFH 279
Query: 213 DFVSRCLVKNPEERATASEMLNH 235
+ L NPEER + +E+++
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQ 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 56/272 (20%), Positives = 85/272 (31%), Gaps = 62/272 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-------LRKKTLSEDEIATI 53
+ + Y + G +++I+ EY S+ + I I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 54 LCDTLKGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
+ L Y+H + I HRD +K NI
Sbjct: 157 IKSVLNSFSYIHNEKNICHRD---------------------------------VKPSNI 183
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGIT 170
L++ G KL+DFG + + D K GT +M PE D+WSLGI
Sbjct: 184 LMDKNGRVKLSDFGESEYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 171 ALEMAEGKPP-YGDIHPM-------RAIFMIPTKPPPSFREPDVW---------TPEFID 213
M P I + P + E ID
Sbjct: 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301
Query: 214 FVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
F+ L KNP ER T+ + L HE++ + +
Sbjct: 302 FLKLFLRKNPAERITSEDALKHEWLADTNIED 333
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 48/243 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCDTL 58
+ + + P +VK YG+ + +VMEY GS+ +++ + + +
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 59 KGLEYLHLRRK---IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
+G+ YLH + IHRD LK N+LL
Sbjct: 113 QGVAYLHSMQPKALIHRD---------------------------------LKPPNLLLV 139
Query: 116 TEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
G K+ DFG A + M G+ WMAPEV + Y D++S GI E+
Sbjct: 140 AGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196
Query: 175 AEGKPPYGDIH--PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
+ P+ +I R ++ + P ++RC K+P +R + E+
Sbjct: 197 ITRRKPFDEIGGPAFRIMWAVHNGTRPPL--IKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
Query: 233 LNH 235
+
Sbjct: 255 VKI 257
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 62/250 (24%), Positives = 102/250 (40%), Gaps = 57/250 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRKKT-LSEDE----IATIL 54
MQ + P++V + S+ D+++V++ G D+ L++ E+ I ++
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELV 125
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
L+YL +R IHRD+K D NILL
Sbjct: 126 M----ALDYLQNQRIIHRDMK----------PD-----------------------NILL 148
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE---IGYDCVADMWSLGITA 171
+ GH + DF +A L + T+ GT +MAPE+ GY D WSLG+TA
Sbjct: 149 DEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 172 LEMAEGKPPY---GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-A 227
E+ G+ PY + T P W+ E + + + L NP++R +
Sbjct: 208 YELLRGRRPYHIRSSTSSKEIVHTFETTVV---TYPSAWSQEMVSLLKKLLEPNPDQRFS 264
Query: 228 TASEMLNHEF 237
S++ N +
Sbjct: 265 QLSDVQNFPY 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 52/255 (20%), Positives = 92/255 (36%), Gaps = 68/255 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +VK YG +VME+ G + + + + ++ D G
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 61 LEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+EY+ + +HRD L++ NI L +
Sbjct: 135 IEYMQNQNPPIVHRD---------------------------------LRSPNIFLQSLD 161
Query: 119 -----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYDCVADMWSLGITA 171
AK+ADFG++ Q ++ + ++G WMAPE I +E Y AD +S +
Sbjct: 162 ENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 172 LEMAEGKPPYGDIHPMRAIFM-----------IPTKPPPSFREPDVWTPEFIDFVSRCLV 220
+ G+ P+ + + F+ IP PP R + C
Sbjct: 219 YTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN----------VIELCWS 268
Query: 221 KNPEERATASEMLNH 235
+P++R S ++
Sbjct: 269 GDPKKRPHFSYIVKE 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 47/283 (16%), Positives = 87/283 (30%), Gaps = 76/283 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCD 56
+++ + +VK + + T ++ME+C GS+ ++ L E E +L D
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+ G+ +L +HR+ +K GNI+
Sbjct: 121 VVGGMNHLRENGIVHRN---------------------------------IKPGNIMRVI 147
Query: 117 EGHA----KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI--------GYDCVADM 164
KL DFG A +L D + ++ GT ++ P++ + Y D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 165 WSLGITALEMAEGKPPYGDIHPMRAIFMI--------------------------PTKPP 198
WS+G+T A G P+ R + P
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
S ++ L + E+ + H
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-38
Identities = 53/248 (21%), Positives = 89/248 (35%), Gaps = 53/248 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
P ++ G K +L +VME+ G ++ + L K + D + +G
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQIARG 117
Query: 61 LEYLHLRRK---IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
+ YLH IHRD LK+ NIL+ +
Sbjct: 118 MNYLHDEAIVPIIHRD---------------------------------LKSSNILILQK 144
Query: 118 GH--------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
K+ DFG+A + T + G WMAPEVI+ + +D+WS G+
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202
Query: 170 TALEMAEGKPPYGDIHPMRAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
E+ G+ P+ I + + + P P F + C +P R
Sbjct: 203 LLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRP 259
Query: 228 TASEMLNH 235
+ + +L+
Sbjct: 260 SFTNILDQ 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-38
Identities = 50/267 (18%), Positives = 96/267 (35%), Gaps = 56/267 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q VV + G+ L I+ C ++ ++R K L ++ I + +KG
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YLH + +H+D LK+ N+ + G
Sbjct: 143 MGYLHAKGILHKD---------------------------------LKSKNVFYD-NGKV 168
Query: 121 KLADFGVAGQLTDTMAKRNT-----VIGTPFWMAPEVIQEIG---------YDCVADMWS 166
+ DFG+ A R G +APE+I+++ + +D+++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIP--TKPPPSFREPDVWTP-EFIDFVSRCLVKNP 223
LG E+ + P+ I+ + KP + E D + C
Sbjct: 229 LGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL----SQIGMGKEISDILLFCWAFEQ 284
Query: 224 EERATASEMLNH-EFIQRHDTDPSQNG 249
EER T +++++ E + + + S G
Sbjct: 285 EERPTFTKLMDMLEKLPKRNRRLSHPG 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-37
Identities = 25/255 (9%), Positives = 61/255 (23%), Gaps = 51/255 (20%)
Query: 7 PYVVKYYGSY--FKNTDLWIVMEYCGA-----GSVSDIMRLRKKTLSEDEIATILCDTLK 59
P + + + ++M S D + + + + + ++
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIR 205
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L + +H N+ + +G
Sbjct: 206 LAANLQSKGLVHGHFTPD---------------------------------NLFIMPDGR 232
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMAEG 177
L D ++ + + E + + + W LG++ +
Sbjct: 233 LMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 178 KPPYGDIHPM------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231
P+G + P R +P +F + R L + R E
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 232 MLNHEFIQRHDTDPS 246
+ + + S
Sbjct: 350 AMETPEFLQLQNEIS 364
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-37
Identities = 60/260 (23%), Positives = 95/260 (36%), Gaps = 56/260 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ + P V+K+ G +K+ L + EY G++ I++ + + D G
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YLH IHRD L + N L+ +
Sbjct: 121 MAYLHSMNIIHRD---------------------------------LNSHNCLVRENKNV 147
Query: 121 KLADFGVA--------------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWS 166
+ADFG+A KR TV+G P+WMAPE+I YD D++S
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207
Query: 167 LGITALEMAEGKPPYGDIHPMRAIFMIPTK----PPPSFREPDVWTPEFIDFVSRCLVKN 222
GI E+ D P F + + P P F RC +
Sbjct: 208 FGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC----PPNCPPSFFPITVRCCDLD 263
Query: 223 PEERATASEMLNH-EFIQRH 241
PE+R + ++ + E ++ H
Sbjct: 264 PEKRPSFVKLEHWLETLRMH 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-37
Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 43/254 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ ++ + S+ +L ++ E+ + + + L+E EI + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L++LH H D ++ NI+ T +
Sbjct: 115 LQFLHSHNIGHFD---------------------------------IRPENIIYQTRRSS 141
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ +FG A QL + P + APEV Q DMWSLG + G
Sbjct: 142 TIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
Query: 179 PP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
P + + + I +F E + + E +DFV R LVK + R TASE L
Sbjct: 201 NPFLAETN--QQIIENIMNAEYTFDEEA-FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
Query: 235 HEFIQRHDTDPSQN 248
H ++++ S
Sbjct: 258 HPWLKQKIERVSTK 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-37
Identities = 34/237 (14%), Positives = 78/237 (32%), Gaps = 53/237 (22%)
Query: 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDT 57
++ P V+ G+ ++ + GS+ +++ + + + D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 58 LKGLEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
+G+ +LH L + +++++
Sbjct: 121 ARGMAFLHTLEPLIPRHA---------------------------------LNSRSVMID 147
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV---ADMWSLGITAL 172
+ A+++ V + P W+APE +Q+ D ADMWS +
Sbjct: 148 EDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 173 EMAEGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
E+ + P+ D+ M + + P P +P + C+ ++P +R
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLRPTI----PPGISPHVSKLMKICMNEDPAKR 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 58/254 (22%), Positives = 107/254 (42%), Gaps = 44/254 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ D P ++K Y + + ++VME G + D + + + +E + A I+ L G
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSG 148
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---E 117
+ YLH +HRD LK N+LL + +
Sbjct: 149 VTYLHKHNIVHRD---------------------------------LKPENLLLESKEKD 175
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
K+ DFG++ + K +GT +++APEV+++ YD D+WS+G+ + G
Sbjct: 176 ALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
PP+G + I K +F P+ W + D + + L + + R +A + L
Sbjct: 234 YPPFGGQTD-QEILRKVEKGKYTFDSPE-WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
Query: 235 HEFIQRHDTDPSQN 248
H +I+ +
Sbjct: 292 HPWIKEMCSKKESG 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 54/249 (21%), Positives = 96/249 (38%), Gaps = 43/249 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ ++ + G L IV ++C S+ + + ++ I T +G
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YLH + IHRD LK+ NI L+ +
Sbjct: 133 MDYLHAKSIIHRD---------------------------------LKSNNIFLHEDNTV 159
Query: 121 KLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMA 175
K+ DFG+A + + G+ WMAPEVI+ Y +D+++ GI E+
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 176 EGKPPYGDIHPMRAI-FMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
G+ PY +I+ I M+ P + ++ CL K +ER + +
Sbjct: 220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279
Query: 233 LNH-EFIQR 240
L E + R
Sbjct: 280 LAEIEELAR 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 49/259 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK-----TLSEDEIATILC 55
P++V+ +Y + L++V E+ + + K+ SE + +
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF--EIVKRADAGFVYSEAVASHYMR 137
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L+ L Y H IHRD +K +LL
Sbjct: 138 QILEALRYCHDNNIIHRD---------------------------------VKPHCVLLA 164
Query: 116 TEGHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
++ ++ KL FGVA QL ++ +GTP +MAPEV++ Y D+W G+
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 173 EMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATA 229
+ G P+ +F K W + D V R L+ +P ER T
Sbjct: 225 ILLSGCLPFYGTKER--LFEGIIKGKYKMNPRQ-WSHISESAKDLVRRMLMLDPAERITV 281
Query: 230 SEMLNHEFIQRHDTDPSQN 248
E LNH +++ D +
Sbjct: 282 YEALNHPWLKERDRYAYKI 300
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-36
Identities = 58/300 (19%), Positives = 91/300 (30%), Gaps = 91/300 (30%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK----------------- 43
M++ P + + Y Y + +VME C G + D + +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 44 ----------------------TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81
E I+ I+ L YLH + HRD
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD-------- 193
Query: 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA--KLADFGVA----GQLTDTM 135
+K N L +T KL DFG++
Sbjct: 194 -------------------------IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 136 AKRNTVIGTPFWMAPEVIQEIG--YDCVADMWSLGITALEMAEGKPP-YGDIHP--MRAI 190
T GTP+++APEV+ Y D WS G+ + G P G + +
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288
Query: 191 FMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247
F P+ + +P D +S L +N +ER A L H +I + +
Sbjct: 289 ----LNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 46/277 (16%), Positives = 86/277 (31%), Gaps = 76/277 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKT--LSEDEIATILCD 56
+++ + +VK + + T ++ME+C GS+ ++ L E E +L D
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+ G+ +L +HR+ +K GNI+
Sbjct: 121 VVGGMNHLRENGIVHRN---------------------------------IKPGNIMRVI 147
Query: 117 EGHA----KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI--------GYDCVADM 164
KL DFG A +L D + ++ GT ++ P++ + Y D+
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 165 WSLGITALEMAEGKPPYGDIHPMRAIFMI--------------------------PTKPP 198
WS+G+T A G P+ R + P
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP 266
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
S ++ L + E+ +
Sbjct: 267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 43/254 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D +++ Y ++ D+ +VMEY G + D + L+E + + +G
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ ++H +H D LK NIL
Sbjct: 200 IRHMHQMYILHLD---------------------------------LKPENILCVNRDAK 226
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ DFG+A + K GTP ++APEV+ DMWS+G+ A + G
Sbjct: 227 QIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 179 PP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
P GD + + + + E +F+S+ L+K R +ASE L
Sbjct: 286 SPFLGDND--AETLNNILACRWDLEDEE-FQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 235 HEFIQRHDTDPSQN 248
H ++ H +
Sbjct: 343 HPWLSDHKLHSRLS 356
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 44/254 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ D P ++K + + ++V E+ G + + + + + E + A I+ L G
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSG 158
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---E 117
+ YLH +HRD +K NILL
Sbjct: 159 ICYLHKHNIVHRD---------------------------------IKPENILLENKNSL 185
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
+ K+ DFG++ + K +GT +++APEV+++ Y+ D+WS G+ + G
Sbjct: 186 LNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
PP+G + I K F D W + E + + L + +R TA E LN
Sbjct: 244 YPPFGG-QNDQDIIKKVEKGKYYFDFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 235 HEFIQRHDTDPSQN 248
+I+++ + +++
Sbjct: 302 SRWIKKYANNINKS 315
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-36
Identities = 59/262 (22%), Positives = 94/262 (35%), Gaps = 50/262 (19%)
Query: 1 MQQCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTL 58
++ C+ P +VK + + ++VME G + + I +KK SE E + I+ +
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLV 116
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+ ++H +HRD LK N+L E
Sbjct: 117 SAVSHMHDVGVVHRD---------------------------------LKPENLLFTDEN 143
Query: 119 HA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
K+ DFG A T T + APE++ + GYD D+WSLG+ M
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203
Query: 176 EGKPP-YGD-----IHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEER 226
G+ P I K SF W + E D + L +P +R
Sbjct: 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA-WKNVSQEAKDLIQGLLTVDPNKR 262
Query: 227 ATASEMLNHEFIQRHDTDPSQN 248
S + +E++Q S
Sbjct: 263 LKMSGLRYNEWLQDGSQLSSNP 284
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 44/254 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q D P ++K Y + ++V E G + D + + +K SE + A I+ L G
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSG 138
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---E 117
+ Y+H + +HRD LK N+LL + +
Sbjct: 139 ITYMHKNKIVHRD---------------------------------LKPENLLLESKSKD 165
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
+ ++ DFG++ + K IGT +++APEV+ YD D+WS G+ + G
Sbjct: 166 ANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
PP+ + I K +F P W + D + + L P R +A + L+
Sbjct: 224 CPPFNGANE-YDILKKVEKGKYTFELPQ-WKKVSESAKDLIRKMLTYVPSMRISARDALD 281
Query: 235 HEFIQRHDTDPSQN 248
HE+IQ + +
Sbjct: 282 HEWIQTYTKEQISV 295
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-36
Identities = 48/254 (18%), Positives = 96/254 (37%), Gaps = 43/254 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q P ++ + ++ ++ +++E+ G + D + +SE E+ + +G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L+++H +H D +K NI+ T+ +
Sbjct: 162 LKHMHEHSIVHLD---------------------------------IKPENIMCETKKAS 188
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ DFG+A +L T + APE++ DMW++G+ + G
Sbjct: 189 SVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
Query: 179 PP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
P G+ + F E + +PE DF+ L K P +R T + L
Sbjct: 248 SPFAGEDD--LETLQNVKRCDWEFDEDA-FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
Query: 235 HEFIQRHDTDPSQN 248
H +++ ++ +
Sbjct: 305 HPWLKGDHSNLTSR 318
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 48/254 (18%), Positives = 90/254 (35%), Gaps = 43/254 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M P +V + ++ + ++ ++ E+ G + + + +SEDE + KG
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L ++H +H D LK NI+ T+
Sbjct: 268 LCHMHENNYVHLD---------------------------------LKPENIMFTTKRSN 294
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
KL DFG+ L GT + APEV + DMWS+G+ + + G
Sbjct: 295 ELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
Query: 179 PP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLN 234
P G+ + + + + + DF+ + L+ +P R T + L
Sbjct: 354 SPFGGEND--DETLRNVKSCDWNMDDSA-FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410
Query: 235 HEFIQRHDTDPSQN 248
H ++ + +
Sbjct: 411 HPWLTPGNAPGRDS 424
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-35
Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 48/256 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
M+ D P +++ Y ++ NTD+++VME C G + + + + K+ E + A I+ D L
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLS 117
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+ Y H HRD LK N L T+
Sbjct: 118 AVAYCHKLNVAHRD---------------------------------LKPENFLFLTDSP 144
Query: 120 A---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
KL DFG+A + T +GTP++++P+V++ Y D WS G+ +
Sbjct: 145 DSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLC 202
Query: 177 GKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEM 232
G PP + + + +F E D W +P+ + R L K+P++R T+ +
Sbjct: 203 GYPPFSAPTDS--EVMLKIREGTFTFPEKD-WLNVSPQAESLIRRLLTKSPKQRITSLQA 259
Query: 233 LNHEFIQRHDTDPSQN 248
L HE+ ++ + +N
Sbjct: 260 LEHEWFEKQLSSSPRN 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 55/271 (20%), Positives = 83/271 (30%), Gaps = 66/271 (24%)
Query: 1 MQQCDSPYVVKYY------GSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT--LSEDEIAT 52
M++ + P VV N + MEYC G + + + L E I T
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
+L D L YLH R IHRD LK NI
Sbjct: 126 LLSDISSALRYLHENRIIHRD---------------------------------LKPENI 152
Query: 113 LLNTEGHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
+L K+ D G A +L +GT ++APE++++ Y D WS G
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 170 TALEMAEGKPPYGDIHPMRAIFMI---------------------PTKPPPSFREPDVWT 208
A E G P+ + P +
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271
Query: 209 PEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ ++ L+ + +R T + N Q
Sbjct: 272 GKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-35
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 51/257 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
++ P +V+ + S + + ++V + G + + I + ++ SE + + + L+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILE 116
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
+ Y H +HR+ LK N+LL ++
Sbjct: 117 SIAYCHSNGIVHRN---------------------------------LKPENLLLASKAK 143
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
KLADFG+A ++ D+ + GTP +++PEV+++ Y D+W+ G+ +
Sbjct: 144 GAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 177 GKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATAS 230
G PP + + I + P+ W TPE + L NP++R TA
Sbjct: 203 GYPPFWDEDQHRLYAQI----KAGAYDYPSPE-WDTVTPEAKSLIDSMLTVNPKKRITAD 257
Query: 231 EMLNHEFIQRHDTDPSQ 247
+ L +I + S
Sbjct: 258 QALKVPWICNRERVASA 274
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 59/274 (21%), Positives = 88/274 (32%), Gaps = 76/274 (27%)
Query: 1 MQQCDSPYVVKYYGS----YFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ + S +T LW++ Y GS+ D L+ TL I+
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY--LQLTTLDTVSCLRIVLS 113
Query: 57 TLKGLEYLHLRRK--------IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLK 108
GL +LH+ HRD LK
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRD---------------------------------LK 140
Query: 109 AGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQE------IGY 158
+ NIL+ G +AD G+A N +GT +MAPEV+ E
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 159 DCVADMWSLGITALEMA----------EGKPPYGDIHPMRAIFMIPTK--------PP-P 199
D+W+ G+ E+A + KPP+ D+ P F K P P
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ D + C +NP R TA +
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 48/257 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLK 59
+++ P V+ + Y TD+ +++E G + D L K++L+E+E L L
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLKQILN 125
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ YLH + H D LK NI+L
Sbjct: 126 GVYYLHSLQIAHFD---------------------------------LKPENIMLLDRNV 152
Query: 120 A----KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
K+ DFG+A ++ + + GTP ++APE++ ADMWS+G+ +
Sbjct: 153 PKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 176 EGKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASE 231
G P GD + + F + + + DF+ R LVK+P++R T +
Sbjct: 212 SGASPFLGDTK--QETLANVSAVNYEFEDEY-FSNTSALAKDFIRRLLVKDPKKRMTIQD 268
Query: 232 MLNHEFIQRHDTDPSQN 248
L H +I+ DT + +
Sbjct: 269 SLQHPWIKPKDTQQALS 285
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-35
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 48/257 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLK 59
++Q V+ + Y TD+ +++E G + D L +K++LSE+E + + L
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILD 126
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEG 118
G+ YLH ++ H D LK NI+L +
Sbjct: 127 GVNYLHTKKIAHFD---------------------------------LKPENIMLLDKNI 153
Query: 119 HA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
KL DFG+A ++ D + + GTP ++APE++ ADMWS+G+ +
Sbjct: 154 PIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 176 EGKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASE 231
G P GD + T F E + + DF+ + LVK +R T E
Sbjct: 213 SGASPFLGDTK--QETLANITSVSYDFDEEF-FSHTSELAKDFIRKLLVKETRKRLTIQE 269
Query: 232 MLNHEFIQRHDTDPSQN 248
L H +I D +
Sbjct: 270 ALRHPWITPVDNQQAMV 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-35
Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 57/233 (24%)
Query: 7 PYVVKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
P +V+ + + +IVMEY G S+ + + L E L + L L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---SKGQKLPVAEAIAYLLEILPAL 195
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
YLH ++ D+K NI+L TE K
Sbjct: 196 SYLHSIGLVYNDLKPE---------------------------------NIML-TEEQLK 221
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
L D G ++ + GTP + APE+++ G D++++G T + P
Sbjct: 222 LIDLGAVSRINSF----GYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTR 276
Query: 182 GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEML 233
+ + P + + + R + +P +R TA EM
Sbjct: 277 NGRYVDG-----LPEDDPVLKTY----DSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-35
Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 55/252 (21%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
+++ D P VVK L++V E G V ++ K LSED+ D +
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQARFYFQDLI 147
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG+EYLH ++ IHRD +K N+L+ +G
Sbjct: 148 KGIEYLHYQKIIHRD---------------------------------IKPSNLLVGEDG 174
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYD-CVADMWSLGITALEMA 175
H K+ADFGV+ + + A + +GTP +MAPE + E + D+W++G+T
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 176 EGKPPYGDIHPM-------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
G+ P+ D M P +P + + D ++R L KNPE R
Sbjct: 235 FGQCPFMDERIMCLHSKIKSQALEFPDQPDIA--------EDLKDLITRMLDKNPESRIV 286
Query: 229 ASEMLNHEFIQR 240
E+ H ++ R
Sbjct: 287 VPEIKLHPWVTR 298
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 50/259 (19%)
Query: 1 MQQCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTL 58
++ S P V+ + Y +++ +++EY G + + + +SE+++ ++ L
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE- 117
+G+ YLH +H D LK NILL++
Sbjct: 142 EGVYYLHQNNIVHLD---------------------------------LKPQNILLSSIY 168
Query: 118 --GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
G K+ DFG++ ++ + ++GTP ++APE++ DMW++GI A +
Sbjct: 169 PLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227
Query: 176 EGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATA 229
P G+ + I ++ + E + + DF+ LVKNPE+R TA
Sbjct: 228 THTSPFVGEDNQETYLNI----SQVNVDYSEET-FSSVSQLATDFIQSLLVKNPEKRPTA 282
Query: 230 SEMLNHEFIQRHDTDPSQN 248
L+H ++Q+ D + +
Sbjct: 283 EICLSHSWLQQWDFENLFH 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 46/254 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+++ D P ++K + ++ +IV E G + D I +++K SE + A I+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFS 132
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--- 116
G+ Y+H +HRD LK NILL +
Sbjct: 133 GITYMHKHNIVHRD---------------------------------LKPENILLESKEK 159
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
+ K+ DFG++ K IGT +++APEV++ YD D+WS G+ +
Sbjct: 160 DCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEML 233
G PP+ I +F P W + + D + + L +P R TA++ L
Sbjct: 218 GTPPFYG-KNEYDILKRVETGKYAFDLPQ-WRTISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 234 NHEFIQRHDTDPSQ 247
H +IQ++ ++
Sbjct: 276 EHPWIQKYSSETPT 289
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-35
Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 48/256 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLK 59
+++ P ++ + + TD+ +++E G + D L K++L+EDE L L
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEATQFLKQILD 119
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ YLH +R H D LK NI+L +
Sbjct: 120 GVHYLHSKRIAHFD---------------------------------LKPENIMLLDKNV 146
Query: 120 A----KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
KL DFG+A ++ + + GTP ++APE++ ADMWS+G+ +
Sbjct: 147 PNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
Query: 176 EGKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASE 231
G P G+ + + F E + + DF+ R LVK+P+ R T ++
Sbjct: 206 SGASPFLGETK--QETLTNISAVNYDFDEEY-FSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
Query: 232 MLNHEFIQRHDTDPSQ 247
L H +I+ +
Sbjct: 263 SLEHSWIKAIRRRNVR 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 47/247 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE----IATILCD 56
M + D P+ VK Y ++ + L+ + Y G + +R + + E A I+
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS- 141
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
LEYLH + IHRD LK NILLN
Sbjct: 142 ---ALEYLHGKGIIHRD---------------------------------LKPENILLNE 165
Query: 117 EGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ H ++ DFG A L+ A+ N+ +GT +++PE++ E +D+W+LG ++
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G PP+ + IF K F P+ + P+ D V + LV + +R EM
Sbjct: 226 VAGLPPFRAGNEYL-IFQKIIKLEYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 282
Query: 235 HEFIQRH 241
+ ++ H
Sbjct: 283 YGPLKAH 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 67/252 (26%), Positives = 96/252 (38%), Gaps = 46/252 (18%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P ++ Y +++V E G + D I LR+K SE E + +L K +EYLH
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLH 133
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA----K 121
+ +HRD LK NIL E +
Sbjct: 134 AQGVVHRD---------------------------------LKPSNILYVDESGNPESIR 160
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY 181
+ DFG A QL T T ++APEV++ GYD D+WSLG+ M G P+
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220
Query: 182 GDIHPM--RAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLNHE 236
+ I S W + D VS+ L +P +R TA+ +L H
Sbjct: 221 ANGPDDTPEEILARIGSGKFSLSGGY-WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 237 FIQRHDTDPSQN 248
+I D P
Sbjct: 280 WIVHWDQLPQYQ 291
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 59/249 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE----IATILCD 56
+Q + P++VK S+ N++L++VMEY G + +R R SE A I+
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVL- 152
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
EYLH I+RD LK N+L++
Sbjct: 153 ---TFEYLHSLDLIYRD---------------------------------LKPENLLIDQ 176
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
+G+ ++ DFG A ++ T+ GTP +APE+I GY+ D W+LG+ EMA
Sbjct: 177 QGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 177 GKPPYGDIHPM---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----AT 228
G PP+ P+ I + P F + + D + L + +R
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSHF------SSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 229 ASEMLNHEF 237
+++ NH++
Sbjct: 288 VNDIKNHKW 296
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 45/247 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
++ D P ++K + + +++IVME C G + + + R K LSE +A ++
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
+ L Y H + +H+D LK NIL
Sbjct: 134 MNALAYFHSQHVVHKD---------------------------------LKPENILFQDT 160
Query: 118 GHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
K+ DFG+A GT +MAPEV + D+WS G+ +
Sbjct: 161 SPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFL 218
Query: 175 AEGKPP-YGDIHPMRAIFMIPTKPPPSF-REPDVWTPEFIDFVSRCLVKNPEERATASEM 232
G P G + T P++ E TP+ +D + + L K+PE R +A+++
Sbjct: 219 LTGCLPFTGTSLE--EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
Query: 233 LNHEFIQ 239
L+HE+ +
Sbjct: 277 LHHEWFK 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 71/249 (28%), Positives = 104/249 (41%), Gaps = 48/249 (19%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P +++ +Y NT ++V + G + D + K TLSE E I+ L+ + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALH 141
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+HRD LK NILL+ + + KL DF
Sbjct: 142 KLNIVHRD---------------------------------LKPENILLDDDMNIKLTDF 168
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI------GYDCVADMWSLGITALEMAEGKP 179
G + QL K V GTP ++APE+I+ GY DMWS G+ + G P
Sbjct: 169 GFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEMLNHE 236
P+ M + + F P+ W + D VSR LV P++R TA E L H
Sbjct: 228 PFWHRKQML-MLRMIMSGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285
Query: 237 FIQRHDTDP 245
F Q++ +
Sbjct: 286 FFQQYVVEE 294
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 55/254 (21%), Positives = 106/254 (41%), Gaps = 45/254 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
++ P +V+ + S + + ++V + G + + I+ ++ SE + + + L+
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILE 139
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
+ Y H +HR+ LK N+LL ++
Sbjct: 140 SIAYCHSNGIVHRN---------------------------------LKPENLLLASKAK 166
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
KLADFG+A ++ D+ + GTP +++PEV+++ Y D+W+ G+ +
Sbjct: 167 GAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEML 233
G PP+ D R ++ + P+ W TPE + L NP++R TA + L
Sbjct: 226 GYPPFWDEDQHR-LYAQIKAGAYDYPSPE-WDTVTPEAKSLIDSMLTVNPKKRITADQAL 283
Query: 234 NHEFIQRHDTDPSQ 247
+I + S
Sbjct: 284 KVPWICNRERVASA 297
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 66/259 (25%), Positives = 106/259 (40%), Gaps = 52/259 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLK 59
++Q P ++ + Y TD+ +++E G + D L +K +LSE+E + + L
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILD 126
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEG 118
G+ YLH ++ H D LK NI+L +
Sbjct: 127 GVNYLHTKKIAHFD---------------------------------LKPENIMLLDKNI 153
Query: 119 HA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
KL DFG+A ++ D + + GTP ++APE++ ADMWS+G+ +
Sbjct: 154 PIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 176 EGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATA 229
G P GD + I T F E + + DF+ + LVK +R T
Sbjct: 213 SGASPFLGDTKQETLANI----TAVSYDFDEEF-FSQTSELAKDFIRKLLVKETRKRLTI 267
Query: 230 SEMLNHEFIQRHDTDPSQN 248
E L H +I DT +
Sbjct: 268 QEALRHPWITPVDTQQAMV 286
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 48/252 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+++ D P ++K + ++ +IV E G + D I +++K SE + A I+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFS 132
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
G+ Y+H +HRD LK NILL ++
Sbjct: 133 GITYMHKHNIVHRD---------------------------------LKPENILLESKEK 159
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K+ DFG++ K IGT +++APEV++ YD D+WS G+ +
Sbjct: 160 DCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 177 GKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEM 232
G PP YG I +F P W + + D + + L +P R TA++
Sbjct: 218 GTPPFYGKNE--YDILKRVETGKYAFDLPQ-WRTISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 233 LNHEFIQRHDTD 244
L H +IQ++ ++
Sbjct: 275 LEHPWIQKYSSE 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 27/261 (10%), Positives = 60/261 (22%), Gaps = 62/261 (23%)
Query: 1 MQQCDSPYVVKYYGSY--FKNTDLWIVMEYCGAGSVSDIMRL-----RKKTLSEDEIATI 53
++ +++ + + + + L K+L +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
++ L LH +H ++ +I+
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPV---------------------------------DIV 238
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----------EIGYDCVA 162
L+ G L F + R + + PE+
Sbjct: 239 LDQRGGVFLTGFEHLVRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222
D W+LG+ + P + I FR + L
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGSEWI-------FRSCKNIPQPVRALLEGFLRYP 347
Query: 223 PEERATASEMLNHEFIQRHDT 243
E+R + + ++ T
Sbjct: 348 KEDRLLPLQAMETPEYEQLRT 368
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-34
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+ + P ++K + T++ +V+E G + D I + K SE + A + L+
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILE 159
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
+ YLH +HRD LK N+L T
Sbjct: 160 AVAYLHENGIVHRD---------------------------------LKPENLLYATPAP 186
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K+ADFG++ + TV GTP + APE+++ Y DMWS+GI +
Sbjct: 187 DAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEML 233
G P+ D + +F F P W + D V + +V +P++R T + L
Sbjct: 246 GFEPFYDERGDQFMFRRILNCEYYFISPW-WDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 234 NHEFIQRHDTD 244
H ++ +
Sbjct: 305 QHPWVTGKAAN 315
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 56/274 (20%), Positives = 92/274 (33%), Gaps = 76/274 (27%)
Query: 1 MQQCDSPYVVKYYGS----YFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ + + T L+++ +Y GS+ D L+ TL + +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY--LKSTTLDAKSMLKLAYS 142
Query: 57 TLKGLEYLHLRRK--------IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLK 108
++ GL +LH HRD LK
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRD---------------------------------LK 169
Query: 109 AGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQEIG------Y 158
+ NIL+ G +AD G+A + NT +GT +M PEV+ E
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 159 DCVADMWSLGITALEMA----------EGKPPYGDIHPMRAIFMIPTK--------PP-P 199
+ADM+S G+ E+A E + PY D+ P + + P P
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ D + ++ C NP R TA +
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 60/263 (22%), Positives = 94/263 (35%), Gaps = 51/263 (19%)
Query: 1 MQQC-DSPYVVKYYGSY----FKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATIL 54
Q P++V Y L I+ME G + I + +E E A I+
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
D +++LH HRD +K N+L
Sbjct: 135 RDIGTAIQFLHSHNIAHRD---------------------------------VKPENLLY 161
Query: 115 NTEGHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171
++ KL DFG A + T + T TP+++APEV+ YD DMWSLG+
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQ--TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 172 LEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEE 225
+ G PP+ + F P+ W + + + L +P E
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE-WSEVSEDAKQLIRLLLKTDPTE 278
Query: 226 RATASEMLNHEFIQRHDTDPSQN 248
R T ++ +NH +I + P
Sbjct: 279 RLTITQFMNHPWINQSMVVPQTP 301
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 58/252 (23%), Positives = 97/252 (38%), Gaps = 59/252 (23%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM----RLRKKTLSEDE----IATI 53
++ +S +VV +Y L +V+ G D+ + + E A I
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
C GLE LH R ++RD LK NIL
Sbjct: 296 CC----GLEDLHRERIVYRD---------------------------------LKPENIL 318
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE 173
L+ GH +++D G+A + + +GT +MAPEV++ Y D W+LG E
Sbjct: 319 LDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 174 MAEGKPP-YGDIHPMRA--IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER---- 226
M G+ P ++ + + + P + + ++P+ S+ L K+P ER
Sbjct: 378 MIAGQSPFQQRKKKIKREEVERLVKEVPEEY--SERFSPQARSLCSQLLCKDPAERLGCR 435
Query: 227 -ATASEMLNHEF 237
+A E+ H
Sbjct: 436 GGSAREVKEHPL 447
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 48/259 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+++ + P ++K +F D +IV+E G + D ++ K L E L
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLL 250
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
++YLH IHRD LK N+LL+++
Sbjct: 251 AVQYLHENGIIHRD---------------------------------LKPENVLLSSQEE 277
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI---GYDCVADMWSLGITALE 173
K+ DFG + L +T + T+ GTP ++APEV+ + GY+ D WSLG+
Sbjct: 278 DCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 336
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATAS 230
G PP+ + ++ T +F W + + +D V + LV +P+ R T
Sbjct: 337 CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV-WAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 231 EMLNHEFIQRHDTDPSQNG 249
E L H ++Q D
Sbjct: 396 EALRHPWLQDEDMKRKFQD 414
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 54/247 (21%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P+++ SY ++ +++V + G + D + K LSE E +I+ L+ + +LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
+HRD LK NILL+ +L+DF
Sbjct: 218 ANNIVHRD---------------------------------LKPENILLDDNMQIRLSDF 244
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQ------EIGYDCVADMWSLGITALEMAEGKP 179
G + L K + GTP ++APE+++ GY D+W+ G+ + G P
Sbjct: 245 GFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
Query: 180 P-YGDIHP--MRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEML 233
P + +R I + F P+ W + D +SR L +PE R TA + L
Sbjct: 304 PFWHRRQILMLRMI----MEGQYQFSSPE-WDDRSSTVKDLISRLLQVDPEARLTAEQAL 358
Query: 234 NHEFIQR 240
H F +R
Sbjct: 359 QHPFFER 365
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 40/216 (18%)
Query: 22 LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81
L++ M ++ ++R R+ L+ I+ L+ H HRD+K
Sbjct: 109 LYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE---- 163
Query: 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTD-TMAKRNT 140
NIL++ + A L DFG+A TD + +
Sbjct: 164 -----------------------------NILVSADDFAYLVDFGIASATTDEKLTQLGN 194
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GD-IHPMRAIFMIPTKPP 198
+GT ++MAPE E AD+++L E G PPY GD + M A P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PR 253
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEML 233
PS P + F ++R + KNPE+R T ++
Sbjct: 254 PSTVRPGI-PVAFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 50/257 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+ P +V+ + S + +++ + G + + I + ++ SE + + + L+
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILE 121
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
+ + H +HR+ LK N+LL ++
Sbjct: 122 AVLHCHQMGVVHRN---------------------------------LKPENLLLASKLK 148
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
KLADFG+A ++ GTP +++PEV+++ Y D+W+ G+ +
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 177 GKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATAS 230
G PP + + + I F P+ W TPE D +++ L NP +R TA+
Sbjct: 209 GYPPFWDEDQHRLYQQI----KAGAYDFPSPE-WDTVTPEAKDLINKMLTINPSKRITAA 263
Query: 231 EMLNHEFIQRHDTDPSQ 247
E L H +I T S
Sbjct: 264 EALKHPWISHRSTVASC 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 60/258 (23%), Positives = 93/258 (36%), Gaps = 68/258 (26%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM------RLRKKTLSEDE----IA 51
+ S ++V ++ TDL +VM G DI E A
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
I+ GLE+LH R I+RD LK N
Sbjct: 297 QIVS----GLEHLHQRNIIYRD---------------------------------LKPEN 319
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171
+LL+ +G+ +++D G+A +L K GTP +MAPE++ YD D ++LG+T
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379
Query: 172 LEMAEGKPP-YGDIHPM------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
EM + P + + + P F +P DF L K+PE
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF------SPASKDFCEALLQKDPE 433
Query: 225 ER-----ATASEMLNHEF 237
+R + + H
Sbjct: 434 KRLGFRDGSCDGLRTHPL 451
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 6e-33
Identities = 34/243 (13%), Positives = 69/243 (28%), Gaps = 35/243 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----KTLSEDEIATILCD 56
++ +K+Y ++ +V E G++ + + L K K + + + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
L +E +H IH DIK N I F + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKP--------------------DNFILGNGFLEQDDE--DDL 218
Query: 117 EGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
L D G + + T + E++ ++ D + + T M
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G + P D+W +F L + ++L
Sbjct: 279 LFGTYMKVKNEGGECKPEGLFRRLP---HLDMWN----EFFHVMLNIPDCHHLPSLDLLR 331
Query: 235 HEF 237
+
Sbjct: 332 QKL 334
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-33
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 63/251 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRK-KTLSEDE----IATIL 54
+ P++++ +G++ ++++M+Y G ++ LRK + A +
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG---ELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
LEYLH + I+RD LK NILL
Sbjct: 117 L----ALEYLHSKDIIYRD---------------------------------LKPENILL 139
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ GH K+ DFG A + D T+ GTP ++APEV+ Y+ D WS GI EM
Sbjct: 140 DKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 196
Query: 175 AEGKPPYGDIHPM---RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----- 226
G P+ D + M I + PP F + D +SR + ++ +R
Sbjct: 197 LAGYTPFYDSNTMKTYEKILNAELRFPPFF------NEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 227 ATASEMLNHEF 237
++ NH +
Sbjct: 251 NGTEDVKNHPW 261
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-33
Identities = 52/275 (18%), Positives = 87/275 (31%), Gaps = 76/275 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ + + K+ LW+V +Y GS+ D L + T++ + + +
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYTVTVEGMIKLALS 147
Query: 57 TLKGLEYLHLRRK--------IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLK 108
T GL +LH+ HRD LK
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRD---------------------------------LK 174
Query: 109 AGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQEIG------Y 158
+ NIL+ G +AD G+A N +GT +MAPEV+ +
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFRE--------------P 204
AD++++G+ E+A G + + PS E P
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294
Query: 205 DVWT-----PEFIDFVSRCLVKNPEERATASEMLN 234
+ W + C N R TA +
Sbjct: 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 32/259 (12%), Positives = 65/259 (25%), Gaps = 62/259 (23%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEY----CGAGSVSDIMRL------RKKTLSEDEIATILCD 56
P K D+W++ + ++ + K+L +
Sbjct: 160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 219
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
++ L LH +H ++ +I+L+
Sbjct: 220 VIRLLASLHHYGLVHTYLRPV---------------------------------DIVLDQ 246
Query: 117 EGHAKLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVI-----QEIGYDCVADMWSLGIT 170
G L F + ++ P A ++ D W+LG+
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 171 ALEMAEGKPPYGD---IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
+ P D + IF P R + L E+R
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVR----------ALLEGFLRYPKEDRL 356
Query: 228 TASEMLNHEFIQRHDTDPS 246
+ + ++ T+ S
Sbjct: 357 LPLQAMETPEYEQLRTELS 375
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+++ + P ++K +F D +IV+E G + D ++ K L E L
Sbjct: 69 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLL 125
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
++YLH IHRD LK N+LL+++
Sbjct: 126 AVQYLHENGIIHRD---------------------------------LKPENVLLSSQEE 152
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI---GYDCVADMWSLGITALE 173
K+ DFG + L +T + T+ GTP ++APEV+ + GY+ D WSLG+
Sbjct: 153 DCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATAS 230
G PP+ + ++ T +F W + + +D V + LV +P+ R T
Sbjct: 212 CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV-WAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 231 EMLNHEFIQRHDTDPS 246
E L H ++Q D
Sbjct: 271 EALRHPWLQDEDMKRK 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 61/263 (23%), Positives = 95/263 (36%), Gaps = 50/263 (19%)
Query: 1 MQQC-DSPYVVKYYGSY----FKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATIL 54
+ P++V+ Y L IVME G + I + +E E + I+
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
+ ++YLH HRD +K N+L
Sbjct: 168 KSIGEAIQYLHSINIAHRD---------------------------------VKPENLLY 194
Query: 115 NTEGHA---KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITA 171
++ KL DFG A + T T TP+++APEV+ YD DMWSLG+
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 172 LEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEE 225
+ G PP+ H + + F P+ W + E + L P +
Sbjct: 254 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE-WSEVSEEVKMLIRNLLKTEPTQ 312
Query: 226 RATASEMLNHEFIQRHDTDPSQN 248
R T +E +NH +I + P
Sbjct: 313 RMTITEFMNHPWIMQSTKVPQTP 335
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 48/250 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
+++ +V Y T ++VM+ G + D I+ + +E + + ++ L
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLS 117
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
++YLH +HRD LK N+L T
Sbjct: 118 AVKYLHENGIVHRD---------------------------------LKPENLLYLTPEE 144
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
+ DFG++ + + T GTP ++APEV+ + Y D WS+G+ +
Sbjct: 145 NSKIMITDFGLSKMEQNGIMS--TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 177 GKPP-YGDIHPMRAIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEM 232
G PP Y + +F + F P W + DF+ L K+P ER T +
Sbjct: 203 GYPPFYEETES--KLFEKIKEGYYEFESPF-WDDISESAKDFICHLLEKDPNERYTCEKA 259
Query: 233 LNHEFIQRHD 242
L+H +I +
Sbjct: 260 LSHPWIDGNT 269
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 60/251 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATIL 54
+++ P++V ++ L++++EY G ++ +L R+ ED +A I
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEIS 131
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
L +LH + I+RD+K + NI+L
Sbjct: 132 M----ALGHLHQKGIIYRDLK----------PE-----------------------NIML 154
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
N +GH KL DFG+ + +T GT +MAPE++ G++ D WSLG +M
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214
Query: 175 AEGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----- 226
G PP G+ + I PP T E D + + L +N R
Sbjct: 215 LTGAPPFTGENRKKTIDKILKCKLNLPPYL------TQEARDLLKKLLKRNAASRLGAGP 268
Query: 227 ATASEMLNHEF 237
A E+ H F
Sbjct: 269 GDAGEVQAHPF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 60/251 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRK-KTLSEDE----IATIL 54
+ + + P++VK + ++ L++++++ G D+ RL K +E++ +A +
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
L++LH I+RD+K + NILL
Sbjct: 137 L----ALDHLHSLGIIYRDLK----------PE-----------------------NILL 159
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ EGH KL DFG++ + D K + GT +MAPEV+ G+ AD WS G+ EM
Sbjct: 160 DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219
Query: 175 AEGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----- 226
G P G M I P +PE + +NP R
Sbjct: 220 LTGTLPFQGKDRKETMTMILKAKLGMPQFL------SPEAQSLLRMLFKRNPANRLGAGP 273
Query: 227 ATASEMLNHEF 237
E+ H F
Sbjct: 274 DGVEEIKRHSF 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 48/237 (20%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+V ++ ++VMEY ++S+ + LS D L G+++ H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
R +HRDIK NIL+++ K+ DFG
Sbjct: 130 MRIVHRDIKPQ---------------------------------NILIDSNKTLKIFDFG 156
Query: 127 VAGQLTD-TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GDI 184
+A L++ ++ + N V+GT + +PE + D D++S+GI EM G+PP+ G+
Sbjct: 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE- 215
Query: 185 HPMRAIFM------IPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLN 234
+ +I + +P + D+ + + R K+ R T EM +
Sbjct: 216 TAV-SIAIKHIQDSVP--NVTTDVRKDI-PQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 60/251 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATIL 54
+Q P++ ++ + L VMEY G ++ L R++ +E+ A I+
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIV 115
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
LEYLH R ++RDIK L+ N++L
Sbjct: 116 S----ALEYLHSRDVVYRDIK----------LE-----------------------NLML 138
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
+ +GH K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM
Sbjct: 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 175 AEGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----- 226
G+ P Y H I M + P + +PE ++ L K+P++R
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPRTL------SPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 227 ATASEMLNHEF 237
+ A E++ H F
Sbjct: 253 SDAKEVMEHRF 263
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 59/253 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDE----IATILC 55
M +SP+VV+ + ++ + L++VMEY G D++ + + E A ++
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVL 179
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L+ +H IHRD+K D N+LL+
Sbjct: 180 ----ALDAIHSMGFIHRDVK----------PD-----------------------NMLLD 202
Query: 116 TEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQEIG----YDCVADMWSLGIT 170
GH KLADFG ++ R +T +GTP +++PEV++ G Y D WS+G+
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 171 ALEMAEGKPPYGDIHPMRAIF---MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER- 226
EM G P+ + + M + D+ + E + + + + E R
Sbjct: 263 LYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTFPDDNDI-SKEAKNLICA-FLTDREVRL 319
Query: 227 --ATASEMLNHEF 237
E+ H F
Sbjct: 320 GRNGVEEIKRHLF 332
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 24 IVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83
IVMEY ++ DI+ + ++ ++ D + L + H IHRD+K
Sbjct: 93 IVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA------ 145
Query: 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNT 140
NI+++ K+ DFG+A +++ +
Sbjct: 146 ---------------------------NIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY-GDIHPMRAIFM-----IP 194
VIGT +++PE + D +D++SLG E+ G+PP+ GD P+ ++ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPV-SVAYQHVREDP 236
Query: 195 TKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLN 234
PPS R + + + V + L KNPE R TA+EM
Sbjct: 237 --IPPSARHEGL-SADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 76/266 (28%)
Query: 7 PYVVKYYGS----YFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLE 62
++++ G+ + DLW++ + GS+SD L+ +S +E+ I +GL
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF--LKANVVSWNELCHIAETMARGLA 135
Query: 63 YLHLRRK----------IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
YLH HRD +K+ N+
Sbjct: 136 YLHEDIPGLKDGHKPAISHRD---------------------------------IKSKNV 162
Query: 113 LLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMW 165
LL A +ADFG+A + + + +GT +MAPEV++ + DM+
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 166 SLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSFRE--------------PDVWTPE 210
++G+ E+A F PS + D W
Sbjct: 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH 282
Query: 211 -----FIDFVSRCLVKNPEERATASE 231
+ + C + E R +A
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGC 308
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 59/249 (23%), Positives = 94/249 (37%), Gaps = 59/249 (23%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILC 55
+ P++V + S+ L+ V++Y G ++ L R++ E A I
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIAS 150
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L YLH ++RD+K + NILL+
Sbjct: 151 ----ALGYLHSLNIVYRDLK----------PE-----------------------NILLD 173
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
++GH L DFG+ + + + +T GTP ++APEV+ + YD D W LG EM
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
Query: 176 EGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----AT 228
G PP Y I P + P+ T + L K+ +R
Sbjct: 234 YGLPPFYSRNTAEMYDNILNKPLQLKPNI------TNSARHLLEGLLQKDRTKRLGAKDD 287
Query: 229 ASEMLNHEF 237
E+ +H F
Sbjct: 288 FMEIKSHVF 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 53/248 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDEIATILCDTL 58
+Q P++ S+ + L VMEY G ++ L R++ SED + +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIV 258
Query: 59 KGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+YLH + + +RD LK N++L+ +
Sbjct: 259 SALDYLHSEKNVVYRD---------------------------------LKLENLMLDKD 285
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEG 177
GH K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM G
Sbjct: 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 178 KPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATA 229
+ P Y H I M + P + PE +S L K+P++R A
Sbjct: 346 RLPFYNQDHEKLFELILMEEIRFPRTL------GPEAKSLLSGLLKKDPKQRLGGGSEDA 399
Query: 230 SEMLNHEF 237
E++ H F
Sbjct: 400 KEIMQHRF 407
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 63/258 (24%), Positives = 102/258 (39%), Gaps = 63/258 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK---TLSEDE----IATI 53
+ D ++ + + ++ L++VMEY G D++ L K + + +A I
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEI 171
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+ ++ +H +HRDIK D NIL
Sbjct: 172 VM----AIDSVHRLGYVHRDIK----------PD-----------------------NIL 194
Query: 114 LNTEGHAKLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVIQEIG-------YDCVADMW 165
L+ GH +LADFG +L D + +GTP +++PE++Q +G Y D W
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 166 SLGITALEMAEGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222
+LG+ A EM G+ P Y D I + + + E DF+ R L+
Sbjct: 255 ALGVFAYEMFYGQTPFYADSTAETYGKI-VHYKEHLSLPLVDEGVPEEARDFIQR-LLCP 312
Query: 223 PEER---ATASEMLNHEF 237
PE R A + H F
Sbjct: 313 PETRLGRGGAGDFRTHPF 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-29
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 70/273 (25%)
Query: 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTL 58
+ QC V++ + + ++V E GS+ I +++ +E E + ++ D
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVA 121
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
L++LH + HRD LK NIL
Sbjct: 122 SALDFLHNKGIAHRD---------------------------------LKPENILCEHPN 148
Query: 119 HA---KLADFGVAGQLTDTMAKR-------NTVIGTPFWMAPEVI-----QEIGYDCVAD 163
K+ DF + + T G+ +MAPEV+ + YD D
Sbjct: 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP--------------SFREPDVW-- 207
+WSLG+ + G PP+ + P F + D W
Sbjct: 209 LWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD-WAH 267
Query: 208 -TPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ D +S+ LV++ ++R +A+++L H ++Q
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 66/251 (26%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRK-KTLSEDE----IATILCDTL 58
D P++V ++ L +++ G D+ L + SE + A I+
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIIL--- 303
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GLE++H R ++RD LK NILL+ G
Sbjct: 304 -GLEHMHNRFVVYRD---------------------------------LKPANILLDEHG 329
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-EIGYDCVADMWSLGITALEMAEG 177
H +++D G+A + K + +GT +MAPEV+Q + YD AD +SLG ++ G
Sbjct: 330 HVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
Query: 178 KPPYGDIHP------MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER----- 226
P+ R + + P SF +PE + L ++ R
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDSF------SPELRSLLEGLLQRDVNRRLGCLG 441
Query: 227 ATASEMLNHEF 237
A E+ F
Sbjct: 442 RGAQEVKESPF 452
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 55/246 (22%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILCDTL 58
+ P++ + + + L+ VME+ G D+M + + + E A I+
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIIS--- 135
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
L +LH + I+RD+K LD N+LL+ EG
Sbjct: 136 -ALMFLHDKGIIYRDLK----------LD-----------------------NVLLDHEG 161
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
H KLADFG+ + T GTP ++APE++QE+ Y D W++G+ EM G
Sbjct: 162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
Query: 179 PP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
P + AI P + + + KNP R +
Sbjct: 222 APFEAENEDDLFEAILNDEVVYPTWL------HEDATGILKSFMTKNPTMRLGSLTQGGE 275
Query: 236 EFIQRH 241
I RH
Sbjct: 276 HAILRH 281
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 67/253 (26%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRK-KTLSEDE----IATILCDTLK 59
SP++V + ++ T L ++++Y G ++ L + + +E E + I+
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVL---- 170
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
LE+LH I+RDIK L+ NILL++ GH
Sbjct: 171 ALEHLHKLGIIYRDIK----------LE-----------------------NILLDSNGH 197
Query: 120 AKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYDCVADMWSLGITALEMAE 176
L DFG++ + D + GT +MAP++++ G+D D WSLG+ E+
Sbjct: 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
Query: 177 GKPP-YGDIHP------MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER--- 226
G P D R I P + D + R L+K+P++R
Sbjct: 258 GASPFTVDGEKNSQAEISRRILKSEPPYPQEM------SALAKDLIQRLLMKDPKKRLGC 311
Query: 227 --ATASEMLNHEF 237
A E+ H F
Sbjct: 312 GPRDADEIKEHLF 324
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 57/246 (23%), Positives = 93/246 (37%), Gaps = 60/246 (24%)
Query: 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILCDTLK 59
P++ + + + L+ VMEY G D+M + + E A I
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAI---- 132
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
GL +L + I+RD+K LD N++L++EGH
Sbjct: 133 GLFFLQSKGIIYRDLK----------LD-----------------------NVMLDSEGH 159
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
K+ADFG+ + T GTP ++APE+I Y D W+ G+ EM G+
Sbjct: 160 IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
Query: 180 P-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASE 231
P G+ ++I P S + E + + K+P +R +
Sbjct: 220 PFEGEDEDELFQSIMEHNVAYPKSM------SKEAVAICKGLMTKHPGKRLGCGPEGERD 273
Query: 232 MLNHEF 237
+ H F
Sbjct: 274 IKEHAF 279
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 56/243 (23%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILCDTL 58
+ P++ + ++ +L+ VMEY G D+M + A I+
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIIL--- 129
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GL++LH + ++RD+K LD NILL+ +G
Sbjct: 130 -GLQFLHSKGIVYRDLK----------LD-----------------------NILLDKDG 155
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
H K+ADFG+ + AK NT GTP ++APE++ Y+ D WS G+ EM G+
Sbjct: 156 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
Query: 179 PP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASEMLN 234
P +G +I M P E D + + V+ PE+R ++
Sbjct: 216 SPFHGQDEEELFHSIRMDNPFYPRWL------EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269
Query: 235 HEF 237
H
Sbjct: 270 HPL 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 50/239 (20%), Positives = 82/239 (34%), Gaps = 50/239 (20%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYC-GAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
V++ + + +++E + D + R L E+ + L+ + + H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH 166
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLAD 124
+HRD +K NIL++ G KL D
Sbjct: 167 NCGVLHRD---------------------------------IKDENILIDLNRGELKLID 193
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKPPYGD 183
FG L DT+ GT + PE I+ Y A +WSLGI +M G P+
Sbjct: 194 FGSGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
Query: 184 IHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
+R + + E + CL P +R T E+ NH ++Q
Sbjct: 252 DEEIIRGQVFFRQRV----------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-29
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 39/247 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ + P +VK + L+++MEY G V D + + + E E + +
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 126
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++Y H +R +HRD LKA N+LL+ + +
Sbjct: 127 VQYCHQKRIVHRD---------------------------------LKAENLLLDADMNI 153
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKP 179
K+ADFG + + T K + G P + APE+ Q YD D+WSLG+ + G
Sbjct: 154 KIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P+ + + +R P + + + + R LV NP +R T +++ +I
Sbjct: 213 PFDGQNLKELRERVLR---GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
Query: 240 RHDTDPS 246
+
Sbjct: 270 AGHEEDE 276
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 56/254 (22%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILC 55
Q + P++V + + + L+ V+EY G D+M + R++ L E+ A I
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L YLH R I+RD+K LD N+LL+
Sbjct: 122 ----ALNYLHERGIIYRDLK----------LD-----------------------NVLLD 144
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+EGH KL D+G+ + +T GTP ++APE+++ Y D W+LG+ EM
Sbjct: 145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 176 EGKPPYGDIHPMRA--------IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
G+ P+ + +F + + P + + + L K+P+ER
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRSLSVKAASVLKSFLNKDPKERL 262
Query: 228 TASEMLNHEFIQRH 241
IQ H
Sbjct: 263 GCHPQTGFADIQGH 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 53/252 (21%), Positives = 87/252 (34%), Gaps = 56/252 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-----RKKTLSEDEIATILC 55
+ + + ++K + +VME G+G + L R L E + I
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-----LDLFAFIDRHPRLDEPLASYIFR 137
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
+ + YL L+ IHRD +K NI++
Sbjct: 138 QLVSAVGYLRLKDIIHRD---------------------------------IKDENIVIA 164
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV-ADMWSLGITALEM 174
+ KL DFG A L T GT + APEV+ Y +MWSLG+T +
Sbjct: 165 EDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 175 AEGKPPYGDIHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
+ P+ ++ + A P E + VS L PE R T +++
Sbjct: 224 VFEENPFCELEETVEAAIHPPYLVSK----------ELMSLVSGLLQPVPERRTTLEKLV 273
Query: 234 NHEFIQRHDTDP 245
++ +
Sbjct: 274 TDPWVTQPVNLA 285
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 56/254 (22%)
Query: 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RL-RKKTLSEDE----IATILC 55
Q + P++V + + + L+ V+EY G D+M + R++ L E+ A I
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISL 164
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L YLH R I+RD+K LD N+LL+
Sbjct: 165 ----ALNYLHERGIIYRDLK----------LD-----------------------NVLLD 187
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+EGH KL D+G+ + +T GTP ++APE+++ Y D W+LG+ EM
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247
Query: 176 EGKPPYGDIHPMRA--------IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
G+ P+ + +F + + P + + + L K+P+ER
Sbjct: 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRSLSVKAASVLKSFLNKDPKERL 305
Query: 228 TASEMLNHEFIQRH 241
IQ H
Sbjct: 306 GCHPQTGFADIQGH 319
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 2e-28
Identities = 55/244 (22%), Positives = 91/244 (37%), Gaps = 52/244 (21%)
Query: 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR--LRKKTLSEDEIATILCDTLKGL 61
P++ + + + L+ VMEY G D+M + E + GL
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK 121
+L + I+RD+K LD N++L++EGH K
Sbjct: 456 FFLQSKGIIYRDLK----------LD-----------------------NVMLDSEGHIK 482
Query: 122 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP- 180
+ADFG+ + T GTP ++APE+I Y D W+ G+ EM G+ P
Sbjct: 483 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 181 YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEML 233
G+ ++I P S + E + + K+P +R ++
Sbjct: 543 EGEDEDELFQSIMEHNVAYPKSM------SKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596
Query: 234 NHEF 237
H F
Sbjct: 597 EHAF 600
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 55/253 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDE----IATILCD 56
+ DS ++ + ++ + +L++VM+Y G + ++ + L E+ +A ++
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI- 186
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
++ +H +HRDIK D NIL++
Sbjct: 187 ---AIDSVHQLHYVHRDIK----------PD-----------------------NILMDM 210
Query: 117 EGHAKLADFGVAGQL-TDTMAKRNTVIGTPFWMAPEVIQEI-----GYDCVADMWSLGIT 170
GH +LADFG +L D + + +GTP +++PE++Q + Y D WSLG+
Sbjct: 211 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 171 ALEMAEGKPP-YGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER- 226
EM G+ P Y + I + + DV + D + R L+ + E R
Sbjct: 271 MYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRR-LICSREHRL 328
Query: 227 --ATASEMLNHEF 237
+ H F
Sbjct: 329 GQNGIEDFKKHPF 341
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 50/276 (18%), Positives = 85/276 (30%), Gaps = 87/276 (31%)
Query: 7 PYVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGL 61
+ ++ + T +VMEY GS+ L T + +GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY--LSLHTSDWVSSCRLAHSVTRGL 124
Query: 62 EYLHLRRK---------IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
YLH HRD L + N+
Sbjct: 125 AYLHTELPRGDHYKPAISHRD---------------------------------LNSRNV 151
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKR--------NTVIGTPFWMAPEVIQEI-------G 157
L+ +G ++DFG++ +LT R + +GT +MAPEV++
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 158 YDCVADMWSLGITALEMA---EGKPPYGDIHPMRAIFMIPTKPPPSFRE----------- 203
DM++LG+ E+ P + + F P+F +
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271
Query: 204 ---PDVWTP------EFIDFVSRCLVKNPEERATAS 230
P+ W + + C ++ E R TA
Sbjct: 272 PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 50/247 (20%), Positives = 91/247 (36%), Gaps = 42/247 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
+++ V++ + +++VMEYC G + + +K + C +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GLEYLH + +H+D +K GN+LL T G
Sbjct: 120 DGLEYLHSQGIVHKD---------------------------------IKPGNLLLTTGG 146
Query: 119 HAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEI-GYD-CVADMWSLGITALEM 174
K++ GVA L A T G+P + PE+ + + D+WS G+T +
Sbjct: 147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G P+ + + I + P P D + L P +R + ++
Sbjct: 207 TTGLYPFEGDNIYKLFENIGKGS---YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 235 HEFIQRH 241
H + ++
Sbjct: 264 HSWFRKK 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 40/248 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P+++K Y TD+ +V+EY G G + D + + KK ++EDE +
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI-VEKKRMTEDEGRRFFQQIICA 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EY H + +HRD LK N+LL+ +
Sbjct: 121 IEYCHRHKIVHRD---------------------------------LKPENLLLDDNLNV 147
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKP 179
K+ADFG++ +TD T G+P + APEVI Y D+WS GI M G+
Sbjct: 148 KIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P+ D + + + PD +P + R +V +P +R T E+ +
Sbjct: 207 PFDDEFIPNLFKKVNSC---VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
Query: 240 RHDTDPSQ 247
+ D +
Sbjct: 264 VNLPDYLR 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 39/242 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P+++K Y TD ++VMEY G + D + + + E E + L
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSA 123
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++Y H +HRD LK N+LL+ +A
Sbjct: 124 VDYCHRHMVVHRD---------------------------------LKPENVLLDAHMNA 150
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKP 179
K+ADFG++ ++D T G+P + APEVI Y D+WS G+ + G
Sbjct: 151 KIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P+ D H I F P+ + L +P +RAT ++ HE+ +
Sbjct: 210 PFDDEHVPTLFKKIRGG---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
Query: 240 RH 241
+
Sbjct: 267 QD 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 47/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + VVK+YG + ++ +EYC G + D + + E + + G
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YLH HRD +K N+LL+ +
Sbjct: 118 VVYLHGIGITHRD---------------------------------IKPENLLLDERDNL 144
Query: 121 KLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEG 177
K++DFG+A +R N + GT ++APE+++ + D+WS GI M G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 178 KPPYGDIH-PMRAIFMI----PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
+ P+ + P + + + + LV+NP R T ++
Sbjct: 205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-----LALLHKILVENPSARITIPDI 259
Query: 233 LNHEFIQRH 241
+ +
Sbjct: 260 KKDRWYNKP 268
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 54/246 (21%), Positives = 82/246 (33%), Gaps = 50/246 (20%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEY-CGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH 65
P V++ + +V+E A + D + + L E + +++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH 156
Query: 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLAD 124
R +HRD +K NIL++ G AKL D
Sbjct: 157 SRGVVHRD---------------------------------IKDENILIDLRRGCAKLID 183
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKPPYGD 183
FG L D GT + PE I Y A +WSLGI +M G P+
Sbjct: 184 FGSGALLHDEPYT--DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
Query: 184 IHP-MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242
+ A P +P+ + RCL P R + E+L ++Q
Sbjct: 242 DQEILEAELHFPAHV----------SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
Query: 243 TDPSQN 248
D N
Sbjct: 292 EDVPLN 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 47/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + VVK+YG + ++ +EYC G + D + + E + + G
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YLH HRD +K N+LL+ +
Sbjct: 118 VVYLHGIGITHRD---------------------------------IKPENLLLDERDNL 144
Query: 121 KLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEG 177
K++DFG+A +R N + GT ++APE+++ + D+WS GI M G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 178 KPPYGDIH-PMRAIFMI----PTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
+ P+ + P + + + + LV+NP R T ++
Sbjct: 205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-----LALLHKILVENPSARITIPDI 259
Query: 233 LNHEFIQRH 241
+ +
Sbjct: 260 KKDRWYNKP 268
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 61/257 (23%), Positives = 95/257 (36%), Gaps = 61/257 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ P +V++ T L I+MEY G + + + + SEDE L G
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSG 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL--NTEG 118
+ Y H + HRD LK N LL +
Sbjct: 129 VSYCHSMQICHRD---------------------------------LKLENTLLDGSPAP 155
Query: 119 HAKLADFGV-AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAE 176
K+ DFG + + K + +GTP ++APEV+ YD +AD+WS G+T M
Sbjct: 156 RLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 177 GKPPYGDIHPM-----------RAIFMIPTKPPPSFREPDVW-TPEFIDFVSRCLVKNPE 224
G P+ D + IP D+ +PE +SR V +P
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIP---------DDIRISPECCHLISRIFVADPA 264
Query: 225 ERATASEMLNHEFIQRH 241
R + E+ H + ++
Sbjct: 265 TRISIPEIKTHSWFLKN 281
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 62/280 (22%), Positives = 104/280 (37%), Gaps = 75/280 (26%)
Query: 1 MQQCDSPYVVK-----YYGSYFKNTDLWIVMEYCGAGSVSDIMRL----RKKTLSEDEIA 51
++ + P VV+ + + +V E+ D+ L + I
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIK 123
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
++ L+GL++LH +HRD LK N
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRD---------------------------------LKPEN 150
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLG-IT 170
IL+ + G KLADFG+A + MA V+ T ++ APEV+ + Y DMWS+G I
Sbjct: 151 ILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 171 ALEMAEGKPPY---GDIHPMRAIFMI--------------------PTKPPPSFRE--PD 205
A EM KP + + + IF + P + P + P+
Sbjct: 210 A-EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE 268
Query: 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
+ + L NP +R +A L H ++ + + +P
Sbjct: 269 M-EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 60/273 (21%), Positives = 98/273 (35%), Gaps = 69/273 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
+++ +VK Y L +V E+ D ++ + + L + L
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L G+ Y H RR +HRD LK N+L+N E
Sbjct: 110 LNGIAYCHDRRVLHRD---------------------------------LKPQNLLINRE 136
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAE 176
G K+ADFG+A + K I T ++ AP+V+ Y D+WS+G EM
Sbjct: 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 177 GKPPY---GDIHPMRAIFMI----------------------PTKPPPSFRE--PDVWTP 209
G P + + + IF I P + +
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL-DE 255
Query: 210 EFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242
ID +S+ L +P +R TA + L H + + ++
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 39/242 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++ P+++K Y +D+++VMEY G + D + + L E E + L G
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSG 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++Y H +HRD LK N+LL+ +A
Sbjct: 129 VDYCHRHMVVHRD---------------------------------LKPENVLLDAHMNA 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-CVADMWSLGITALEMAEGKP 179
K+ADFG++ ++D T G+P + APEVI Y D+WS G+ + G
Sbjct: 156 KIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P+ D H I F P P I + L +P +RAT ++ HE+ +
Sbjct: 215 PFDDDHVPTLFKKICDG---IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
Query: 240 RH 241
+
Sbjct: 272 QD 273
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 57/268 (21%), Positives = 91/268 (33%), Gaps = 68/268 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
+++ +V+ + + L +V E+C D L + + + L
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
LKGL + H R +HRD LK N+L+N
Sbjct: 111 LKGLGFCHSRNVLHRD---------------------------------LKPQNLLINRN 137
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAE 176
G KLA+FG+A + + + T ++ P+V+ Y DMWS G E+A
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 177 GKPPY----GDIHPMRAIFMI---PT-------------KPPPSFREPDVWTPEF----- 211
P ++ IF + PT KP P +
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 212 --IDFVSRCLVKNPEERATASEMLNHEF 237
D + L NP +R +A E L H +
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 58/271 (21%), Positives = 96/271 (35%), Gaps = 73/271 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q +V K ++V E+ ++ D + L L + L + G
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ + H IHRD +K NIL++ G
Sbjct: 137 IGFCHSHNIIHRD---------------------------------IKPENILVSQSGVV 163
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLG-ITALEMAE 176
KL DFG A L + + T ++ APE++ +G Y D+W++G + EM
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELL--VGDVKYGKAVDVWAIGCLVT-EMFM 220
Query: 177 GKP--PYGD--IHPMRAIFMI---PT---------------------KPPPSFRE--PDV 206
G+P P GD I + I M K P
Sbjct: 221 GEPLFP-GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK- 278
Query: 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ ID +CL +P++R +E+L+H+F
Sbjct: 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 72/278 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
+++ P +V L +V E+ D ++ K L + +I L
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+G+ + H R +HRD LK N+L+N++
Sbjct: 129 LRGVAHCHQHRILHRD---------------------------------LKPQNLLINSD 155
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAE 176
G KLADFG+A + + T ++ AP+V+ Y D+WS+G EM
Sbjct: 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
Query: 177 GKPPY---GDIHPMRAIFMI-----------------------PTKPPPSFRE--PDVWT 208
GKP + D + IF I + P
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF-C 274
Query: 209 PEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246
E ID +S L +P +R +A + +NH + + D DP
Sbjct: 275 QEGIDLLSNMLCFDPNKRISARDAMNHPYFK--DLDPQ 310
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 72/255 (28%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D ++VM + D+ ++ SE++I ++ LKGL+Y+H +HRD
Sbjct: 103 DFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD------- 151
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK GN+ +N + K+ DFG+A M
Sbjct: 152 --------------------------LKPGNLAVNEDCELKILDFGLARHADAEMTGY-- 183
Query: 141 VIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAIFMI--- 193
+ T ++ APEVI + Y+ D+WS+G EM GK D + + I +
Sbjct: 184 -VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 194 ---------------------PTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATAS 230
P P F + P +P+ D + + L + ++R TA+
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKRLTAA 301
Query: 231 EMLNHEFIQR-HDTD 244
+ L H F + D +
Sbjct: 302 QALTHPFFEPFRDPE 316
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 57/270 (21%), Positives = 97/270 (35%), Gaps = 90/270 (33%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D+++VME A ++ ++ + L + ++ +L L G+++LH IHRD
Sbjct: 141 DVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD------- 189
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA------GQLTDT 134
LK NI++ ++ K+ DFG+A +T
Sbjct: 190 --------------------------LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 135 MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAIF 191
+ R ++ APEVI +GY D+WS+G EM K P D I +
Sbjct: 224 VVTR-------YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 192 MI-----------------------PTKPPPSFRE--PDVW-----------TPEFIDFV 215
P +F + PD + D +
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336
Query: 216 SRCLVKNPEERATASEMLNHEFIQR-HDTD 244
S+ LV +P +R + + L H +I +D
Sbjct: 337 SKMLVIDPAKRISVDDALQHPYINVWYDPA 366
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 90/278 (32%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
+Q+ P ++ ++ +++ +V ++ +D I++ L+ I + T
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+GLEYLH +HRD LK N+LL+
Sbjct: 122 LQGLEYLHQHWILHRD---------------------------------LKPNNLLLDEN 148
Query: 118 GHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSL 167
G KLADFG+A T + V+ T ++ APE++ G Y DMW++
Sbjct: 149 GVLKLADFGLAKSFGSPNRAYT------HQVV-TRWYRAPELL--FGARMYGVGVDMWAV 199
Query: 168 G-ITALEMAEGKP--PYG--DIHPMRAIFMI---------------------PTKPPPSF 201
G I A E+ P P G D+ + IF + P
Sbjct: 200 GCILA-ELLLRVPFLP-GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 257
Query: 202 RE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ +D + + NP R TA++ L ++
Sbjct: 258 HHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-25
Identities = 58/278 (20%), Positives = 96/278 (34%), Gaps = 87/278 (31%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q P +V + + L +V EYC +V + ++ + E + +I TL+
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ + H IHRD +K NIL+
Sbjct: 115 VNFCHKHNCIHRD---------------------------------VKPENILITKHSVI 141
Query: 121 KLADFGVA-------GQLTDTMAKRNTVIGTPFWM-APEVIQEIG---YDCVADMWSLG- 168
KL DFG A D +A R W +PE++ +G Y D+W++G
Sbjct: 142 KLCDFGFARLLTGPSDYYDDEVATR--------WYRSPELL--VGDTQYGPPVDVWAIGC 191
Query: 169 ITALEMAEGKP--PYGD--IHPMRAIFMI---PTK-----------------PPPSFREP 204
+ A E+ G P P G + + I P P EP
Sbjct: 192 VFA-ELLSGVPLWP-GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEP 249
Query: 205 -----DVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ + + CL +P ER T ++L+H +
Sbjct: 250 LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-25
Identities = 57/264 (21%), Positives = 96/264 (36%), Gaps = 78/264 (29%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
D++IVME A ++ ++ + L + ++ +L L G+++LH IHRD
Sbjct: 104 DVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD------- 152
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 140
LK NI++ ++ K+ DFG+A +
Sbjct: 153 --------------------------LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 141 VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAIFMI---- 193
V+ T ++ APEVI +GY D+WS+G EM +G P D I +
Sbjct: 187 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 194 -------------------PTKPPPSFRE-------------PDVWTPEFIDFVSRCLVK 221
P SF + + + D +S+ LV
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 222 NPEERATASEMLNHEFIQR-HDTD 244
+ +R + E L H +I +D
Sbjct: 306 DASKRISVDEALQHPYINVWYDPS 329
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-24
Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 45/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D+P+V + G +T + ++ + G + D +R K + + KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL RR +HRD L A N+L+ T H
Sbjct: 130 MNYLEDRRLVHRD---------------------------------LAARNVLVKTPQHV 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K+ DFG+A L + + G P WMA E I Y +D+WS G+T E M G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY I ++ R +P + T + + +C + + + R E+
Sbjct: 217 SKPYDGIPASEISSILEK----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL--I 270
Query: 236 EFIQRHDTDPS 246
+ DP
Sbjct: 271 IEFSKMARDPQ 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-24
Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 75/272 (27%)
Query: 1 MQQCDSPYVVK-----YYGSYFKNTDLWIVMEYCGAGSVSDIMRL----RKKTLSEDEIA 51
++ + P VV+ + T L +V E+ D+ + + + I
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIK 123
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
++ L+GL++LH R +HRD LK N
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRD---------------------------------LKPQN 150
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLG-IT 170
IL+ + G KLADFG+A + MA + V+ T ++ APEV+ + Y D+WS+G I
Sbjct: 151 ILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIF 209
Query: 171 ALEMAEGKP--P-YGDIHPMRAIFMI--------------------PTKPPPSFRE--PD 205
A EM KP D+ + I + +K + D
Sbjct: 210 A-EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 268
Query: 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ D + +CL NP +R +A L+H +
Sbjct: 269 I-DELGKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 50/251 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
++Q P +V+ G + ++IVME G +R L + ++ D G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL + IHRD+ A R N L+ +
Sbjct: 226 MEYLESKCCIHRDLAA--------R-------------------------NCLVTEKNVL 252
Query: 121 KLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K++DFG++ + D + + + P W APE + Y +D+WS GI E + G
Sbjct: 253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312
Query: 178 KPPYGDIHPMRAIFMIPT----KPPPSFREPDVWTPEFI-DFVSRCLVKNPEERATASEM 232
PY ++ + + P P+ + + +C P +R + S +
Sbjct: 313 ASPYPNLSNQQTREFVEKGGRLPCPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 233 LNH--EFIQRH 241
+RH
Sbjct: 366 YQELQSIRKRH 376
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 66/267 (24%), Positives = 101/267 (37%), Gaps = 81/267 (30%)
Query: 21 DLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
+++I+ E +D+ R + + LS+D I + TL+ ++ LH IHRD
Sbjct: 88 EVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD------ 137
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK N+L+N+ K+ DFG+A + ++ A +
Sbjct: 138 ---------------------------LKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 140 TVIGTPFWM----------APEVI-QEIGYDCVADMWSLGITALEMAEGKP--------- 179
G M APEV+ Y D+WS G E+ +P
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 180 -----------PYGD-----IHPMRAIFMI---PTKPPPSFRE--PDVWTPEFIDFVSRC 218
P+ D I RA I P P + P V P+ ID + R
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV-NPKGIDLLQRM 289
Query: 219 LVKNPEERATASEMLNHEFIQR-HDTD 244
LV +P +R TA E L H ++Q HD +
Sbjct: 290 LVFDPAKRITAKEALEHPYLQTYHDPN 316
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 55/256 (21%), Positives = 83/256 (32%), Gaps = 70/256 (27%)
Query: 7 PYVVKYYGSY----FKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLKGL 61
P++V+ Y L IVME G + I + +E E + I+ + +
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 62 EYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA- 120
+YLH HRD +K N+L ++
Sbjct: 131 QYLHSINIAHRD---------------------------------VKPENLLYTSKRPNA 157
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
KL DFG A E E YD DMWSLG+ + G
Sbjct: 158 ILKLTDFG---------------------FAKETTGE-KYDKSCDMWSLGVIMYILLCGY 195
Query: 179 PPYGDIHPMR---AIFMIPTKPPPSFREPDVW---TPEFIDFVSRCLVKNPEERATASEM 232
PP+ H + + F P+ W + E + L P +R T +E
Sbjct: 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
Query: 233 LNHEFIQRHDTDPSQN 248
+NH +I + P
Sbjct: 255 MNHPWIMQSTKVPQTP 270
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 50/263 (19%), Positives = 82/263 (31%), Gaps = 82/263 (31%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80
L++V E ++ ++ ++ +S I + L GL LH +HRD
Sbjct: 108 KLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRD------- 159
Query: 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA------GQLTDT 134
L GNILL + DF +A T
Sbjct: 160 --------------------------LHPGNILLADNNDITICDFNLAREDTADANKTHY 193
Query: 135 MAKRNTVIGTPFWM-APEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRA 189
+ R W APE++ Q G+ + DMWS G EM K + +
Sbjct: 194 VTHR--------WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 190 IF-------------------------MIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKN 222
I + P ++ P P +D +++ L N
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFN 304
Query: 223 PEERATASEMLNHEFIQR-HDTD 244
P+ R + + L H + + D
Sbjct: 305 PQRRISTEQALRHPYFESLFDPL 327
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 83/261 (31%)
Query: 21 DLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D ++VM + G +D+ + ++ + L ED I ++ LKGL Y+H IHRD
Sbjct: 104 DFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD------ 153
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA----GQLTDTM 135
LK GN+ +N + K+ DFG+A ++T +
Sbjct: 154 ---------------------------LKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 136 AKRNTVIGTPFWM-APEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAI 190
R W APEVI + Y D+WS+G EM GK D + ++ I
Sbjct: 187 VTR--------WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 191 FMI------------------------PTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPE 224
+ P F + +P ++ + + LV + E
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA-SPLAVNLLEKMLVLDAE 297
Query: 225 ERATASEMLNHEFIQR-HDTD 244
+R TA E L H + + HDT+
Sbjct: 298 QRVTAGEALAHPYFESLHDTE 318
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 56/256 (21%), Positives = 101/256 (39%), Gaps = 73/256 (28%)
Query: 21 DLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D+++V GA D+ ++ + L++D + ++ L+GL+Y+H IHRD
Sbjct: 108 DVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD------ 157
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 139
LK N+ +N + K+ DFG+A D M
Sbjct: 158 ---------------------------LKPSNLAVNEDCELKILDFGLARHTADEMTGY- 189
Query: 140 TVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-IHPMRAIFMI-- 193
+ T ++ APE++ + Y+ D+WS+G E+ G+ P D I ++ I +
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 194 ----------------------PTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATA 229
P +F P +D + + LV + ++R TA
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITA 306
Query: 230 SEMLNHEFIQR-HDTD 244
++ L H + + HD D
Sbjct: 307 AQALAHAYFAQYHDPD 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-24
Identities = 58/279 (20%), Positives = 98/279 (35%), Gaps = 81/279 (29%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--------RKKTLSEDEIAT 52
M++ +V+ Y L +V E+ +D+ + + L + +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
L+GL + H + +HRD LK N+
Sbjct: 113 FQWQLLQGLAFCHENKILHRD---------------------------------LKPQNL 139
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI-QEIGYDCVADMWSLGI 169
L+N G KL DFG+A + + V+ T ++ AP+V+ Y D+WS G
Sbjct: 140 LINKRGQLKLGDFGLARAFGIPV-NTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGC 197
Query: 170 TALEMAEGKPPY---GDIHPMRAIFMI----------------------PTKPPPSFRE- 203
EM GKP + D ++ IF I +PP R+
Sbjct: 198 ILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQV 257
Query: 204 -----PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ +DF+ L NP+ R +A + L+H +
Sbjct: 258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-24
Identities = 57/284 (20%), Positives = 97/284 (34%), Gaps = 86/284 (30%)
Query: 1 MQQCDSPYVV--------KYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDE 49
+Q VV K +++V ++C D+ L + E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSE 125
Query: 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
I ++ L GL Y+H + +HRD +KA
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRD---------------------------------MKA 152
Query: 110 GNILLNTEGHAKLADFGVA---GQLTDTMAKR--NTVIGTPFWMAPEVI-QEIGYDCVAD 163
N+L+ +G KLADFG+A ++ R N V+ T ++ PE++ E Y D
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPID 211
Query: 164 MWSLG-ITALEMAEGKPPY---GDIHPMRAIFMI-----------------------PTK 196
+W G I A EM P + H + I +
Sbjct: 212 LWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 270
Query: 197 PPPSFRE--PDVWTPEF-IDFVSRCLVKNPEERATASEMLNHEF 237
++ + +D + + LV +P +R + + LNH+F
Sbjct: 271 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-24
Identities = 52/293 (17%), Positives = 91/293 (31%), Gaps = 94/293 (32%)
Query: 5 DSPYVVKYYGS-YFKNTDLW---IVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
+ +++K K + +V E G ++ +++ + + + + I L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 60 GLEYLHLRRK-IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
GL+Y+H R IH D +K N+L+
Sbjct: 143 GLDYMHRRCGIIHTD---------------------------------IKPENVLMEIVD 169
Query: 119 HA------KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
K+AD G A + I T + +PEV+ + C AD+WS
Sbjct: 170 SPENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 226
Query: 173 EMAEGKP---------PYGDIHPMRAIFMIPTKPPPSFRE-------------------- 203
E+ G D + I + + P
Sbjct: 227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 286
Query: 204 ------PDVWT----------PEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
DV T E DF+S L +P +RA A ++NH +++
Sbjct: 287 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-23
Identities = 53/270 (19%), Positives = 89/270 (32%), Gaps = 72/270 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD---IMRLRKKTLSEDEIATILCDT 57
++ +V + L +V EY D + ++ + L
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE 117
L+GL Y H ++ +HRD LK N+L+N
Sbjct: 110 LRGLAYCHRQKVLHRD---------------------------------LKPQNLLINER 136
Query: 118 GHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMA 175
G KLADFG+A + N V+ T ++ P+++ Y DMW +G EMA
Sbjct: 137 GELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195
Query: 176 EGKPPY---GDIHPMRAIFMI-----------------------PTKPPPSFRE--PDVW 207
G+P + + IF I P + P +
Sbjct: 196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL- 254
Query: 208 TPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ D +++ L R +A + + H F
Sbjct: 255 DSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 55/288 (19%), Positives = 100/288 (34%), Gaps = 88/288 (30%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTL 58
+++ +++ N L ++ EY +D+ + + +S I + L +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-- 116
G+ + H RR +HRD LK N+LL+
Sbjct: 143 NGVNFCHSRRCLHRD---------------------------------LKPQNLLLSVSD 169
Query: 117 ---EGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMW 165
K+ DFG+A Q T + +I T ++ PE++ Y D+W
Sbjct: 170 ASETPVLKIGDFGLARAFGIPIRQFT------HEII-TLWYRPPEILLGSRHYSTSVDIW 222
Query: 166 SLG-ITALEMAEGKPPY---GDIHPMRAIFMI----------------------PTKPPP 199
S+ I A EM P + +I + IF + P
Sbjct: 223 SIACIWA-EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK 281
Query: 200 SFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
+ + + E +D ++ L +P +R +A L H + +D DP
Sbjct: 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 62/267 (23%), Positives = 99/267 (37%), Gaps = 89/267 (33%)
Query: 21 DLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D++IV + +D+ + L+ + LS D I L L+GL+Y+H +HRD
Sbjct: 104 DVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD------ 153
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA----------G 129
LK N+LLNT K+ DFG+A G
Sbjct: 154 ---------------------------LKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 130 QLTDTMAKRNTVIGTPFWM-APEVI-QEIGYDCVADMWSLGITALEMAEGKP--PYGD-I 184
LT+ +A R W APE++ GY D+WS+G EM +P P +
Sbjct: 187 FLTEYVATR--------WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238
Query: 185 HPMRAIFMI------------------------PTKPPPSFRE--PDVWTPEFIDFVSRC 218
+ I I P K + P+ + +D + +
Sbjct: 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKM 297
Query: 219 LVKNPEERATASEMLNHEFIQR-HDTD 244
L NP +R + L H ++++ +D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYDPS 324
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-23
Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 45/252 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D+P+V + G +T + ++ + G + D +R K + + KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL RR +HRD L A N+L+ T H
Sbjct: 130 MNYLEDRRLVHRD---------------------------------LAARNVLVKTPQHV 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
K+ DFG+A L + + G P WMA E I Y +D+WS G+T E M G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY I ++ R +P + T + + +C + + + R E+
Sbjct: 217 SKPYDGIPASEISSILEK----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL--I 270
Query: 236 EFIQRHDTDPSQ 247
+ DP +
Sbjct: 271 IEFSKMARDPQR 282
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 58/287 (20%), Positives = 98/287 (34%), Gaps = 89/287 (31%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLK 59
+ + GS + ++IV EY +D+ L + L E+ + L+
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG- 118
GL+Y+H +HRD LK N+ +NTE
Sbjct: 132 GLKYIHSANVLHRD---------------------------------LKPANLFINTEDL 158
Query: 119 HAKLADFGVA----------GQLTDTMAKRNTVIGTPFWM-APEVI-QEIGYDCVADMWS 166
K+ DFG+A G L++ + + W +P ++ Y DMW+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTK--------WYRSPRLLLSPNNYTKAIDMWA 210
Query: 167 LGITALEMAEGKP--PYGD-IHPMRAIFMI-----------------------PTKPPPS 200
G EM GK + M+ I T+P
Sbjct: 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKP 270
Query: 201 FRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR-HDTD 244
+ P + + E +DF+ + L +P +R TA E L+H ++
Sbjct: 271 LTQLLPGI-SREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 63/265 (23%), Positives = 89/265 (33%), Gaps = 74/265 (27%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYL 64
Y G L +V++Y +V + R K+TL + + + L Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLA 123
H HRDIK N+LL+ + KL
Sbjct: 173 HSFGICHRDIKPQ---------------------------------NLLLDPDTAVLKLC 199
Query: 124 DFGVAGQLTDTMAKRNTV-IGTPFWMAPEVI-QEIGYDCVADMWSLG-ITALEMAEGKP- 179
DFG A QL + N I + ++ APE+I Y D+WS G + A E+ G+P
Sbjct: 200 DFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPI 256
Query: 180 -PYGD-----------------------IHPMRAIFMIPTKPPPSFRE---PDVWTPEFI 212
P GD ++P F P + + P PE I
Sbjct: 257 FP-GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT-PPEAI 314
Query: 213 DFVSRCLVKNPEERATASEMLNHEF 237
SR L P R T E H F
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHSF 339
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 49/251 (19%), Positives = 91/251 (36%), Gaps = 70/251 (27%)
Query: 20 TDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76
L ++MEY ++ +++ +++ + I+ + + + ++H HRDIK
Sbjct: 111 KYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169
Query: 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-KLADFGVAGQLTDTM 135
N+L+N++ + KL DFG A +L +
Sbjct: 170 Q---------------------------------NLLVNSKDNTLKLCDFGSAKKLIPSE 196
Query: 136 AKRNTV-IGTPFWMAPEVI-QEIGYDCVADMWSLG-ITALEMAEGKP------------- 179
+ I + F+ APE++ Y D+WS+G + E+ GKP
Sbjct: 197 P--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG-ELILGKPLFSGETSIDQLVR 253
Query: 180 -------P----YGDIHPMRAIFMIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEER 226
P ++P PT +R+ P+ ID + + L P+ R
Sbjct: 254 IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313
Query: 227 ATASEMLNHEF 237
E + H F
Sbjct: 314 INPYEAMAHPF 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 55/253 (21%), Positives = 87/253 (34%), Gaps = 64/253 (25%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ +VKY G +L ++MEY GS+ D ++ K+ + ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG+EYL +R IHRD L NIL+ E
Sbjct: 125 KGMEYLGTKRYIHRD---------------------------------LATRNILVENEN 151
Query: 119 HAKLADFGVAGQLTDT----MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALE 173
K+ DFG+ L K P FW APE + E + +D+WS G+ E
Sbjct: 152 RVKIGDFGLTKVLPQDKEFFKVKEPGES--PIFWYAPESLTESKFSVASDVWSFGVVLYE 209
Query: 174 M----------------AEGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFV 215
+ G G + I ++ + R PD E +
Sbjct: 210 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----NGRLPRPDGCPDEIYMIM 265
Query: 216 SRCLVKNPEERAT 228
+ C N +R +
Sbjct: 266 TECWNNNVNQRPS 278
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-22
Identities = 55/249 (22%), Positives = 90/249 (36%), Gaps = 57/249 (22%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ S ++VKY G L +VMEY +G + D ++ + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG+EYL RR +HRD L A NIL+ +E
Sbjct: 138 KGMEYLGSRRCVHRD---------------------------------LAARNILVESEA 164
Query: 119 HAKLADFGVAGQLTDT----MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALE 173
H K+ADFG+A L + + P FW APE + + + +D+WS G+ E
Sbjct: 165 HVKIADFGLAKLLPLDKDYYVVREPGQS--PIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222
Query: 174 MA-EGKPPYGDIHPMRAIFMIPTKPPPSFRE-------------PDVWTPEFIDFVSRCL 219
+ + M + P+ P E + + C
Sbjct: 223 LFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW 281
Query: 220 VKNPEERAT 228
+P++R +
Sbjct: 282 APSPQDRPS 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-22
Identities = 55/253 (21%), Positives = 87/253 (34%), Gaps = 64/253 (25%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ +VKY G +L ++MEY GS+ D ++ K+ + ++
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG+EYL +R IHRD L NIL+ E
Sbjct: 156 KGMEYLGTKRYIHRD---------------------------------LATRNILVENEN 182
Query: 119 HAKLADFGVAGQLTDT----MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALE 173
K+ DFG+ L K P FW APE + E + +D+WS G+ E
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGES--PIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 174 M----------------AEGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFV 215
+ G G + I ++ + R PD E +
Sbjct: 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----NGRLPRPDGCPDEIYMIM 296
Query: 216 SRCLVKNPEERAT 228
+ C N +R +
Sbjct: 297 TECWNNNVNQRPS 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 48/252 (19%), Positives = 88/252 (34%), Gaps = 63/252 (25%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ +VKY G + + ++ME+ +GS+ + + K ++ +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
KG++YL R+ +HRD L A N+L+ +E
Sbjct: 137 KGMDYLGSRQYVHRD---------------------------------LAARNVLVESEH 163
Query: 119 HAKLADFGVAGQLTDT----MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALE 173
K+ DFG+ + K + P FW APE + + + +D+WS G+T E
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKDDRDS--PVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 174 M---------------AEGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVS 216
+ P +G + R + + R P E +
Sbjct: 222 LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE----GKRLPCPPNCPDEVYQLMR 277
Query: 217 RCLVKNPEERAT 228
+C P R +
Sbjct: 278 KCWEFQPSNRTS 289
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 57/251 (22%), Positives = 91/251 (36%), Gaps = 45/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ D ++V+ G ++ L +V +Y GS+ D +R + L + KG
Sbjct: 69 IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +HR+ L A N+LL +
Sbjct: 128 MYYLEEHGMVHRN---------------------------------LAARNVLLKSPSQV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIG-TPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEG 177
++ADFGVA L + TP WMA E I Y +D+WS G+T E M G
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY + ++ R +P + T + + +C + + R T E+
Sbjct: 215 AEPYAGLRLAEVPDLLEK----GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL--A 268
Query: 236 EFIQRHDTDPS 246
R DP
Sbjct: 269 NEFTRMARDPP 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 55/250 (22%), Positives = 95/250 (38%), Gaps = 44/250 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+Q D P++VK G +N +WI+ME C G + +++RK +L +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YL +R +HRD + A N+L+++
Sbjct: 504 LAYLESKRFVHRD---------------------------------IAARNVLVSSNDCV 530
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EGK 178
KL DFG++ + D+ + + P WMAPE I + +D+W G+ E+ G
Sbjct: 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
P+ + I I R P P +++C +P R +E+
Sbjct: 591 KPFQGVKNNDVIGRIENG----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL--KA 644
Query: 237 FIQRHDTDPS 246
+ +
Sbjct: 645 QLSTILEEEK 654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 67/267 (25%), Positives = 93/267 (34%), Gaps = 78/267 (29%)
Query: 8 YVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYL 64
G L +V+EY +V R K+T+ I + L+ L Y+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLA 123
H HRDIK N+LL+ G KL
Sbjct: 158 HSIGICHRDIKPQ---------------------------------NLLLDPPSGVLKLI 184
Query: 124 DFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEIG---YDCVADMWSLG-ITALEMAEGK 178
DFG A L + N I + ++ APE+I G Y D+WS G + A E+ +G+
Sbjct: 185 DFGSAKILIAG--EPNVSYICSRYYRAPELI--FGATNYTTNIDIWSTGCVMA-ELMQGQ 239
Query: 179 P--PYGD-----------------------IHPMRAIFMIPTKPPPSFRE---PDVWTPE 210
P P G+ ++P P P F + P P+
Sbjct: 240 PLFP-GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT-PPD 297
Query: 211 FIDFVSRCLVKNPEERATASEMLNHEF 237
ID +SR L P R TA E L H F
Sbjct: 298 AIDLISRLLEYTPSARLTAIEALCHPF 324
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-21
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 37/189 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q +++ G K + I+ EY G++ +R + S ++ +L G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 160 MKYLANMNYVHRD---------------------------------LAARNILVNSNLVC 186
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L D T G W APE I + +D+WS GI E M
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246
Query: 177 GKPPYGDIH 185
G+ PY ++
Sbjct: 247 GERPYWELS 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 59/259 (22%), Positives = 86/259 (33%), Gaps = 75/259 (28%)
Query: 17 FKNTDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLHLRRK--IH 71
++ L +VMEY ++ R R+ I L ++ + LHL H
Sbjct: 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154
Query: 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQ 130
RDIK N+L+N G KL DFG A +
Sbjct: 155 RDIKPH---------------------------------NVLVNEADGTLKLCDFGSAKK 181
Query: 131 LTDTMAKRNTV-IGTPFWMAPEVI-QEIGYDCVADMWSLG-ITALEMAEGKP-------- 179
L+ + N I + ++ APE+I Y D+WS+G I A EM G+P
Sbjct: 182 LSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIFRGDNSA 238
Query: 180 ------------P----YGDIHPMRAIFMIPTKPPPSFRE--PDVWT---PEFIDFVSRC 218
P ++P + + D E D +S
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 219 LVKNPEERATASEMLNHEF 237
L PEER E L H +
Sbjct: 299 LQYLPEERMKPYEALCHPY 317
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-20
Identities = 55/278 (19%), Positives = 85/278 (30%), Gaps = 67/278 (24%)
Query: 24 IVMEYCGAGSVSDIM-RLRKKTLSEDEIATILCDTLKGLEYLHLRRK-IHRDIKAG---- 77
+V E G + + + + L + I+ L+GL+YLH + + IH DIK
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180
Query: 78 ------------SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADF 125
T V T F + + K+AD
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240
Query: 126 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPY---- 181
G A + I T + + EV+ GY+ AD+WS A E+A G +
Sbjct: 241 GNACWVHK---HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297
Query: 182 -GDIHPMRAIF--MIPT--KPPPSF------------------REPDVWTP--------- 209
+ +I K P +
Sbjct: 298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK 357
Query: 210 ---------EFIDFVSRCLVKNPEERATASEMLNHEFI 238
F DF+ L PE+RATA+E L H ++
Sbjct: 358 YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 37/188 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P +++ G + IV EY GS+ +R + ++ +L G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +HRD L A N+L+++
Sbjct: 164 MRYLSDLGYVHRD---------------------------------LAARNVLVDSNLVC 190
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L D T G W APE I + +D+WS G+ E +A
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY 250
Query: 177 GKPPYGDI 184
G+ PY ++
Sbjct: 251 GERPYWNM 258
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-20
Identities = 50/249 (20%), Positives = 85/249 (34%), Gaps = 59/249 (23%)
Query: 1 MQQCDSPYVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
++ +++KY G L +VMEY GS+ D L + ++ ++
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQIC 144
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+G+ YLH + IHRD L A N+LL+ +
Sbjct: 145 EGMAYLHAQHYIHRD---------------------------------LAARNVLLDNDR 171
Query: 119 HAKLADFGVAGQLTDT----MAKRNTVIGTP-FWMAPEVIQEIGYDCVADMWSLGITALE 173
K+ DFG+A + + + + P FW APE ++E + +D+WS G+T E
Sbjct: 172 LVKIGDFGLAKAVPEGHEYYRVREDGDS--PVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 174 MAE-GKPPYGDIHPMRAIFMIPTKPPPSFRE-------------PDVWTPEFIDFVSRCL 219
+ + I + + PD E + C
Sbjct: 230 LLTHCDSSQSPPTKFLELIGIA-QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCW 288
Query: 220 VKNPEERAT 228
R T
Sbjct: 289 ETEASFRPT 297
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-20
Identities = 49/234 (20%), Positives = 82/234 (35%), Gaps = 43/234 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D +++ YG + +V E GS+ D +R + ++ +G
Sbjct: 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +R IHRD L A N+LL T
Sbjct: 134 MGYLESKRFIHRD---------------------------------LAARNLLLATRDLV 160
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEMA-E 176
K+ DFG+ L W APE ++ + +D W G+T EM
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 220
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
G+ P+ ++ + + I R P+ + + + +C PE+R T
Sbjct: 221 GQEPWIGLNGSQILHKIDK---EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 42/233 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLK 59
M++ P +V+ G + +I+ E+ G++ D +R ++ +S + +
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+EYL + IHR+ L A N L+
Sbjct: 330 AMEYLEKKNFIHRN---------------------------------LAARNCLVGENHL 356
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG++ +T + P W APE + + +D+W+ G+ E+A G
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
PY I + ++ +R P+ + + + C NP +R +
Sbjct: 417 MSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPS 465
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 48/188 (25%), Positives = 75/188 (39%), Gaps = 37/188 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P +++ G K+ + IV EY GS+ +R + ++ +L G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 160 MKYLSDMGYVHRD---------------------------------LAARNILINSNLVC 186
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG+ L D T G W +PE I + +D+WS GI E M+
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 177 GKPPYGDI 184
G+ PY ++
Sbjct: 247 GERPYWEM 254
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 9e-20
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 38/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D+PY+V+ G L +VME G G + + +++ + +A +L G
Sbjct: 390 MHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 448
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL + +HR+ L A N+LL +A
Sbjct: 449 MKYLEEKNFVHRN---------------------------------LAARNVLLVNRHYA 475
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L + + W APE I + +D+WS G+T E ++
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535
Query: 177 GKPPYGDI 184
G+ PY +
Sbjct: 536 GQKPYKKM 543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-19
Identities = 21/236 (8%), Positives = 51/236 (21%), Gaps = 71/236 (30%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
D P V + +V E+ GS+ ++ S + +
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA 145
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H + ++ +G LA
Sbjct: 146 HRAGVALSIDHPS---------------------------------RVRVSIDGDVVLAY 172
Query: 125 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDI 184
P+ D+ +G + + + P +
Sbjct: 173 PATMPDAN-----------------PQ----------DDIRGIGASLYALLVNRWPLPEA 205
Query: 185 HPMRAIFMIPTK-----PPPSFREPDVWTPEFIDFVSRCLVKNPEER--ATASEML 233
+ P+ + D+ + +R + + R +T ++
Sbjct: 206 GVRSGLAPAERDTAGQPIEPADIDRDI-PFQISAVAARSVQGDGGIRSASTLLNLM 260
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 58/280 (20%)
Query: 5 DSPYVVKYYGS-YFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLE 62
++ +VKY+G + + + ++ E G S+ +I+ ++I + LK L
Sbjct: 94 NNNNIVKYHGKFMYYD-HMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKL 122
YL H D+K + L + I +T+ ++R K+ I KL
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI--------KL 203
Query: 123 ADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA------- 175
DFG A +D ++I T + APEVI +G+D +DMWS G E+
Sbjct: 204 IDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 176 --------------EGKPP--------------YGDIHPMRAIFMIPTKPPPSFREPDVW 207
P Y + ++ + S +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 208 TP--------EFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
P F DF+ L +P R + +E+L H+F++
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 39/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +V+ YG + + +V E+ G +SD +R ++ + + + + D +G
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL IHRD L A N L+
Sbjct: 117 MAYLEEACVIHRD---------------------------------LAARNCLVGENQVI 143
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG+ + D +T GT F W +PEV Y +D+WS G+ E +E
Sbjct: 144 KVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201
Query: 177 GKPPYGDI 184
GK PY +
Sbjct: 202 GKIPYENR 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 39/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +VK+YG K ++IV EY G + + +R K L ++ + D +G
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ +L + IHRD L A N L++ +
Sbjct: 117 MAFLESHQFIHRD---------------------------------LAARNCLVDRDLCV 143
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG+ + D + GT F W APEV Y +D+W+ GI E +
Sbjct: 144 KVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201
Query: 177 GKPPYGDI 184
GK PY
Sbjct: 202 GKMPYDLY 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-19
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 38/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D+PY+V+ G L +VME G G + + +++ + +A +L G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL + +HRD L A N+LL +A
Sbjct: 123 MKYLEEKNFVHRD---------------------------------LAARNVLLVNRHYA 149
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L + + W APE I + +D+WS G+T E ++
Sbjct: 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 209
Query: 177 GKPPYGDI 184
G+ PY +
Sbjct: 210 GQKPYKKM 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 45/253 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M++ +V+ Y + ++IV EY GS+ D ++ K L ++ +
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ Y+ +HRD L+A NIL+
Sbjct: 292 GMAYVERMNYVHRD---------------------------------LRAANILVGENLV 318
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D P W APE + +D+WS GI E+ +G
Sbjct: 319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ PY + + + +R P D + +C K PEER T +
Sbjct: 379 RVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL--Q 432
Query: 236 EFIQRHDTDPSQN 248
F++ + T
Sbjct: 433 AFLEDYFTSTEPQ 445
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 39/188 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +V+ YG K ++I+ EY G + + +R + ++ + D +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL ++ +HRD L A N L+N +G
Sbjct: 133 MEYLESKQFLHRD---------------------------------LAARNCLVNDQGVV 159
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ + D + G+ F W PEV+ + +D+W+ G+ E +
Sbjct: 160 KVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217
Query: 177 GKPPYGDI 184
GK PY
Sbjct: 218 GKMPYERF 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 45/253 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M++ +V+ Y + ++IV EY GS+ D ++ K L ++ +
Sbjct: 316 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ Y+ +HRD L+A NIL+
Sbjct: 375 GMAYVERMNYVHRD---------------------------------LRAANILVGENLV 401
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D P W APE + +D+WS GI E+ +G
Sbjct: 402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
+ PY + + + +R P D + +C K PEER T +
Sbjct: 462 RVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL--Q 515
Query: 236 EFIQRHDTDPSQN 248
F++ + T
Sbjct: 516 AFLEDYFTSTEPQ 528
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 65/341 (19%), Positives = 107/341 (31%), Gaps = 136/341 (39%)
Query: 1 MQQCDSPYVVKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMRLRKK--TLSEDEIATI 53
+ + + +VVK K +L++V+E SD +L + L+E I T+
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTL 161
Query: 54 LCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
L + L G++Y+H +HRD LK N L
Sbjct: 162 LYNLLVGVKYVHSAGILHRD---------------------------------LKPANCL 188
Query: 114 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM------------------------- 148
+N + K+ DFG+A + + + +P
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 149 --APEVI-QEIGYDCVADMWSLG-ITALEM-----------AEGKP-------------- 179
APE+I + Y D+WS+G I A E+ A+ P
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFA-ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQ 307
Query: 180 ---------PYGDIHPMRAIF------------------------MIPTKPPPSFRE--P 204
G+ + IF + P + E P
Sbjct: 308 KAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367
Query: 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR-HDTD 244
+ + I + R LV NP +R T +E L H F + +
Sbjct: 368 AS-SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 62/304 (20%), Positives = 98/304 (32%), Gaps = 98/304 (32%)
Query: 5 DSPYVVKYYGS-YFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLE 62
++ V+ + F+N + + E ++ ++++ K + S + L+ L+
Sbjct: 157 NTMNVIHMLENFTFRN-HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-- 120
LH R IH D LK NILL +G +
Sbjct: 215 ALHKNRIIHCD---------------------------------LKPENILLKQQGRSGI 241
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE------- 173
K+ DFG + + T I + F+ APEVI Y DMWSLG E
Sbjct: 242 KVIDFGSSCYEHQRV---YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 174 ------------MAE--GKPP-----------------------YGDIHPMRAIFMIPTK 196
M E G P ++ + +
Sbjct: 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 197 P-------PPSFRE-----PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244
PP RE P F+DF+ +CL +P R T + L H +++R
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418
Query: 245 PSQN 248
P
Sbjct: 419 PPTG 422
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 44/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+Q D P++VK G +N +WI+ME C G + +++RK +L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YL +R +HRD + A N+L+++
Sbjct: 129 LAYLESKRFVHRD---------------------------------IAARNVLVSSNDCV 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALE-MAEGK 178
KL DFG++ + D+ + + P WMAPE I + +D+W G+ E + G
Sbjct: 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236
P+ + I I R P P +++C +P R +E+
Sbjct: 216 KPFQGVKNNDVIGRIEN----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL--KA 269
Query: 237 FIQRHDTDPSQ 247
+ +
Sbjct: 270 QLSTILEEEKA 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 58/293 (19%), Positives = 93/293 (31%), Gaps = 107/293 (36%)
Query: 21 DLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79
D+++V +Y +D+ +R L ++ +K ++YLH +HRD
Sbjct: 85 DVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRD------ 134
Query: 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA----------- 128
+K NILLN E H K+ADFG++
Sbjct: 135 ---------------------------MKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 129 -GQLTDTMAKRNTVIGTPFWM---------APEVI-QEIGYDCVADMWSLG-ITALEMAE 176
L+ N P APE++ Y DMWSLG I E+
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILC 226
Query: 177 GKP--PYGD-IHPMRAIFMI------------------------PTKPPPSFREPDVW-- 207
GKP P ++ + I + K
Sbjct: 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 208 ---------------TPEFIDFVSRCLVKNPEERATASEMLNHEFIQR-HDTD 244
E +D + + L NP +R +A++ L H F+ H+ +
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 58/303 (19%), Positives = 87/303 (28%), Gaps = 105/303 (34%)
Query: 5 DSPYVVKYYGS-YFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLE 62
Y+V F+N L +V E ++ D++R +S + L
Sbjct: 114 MKYYIVHLKRHFMFRN-HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 63 YLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+L IH D LK NILL +
Sbjct: 172 FLATPELSIIHCD---------------------------------LKPENILLCNPKRS 198
Query: 121 --KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA--- 175
K+ DFG + QL + I + F+ +PEV+ + YD DMWSLG +EM
Sbjct: 199 AIKIVDFGSSCQLGQRI---YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 176 ------------------EGKPP-----------------------------------YG 182
G PP
Sbjct: 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 183 DIHPMRAIFMIPTKPPPSFREPDVWT-----PEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ I + T P R + +F D + R L +P+ R L H F
Sbjct: 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375
Query: 238 IQR 240
++
Sbjct: 376 FKK 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 45/234 (19%), Positives = 83/234 (35%), Gaps = 75/234 (32%)
Query: 43 KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYK 102
+TL++ +I + + LK L+Y H +HRD
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRD----------------------------- 155
Query: 103 TLFRLKAGNILLNTEGHA-KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGY 158
+K N++++ E +L D+G+A + + N + + ++ PE++ Q Y
Sbjct: 156 ----VKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQM--Y 208
Query: 159 DCVADMWSLGITALEMAEGKPPY--GD--IHPMRAIF----------------------- 191
D DMWSLG M K P+ G + I
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268
Query: 192 --MIPTKPPPSFRE------PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
++ + + +PE +DF+ + L + + R TA E + H +
Sbjct: 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 45/234 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQ D+PY+V+ G + +VME G ++ ++ + + + + I ++ G
Sbjct: 72 MQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMG 129
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A N+LL T+ +A
Sbjct: 130 MKYLEESNFVHRD---------------------------------LAARNVLLVTQHYA 156
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MAE 176
K++DFG++ L + W APE I + +D+WS G+ E +
Sbjct: 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
G+ PY + M+ R P E D ++ C + E R
Sbjct: 217 GQKPYRGMKGSEVTAMLEK----GERMGCPAGCPREMYDLMNLCWTYDVENRPG 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 60/311 (19%), Positives = 96/311 (30%), Gaps = 129/311 (41%)
Query: 21 DLWIVMEYCGAGSVSDIMRLRKK--TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78
+L+IV+E SD+ +L K L+E+ I TIL + L G ++H IHRD
Sbjct: 104 ELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRD----- 154
Query: 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVA---------- 128
LK N LLN + K+ DFG+A
Sbjct: 155 ----------------------------LKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 129 --GQLTDTMAKRNTVIGTPFWM----------APEVI-QEIGYDCVADMWSLG-ITALEM 174
L + + APE+I + Y D+WS G I
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI----F 242
Query: 175 AE----------------------------------------------------GKPPYG 182
AE G P
Sbjct: 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302
Query: 183 DIHPMRA------IFMIPTKPPPSFRE--PDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
D+ + I + P + P + ++ P + + + I+ + L NP +R T + L+
Sbjct: 303 DLKNINKPEVIKYIKLFPHRKPINLKQKYPSI-SDDGINLLESMLKFNPNKRITIDQALD 361
Query: 235 HEFIQR-HDTD 244
H +++
Sbjct: 362 HPYLKDVRKKK 372
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-17
Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 40/188 (21%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+ D P++VK G + WI+ME G + + K +L + K
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +HRD + NIL+ +
Sbjct: 126 MAYLESINCVHRD---------------------------------IAVRNILVASPECV 152
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEMA-E 176
KL DFG++ + D + + T WM+PE I + +D+W + E+
Sbjct: 153 KLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210
Query: 177 GKPPYGDI 184
GK P+ +
Sbjct: 211 GKQPFFWL 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 46/235 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTLK 59
M++ P +V+ G + +I+ E+ G++ D +R ++ +S + +
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+EYL + IHRD L A N L+
Sbjct: 123 AMEYLEKKNFIHRD---------------------------------LAARNCLVGENHL 149
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-MA 175
K+ADFG++ +T + G F W APE + + +D+W+ G+ E
Sbjct: 150 VKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
G PY I + ++ +R P+ + + + C NP +R +
Sbjct: 208 YGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPS 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 52/251 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTL 58
M Q +V+ G + L+IV EY GS+ D +R R + L D + D
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+ +EYL +HRD L A N+L++ +
Sbjct: 300 EAMEYLEGNNFVHRD---------------------------------LAARNVLVSEDN 326
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALEMA 175
AK++DFG+ + + T W APE ++E + +D+WS GI E+
Sbjct: 327 VAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 176 -EGKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATASEM 232
G+ PY I + + ++ PD P D + C + R T ++
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436
Query: 233 LNH-EFIQRHD 242
E I+ H+
Sbjct: 437 REQLEHIRTHE 447
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-17
Identities = 44/281 (15%), Positives = 81/281 (28%), Gaps = 66/281 (23%)
Query: 5 DSPYVVKYYGS-YFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLE 62
+ V F + I E G + + ++ + + + L
Sbjct: 80 NKFLCVLMSDWFNFHG-HMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 63 YLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA-- 120
+LH + H D+K N++ + + + +
Sbjct: 138 FLHENQLTHTDLKPE----------------NILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP- 179
++ADFG A + T++ T + PEVI E+G+ D+WS+G E G
Sbjct: 182 RVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 180 ---------------------------------------PYGDIHPMRAIFMIPTKPPPS 200
+ + KP S
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 201 -FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
+ + + D + R L +P +R T +E L H F
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 52/306 (16%), Positives = 94/306 (30%), Gaps = 110/306 (35%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRL-----------RKKTLSE 47
+++ P V+ + + D +W++ +Y D+ + + L
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPR 127
Query: 48 DEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRL 107
+ ++L L G+ YLH +HRD L
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRD---------------------------------L 154
Query: 108 KAGNILLNTE----GHAKLADFGVA---GQLTDTMAKRNTVIGTPFWM-APEVIQEIG-- 157
K NIL+ E G K+AD G A +A + V+ T FW APE++ +G
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-FWYRAPELL--LGAR 211
Query: 158 -YDCVADMWSLG-ITALEMAEGKP------------PYGDIHPMRAIFMI---PT----- 195
Y D+W++G I A E+ +P + IF + P
Sbjct: 212 HYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 270
Query: 196 -----------------KPPPSFREPDVWTPEF-------IDFVSRCLVKNPEERATASE 231
+ + + L +P +R T+ +
Sbjct: 271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330
Query: 232 MLNHEF 237
+ +
Sbjct: 331 AMQDPY 336
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-17
Identities = 48/236 (20%), Positives = 87/236 (36%), Gaps = 49/236 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
M+ P V+ G ++ +V+ Y G + + +R + ++ K
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G++YL ++ +HRD L A N +L+ +
Sbjct: 140 GMKYLASKKFVHRD---------------------------------LAARNCMLDEKFT 166
Query: 120 AKLADFGVAGQL--TDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALE-M 174
K+ADFG+A + + + N P WMA E +Q + +D+WS G+ E M
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 175 AEGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVSRCLVKNPEER 226
G PPY D++ + P + P+ + + + +C E R
Sbjct: 227 TRGAPPYPDVNTFDITVYLLQGRRLLQPEY------CPDPLYEVMLKCWHPKAEMR 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-17
Identities = 41/271 (15%), Positives = 78/271 (28%), Gaps = 70/271 (25%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + ++V YG + +V E+ GS+ ++ K ++ +
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH- 119
+ +L IH + + A NILL E
Sbjct: 126 MHFLEENTLIHGN---------------------------------VCAKNILLIREEDR 152
Query: 120 -------AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIG-YDCVADMWSLGIT 170
KL+D G++ + + W+ PE I+ + D WS G T
Sbjct: 153 KTGNPPFIKLSDPGISITVLPKDILQ-----ERIPWVPPECIENPKNLNLATDKWSFGTT 207
Query: 171 ALE-MAEGKPPYGDIHPMRAIFMIPT-----KPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
E + G P + R + P E + ++ C+ P+
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKA---------AELANLINNCMDYEPD 258
Query: 225 ER-------ATASEMLNHEFIQRHDTDPSQN 248
R + + + + R +
Sbjct: 259 HRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH 289
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-17
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 43/233 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLK 59
M+ +VK + K ++I+ E+ GS+ D ++ + + ++ +
Sbjct: 237 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ ++ R IHRD L+A NIL++
Sbjct: 296 GMAFIEQRNYIHRD---------------------------------LRAANILVSASLV 322
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D P W APE I + +D+WS GI +E+ G
Sbjct: 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERAT 228
+ PY + I + +R P+ E + + RC PEER T
Sbjct: 383 RIPYPGMSNPEVIRALERG----YRMPRPENCPEELYNIMMRCWKNRPEERPT 431
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 46/235 (19%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
M+ P V+ G ++ +V+ Y G + + +R + ++ K
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+++L ++ +HRD L A N +L+ +
Sbjct: 204 GMKFLASKKFVHRD---------------------------------LAARNCMLDEKFT 230
Query: 120 AKLADFGVAGQL--TDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALE-M 174
K+ADFG+A + + + N P WMA E +Q + +D+WS G+ E M
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 175 AEGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEER 226
G PPY D++ + P + ++ + + +C E R
Sbjct: 291 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMR 340
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 45/191 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTL 58
M Q +V+ G + L+IV EY GS+ D +R R + L D + D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+ +EYL +HRD L A N+L++ +
Sbjct: 128 EAMEYLEGNNFVHRD---------------------------------LAARNVLVSEDN 154
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWSLGITALE-M 174
AK++DFG+ + + T W APE ++E + +D+WS GI E
Sbjct: 155 VAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
Query: 175 AEGKPPYGDIH 185
+ G+ PY I
Sbjct: 209 SFGRVPYPRIP 219
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-16
Identities = 51/285 (17%), Positives = 80/285 (28%), Gaps = 74/285 (25%)
Query: 5 DSPYVVKYYGS-YFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLKGLE 62
+ V+ + IV E G S D ++ D I + K +
Sbjct: 75 STFRCVQMLEWFEHHG-HICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 63 YLHLRRKIHRDIK------AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+LH + H D+K S + +I I
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI---------------- 176
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K+ DFG A + +T++ T + APEVI +G+ D+WS+G +E
Sbjct: 177 ----KVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 177 GKP----------------------------------------PYGDIHPMRAIFMIPTK 196
G + + K
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 197 PPPSF-REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
P F DV D + + L +P +R T E L H F
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-16
Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 37/187 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M+Q +V+ Y + ++I+ EY GS+ D ++ L+ +++ + +
Sbjct: 62 MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ ++ R IHRD L+A NIL++
Sbjct: 121 GMAFIEERNYIHRD---------------------------------LRAANILVSDTLS 147
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D P W APE I + +D+WS GI E+ G
Sbjct: 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 178 KPPYGDI 184
+ PY +
Sbjct: 208 RIPYPGM 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 46/237 (19%), Positives = 86/237 (36%), Gaps = 47/237 (19%)
Query: 1 MQQCDSPYVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
M+ + P V+ G +++ Y G + +R ++ + ++ + +
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+EYL ++ +HRD L A N +L+
Sbjct: 136 GMEYLAEQKFVHRD---------------------------------LAARNCMLDESFT 162
Query: 120 AKLADFGVAGQL--TDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLGITALEMA 175
K+ADFG+A + + + + P W A E +Q + +D+WS G+ E+
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 176 E-GKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
G PPY I P + P P + ++ + +C +P R T
Sbjct: 223 TRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPT 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 54/266 (20%), Positives = 90/266 (33%), Gaps = 65/266 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------KTLSEDEIATIL 54
+ + + +V+ G ++ +I+ME G + +R + +L+ ++ +
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
D G +YL IHRDI A R N LL
Sbjct: 147 RDIACGCQYLEENHFIHRDIAA-----------------------------R----NCLL 173
Query: 115 NTEGH---AKLADFGVAGQL--TDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWS 166
G AK+ DFG+A + K WM PE E + D WS
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGG---CAMLPVKWMPPEAFMEGIFTSKTDTWS 230
Query: 167 LGITALEMA-EGKPPYGDIHPMRAIFMIPT----KPPPSFREPDVWTPEFI-DFVSRCLV 220
G+ E+ G PY + + + PP + P + +++C
Sbjct: 231 FGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN-------CPGPVYRIMTQCWQ 283
Query: 221 KNPEERATASEMLNHEFIQRHDTDPS 246
PE+R + + E I+ DP
Sbjct: 284 HQPEDRPNFAII--LERIEYCTQDPD 307
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-14
Identities = 53/266 (19%), Positives = 90/266 (33%), Gaps = 65/266 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------KTLSEDEIATIL 54
+ + + +V+ G ++ +I++E G + +R + +L+ ++ +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
D G +YL IHRDI A R N LL
Sbjct: 188 RDIACGCQYLEENHFIHRDIAA-----------------------------R----NCLL 214
Query: 115 NTEGH---AKLADFGVAGQL--TDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWS 166
G AK+ DFG+A + K WM PE E + D WS
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRAGYYRKGG---CAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 167 LGITALEMA-EGKPPYGDIHPMRAIFMIPT----KPPPSFREPDVWTPEFI-DFVSRCLV 220
G+ E+ G PY + + + PP + P + +++C
Sbjct: 272 FGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN-------CPGPVYRIMTQCWQ 324
Query: 221 KNPEERATASEMLNHEFIQRHDTDPS 246
PE+R + + E I+ DP
Sbjct: 325 HQPEDRPNFAII--LERIEYCTQDPD 348
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-13
Identities = 46/267 (17%), Positives = 96/267 (35%), Gaps = 63/267 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMR-LRKKTLSEDEIATILCDTL- 58
M++ + +VV+ G + ++ME G + +R LR + +A +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 59 -------KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
G+ YL+ + +HRD L A N
Sbjct: 142 QMAGEIADGMAYLNANKFVHRD---------------------------------LAARN 168
Query: 112 ILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSL 167
++ + K+ DFG+ + +T ++ P WM+PE +++ + +D+WS
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--PVRWMSPESLKDGVFTTYSDVWSF 226
Query: 168 GITALEMAE-GKPPYGDIHPMRAIFMIPT----KPPPSFREPDVWTPEFI-DFVSRCLVK 221
G+ E+A + PY + + + + P + P+ + + + C
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN-------CPDMLFELMRMCWQY 279
Query: 222 NPEERATASEMLNHEFIQRHDTDPSQN 248
NP+ R + E+ I+ +
Sbjct: 280 NPKMRPSFLEI--ISSIKEEMEPGFRE 304
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 50/269 (18%), Positives = 93/269 (34%), Gaps = 60/269 (22%)
Query: 1 MQQCDSPYVVKYYG------SYFKNTDLWIVMEYCGAGSVSDIMRLRK-----KTLSEDE 49
M++ D P+V K G + + +++ + G + + + L
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
+ + D G+EYL R IHRD+ A R
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAA-----------------------------R--- 166
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSL 167
N +L + +ADFG++ ++ R P W+A E + + Y +D+W+
Sbjct: 167 -NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 168 GITALEMAE-GKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVSRCLVKN 222
G+T E+ G+ PY I + P E + D + +C +
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPE------CMEEVYDLMYQCWSAD 279
Query: 223 PEERATASE---MLNHEFIQRHDTDPSQN 248
P++R + + L + SQ+
Sbjct: 280 PKQRPSFTCLRMELENILGHLSVLSTSQD 308
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 49/269 (18%), Positives = 88/269 (32%), Gaps = 66/269 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--------------KKTLS 46
+ ++V+++G + L +V EY G ++ +R L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 47 EDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFR 106
++ + G+ YL +HRD
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRD--------------------------------- 183
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVA 162
L N L+ K+ DFG++ + T T++ P WM PE I + +
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTES 241
Query: 163 DMWSLGITALEMA-EGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVSR 217
D+WS G+ E+ GK P+ + AI I P P + +
Sbjct: 242 DVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA------CPPEVYAIMRG 295
Query: 218 CLVKNPEERATASEMLNHEFIQRHDTDPS 246
C + P++R + ++ H +Q P
Sbjct: 296 CWQREPQQRHSIKDV--HARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 46/252 (18%), Positives = 85/252 (33%), Gaps = 56/252 (22%)
Query: 1 MQQCDSPYVVKYYG-----SYFKNTDLWIVMEYCGAGSVSDIMRLRK-----KTLSEDEI 50
M+ P V++ G S +++ + G + + + K + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 51 ATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAG 110
+ D G+EYL R +HRD L A
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRD---------------------------------LAAR 176
Query: 111 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVADMWSLG 168
N +L + +ADFG++ ++ R I P W+A E + + Y +D+W+ G
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 169 ITALEMAE-GKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVSRCLVKNP 223
+T E+A G PY + + P + + + + C +P
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED------CLDELYEIMYSCWRTDP 290
Query: 224 EERATASEMLNH 235
+R T S +
Sbjct: 291 LDRPTFSVLRLQ 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-12
Identities = 34/131 (25%), Positives = 53/131 (40%), Gaps = 38/131 (29%)
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
I G+ +LH IHRDIK+ NI
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSA---------------------------------NI 164
Query: 113 LLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV-ADMWSLGI 169
LL+ AK++DFG+A + + ++GT +MAPE ++ G +D++S G+
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGV 222
Query: 170 TALEMAEGKPP 180
LE+ G P
Sbjct: 223 VLLEIITGLPA 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-12
Identities = 51/269 (18%), Positives = 84/269 (31%), Gaps = 67/269 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGS---------------VSDIMRLRKKTL 45
+ ++VK+YG L +V EY G V R K L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 46 SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLF 105
++ I G+ YL + +HRD
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRD-------------------------------- 158
Query: 106 RLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPF---WMAPEVIQEIGYDCV 161
L N L+ K+ DFG++ + T + T WM PE I +
Sbjct: 159 -LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPIRWMPPESIMYRKFTTE 215
Query: 162 ADMWSLGITALEMA-EGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFI-DFVS 216
+D+WS G+ E+ GK P+ + I I P P+ + D +
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV------CPKEVYDVML 269
Query: 217 RCLVKNPEERATASEMLNHEFIQRHDTDP 245
C + P++R E+ ++ +
Sbjct: 270 GCWQREPQQRLNIKEI--YKILHALGKAT 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 42/214 (19%), Positives = 69/214 (32%), Gaps = 57/214 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGS---------------VSDIMRLRKKTL 45
+ P VV G K+ L ++ YC G +D R K L
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 46 SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLF 105
+ ++ G+EYL +H+D
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKD-------------------------------- 153
Query: 106 RLKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPF---WMAPEVIQEIGYDC 160
L N+L+ + + K++D G+ ++ D + WMAPE I +
Sbjct: 154 -LATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG---NSLLPIRWMAPEAIMYGKFSI 209
Query: 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMI 193
+D+WS G+ E+ G PY + MI
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 46/193 (23%), Positives = 72/193 (37%), Gaps = 53/193 (27%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL-------- 58
+V G+ + ++ EYC G + + +R + + L D I T
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 59 -----KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNIL 113
+G+ +L + IHRD + A N+L
Sbjct: 170 SSQVAQGMAFLASKNCIHRD---------------------------------VAARNVL 196
Query: 114 LNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGI 169
L AK+ DFG+A + + + K N + P WMAPE I + Y +D+WS GI
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 170 TALEMAE-GKPPY 181
E+ G PY
Sbjct: 255 LLWEIFSLGLNPY 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 63/256 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGS---------------VSDIMRLRKKTLSEDEIA 51
++ G+ ++ L++++EY G+ DI R+ ++ ++ ++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
+ +G+EYL ++ IHRD L A N
Sbjct: 207 SCTYQLARGMEYLASQKCIHRD---------------------------------LAARN 233
Query: 112 ILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSL 167
+L+ K+ADFG+A + + N + P WMAPE + + Y +D+WS
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSF 291
Query: 168 GITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPE 224
G+ E+ G PY I ++ R +P T E + C P
Sbjct: 292 GVLMWEIFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPS 347
Query: 225 ERATASEMLNHEFIQR 240
+R T ++ E + R
Sbjct: 348 QRPTFKQL--VEDLDR 361
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 65/264 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIA 51
++ G+ ++ L++++EY G++ + ++ R+ + LS ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
+ +G+EYL ++ IHRD L A N
Sbjct: 195 SCAYQVARGMEYLASKKCIHRD---------------------------------LAARN 221
Query: 112 ILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPF---WMAPEVIQEIGYDCVADMWS 166
+L+ + K+ADFG+A + D K WMAPE + + Y +D+WS
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTT---NGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 167 LGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNP 223
G+ E+ G PY + ++ R +P T E + C P
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKE----GHRMDKPSNCTNELYMMMRDCWHAVP 334
Query: 224 EERATASEMLNHEFIQRHDTDPSQ 247
+R T ++ E + R S
Sbjct: 335 SQRPTFKQL--VEDLDRIVALTSN 356
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 59/266 (22%), Positives = 98/266 (36%), Gaps = 66/266 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT---------LSEDEIATILCDT 57
+V G+ ++ EYC G + + +R ++ + + ED+ + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 58 L--------KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
L KG+ +L + IHRD L A
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRD---------------------------------LAA 173
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPF-WMAPEVIQEIGYDCVADMW 165
NILL K+ DFG+A + + K N + P WMAPE I Y +D+W
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVW 231
Query: 166 SLGITALEMAE-GKPPYGDIHPMRAIF-MIPTKPPPSFR--EPDVWTPEFIDFVSRCLVK 221
S GI E+ G PY + + MI FR P+ E D + C
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG----FRMLSPEHAPAEMYDIMKTCWDA 287
Query: 222 NPEERATASEMLNHEFIQRHDTDPSQ 247
+P +R T ++ + I++ ++ +
Sbjct: 288 DPLKRPTFKQI--VQLIEKQISESTN 311
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 52/206 (25%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIA 51
P ++ G+ L++ +EY G++ D +R TLS ++
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
D +G++YL ++ IHRD L A N
Sbjct: 146 HFAADVARGMDYLSQKQFIHRD---------------------------------LAARN 172
Query: 112 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSLGIT 170
IL+ AK+ADFG++ + K + P WMA E + Y +D+WS G+
Sbjct: 173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 171 ALE-MAEGKPPYGDIHPMRAIFMIPT 195
E ++ G PY + +P
Sbjct: 231 LWEIVSLGGTPYCGMTCAELYEKLPQ 256
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 63/256 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGS---------------VSDIMRLRKKTLSEDEIA 51
++ G+ ++ L++++EY G+ DI R+ ++ ++ ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
+ +G+EYL ++ IHRD L A N
Sbjct: 161 SCTYQLARGMEYLASQKCIHRD---------------------------------LAARN 187
Query: 112 ILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYDCVADMWSL 167
+L+ K+ADFG+A + + N + P WMAPE + + Y +D+WS
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSF 245
Query: 168 GITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFR--EPDVWTPEFIDFVSRCLVKNPE 224
G+ E+ G PY I ++ R +P T E + C P
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPS 301
Query: 225 ERATASEMLNHEFIQR 240
+R T ++ E + R
Sbjct: 302 QRPTFKQL--VEDLDR 315
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-10
Identities = 54/233 (23%), Positives = 76/233 (32%), Gaps = 55/233 (23%)
Query: 26 MEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDR 85
L K L+ + + KG+E+L R+ IHRD
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD------------ 218
Query: 86 LDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT- 144
L A NILL+ + K+ DFG+A +
Sbjct: 219 ---------------------LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 145 PF-WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIF--------MIP 194
P WMAPE I + Y +D+WS G+ E+ G PY + M
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-- 315
Query: 195 TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247
R PD TPE + C P +R T SE+ E + +Q
Sbjct: 316 -------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL--VEHLGNLLQANAQ 359
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 31/133 (23%), Positives = 48/133 (36%), Gaps = 53/133 (39%)
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+GL YLH R IHRD+K+ NILL+
Sbjct: 150 RGLHYLHTRAIIHRDVKSI---------------------------------NILLDENF 176
Query: 119 HAKLADFGVAGQLTDTMAKRNT-----VIGTPFWMAPEVIQEIGYDCV------ADMWSL 167
K+ DFG++ + T+ T V GT ++ PE Y +D++S
Sbjct: 177 VPKITDFGISKKGTEL---DQTHLSTVVKGTLGYIDPE------YFIKGRLTEKSDVYSF 227
Query: 168 GITALEMAEGKPP 180
G+ E+ +
Sbjct: 228 GVVLFEVLCARSA 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 56/279 (20%), Positives = 91/279 (32%), Gaps = 77/279 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------------------ 42
M + D+P +VK G + ++ EY G +++ +R
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 43 -----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97
LS E I G+ YL R+ +HRD+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT--------------------- 202
Query: 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVI 153
R N L+ K+ADFG++ + A N I P WM PE I
Sbjct: 203 --------R----NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI--PIRWMPPESI 248
Query: 154 QEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPT----KPPPSFREPDVWT 208
Y +D+W+ G+ E+ G PY + I+ + P +
Sbjct: 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN-------C 301
Query: 209 PEFI-DFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246
P + + + C K P +R + + H +QR
Sbjct: 302 PLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCERAE 338
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 56/269 (20%), Positives = 93/269 (34%), Gaps = 67/269 (24%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL-------- 58
+V G+ + ++++ EYC G + + +R +++ SEDEI L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 59 --------------KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
KG+E+L + +HRD
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRD------------------------------- 197
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYDCVA 162
L A N+L+ K+ DFG+A + P WMAPE + E Y +
Sbjct: 198 --LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 255
Query: 163 DMWSLGITALEMAE-GKPPYGDIHPMRAIF-MIPTKPPPSFR--EPDVWTPEFIDFVSRC 218
D+WS GI E+ G PY I + +I F+ +P T E + C
Sbjct: 256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN----GFKMDQPFYATEEIYIIMQSC 311
Query: 219 LVKNPEERATASEMLNHEFIQRHDTDPSQ 247
+ +R + + F+ D +
Sbjct: 312 WAFDSRKRPSFPNL--TSFLGCQLADAEE 338
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 63/209 (30%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------------------ 42
++Q + P+V+K YG+ ++ L +++EY GS+ +R +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 43 -----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97
+ L+ ++ + +G++YL + +HRD
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD------------------------ 175
Query: 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVI 153
L A NIL+ K++DFG++ + + + + I P WMA E +
Sbjct: 176 ---------LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI--PVKWMAIESL 224
Query: 154 QEIGYDCVADMWSLGITALEMAE-GKPPY 181
+ Y +D+WS G+ E+ G PY
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 48/203 (23%), Positives = 74/203 (36%), Gaps = 57/203 (28%)
Query: 1 MQQCDS-PYVVKYYGSYFKNTD-LWIVMEYCGAGS---------------VSDIMRLRKK 43
+ VV G+ K L +++E+C G+ L K
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 44 TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKT 103
L+ + + KG+E+L R+ IHRD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRD------------------------------ 173
Query: 104 LFRLKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPF-WMAPEVIQEIGYD 159
L A NILL+ + K+ DFG+A + + K + + P WMAPE I + Y
Sbjct: 174 ---LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFDRVYT 228
Query: 160 CVADMWSLGITALEMAE-GKPPY 181
+D+WS G+ E+ G PY
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPY 251
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 36/134 (26%), Positives = 51/134 (38%), Gaps = 39/134 (29%)
Query: 53 ILCDTLKGLEYLH--LRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKA 109
I + +GL YLH KI HRD+KA
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAA-------------------------------- 163
Query: 110 GNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYDCV-ADMWSL 167
NILL+ E A + DFG+A + T V GT +APE + G D++
Sbjct: 164 -NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGY 221
Query: 168 GITALEMAEGKPPY 181
G+ LE+ G+ +
Sbjct: 222 GVMLLELITGQRAF 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-07
Identities = 28/154 (18%), Positives = 46/154 (29%), Gaps = 47/154 (30%)
Query: 15 SYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKI-HRD 73
+FK+ L+IV+E+ G D+ ++R K S +IL L + HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGG--IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRD 187
Query: 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD--------- 124
L GN+LL KL
Sbjct: 188 ---------------------------------LHWGNVLLKKTSLKKLHYTLNGKSSTI 214
Query: 125 --FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156
G+ + D R G + + +++
Sbjct: 215 PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-06
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK 69
V Y+G + +V++ G S+ D++ L + S +A L ++ +H +
Sbjct: 71 VYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 70 IHRDIK 75
++RDIK
Sbjct: 128 VYRDIK 133
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 16/66 (24%), Positives = 31/66 (46%), Gaps = 3/66 (4%)
Query: 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK 69
+++ G+ +VME G S+ D+ + S + + + +EY+H +
Sbjct: 70 IRWCGAEGDYN--VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126
Query: 70 IHRDIK 75
IHRD+K
Sbjct: 127 IHRDVK 132
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 18/69 (26%), Positives = 29/69 (42%), Gaps = 3/69 (4%)
Query: 10 VKYYGSYFKNTDLW--IVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR 67
G + KN + ++M+ G+ + I K S + + L LEY+H
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH 171
Query: 68 RKIHRDIKA 76
+H DIKA
Sbjct: 172 EYVHGDIKA 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 3/66 (4%)
Query: 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK 69
V Y+G K +V+E G S+ D+ L +T S + I + +EY+H +
Sbjct: 70 VYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 70 IHRDIK 75
I+RD+K
Sbjct: 127 IYRDVK 132
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 16/66 (24%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRK 69
V+++G +VM+ G S+ D+ + LS + + + +E++H +
Sbjct: 68 VRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 70 IHRDIK 75
+HRDIK
Sbjct: 125 LHRDIK 130
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 4/69 (5%)
Query: 10 VKYYGSYFKNTDLW--IVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR 67
G + +VME G + I + + + L LEY+H
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT-FKKSTVLQLGIRMLDVLEYIHEN 170
Query: 68 RKIHRDIKA 76
+H DIKA
Sbjct: 171 EYVHGDIKA 179
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 1e-04
Identities = 36/250 (14%), Positives = 75/250 (30%), Gaps = 57/250 (22%)
Query: 23 WIVMEYCGAGSVSDIMRLRKKTLSE-DEIATILCDTLKGLEY------LHLRRKIHRDIK 75
W+ ++ C S ++ + +K L + D T D ++ LRR + K
Sbjct: 186 WLNLKNCN--SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS--K 241
Query: 76 AGSGTL-----VYDR--LDYCSIKC------------NVITNQIYKTLFRLKAGNILLNT 116
L V + + ++ C + ++ + L
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 117 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA--PEVIQE----------IGYDCVADM 164
E + L + + R + P ++ E I++ + D + +
Sbjct: 302 EVKSLLLKY--LDCRPQDL-PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358
Query: 165 WSLGITALEMAEGKPPYGDIHPMRAIFM----IPTKPPPSF-REPDVWTPEFI--DFVSR 217
+ LE AE + + + ++F IPT + +
Sbjct: 359 IESSLNVLEPAEYRKMFDRL----SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 218 CLV-KNPEER 226
LV K P+E
Sbjct: 415 SLVEKQPKES 424
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 32/167 (19%), Positives = 60/167 (35%), Gaps = 44/167 (26%)
Query: 24 IVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82
+V+ G S+ + + K LSE + + C L LE+LH +H ++
Sbjct: 135 LVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV-------- 185
Query: 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAK--LADFGVAGQLTDT------ 134
A NI ++ E ++ LA +G A + +
Sbjct: 186 -------------------------TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 135 -MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
R+ G +++ ++ + G +D+ SLG L+ G P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 251 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.64 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.34 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 91.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 85.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 85.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 83.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 80.51 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=381.27 Aligned_cols=208 Identities=38% Similarity=0.778 Sum_probs=187.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.+++.. ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK----- 197 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK----- 197 (346)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC-----
Confidence 4578999999999999999999999999999999999863 579999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+|+.............||+.|+|||++.+.+|+.
T Consensus 198 ----------------------------p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~ 249 (346)
T 4fih_A 198 ----------------------------SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 249 (346)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred ----------------------------HHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCc
Confidence 9999999999999999999987765545556678999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+||++|+|++|.+||.+.+.......+....++....+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 250 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 99999999999999999999988877776666655555555556778999999999999999999999999999999997
Q ss_pred ccC
Q psy3253 241 HDT 243 (251)
Q Consensus 241 ~~~ 243 (251)
...
T Consensus 330 ~~~ 332 (346)
T 4fih_A 330 AGP 332 (346)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=373.29 Aligned_cols=208 Identities=27% Similarity=0.487 Sum_probs=183.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.+++. +.+.+++.+++.++.||+.||.|||++||+|||||
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK----- 153 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK----- 153 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC-----
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC-----
Confidence 678999999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+|+.............||+.|+|||++.+..++.
T Consensus 154 ----------------------------p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~ 205 (304)
T 3ubd_A 154 ----------------------------PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205 (304)
T ss_dssp ----------------------------GGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCT
T ss_pred ----------------------------HHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCC
Confidence 8999999999999999999986654444555678999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++||||+||++|+|++|.+||.+.+.......+.... ...+..+|+++.+||.+||+.||++||| ++|+++|
T Consensus 206 ~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999999999998887777666555442 2346678999999999999999999998 5899999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|+.
T Consensus 283 p~f~~idw~~ 292 (304)
T 3ubd_A 283 SFFSTIDWNK 292 (304)
T ss_dssp GGGTTCCHHH
T ss_pred ccccCCCHHH
Confidence 9999988853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=373.11 Aligned_cols=208 Identities=27% Similarity=0.485 Sum_probs=185.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|++++.+|+|||||+||+|.++++ +.+.+++.+++.++.||+.||.|||++||+|||||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlK----- 159 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK----- 159 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC-----
Confidence 578999999999999999999999999999999999997 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--cccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+|+..... ........||+.|+|||++.+..+
T Consensus 160 ----------------------------PeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y 211 (311)
T 4aw0_A 160 ----------------------------PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211 (311)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB
T ss_pred ----------------------------HHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC
Confidence 88999999999999999999876432 223455679999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH------H
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE------M 232 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e------v 232 (251)
+.++|+||+||++|+|++|.+||.+.+.......+.... +..+..+++++.+||.+||+.||++|||++| +
T Consensus 212 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i 288 (311)
T 4aw0_A 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 288 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHH
Confidence 999999999999999999999998877766665555442 2346678999999999999999999999998 5
Q ss_pred hcChhhhhccCCC
Q psy3253 233 LNHEFIQRHDTDP 245 (251)
Q Consensus 233 l~hp~~~~~~~~~ 245 (251)
++||||+..+|+.
T Consensus 289 ~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 289 KAHPFFESVTWEN 301 (311)
T ss_dssp HTSGGGTTCCCTT
T ss_pred HCCCCcCCCCHHH
Confidence 8999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=382.41 Aligned_cols=208 Identities=38% Similarity=0.782 Sum_probs=188.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.++++ ...+++.+++.++.||+.||.|||++||+|||||
T Consensus 202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiK----- 274 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK----- 274 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC-----
Confidence 457899999999999999999999999999999999986 3569999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+|+.............||+.|+|||++.+..|+.
T Consensus 275 ----------------------------p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~ 326 (423)
T 4fie_A 275 ----------------------------SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 326 (423)
T ss_dssp ----------------------------TTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCT
T ss_pred ----------------------------HHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCc
Confidence 8899999999999999999987765545556678999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|||||||++|+|++|.+||.+.+.......+.....+....+..+++++.+||.+||..||++|||++|+|+||||++
T Consensus 327 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 99999999999999999999988877777766665555566667789999999999999999999999999999999997
Q ss_pred ccC
Q psy3253 241 HDT 243 (251)
Q Consensus 241 ~~~ 243 (251)
...
T Consensus 407 ~~~ 409 (423)
T 4fie_A 407 AGP 409 (423)
T ss_dssp CCC
T ss_pred CCC
Confidence 643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=373.86 Aligned_cols=206 Identities=28% Similarity=0.539 Sum_probs=182.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.+++...+ ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK---- 152 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIK---- 152 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCC----
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC----
Confidence 457899999999999999999999999999999999997443 467999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+|+.............||+.|+|||++.+..|+
T Consensus 153 -----------------------------p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~ 203 (350)
T 4b9d_A 153 -----------------------------SQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203 (350)
T ss_dssp -----------------------------GGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred -----------------------------HHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCC
Confidence 899999999999999999998765443334456799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.++||||+||++|+|++|++||.+.+.......+.....+. .+..+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 204 ~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP--VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC--CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 99999999999999999999998887777666655543332 3567899999999999999999999999999999997
Q ss_pred hc
Q psy3253 240 RH 241 (251)
Q Consensus 240 ~~ 241 (251)
+.
T Consensus 282 ~~ 283 (350)
T 4b9d_A 282 KR 283 (350)
T ss_dssp TT
T ss_pred cC
Confidence 53
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=358.93 Aligned_cols=202 Identities=30% Similarity=0.539 Sum_probs=169.6
Q ss_pred CCCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~di 74 (251)
|++++|||||+++++|.+ +..+|+|||||+||+|.++++ +...+++..++.++.||+.||.|||++| |+||||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDl 157 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEeccc
Confidence 468999999999999975 346899999999999999997 4578999999999999999999999998 999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
| |+||+++ .++.+||+|||+|+..... ......||+.|+|||++
T Consensus 158 K---------------------------------p~NILl~~~~g~vKl~DFGla~~~~~~--~~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 158 K---------------------------------CDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp C---------------------------------GGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGG
T ss_pred C---------------------------------hhheeEECCCCCEEEEeCcCCEeCCCC--ccCCcccCccccCHHHc
Confidence 8 8899987 4789999999999754322 33456799999999998
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+ +++.++|||||||++|+|+||++||.+....... ..+..... ....+...++++.+||.+||+.||++|||++|+
T Consensus 203 ~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~ 280 (290)
T 3fpq_A 203 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280 (290)
T ss_dssp GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 65 6999999999999999999999999765544333 33333322 222355678999999999999999999999999
Q ss_pred hcChhhhh
Q psy3253 233 LNHEFIQR 240 (251)
Q Consensus 233 l~hp~~~~ 240 (251)
++||||++
T Consensus 281 l~Hp~~~~ 288 (290)
T 3fpq_A 281 LNHAFFQE 288 (290)
T ss_dssp HTSGGGC-
T ss_pred hcCccccC
Confidence 99999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=364.82 Aligned_cols=210 Identities=32% Similarity=0.455 Sum_probs=179.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.++++ ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK----- 177 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK----- 177 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC-----
Confidence 678999999999999999999999999999999999997 44689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccc-----cccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMA-----KRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++.++ .+||+|||+|+....... ......||+.|+|||++.
T Consensus 178 ----------------------------p~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 178 ----------------------------ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp ----------------------------GGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred ----------------------------HHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence 8899998887 599999999986543211 123346999999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH--
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM-- 232 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev-- 232 (251)
+.+++.++||||+||++|+|++|.+||.+.+.......+.....+....+..+++++.++|.+||+.||++|||++|+
T Consensus 230 ~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999999999999999999999877666655555444433334567889999999999999999999999997
Q ss_pred -----------hcChhhhhccCC
Q psy3253 233 -----------LNHEFIQRHDTD 244 (251)
Q Consensus 233 -----------l~hp~~~~~~~~ 244 (251)
++|||+.+...+
T Consensus 310 ~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 310 KVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHhhhhhccCCCcCCCCCC
Confidence 679999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=354.39 Aligned_cols=201 Identities=26% Similarity=0.464 Sum_probs=167.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+||||| +|+|.+++. ..+.+++.+++.++.||+.||+|||++||+|||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiK----- 139 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK----- 139 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC-----
Confidence 35789999999999999999999999999 679999997 56789999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC-C
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-D 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~ 159 (251)
|+||+++.++.+||+|||+|+..... .......||+.|+|||++.+..+ +
T Consensus 140 ----------------------------P~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~ 190 (275)
T 3hyh_A 140 ----------------------------PENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAG 190 (275)
T ss_dssp ----------------------------TTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCC
T ss_pred ----------------------------hHHeEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCC
Confidence 88999999999999999999765433 23345679999999999988876 5
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.++||||+||++|+|++|++||.+.+.......+.... ...+..+++++.+||.+||+.||++|||++|+++||||+
T Consensus 191 ~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred ChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 79999999999999999999998876665555444432 233567899999999999999999999999999999997
Q ss_pred h
Q psy3253 240 R 240 (251)
Q Consensus 240 ~ 240 (251)
.
T Consensus 268 ~ 268 (275)
T 3hyh_A 268 V 268 (275)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=343.37 Aligned_cols=205 Identities=23% Similarity=0.413 Sum_probs=178.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------------KTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
|++++|||||+++++|.+++.+|+|||||++|+|.++++..+ ..+++.+++.++.||+.||.|||+++
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999999999999999997432 46999999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPF 146 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~ 146 (251)
|+||||| |+||+++.++.+||+|||+|+....... ......||+.
T Consensus 149 iiHRDlK---------------------------------p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 195 (299)
T 4asz_A 149 FVHRDLA---------------------------------TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195 (299)
T ss_dssp CCCSCCS---------------------------------GGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGG
T ss_pred cccCccC---------------------------------HhhEEECCCCcEEECCcccceecCCCCceeecCceecChh
Confidence 9999988 8999999999999999999976543221 2233468999
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
|+|||++.+..++.++|||||||++|||+| |+.||.+.+.......+..+..+ ..|..+|+++.+|+.+||+.||++
T Consensus 196 ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~~dP~~ 273 (299)
T 4asz_A 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPQEVYELMLGCWQREPHM 273 (299)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCccchHHHHHHHHHHcCCChhH
Confidence 999999999999999999999999999998 89999888777766665554332 346778999999999999999999
Q ss_pred cCCHHHHhcChhhhhcc
Q psy3253 226 RATASEMLNHEFIQRHD 242 (251)
Q Consensus 226 Rps~~evl~hp~~~~~~ 242 (251)
|||++|++ +|+++..
T Consensus 274 RPs~~~i~--~~L~~~~ 288 (299)
T 4asz_A 274 RKNIKGIH--TLLQNLA 288 (299)
T ss_dssp SCCHHHHH--HHHHHHH
T ss_pred CcCHHHHH--HHHHHHH
Confidence 99999994 7887654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=336.12 Aligned_cols=202 Identities=26% Similarity=0.450 Sum_probs=164.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+ +.+|+|||||++|+|.++++.....+++.++..++.||+.||.|||++||+|||||
T Consensus 86 l~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlK----- 159 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK----- 159 (307)
T ss_dssp HTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC-----
T ss_pred HHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccC-----
Confidence 578999999999998854 56899999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccccccccccccc---
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQE--- 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--- 155 (251)
|+||+++.++.+||+|||+|+...... .......||+.|+|||++.+
T Consensus 160 ----------------------------p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~ 211 (307)
T 3omv_A 160 ----------------------------SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211 (307)
T ss_dssp ----------------------------SSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSS
T ss_pred ----------------------------HHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC
Confidence 889999999999999999997654321 22344578999999999953
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh-cCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM-IPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+++.++|||||||++|+|+||+.||.+.+....... +... .+.....+..+++++.+|+.+||+.||++|||++||
T Consensus 212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred CCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 4589999999999999999999999987665443322 2221 111123456789999999999999999999999998
Q ss_pred hcCh
Q psy3253 233 LNHE 236 (251)
Q Consensus 233 l~hp 236 (251)
+++-
T Consensus 292 ~~~L 295 (307)
T 3omv_A 292 LSSI 295 (307)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=366.61 Aligned_cols=205 Identities=26% Similarity=0.463 Sum_probs=177.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++|||||+++++|++...+|+|||||.||+|.+++. +.+.+++..++.++.||+.||.|||++||||||||
T Consensus 247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK------ 319 (689)
T 3v5w_A 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK------ 319 (689)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS------
T ss_pred hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc------
Confidence 56799999999999999999999999999999999997 45789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 160 (251)
|+||+++.+|++||+|||+|+..... ......||+.|+|||++.+ ..|+.
T Consensus 320 ---------------------------PeNILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~ 370 (689)
T 3v5w_A 320 ---------------------------PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDS 370 (689)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred ---------------------------hHHeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCc
Confidence 99999999999999999999876543 3345689999999999964 57999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcch---hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEM 232 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ev 232 (251)
++|+||+||++|+|++|.+||.+.+... ....+... ....+..+++++.+||.+||+.||++|++ ++|+
T Consensus 371 ~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 9999999999999999999996543322 12222222 22346778999999999999999999998 7999
Q ss_pred hcChhhhhccCCC
Q psy3253 233 LNHEFIQRHDTDP 245 (251)
Q Consensus 233 l~hp~~~~~~~~~ 245 (251)
++||||+..+|+.
T Consensus 448 ~~HpfF~~idW~~ 460 (689)
T 3v5w_A 448 KESPFFRSLDWQM 460 (689)
T ss_dssp TTSGGGTTCCHHH
T ss_pred hcCccccCCCHHH
Confidence 9999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=338.35 Aligned_cols=200 Identities=22% Similarity=0.400 Sum_probs=174.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
|++++|||||+++|++.++..+++|||||++|+|.+++..+. ..+++.++..++.||+.||.|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999996432 35899999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~ 143 (251)
+++|+||||| |+||+++.++.+||+|||+++...... .......|
T Consensus 163 ~~~iiHRDLK---------------------------------~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~g 209 (308)
T 4gt4_A 163 SHHVVHKDLA---------------------------------TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209 (308)
T ss_dssp HTTCCCSCCS---------------------------------GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCB
T ss_pred hCCCCCCCcc---------------------------------ccceEECCCCCEEECCcccceeccCCCceeEeccccc
Confidence 9999999988 999999999999999999998654322 12334568
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
|+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+..+..+ +.+..+++++.+|+.+||+.|
T Consensus 210 t~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~C~~~d 287 (308)
T 4gt4_A 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEF 287 (308)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCcccchHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999998 89999888877777666554332 346789999999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||++||+++
T Consensus 288 P~~RPs~~ei~~~ 300 (308)
T 4gt4_A 288 PSRRPRFKDIHSR 300 (308)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=340.61 Aligned_cols=200 Identities=22% Similarity=0.418 Sum_probs=167.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--------------KKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
|++++|||||+++++|.++..+|+|||||++|+|.++++.. ...+++.+++.++.||+.||.|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 57899999999999999999999999999999999999743 2468999999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~ 144 (251)
++|+||||| |+||+++.++.+||+|||+++....... ......||
T Consensus 177 ~~iiHRDLK---------------------------------p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 177 LHFVHRDLA---------------------------------TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp TTCCCSCCC---------------------------------GGGEEEETTTEEEECCCC----------------CCCC
T ss_pred CCeeccccc---------------------------------HhhEEECCCCcEEEcccccceeccCCCcceecCccccc
Confidence 999999988 9999999999999999999986543221 22345689
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.......+..+.. ...+..+++++.+|+.+||+.||
T Consensus 224 ~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP 301 (329)
T 4aoj_A 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREP 301 (329)
T ss_dssp GGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSST
T ss_pred ccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcCh
Confidence 99999999999999999999999999999999 8999988877766665544432 33467899999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++||+++
T Consensus 302 ~~RPs~~ei~~~ 313 (329)
T 4aoj_A 302 QQRHSIKDVHAR 313 (329)
T ss_dssp TTSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=337.21 Aligned_cols=207 Identities=23% Similarity=0.410 Sum_probs=157.1
Q ss_pred CCCCCCCccceeeeeEeeCC------------eEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------------DLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------------~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
|++++|||||+++++|.+.+ ++|+|||||++|+|.+++..+. ....+..++.++.||+.||.|||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999997543 4799999999999999997332 234567789999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----------
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---------- 136 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---------- 136 (251)
+||+||||| |+||+++.++.+||+|||+|+.......
T Consensus 137 ~~IiHRDlK---------------------------------p~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 183 (299)
T 4g31_A 137 KGLMHRDLK---------------------------------PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183 (299)
T ss_dssp TTCCCCCCC---------------------------------GGGEEECTTCCEEECCCCCC------------------
T ss_pred CcCccccCc---------------------------------HHHeEECCCCcEEEccCccceecCCCcccccccccccc
Confidence 999999988 8899999999999999999986543211
Q ss_pred --cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHH
Q psy3253 137 --KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFID 213 (251)
Q Consensus 137 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (251)
......||+.|+|||++.+.+++.++||||+||++|+|++ ||.+.... .....+.....+. .+...++...+
T Consensus 184 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~~~ 258 (299)
T 4g31_A 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPP--LFTQKYPCEYV 258 (299)
T ss_dssp --------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCH--HHHHHCHHHHH
T ss_pred ccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCC--CCcccCHHHHH
Confidence 1233469999999999999999999999999999999996 77543221 2222222221111 12334677889
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
||.+||+.||++|||++|+++||||++.+|+.
T Consensus 259 li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 259 MVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 99999999999999999999999999998865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=337.13 Aligned_cols=201 Identities=29% Similarity=0.396 Sum_probs=160.3
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+|||||+++++|.+++++|+|||||+||+|.++++ .+++.+++.++.||+.||+|||++||+|||||
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiK--------- 144 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVK--------- 144 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---------
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCC---------
Confidence 79999999999999999999999999999999883 59999999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccc---------------------------
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMA--------------------------- 136 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~--------------------------- 136 (251)
|+||+++.+ +.+||+|||+|+.......
T Consensus 145 ------------------------PeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (361)
T 4f9c_A 145 ------------------------PSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRR 200 (361)
T ss_dssp ------------------------GGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------------------
T ss_pred ------------------------HHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccc
Confidence 888888766 7899999999975432211
Q ss_pred -cccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC-cchhhhhc--------------------
Q psy3253 137 -KRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIH-PMRAIFMI-------------------- 193 (251)
Q Consensus 137 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~~-------------------- 193 (251)
......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.... .......+
T Consensus 201 ~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~ 280 (361)
T 4f9c_A 201 QQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSI 280 (361)
T ss_dssp -----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEE
T ss_pred ccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccc
Confidence 11234689999999999775 48899999999999999999999995432 21111100
Q ss_pred ------------------CC-------------CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 194 ------------------PT-------------KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 194 ------------------~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
.. ........+..+++++.|||.+||++||++|+|++|+|+||||++.+
T Consensus 281 ~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 281 LCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp EESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 00 00011122456789999999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=358.25 Aligned_cols=211 Identities=22% Similarity=0.376 Sum_probs=183.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++..+|+|||||+||+|.+++......+++.+++.++.||+.||.|||++||+|||||
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlK----- 282 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK----- 282 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC-----
Confidence 457899999999999999999999999999999999997556789999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCC--CCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++. .+.+||+|||+++..... .......||+.|+|||++.+.++
T Consensus 283 ----------------------------p~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y 333 (573)
T 3uto_A 283 ----------------------------PENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 333 (573)
T ss_dssp ----------------------------GGGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCB
T ss_pred ----------------------------hhhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCC
Confidence 77888764 378999999999876543 22334578999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|.+||.+.+.......+.... ......+..+++++.+||.+||+.||++|||++|+|+|||
T Consensus 334 ~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 999999999999999999999998887776665554432 2222334678999999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|+...+..
T Consensus 414 ~~~~~~~~ 421 (573)
T 3uto_A 414 LTPGNAPG 421 (573)
T ss_dssp TSCCCCTT
T ss_pred cCCCCCCC
Confidence 99887764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=342.54 Aligned_cols=208 Identities=22% Similarity=0.397 Sum_probs=169.5
Q ss_pred CCCCCCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++|||||++++++.. ..++|+|||||+ |+|.+++. ..+.+++..++.++.||+.||.|||++||+||||
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDl 184 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDL 184 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCc
Confidence 457899999999999864 357999999995 68999986 5678999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc----cccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT----MAKRNTVIGTPFWMAP 150 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~y~aP 150 (251)
| |+||+++.++.+||+|||+|+..... ........||+.|+||
T Consensus 185 K---------------------------------P~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~AP 231 (398)
T 4b99_A 185 K---------------------------------PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231 (398)
T ss_dssp C---------------------------------GGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCH
T ss_pred C---------------------------------ccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCH
Confidence 8 89999999999999999999865432 1223456799999999
Q ss_pred cccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC--------------------CCCC----
Q psy3253 151 EVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP--------------------PSFR---- 202 (251)
Q Consensus 151 E~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------------------~~~~---- 202 (251)
|++.+. .++.++||||+||++|+|++|.+||.+.+.......+.. ..+ ....
T Consensus 232 Ev~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
T 4b99_A 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWE 311 (398)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHH
T ss_pred HHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHH
Confidence 998775 468999999999999999999999987665444332211 000 0000
Q ss_pred -CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 203 -EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 203 -~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
....+++++.+||.+||.+||++|||++|+|+||||++...
T Consensus 312 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 312 TVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 02346899999999999999999999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=332.56 Aligned_cols=203 Identities=30% Similarity=0.513 Sum_probs=169.2
Q ss_pred CCCC-CCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQCD-SPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~L 64 (251)
+++. |||||+++++|.+ +..+|+|||||++|+|.++++.. ...+++..++.++.||+.||.||
T Consensus 122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 3454 5999999999976 45789999999999999999743 23489999999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVI 142 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 142 (251)
|+++||||||| |+||+++.++.+||+|||+|+...... .......
T Consensus 202 H~~~iiHRDLK---------------------------------~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~ 248 (353)
T 4ase_A 202 ASRKCIHRDLA---------------------------------ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248 (353)
T ss_dssp HHTTCCCSCCS---------------------------------GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred hhCCeecCccC---------------------------------ccceeeCCCCCEEECcchhhhhcccCCCceeecccc
Confidence 99999999988 899999999999999999998654322 2334456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 143 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
||+.|+|||++.+..++.++|||||||++|||+| |..||.+....... ..+..+. ....+..+++++.++|.+||+
T Consensus 249 gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~--~~~~p~~~~~~~~~li~~c~~ 326 (353)
T 4ase_A 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWH 326 (353)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcC
Confidence 8999999999999999999999999999999998 99999876544333 2232222 233467789999999999999
Q ss_pred cCcCccCCHHHHhcC--hhhh
Q psy3253 221 KNPEERATASEMLNH--EFIQ 239 (251)
Q Consensus 221 ~~p~~Rps~~evl~h--p~~~ 239 (251)
.||++|||++|+++| .+++
T Consensus 327 ~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 327 GEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhHCcCHHHHHHHHHHHHH
Confidence 999999999999988 4544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=314.38 Aligned_cols=206 Identities=42% Similarity=0.836 Sum_probs=181.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|||||
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk------ 143 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK------ 143 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC------
Confidence 468999999999999999999999999999999999973 479999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||++..............||+.|+|||++.+..++.+
T Consensus 144 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 196 (297)
T 3fxz_A 144 ---------------------------SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196 (297)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTH
T ss_pred ---------------------------HHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcH
Confidence 88999999999999999999776655445555678999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||+||++|+|++|..||.+.+.......+.....+....+..+++.+.++|.+||+.||++|||++|+++||||+..
T Consensus 197 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999877665555444333333444567789999999999999999999999999999999865
Q ss_pred c
Q psy3253 242 D 242 (251)
Q Consensus 242 ~ 242 (251)
.
T Consensus 277 ~ 277 (297)
T 3fxz_A 277 K 277 (297)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=316.06 Aligned_cols=207 Identities=29% Similarity=0.513 Sum_probs=181.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk----- 132 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK----- 132 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC-----
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC-----
Confidence 357899999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.
T Consensus 133 ----------------------------p~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 184 (337)
T 1o6l_A 133 ----------------------------LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred ----------------------------HHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCc
Confidence 8899999999999999999976443333445567899999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++|+||+||++|+|++|..||.+.+.......+... ....+..+++++.++|.+||+.||++|| +++|+++|
T Consensus 185 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999999999999877665555444332 2223567899999999999999999999 99999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|+
T Consensus 262 ~~f~~~~~~ 270 (337)
T 1o6l_A 262 RFFLSINWQ 270 (337)
T ss_dssp GGGTTCCHH
T ss_pred CCcCCCCHH
Confidence 999988775
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=313.50 Aligned_cols=204 Identities=27% Similarity=0.491 Sum_probs=177.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+++|+|.+++. ..+.+++..++.++.|++.||+|||++|++|||||
T Consensus 69 ~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk------ 141 (328)
T 3fe3_A 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK------ 141 (328)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC------
T ss_pred HhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCC------
Confidence 46899999999999999999999999999999999997 34679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC-c
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-C 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 160 (251)
|+||+++.++.+||+|||++...... .......||+.|+|||++.+..++ .
T Consensus 142 ---------------------------p~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (328)
T 3fe3_A 142 ---------------------------AENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGP 193 (328)
T ss_dssp ---------------------------GGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred ---------------------------HHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCc
Confidence 88999999999999999999765433 233445689999999999887765 7
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+||++|+|++|..||.+.+.......+... ....+..+++++.+++.+||+.||++|||++|+++||||+.
T Consensus 194 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG---KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 899999999999999999999887766655544433 22335668999999999999999999999999999999987
Q ss_pred ccC
Q psy3253 241 HDT 243 (251)
Q Consensus 241 ~~~ 243 (251)
...
T Consensus 271 ~~~ 273 (328)
T 3fe3_A 271 GHE 273 (328)
T ss_dssp TCT
T ss_pred CCc
Confidence 554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.39 Aligned_cols=204 Identities=26% Similarity=0.458 Sum_probs=176.0
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||++++++|.+...+|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk--------- 151 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLK--------- 151 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC---------
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC---------
Confidence 79999999999999999999999999999999997 44679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++++||+|||+++.............||+.|+|||++.+..++.++|+
T Consensus 152 ------------------------p~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 207 (353)
T 3txo_A 152 ------------------------LDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207 (353)
T ss_dssp ------------------------GGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHH
T ss_pred ------------------------HHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCC
Confidence 89999999999999999999765444344555678999999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH------HHHhcChhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA------SEMLNHEFI 238 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~evl~hp~~ 238 (251)
||+||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||+.||++||++ +|+++||||
T Consensus 208 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred CcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 999999999999999998877766665554432 22356689999999999999999999999 899999999
Q ss_pred hhccCCC
Q psy3253 239 QRHDTDP 245 (251)
Q Consensus 239 ~~~~~~~ 245 (251)
+..+|+.
T Consensus 285 ~~~~w~~ 291 (353)
T 3txo_A 285 KEIDWAQ 291 (353)
T ss_dssp TTCCHHH
T ss_pred cCCCHHH
Confidence 9988753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=313.75 Aligned_cols=204 Identities=26% Similarity=0.487 Sum_probs=179.4
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++.+....|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk-------- 145 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK-------- 145 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC--------
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC--------
Confidence 3899999999999999999999999999999999973 4679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.++|
T Consensus 146 -------------------------p~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (345)
T 1xjd_A 146 -------------------------LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 200 (345)
T ss_dssp -------------------------GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred -------------------------hhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhh
Confidence 8999999999999999999976543333445567899999999999989999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH-HHhcChhhhhcc
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS-EMLNHEFIQRHD 242 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~hp~~~~~~ 242 (251)
+||+||++|+|++|..||.+.+.......+..... ..+..+++++.++|.+||..||++||+++ |+++||||+..+
T Consensus 201 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 99999999999999999988776665554443321 23566899999999999999999999998 999999999988
Q ss_pred CC
Q psy3253 243 TD 244 (251)
Q Consensus 243 ~~ 244 (251)
|+
T Consensus 278 w~ 279 (345)
T 1xjd_A 278 WE 279 (345)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=309.33 Aligned_cols=203 Identities=28% Similarity=0.540 Sum_probs=179.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk------ 133 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK------ 133 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC------
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC------
Confidence 46899999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||+++.... ......||+.|+|||++.+..++.+
T Consensus 134 ---------------------------p~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 183 (318)
T 1fot_A 134 ---------------------------PENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKS 183 (318)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTT
T ss_pred ---------------------------hheEEEcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcc
Confidence 8899999999999999999976543 2334568999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcCh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHE 236 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~hp 236 (251)
+|+||+||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||..||++|| +++|+++||
T Consensus 184 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 999999999999999999998776665554444332 223567899999999999999999999 999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+..+|+
T Consensus 261 ~f~~~~~~ 268 (318)
T 1fot_A 261 WFKEVVWE 268 (318)
T ss_dssp GGSSCCHH
T ss_pred cccCCCHH
Confidence 99988775
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.63 Aligned_cols=207 Identities=28% Similarity=0.434 Sum_probs=181.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||++++++|.+...+|+||||+.||+|.+++. +...+++..++.++.||+.||.|||++||+|||||
T Consensus 94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk------ 166 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK------ 166 (373)
T ss_dssp CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC------
T ss_pred HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC------
Confidence 56899999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++++||+|||+++.............||+.|+|||++.+..++.+
T Consensus 167 ---------------------------p~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 219 (373)
T 2r5t_A 167 ---------------------------PENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT 219 (373)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTH
T ss_pred ---------------------------HHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCch
Confidence 89999999999999999999764433334455678999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH----HHHhcChh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA----SEMLNHEF 237 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~evl~hp~ 237 (251)
+|+|||||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||+.||++||++ +|+++|||
T Consensus 220 ~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 220 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 999999999999999999998877666555444332 22356789999999999999999999986 69999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|+..+|+.
T Consensus 297 f~~~~w~~ 304 (373)
T 2r5t_A 297 FSLINWDD 304 (373)
T ss_dssp GTTCCHHH
T ss_pred ccCCCHHH
Confidence 99988753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=312.11 Aligned_cols=207 Identities=24% Similarity=0.405 Sum_probs=180.2
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+.+ +||||+++++++.+...+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 75 ~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk----- 148 (353)
T 2i0e_A 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK----- 148 (353)
T ss_dssp TCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC-----
T ss_pred HhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC-----
Confidence 344 799999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.
T Consensus 149 ----------------------------p~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (353)
T 2i0e_A 149 ----------------------------LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200 (353)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred ----------------------------HHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCC
Confidence 8999999999999999999976443333445567899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|+|||||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||..||++||+ ++|+++|
T Consensus 201 ~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred cccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999998877666555444332 2235678999999999999999999994 6999999
Q ss_pred hhhhhccCCC
Q psy3253 236 EFIQRHDTDP 245 (251)
Q Consensus 236 p~~~~~~~~~ 245 (251)
|||+..+|+.
T Consensus 278 ~~f~~~~w~~ 287 (353)
T 2i0e_A 278 AFFRYIDWEK 287 (353)
T ss_dssp GGGTTCCHHH
T ss_pred ccccCCCHHH
Confidence 9999988753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=313.21 Aligned_cols=208 Identities=29% Similarity=0.471 Sum_probs=177.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.+....|+||||+.||+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk----- 142 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK----- 142 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 467899999999999999999999999999999999996 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCcccccccccccccccccccccccC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++ .+||+|||++...... .......||+.|+|||++.+.
T Consensus 143 ----------------------------p~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 193 (361)
T 2yab_A 143 ----------------------------PENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYE 193 (361)
T ss_dssp ----------------------------GGGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTC
T ss_pred ----------------------------HHHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCC
Confidence 7788887665 7999999999765543 223345689999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCC-CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP-SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++.++||||+||++|+|++|.+||.+.+.......+...... ....+..+++++.+||.+||..||++|||++|+++|
T Consensus 194 ~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999999887666655544333211 111235679999999999999999999999999999
Q ss_pred hhhhhccC
Q psy3253 236 EFIQRHDT 243 (251)
Q Consensus 236 p~~~~~~~ 243 (251)
|||+..+|
T Consensus 274 p~~~~~~~ 281 (361)
T 2yab_A 274 PWITPVDT 281 (361)
T ss_dssp TTTSCSSH
T ss_pred cCcCCCch
Confidence 99986654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=318.86 Aligned_cols=207 Identities=29% Similarity=0.502 Sum_probs=179.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni 79 (251)
|++++||||++++++|.+...+|+||||+++|+|.+++. ....+++..++.++.||+.||.|||+ .||+|||||
T Consensus 202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlk---- 276 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK---- 276 (446)
T ss_dssp CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCC----
T ss_pred HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCC----
Confidence 567899999999999999999999999999999999997 45689999999999999999999998 999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++
T Consensus 277 -----------------------------p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 277 -----------------------------LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp -----------------------------GGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC
T ss_pred -----------------------------HHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCC
Confidence 889999999999999999997654433344556789999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhc
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~ 234 (251)
.++|||||||++|+|++|..||.+.+.......+.... ...+..+++++.+||.+||+.||++|| |++|+++
T Consensus 328 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999999999999998777665554443332 223567899999999999999999999 9999999
Q ss_pred ChhhhhccCC
Q psy3253 235 HEFIQRHDTD 244 (251)
Q Consensus 235 hp~~~~~~~~ 244 (251)
||||+..+|+
T Consensus 405 hp~f~~~~~~ 414 (446)
T 4ejn_A 405 HRFFAGIVWQ 414 (446)
T ss_dssp SGGGTTCCHH
T ss_pred CccccCCCHH
Confidence 9999998775
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.04 Aligned_cols=204 Identities=29% Similarity=0.515 Sum_probs=174.7
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||++++++|.+...+|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLK--------- 180 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK--------- 180 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC---------
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC---------
Confidence 89999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.++|+
T Consensus 181 ------------------------p~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Di 236 (396)
T 4dc2_A 181 ------------------------LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236 (396)
T ss_dssp ------------------------GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHH
T ss_pred ------------------------HHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHH
Confidence 99999999999999999999764433344556678999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCc---------chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH------
Q psy3253 165 WSLGITALEMAEGKPPYGDIHP---------MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA------ 229 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------ 229 (251)
||+||++|+|++|.+||..... ......+... ....+..+++++.+||.+||+.||++||++
T Consensus 237 wslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 313 (396)
T 4dc2_A 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 313 (396)
T ss_dssp HHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHH
T ss_pred HHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCH
Confidence 9999999999999999953211 1111112221 223456789999999999999999999985
Q ss_pred HHHhcChhhhhccCCC
Q psy3253 230 SEMLNHEFIQRHDTDP 245 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~ 245 (251)
+|+++||||+..+|+.
T Consensus 314 ~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 314 ADIQGHPFFRNVDWDM 329 (396)
T ss_dssp HHHHHSTTTTTCCHHH
T ss_pred HHHhcCccccCCCHHH
Confidence 8999999999988753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=308.94 Aligned_cols=200 Identities=24% Similarity=0.333 Sum_probs=152.8
Q ss_pred CCCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------C
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR--------R 68 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~ 68 (251)
|.+++|||||++++++.+++ .+|+|||||++|+|.++++. ..+++..+..++.|++.||.|||++ +
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~ 128 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence 45789999999999997653 58999999999999999973 5799999999999999999999987 9
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----cccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGT 144 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~ 144 (251)
|+||||| |+||+++.++.+||+|||+++....... ......||
T Consensus 129 IiHRDlK---------------------------------p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 129 IAHRDLK---------------------------------SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EECSCCC---------------------------------GGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CC
T ss_pred EeeccCC---------------------------------cccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccc
Confidence 9999988 9999999999999999999976543211 12335689
Q ss_pred cccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcch---------------hhhhcC-CCCCCCCC
Q psy3253 145 PFWMAPEVIQEI------GYDCVADMWSLGITALEMAEGKPPYGDIHPMR---------------AIFMIP-TKPPPSFR 202 (251)
Q Consensus 145 ~~y~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~-~~~~~~~~ 202 (251)
+.|+|||++.+. .++.++|||||||++|||+||.+||....... ....+. ....+..+
T Consensus 176 ~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p 255 (303)
T 3hmm_A 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred ccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCC
Confidence 999999999653 46779999999999999999988764322111 111111 11111111
Q ss_pred C---CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 203 E---PDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 203 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
. ....+..+.+|+.+||+.||++|||++||++.
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 11123468899999999999999999999853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=305.54 Aligned_cols=207 Identities=41% Similarity=0.794 Sum_probs=180.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++......++||||+++++|.+++. ...+++..+..++.|++.||.|||+.|++|||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk----- 168 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK----- 168 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 467899999999999999999999999999999999885 4579999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++..............||+.|+|||++.+..++.
T Consensus 169 ----------------------------p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (321)
T 2c30_A 169 ----------------------------SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220 (321)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred ----------------------------HHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCc
Confidence 8899999999999999999976654433444567899999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||||+++|+|++|..||...........+.....+.......+++++.+++.+||+.||++|||++|+++||||.+
T Consensus 221 ~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 99999999999999999999987766555544444443344445567999999999999999999999999999999986
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 301 ~~ 302 (321)
T 2c30_A 301 TG 302 (321)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=309.53 Aligned_cols=206 Identities=28% Similarity=0.467 Sum_probs=174.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+||||+.+++|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk------ 148 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGHLHQKGIIYRDLK------ 148 (327)
T ss_dssp HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC------
T ss_pred HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCC------
Confidence 46899999999999999999999999999999999997 44679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.+
T Consensus 149 ---------------------------p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 201 (327)
T 3a62_A 149 ---------------------------PENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201 (327)
T ss_dssp ---------------------------TTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTH
T ss_pred ---------------------------HHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCc
Confidence 88999999999999999999754433333444568999999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcCh
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNHE 236 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~hp 236 (251)
+|+|||||++|+|++|..||.+.+.......+... ....+..+++++.++|.+||..||++|| +++|+++||
T Consensus 202 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 99999999999999999999877665554444332 1223566899999999999999999999 899999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+..+|+
T Consensus 279 ~f~~~~~~ 286 (327)
T 3a62_A 279 FFRHINWE 286 (327)
T ss_dssp GGSSCCHH
T ss_pred cccCCCHH
Confidence 99988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.65 Aligned_cols=207 Identities=26% Similarity=0.399 Sum_probs=177.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+||||+.||+|.+++. ....+++..+..++.||+.||.|||++||+|||||
T Consensus 65 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlK------ 137 (444)
T 3soa_A 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLK------ 137 (444)
T ss_dssp HHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS------
T ss_pred HhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC------
Confidence 46899999999999999999999999999999999997 45789999999999999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecC---CCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++ .++.+||+|||++..............||+.|+|||++.+..+
T Consensus 138 ---------------------------p~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (444)
T 3soa_A 138 ---------------------------PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190 (444)
T ss_dssp ---------------------------STTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCB
T ss_pred ---------------------------HHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCC
Confidence 6677776 4567999999999776554444445678999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|.+||.+.+.......+.... ......+..+++++.+||.+||+.||++|||++|+|+|||
T Consensus 191 ~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 999999999999999999999998877665554443322 1222234578999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|+...
T Consensus 271 ~~~~~ 275 (444)
T 3soa_A 271 ISHRS 275 (444)
T ss_dssp THHHH
T ss_pred ccCCc
Confidence 98653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=309.24 Aligned_cols=204 Identities=29% Similarity=0.487 Sum_probs=180.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk----- 168 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK----- 168 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCc-----
Confidence 4678999999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.
T Consensus 169 ----------------------------p~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 217 (350)
T 1rdq_E 169 ----------------------------PENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCT
T ss_pred ----------------------------cceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCC
Confidence 88999999999999999999765432 23456899999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|+|||||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||+.||++||+ ++|+++|
T Consensus 218 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred cCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999999999999998777666555444332 2235678999999999999999999998 9999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|+
T Consensus 295 ~~f~~~~w~ 303 (350)
T 1rdq_E 295 KWFATTDWI 303 (350)
T ss_dssp GGGTTCCHH
T ss_pred cCcCCCCHH
Confidence 999998874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=309.77 Aligned_cols=203 Identities=29% Similarity=0.520 Sum_probs=173.2
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||++++++|.+....|+||||+.+|+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk--------- 137 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK--------- 137 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC---------
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC---------
Confidence 89999999999999999999999999999999997 44679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..++.++|+
T Consensus 138 ------------------------p~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 193 (345)
T 3a8x_A 138 ------------------------LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193 (345)
T ss_dssp ------------------------GGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred ------------------------HHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhH
Confidence 89999999999999999999764433334455678999999999999899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC---------cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH------
Q psy3253 165 WSLGITALEMAEGKPPYGDIH---------PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA------ 229 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------ 229 (251)
||+||++|+|++|..||.... .......+... ....+..+++++.++|.+||+.||++||++
T Consensus 194 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 270 (345)
T 3a8x_A 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 270 (345)
T ss_dssp HHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHH
T ss_pred HHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCH
Confidence 999999999999999996421 11111122222 222356789999999999999999999995
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
+|+++||||+..+|+
T Consensus 271 ~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 271 ADIQGHPFFRNVDWD 285 (345)
T ss_dssp HHHHTSGGGTTCCHH
T ss_pred HHHhcCCccCCCCHH
Confidence 899999999998875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=305.31 Aligned_cols=209 Identities=27% Similarity=0.458 Sum_probs=171.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+++ +|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik------ 146 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK------ 146 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc------
Confidence 468999999999999999999999999975 8988887666779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 160 (251)
|+||+++.++.+||+|||++..............+|+.|+|||++.+ ..++.
T Consensus 147 ---------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (311)
T 3niz_A 147 ---------------------------PQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199 (311)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCT
T ss_pred ---------------------------hHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCc
Confidence 88999999999999999999876544334444567999999999876 56899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCCC-CC-----------------------CCCCCCCHHHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPPP-SF-----------------------REPDVWTPEFID 213 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-~~-----------------------~~~~~~~~~~~~ 213 (251)
++||||+||++|+|++|..||.+.........+. ....+ .+ .....+++++.+
T Consensus 200 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3niz_A 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHH
T ss_pred hHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHH
Confidence 9999999999999999999997655443332211 11000 00 012346789999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
||.+||+.||++|||++|+++||||+..+++
T Consensus 280 li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 280 LLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred HHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 9999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=304.15 Aligned_cols=215 Identities=26% Similarity=0.445 Sum_probs=172.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++.+++..++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++|++|||||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 135 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 468899999999999999999999999997 59999987442 468999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||++..............+|+.|+|||++.+
T Consensus 136 ---------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 136 ---------------------------------PQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp ---------------------------------GGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred ---------------------------------hHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhC
Confidence 88999999999999999999766543333344567999999999976
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCC--------------CC--------------CCC
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPP--------------PS--------------FRE 203 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~--------------~~--------------~~~ 203 (251)
..++.++||||+||++|+|++|..||.+.+.......+. .... .. ...
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T 2pmi_A 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262 (317)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence 468999999999999999999999997765443322210 0000 00 001
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQNG 249 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~~~ 249 (251)
...+++++.+||.+||+.||++|||++|+++||||++..+.+...+
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~ 308 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGG 308 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC------
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccc
Confidence 2357889999999999999999999999999999999988876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=309.25 Aligned_cols=208 Identities=25% Similarity=0.327 Sum_probs=175.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||++||+|.+++......+++.++..++.|++.||.|||++|++|||||
T Consensus 56 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlk------ 129 (321)
T 1tki_A 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR------ 129 (321)
T ss_dssp HHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC------
Confidence 46799999999999999999999999999999999997555679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCC--CCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++. ++.+||+|||++...... .......+|+.|+|||++.+..++
T Consensus 130 ---------------------------p~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (321)
T 1tki_A 130 ---------------------------PENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVS 181 (321)
T ss_dssp ---------------------------GGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEEC
T ss_pred ---------------------------HHHEEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCC
Confidence 77888876 688999999999765433 223345689999999999888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
.++||||+||++|+|++|..||.+.........+..... .....+..+++++.+++.+||..||++|||++|+++||||
T Consensus 182 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 999999999999999999999987766555544433221 1111234679999999999999999999999999999999
Q ss_pred hhccC
Q psy3253 239 QRHDT 243 (251)
Q Consensus 239 ~~~~~ 243 (251)
++...
T Consensus 262 ~~~~~ 266 (321)
T 1tki_A 262 KQKIE 266 (321)
T ss_dssp HSCGG
T ss_pred ccCcc
Confidence 86543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=311.55 Aligned_cols=208 Identities=28% Similarity=0.392 Sum_probs=171.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++||||+++++++.++...|+||||+++++|.+++... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlk--- 157 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK--- 157 (351)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC---
Confidence 4689999999999999999999999999999999888533 3458999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCccccccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++ .+||+|||++..............||+.|+|||++.+
T Consensus 158 ------------------------------p~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 158 ------------------------------PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp ------------------------------GGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred ------------------------------hHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence 7788876554 4999999999876554333445678999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-CCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+||++|+|++|..||.+.... ....+. .........+..+++++.++|.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 89999999999999999999999999765432 222221 1111111123567999999999999999999999999999
Q ss_pred ChhhhhccC
Q psy3253 235 HEFIQRHDT 243 (251)
Q Consensus 235 hp~~~~~~~ 243 (251)
||||+..++
T Consensus 287 hp~~~~~~~ 295 (351)
T 3c0i_A 287 HPWLKERDR 295 (351)
T ss_dssp SHHHHTHHH
T ss_pred ChhhcCCcc
Confidence 999987553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=305.69 Aligned_cols=202 Identities=29% Similarity=0.489 Sum_probs=173.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+ +|+|.+++. ....+++.+++.++.|++.||.|||++|++|||||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk----- 135 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV-EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK----- 135 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCS-----
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCc-----
Confidence 46789999999999999999999999999 679999887 34679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC-C
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-D 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~ 159 (251)
|+||+++.++.+||+|||++...... .......||+.|+|||++.+..+ +
T Consensus 136 ----------------------------p~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 186 (336)
T 3h4j_B 136 ----------------------------PENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAG 186 (336)
T ss_dssp ----------------------------TTTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGC
T ss_pred ----------------------------hhhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCC
Confidence 88999999999999999999765433 22344568999999999988776 6
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
+++||||+||++|+|++|..||.+.........+... ....+..+++++.++|.+||+.||++|||++|+++||||+
T Consensus 187 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC---VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS---CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred CccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 8999999999999999999999766554444333222 2334667899999999999999999999999999999998
Q ss_pred hc
Q psy3253 240 RH 241 (251)
Q Consensus 240 ~~ 241 (251)
..
T Consensus 264 ~~ 265 (336)
T 3h4j_B 264 VN 265 (336)
T ss_dssp TT
T ss_pred cC
Confidence 53
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=312.18 Aligned_cols=207 Identities=29% Similarity=0.593 Sum_probs=175.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.+....|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlk----- 142 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK----- 142 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc-----
Confidence 357899999999999999999999999999999999997 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc---CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE---IG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~ 157 (251)
|+||+++.++.++|+|||++...... .......||+.|+|||++.+ ..
T Consensus 143 ----------------------------p~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~ 193 (384)
T 4fr4_A 143 ----------------------------PDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAG 193 (384)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCC
T ss_pred ----------------------------HHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCC
Confidence 89999999999999999999765433 23345678999999999964 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcch---hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-HHHHh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMR---AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-ASEML 233 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~evl 233 (251)
++.++|+|||||++|+|++|..||....... ....+... ....+..+++++.+||.+||+.||++||+ +++++
T Consensus 194 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 8899999999999999999999996433222 11111111 22335678999999999999999999998 99999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+..+|+.
T Consensus 271 ~hp~f~~~~w~~ 282 (384)
T 4fr4_A 271 NFPYMNDINWDA 282 (384)
T ss_dssp TSGGGTTCCHHH
T ss_pred cChhhhcCCHHH
Confidence 999999988753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=316.97 Aligned_cols=209 Identities=26% Similarity=0.441 Sum_probs=179.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+.++||||++++++|.++..+|+||||++||+|.++++. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLK------ 195 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK------ 195 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC------
Confidence 457999999999999999999999999999999999863 579999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCC---
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIG--- 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--- 157 (251)
|+||+++.++++||+|||+++....... ......||+.|+|||++.+..
T Consensus 196 ---------------------------p~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~ 248 (410)
T 3v8s_A 196 ---------------------------PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248 (410)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred ---------------------------HHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCc
Confidence 9999999999999999999976543322 234567899999999997655
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCc--cCCHHHHh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEE--RATASEML 233 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~evl 233 (251)
++.++|+|||||++|+|++|.+||.+.+.......+... ....++....+++++.+||.+||..+|++ |++++|++
T Consensus 249 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp EEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred CCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 788999999999999999999999887766655554332 11233334568999999999999999988 99999999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+..+|+.
T Consensus 329 ~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 329 RHLFFKNDQWAW 340 (410)
T ss_dssp TSGGGCCSSCCS
T ss_pred cCccccCCCHHH
Confidence 999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=296.29 Aligned_cols=210 Identities=28% Similarity=0.517 Sum_probs=153.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~----- 139 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLT----- 139 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCC-----
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 357899999999999999999999999999999999998656789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.
T Consensus 140 ----------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (278)
T 3cok_A 140 ----------------------------LSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191 (278)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECC----------------------------
T ss_pred ----------------------------HHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCc
Confidence 8899999999999999999976554333334456889999999999888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+|+++|+|++|..||...........+... ....+..++.++.++|.+||+.||++|||++|+++||||++
T Consensus 192 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred hhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc---ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 999999999999999999999765544433322221 23345668999999999999999999999999999999987
Q ss_pred ccCCCC
Q psy3253 241 HDTDPS 246 (251)
Q Consensus 241 ~~~~~~ 246 (251)
......
T Consensus 269 ~~~~~~ 274 (278)
T 3cok_A 269 NSSTKS 274 (278)
T ss_dssp ------
T ss_pred CCCccc
Confidence 665443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=299.32 Aligned_cols=207 Identities=28% Similarity=0.470 Sum_probs=167.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+.+ +|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk----- 127 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK----- 127 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-----
Confidence 4678999999999999999999999999975 9999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+||+|||++..............+|+.|+|||++.+ ..++
T Consensus 128 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (288)
T 1ob3_A 128 ----------------------------PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (288)
T ss_dssp ----------------------------GGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred ----------------------------HHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCC
Confidence 88999999999999999999765433333344567999999999965 4589
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC----CCC-------------CCCC---------CCCCCCCHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP----TKP-------------PPSF---------REPDVWTPEFID 213 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~-------------~~~~---------~~~~~~~~~~~~ 213 (251)
.++||||+||++|+|++|.+||.+.+.......+. ... .... .....+++++.+
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T 1ob3_A 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (288)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence 99999999999999999999997665433322110 000 0000 112457899999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|.+||+.||++|||++|+++||||++.
T Consensus 260 li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 260 LLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 9999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=317.41 Aligned_cols=211 Identities=24% Similarity=0.420 Sum_probs=179.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||++++++|.++..+|+||||+.||+|.+++......+++..++.++.||+.||.|||++||+|||||
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK------ 202 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK------ 202 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC------
Confidence 35789999999999999999999999999999999998556789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccc-----c
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||++. .
T Consensus 203 ---------------------------p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 255 (437)
T 4aw2_A 203 ---------------------------PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255 (437)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSC
T ss_pred ---------------------------HHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCC
Confidence 9999999999999999999976543322 223457899999999996 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCC-CCCCCCCHHHHHHHHHhhhcCcCc--cCCHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSF-REPDVWTPEFIDFVSRCLVKNPEE--RATASE 231 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~--Rps~~e 231 (251)
..++.++|+||+||++|+|++|.+||.+.+.......+.... ...+ .....+++++.+||.+||..+|++ |++++|
T Consensus 256 ~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e 335 (437)
T 4aw2_A 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIED 335 (437)
T ss_dssp CEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred CCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence 568999999999999999999999998877665554443211 1111 123458999999999999998888 999999
Q ss_pred HhcChhhhhccCCC
Q psy3253 232 MLNHEFIQRHDTDP 245 (251)
Q Consensus 232 vl~hp~~~~~~~~~ 245 (251)
+++||||+..+|+.
T Consensus 336 il~Hpff~~i~w~~ 349 (437)
T 4aw2_A 336 FKKHPFFSGIDWDN 349 (437)
T ss_dssp HHTSGGGTTCCTTT
T ss_pred HhCCCccCCCCHHH
Confidence 99999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=305.10 Aligned_cols=210 Identities=24% Similarity=0.434 Sum_probs=164.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||++ |+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlk----- 159 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK----- 159 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCC-----
Confidence 467899999999999999999999999997 59999997 45679999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceec-----CCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-----NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~-----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||++ +..+.+||+|||++..............+|+.|+|||++.+
T Consensus 160 ----------------------------p~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 160 ----------------------------PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp ----------------------------GGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT
T ss_pred ----------------------------HHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC
Confidence 667777 34455999999999766544334444567999999999976
Q ss_pred C-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC-C-------------CCCC----------CCCC
Q psy3253 156 I-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP-P-------------SFRE----------PDVW 207 (251)
Q Consensus 156 ~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-~-------------~~~~----------~~~~ 207 (251)
. .++.++||||+||++|+|++|..||.+.........+.. ... . .+.. ...+
T Consensus 212 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
T 3gbz_A 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALL 291 (329)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGS
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhccccc
Confidence 4 489999999999999999999999977655443322210 000 0 0000 0116
Q ss_pred CHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 208 TPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 208 ~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
++++.+||.+||+.||++|||++|+++||||+..+|+|
T Consensus 292 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 78999999999999999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.59 Aligned_cols=211 Identities=30% Similarity=0.573 Sum_probs=169.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++.++...|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 81 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk----- 155 (389)
T 3gni_B 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK----- 155 (389)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 4689999999999999999999999999999999999744 3679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-------cccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-------AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++|+|||.+....... .......+|+.|+|||++
T Consensus 156 ----------------------------p~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 156 ----------------------------ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp ----------------------------GGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred ----------------------------HHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence 889999999999999999886442211 112223678889999999
Q ss_pred cc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC---------------------------------
Q psy3253 154 QE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP--------------------------------- 198 (251)
Q Consensus 154 ~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------- 198 (251)
.+ ..++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 208 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (389)
T 3gni_B 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287 (389)
T ss_dssp STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------
T ss_pred hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccccc
Confidence 77 6789999999999999999999999976555444333221110
Q ss_pred ----------CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 199 ----------PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 199 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
.....+..+++++.+||.+||+.||++|||++|+|+||||+...+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp ------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence 01112455789999999999999999999999999999999877654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=313.45 Aligned_cols=211 Identities=27% Similarity=0.400 Sum_probs=177.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||++++++|++...+|+||||+.||+|.+++...+..+++..++.++.||+.||.|||++||+|||||
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK------ 189 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK------ 189 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC------
Confidence 35789999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccc------
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQ------ 154 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~------ 154 (251)
|+||+++.++++||+|||+++....... ......||+.|+|||++.
T Consensus 190 ---------------------------p~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~ 242 (412)
T 2vd5_A 190 ---------------------------PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242 (412)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred ---------------------------HHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCc
Confidence 9999999999999999999976543322 223457899999999996
Q ss_pred -cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCC-CCCCCCCHHHHHHHHHhhhcCcCcc---CC
Q psy3253 155 -EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSF-REPDVWTPEFIDFVSRCLVKNPEER---AT 228 (251)
Q Consensus 155 -~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~R---ps 228 (251)
...++.++|+|||||++|+|++|..||.+.+.......+.... ...+ ..+..+++++.+||.+||. +|++| ++
T Consensus 243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~ 321 (412)
T 2vd5_A 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGG 321 (412)
T ss_dssp TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTT
T ss_pred CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence 3568999999999999999999999998776665544443211 0111 1235689999999999999 99998 59
Q ss_pred HHHHhcChhhhhccCCCC
Q psy3253 229 ASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 229 ~~evl~hp~~~~~~~~~~ 246 (251)
++|+++||||+..+|+.-
T Consensus 322 ~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 322 AGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp HHHHHTSGGGTTCCSTTS
T ss_pred HHHHhcCCCcCCCCHHHH
Confidence 999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=294.56 Aligned_cols=207 Identities=24% Similarity=0.373 Sum_probs=169.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+++ +|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dik----- 128 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK----- 128 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 4678999999999999999999999999975 7777776667889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~ 159 (251)
|+||+++.++.+||+|||++..............+|+.|+|||++.+.. ++
T Consensus 129 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (292)
T 3o0g_A 129 ----------------------------PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred ----------------------------HHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcC
Confidence 8899999999999999999987654444445567899999999997755 79
Q ss_pred cchhHHHHHHHHHHHHhCCCCC-CCCCcchhhhhcC---CC-----------------------CCCCCCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPY-GDIHPMRAIFMIP---TK-----------------------PPPSFREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~---~~-----------------------~~~~~~~~~~~~~~~~ 212 (251)
.++||||+||++|+|++|..|| .+.+.......+. .. ..........+++++.
T Consensus 181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (292)
T 3o0g_A 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260 (292)
T ss_dssp THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred chHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHH
Confidence 9999999999999999887775 4333322221110 00 0001111235789999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||.+||+.||++|||++|+++||||++.
T Consensus 261 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 261 DLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=298.83 Aligned_cols=210 Identities=82% Similarity=1.375 Sum_probs=183.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~------ 152 (314)
T 3com_A 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK------ 152 (314)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcC------
Confidence 57899999999999999999999999999999999998677889999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.+
T Consensus 153 ---------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 205 (314)
T 3com_A 153 ---------------------------AGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV 205 (314)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTT
T ss_pred ---------------------------HHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCcc
Confidence 88999999999999999999766544344445568899999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||||+++|+|++|..||...........+.......+..+..+++++.++|.+||..||++|||++|+++||||+..
T Consensus 206 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 99999999999999999999877665554444444444444566689999999999999999999999999999999876
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
.+.
T Consensus 286 ~~~ 288 (314)
T 3com_A 286 KGV 288 (314)
T ss_dssp CCG
T ss_pred Ccc
Confidence 543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=299.04 Aligned_cols=204 Identities=33% Similarity=0.552 Sum_probs=170.8
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+ ....|+||||+++++|.+++. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk--- 164 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK--- 164 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC---
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC---
Confidence 357899999999999986 568999999999999988653 4679999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 157 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 157 (251)
|+||+++.++.+||+|||++..............+|+.|+|||.+.+..
T Consensus 165 ------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 214 (298)
T 2zv2_A 165 ------------------------------PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRK 214 (298)
T ss_dssp ------------------------------GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCC
T ss_pred ------------------------------HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCC
Confidence 8899999999999999999976654433334457899999999997655
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 158 --YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 158 --~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++.++|||||||++|+|++|..||.+.........+.... ........+++++.++|.+||+.||++|||++|+++|
T Consensus 215 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhccc-CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 3778999999999999999999998766544433332221 1223345689999999999999999999999999999
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
|||++
T Consensus 294 p~~~~ 298 (298)
T 2zv2_A 294 PWVTR 298 (298)
T ss_dssp HHHHC
T ss_pred ccccC
Confidence 99974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.85 Aligned_cols=208 Identities=31% Similarity=0.541 Sum_probs=176.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlk----- 136 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIK----- 136 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCC-----
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCC-----
Confidence 3678999999999999999999999999999999999973 4679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++...... ......+++.|+|||.+.+..++.
T Consensus 137 ----------------------------p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 186 (279)
T 3fdn_A 137 ----------------------------PENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDE 186 (279)
T ss_dssp ----------------------------GGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCT
T ss_pred ----------------------------hHhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCc
Confidence 88999999999999999998654332 223456789999999999988999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+|+++|+|++|..||...+.......+... ....+..+++++.++|.+||+.||++|||++|+++||||+.
T Consensus 187 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred cchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 999999999999999999999877655554433332 22235668999999999999999999999999999999998
Q ss_pred ccCCCCC
Q psy3253 241 HDTDPSQ 247 (251)
Q Consensus 241 ~~~~~~~ 247 (251)
....++.
T Consensus 264 ~~~~~~~ 270 (279)
T 3fdn_A 264 NSSKPSN 270 (279)
T ss_dssp HCSSCCC
T ss_pred CccCccc
Confidence 7776654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.77 Aligned_cols=210 Identities=21% Similarity=0.391 Sum_probs=176.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+.+|+|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk----- 176 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK----- 176 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc-----
Confidence 468899999999999999999999999999999999997555689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecC--CCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN--TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++ ..+.+||+|||++....... ......+|+.|+|||++.+..+
T Consensus 177 ----------------------------p~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 227 (387)
T 1kob_A 177 ----------------------------PENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPV 227 (387)
T ss_dssp ----------------------------GGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCB
T ss_pred ----------------------------hHHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhccCCCC
Confidence 7788886 34679999999997654332 2233468999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|..||.+.+.......+... .......+..+++++.+||.+||..||++|||++|+++|||
T Consensus 228 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 99999999999999999999999877655444333222 11122234568999999999999999999999999999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|+...+.
T Consensus 308 ~~~~~~~ 314 (387)
T 1kob_A 308 LKGDHSN 314 (387)
T ss_dssp TSSCCTT
T ss_pred ccCCccc
Confidence 9875443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=304.46 Aligned_cols=207 Identities=28% Similarity=0.448 Sum_probs=173.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk------ 141 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK------ 141 (326)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCC------
Confidence 46899999999999999999999999999999999996 45789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++ .+||+|||++...... .......+|+.|+|||++.+..
T Consensus 142 ---------------------------p~NIll~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 193 (326)
T 2y0a_A 142 ---------------------------PENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP 193 (326)
T ss_dssp ---------------------------GGGEEESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCC
T ss_pred ---------------------------HHHEEEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCC
Confidence 7788887766 7999999999765432 2233456899999999999889
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|..||.+.........+.... ......+..+++.+.++|.+||+.||++|||++|+++||
T Consensus 194 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 9999999999999999999999997766554443332221 111112356789999999999999999999999999999
Q ss_pred hhhhccC
Q psy3253 237 FIQRHDT 243 (251)
Q Consensus 237 ~~~~~~~ 243 (251)
||+..++
T Consensus 274 ~~~~~~~ 280 (326)
T 2y0a_A 274 WIKPKDT 280 (326)
T ss_dssp TTSCCSH
T ss_pred CccCCcc
Confidence 9986554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.71 Aligned_cols=212 Identities=22% Similarity=0.391 Sum_probs=170.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||++ |+|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dik----- 127 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK----- 127 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCC-----
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcC-----
Confidence 467899999999999999999999999996 59999998777789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.++|+|||++..............+|+.|+|||++.+ ..++
T Consensus 128 ----------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 179 (324)
T 3mtl_A 128 ----------------------------PQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179 (324)
T ss_dssp ----------------------------GGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCC
T ss_pred ----------------------------HHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCC
Confidence 88999999999999999999765544333444567999999999876 5689
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCCC-C-----------------------CCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPPP-S-----------------------FREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~-----------------------~~~~~~~~~~~~ 212 (251)
.++||||+||++|+|++|..||.+.+.......+.. .... . ......+++++.
T Consensus 180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (324)
T 3mtl_A 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259 (324)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHH
Confidence 999999999999999999999987655443322111 1000 0 001235688999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
+||.+||+.||++|||++|+++||||+...+...
T Consensus 260 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred HHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 9999999999999999999999999998776543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.85 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=173.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+.+|+|.+++. ....+++..+..++.||+.||.|||++||+|||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk------ 155 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLK------ 155 (362)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS------
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc------
Confidence 46899999999999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCC---CCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.+ +.+||+|||++...... .......||+.|+|||++.+..+
T Consensus 156 ---------------------------p~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 156 ---------------------------PENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp ---------------------------GGGEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCC
T ss_pred ---------------------------hHHEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCC
Confidence 778887654 45999999999766533 22334568999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|.+||.+.+.......+..... .....+..+++++.+||.+||+.||++|||++|+++|||
T Consensus 208 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 9999999999999999999999987766555544333211 111223567999999999999999999999999999999
Q ss_pred hhhc
Q psy3253 238 IQRH 241 (251)
Q Consensus 238 ~~~~ 241 (251)
|+..
T Consensus 288 ~~~~ 291 (362)
T 2bdw_A 288 ICNR 291 (362)
T ss_dssp HHTH
T ss_pred cCCC
Confidence 9754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=303.14 Aligned_cols=209 Identities=25% Similarity=0.382 Sum_probs=152.9
Q ss_pred CCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++. ||||+++++++.++...|+||||+++|+|.+++. ....+++.+++.++.|++.||.|||++|++|||||
T Consensus 61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk------ 133 (325)
T 3kn6_A 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK------ 133 (325)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC------
Confidence 454 9999999999999999999999999999999997 46789999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++ .++|+|||++..............+|+.|+|||++.+..+
T Consensus 134 ---------------------------p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 186 (325)
T 3kn6_A 134 ---------------------------PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186 (325)
T ss_dssp ---------------------------GGGEEEEC----CEEEECCCTTCEECCC----------------------CCC
T ss_pred ---------------------------HHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCC
Confidence 7777776554 7999999999765544333445567899999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCc-------chhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHP-------MRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
+.++||||+||++|+|++|..||.+.+. ......+..... .....+..+++++.+||.+||+.||++|||++
T Consensus 187 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 266 (325)
T 3kn6_A 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTT
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHH
Confidence 9999999999999999999999965432 122222332211 11111245799999999999999999999999
Q ss_pred HHhcChhhhhccCCC
Q psy3253 231 EMLNHEFIQRHDTDP 245 (251)
Q Consensus 231 evl~hp~~~~~~~~~ 245 (251)
|+++||||+.....+
T Consensus 267 ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 267 GLRYNEWLQDGSQLS 281 (325)
T ss_dssp TSTTCGGGCTTCCCC
T ss_pred HHhcChhhccCccCC
Confidence 999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=308.14 Aligned_cols=209 Identities=27% Similarity=0.386 Sum_probs=176.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++++|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk----- 214 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK----- 214 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC-----
Confidence 468899999999999999999999999999999999997666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceec--CCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL--NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||++ +.++.+||+|||++...... .......||+.|+|||++.+..+
T Consensus 215 ----------------------------p~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 265 (373)
T 2x4f_A 215 ----------------------------PENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFV 265 (373)
T ss_dssp ----------------------------GGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBC
T ss_pred ----------------------------HHHEEEecCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCC
Confidence 778877 45678999999999765433 22334468999999999988889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|||||||++|+|++|..||.+.+.......+... ..........+++++.+||.+||+.||++|||++|+++|||
T Consensus 266 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 99999999999999999999999877665544433222 11122223568999999999999999999999999999999
Q ss_pred hhhccC
Q psy3253 238 IQRHDT 243 (251)
Q Consensus 238 ~~~~~~ 243 (251)
|+...+
T Consensus 346 ~~~~~~ 351 (373)
T 2x4f_A 346 LSDHKL 351 (373)
T ss_dssp HHCHHH
T ss_pred cCCCch
Confidence 987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=292.69 Aligned_cols=205 Identities=28% Similarity=0.516 Sum_probs=166.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++||||+++++++.+....++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dik-- 151 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK-- 151 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS--
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCC--
Confidence 3578999999999999999999999999999999998853 34789999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||++ +.++.++|+|||++...... .......+++.|+|||++.
T Consensus 152 -------------------------------p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 152 -------------------------------PENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp -------------------------------GGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT
T ss_pred -------------------------------HHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc
Confidence 777777 44577999999999765433 2233456889999999985
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+|+++|+|++|..||.+.......................+++++.+++.+||+.||++|||++|+++
T Consensus 200 -~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 200 -RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4689999999999999999999999987765554433322222222233457999999999999999999999999999
Q ss_pred Chhhhh
Q psy3253 235 HEFIQR 240 (251)
Q Consensus 235 hp~~~~ 240 (251)
||||++
T Consensus 279 hp~f~~ 284 (285)
T 3is5_A 279 HEWFKQ 284 (285)
T ss_dssp SGGGGC
T ss_pred CHHhhc
Confidence 999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=303.28 Aligned_cols=207 Identities=23% Similarity=0.386 Sum_probs=171.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...|+||||+++|+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlk------ 132 (323)
T 3tki_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK------ 132 (323)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS------
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccc------
Confidence 46799999999999999999999999999999999986 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--cccccccccccccccccccccCCC-
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGY- 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~- 158 (251)
|+||+++.++.+||+|||++...... ........||+.|+|||++.+..+
T Consensus 133 ---------------------------p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 185 (323)
T 3tki_A 133 ---------------------------PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185 (323)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBC
T ss_pred ---------------------------hHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCC
Confidence 88999999999999999999754322 112234568999999999987765
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++||||+||++|+|++|..||.........................+++++.+||.+||+.||++|||++|+++||||
T Consensus 186 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 77899999999999999999999765443222211111112222345689999999999999999999999999999999
Q ss_pred hhcc
Q psy3253 239 QRHD 242 (251)
Q Consensus 239 ~~~~ 242 (251)
++..
T Consensus 266 ~~~~ 269 (323)
T 3tki_A 266 NKPL 269 (323)
T ss_dssp TCCC
T ss_pred cccc
Confidence 8643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=325.75 Aligned_cols=204 Identities=25% Similarity=0.420 Sum_probs=181.9
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||+|++++++|++...+|+||||++||+|.++++. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLK--------- 469 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK--------- 469 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCC---------
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCC---------
Confidence 799999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhH
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 164 (251)
|+||+++.++++||+|||+++.............||+.|+|||++.+..++.++|+
T Consensus 470 ------------------------p~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~Dv 525 (674)
T 3pfq_A 470 ------------------------LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525 (674)
T ss_dssp ------------------------STTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHH
T ss_pred ------------------------hhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceE
Confidence 88999999999999999999764433344455678999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH-----HHHhcChhhh
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-----SEMLNHEFIQ 239 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~evl~hp~~~ 239 (251)
|||||++|+|++|.+||.+.+.......+.... ...+..+++++.+||.+||+.||++||++ +|+++||||+
T Consensus 526 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred echHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 999999999999999998887777666655542 23356789999999999999999999998 9999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|+.
T Consensus 603 ~i~w~~ 608 (674)
T 3pfq_A 603 YIDWEK 608 (674)
T ss_dssp SCCHHH
T ss_pred CCCHHH
Confidence 988864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=296.88 Aligned_cols=210 Identities=44% Similarity=0.880 Sum_probs=175.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+...++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk------ 144 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK------ 144 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS------
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC------
Confidence 46799999999999999999999999999999999998667889999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc-----ccC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI-----QEI 156 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~ 156 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+ ...
T Consensus 145 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (302)
T 2j7t_A 145 ---------------------------AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197 (302)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTST
T ss_pred ---------------------------HHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCC
Confidence 889999999999999999875433222223345678999999998 356
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
.++.++||||||+++|+|++|..||...+.......+.....+....+..++.++.++|.+||..||++|||++|+++||
T Consensus 198 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp TTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred CCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 78899999999999999999999998776655544443333333344567899999999999999999999999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+...+.
T Consensus 278 ~~~~~~~~ 285 (302)
T 2j7t_A 278 FVSSITSN 285 (302)
T ss_dssp TTTTCCCC
T ss_pred HHhhhccc
Confidence 99987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=311.32 Aligned_cols=203 Identities=30% Similarity=0.518 Sum_probs=176.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....|+||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++|++|||||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLk----- 143 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK----- 143 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCccccc-----
Confidence 467899999999999999999999999999999999986 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC-C
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-D 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~ 159 (251)
|+||+++.++.+||+|||++...... .......||+.|+|||++.+..+ +
T Consensus 144 ----------------------------p~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 194 (476)
T 2y94_A 144 ----------------------------PENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAG 194 (476)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCS
T ss_pred ----------------------------HHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCC
Confidence 88999999999999999999765433 22334568999999999988765 6
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
.++||||+||++|+|++|..||.+.+.......+.... ...+..+++++.+||.+||+.||++|||++|+++||||+
T Consensus 195 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred CcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 89999999999999999999998776655555544432 233566899999999999999999999999999999998
Q ss_pred hc
Q psy3253 240 RH 241 (251)
Q Consensus 240 ~~ 241 (251)
..
T Consensus 272 ~~ 273 (476)
T 2y94_A 272 QD 273 (476)
T ss_dssp TT
T ss_pred hc
Confidence 64
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=289.89 Aligned_cols=211 Identities=27% Similarity=0.529 Sum_probs=175.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk----- 133 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK----- 133 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC-----
Confidence 357899999999999999999999999999999999987 45679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||++ +.++.++|+|||++...... .......+|+.|+|||.+.+.
T Consensus 134 ----------------------------p~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~- 183 (277)
T 3f3z_A 134 ----------------------------PENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL- 183 (277)
T ss_dssp ----------------------------GGGEEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-
T ss_pred ----------------------------HHHEEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-
Confidence 778887 67788999999999765433 233345689999999998664
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCC-CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP-SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+|+++|+|++|..||...........+...... .......+++++.+++.+||+.||++|||++|+++||
T Consensus 184 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 899999999999999999999999877665555444333211 1111236799999999999999999999999999999
Q ss_pred hhhhccCCCCC
Q psy3253 237 FIQRHDTDPSQ 247 (251)
Q Consensus 237 ~~~~~~~~~~~ 247 (251)
||++....+.+
T Consensus 264 ~~~~~~~~~~~ 274 (277)
T 3f3z_A 264 WFEKQLSSSPR 274 (277)
T ss_dssp HHHHHHCCSGG
T ss_pred HHhcccccccc
Confidence 99987665543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=290.35 Aligned_cols=210 Identities=26% Similarity=0.414 Sum_probs=176.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+.+++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik------ 132 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLK------ 132 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC------
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCC------
Confidence 46799999999999999999999999999999999887 34679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCC---eEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++. ++|+|||.+...... .......+++.|+|||.+.+..+
T Consensus 133 ---------------------------p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 184 (284)
T 3kk8_A 133 ---------------------------PENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 184 (284)
T ss_dssp ---------------------------GGGEEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCB
T ss_pred ---------------------------HHHEEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCC
Confidence 77888865544 999999999765433 22234568999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+|+++|+|++|..||.+.+.......+... ..........+++++.+++.+||+.||++|||++|+++|||
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 99999999999999999999999877665554443222 11222234578999999999999999999999999999999
Q ss_pred hhhccCCCC
Q psy3253 238 IQRHDTDPS 246 (251)
Q Consensus 238 ~~~~~~~~~ 246 (251)
|+...+...
T Consensus 265 ~~~~~~~~~ 273 (284)
T 3kk8_A 265 ICNRERVAS 273 (284)
T ss_dssp HHSCCCGGG
T ss_pred ccCChhHHh
Confidence 998766543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=290.22 Aligned_cols=207 Identities=29% Similarity=0.528 Sum_probs=178.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~------ 142 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK------ 142 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC------
Confidence 57899999999999999999999999999999999886 44689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.+
T Consensus 143 ---------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 195 (294)
T 2rku_A 143 ---------------------------LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195 (294)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTH
T ss_pred ---------------------------hHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCch
Confidence 88999999999999999999765533333444568899999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+|+++|+|++|..||...........+... ....+..+++.+.+++.+||+.||++|||++|+++||||+..
T Consensus 196 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 99999999999999999999876655544433332 223356789999999999999999999999999999999876
Q ss_pred cCCC
Q psy3253 242 DTDP 245 (251)
Q Consensus 242 ~~~~ 245 (251)
...+
T Consensus 273 ~~~~ 276 (294)
T 2rku_A 273 YIPA 276 (294)
T ss_dssp CCCS
T ss_pred CcCC
Confidence 6544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=298.65 Aligned_cols=205 Identities=30% Similarity=0.442 Sum_probs=169.0
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++.++...|+||||++||+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlk--------- 143 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK--------- 143 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC---------
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC---------
Confidence 79999999999999999999999999999999997 55789999999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCC-C---CCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-E---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||++.. + +.+||+|||++..............+|+.|+|||++.+..++.
T Consensus 144 ------------------------p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 199 (342)
T 2qr7_A 144 ------------------------PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDA 199 (342)
T ss_dssp ------------------------GGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHH
T ss_pred ------------------------HHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCC
Confidence 77777532 2 3499999999986654433444556899999999998888899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCC---CcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDI---HPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++|+||+||++|+|++|..||.+. ........+... .......+..+++++.+||.+||..||++|||++|+++||
T Consensus 200 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 200 ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 999999999999999999999653 222222222222 1111123456899999999999999999999999999999
Q ss_pred hhhhccC
Q psy3253 237 FIQRHDT 243 (251)
Q Consensus 237 ~~~~~~~ 243 (251)
||...+.
T Consensus 280 ~~~~~~~ 286 (342)
T 2qr7_A 280 WIVHWDQ 286 (342)
T ss_dssp HHHTGGG
T ss_pred eecCccc
Confidence 9976543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=295.27 Aligned_cols=207 Identities=26% Similarity=0.409 Sum_probs=164.7
Q ss_pred CCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 4 CDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++||||+++++++.... ..+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk-- 147 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK-- 147 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC--
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC--
Confidence 46999999999998754 5899999996 59999997433 349999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||++...... .......+|+.|+|||++.+..
T Consensus 148 -------------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 195 (308)
T 3g33_A 148 -------------------------------PENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST 195 (308)
T ss_dssp -------------------------------TTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC
T ss_pred -------------------------------HHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCC
Confidence 88899988999999999999765433 2334456899999999999989
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC----CCCCCC--------------------CCCCCCCHHHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT----KPPPSF--------------------REPDVWTPEFID 213 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~--------------------~~~~~~~~~~~~ 213 (251)
++.++||||+||++|+|++|.+||.+.+.......+.. .....+ .....+++++.+
T Consensus 196 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (308)
T 3g33_A 196 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ 275 (308)
T ss_dssp CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHH
T ss_pred CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHH
Confidence 99999999999999999999999977655444332211 000000 012357899999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
||.+||+.||++|||++|+|+||||++.+.++
T Consensus 276 li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~~ 307 (308)
T 3g33_A 276 LLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307 (308)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSTTC-------
T ss_pred HHHHHhcCCCccCCCHHHHhcCccccCCCCCC
Confidence 99999999999999999999999999876544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=301.06 Aligned_cols=204 Identities=29% Similarity=0.471 Sum_probs=159.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+.+|+|.+++. ..+.+++..++.++.|++.||.|||++|++|||||
T Consensus 71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk------ 143 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK------ 143 (361)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC------
T ss_pred HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC------
Confidence 46899999999999999999999999999999999997 34679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCC--eEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++. +||+|||+++..... .......||+.|+|||++.+..++
T Consensus 144 ---------------------------p~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 195 (361)
T 3uc3_A 144 ---------------------------LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYD 195 (361)
T ss_dssp ---------------------------GGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCC
T ss_pred ---------------------------HHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCC
Confidence 88888876665 999999998743322 223345689999999999887776
Q ss_pred cc-hhHHHHHHHHHHHHhCCCCCCCCCcchh----hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CV-ADMWSLGITALEMAEGKPPYGDIHPMRA----IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~-~DvwslG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.+ +||||+||++|+|++|..||.+...... ...+... .........+++++.+||.+||+.||++|||++|+++
T Consensus 196 ~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 65 8999999999999999999976443221 1111111 1222334467999999999999999999999999999
Q ss_pred Chhhhhc
Q psy3253 235 HEFIQRH 241 (251)
Q Consensus 235 hp~~~~~ 241 (251)
||||.+.
T Consensus 275 hp~f~~~ 281 (361)
T 3uc3_A 275 HSWFLKN 281 (361)
T ss_dssp SHHHHTT
T ss_pred CcchhcC
Confidence 9999654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=299.72 Aligned_cols=209 Identities=26% Similarity=0.364 Sum_probs=165.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++|+|.+++. ....+++.+++.++.|++.||.|||++|++|||||
T Consensus 103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik------ 175 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK------ 175 (349)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC------
T ss_pred HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC------
Confidence 46799999999999999999999999999999999986 45679999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++. ++.+||+|||++...... .......||+.|+|||++.+..+
T Consensus 176 ---------------------------p~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 227 (349)
T 2w4o_A 176 ---------------------------PENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227 (349)
T ss_dssp ---------------------------GGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCC
T ss_pred ---------------------------cccEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCC
Confidence 77777764 788999999999765432 22234568999999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcch-hhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMR-AIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
+.++|||||||++|+|++|..||.+..... ....+... ..........++.++.+||.+||+.||++|||++|+++||
T Consensus 228 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999999999999999999999997655443 22222222 1111223456899999999999999999999999999999
Q ss_pred hhhhccCCC
Q psy3253 237 FIQRHDTDP 245 (251)
Q Consensus 237 ~~~~~~~~~ 245 (251)
||+....+.
T Consensus 308 ~~~~~~~~~ 316 (349)
T 2w4o_A 308 WVTGKAANF 316 (349)
T ss_dssp TTTSTTCCC
T ss_pred ccCCCccch
Confidence 998766543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=297.22 Aligned_cols=210 Identities=24% Similarity=0.441 Sum_probs=166.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlk------ 129 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK------ 129 (311)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC------
Confidence 46899999999999999999999999999999988876 56779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 160 (251)
|+||+++.++.++|+|||++..............+++.|+|||++.+ ..++.
T Consensus 130 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (311)
T 4agu_A 130 ---------------------------PENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182 (311)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCT
T ss_pred ---------------------------hhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCc
Confidence 88999999999999999999766544333445568899999999975 66899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---------------------CCCCCCCC-------CCCCCCHHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---------------------TKPPPSFR-------EPDVWTPEFI 212 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------------~~~~~~~~-------~~~~~~~~~~ 212 (251)
++||||+|+++|++++|..||.+.........+. ....+... ....+++++.
T Consensus 183 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (311)
T 4agu_A 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHH
T ss_pred chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHH
Confidence 9999999999999999999997765443322110 00000000 0145788999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+++.+||+.||++|||++|+++||||++..+..
T Consensus 263 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 263 GLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred HHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 999999999999999999999999999876654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=288.19 Aligned_cols=204 Identities=30% Similarity=0.537 Sum_probs=167.3
Q ss_pred CCCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~di 74 (251)
|++++||||+++++++.. +...++||||+++++|.+++. ....+++..++.++.|++.||.|||++| ++||||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~di 157 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH-HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCC
Confidence 467899999999999875 456899999999999999997 4467999999999999999999999999 999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
| |+||+++ .++.++|+|||++...... ......+++.|+|||++
T Consensus 158 k---------------------------------p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 158 K---------------------------------CDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp C---------------------------------GGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGG
T ss_pred C---------------------------------HHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHH
Confidence 8 8899987 7889999999999654332 22334688999999988
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
.+ .++.++||||+||++|+|++|..||......................+...++++.++|.+||+.||++|||++|++
T Consensus 203 ~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 203 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 64 58999999999999999999999997654443332222222222223456789999999999999999999999999
Q ss_pred cChhhhhc
Q psy3253 234 NHEFIQRH 241 (251)
Q Consensus 234 ~hp~~~~~ 241 (251)
+||||++.
T Consensus 282 ~h~~f~~~ 289 (290)
T 1t4h_A 282 NHAFFQEE 289 (290)
T ss_dssp TSGGGC--
T ss_pred hCcccccC
Confidence 99999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=295.69 Aligned_cols=206 Identities=30% Similarity=0.530 Sum_probs=177.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+||||+++++|.+++. ....+++.+++.++.||+.||.|||++|++|||||
T Consensus 96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk------ 168 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK------ 168 (335)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC------
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC------
Confidence 57899999999999999999999999999999999987 44689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++..............+++.|+|||++.+..++.+
T Consensus 169 ---------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 221 (335)
T 2owb_A 169 ---------------------------LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221 (335)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTH
T ss_pred ---------------------------chhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCch
Confidence 88999999999999999999766533333444568899999999998889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||||+++|+|++|..||...........+... ....+..+++++.++|.+||+.||++|||++|+++||||+..
T Consensus 222 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred hhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999776554444333222 222356789999999999999999999999999999999876
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 299 ~~~ 301 (335)
T 2owb_A 299 YIP 301 (335)
T ss_dssp CCC
T ss_pred Ccc
Confidence 543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=287.73 Aligned_cols=205 Identities=23% Similarity=0.450 Sum_probs=176.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~------ 141 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIK------ 141 (284)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS------
T ss_pred hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC------
Confidence 578999999999999999999999999999999999974 4579999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||++...... ......+++.|+|||.+.+..++.+
T Consensus 142 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (284)
T 2vgo_A 142 ---------------------------PENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEK 192 (284)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTT
T ss_pred ---------------------------HHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcc
Confidence 88999999999999999998654432 2234567899999999999889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|+||+|+++|++++|..||...........+... ....+..+++++.++|.+||..||++|||++|+++||||+..
T Consensus 193 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc---ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 99999999999999999999876655544433332 122356689999999999999999999999999999999876
Q ss_pred cCCC
Q psy3253 242 DTDP 245 (251)
Q Consensus 242 ~~~~ 245 (251)
....
T Consensus 270 ~~~~ 273 (284)
T 2vgo_A 270 SRRV 273 (284)
T ss_dssp CCCC
T ss_pred cccc
Confidence 5443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=294.14 Aligned_cols=196 Identities=27% Similarity=0.423 Sum_probs=168.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g-sL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....++||||+.+| +|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk---- 157 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK---- 157 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS----
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccC----
Confidence 46789999999999999999999999999766 9999987 55689999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC-
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY- 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~- 158 (251)
|+||+++.++.+||+|||++...... .......||+.|+|||++.+..+
T Consensus 158 -----------------------------p~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 207 (335)
T 3dls_A 158 -----------------------------DENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYR 207 (335)
T ss_dssp -----------------------------GGGEEECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBC
T ss_pred -----------------------------HHHEEEcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCC
Confidence 88999999999999999999765433 22334568999999999988776
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|||||||++|+|++|..||....... . .....+..+++++.++|.+||+.||++|||++|+++||||
T Consensus 208 ~~~~DiwslG~il~el~~g~~pf~~~~~~~------~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 208 GPELEMWSLGVTLYTLVFEENPFCELEETV------E---AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T---TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred CCcccchhHHHHHHHHHhCCCchhhHHHHH------h---hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 789999999999999999999997533211 1 1222355689999999999999999999999999999999
Q ss_pred hh
Q psy3253 239 QR 240 (251)
Q Consensus 239 ~~ 240 (251)
++
T Consensus 279 ~~ 280 (335)
T 3dls_A 279 TQ 280 (335)
T ss_dssp TC
T ss_pred cC
Confidence 75
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=312.12 Aligned_cols=208 Identities=26% Similarity=0.496 Sum_probs=176.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....|+||||+.+|+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk----- 153 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK----- 153 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC-----
Confidence 468899999999999999999999999999999999987 56789999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||++ +.++.+||+|||++....... ......||+.|+|||++.+ .
T Consensus 154 ----------------------------p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~ 203 (484)
T 3nyv_A 154 ----------------------------PENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-T 203 (484)
T ss_dssp ----------------------------GGGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-C
T ss_pred ----------------------------HHHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCceeecC-C
Confidence 777777 456789999999997654332 2334568999999999866 6
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|.+||.+.+.......+.... ....+.+..+++++.+||.+||+.||++|||++|+|+||
T Consensus 204 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 8999999999999999999999998877666555443332 222233456899999999999999999999999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||+...++
T Consensus 284 ~~~~~~~~ 291 (484)
T 3nyv_A 284 WIQTYTKE 291 (484)
T ss_dssp HHHHHTC-
T ss_pred hhcccccc
Confidence 99987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.63 Aligned_cols=207 Identities=29% Similarity=0.414 Sum_probs=162.8
Q ss_pred CCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
..+||||++++++|.. ...+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk-- 188 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK-- 188 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC--
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC--
Confidence 3589999999999876 567999999999999999997432 469999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++. ++.+||+|||+++..... .......+|+.|+|||++.
T Consensus 189 -------------------------------p~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 189 -------------------------------PENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp -------------------------------GGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSC
T ss_pred -------------------------------cceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcC
Confidence 88888876 688999999999765432 2233456799999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh----hhhcC-CCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA----IFMIP-TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
+..++.++|||||||++|+|++|..||.+...... ...+. .........+..+++++.+||.+||+.||++|||+
T Consensus 237 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 316 (400)
T 1nxk_A 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316 (400)
T ss_dssp CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 99999999999999999999999999965433221 11111 11111122245689999999999999999999999
Q ss_pred HHHhcChhhhhccC
Q psy3253 230 SEMLNHEFIQRHDT 243 (251)
Q Consensus 230 ~evl~hp~~~~~~~ 243 (251)
+|+++||||.....
T Consensus 317 ~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 317 TEFMNHPWIMQSTK 330 (400)
T ss_dssp HHHHHSHHHHTTTT
T ss_pred HHHhcCccccCCCC
Confidence 99999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=313.95 Aligned_cols=207 Identities=27% Similarity=0.416 Sum_probs=176.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++||||++++++|.+...+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK--- 316 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK--- 316 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC---
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC---
Confidence 4679999999999999999999999999999999998743 3469999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++++||+|||+++.............||+.|+|||++.+..+
T Consensus 317 ------------------------------P~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 366 (543)
T 3c4z_A 317 ------------------------------PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366 (543)
T ss_dssp ------------------------------GGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCB
T ss_pred ------------------------------hHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCC
Confidence 99999999999999999999876544333444578999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCc----chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----H
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHP----MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----A 229 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~ 229 (251)
+.++|+||+||++|+|++|.+||.+... ......+... ....+..+++++.++|.+||+.||++||+ +
T Consensus 367 ~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a 443 (543)
T 3c4z_A 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443 (543)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBS
T ss_pred ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCH
Confidence 9999999999999999999999976532 2222222222 12235678999999999999999999996 5
Q ss_pred HHHhcChhhhhccCC
Q psy3253 230 SEMLNHEFIQRHDTD 244 (251)
Q Consensus 230 ~evl~hp~~~~~~~~ 244 (251)
+|+++||||+..+|.
T Consensus 444 ~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 444 DGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHTSGGGTTCCHH
T ss_pred HHHHcCccccCCCHH
Confidence 899999999998774
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=315.15 Aligned_cols=206 Identities=26% Similarity=0.425 Sum_probs=174.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++.+....|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLK----- 313 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK----- 313 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCc-----
Confidence 46899999999999999999999999999999999987433 359999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.
T Consensus 314 ----------------------------PeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~ 364 (576)
T 2acx_A 314 ----------------------------PENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTF 364 (576)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESS
T ss_pred ----------------------------hheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCc
Confidence 899999999999999999997654332 223347899999999999888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASE 231 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e 231 (251)
++|+||+||++|+|++|.+||.+.... .....+... + ...+..+++++.+||.+||..||++|| +++|
T Consensus 365 ~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~--~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~e 441 (576)
T 2acx_A 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441 (576)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c--ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHH
Confidence 999999999999999999999765321 112222211 1 123567899999999999999999999 8999
Q ss_pred HhcChhhhhccCC
Q psy3253 232 MLNHEFIQRHDTD 244 (251)
Q Consensus 232 vl~hp~~~~~~~~ 244 (251)
+++||||+..+|+
T Consensus 442 il~HpfF~~i~w~ 454 (576)
T 2acx_A 442 VKEHPLFKKLNFK 454 (576)
T ss_dssp HHTSGGGTTCCHH
T ss_pred HHhChhhccCCHH
Confidence 9999999998774
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.23 Aligned_cols=208 Identities=27% Similarity=0.488 Sum_probs=174.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....|+|||||.+|+|.+++.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 76 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk------ 148 (486)
T 3mwu_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK------ 148 (486)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS------
T ss_pred HhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc------
Confidence 568999999999999999999999999999999998873 4689999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecC---CCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++ .++.+||+|||++...... .......||+.|+|||++.+ .+
T Consensus 149 ---------------------------p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~ 199 (486)
T 3mwu_A 149 ---------------------------PENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TY 199 (486)
T ss_dssp ---------------------------GGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CC
T ss_pred ---------------------------hHHEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CC
Confidence 7777774 4557999999999765433 22334568999999999875 58
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|.+||.+.+.......+... .....+.+..+++++.+||.+||+.||++|||++|+|+|||
T Consensus 200 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 99999999999999999999999887766555444332 22222334568999999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|+......
T Consensus 280 ~~~~~~~~ 287 (486)
T 3mwu_A 280 IQKYSSET 287 (486)
T ss_dssp HHHTCCCC
T ss_pred hccCcccC
Confidence 99876654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=295.76 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=174.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dik------ 142 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK------ 142 (321)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC------
Confidence 46899999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++ .++|+|||++...... .......+|+.|+|||++.+..
T Consensus 143 ---------------------------p~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 194 (321)
T 2a2a_A 143 ---------------------------PENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP 194 (321)
T ss_dssp ---------------------------GGGEEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCC
T ss_pred ---------------------------hHHEEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCC
Confidence 8888887776 7999999999765543 2223446899999999999889
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|..||.+.........+..... .....+..+++.+.++|.+||..||++|||++|+++||
T Consensus 195 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 99999999999999999999999987766555444333211 11111256789999999999999999999999999999
Q ss_pred hhhhccC
Q psy3253 237 FIQRHDT 243 (251)
Q Consensus 237 ~~~~~~~ 243 (251)
||+..++
T Consensus 275 ~~~~~~~ 281 (321)
T 2a2a_A 275 WITPVDN 281 (321)
T ss_dssp TTSCSSH
T ss_pred cccCCCc
Confidence 9987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.94 Aligned_cols=210 Identities=23% Similarity=0.376 Sum_probs=172.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++ +|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk------ 139 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK------ 139 (346)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC------
T ss_pred hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC------
Confidence 467899999999999999999999999975 8999887556679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ 160 (251)
|+||+++.++.+||+|||++..............+|+.|+|||++.+ ..++.
T Consensus 140 ---------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 192 (346)
T 1ua2_A 140 ---------------------------PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 192 (346)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCH
T ss_pred ---------------------------HHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCc
Confidence 88999999999999999999876544334445568999999999965 45889
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC----CCCCCCC---------------------CCCCCCHHHHHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT----KPPPSFR---------------------EPDVWTPEFIDFV 215 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~---------------------~~~~~~~~~~~li 215 (251)
++||||+||++|+|++|.+||.+.+.......+.. .....+. ....+++++.+||
T Consensus 193 ~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 272 (346)
T 1ua2_A 193 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI 272 (346)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHH
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHH
Confidence 99999999999999999999977655433322110 0000000 0144678999999
Q ss_pred HHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 216 SRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 216 ~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
.+||+.||++|||++|+++||||+...+..
T Consensus 273 ~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 273 QGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp HHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred HHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 999999999999999999999998766554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=286.98 Aligned_cols=211 Identities=45% Similarity=0.834 Sum_probs=167.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-------RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
|++++||||+++++++......++||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++|||
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 146 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5678999999999999999999999999999999999963 245699999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-----ccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-----AKRNTVIGTPFWM 148 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~ 148 (251)
|| |+||+++.++.++|+|||++....... .......+++.|+
T Consensus 147 l~---------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~ 193 (303)
T 2vwi_A 147 VK---------------------------------AGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193 (303)
T ss_dssp CS---------------------------------GGGEEECTTCCEEECCCHHHHHCC---------------CCCTTC
T ss_pred CC---------------------------------hhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCcccc
Confidence 88 889999999999999999986543221 1123346788999
Q ss_pred ccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCC-------CCCCCCCCHHHHHHHHHhhh
Q psy3253 149 APEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPS-------FREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 149 aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~ 220 (251)
|||++.+ ..++.++|||||||++|+|++|..||................... ......+++++.+++.+||+
T Consensus 194 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 273 (303)
T 2vwi_A 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273 (303)
T ss_dssp CHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCC
T ss_pred CHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHcc
Confidence 9999865 568999999999999999999999997765544432222211111 12235678999999999999
Q ss_pred cCcCccCCHHHHhcChhhhhccCC
Q psy3253 221 KNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 221 ~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.||++|||++|+++||||+...+.
T Consensus 274 ~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 274 KDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp SSGGGSCCHHHHHTSTTC------
T ss_pred CChhhCcCHHHHhhChhhhcCCCC
Confidence 999999999999999999876654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=288.12 Aligned_cols=207 Identities=36% Similarity=0.699 Sum_probs=160.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~ 77 (251)
+.++||||+++++++.++...++||||++ |+|.+++.. ....+++..++.++.|++.||.|||++ |++|||||
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk-- 137 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK-- 137 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS--
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC--
Confidence 56899999999999999999999999997 488887753 457899999999999999999999998 99999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc----
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---- 153 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~---- 153 (251)
|+||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus 138 -------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 185 (290)
T 3fme_A 138 -------------------------------PSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPEL 185 (290)
T ss_dssp -------------------------------GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCT
T ss_pred -------------------------------HHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhh
Confidence 88999999999999999999765433 223334688999999996
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+..++.++||||+||++|++++|..||...... ............. .....+++++.+++.+||+.||++|||++|+
T Consensus 186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~ 264 (290)
T 3fme_A 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-LPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264 (290)
T ss_dssp TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-cccccCCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 5567899999999999999999999999753322 2222221221112 2245689999999999999999999999999
Q ss_pred hcChhhhhccCC
Q psy3253 233 LNHEFIQRHDTD 244 (251)
Q Consensus 233 l~hp~~~~~~~~ 244 (251)
++||||+.....
T Consensus 265 l~hp~f~~~~~~ 276 (290)
T 3fme_A 265 MQHPFFTLHESK 276 (290)
T ss_dssp TTSHHHHHHHHS
T ss_pred HhCcccccCccc
Confidence 999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=289.58 Aligned_cols=206 Identities=58% Similarity=1.037 Sum_probs=178.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~------ 146 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIK------ 146 (303)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC------
Confidence 46799999999999999999999999999999999985 4679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.+
T Consensus 147 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 199 (303)
T 3a7i_A 147 ---------------------------AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199 (303)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred ---------------------------hheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCch
Confidence 88999999999999999999766544434455668899999999998899999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||||+++|+|++|..||...........+....... .+..++..+.+++.+||..||++|||++|+++||||.+.
T Consensus 200 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC--CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 999999999999999999998776655544433332222 356789999999999999999999999999999999875
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
...
T Consensus 278 ~~~ 280 (303)
T 3a7i_A 278 AKK 280 (303)
T ss_dssp CCC
T ss_pred CCc
Confidence 443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=308.12 Aligned_cols=205 Identities=26% Similarity=0.494 Sum_probs=173.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.+....|+|||||.+|+|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk----- 163 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK----- 163 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-----
Confidence 467899999999999999999999999999999999887 44679999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++. ++.+||+|||++...... .......||+.|+|||++. ..
T Consensus 164 ----------------------------p~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~-~~ 213 (494)
T 3lij_A 164 ----------------------------PENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLR-KK 213 (494)
T ss_dssp ----------------------------GGGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHT-TC
T ss_pred ----------------------------hhhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHc-cc
Confidence 77777754 345999999999765543 2334456899999999986 46
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|.+||.+.........+.... ......+..+++++.+||.+||+.||++|||++|+|+||
T Consensus 214 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 8999999999999999999999998877665554443322 112223456899999999999999999999999999999
Q ss_pred hhhhc
Q psy3253 237 FIQRH 241 (251)
Q Consensus 237 ~~~~~ 241 (251)
||+..
T Consensus 294 ~~~~~ 298 (494)
T 3lij_A 294 WIKEM 298 (494)
T ss_dssp HHHHH
T ss_pred ccccC
Confidence 99874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=287.12 Aligned_cols=209 Identities=23% Similarity=0.380 Sum_probs=171.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 132 (276)
T 2yex_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK------ 132 (276)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS------
T ss_pred HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC------
Confidence 46899999999999999999999999999999999885 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCC-
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY- 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~- 158 (251)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..+
T Consensus 133 ---------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (276)
T 2yex_A 133 ---------------------------PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185 (276)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBC
T ss_pred ---------------------------hHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCC
Confidence 889999999999999999997543221 12234467889999999987665
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|+||+|+++|+|++|..||......... ...... .........+++.+.++|.+||+.||++|||++|+++|||
T Consensus 186 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 67899999999999999999999765433221 111111 1122234567999999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|++.....
T Consensus 265 ~~~~~~~~ 272 (276)
T 2yex_A 265 YNKPLKKG 272 (276)
T ss_dssp TTCCCC--
T ss_pred ccChhhcc
Confidence 98765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=290.10 Aligned_cols=197 Identities=27% Similarity=0.361 Sum_probs=163.7
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||++++++|.++...|+||||+ +++|.+++...+..+++..++.++.|++.||.|||++|++|||||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik-------- 184 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK-------- 184 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS--------
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC--------
Confidence 48999999999999999999999999 679999998777789999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
|+||+++.++.+||+|||++...... .......||+.|+|||++.+ .++.++|
T Consensus 185 -------------------------p~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~D 237 (311)
T 3p1a_A 185 -------------------------PANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAAD 237 (311)
T ss_dssp -------------------------GGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHH
T ss_pred -------------------------HHHEEECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhh
Confidence 88999999999999999998765433 22334458999999999876 7899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
||||||++|+|++|..|+......... ..... ....+..+++++.++|.+||+.||++|||++|+++||||++
T Consensus 238 iwslG~il~el~~g~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 238 VFSLGLTILEVACNMELPHGGEGWQQL---RQGYL-PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHHHHTCCCCSSHHHHHHH---TTTCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHHHhCCCCCCCccHHHHH---hccCC-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999997666543322222 11111 11124567999999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=297.52 Aligned_cols=208 Identities=37% Similarity=0.738 Sum_probs=171.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni 79 (251)
|++++||||+++++++.++...++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ |++|||||
T Consensus 85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk---- 159 (360)
T 3eqc_A 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK---- 159 (360)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS----
T ss_pred HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCcc----
Confidence 4678999999999999999999999999999999999974 46799999999999999999999996 99999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++...... ......+|+.|+|||++.+..++
T Consensus 160 -----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 208 (360)
T 3eqc_A 160 -----------------------------PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS 208 (360)
T ss_dssp -----------------------------GGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCS
T ss_pred -----------------------------HHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCC
Confidence 88999999999999999998654322 22334689999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc------------------------------------------CCCC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI------------------------------------------PTKP 197 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~------------------------------------------~~~~ 197 (251)
.++||||+||++|+|++|..||...+........ ....
T Consensus 209 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3eqc_A 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288 (360)
T ss_dssp HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSC
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC
Confidence 9999999999999999999999765443321111 0011
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 198 PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 198 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
. .......++.++.+||.+||+.||++|||++|+++||||++.+++.
T Consensus 289 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 289 P-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp C-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred C-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 1 1112344788999999999999999999999999999999876654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=294.48 Aligned_cols=203 Identities=45% Similarity=0.835 Sum_probs=173.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+. |+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk------ 181 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK------ 181 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS------
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC------
Confidence 46899999999999999999999999996 68988887677889999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---cCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~ 158 (251)
|+||+++.++.+||+|||++...... ....||+.|+|||++. ...+
T Consensus 182 ---------------------------p~NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~ 230 (348)
T 1u5q_A 182 ---------------------------AGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 230 (348)
T ss_dssp ---------------------------GGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCB
T ss_pred ---------------------------HHHEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccccCCCC
Confidence 88999999999999999999765432 2356899999999984 5678
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~ 238 (251)
+.++|||||||++|+|++|..||.+.+.......+.....+. .....+++.+.++|.+||+.||++|||++|+++||||
T Consensus 231 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 999999999999999999999998766555444333332222 2245679999999999999999999999999999999
Q ss_pred hhccC
Q psy3253 239 QRHDT 243 (251)
Q Consensus 239 ~~~~~ 243 (251)
.+...
T Consensus 310 ~~~~~ 314 (348)
T 1u5q_A 310 LRERP 314 (348)
T ss_dssp HSCCC
T ss_pred hccCC
Confidence 87543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.00 Aligned_cols=207 Identities=25% Similarity=0.437 Sum_probs=165.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.++.. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk------ 151 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK------ 151 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC------
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcC------
Confidence 46899999999999999999999999999988888765 56789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 160 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+.+. .++.
T Consensus 152 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 204 (331)
T 4aaa_A 152 ---------------------------PENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204 (331)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCT
T ss_pred ---------------------------hheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcch
Confidence 889999999999999999997655443334445688999999999764 6899
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---------------------CCCCCCCC-------CCCCCCHHHH
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---------------------TKPPPSFR-------EPDVWTPEFI 212 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------------~~~~~~~~-------~~~~~~~~~~ 212 (251)
++||||+||++|+|++|..||.+.........+. ....+... ....+++++.
T Consensus 205 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 284 (331)
T 4aaa_A 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI 284 (331)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHH
Confidence 9999999999999999999997765443322110 00000000 1235789999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
+||.+||+.||++|||++|+|+||||+...
T Consensus 285 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 285 DLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred HHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=309.62 Aligned_cols=208 Identities=26% Similarity=0.491 Sum_probs=175.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+|||||.+|+|.+++. ....+++..++.++.||+.||.|||++|++|||||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk----- 173 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIK----- 173 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc-----
Confidence 357899999999999999999999999999999999987 34679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++ .+||+|||++...... .......||+.|+|||++.+ .
T Consensus 174 ----------------------------p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~ 223 (504)
T 3q5i_A 174 ----------------------------PENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-K 223 (504)
T ss_dssp ----------------------------GGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-C
T ss_pred ----------------------------HHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-C
Confidence 7788887665 6999999999765543 23344568999999999864 6
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|.+||.+.+.......+..... .....+..+++++.+||.+||+.||++|||++|+|+||
T Consensus 224 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 89999999999999999999999988776666555443321 11122356899999999999999999999999999999
Q ss_pred hhhhccCC
Q psy3253 237 FIQRHDTD 244 (251)
Q Consensus 237 ~~~~~~~~ 244 (251)
||++....
T Consensus 304 ~~~~~~~~ 311 (504)
T 3q5i_A 304 WIKKYANN 311 (504)
T ss_dssp HHHHTCCC
T ss_pred hhhhchhc
Confidence 99987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=292.92 Aligned_cols=207 Identities=27% Similarity=0.478 Sum_probs=171.4
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.||||+++++++.+....++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik-------- 158 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK-------- 158 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC--------
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC--------
Confidence 5799999999999999999999999999999988522 3679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++. ++.++|+|||++....... ......+++.|+|||++.+..++.
T Consensus 159 -------------------------p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 212 (327)
T 3lm5_A 159 -------------------------PQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITT 212 (327)
T ss_dssp -------------------------GGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCT
T ss_pred -------------------------hHHEEEecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCc
Confidence 77888776 6789999999997654332 223456899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-CCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
++||||+||++|+|++|..||.+.+.......+.. ...........+++.+.++|.+||+.||++|||++|+++||||+
T Consensus 213 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 99999999999999999999987766554433222 11222233567899999999999999999999999999999999
Q ss_pred hccCCC
Q psy3253 240 RHDTDP 245 (251)
Q Consensus 240 ~~~~~~ 245 (251)
..+|+.
T Consensus 293 ~~~~~~ 298 (327)
T 3lm5_A 293 QWDFEN 298 (327)
T ss_dssp CCCTTC
T ss_pred cccccc
Confidence 988865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=297.73 Aligned_cols=213 Identities=27% Similarity=0.430 Sum_probs=171.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---------------------------------------C
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------------------------------K 42 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---------------------------------------~ 42 (251)
++++||||+++++++.+....++||||+++|+|.+++... .
T Consensus 83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 4679999999999999999999999999999999988410 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC--Ce
Q psy3253 43 KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG--HA 120 (251)
Q Consensus 43 ~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~--~~ 120 (251)
..+++..++.++.||+.||.|||++|++||||| |+||+++.++ .+
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk---------------------------------p~NIll~~~~~~~~ 209 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIK---------------------------------PENFLFSTNKSFEI 209 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCC---------------------------------GGGEEESCSSSCCE
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCccccCCC---------------------------------hhhEEEecCCCceE
Confidence 123677888999999999999999999999988 8888887665 79
Q ss_pred EecccccccccCcccc----ccccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC
Q psy3253 121 KLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP 194 (251)
Q Consensus 121 kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 194 (251)
||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 210 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 289 (345)
T 3hko_A 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289 (345)
T ss_dssp EECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 9999999975432211 2234568999999999965 678899999999999999999999998776655554433
Q ss_pred CCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 195 TKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 195 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
... .........+++++.++|.+||+.||++|||++|+++||||++..+.-.+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~~~ 343 (345)
T 3hko_A 290 NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343 (345)
T ss_dssp HCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCSSC
T ss_pred hcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhhEe
Confidence 222 11222234578999999999999999999999999999999998876554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=283.75 Aligned_cols=202 Identities=28% Similarity=0.465 Sum_probs=165.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~------ 138 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK------ 138 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCC------
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC------
Confidence 578999999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC-Cc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-DC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~ 160 (251)
|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..+ +.
T Consensus 139 ---------------------------p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~ 190 (276)
T 2h6d_A 139 ---------------------------PENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGP 190 (276)
T ss_dssp ---------------------------GGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHH
T ss_pred ---------------------------hhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcCCCCCCc
Confidence 889999999999999999997654332 2233467889999999987665 67
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|+||+|+++|+|++|..||...........+.... ...+..++.++.+++.+||+.||++|||++|+++||||++
T Consensus 191 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 9999999999999999999998766555444333321 2235667999999999999999999999999999999986
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 268 ~ 268 (276)
T 2h6d_A 268 D 268 (276)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=287.00 Aligned_cols=205 Identities=24% Similarity=0.397 Sum_probs=172.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dik------ 133 (304)
T 2jam_A 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK------ 133 (304)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCC------
T ss_pred HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC------
Confidence 468999999999999999999999999999999999874 4679999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||++ +.++.++|+|||++...... ......+++.|+|||.+.+..+
T Consensus 134 ---------------------------p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 134 ---------------------------PENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp ---------------------------GGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSC
T ss_pred ---------------------------HHHEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCC
Confidence 777776 56788999999998654322 2233457899999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|..||...........+.... ......+..+++++.++|.+||..||++|||++|+++|||
T Consensus 185 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 999999999999999999999998766554443332221 1122234568999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|+...
T Consensus 265 ~~~~~ 269 (304)
T 2jam_A 265 IDGNT 269 (304)
T ss_dssp HHSSC
T ss_pred ccCCC
Confidence 98643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=299.95 Aligned_cols=204 Identities=26% Similarity=0.443 Sum_probs=163.6
Q ss_pred CCC-CCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 3 QCD-SPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 3 ~l~-hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++. ||||+++++++... ..+|+||||++ ++|.++++. ..+++..+..++.||+.||+|||++||+|||||
T Consensus 64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk---- 136 (388)
T 3oz6_A 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK---- 136 (388)
T ss_dssp HTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC----
T ss_pred hccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC----
Confidence 454 99999999999754 37999999996 599999863 579999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc---------------------cccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT---------------------MAKR 138 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~---------------------~~~~ 138 (251)
|+||+++.++.+||+|||+++..... ....
T Consensus 137 -----------------------------p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (388)
T 3oz6_A 137 -----------------------------PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187 (388)
T ss_dssp -----------------------------GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-------------
T ss_pred -----------------------------HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccc
Confidence 88999999999999999999754321 1112
Q ss_pred ccccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---CC----------------
Q psy3253 139 NTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---PP---------------- 198 (251)
Q Consensus 139 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~---------------- 198 (251)
....+|+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+... +.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 267 (388)
T 3oz6_A 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMI 267 (388)
T ss_dssp --CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHH
Confidence 23468999999999976 67899999999999999999999999876654443322110 00
Q ss_pred -----------CCC--------------CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 199 -----------PSF--------------REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 199 -----------~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
... ..+..+++++.+||.+||+.||++|||++|+++||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 268 ESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred HhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 000 01236789999999999999999999999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=304.84 Aligned_cols=209 Identities=26% Similarity=0.404 Sum_probs=161.0
Q ss_pred CCCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
++++||||+++++++.. ...+|+||||+ +++|.+++. ....+++..++.++.||+.||+|||++||+|||||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK- 183 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK- 183 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC-
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC-
Confidence 46899999999999953 35799999999 569999987 56789999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--------------------
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-------------------- 136 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-------------------- 136 (251)
|+||+++.++.+||+|||+++.......
T Consensus 184 --------------------------------p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (458)
T 3rp9_A 184 --------------------------------PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231 (458)
T ss_dssp --------------------------------GGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--------------
T ss_pred --------------------------------hhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccc
Confidence 8899999999999999999976542211
Q ss_pred -------ccccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCcc----------
Q psy3253 137 -------KRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAE-----------GKPPYGDIHPM---------- 187 (251)
Q Consensus 137 -------~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~-----------g~~p~~~~~~~---------- 187 (251)
......||+.|+|||++ ....++.++|||||||++|+|++ |.++|.+.+..
T Consensus 232 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~ 311 (458)
T 3rp9_A 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311 (458)
T ss_dssp -------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---------------
T ss_pred ccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccc
Confidence 12334579999999986 55679999999999999999998 66777543210
Q ss_pred -------------hhhhhcC------------------------CCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 188 -------------RAIFMIP------------------------TKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 188 -------------~~~~~~~------------------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
..+..+. .... .........++++.+||.+||..||++|||+
T Consensus 312 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~ 391 (458)
T 3rp9_A 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391 (458)
T ss_dssp -----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCH
Confidence 0000000 0000 0011124568999999999999999999999
Q ss_pred HHHhcChhhhhccCCC
Q psy3253 230 SEMLNHEFIQRHDTDP 245 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~ 245 (251)
+|+|+||||+...+..
T Consensus 392 ~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 392 NECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHSGGGTTTCCGG
T ss_pred HHHhcCHhhhhcCCCc
Confidence 9999999999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=290.47 Aligned_cols=208 Identities=24% Similarity=0.383 Sum_probs=159.5
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+||||+++++++.++...|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk-------- 138 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK-------- 138 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC--------
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC--------
Confidence 4799999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCC---eEecccccccccCccc-------cccccccccccccccccc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH---AKLADFGVAGQLTDTM-------AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~---~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++. +||+|||++....... .......+|+.|+|||++
T Consensus 139 -------------------------p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (316)
T 2ac3_A 139 -------------------------PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193 (316)
T ss_dssp -------------------------GGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHH
T ss_pred -------------------------HHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHh
Confidence 77888876665 9999999987543211 111233488999999999
Q ss_pred cc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch---------------hhhhcCCCCCCCCC--CCCCCCHHH
Q psy3253 154 QE-----IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR---------------AIFMIPTKPPPSFR--EPDVWTPEF 211 (251)
Q Consensus 154 ~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~--~~~~~~~~~ 211 (251)
.+ ..++.++||||+||++|+|++|..||.+..... ....+.... ..+. ....+++++
T Consensus 194 ~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~ 272 (316)
T 2ac3_A 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAA 272 (316)
T ss_dssp HHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHH
T ss_pred hcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC-cccCchhcccCCHHH
Confidence 65 557889999999999999999999996543211 111111111 1111 124578999
Q ss_pred HHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 212 IDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 212 ~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
.+||.+||+.||++|||++|+++||||+...++..
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~ 307 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTTCC-------
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChhhcCCCCccc
Confidence 99999999999999999999999999998766543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.79 Aligned_cols=225 Identities=25% Similarity=0.388 Sum_probs=166.3
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.++||||+++++++......|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence 456999999999999999999999999 889999997543 469999999999999999999999999999999887777
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
..+......... ... ..-+...+....++.+||+|||++...... .....+|+.|+|||++.+..++.+
T Consensus 171 ~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 171 DDPYFEKSLITV----RRV----TDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp SCTTCCEEEEEE----ECT----TTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred ccccccccccch----hcc----cccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCc
Confidence 632110000000 000 000011122345788999999999754432 234567999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC--------------------CCCCCC--------------
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP--------------------PSFREP-------------- 204 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------------------~~~~~~-------------- 204 (251)
+||||+||++|+|++|..||...+.......+.. ..+ .....+
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 319 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence 9999999999999999999976554333221110 000 000000
Q ss_pred ------CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhh
Q psy3253 205 ------DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239 (251)
Q Consensus 205 ------~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~ 239 (251)
...++.+.+||.+||+.||++|||++|+|+||||+
T Consensus 320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 11247788999999999999999999999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=285.89 Aligned_cols=209 Identities=27% Similarity=0.446 Sum_probs=172.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+++++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 135 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK------ 135 (283)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS------
T ss_pred HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC------
Confidence 46789999999999999999999999999999999997 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+..
T Consensus 136 ---------------------------p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 187 (283)
T 3bhy_A 136 ---------------------------PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEP 187 (283)
T ss_dssp ---------------------------GGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCC
T ss_pred ---------------------------hHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcceecCCC
Confidence 7788877665 79999999997654332 223345788999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++|+||+|+++|++++|..||.+.+.......+..... .....+..+++.+.+++.+||..||++|||++|+++||
T Consensus 188 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 188 LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 99999999999999999999999987766554443322211 11112356789999999999999999999999999999
Q ss_pred hhhhccCCC
Q psy3253 237 FIQRHDTDP 245 (251)
Q Consensus 237 ~~~~~~~~~ 245 (251)
||+...+..
T Consensus 268 ~~~~~~~~~ 276 (283)
T 3bhy_A 268 WIKAIRRRN 276 (283)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHHHh
Confidence 999766554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=289.37 Aligned_cols=205 Identities=48% Similarity=0.936 Sum_probs=165.3
Q ss_pred CCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 5 DSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 5 ~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
+||||+++++++.. ....++||||+++++|.+++... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk-- 156 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK-- 156 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS--
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc--
Confidence 79999999999986 46799999999999999999743 3579999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc---
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--- 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 154 (251)
|+||+++.++.++|+|||++..............+++.|+|||++.
T Consensus 157 -------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (326)
T 2x7f_A 157 -------------------------------GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205 (326)
T ss_dssp -------------------------------GGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC---
T ss_pred -------------------------------HHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhcccc
Confidence 8899999999999999999976544333334456889999999986
Q ss_pred --cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 155 --EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 155 --~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
+..++.++|||||||++|+|++|..||.+.........+.....+. .....+++.+.++|.+||..||++|||++|+
T Consensus 206 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp -----CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc-CCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 5668899999999999999999999998776655544433332222 2345679999999999999999999999999
Q ss_pred hcChhhhhccC
Q psy3253 233 LNHEFIQRHDT 243 (251)
Q Consensus 233 l~hp~~~~~~~ 243 (251)
++||||+...+
T Consensus 285 l~hp~~~~~~~ 295 (326)
T 2x7f_A 285 MKHPFIRDQPN 295 (326)
T ss_dssp HTSHHHHCCTT
T ss_pred hhChHHhhCcc
Confidence 99999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=286.10 Aligned_cols=209 Identities=33% Similarity=0.537 Sum_probs=166.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK--TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++++......++||||+.+++|.+++..... .+++..+..++.|++.||.|||++|++|||||
T Consensus 74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~---- 149 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK---- 149 (295)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS----
T ss_pred HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC----
Confidence 578999999999999999999999999999999999975433 46789999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCcccccccccccccccccccccccCC-
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~- 157 (251)
|+||+++. ++.++|+|||.+..............+++.|+|||++.+..
T Consensus 150 -----------------------------p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 200 (295)
T 2clq_A 150 -----------------------------GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200 (295)
T ss_dssp -----------------------------GGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGG
T ss_pred -----------------------------hhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCC
Confidence 88888876 78999999999976554333334456889999999997643
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 -YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 -~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||||+++|+|++|..||......................+..+++++.+++.+||+.||++|||++|+++||
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 7889999999999999999999996543322111100000111123567899999999999999999999999999999
Q ss_pred hhhhccC
Q psy3253 237 FIQRHDT 243 (251)
Q Consensus 237 ~~~~~~~ 243 (251)
||+....
T Consensus 281 ~~~~~~~ 287 (295)
T 2clq_A 281 FLKVSSK 287 (295)
T ss_dssp GGCC---
T ss_pred hhhhccc
Confidence 9986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.35 Aligned_cols=211 Identities=24% Similarity=0.424 Sum_probs=168.1
Q ss_pred CCCCCCccceeeeeEee--------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 2 QQCDSPYVVKYYGSYFK--------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
++++||||+++++++.. ....|+||||+++ +|.+.+......+++.+++.++.||+.||.|||++|++|||
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D 149 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 46799999999999986 4468999999975 88888875667899999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc----ccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT----MAKRNTVIGTPFWMA 149 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~y~a 149 (251)
|| |+||+++.++.+||+|||++...... ........+|+.|+|
T Consensus 150 lk---------------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 196 (351)
T 3mi9_A 150 MK---------------------------------AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196 (351)
T ss_dssp CS---------------------------------GGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCC
T ss_pred CC---------------------------------HHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccC
Confidence 88 88999999999999999999765421 122234467899999
Q ss_pred cccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCCCCC-CCCC-------------------
Q psy3253 150 PEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPPPSF-REPD------------------- 205 (251)
Q Consensus 150 PE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~------------------- 205 (251)
||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+. ...+... ....
T Consensus 197 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (351)
T 3mi9_A 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 276 (351)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHH
T ss_pred chhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHH
Confidence 999876 558999999999999999999999998765543332211 1111110 0000
Q ss_pred ------CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 206 ------VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 206 ------~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
..++++.+||.+||+.||++|||++|+++||||+....+..
T Consensus 277 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 277 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp HHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred HHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 02678999999999999999999999999999987666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.19 Aligned_cols=196 Identities=11% Similarity=0.071 Sum_probs=158.9
Q ss_pred CCCCCCCccceee-------eeEeeCC-----------------eEEEEEEccCCCCHHHHHHHhCCCCC-------HHH
Q psy3253 1 MQQCDSPYVVKYY-------GSYFKNT-----------------DLWIVMEYCGAGSVSDIMRLRKKTLS-------EDE 49 (251)
Q Consensus 1 l~~l~hpniv~l~-------~~~~~~~-----------------~~~lv~e~~~~gsL~~~~~~~~~~l~-------~~~ 49 (251)
|++++|||||+++ +++.+.+ ..|+||||+ +|+|.+++... ..++ +..
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~ 207 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHA 207 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHH
Confidence 4678999999998 6665443 389999999 67999999743 2344 478
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEeccccccc
Q psy3253 50 IATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 50 ~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~ 129 (251)
+..++.||+.||.|||++||+||||| |+||+++.++.+||+|||+++
T Consensus 208 ~~~i~~qi~~aL~~LH~~~ivHrDik---------------------------------p~NIll~~~~~~kL~DFG~a~ 254 (377)
T 3byv_A 208 RLQLTLQVIRLLASLHHYGLVHTYLR---------------------------------PVDIVLDQRGGVFLTGFEHLV 254 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCC---------------------------------GGGEEECTTCCEEECCGGGCE
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCC---------------------------------HHHEEEcCCCCEEEEechhhe
Confidence 88899999999999999999999988 889999999999999999997
Q ss_pred ccCcccccccccccccccccccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC
Q psy3253 130 QLTDTMAKRNTVIGTPFWMAPEVIQEI-----------GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP 198 (251)
Q Consensus 130 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 198 (251)
.... ......| +.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...
T Consensus 255 ~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-- 328 (377)
T 3byv_A 255 RDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-- 328 (377)
T ss_dssp ETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--
T ss_pred ecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--
Confidence 5433 2233456 889999999877 8999999999999999999999999765544433333221
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 199 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
+..+++++.++|.+||+.||++|||++|+++||||+...
T Consensus 329 -----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 329 -----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp -----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred -----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 356799999999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=292.16 Aligned_cols=204 Identities=25% Similarity=0.473 Sum_probs=161.1
Q ss_pred CCCC--CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 3 QCDS--PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 3 ~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++| |||+++++++.++...|+|||+. +++|.+++. ....+++.++..++.||+.||.|||++||+|||||
T Consensus 63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDik----- 135 (343)
T 3dbq_A 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK----- 135 (343)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred hhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC-----
Confidence 4555 99999999999999999999954 789999997 46789999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccccccccc---
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE--- 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--- 155 (251)
|+||+++ ++.+||+|||++........ ......||+.|+|||++.+
T Consensus 136 ----------------------------p~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 186 (343)
T 3dbq_A 136 ----------------------------PANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186 (343)
T ss_dssp ----------------------------GGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-
T ss_pred ----------------------------cceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccc
Confidence 7788885 56799999999976543322 1234568999999999864
Q ss_pred --------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 156 --------IGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 156 --------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
..++.++|||||||++|+|++|..||...... .....+.. .......+...++++.+++.+||+.||++|
T Consensus 187 ~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dp~~R 265 (343)
T 3dbq_A 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265 (343)
T ss_dssp ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred cccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHcCCChhHC
Confidence 67889999999999999999999999764332 22222211 112233456678899999999999999999
Q ss_pred CCHHHHhcChhhhhccC
Q psy3253 227 ATASEMLNHEFIQRHDT 243 (251)
Q Consensus 227 ps~~evl~hp~~~~~~~ 243 (251)
||++|+++||||+....
T Consensus 266 pt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 266 ISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCHHHHHTSHHHHSCCC
T ss_pred CCHHHHHhCccccccCC
Confidence 99999999999986443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.73 Aligned_cols=211 Identities=25% Similarity=0.422 Sum_probs=163.0
Q ss_pred CCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
++++||||+++++++... ...|+||||++ ++|.+++. ....+++..++.++.||+.||+|||++||+|||||
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk- 156 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLK- 156 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-
Confidence 468999999999999766 57999999996 59999997 55779999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--------------------
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-------------------- 136 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-------------------- 136 (251)
|+||+++.++.+||+|||+++.......
T Consensus 157 --------------------------------p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (432)
T 3n9x_A 157 --------------------------------PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204 (432)
T ss_dssp --------------------------------GGGEEECTTCCEEECCCTTCEEC-------------------------
T ss_pred --------------------------------HHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccch
Confidence 8899999999999999999986543211
Q ss_pred --ccccccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCC-----------CCCCCcc---------------
Q psy3253 137 --KRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITALEMAEGKPP-----------YGDIHPM--------------- 187 (251)
Q Consensus 137 --~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~p-----------~~~~~~~--------------- 187 (251)
......+|+.|+|||++ ....++.++||||+||++|+|++|..| |.+.+..
T Consensus 205 ~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~ 284 (432)
T 3n9x_A 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284 (432)
T ss_dssp ------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHH
T ss_pred hccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccc
Confidence 12445689999999986 566799999999999999999985444 4332100
Q ss_pred -----hhhhhcCCC--------------------CCCCCC-----CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 188 -----RAIFMIPTK--------------------PPPSFR-----EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 188 -----~~~~~~~~~--------------------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
..+..+... .+.... ....+++++.+||.+||+.||++|||++|+|+|||
T Consensus 285 ~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred hHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 000000000 000000 11457999999999999999999999999999999
Q ss_pred hhhccCCCCC
Q psy3253 238 IQRHDTDPSQ 247 (251)
Q Consensus 238 ~~~~~~~~~~ 247 (251)
|+...+....
T Consensus 365 f~~~~~~~~e 374 (432)
T 3n9x_A 365 LKDVRKKKLE 374 (432)
T ss_dssp GTTTCCTTTC
T ss_pred hhhccCcccC
Confidence 9998776544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.47 Aligned_cols=204 Identities=11% Similarity=0.113 Sum_probs=154.5
Q ss_pred CCCccceee-------eeEeeC-----------------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHH------HHHH
Q psy3253 5 DSPYVVKYY-------GSYFKN-----------------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEI------ATIL 54 (251)
Q Consensus 5 ~hpniv~l~-------~~~~~~-----------------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~------~~~~ 54 (251)
+||||++++ +++... ...|+||||++ |+|.+++...+..+.+... ..++
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT 200 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHH
Confidence 799988765 444332 34899999998 7999999865555555555 6777
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc
Q psy3253 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT 134 (251)
Q Consensus 55 ~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~ 134 (251)
.||+.||.|||++||+||||| |+||+++.++.+||+|||+++.....
T Consensus 201 ~qi~~aL~~LH~~~ivHrDik---------------------------------p~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFT---------------------------------PDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCS---------------------------------GGGEEECTTSCEEECCGGGEEETTCE
T ss_pred HHHHHHHHHHHHCCCccCcCC---------------------------------HHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999988 88999999999999999999765432
Q ss_pred ccccccccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh------hcCCCCCCCCCCCCC
Q psy3253 135 MAKRNTVIGTPFWMAPEVIQE--IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF------MIPTKPPPSFREPDV 206 (251)
Q Consensus 135 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~ 206 (251)
. ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .........+..+..
T Consensus 248 ~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (371)
T 3q60_A 248 G---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324 (371)
T ss_dssp E---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSC
T ss_pred c---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccC
Confidence 1 13456789999999987 779999999999999999999999997653321110 011112223333457
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+++++.+||.+||+.||++|||++|+++||||++..+..
T Consensus 325 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 899999999999999999999999999999999877653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=284.41 Aligned_cols=206 Identities=34% Similarity=0.505 Sum_probs=171.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++.++...++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~--------- 151 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLK--------- 151 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---------
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC---------
Confidence 599999999999999999999999999999999974 4689999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc------cCCC
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ------EIGY 158 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~ 158 (251)
|+||+++.++.++|+|||.+...... .......+++.|+|||++. ...+
T Consensus 152 ------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 206 (298)
T 1phk_A 152 ------------------------PENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGY 206 (298)
T ss_dssp ------------------------GGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCB
T ss_pred ------------------------cceEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccC
Confidence 88999999999999999999765433 2233456788999999985 4567
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||||+++|+|++|..||...........+.... .........++.++.+++.+||+.||++|||++|+++|||
T Consensus 207 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 889999999999999999999997766554443332221 1112223467899999999999999999999999999999
Q ss_pred hhhccCCC
Q psy3253 238 IQRHDTDP 245 (251)
Q Consensus 238 ~~~~~~~~ 245 (251)
|++..++.
T Consensus 287 ~~~~~~~~ 294 (298)
T 1phk_A 287 FQQYVVEE 294 (298)
T ss_dssp GCTTC---
T ss_pred hhhccchh
Confidence 99887764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=296.04 Aligned_cols=201 Identities=30% Similarity=0.512 Sum_probs=169.8
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++......|+||||+++++|.+++. ....+++..+..++.||+.||.|||+.|++|||||
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk--------- 227 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK--------- 227 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---------
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC---------
Confidence 79999999999999999999999999999999997 44679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc------CCC
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE------IGY 158 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~ 158 (251)
|+||+++.++.++|+|||++...... .......||+.|+|||++.+ ..+
T Consensus 228 ------------------------p~NIl~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 282 (365)
T 2y7j_A 228 ------------------------PENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGY 282 (365)
T ss_dssp ------------------------GGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCB
T ss_pred ------------------------HHHEEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCC
Confidence 88999999999999999999765533 22344568999999999853 357
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|||||||++|+|++|..||.+.........+..... .....+..+++.+.++|.+||..||++|||++|+++|||
T Consensus 283 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 8899999999999999999999987665544433322211 111123467899999999999999999999999999999
Q ss_pred hhh
Q psy3253 238 IQR 240 (251)
Q Consensus 238 ~~~ 240 (251)
|++
T Consensus 363 f~r 365 (365)
T 2y7j_A 363 FER 365 (365)
T ss_dssp GCC
T ss_pred cCC
Confidence 974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=297.64 Aligned_cols=211 Identities=30% Similarity=0.422 Sum_probs=166.0
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|++++||||++++++|.... ..++||||+.+ ++.+.+. .....+++..++.++.||+.||.|||++||+|
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 164 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 35789999999999996543 38899999976 4444332 23578999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCcccccccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|||| |+||+++ .++.+||+|||+++..... .......+|+.|+||
T Consensus 165 rDlk---------------------------------p~Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aP 210 (394)
T 4e7w_A 165 RDIK---------------------------------PQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAP 210 (394)
T ss_dssp SCCS---------------------------------GGGEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCH
T ss_pred CCCC---------------------------------HHHEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCH
Confidence 9988 8899998 7889999999999765433 223345678999999
Q ss_pred cccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-------------------CCCCCC-------CC
Q psy3253 151 EVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-------------------KPPPSF-------RE 203 (251)
Q Consensus 151 E~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~~~~~-------~~ 203 (251)
|++.+. .++.++||||+||++|+|++|++||.+.+.......+.. ...+.. ..
T Consensus 211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (394)
T 4e7w_A 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290 (394)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence 998664 589999999999999999999999987654433222110 000000 01
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
+..+++++.+||.+||+.||++|||++|+++||||+...+...
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 2347899999999999999999999999999999998776543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=280.37 Aligned_cols=214 Identities=22% Similarity=0.362 Sum_probs=160.0
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+||||+++++++.++...++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 8999999999999999999999999999999999743 2679999999999999999999999999999999666655
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC-CCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ 160 (251)
..+........ .............++|+|||.+...... ....+++.|+|||.+.+. .++.
T Consensus 149 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~ 210 (289)
T 1x8b_A 149 SRTSIPNAASE--------------EGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLP 210 (289)
T ss_dssp C----------------------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred cCCCCCccccc--------------ccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCc
Confidence 42110000000 0000001124457999999999765433 223578999999999765 5668
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++|||||||++|++++|.+++......... .....+ ..+..+++++.+++.+||+.||++|||++|+++||||+.
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGDQWHEI---RQGRLP--RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSHHHHHH---HTTCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchhHHHHH---HcCCCC--CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 999999999999999999887554333222 222211 235678999999999999999999999999999999986
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 286 ~ 286 (289)
T 1x8b_A 286 A 286 (289)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=287.21 Aligned_cols=206 Identities=26% Similarity=0.510 Sum_probs=163.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRR--KIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~dik~~ 77 (251)
++++||||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++| ++|||||
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dik-- 166 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK-- 166 (309)
T ss_dssp HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCC--
T ss_pred HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCC--
Confidence 46899999999999999999999999999999999997332 23999999999999999999999999 9999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+..
T Consensus 167 -------------------------------p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 167 -------------------------------SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp -------------------------------GGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCC
T ss_pred -------------------------------hhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC
Confidence 8899999999999999999975544333344567899999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc--C
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN--H 235 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~--h 235 (251)
++.++|||||||++|+|++|..||.+.+.......+.... .....+..+++++.++|.+||+.||++|||++|+++ .
T Consensus 216 ~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999998876665554432111 123346778999999999999999999999999987 4
Q ss_pred hhhhhc
Q psy3253 236 EFIQRH 241 (251)
Q Consensus 236 p~~~~~ 241 (251)
++++..
T Consensus 295 ~~~~~~ 300 (309)
T 3p86_A 295 PLIKSA 300 (309)
T ss_dssp HHHC--
T ss_pred HHHHhC
Confidence 555543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=286.54 Aligned_cols=205 Identities=28% Similarity=0.486 Sum_probs=167.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+++|+|.++++.....+++.++..++.|++.||.|||++|++|||||
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlk----- 135 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN----- 135 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC-----
Confidence 467899999999999999999999999999999999998667889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--------------ccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--------------RNTVIGTPF 146 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~ 146 (251)
|+||+++.++.+||+|||++......... .....||+.
T Consensus 136 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (310)
T 3s95_A 136 ----------------------------SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187 (310)
T ss_dssp ----------------------------TTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred ----------------------------cCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence 88999999999999999999765432211 113468999
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
|+|||++.+..++.++||||||+++|++++|..||......................+..+++++.+++.+||+.||++|
T Consensus 188 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 267 (310)
T 3s95_A 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267 (310)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGS
T ss_pred eeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999999998654332221111000000111245678999999999999999999
Q ss_pred CCHHHHhcChhhhh
Q psy3253 227 ATASEMLNHEFIQR 240 (251)
Q Consensus 227 ps~~evl~hp~~~~ 240 (251)
||++|+++ +++.
T Consensus 268 ps~~~l~~--~L~~ 279 (310)
T 3s95_A 268 PSFVKLEH--WLET 279 (310)
T ss_dssp CCHHHHHH--HHHH
T ss_pred cCHHHHHH--HHHH
Confidence 99999985 5543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=300.89 Aligned_cols=206 Identities=29% Similarity=0.463 Sum_probs=160.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++. ....|+||||+.+|+|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 195 ~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk------ 266 (419)
T 3i6u_A 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK------ 266 (419)
T ss_dssp HHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC------
T ss_pred HhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC------
Confidence 4689999999999985 456899999999999999886 45789999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCC---CCeEecccccccccCccccccccccccccccccccccc---
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--- 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 155 (251)
|+||+++.+ ..+||+|||+++..... .......||+.|+|||++.+
T Consensus 267 ---------------------------p~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 318 (419)
T 3i6u_A 267 ---------------------------PENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGT 318 (419)
T ss_dssp ---------------------------GGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----
T ss_pred ---------------------------hHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCC
Confidence 778887544 35999999999865533 22334568999999999853
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh-hhhcCCCCCC-CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA-IFMIPTKPPP-SFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.++||||+||++|+|++|..||........ ...+...... ....+..+++++.++|.+||+.||++|||++|++
T Consensus 319 ~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 5678899999999999999999999975433222 2222222111 1112356799999999999999999999999999
Q ss_pred cChhhhhccC
Q psy3253 234 NHEFIQRHDT 243 (251)
Q Consensus 234 ~hp~~~~~~~ 243 (251)
+||||+..++
T Consensus 399 ~hp~~~~~~~ 408 (419)
T 3i6u_A 399 RHPWLQDEDM 408 (419)
T ss_dssp HSGGGCCHHH
T ss_pred CCcccCChhH
Confidence 9999987554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=291.69 Aligned_cols=204 Identities=27% Similarity=0.467 Sum_probs=167.3
Q ss_pred CCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++... ..+|+||||+ +++|.++++. ..+++..++.++.||+.||+|||++|++|||||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 155 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 155 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 468999999999999765 3469999999 7899999873 679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++..... .....+|+.|+|||++.+
T Consensus 156 ---------------------------------p~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 156 ---------------------------------PGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp ---------------------------------GGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHT
T ss_pred ---------------------------------HHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhC
Confidence 88999999999999999999765432 233467899999999876
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---------------------------CCCCCC-CCCCCC
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---------------------------TKPPPS-FREPDV 206 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------------------~~~~~~-~~~~~~ 206 (251)
..++.++||||+||++|+|++|++||.+.+.......+. ...... ......
T Consensus 200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (367)
T 1cm8_A 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279 (367)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT
T ss_pred CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 678999999999999999999999997765433322211 000001 112345
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.++++.+|+.+||..||++|||++|+++||||+...+.
T Consensus 280 ~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 78999999999999999999999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.30 Aligned_cols=208 Identities=27% Similarity=0.444 Sum_probs=173.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHH------HHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDI------MRLR-KKTLSEDEIATILCDTLKGLEYLHL-RRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~------~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~ 72 (251)
|++++||||+++++++.+....++||||+++|+|.++ +... ...+++..++.++.|++.||.|||+ +|++||
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 4678999999999999999999999999999999998 5422 5679999999999999999999999 999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
||| |+||+++.++.++|+|||.+...... ......+++.|+|||+
T Consensus 177 dl~---------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~ 221 (348)
T 2pml_X 177 DVK---------------------------------PSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEF 221 (348)
T ss_dssp CCC---------------------------------GGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGG
T ss_pred CCC---------------------------------hHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchh
Confidence 988 88999999999999999999765433 2334567899999999
Q ss_pred cccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCc-chhhhhcCCCCCCCCCC-----------------CCCCCHHHH
Q psy3253 153 IQEI-GYDC-VADMWSLGITALEMAEGKPPYGDIHP-MRAIFMIPTKPPPSFRE-----------------PDVWTPEFI 212 (251)
Q Consensus 153 ~~~~-~~~~-~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~ 212 (251)
+.+. .++. ++||||+||++|+|++|..||..... ......+..... .+.. ...+++++.
T Consensus 222 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 222 FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp GSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHH
T ss_pred hcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHH
Confidence 9876 5666 89999999999999999999977655 333333332211 1110 156799999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
+++.+||+.||++|||++|+++||||+..+++
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 99999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=288.89 Aligned_cols=211 Identities=26% Similarity=0.480 Sum_probs=168.9
Q ss_pred CCCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
|++++||||+++++++.... ..|+||||+++++|.++++ ....+++..++.++.|++.||.|||++|++|||||
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk- 143 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK- 143 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC-
Confidence 56889999999999987654 3499999999999999997 44679999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc---cccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.+||+|||++....... .......||+.|+|||++
T Consensus 144 --------------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 191 (311)
T 3ork_A 144 --------------------------------PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191 (311)
T ss_dssp --------------------------------GGGEEEETTSCEEECCCSCC------------------CCTTCCHHHH
T ss_pred --------------------------------HHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHh
Confidence 889999999999999999997654321 122334589999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+..++.++|||||||++|+|++|..||.+............. ..+.......+++++.++|.+||+.||++||+..++
T Consensus 192 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 9989999999999999999999999999877665544332222 111112245689999999999999999999999999
Q ss_pred hcChhhhhccCCC
Q psy3253 233 LNHEFIQRHDTDP 245 (251)
Q Consensus 233 l~hp~~~~~~~~~ 245 (251)
+.|+|++.....+
T Consensus 272 l~~~l~~~~~~~~ 284 (311)
T 3ork_A 272 MRADLVRVHNGEP 284 (311)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHhcCCC
Confidence 9999998765444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=282.60 Aligned_cols=208 Identities=27% Similarity=0.429 Sum_probs=170.7
Q ss_pred CCCCCccceeeeeEe-----eCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 3 QCDSPYVVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 3 ~l~hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
+++||||+++++++. .....++||||+. |+|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlk- 147 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK- 147 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-
Confidence 358999999999987 4567999999997 59999997543 459999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccC
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++.++|+|||++...... .......+++.|+|||++.+.
T Consensus 148 --------------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 194 (326)
T 1blx_A 148 --------------------------------PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS 194 (326)
T ss_dssp --------------------------------GGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTC
T ss_pred --------------------------------HHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcC
Confidence 88999999999999999999765433 223345678999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC------------------------CCCCCCCCCCCCCHHHH
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT------------------------KPPPSFREPDVWTPEFI 212 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~ 212 (251)
.++.++|||||||++|+|++|..||.+.........+.. ...........+++.+.
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 1blx_A 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK 274 (326)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHH
T ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHH
Confidence 899999999999999999999999977654433222110 00000112355789999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+||.+||..||++|||++|+++||||+...+..
T Consensus 275 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 275 DLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred HHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 999999999999999999999999999877654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=289.88 Aligned_cols=203 Identities=28% Similarity=0.462 Sum_probs=168.3
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYD 84 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~ 84 (251)
+||||+++++++......++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk--------- 186 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK--------- 186 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC---------
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC---------
Confidence 699999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-cccccccccccccccccccc--CCCCcc
Q psy3253 85 RLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQE--IGYDCV 161 (251)
Q Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~ 161 (251)
|+||+++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.+
T Consensus 187 ------------------------p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 242 (355)
T 1vzo_A 187 ------------------------LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242 (355)
T ss_dssp ------------------------GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred ------------------------HHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCch
Confidence 889999999999999999997654322 22334568999999999975 447889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcch----hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHH
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMR----AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEM 232 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ev 232 (251)
+|||||||++|+|++|..||....... ....+... ....+..++..+.+||.+||..||++|| |++|+
T Consensus 243 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el 319 (355)
T 1vzo_A 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc---CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH
Confidence 999999999999999999996433221 11111111 1123566899999999999999999999 99999
Q ss_pred hcChhhhhccCC
Q psy3253 233 LNHEFIQRHDTD 244 (251)
Q Consensus 233 l~hp~~~~~~~~ 244 (251)
++||||+..+|.
T Consensus 320 l~h~~f~~~~~~ 331 (355)
T 1vzo_A 320 KEHLFFQKINWD 331 (355)
T ss_dssp HTSGGGTTCCHH
T ss_pred HcCcchhcCChh
Confidence 999999987764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=280.81 Aligned_cols=207 Identities=27% Similarity=0.492 Sum_probs=172.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~------ 148 (287)
T 2wei_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK------ 148 (287)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC------
T ss_pred HhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC------
Confidence 578999999999999999999999999999999998873 4579999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++. ++.++|+|||++...... .......+++.|+|||.+.+ .+
T Consensus 149 ---------------------------p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~ 199 (287)
T 2wei_A 149 ---------------------------PENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TY 199 (287)
T ss_dssp ---------------------------GGGEEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTT-CC
T ss_pred ---------------------------hhhEEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcC-CC
Confidence 77777754 346999999999765433 22233457889999999865 48
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|+||+|+++|+|++|..||.+.+.......+... ..........+++++.++|.+||..||++|||++|+++|||
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 99999999999999999999999877655544433222 11222233568999999999999999999999999999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|++..++
T Consensus 280 ~~~~~~~ 286 (287)
T 2wei_A 280 IQKYSSE 286 (287)
T ss_dssp HHHHCCC
T ss_pred HhccccC
Confidence 9988765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=291.29 Aligned_cols=201 Identities=25% Similarity=0.479 Sum_probs=160.5
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccc
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDR 85 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~ 85 (251)
||||+++++++..+..+|+|||+ .+++|.+++. ....+++.++..++.||+.||.|||++||+|||||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk---------- 182 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK---------- 182 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCC----------
T ss_pred CCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC----------
Confidence 69999999999999999999995 5789999997 45689999999999999999999999999999988
Q ss_pred cccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccccccccc--------
Q psy3253 86 LDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE-------- 155 (251)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------- 155 (251)
|+||+++ ++.+||+|||++........ ......||+.|+|||++.+
T Consensus 183 -----------------------p~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 238 (390)
T 2zmd_A 183 -----------------------PANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238 (390)
T ss_dssp -----------------------GGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-------
T ss_pred -----------------------HHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccccc
Confidence 8888884 57899999999976543221 1234568999999999865
Q ss_pred ---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 156 ---IGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 156 ---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
..++.++|||||||++|+|++|..||...... .....+... ......+...+.++.+||.+||+.||++|||++|
T Consensus 239 ~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 317 (390)
T 2zmd_A 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 317 (390)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT-TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc-cccCCCCccchHHHHHHHHHHcccChhhCCCHHH
Confidence 36888999999999999999999999765332 222222221 1122335556889999999999999999999999
Q ss_pred HhcChhhhhccC
Q psy3253 232 MLNHEFIQRHDT 243 (251)
Q Consensus 232 vl~hp~~~~~~~ 243 (251)
+++||||+....
T Consensus 318 ll~hp~~~~~~~ 329 (390)
T 2zmd_A 318 LLAHPYVQIQTH 329 (390)
T ss_dssp HHTSHHHHSCC-
T ss_pred HhhCcCccccCc
Confidence 999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=298.11 Aligned_cols=211 Identities=21% Similarity=0.440 Sum_probs=156.2
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRK--------KTLSEDEIATILCDTLKGLEYLHLRRKI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~LH~~~ii 70 (251)
|++++||||+++++++.. ....|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 150 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 356899999999999954 678999999996 58888885221 2499999999999999999999999999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceec----CCCCCeEecccccccccCccc---cccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL----NTEGHAKLADFGVAGQLTDTM---AKRNTVIG 143 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~----~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~ 143 (251)
||||| |+||++ +.++.+||+|||+++...... .......|
T Consensus 151 H~Dlk---------------------------------p~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g 197 (405)
T 3rgf_A 151 HRDLK---------------------------------PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197 (405)
T ss_dssp CCCCC---------------------------------GGGEEECCSSTTTTCEEECCTTCCC----------------C
T ss_pred CCCcC---------------------------------HHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCcee
Confidence 99999 777777 567889999999997654321 12234568
Q ss_pred cccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch---------h---hhhcCCCCCC-CCC-------
Q psy3253 144 TPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR---------A---IFMIPTKPPP-SFR------- 202 (251)
Q Consensus 144 ~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------~---~~~~~~~~~~-~~~------- 202 (251)
|+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+..... . +......... .+.
T Consensus 198 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 277 (405)
T 3rgf_A 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE 277 (405)
T ss_dssp CCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTT
T ss_pred cCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcc
Confidence 999999999977 458999999999999999999999996543210 0 0000000000 000
Q ss_pred ------------------------CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 203 ------------------------EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 203 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
.....++++.+||.+||++||++|||++|+|+||||+...+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 278 HSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred hhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 0112267899999999999999999999999999999876654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=292.73 Aligned_cols=208 Identities=24% Similarity=0.417 Sum_probs=166.6
Q ss_pred CCCCCCCccceeeeeEee--------------------------------------CCeEEEEEEccCCCCHHHHHH---
Q psy3253 1 MQQCDSPYVVKYYGSYFK--------------------------------------NTDLWIVMEYCGAGSVSDIMR--- 39 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--------------------------------------~~~~~lv~e~~~~gsL~~~~~--- 39 (251)
|++++||||++++++|.. ....++||||+. |+|.+.+.
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH
Confidence 468899999999999843 334899999997 58887775
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCC
Q psy3253 40 LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEG 118 (251)
Q Consensus 40 ~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~ 118 (251)
..+..+++..++.++.||+.||.|||++|++||||| |+||+++ .++
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dik---------------------------------p~Nil~~~~~~ 179 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK---------------------------------PQNLLVNSKDN 179 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC---------------------------------GGGEEEETTTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccC---------------------------------HHHEEEcCCCC
Confidence 245789999999999999999999999999999988 8888886 578
Q ss_pred CeEecccccccccCcccccccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC--
Q psy3253 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-- 195 (251)
Q Consensus 119 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 195 (251)
.+||+|||+++..... .......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+..
T Consensus 180 ~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 258 (383)
T 3eb0_A 180 TLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIM 258 (383)
T ss_dssp EEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 8999999999765433 223345678899999998764 489999999999999999999999987655443322210
Q ss_pred -C----------------CCCC-------CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 196 -K----------------PPPS-------FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 196 -~----------------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
. ..+. ...+..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 0 0000 0013457899999999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=283.99 Aligned_cols=210 Identities=23% Similarity=0.429 Sum_probs=160.8
Q ss_pred CCCCCCCccceeeeeEeeCCeE------EEEEEccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDL------WIVMEYCGAGSVSDIMRLRK-----KTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~------~lv~e~~~~gsL~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
|++++||||+++++++...... ++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++|+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 4678999999999999876554 99999999999999996332 269999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
+||||| |+||+++.++.+||+|||++........ ......+++.|
T Consensus 159 vH~Dik---------------------------------p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y 205 (323)
T 3qup_A 159 IHRDLA---------------------------------ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205 (323)
T ss_dssp CCSCCS---------------------------------GGGEEECTTSCEEECCCCC-----------------CCGGG
T ss_pred ccCCCC---------------------------------cceEEEcCCCCEEEeeccccccccccccccccccccCcccc
Confidence 999988 8899999999999999999976543221 12233457789
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+|||.+.+..++.++||||+||++|+|++ |..||.+.........+..... ...+..+++++.+++.+||+.||++|
T Consensus 206 ~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~R 283 (323)
T 3qup_A 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--LKQPPECMEEVYDLMYQCWSADPKQR 283 (323)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred cCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--CCCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999899999999999999999999 9999988777666555444432 23356789999999999999999999
Q ss_pred CC-------HHHHhcChhhhhccCCC
Q psy3253 227 AT-------ASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 227 ps-------~~evl~hp~~~~~~~~~ 245 (251)
|| ++++++|||+.....++
T Consensus 284 ps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 284 PSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp CCHHHHHHHHHHHHHC----------
T ss_pred cCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 99 78889999998766554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=277.69 Aligned_cols=200 Identities=25% Similarity=0.453 Sum_probs=172.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik----- 133 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA----- 133 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcc-----
Confidence 357899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++
T Consensus 134 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 185 (269)
T 4hcu_A 134 ----------------------------ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185 (269)
T ss_dssp ----------------------------GGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred ----------------------------hheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCC
Confidence 8899998889999999999976543221 22334457789999999988999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|+||+|+++|+|++ |..||...........+..... ...+...++++.+++.+||+.||++|||++|+++|
T Consensus 186 ~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc--CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999 9999988777666555544422 22356679999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=285.81 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=169.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++|+|.++++.....+++..+..++.|++.||.|||++|++|||||
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk----- 178 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA----- 178 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC-----
Confidence 467899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||+++........ .....+|+.|+|||++.+..
T Consensus 179 ----------------------------p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 179 ----------------------------ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred ----------------------------cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 88999999999999999999765432211 12233566899999999889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|||||||++|+|++ |..||.+.........+.... ....+..+++++.++|.+||..||++|||++|+++
T Consensus 231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999 999998877766665554443 22346678999999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=282.72 Aligned_cols=207 Identities=29% Similarity=0.540 Sum_probs=171.4
Q ss_pred CCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Q psy3253 2 QQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLR---KKTLSEDEIATILCDTLKGLEYLHLRR-----KIH 71 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~LH~~~-----iiH 71 (251)
++++||||+++++++.. ....++||||+++++|.+++... ...+++..+..++.|++.||.|||++| ++|
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 46899999999998854 56899999999999999999643 345999999999999999999999999 999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 151 (251)
|||| |+||+++.++.++|+|||.+..............+++.|+|||
T Consensus 140 ~dl~---------------------------------p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 140 RDLK---------------------------------PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186 (279)
T ss_dssp CCCS---------------------------------GGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHH
T ss_pred eccc---------------------------------hhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChH
Confidence 9988 8899999999999999999976544322233446789999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
.+.+..++.++||||||+++|+|++|..||...+.......+...... ..+..+++++.+++.+||+.||++|||++|
T Consensus 187 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (279)
T 2w5a_A 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPSVEE 264 (279)
T ss_dssp HHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--cCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence 999888999999999999999999999999877665554444333222 235568999999999999999999999999
Q ss_pred HhcChhhhhccC
Q psy3253 232 MLNHEFIQRHDT 243 (251)
Q Consensus 232 vl~hp~~~~~~~ 243 (251)
+++|+|+.....
T Consensus 265 ll~~~~~~~~~~ 276 (279)
T 2w5a_A 265 ILENPLILEHHH 276 (279)
T ss_dssp HHTSTTCCGGGS
T ss_pred HHhChhhhhhcc
Confidence 999999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=290.07 Aligned_cols=199 Identities=24% Similarity=0.468 Sum_probs=169.4
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++ +||||+++++++.+...+|+||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||
T Consensus 141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 220 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220 (370)
T ss_dssp HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 356 89999999999999999999999999999999997543 35899999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccc
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIG 143 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 143 (251)
++|++||||| |+||+++.++.+||+|||+++....... ......+
T Consensus 221 ~~~ivHrDlk---------------------------------p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 267 (370)
T 2psq_A 221 SQKCIHRDLA---------------------------------ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267 (370)
T ss_dssp HTTEECSCCC---------------------------------GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTS
T ss_pred hCCeeccccc---------------------------------hhhEEECCCCCEEEccccCCcccCcccceecccCCCc
Confidence 9999999988 8899999999999999999976543221 1223346
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q psy3253 144 TPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222 (251)
Q Consensus 144 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 222 (251)
++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..... ...+..+++++.++|.+||+.|
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~d 345 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAV 345 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCC
Confidence 778999999999899999999999999999999 9999987766665554444432 2345678999999999999999
Q ss_pred cCccCCHHHHhcC
Q psy3253 223 PEERATASEMLNH 235 (251)
Q Consensus 223 p~~Rps~~evl~h 235 (251)
|++|||++|++++
T Consensus 346 P~~Rpt~~ell~~ 358 (370)
T 2psq_A 346 PSQRPTFKQLVED 358 (370)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=305.18 Aligned_cols=202 Identities=25% Similarity=0.450 Sum_probs=157.2
Q ss_pred CCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++... .+.|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 116 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk 191 (464)
T 3ttj_A 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191 (464)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 468999999999999654 467999999975 6766664 459999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++..... .......+|+.|+|||++.+
T Consensus 192 ---------------------------------p~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 192 ---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp ---------------------------------GGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTT
T ss_pred ---------------------------------hHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcC
Confidence 88999999999999999999765432 22344568999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CC------------------CCCCC---C----CCC-
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KP------------------PPSFR---E----PDV- 206 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~------------------~~~~~---~----~~~- 206 (251)
..++.++||||+||++|+|++|++||.+.+.......+.. .+ .+... . +..
T Consensus 238 ~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (464)
T 3ttj_A 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 317 (464)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGG
T ss_pred CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccc
Confidence 9999999999999999999999999987654333222110 00 00000 0 000
Q ss_pred ----------CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 207 ----------WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 207 ----------~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
.++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 318 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 14678999999999999999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=289.05 Aligned_cols=182 Identities=24% Similarity=0.388 Sum_probs=144.1
Q ss_pred EEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchh
Q psy3253 22 LWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQ 99 (251)
Q Consensus 22 ~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~ 99 (251)
.++|||||++++|.+++.... ....+..++.++.||+.||.|||++|++|||||
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk------------------------ 191 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK------------------------ 191 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------------------------
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCC------------------------
Confidence 899999999999999997432 235666789999999999999999999999988
Q ss_pred hhhhhhhcccCceecCCCCCeEecccccccccCccc------------ccccccccccccccccccccCCCCcchhHHHH
Q psy3253 100 IYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------------AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSL 167 (251)
Q Consensus 100 ~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 167 (251)
|+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+
T Consensus 192 ---------p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 192 ---------PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp ---------GGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHH
T ss_pred ---------cccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHH
Confidence 889999999999999999997665432 12233468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 168 GITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 168 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
||++|+|++|..|+.... ...........+ ......++++.++|.+||+.||++|||++|+++||||++
T Consensus 263 G~il~el~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 263 GLILFELLYSFSTQMERV--RIITDVRNLKFP--LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHSCCCCHHHHH--HHHHHHHTTCCC--HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHHHHcCCChhHHH--HHHHHhhccCCC--cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 999999999877653211 111111111111 112345688899999999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=295.49 Aligned_cols=206 Identities=27% Similarity=0.408 Sum_probs=164.4
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
..+||||+++++++....+.|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK------ 227 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK------ 227 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCS------
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC------
Confidence 4589999999999999999999999995 69999987544 469999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCC--eEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++. +||+|||+++.... ......+|+.|+|||++.+..++
T Consensus 228 ---------------------------p~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 228 ---------------------------PENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp ---------------------------GGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCC
T ss_pred ---------------------------HHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCC
Confidence 88889888876 99999999965432 22345678999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC----------------------CCCCC-----------------
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT----------------------KPPPS----------------- 200 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------------~~~~~----------------- 200 (251)
.++|||||||++|+|++|.+||.+.+.......+.. ...+.
T Consensus 278 ~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (429)
T 3kvw_A 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357 (429)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCE
T ss_pred chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccccccccc
Confidence 999999999999999999999977654332211100 00000
Q ss_pred ------------C-----CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 201 ------------F-----REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 201 ------------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
. ......++++.+||.+||++||++|||++|+|+||||++....+
T Consensus 358 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp ECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred ccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence 0 00123478899999999999999999999999999999765443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=291.18 Aligned_cols=199 Identities=24% Similarity=0.438 Sum_probs=170.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++|+|.++++..+..+++..+..++.|++.||.|||++|++|||||
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk----- 240 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA----- 240 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccC-----
Confidence 468899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++........ .....++..|+|||++.+..+
T Consensus 241 ----------------------------p~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 292 (377)
T 3cbl_A 241 ----------------------------ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292 (377)
T ss_dssp ----------------------------GGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred ----------------------------HHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC
Confidence 88999999999999999999754432111 122235677999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|++++ |..||.+.........+.... ....+..+++++.++|.+||+.||++|||++|+++
T Consensus 293 ~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999998 999998876665554444332 22346678999999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.34 Aligned_cols=207 Identities=23% Similarity=0.391 Sum_probs=158.0
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++ +||||+++++++.+....|+|||||. |+|.+++......+.+..+..++.||+.||.|||++||+|||||
T Consensus 73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK------ 145 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK------ 145 (432)
T ss_dssp HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS------
T ss_pred hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC------
Confidence 45 79999999999999999999999996 59999998666667777788999999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecC-----CCCCeEecccccccccCccc---cccccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-----TEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-----~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++ ....++|+|||+++...... .......||+.|+|||++
T Consensus 146 ---------------------------p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l 198 (432)
T 3p23_A 146 ---------------------------PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198 (432)
T ss_dssp ---------------------------TTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGT
T ss_pred ---------------------------HHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhh
Confidence 5555553 22357899999997654321 123345689999999999
Q ss_pred c---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 154 Q---EIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 154 ~---~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
. ...++.++||||+||++|+|++ |..||..........................+..+.+||.+||+.||++|||+
T Consensus 199 ~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 278 (432)
T 3p23_A 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278 (432)
T ss_dssp SCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred hcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCH
Confidence 7 4567889999999999999999 99999665444333322222222222223345668999999999999999999
Q ss_pred HHHhcChhhhhccC
Q psy3253 230 SEMLNHEFIQRHDT 243 (251)
Q Consensus 230 ~evl~hp~~~~~~~ 243 (251)
+|+++||||...+|
T Consensus 279 ~evl~hp~f~~~~~ 292 (432)
T 3p23_A 279 KHVLKHPFFWSLEK 292 (432)
T ss_dssp HHHHTSTTTCCHHH
T ss_pred HHHHhCccccChHH
Confidence 99999999976443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=291.64 Aligned_cols=204 Identities=23% Similarity=0.386 Sum_probs=172.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++.+....++||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 208 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208 (367)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 46799999999999999999999999999999999997554 458999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCcc--cccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAP 150 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aP 150 (251)
|+||+++.++ .+||+|||+++..... ........+|+.|+||
T Consensus 209 ---------------------------------p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 209 ---------------------------------ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp ---------------------------------GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred ---------------------------------hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 8888887544 5999999999754321 1223334568899999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
|++.+..++.++|||||||++|+|++ |..||.+.........+...... ..+..+++.+.+++.+||+.||++|||+
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~ 333 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNF 333 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence 99998899999999999999999998 99999887776666555444322 2356789999999999999999999999
Q ss_pred HHHhcChhhhh
Q psy3253 230 SEMLNHEFIQR 240 (251)
Q Consensus 230 ~evl~hp~~~~ 240 (251)
+|++++.++-.
T Consensus 334 ~eil~~l~~~~ 344 (367)
T 3l9p_A 334 AIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=279.44 Aligned_cols=208 Identities=25% Similarity=0.482 Sum_probs=168.9
Q ss_pred CCCCCCCccceeeeeEe--eCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++||||+++++++. +....++||||+.++ |.+++... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlk-- 136 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIK-- 136 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS--
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCC--
Confidence 46789999999999984 456899999999775 77777533 4679999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--ccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||.+...... ........+++.|+|||++.+
T Consensus 137 -------------------------------p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 137 -------------------------------PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp -------------------------------GGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred -------------------------------cccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence 88999999999999999999765422 112234457899999999976
Q ss_pred CC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IG--YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
.. ++.++||||+|+++|+|++|..||.+.+.......+... ....+..+++.+.+++.+||+.||++|||++|++
T Consensus 186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 262 (305)
T 2wtk_C 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG---SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262 (305)
T ss_dssp CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 44 377999999999999999999999876655544443332 2233567899999999999999999999999999
Q ss_pred cChhhhhccCCC
Q psy3253 234 NHEFIQRHDTDP 245 (251)
Q Consensus 234 ~hp~~~~~~~~~ 245 (251)
+||||+.....+
T Consensus 263 ~~~~~~~~~~~~ 274 (305)
T 2wtk_C 263 QHSWFRKKHPPA 274 (305)
T ss_dssp HSHHHHSCCCC-
T ss_pred cCcccccCCCCc
Confidence 999998766544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=280.20 Aligned_cols=212 Identities=20% Similarity=0.375 Sum_probs=177.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------KTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|++++||||+++++++.++...++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++|++|
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 467899999999999999999999999999999999997432 46799999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 149 (251)
|||| |+||+++.++.++|+|||++........ ......+++.|+|
T Consensus 162 ~dik---------------------------------p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 208 (322)
T 1p4o_A 162 RDLA---------------------------------ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208 (322)
T ss_dssp SCCS---------------------------------GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCC
T ss_pred CCCc---------------------------------cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccC
Confidence 9988 8899999999999999999975543221 2233456788999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||++.+..++.++||||+||++|+|++ |..||.+.+.......+..... ...+..+++.+.+++.+||+.||++|||
T Consensus 209 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps 286 (322)
T 1p4o_A 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPS 286 (322)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 999988889999999999999999999 8999987766655544433322 2235678999999999999999999999
Q ss_pred HHHHhcC------hhhhhccCCCCC
Q psy3253 229 ASEMLNH------EFIQRHDTDPSQ 247 (251)
Q Consensus 229 ~~evl~h------p~~~~~~~~~~~ 247 (251)
++|++++ ++|+..++....
T Consensus 287 ~~e~l~~L~~~~~~~~~~~~~~~~~ 311 (322)
T 1p4o_A 287 FLEIISSIKEEMEPGFREVSFYYSE 311 (322)
T ss_dssp HHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred HHHHHHHHHHhhccCCccccccccc
Confidence 9999887 788876665544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.30 Aligned_cols=202 Identities=24% Similarity=0.422 Sum_probs=155.9
Q ss_pred CCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++.... ..|+||||+++ +|.+++. ..+++..+..++.||+.||.|||++|++|||||
T Consensus 79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 154 (371)
T 2xrw_A 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 154 (371)
T ss_dssp HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 4689999999999997654 78999999964 8888875 469999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||++...... .......+|+.|+|||++.+
T Consensus 155 ---------------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 155 ---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp ---------------------------------GGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTT
T ss_pred ---------------------------------HHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcC
Confidence 88999999999999999999765432 12234568899999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCC---------------------CCC------------
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPP---------------------SFR------------ 202 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~------------ 202 (251)
..++.++||||+||++|+|++|..||.+.+.......+...... .+.
T Consensus 201 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (371)
T 2xrw_A 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL 280 (371)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc
Confidence 89999999999999999999999999876654433322211100 000
Q ss_pred CCC------CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 203 EPD------VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 203 ~~~------~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
.+. ..++++.+||.+||+.||++|||++|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 281 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 014678999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=288.87 Aligned_cols=207 Identities=22% Similarity=0.386 Sum_probs=160.2
Q ss_pred CCCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
++++||||+++++++.. ....|+||||+. |+|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk- 161 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH- 161 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC-
Confidence 46899999999999854 346899999997 69999887666689999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 155 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 155 (251)
|+||+++.++.++|+|||++...... .......+++.|+|||++.+
T Consensus 162 --------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 208 (362)
T 3pg1_A 162 --------------------------------PGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQF 208 (362)
T ss_dssp --------------------------------GGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTC
T ss_pred --------------------------------hHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCC
Confidence 88999999999999999999754432 22334567889999999876
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-----------------------CCCCCC------CCCCC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-----------------------KPPPSF------REPDV 206 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------------~~~~~~------~~~~~ 206 (251)
..++.++||||+||++|++++|..||.+.+.......+.. ...... .....
T Consensus 209 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (362)
T 3pg1_A 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288 (362)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTT
T ss_pred CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCC
Confidence 6789999999999999999999999977553332221100 000000 01245
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
.++.+.+||.+||+.||++|||++|+++||||+....
T Consensus 289 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 289 ADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 6889999999999999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.11 Aligned_cols=207 Identities=33% Similarity=0.642 Sum_probs=162.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni~ 80 (251)
+.++||||+++++++.++...++||||+ ++.+..+.......+++..+..++.|++.||.|||++ |++|||||
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlk----- 152 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK----- 152 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCC-----
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCC-----
Confidence 4579999999999999999999999999 5677777665578899999999999999999999996 99999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.++|+|||++....... ......+++.|+|||++. .
T Consensus 153 ----------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 203 (318)
T 2dyl_A 153 ----------------------------PSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTK 203 (318)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC------
T ss_pred ----------------------------HHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccc
Confidence 889999999999999999997654322 223346789999999994 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIH-PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+||++|+|++|..||.... .......+.............+++++.++|.+||..||++|||++|+++
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 568889999999999999999999997643 2233333333333333334568999999999999999999999999999
Q ss_pred ChhhhhccC
Q psy3253 235 HEFIQRHDT 243 (251)
Q Consensus 235 hp~~~~~~~ 243 (251)
||||++...
T Consensus 284 h~~~~~~~~ 292 (318)
T 2dyl_A 284 HSFIKRYET 292 (318)
T ss_dssp SHHHHHHHH
T ss_pred CHHHHhccc
Confidence 999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=275.93 Aligned_cols=199 Identities=26% Similarity=0.458 Sum_probs=170.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik------ 131 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA------ 131 (268)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCS------
T ss_pred HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC------
Confidence 46889999999999999999999999999999999998766779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.
T Consensus 132 ---------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (268)
T 3sxs_A 132 ---------------------------ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184 (268)
T ss_dssp ---------------------------GGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEET
T ss_pred ---------------------------cceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCch
Confidence 8899999999999999999975543321 222334567799999999888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++||||+|+++|++++ |..||...........+..... ...+...++++.+++.+||+.||++|||++|++++
T Consensus 185 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR--LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC--CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999 9999987766665554444332 22356679999999999999999999999999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=286.00 Aligned_cols=208 Identities=28% Similarity=0.401 Sum_probs=147.5
Q ss_pred CCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
.++||||+++++++.. +...++||||+++|+|.+++.... ..+++.+++.++.||+.||.|||++|++|||||
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlk-- 155 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK-- 155 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCS--
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC--
Confidence 4689999999999976 455899999999999999997443 469999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++. ++.++|+|||++...... ......+|+.|+|||++.
T Consensus 156 -------------------------------p~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 156 -------------------------------PENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp -------------------------------GGGEEESCSSTTCCEEECCCTTCEEC-----------------------
T ss_pred -------------------------------HHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhC
Confidence 77888765 455999999999765432 223446789999999998
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh----hcC-CCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF----MIP-TKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
+..++.++||||+||++|+|++|..||.......... .+. ............+++++.+||.+||+.||++|||+
T Consensus 203 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (336)
T 3fhr_A 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282 (336)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCH
Confidence 8889999999999999999999999996544332211 111 11111222345689999999999999999999999
Q ss_pred HHHhcChhhhhccCCC
Q psy3253 230 SEMLNHEFIQRHDTDP 245 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~ 245 (251)
+|+++||||++....+
T Consensus 283 ~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 283 TQFMNHPWINQSMVVP 298 (336)
T ss_dssp HHHHHSHHHHTGGGSC
T ss_pred HHHhcCccccccccCC
Confidence 9999999998765444
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=277.58 Aligned_cols=206 Identities=24% Similarity=0.365 Sum_probs=166.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...|+||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk----- 138 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK----- 138 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-----
Confidence 467899999999999999999999999999999999997 44689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... .......||+.|+|||.+.+..++
T Consensus 139 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 139 ----------------------------PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCC
T ss_pred ----------------------------HHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC
Confidence 889999999999999999997654332 122334689999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCC--CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPS--FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
.++||||+|+++|+|++|..||.+...............+. ......+++.+.+++.+||..||++||+..+.+.+.|
T Consensus 191 ~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 99999999999999999999998776554433322221111 1224568999999999999999999996666666666
Q ss_pred hhh
Q psy3253 238 IQR 240 (251)
Q Consensus 238 ~~~ 240 (251)
.+-
T Consensus 271 ~~~ 273 (294)
T 4eqm_A 271 SSV 273 (294)
T ss_dssp HTS
T ss_pred HHH
Confidence 553
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.48 Aligned_cols=206 Identities=25% Similarity=0.425 Sum_probs=166.5
Q ss_pred CCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
++++||||+++++++... ...|+||||++ |+|.+++. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik- 155 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLK- 155 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-
Confidence 468999999999999754 36899999996 59999986 3579999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---cccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVI 153 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++.++|+|||++......... .....+|+.|+|||++
T Consensus 156 --------------------------------p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 156 --------------------------------PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp --------------------------------GGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred --------------------------------hHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHh
Confidence 88999999999999999999765433221 2334689999999987
Q ss_pred cc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CC----------------------CCC---CCCC
Q psy3253 154 QE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KP----------------------PPS---FREP 204 (251)
Q Consensus 154 ~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~----------------------~~~---~~~~ 204 (251)
.+ ..++.++||||+||++|+|++|.+||.+.+.......+.. .. ... ....
T Consensus 204 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (364)
T 3qyz_A 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 283 (364)
T ss_dssp HTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred cCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC
Confidence 54 5589999999999999999999999977654443322210 00 000 0012
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
..+++++.+||.+||+.||++|||++|+++||||++...
T Consensus 284 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 456899999999999999999999999999999997633
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.52 Aligned_cols=210 Identities=27% Similarity=0.383 Sum_probs=164.6
Q ss_pred CCCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|++++||||++++++|... ..+++||||+.+ +|.+++. .....+++..++.++.||+.||.|||++||+|
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 179 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3578999999999988532 247899999975 7776664 23578999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|||| |+||+++.+ +.+||+|||+++..... .......+|+.|+||
T Consensus 180 rDlk---------------------------------p~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aP 225 (420)
T 1j1b_A 180 RDIK---------------------------------PQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAP 225 (420)
T ss_dssp SCCS---------------------------------GGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCH
T ss_pred cCCC---------------------------------hhhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCH
Confidence 9988 888888855 56899999999765432 222345679999999
Q ss_pred cccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---------------C-CCCCCC----------C
Q psy3253 151 EVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---------------K-PPPSFR----------E 203 (251)
Q Consensus 151 E~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------~-~~~~~~----------~ 203 (251)
|++.+. .++.++||||+||++|+|++|++||.+.+.......+.. . ....+. .
T Consensus 226 E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 305 (420)
T 1j1b_A 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 305 (420)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHS
T ss_pred HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhc
Confidence 999664 789999999999999999999999977654332221110 0 000000 1
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~ 245 (251)
+...++++.+||.+||..||++|||++|+++||||+...+..
T Consensus 306 ~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred CCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 234689999999999999999999999999999998876554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.95 Aligned_cols=210 Identities=24% Similarity=0.397 Sum_probs=172.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------------------KTLSEDEIATILCDT 57 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------------------~~l~~~~~~~~~~~i 57 (251)
|++++||||+++++++.++...++||||+++|+|.+++.... ..+++.+++.++.||
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997532 578999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-- 135 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 135 (251)
+.||.|||++|++||||| |+||+++.++.+||+|||++.......
T Consensus 184 ~~~l~~LH~~~ivH~Dlk---------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 230 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLA---------------------------------TRNCLVGENMVVKIADFGLSRNIYSADYY 230 (343)
T ss_dssp HHHHHHHHHTTCCCSCCS---------------------------------GGGEEECGGGCEEECCCSCHHHHTGGGCB
T ss_pred HHHHHHHHhCCeecCCCC---------------------------------cceEEECCCCeEEEeecCCCcccccCccc
Confidence 999999999999999988 889999999999999999997554321
Q ss_pred ccccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHH
Q psy3253 136 AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214 (251)
Q Consensus 136 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 214 (251)
.......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...... ..+..+++++.++
T Consensus 231 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 308 (343)
T 1luf_A 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNL 308 (343)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHH
T ss_pred cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC--CCCCCCCHHHHHH
Confidence 12233456888999999988889999999999999999999 99999877766655554444322 2356789999999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
+.+||+.||++|||++|++ ..+++......+
T Consensus 309 i~~~l~~~p~~Rps~~~~~--~~L~~~~~~~~~ 339 (343)
T 1luf_A 309 MRLCWSKLPADRPSFCSIH--RILQRMCERAEG 339 (343)
T ss_dssp HHHHTCSSGGGSCCHHHHH--HHHHHTTC----
T ss_pred HHHHcccCcccCCCHHHHH--HHHHHHHhhhhh
Confidence 9999999999999999998 456655444433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=276.87 Aligned_cols=198 Identities=27% Similarity=0.489 Sum_probs=158.4
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++. ++..++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 71 ~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk------ 143 (281)
T 1mp8_A 71 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA------ 143 (281)
T ss_dssp HTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS------
T ss_pred HhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc------
Confidence 5789999999999984 567899999999999999998666789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.
T Consensus 144 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (281)
T 1mp8_A 144 ---------------------------ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196 (281)
T ss_dssp ---------------------------GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSH
T ss_pred ---------------------------HHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCC
Confidence 8899998889999999999976543221 122334567899999999889999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++||||+||++|++++ |..||.+.........+...... ..+..+++++.+++.+||+.||++|||++|++++
T Consensus 197 ~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999996 99999877666555544443322 2356789999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=276.20 Aligned_cols=199 Identities=23% Similarity=0.416 Sum_probs=171.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 74 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik------ 147 (283)
T 3gen_A 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA------ 147 (283)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS------
T ss_pred hcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCc------
Confidence 57899999999999999999999999999999999998656789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.
T Consensus 148 ---------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 200 (283)
T 3gen_A 148 ---------------------------ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200 (283)
T ss_dssp ---------------------------GGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred ---------------------------cceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCc
Confidence 8899999999999999999976543221 222334567899999999889999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++||||+|+++|++++ |..||...+.......+..... ...+...++.+.+++.+||+.||++|||++|+++|
T Consensus 201 ~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999998 9999988776666555544432 22356679999999999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=285.09 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=164.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++..+. .|+||||+.+++|.+++. ....+++..+..++.||+.||.|||++|++|||||
T Consensus 70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk------ 141 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK------ 141 (322)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC------
Confidence 4679999999999997654 899999999999999886 45789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCC---CeEecccccccccCcccccccccccccccccccccc---c
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG---HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---E 155 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 155 (251)
|+||+++.++ .++|+|||++....... ......+++.|+|||++. .
T Consensus 142 ---------------------------p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 193 (322)
T 2ycf_A 142 ---------------------------PENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGT 193 (322)
T ss_dssp ---------------------------GGGEEESSSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTT
T ss_pred ---------------------------HHHEEEecCCCCCeEEEccCccceeccccc-ccccccCCcCccCchhhccCCC
Confidence 7788887655 49999999997654321 223345789999999974 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh-hhhcCCCCCC-CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA-IFMIPTKPPP-SFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.++|||||||++|+|++|..||........ ...+...... ....+..+++++.+++.+||+.||++|||++|++
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 194 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp TTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 6688999999999999999999999965433221 1111111111 1111345789999999999999999999999999
Q ss_pred cChhhhhcc
Q psy3253 234 NHEFIQRHD 242 (251)
Q Consensus 234 ~hp~~~~~~ 242 (251)
+||||+..+
T Consensus 274 ~h~~~~~~~ 282 (322)
T 2ycf_A 274 RHPWLQDED 282 (322)
T ss_dssp TSGGGCCHH
T ss_pred hCcCcCCHH
Confidence 999997644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=290.86 Aligned_cols=204 Identities=23% Similarity=0.472 Sum_probs=154.2
Q ss_pred CCCCCCccceeeeeEeeC------CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++... ...|+++|++ +++|.+++. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 159 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 468999999999999653 5689999999 679999986 3679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++..... .....+|+.|+|||++.+
T Consensus 160 ---------------------------------p~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 160 ---------------------------------PSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp ---------------------------------GGGEEECTTCCEEECC------------------CCCTTCCHHHHTT
T ss_pred ---------------------------------HhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcC
Confidence 88999999999999999999765432 233567999999999976
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---C------------------------CCCCC-CCCCC
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---K------------------------PPPSF-REPDV 206 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~------------------------~~~~~-~~~~~ 206 (251)
..++.++||||+||++|+|++|.+||.+.+.......+.. . ....+ .....
T Consensus 204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (367)
T 2fst_X 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283 (367)
T ss_dssp CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTT
T ss_pred CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCC
Confidence 6789999999999999999999999977654433222110 0 00000 01234
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.++++.+||.+||+.||++|||++|+|+||||+.....
T Consensus 284 ~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 68899999999999999999999999999999876543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=279.41 Aligned_cols=209 Identities=37% Similarity=0.695 Sum_probs=152.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL----RKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~ 76 (251)
+.++||||+++++++.+.+..++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++ |++|||||
T Consensus 76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk- 153 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK- 153 (327)
T ss_dssp SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC-
T ss_pred HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC-
Confidence 567999999999999999999999999975 88888752 257899999999999999999999998 99999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc---
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--- 153 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--- 153 (251)
|+||+++.++.+||+|||++....... ......+++.|+|||++
T Consensus 154 --------------------------------p~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 200 (327)
T 3aln_A 154 --------------------------------PSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPS 200 (327)
T ss_dssp --------------------------------GGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred --------------------------------HHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccc
Confidence 889999999999999999997654332 22334688899999998
Q ss_pred -ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCC--CCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 154 -QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSF--REPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 154 -~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
.+..++.++|||||||++|+|++|..||...... .....+.....+.+ .....+++++.+++.+||+.||++|||+
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp -----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence 4567899999999999999999999999764332 22222222222222 1234689999999999999999999999
Q ss_pred HHHhcChhhhhccCCC
Q psy3253 230 SEMLNHEFIQRHDTDP 245 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~ 245 (251)
+|+++||||....+..
T Consensus 281 ~ell~hp~~~~~~~~~ 296 (327)
T 3aln_A 281 KELLKHPFILMYEERA 296 (327)
T ss_dssp HHHTTSHHHHHHHHSC
T ss_pred HHHHhChHHHHhHhhH
Confidence 9999999998876554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=281.88 Aligned_cols=211 Identities=24% Similarity=0.431 Sum_probs=165.2
Q ss_pred CCCCCCCccceeeeeEe--------------eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 1 MQQCDSPYVVKYYGSYF--------------KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~--------------~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
|++++||||+++++++. +....++||||++ |+|.+++. ...+++..++.++.|++.||.|||+
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~ 138 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS 138 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh
Confidence 35789999999999873 3467899999997 59999985 4679999999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCccc---ccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTM---AKRNTVI 142 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 142 (251)
+|++||||| |+||+++ .++.+||+|||++....... .......
T Consensus 139 ~~i~H~dlk---------------------------------p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 185 (320)
T 2i6l_A 139 ANVLHRDLK---------------------------------PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185 (320)
T ss_dssp TTCBCCCCS---------------------------------GGGEEEETTTTEEEECCCTTCBCC--------CCCGGG
T ss_pred CCEecCCCC---------------------------------HHHEEEcCCCCeEEEccCccccccCCCccccccccccc
Confidence 999999988 8888886 45689999999997654221 1223345
Q ss_pred ccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-----------------------
Q psy3253 143 GTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP----------------------- 198 (251)
Q Consensus 143 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 198 (251)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+....+
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (320)
T 2i6l_A 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMT 265 (320)
T ss_dssp SCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT
T ss_pred ccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccccccccc
Confidence 6888999998865 6789999999999999999999999977655433322111100
Q ss_pred ----CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 199 ----PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 199 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
+.......++.++.++|.+||+.||++|||++|+++||||+..+++..+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 0001124579999999999999999999999999999999999887754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=283.60 Aligned_cols=210 Identities=27% Similarity=0.374 Sum_probs=165.0
Q ss_pred CCCCCccceeeeeEeeCCe-------EEEEEEccCCCCHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTD-------LWIVMEYCGAGSVSDIMR---LRKKTLSEDEIATILCDTLKGLEYLH--LRRKI 70 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~-------~~lv~e~~~~gsL~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~LH--~~~ii 70 (251)
+++||||++++++|..... .++||||+.+ +|.+.+. .....+++..+..++.|++.||.||| ++|++
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~iv 153 (360)
T 3e3p_A 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153 (360)
T ss_dssp HHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCB
T ss_pred hcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence 4689999999999975433 8999999976 6655543 24567899999999999999999999 99999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCC-CCCeEecccccccccCccccccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 149 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 149 (251)
||||| |+||+++. ++.+||+|||++....... ......+|+.|+|
T Consensus 154 H~Dlk---------------------------------p~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~a 199 (360)
T 3e3p_A 154 HRDIK---------------------------------PHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRA 199 (360)
T ss_dssp CSCCC---------------------------------GGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCC
T ss_pred cCcCC---------------------------------HHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeC
Confidence 99988 88888886 7899999999997655432 2334567899999
Q ss_pred ccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C---------------------CC-----
Q psy3253 150 PEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P---------------------PP----- 199 (251)
Q Consensus 150 PE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~---------------------~~----- 199 (251)
||++.+. .++.++|||||||++|+|++|..||.+.+.......+... . ..
T Consensus 200 PE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3e3p_A 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279 (360)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH
T ss_pred HHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccc
Confidence 9998654 4899999999999999999999999776554333222110 0 00
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 200 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
........++++.+||.+||+.||++|||++|+++||||+...+....
T Consensus 280 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 001122356889999999999999999999999999999988766543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.83 Aligned_cols=210 Identities=25% Similarity=0.450 Sum_probs=167.0
Q ss_pred CCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
++++||||+++++++... ...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|||||
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk- 139 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK- 139 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC-
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC-
Confidence 467999999999988654 67999999996 599999863 579999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----------ccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----------RNTVIGTPF 146 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~ 146 (251)
|+||+++.++.++|+|||++......... .....||+.
T Consensus 140 --------------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (353)
T 2b9h_A 140 --------------------------------PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187 (353)
T ss_dssp --------------------------------GGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGG
T ss_pred --------------------------------HHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccccc
Confidence 88999999999999999999765432111 122357889
Q ss_pred ccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CCCC--------------------CCC-
Q psy3253 147 WMAPEVIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TKPP--------------------PSF- 201 (251)
Q Consensus 147 y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~--------------------~~~- 201 (251)
|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+. .... +..
T Consensus 188 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 2b9h_A 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267 (353)
T ss_dssp GCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC
T ss_pred ccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC
Confidence 999998754 678999999999999999999999997765432221110 0000 000
Q ss_pred -----CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCCC
Q psy3253 202 -----REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 202 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~~ 247 (251)
.....+++++.++|.+||+.||++|||++|+++||||+...+....
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence 0124678999999999999999999999999999999987766543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=277.85 Aligned_cols=200 Identities=26% Similarity=0.512 Sum_probs=169.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------------------KTLSEDEIATILCDT 57 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------------------~~l~~~~~~~~~~~i 57 (251)
|++++||||+++++++.+....++||||+.+++|.+++.... ..+++.+++.++.||
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 467899999999999999999999999999999999997532 238999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA- 136 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~- 136 (251)
+.||.|||++|++||||| |+||+++.++.++|+|||++........
T Consensus 160 ~~~l~~lH~~~ivH~dik---------------------------------p~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 206 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLA---------------------------------ARNILVAEGRKMKISDFGLSRDVYEEDSY 206 (314)
T ss_dssp HHHHHHHHHTTEECCCCS---------------------------------GGGEEEETTTEEEECCCTTCEECTTTSCE
T ss_pred HHHHHHHHHCCCcccccc---------------------------------hheEEEcCCCCEEEccccccccccccccc
Confidence 999999999999999988 8899999999999999999976543211
Q ss_pred -cccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHH
Q psy3253 137 -KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214 (251)
Q Consensus 137 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 214 (251)
......+++.|+|||.+.+..++.++||||+||++|+|++ |..||.+.........+..... ...+..+++++.++
T Consensus 207 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 284 (314)
T 2ivs_A 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRL 284 (314)
T ss_dssp ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHH
T ss_pred eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHH
Confidence 2233346778999999988889999999999999999999 9999987766665554444332 23356789999999
Q ss_pred HHHhhhcCcCccCCHHHHhcC
Q psy3253 215 VSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~h 235 (251)
+.+||+.||++|||++|++++
T Consensus 285 i~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 285 MLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=282.88 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=165.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++. +...++||||+.+|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 70 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik------ 142 (325)
T 3kex_A 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA------ 142 (325)
T ss_dssp HTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCS------
T ss_pred hcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccc------
Confidence 4689999999999986 456899999999999999998555789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++
T Consensus 143 ---------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (325)
T 3kex_A 143 ---------------------------ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195 (325)
T ss_dssp ---------------------------STTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC
T ss_pred ---------------------------hheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCC
Confidence 8889998899999999999986543321 22334567789999999988999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++||||+||++|++++ |..||.+.........+..... ...+..+++++.+++.+||..||++|||++|++++
T Consensus 196 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999 9999987766555544444322 22355678899999999999999999999999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=286.19 Aligned_cols=198 Identities=24% Similarity=0.469 Sum_probs=170.1
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
++ +||||+++++++.++...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 45 89999999999999999999999999999999997543 359999999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~ 144 (251)
+|++||||| |+||+++.++.+||+|||++....... .......+|
T Consensus 210 ~~ivH~Dlk---------------------------------p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t 256 (382)
T 3tt0_A 210 KKCIHRDLA---------------------------------ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256 (382)
T ss_dssp TTCCCSCCC---------------------------------GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCG
T ss_pred CCEecCCCC---------------------------------cceEEEcCCCcEEEcccCcccccccccccccccCCCCC
Confidence 999999988 889999999999999999997654322 122334467
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+...... ..+..+++++.+++.+||+.||
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCSSCCHHHHHHHHHHTCSSG
T ss_pred cceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCh
Confidence 78999999999999999999999999999999 99999887766665555444322 2356789999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++|++++
T Consensus 335 ~~Rps~~ell~~ 346 (382)
T 3tt0_A 335 SQRPTFKQLVED 346 (382)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=286.02 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=159.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++|+|.++++.....+++.++..++.||+.||.|||++|++|||||
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk----- 174 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA----- 174 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC-----
Confidence 468899999999999999999999999999999999998666689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++........ .....++..|+|||++.+..
T Consensus 175 ----------------------------p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (373)
T 2qol_A 175 ----------------------------ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226 (373)
T ss_dssp ----------------------------GGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC
T ss_pred ----------------------------cceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence 88999999999999999999765432211 11223466799999999889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|||||||++|++++ |..||.+.........+.... ....+..++.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY--RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999997 999998776665554443332 12235568999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=286.61 Aligned_cols=203 Identities=26% Similarity=0.455 Sum_probs=162.2
Q ss_pred CCCCCCccceeeeeEeeCCeE------EEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDL------WIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~------~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++...... |+||||+. ++|.+++. ..+++..+..++.|++.||.|||++|++|||||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 171 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 171 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence 468999999999999876654 99999996 58888763 569999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||+++..... .....+|+.|+|||++.+
T Consensus 172 ---------------------------------p~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 172 ---------------------------------PGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp ---------------------------------GGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSC
T ss_pred ---------------------------------HHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcC
Confidence 88999999999999999999755432 234567899999999977
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---------------------------CCCCC-CCCCCC
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---------------------------KPPPS-FREPDV 206 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~ 206 (251)
..++.++||||+||++|+|++|..||.+.+.......+.. ..... ...+..
T Consensus 216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (371)
T 4exu_A 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 295 (371)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTT
T ss_pred CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccc
Confidence 7789999999999999999999999977654333222110 00000 001245
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
+++++.+||.+||+.||++|||++|+++||||+....+
T Consensus 296 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 296 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred cChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 68999999999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.03 Aligned_cols=204 Identities=24% Similarity=0.387 Sum_probs=161.8
Q ss_pred CCC-CCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 3 QCD-SPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 3 ~l~-hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
+++ ||||+++++++.+ ....++||||+.+++|.++++ .+++..++.++.||+.||.|||++|++|||||
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik---- 157 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVK---- 157 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS----
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC----
Confidence 454 9999999999987 667999999999999998874 48999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCccccccccccccccccccccccc-CC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 157 (251)
|+||+++.++ .++|+|||++...... .......+++.|+|||.+.+ ..
T Consensus 158 -----------------------------p~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 207 (330)
T 3nsz_A 158 -----------------------------PHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQM 207 (330)
T ss_dssp -----------------------------GGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCC
T ss_pred -----------------------------HHHEEEcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCc
Confidence 8888888666 7999999999765433 22334567889999999976 67
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhc----------------C------------CCCC------CCCC
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMI----------------P------------TKPP------PSFR 202 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~----------------~------------~~~~------~~~~ 202 (251)
++.++||||+||++|+|++|..||...... .....+ . .... ....
T Consensus 208 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (330)
T 3nsz_A 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 287 (330)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTT
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcccc
Confidence 899999999999999999999999432211 110000 0 0000 0011
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.+..+++++.+||.+||+.||++|||++|+|+||||+...++
T Consensus 288 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp TGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred ccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 123378999999999999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=275.89 Aligned_cols=206 Identities=26% Similarity=0.465 Sum_probs=159.5
Q ss_pred CCCCCCCccceeeeeEee-------------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-------------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
|++++||||+++++++.+ ....|+||||+++|+|.+++......+++..+..++.|++.||.|||++
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 135 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999998865 3568999999999999999986666789999999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc------------
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM------------ 135 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~------------ 135 (251)
|++||||| |+||+++.++.++|+|||.+.......
T Consensus 136 ~i~H~dlk---------------------------------p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 182 (303)
T 1zy4_A 136 GIIHRDLK---------------------------------PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182 (303)
T ss_dssp TCCCSCCC---------------------------------GGGEEECTTSCEEECCCCCCSCTTC--------------
T ss_pred CeecccCC---------------------------------HHhEEEcCCCCEEEeeCcchhhcccccchhccccccccc
Confidence 99999988 889999999999999999997654221
Q ss_pred --ccccccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC-CcchhhhhcCCC-CCCCCCCCCCCCHH
Q psy3253 136 --AKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDI-HPMRAIFMIPTK-PPPSFREPDVWTPE 210 (251)
Q Consensus 136 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~ 210 (251)
.......+++.|+|||++.+. .++.++||||+||++|+|++ ||... +.......+... .......+...++.
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (303)
T 1zy4_A 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKV 259 (303)
T ss_dssp -----------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHH
T ss_pred cccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHH
Confidence 122334578899999999764 68999999999999999998 45322 112222221111 11111234556788
Q ss_pred HHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 211 FIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 211 ~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
+.+++.+||+.||++|||++|+++||||+...
T Consensus 260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 99999999999999999999999999997644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=283.85 Aligned_cols=200 Identities=23% Similarity=0.441 Sum_probs=159.7
Q ss_pred CCCCCCCccceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++. .+...++||||+++|+|.++++.....+++..+..++.||+.||.|||++|++|||||
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk---- 219 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA---- 219 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCC----
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccc----
Confidence 57889999999999875 4567899999999999999998666779999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++....... ......+++.|+|||.+.+
T Consensus 220 -----------------------------p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 270 (373)
T 3c1x_A 220 -----------------------------ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270 (373)
T ss_dssp -----------------------------GGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH
T ss_pred -----------------------------hheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC
Confidence 8899999999999999999975533211 1123346778999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++|||||||++|+|++ |.+||.+.+.......+..... ...+..+++.+.+++.+||+.||++|||++|+++
T Consensus 271 ~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999 7888876655554444333322 2335678999999999999999999999999986
Q ss_pred C
Q psy3253 235 H 235 (251)
Q Consensus 235 h 235 (251)
+
T Consensus 349 ~ 349 (373)
T 3c1x_A 349 R 349 (373)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=270.27 Aligned_cols=199 Identities=25% Similarity=0.445 Sum_probs=169.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++...++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~------ 131 (267)
T 3t9t_A 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA------ 131 (267)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC------
T ss_pred HhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCc------
Confidence 57899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.
T Consensus 132 ---------------------------p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (267)
T 3t9t_A 132 ---------------------------ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184 (267)
T ss_dssp ---------------------------GGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred ---------------------------hheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccc
Confidence 8899998899999999999976543211 122334567899999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++|+||+|+++|+|++ |..||...........+..... ...+..+++.+.+++.+||+.||++|||++|++++
T Consensus 185 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc--CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999 8999987766555544444322 22355679999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=274.92 Aligned_cols=222 Identities=21% Similarity=0.287 Sum_probs=163.9
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
..|++++++++++.+..+.++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||+.
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 35667999999999999999999999 889999997443 3689999999999999999999999999999996666554
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
........... . ...-....++.++|+|||++..... ......+|+.|+|||++.+..++.++
T Consensus 153 ~~~~~~~~~~~-------------~-~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 153 QSDYTEAYNPK-------------I-KRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp CCCEEEEEC------------------CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred ccccccccCCc-------------c-ccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcch
Confidence 22110000000 0 0000111266799999999975432 22345678999999999998999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCC--------------------------------------CCC
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPP--------------------------------------PSF 201 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~--------------------------------------~~~ 201 (251)
|||||||++|++++|..||...+.......+ ....+ ...
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 9999999999999999999766544322211 00000 000
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 202 REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 202 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
......++++.+||.+||+.||++|||++|+++||||+....
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence 111223567899999999999999999999999999997653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=277.73 Aligned_cols=199 Identities=26% Similarity=0.449 Sum_probs=167.9
Q ss_pred CCCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 1 l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~L 64 (251)
|+++ +||||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.||+.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3567 89999999999999999999999999999999997432 4799999999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 144 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 144 (251)
|++|++||||| |+||+++.++.++|+|||++...... .......++
T Consensus 159 H~~~ivH~dlk---------------------------------p~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~ 204 (327)
T 1fvr_A 159 SQKQFIHRDLA---------------------------------ARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLP 204 (327)
T ss_dssp HHTTEECSCCS---------------------------------GGGEEECGGGCEEECCTTCEESSCEE-CCC----CC
T ss_pred HhCCccCCCCc---------------------------------cceEEEcCCCeEEEcccCcCcccccc-ccccCCCCC
Confidence 99999999988 88999988999999999998643322 222334467
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
+.|+|||.+.+..++.++||||+||++|+|++ |..||.+.+.......+..... ...+..+++++.+++.+||..||
T Consensus 205 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp TTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred ccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCCh
Confidence 78999999988889999999999999999998 9999987776665555444322 23356789999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++|++++
T Consensus 283 ~~Rps~~ell~~ 294 (327)
T 1fvr_A 283 YERPSFAQILVS 294 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.51 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=166.0
Q ss_pred CCCCCCCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+.. ..|+||||+++|+|.++++..+. .+++..++.++.||+.||.|||++|++|||||
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk--- 316 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA--- 316 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC---
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC---
Confidence 45789999999999987654 79999999999999999986544 47999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++..... .....++..|+|||++.+..+
T Consensus 317 ------------------------------p~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 317 ------------------------------ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp ------------------------------GGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCC
T ss_pred ------------------------------HhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCC
Confidence 88999999999999999999754322 122346788999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.........+..+. ....+..+++++.++|.+||+.||++|||++|+++
T Consensus 364 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999998 999998776665555444433 23346778999999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=280.10 Aligned_cols=202 Identities=24% Similarity=0.395 Sum_probs=158.8
Q ss_pred CCCCCCccceeeeeEeeCC--eEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++++||||+++++++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++|||||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk-- 139 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK-- 139 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS--
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC--
Confidence 4689999999999998655 7899999999999999997433 339999999999999999999999999999999
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceec----CCCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL----NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|+||++ +.++.+||+|||+++...... ......+|+.|+|||++
T Consensus 140 -------------------------------p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 140 -------------------------------PGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp -------------------------------GGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHH
T ss_pred -------------------------------HHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHHHh
Confidence 777776 566779999999997655432 23345689999999998
Q ss_pred c--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc----hhhhhcCCCCC----------------------C
Q psy3253 154 Q--------EIGYDCVADMWSLGITALEMAEGKPPYGDIHPM----RAIFMIPTKPP----------------------P 199 (251)
Q Consensus 154 ~--------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~----------------------~ 199 (251)
. +..++.++|||||||++|+|++|..||...... .....+....+ .
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 4euu_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (319)
T ss_dssp HHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCc
Confidence 6 567899999999999999999999999543221 11111111110 0
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 200 SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 200 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
.......+++.+.+++.+||+.||++|||++|+++||-
T Consensus 268 ~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 01112233567899999999999999999999999984
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=278.45 Aligned_cols=198 Identities=25% Similarity=0.431 Sum_probs=167.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++. .++|+||+.+|+|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik------ 144 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA------ 144 (327)
T ss_dssp HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC------
T ss_pred HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC------
Confidence 4689999999999998754 789999999999999998777889999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++........ .....+|..|+|||.+.+..++
T Consensus 145 ---------------------------p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3poz_A 145 ---------------------------ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp ---------------------------GGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCC
T ss_pred ---------------------------hheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCC
Confidence 88999999999999999999765433221 2223457789999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|||||||++|++++ |..||.+.........+.... ....+..++.++.+++.+||+.||++|||++|++++
T Consensus 198 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999 999998776655554444333 223356689999999999999999999999999865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=284.48 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=158.5
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCCCcc
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLH--LRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH--~~~iiH~dik~~Ni~~~ 82 (251)
|++|+++++++....+.|+||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.||+|||||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk------- 186 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK------- 186 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS-------
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC-------
Confidence 4569999999999999999999995 59999997544 56999999999999999999999 5799999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecC--CCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN--TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++ .++.+||+|||+++..... .....+|+.|+|||++.+..++.
T Consensus 187 --------------------------p~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~ 237 (382)
T 2vx3_A 187 --------------------------PENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDL 237 (382)
T ss_dssp --------------------------GGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCT
T ss_pred --------------------------cccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCc
Confidence 7788884 4678999999999765432 23456789999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C-------------------------------CCCCCCCC-
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P-------------------------------PPSFREPD- 205 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------------------------~~~~~~~~- 205 (251)
++|||||||++|+|++|.+||.+.+.......+... . ...+..+.
T Consensus 238 ~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (382)
T 2vx3_A 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT 317 (382)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcch
Confidence 999999999999999999999766544332211100 0 00000000
Q ss_pred ----------------------C----CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 206 ----------------------V----WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 206 ----------------------~----~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
. ..+++.+||.+||++||++|||++|+|+||||+...+
T Consensus 318 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 318 RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp SCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred hhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence 0 0137899999999999999999999999999987655
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=271.95 Aligned_cols=199 Identities=23% Similarity=0.447 Sum_probs=165.1
Q ss_pred CCCCCCCccceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++. .+...++||||+++|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dik---- 155 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA---- 155 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc----
Confidence 35789999999999864 5567899999999999999998666789999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......+|+.|+|||.+.+
T Consensus 156 -----------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (298)
T 3f66_A 156 -----------------------------ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206 (298)
T ss_dssp -----------------------------GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH
T ss_pred -----------------------------hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC
Confidence 8899999999999999999976543221 1233446778999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+|+++|++++ |.+||.+.........+..... ...+..+++.+.+++.+||+.||++|||++|+++
T Consensus 207 ~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999 6677766655554444433322 2235668999999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=280.42 Aligned_cols=201 Identities=23% Similarity=0.424 Sum_probs=166.2
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCC----------------------CCCHHHHHHHHHHHH
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK----------------------TLSEDEIATILCDTL 58 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~----------------------~l~~~~~~~~~~~i~ 58 (251)
+++ +||||+++++++......++||||+++|+|.+++..... .+++..++.++.||+
T Consensus 103 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 182 (344)
T 1rjb_A 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182 (344)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHH
T ss_pred HhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHH
Confidence 345 899999999999999999999999999999999974432 378999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--
Q psy3253 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-- 136 (251)
Q Consensus 59 ~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-- 136 (251)
.||.|||++|++||||| |+||+++.++.++|+|||++........
T Consensus 183 ~aL~~LH~~~ivH~Dik---------------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 183 KGMEFLEFKSCVHRDLA---------------------------------ARNVLVTHGKVVKICDFGLARDIMSDSNYV 229 (344)
T ss_dssp HHHHHHHHTTEEETTCS---------------------------------GGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred HHHHHHHhCCcccCCCC---------------------------------hhhEEEcCCCcEEeCCCccCcccccCccce
Confidence 99999999999999988 8899999999999999999976543221
Q ss_pred cccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHH
Q psy3253 137 KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFV 215 (251)
Q Consensus 137 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 215 (251)
......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.............. .....+..+++++.+++
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 308 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYIIM 308 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC-CCCCCCCCCCHHHHHHH
Confidence 2233456788999999988899999999999999999998 999997765443332221111 12233566799999999
Q ss_pred HHhhhcCcCccCCHHHHhcCh
Q psy3253 216 SRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 216 ~~~l~~~p~~Rps~~evl~hp 236 (251)
.+||+.||++|||++|++++.
T Consensus 309 ~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 309 QSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=273.43 Aligned_cols=205 Identities=26% Similarity=0.475 Sum_probs=157.9
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccc
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDR 85 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~ 85 (251)
||||+++++++.++...++|||+ .+++|.+++. ....+++..++.++.|++.||.|||++|++|||||
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk---------- 154 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK---------- 154 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC----------
T ss_pred CCceEEEEEEeecCCEEEEEEec-CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC----------
Confidence 69999999999999999999995 4789999997 45689999999999999999999999999999988
Q ss_pred cccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccccccccc--------
Q psy3253 86 LDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQE-------- 155 (251)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------- 155 (251)
|+||+++ ++.+||+|||++........ ......+++.|+|||.+.+
T Consensus 155 -----------------------p~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 210 (313)
T 3cek_A 155 -----------------------PANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210 (313)
T ss_dssp -----------------------GGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC------
T ss_pred -----------------------cccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccc
Confidence 7788885 47899999999976543221 1233467899999999865
Q ss_pred ---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH
Q psy3253 156 ---IGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE 231 (251)
Q Consensus 156 ---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 231 (251)
..++.++||||||+++|+|++|..||...... .....+... ......+...+.++.+++.+||+.||++|||++|
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp ----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc-ccccCCcccchHHHHHHHHHHccCCcccCcCHHH
Confidence 46888999999999999999999999764332 222111111 1122335566899999999999999999999999
Q ss_pred HhcChhhhhccCCCCC
Q psy3253 232 MLNHEFIQRHDTDPSQ 247 (251)
Q Consensus 232 vl~hp~~~~~~~~~~~ 247 (251)
+++||||+......++
T Consensus 290 ll~h~~~~~~~~~~~~ 305 (313)
T 3cek_A 290 LLAHPYVQIQTHPVNQ 305 (313)
T ss_dssp HHTSHHHHCC------
T ss_pred HhcCccccCCCCchhh
Confidence 9999999987666554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.45 Aligned_cols=199 Identities=23% Similarity=0.386 Sum_probs=164.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+....++||||+++|+|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 101 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik------ 174 (333)
T 1mqb_A 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA------ 174 (333)
T ss_dssp HTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC------
T ss_pred HhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC------
Confidence 57899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++......... .....++..|+|||++.+..+
T Consensus 175 ---------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 175 ---------------------------ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp ---------------------------GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred ---------------------------hheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 88999999999999999999765432211 122234678999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|||||||++|++++ |..||.+.........+..... ...+..+++++.+++.+||+.||++||+++|++++
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998 9999987766655544443322 22356789999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=270.19 Aligned_cols=196 Identities=26% Similarity=0.517 Sum_probs=157.5
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR---KIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~---iiH~dik~~N 78 (251)
++++||||+++++++.++...++||||+++++|.+++. ...+++..+..++.|++.||.|||++| ++|||||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dik--- 135 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK--- 135 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCS---
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCc---
Confidence 46799999999999999999999999999999999985 568999999999999999999999999 8999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCC--------CCCeEecccccccccCcccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--------EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|+||+++. ++.++|+|||++....... .....+++.|+||
T Consensus 136 ------------------------------p~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aP 183 (271)
T 3dtc_A 136 ------------------------------SSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAP 183 (271)
T ss_dssp ------------------------------GGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCH
T ss_pred ------------------------------hHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCH
Confidence 66666654 6779999999997654332 2234678999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
|.+.+..++.++||||+|+++|++++|..||.+.+.......+.... .....+..+++++.+++.+||+.||++|||++
T Consensus 184 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 262 (271)
T 3dtc_A 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFT 262 (271)
T ss_dssp HHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-CCCCCCcccCHHHHHHHHHHhcCCcccCcCHH
Confidence 99998889999999999999999999999998776655444333222 22334677899999999999999999999999
Q ss_pred HHhcC
Q psy3253 231 EMLNH 235 (251)
Q Consensus 231 evl~h 235 (251)
|++++
T Consensus 263 e~l~~ 267 (271)
T 3dtc_A 263 NILDQ 267 (271)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=273.50 Aligned_cols=200 Identities=27% Similarity=0.459 Sum_probs=169.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++ .....++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 65 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk------ 137 (287)
T 1u59_A 65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA------ 137 (287)
T ss_dssp HHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS------
T ss_pred HhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCc------
Confidence 467999999999999 5567999999999999999997556779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||++.+..+
T Consensus 138 ---------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (287)
T 1u59_A 138 ---------------------------ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190 (287)
T ss_dssp ---------------------------GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred ---------------------------hheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCC
Confidence 8899999899999999999976543211 1222345788999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+|+++|+|++ |..||...........+...... ..+..+++++.++|.+||+.||++|||++|++++.+
T Consensus 191 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC--CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999998 99999877665555444443322 235678999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.04 Aligned_cols=199 Identities=26% Similarity=0.436 Sum_probs=163.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++. .+++++|+.+|+|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik----- 144 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA----- 144 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCC-----
Confidence 46789999999999998664 889999999999999998777889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||+++....... ......+++.|+|||.+.+..+
T Consensus 145 ----------------------------p~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 145 ----------------------------ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp ----------------------------GGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCC
T ss_pred ----------------------------HHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC
Confidence 8899998889999999999976543221 1222345778999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|||||||++|+|++ |..||.+.........+..... ...+..++.++.+++.+||..||++|||++|+++.
T Consensus 197 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999 9999987766665554444332 23356689999999999999999999999999853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=283.13 Aligned_cols=198 Identities=29% Similarity=0.517 Sum_probs=162.6
Q ss_pred CC-CCCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHHhCC-------------------------------------
Q psy3253 3 QC-DSPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRLRKK------------------------------------- 43 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~~~~------------------------------------- 43 (251)
++ +||||+++++++.+.. ..++||||+.+|+|.+++.....
T Consensus 81 ~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (359)
T 3vhe_A 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQ 160 (359)
T ss_dssp HHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------
T ss_pred hhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccc
Confidence 34 7999999999998754 48999999999999999974322
Q ss_pred ----------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccc
Q psy3253 44 ----------------------------TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNV 95 (251)
Q Consensus 44 ----------------------------~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~ 95 (251)
.+++..++.++.|++.||.|||++|++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dik-------------------- 220 (359)
T 3vhe_A 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA-------------------- 220 (359)
T ss_dssp -----------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS--------------------
T ss_pred cccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCC--------------------
Confidence 18999999999999999999999999999988
Q ss_pred cchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCCCcchhHHHHHHHHHH
Q psy3253 96 ITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE 173 (251)
Q Consensus 96 ~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~ 173 (251)
|+||+++.++.++|+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+
T Consensus 221 -------------p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 287 (359)
T 3vhe_A 221 -------------ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287 (359)
T ss_dssp -------------GGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred -------------hhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHH
Confidence 889999989999999999997653321 22334567888999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCcchhhhh-cCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 174 MAE-GKPPYGDIHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 174 l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
|++ |..||.+......... +.... ....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 288 llt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 288 IFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCccchhHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 998 9999976654333222 22221 223356689999999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.99 Aligned_cols=203 Identities=26% Similarity=0.466 Sum_probs=162.1
Q ss_pred CCCCCCccceeeeeEeeCCe------EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++..... .|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++|++|||||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 153 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 153 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 46799999999999986643 599999996 58888763 469999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++...... .....+|+.|+|||++.+
T Consensus 154 ---------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 154 ---------------------------------PGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp ---------------------------------GGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSC
T ss_pred ---------------------------------HHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhC
Confidence 88999999999999999999764422 233467899999999876
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---------------------------CCCCCCC-CCCCCC
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------------PTKPPPS-FREPDV 206 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------~~~~~~~-~~~~~~ 206 (251)
..++.++||||+||++|+|++|..||.+.+.......+ ....... ......
T Consensus 198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (353)
T 3coi_A 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277 (353)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTT
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCC
Confidence 67899999999999999999999999765533222111 0111111 112346
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
+++++.++|.+||+.||++|||++|+++||||+.....
T Consensus 278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 78999999999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=270.25 Aligned_cols=200 Identities=23% Similarity=0.455 Sum_probs=166.5
Q ss_pred CCCCCCCccceeeeeEeeCCeE-EEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~-~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+.... +++|||+.+|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik---- 151 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA---- 151 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC----
Confidence 3578999999999999876654 99999999999999998666789999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc----cccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 152 -----------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 152 -----------------------------ARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp -----------------------------GGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred -----------------------------cceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc
Confidence 889999999999999999997554321 12233456788999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||+|+++|+|++ +.+||...+.......+..... ...+..+++++.+++.+||+.||++|||++|+++
T Consensus 203 ~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC--CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999 5556666555555444433332 2335678999999999999999999999999985
Q ss_pred C
Q psy3253 235 H 235 (251)
Q Consensus 235 h 235 (251)
.
T Consensus 281 ~ 281 (298)
T 3pls_A 281 E 281 (298)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=273.95 Aligned_cols=194 Identities=21% Similarity=0.365 Sum_probs=158.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++...++||||+++|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk----- 140 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVC----- 140 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcC-----
Confidence 357899999999999999999999999999999999998666669999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCC--------eEecccccccccCcccccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH--------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++. ++|+|||++...... ....+++.|+|||+
T Consensus 141 ----------------------------p~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~ 188 (289)
T 4fvq_A 141 ----------------------------AKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPEC 188 (289)
T ss_dssp ----------------------------GGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHH
T ss_pred ----------------------------cceEEEecCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHH
Confidence 66666665554 999999998654332 23456888999999
Q ss_pred ccc-CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 153 IQE-IGYDCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 153 ~~~-~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
+.+ ..++.++||||+||++|+|++| .+||...+........... ...+...++++.+++.+||+.||++|||++
T Consensus 189 ~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 264 (289)
T 4fvq_A 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR----HQLPAPKAAELANLINNCMDYEPDHRPSFR 264 (289)
T ss_dssp HHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc----CCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 987 7789999999999999999995 5555554443333222221 122445688899999999999999999999
Q ss_pred HHhcC
Q psy3253 231 EMLNH 235 (251)
Q Consensus 231 evl~h 235 (251)
|++++
T Consensus 265 ~ll~~ 269 (289)
T 4fvq_A 265 AIIRD 269 (289)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.06 Aligned_cols=203 Identities=23% Similarity=0.376 Sum_probs=168.7
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK------KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
++++||||+++++++.+....|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk 167 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167 (327)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence 46799999999999999999999999999999999998543 358999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCccc--ccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAP 150 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aP 150 (251)
|+||+++. +..++|+|||++....... .......+++.|+||
T Consensus 168 ---------------------------------p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 168 ---------------------------------ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp ---------------------------------GGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred ---------------------------------HhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 77888873 4469999999986543221 122334568889999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
|.+.+..++.++|||||||++|+|++ |..||...........+...... ..+..+++.+.++|.+||+.||++|||+
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~ 292 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNF 292 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 99988889999999999999999998 99999877665555444433222 2356789999999999999999999999
Q ss_pred HHHhcChhhh
Q psy3253 230 SEMLNHEFIQ 239 (251)
Q Consensus 230 ~evl~hp~~~ 239 (251)
+|++++.|+-
T Consensus 293 ~~ll~~l~~~ 302 (327)
T 2yfx_A 293 AIILERIEYC 302 (327)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.18 Aligned_cols=199 Identities=19% Similarity=0.239 Sum_probs=160.0
Q ss_pred CCCCCCccceeeeeEeeC----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++++||||+++++++... ...|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+|||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk-- 179 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK-- 179 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC--
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC--
Confidence 568999999999999764 4589999999 999999998766889999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecC--CCCCeEecccccccccCccccc-------ccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN--TEGHAKLADFGVAGQLTDTMAK-------RNTVIGTPFWM 148 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~ 148 (251)
|+||+++ .++.+||+|||+++........ .....||+.|+
T Consensus 180 -------------------------------p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 228 (364)
T 3op5_A 180 -------------------------------ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228 (364)
T ss_dssp -------------------------------GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTC
T ss_pred -------------------------------HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCcc
Confidence 8888887 7889999999999765432211 12334899999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh-cCC---CCCC----CCCCCCCCCHHHHHHHHHhhh
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM-IPT---KPPP----SFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~---~~~~----~~~~~~~~~~~~~~li~~~l~ 220 (251)
|||++.+..++.++|||||||++|+|++|..||.+......... ... .... .......+++++.+++.+||.
T Consensus 229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 308 (364)
T 3op5_A 229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKL 308 (364)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHT
T ss_pred CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhc
Confidence 99999998999999999999999999999999975322211110 000 0000 000125679999999999999
Q ss_pred cCcCccCCHHHHhc
Q psy3253 221 KNPEERATASEMLN 234 (251)
Q Consensus 221 ~~p~~Rps~~evl~ 234 (251)
.||++||+++++++
T Consensus 309 ~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 309 LDYTEKPLYENLRD 322 (364)
T ss_dssp CCTTCCCCHHHHHH
T ss_pred CCCCCCCCHHHHHH
Confidence 99999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.01 Aligned_cols=198 Identities=25% Similarity=0.428 Sum_probs=163.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.++ ..++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 68 ~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk------ 140 (281)
T 3cc6_A 68 KNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA------ 140 (281)
T ss_dssp HHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS------
T ss_pred HhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc------
Confidence 457899999999998654 5789999999999999998777789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.
T Consensus 141 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 193 (281)
T 3cc6_A 141 ---------------------------VRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193 (281)
T ss_dssp ---------------------------GGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCH
T ss_pred ---------------------------cceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCc
Confidence 8899998899999999999976543321 123334577899999998889999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++||||||+++|+|++ |..||...........+..... ...+..+++.+.+++.+||+.||++|||++|++++
T Consensus 194 ~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999998 9999976655554443333222 22356689999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.95 Aligned_cols=199 Identities=22% Similarity=0.412 Sum_probs=169.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+....|+||||+.+|+|.++++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk---- 345 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA---- 345 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS----
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC----
Confidence 35689999999999999999999999999999999999753 3568999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||++.+..+
T Consensus 346 -----------------------------p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 346 -----------------------------ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp -----------------------------GGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred -----------------------------hhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 8899999999999999999976543221 2223345678999999998889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.+.......+.... ....+..+++++.+||.+||+.||++|||++|+++
T Consensus 397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999 999998777665554444332 23346778999999999999999999999999984
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.29 Aligned_cols=198 Identities=25% Similarity=0.435 Sum_probs=167.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++. ....|+||||+.+|+|.++++.. ...+++..+..++.||+.||.|||++|++|||||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk---- 311 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR---- 311 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS----
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC----
Confidence 46899999999999986 66799999999999999999733 2478999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-ccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++........ .....++..|+|||++....+
T Consensus 312 -----------------------------p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 362 (454)
T 1qcf_A 312 -----------------------------AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362 (454)
T ss_dssp -----------------------------GGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC
T ss_pred -----------------------------HHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCC
Confidence 88999999999999999999765432211 222345678999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.+.......+.... ....+..+++++.++|.+||+.||++|||++++++
T Consensus 363 ~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999 999998877666554443332 22346678999999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=269.67 Aligned_cols=199 Identities=22% Similarity=0.411 Sum_probs=169.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++.++...++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik----- 138 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA----- 138 (288)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCS-----
T ss_pred HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCC-----
Confidence 4689999999999999999999999999999999999753 3569999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++
T Consensus 139 ----------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (288)
T 3kfa_A 139 ----------------------------ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190 (288)
T ss_dssp ----------------------------GGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred ----------------------------cceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCC
Confidence 889999888999999999997654332 222334567789999999988999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++||||+|+++|+|++ |..||.+.+.......+..... ...+..+++++.+++.+||..||++|||++|+++.
T Consensus 191 ~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 99999999999999999 9999987766655544443322 23456789999999999999999999999999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=271.62 Aligned_cols=200 Identities=25% Similarity=0.331 Sum_probs=157.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++..+...|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk----- 161 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK----- 161 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCC-----
Confidence 4678999999999999999999999999999999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc-ccccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++
T Consensus 162 ----------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 213 (309)
T 2h34_A 162 ----------------------------PENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213 (309)
T ss_dssp ----------------------------GGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----
T ss_pred ----------------------------hHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCC
Confidence 889999999999999999987654322 122344678899999999988899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-CHHHHhc
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-TASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~evl~ 234 (251)
.++||||||+++|+|++|..||.+.........+..........+..+++++.++|.+||+.||++|| |++++++
T Consensus 214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999999997765543333333322222234567899999999999999999999 7888874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=285.03 Aligned_cols=232 Identities=25% Similarity=0.291 Sum_probs=158.6
Q ss_pred CCCccceeeeeEe----eCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q psy3253 5 DSPYVVKYYGSYF----KNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGS 78 (251)
Q Consensus 5 ~hpniv~l~~~~~----~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~N 78 (251)
+||||++++++|. +..+.|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4899999999997 556899999999 55776666533 36799999999999999999999998 99999999999
Q ss_pred CCcccccccc----------cccccc------ccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccc
Q psy3253 79 GTLVYDRLDY----------CSIKCN------VITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 142 (251)
Q Consensus 79 i~~~~~~~~~----------~~~~~~------~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 142 (251)
||+..+.... ...... ..............+....-.....++|+|||++...... .....
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~ 254 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDI 254 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCC
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCC
Confidence 9987432100 000000 0000000000000011111122347999999999765432 23346
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh---------hhhcCCCCC---------------
Q psy3253 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA---------IFMIPTKPP--------------- 198 (251)
Q Consensus 143 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---------~~~~~~~~~--------------- 198 (251)
+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ........+
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 79999999999998999999999999999999999999965432110 000000000
Q ss_pred -----CC----------------CCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 199 -----PS----------------FREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 199 -----~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
.. ...+...++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 0011223467889999999999999999999999999973
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.95 Aligned_cols=199 Identities=25% Similarity=0.445 Sum_probs=159.2
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.. ....++||||+++|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik--- 141 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA--- 141 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS---
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC---
Confidence 357899999999999864 356899999999999999998666679999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---ccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 142 ------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 142 ------------------------------TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp ------------------------------GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH
T ss_pred ------------------------------HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC
Confidence 8899999999999999999976543221 1222345677999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc----------------hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPM----------------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCL 219 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 219 (251)
..++.++||||+|+++|++++|..|+...... .....+... .....+..+++++.+++.+||
T Consensus 192 ~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l 269 (295)
T 3ugc_A 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN--GRLPRPDGCPDEIYMIMTECW 269 (295)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHS
T ss_pred CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc--CcCCCCcCcCHHHHHHHHHHc
Confidence 99999999999999999999999988543211 011111111 123346778999999999999
Q ss_pred hcCcCccCCHHHHhc
Q psy3253 220 VKNPEERATASEMLN 234 (251)
Q Consensus 220 ~~~p~~Rps~~evl~ 234 (251)
+.||++|||++|+++
T Consensus 270 ~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 270 NNNVNQRPSFRDLAL 284 (295)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCCCHHHHHH
Confidence 999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.10 Aligned_cols=199 Identities=24% Similarity=0.439 Sum_probs=165.3
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCC-----------------CCCHHHHHHHHHHHHHHHHHH
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK-----------------TLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~-----------------~l~~~~~~~~~~~i~~~l~~L 64 (251)
++ +||||+++++++.++...++||||+++|+|.+++..... .+++..++.++.|++.||.||
T Consensus 82 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 161 (313)
T 1t46_A 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (313)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 45 899999999999999999999999999999999975432 489999999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVI 142 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 142 (251)
|++|++||||| |+||+++.++.++|+|||++........ ......
T Consensus 162 H~~~i~H~dlk---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 208 (313)
T 1t46_A 162 ASKNCIHRDLA---------------------------------ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208 (313)
T ss_dssp HHTTCCCSCCS---------------------------------GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSE
T ss_pred HHCCeecCCCc---------------------------------cceEEEcCCCCEEEccccccccccccccceeccCCC
Confidence 99999999988 8899999999999999999976543322 123345
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 143 GTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 143 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.............. .....+..+++++.+++.+||+.
T Consensus 209 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 287 (313)
T 1t46_A 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDA 287 (313)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC-CCCCCcccCCHHHHHHHHHHcCC
Confidence 6778999999988899999999999999999998 999997665433322221111 11223566899999999999999
Q ss_pred CcCccCCHHHHhcC
Q psy3253 222 NPEERATASEMLNH 235 (251)
Q Consensus 222 ~p~~Rps~~evl~h 235 (251)
||++|||++|++++
T Consensus 288 dp~~Rps~~ell~~ 301 (313)
T 1t46_A 288 DPLKRPTFKQIVQL 301 (313)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=272.93 Aligned_cols=194 Identities=26% Similarity=0.378 Sum_probs=164.5
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGA-GSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~-gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.||||+++++++.++...++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk-------- 176 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK-------- 176 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS--------
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCC--------
Confidence 479999999999999999999999975 899999974 5689999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCcccccccccccccccccccccccCCC-Ccc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-DCV 161 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~ 161 (251)
|+||+++ .++.+||+|||++...... ......+|+.|+|||++.+..+ +.+
T Consensus 177 -------------------------p~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (320)
T 3a99_A 177 -------------------------DENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRS 229 (320)
T ss_dssp -------------------------GGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHH
T ss_pred -------------------------HHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCcc
Confidence 8888888 6788999999999765433 2233468899999999977665 678
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+|||||||++|+|++|..||...... .. . ....+..+++++.++|.+||+.||++|||++|+++||||+..
T Consensus 230 ~Di~slG~il~el~~g~~pf~~~~~~--~~---~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 230 AAVWSLGILLYDMVCGDIPFEHDEEI--IR---G----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCSHHHH--HH---C----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred chHHhHHHHHHHHHHCCCCCCChhhh--hc---c----cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999999999654321 11 1 112345679999999999999999999999999999999876
Q ss_pred cC
Q psy3253 242 DT 243 (251)
Q Consensus 242 ~~ 243 (251)
..
T Consensus 301 ~~ 302 (320)
T 3a99_A 301 LL 302 (320)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=264.17 Aligned_cols=195 Identities=16% Similarity=0.336 Sum_probs=162.2
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKK-TLSEDEIATILCDTLKGLEYLHLRR--KIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~dik 75 (251)
|++++||||+++++++.+. ...++||||+++|+|.+++..... .+++..+..++.|++.||.|||++| ++|||||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 4678999999999999876 788999999999999999974332 5899999999999999999999999 9999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++++|||++..... ....+|+.|+|||.+.+
T Consensus 141 ---------------------------------p~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 141 ---------------------------------SRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp ---------------------------------GGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCHHHHHS
T ss_pred ---------------------------------cceEEEcCCcceeEEeccceeeecc-----cCccCCccccChhhhcc
Confidence 8899999999999998887754322 23467889999999976
Q ss_pred CCCCc---chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDC---VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~---~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
..++. ++||||+||++|++++|..||.+.........+.... .....+..+++++.+++.+||+.||++|||++|+
T Consensus 183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 55444 7999999999999999999998776655443332221 1223356789999999999999999999999999
Q ss_pred hc
Q psy3253 233 LN 234 (251)
Q Consensus 233 l~ 234 (251)
++
T Consensus 262 l~ 263 (271)
T 3kmu_A 262 VP 263 (271)
T ss_dssp HH
T ss_pred HH
Confidence 84
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=272.82 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=159.4
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEc-cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEY-CGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~-~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
++||||+++++++.+....++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 95 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk------- 166 (312)
T 2iwi_A 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK------- 166 (312)
T ss_dssp CCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCS-------
T ss_pred CCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC-------
Confidence 3899999999999999999999999 788999999974 4679999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCcccccccccccccccccccccccCCCC-c
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD-C 160 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 160 (251)
|+||+++ .++.++|+|||++...... ......++..|+|||++.+..+. .
T Consensus 167 --------------------------p~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 218 (312)
T 2iwi_A 167 --------------------------DENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHAL 218 (312)
T ss_dssp --------------------------GGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHH
T ss_pred --------------------------hhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCc
Confidence 8889988 7888999999999765533 22344578899999999776664 4
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+||++|++++|..||...... .. . ....+..+++++.++|.+||+.||++|||++|+++||||+.
T Consensus 219 ~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 219 PATVWSLGILLYDMVCGDIPFERDQEI--LE----A---ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCSHHHH--HH----T---CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred cchHHHHHHHHHHHHHCCCCCCChHHH--hh----h---ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 899999999999999999999654221 11 1 11234568999999999999999999999999999999987
Q ss_pred ccCCC
Q psy3253 241 HDTDP 245 (251)
Q Consensus 241 ~~~~~ 245 (251)
...+.
T Consensus 290 ~~~~~ 294 (312)
T 2iwi_A 290 PAEDV 294 (312)
T ss_dssp -----
T ss_pred chhcc
Confidence 65544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=294.99 Aligned_cols=203 Identities=26% Similarity=0.463 Sum_probs=168.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.. ...++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+|||||
T Consensus 390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk----- 463 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA----- 463 (613)
T ss_dssp HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS-----
T ss_pred HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCC-----
Confidence 468899999999999976 56999999999999999997566779999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......+++.|+|||++.+..
T Consensus 464 ----------------------------p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~ 515 (613)
T 2ozo_A 464 ----------------------------ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515 (613)
T ss_dssp ----------------------------GGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC
T ss_pred ----------------------------HHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC
Confidence 8899999999999999999976543211 112223467899999999889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh---
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML--- 233 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl--- 233 (251)
++.++|||||||++|+|++ |..||.+.+.......+..+.. ...+..+++++.++|.+||+.||++|||+++++
T Consensus 516 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999998 9999988777666655544432 334667899999999999999999999999984
Q ss_pred cChhhh
Q psy3253 234 NHEFIQ 239 (251)
Q Consensus 234 ~hp~~~ 239 (251)
++.|+.
T Consensus 594 ~~~~~~ 599 (613)
T 2ozo_A 594 RACYYS 599 (613)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=266.16 Aligned_cols=195 Identities=26% Similarity=0.452 Sum_probs=160.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~dik~~N 78 (251)
|++++||||+++++++.+.. ++||||+.+|+|.+++......+++..++.++.|++.||.|||++| ++|||||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dik--- 151 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR--- 151 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCS---
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCC---
Confidence 46789999999999997665 7999999999999999766678999999999999999999999999 9999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCC-----eEecccccccccCccccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-----AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++. ++|+|||++..... ......+++.|+|||++
T Consensus 152 ------------------------------p~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 152 ------------------------------SPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETI 198 (287)
T ss_dssp ------------------------------GGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGS
T ss_pred ------------------------------cceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhh
Confidence 77888876665 99999999975443 23345689999999998
Q ss_pred --ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh--hhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 154 --QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA--IFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 154 --~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
....++.++||||+||++|+|++|..||........ ...+.. .......+..+++++.+++.+||+.||++|||+
T Consensus 199 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 277 (287)
T 4f0f_A 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277 (287)
T ss_dssp SCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCH
Confidence 445678899999999999999999999976544332 111111 111223456789999999999999999999999
Q ss_pred HHHhc
Q psy3253 230 SEMLN 234 (251)
Q Consensus 230 ~evl~ 234 (251)
+|+++
T Consensus 278 ~~ll~ 282 (287)
T 4f0f_A 278 SYIVK 282 (287)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=268.76 Aligned_cols=196 Identities=25% Similarity=0.434 Sum_probs=165.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++ .....++||||+.+++|.+++. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 73 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik------ 144 (291)
T 1xbb_A 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA------ 144 (291)
T ss_dssp HTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS------
T ss_pred HhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH-hCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCC------
Confidence 578999999999999 6677899999999999999997 45679999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---ccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..+
T Consensus 145 ---------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 197 (291)
T 1xbb_A 145 ---------------------------ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197 (291)
T ss_dssp ---------------------------GGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred ---------------------------cceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCC
Confidence 88999988999999999999765432211 122235678999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++||||||+++|+|++ |..||.+.........+...... ..+..+++++.+++.+||+.||++|||++|+++
T Consensus 198 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999 99999877666555544443322 235678999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=273.90 Aligned_cols=204 Identities=25% Similarity=0.315 Sum_probs=161.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDTLKGLEYLHLR---RKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~LH~~---~iiH~di 74 (251)
|++++||||+++++++.+....++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++ |++||||
T Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl 160 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV 160 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCC
T ss_pred HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Confidence 457899999999999999999999999999999999997432 3499999999999999999999999 9999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-ccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 153 (251)
| |+||+++.++.++|+|||++........ ......||+.|+|||++
T Consensus 161 k---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 161 K---------------------------------AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp S---------------------------------GGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred c---------------------------------hhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHh
Confidence 8 8899999999999999999976543222 22334589999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----Ccchhhhhc---CCCCC--------CCCCCCCCCCHHHHHHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDI-----HPMRAIFMI---PTKPP--------PSFREPDVWTPEFIDFVSR 217 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~-----~~~~~~~~~---~~~~~--------~~~~~~~~~~~~~~~li~~ 217 (251)
.+..++.++||||+||++|+|++|..||... ........+ ..... .....+...+..+.+++.+
T Consensus 208 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 287 (326)
T 3uim_A 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287 (326)
T ss_dssp HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHH
T ss_pred ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHH
Confidence 8888999999999999999999999999421 111111000 00000 0001112224678999999
Q ss_pred hhhcCcCccCCHHHHhcChh
Q psy3253 218 CLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 218 ~l~~~p~~Rps~~evl~hp~ 237 (251)
||+.||++|||++|+++|-.
T Consensus 288 cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 288 CTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HTCSCGGGSCCHHHHHHHHH
T ss_pred HhCcCCccCCCHHHHHHHhc
Confidence 99999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=269.87 Aligned_cols=199 Identities=21% Similarity=0.384 Sum_probs=160.5
Q ss_pred CCCCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 2 QQCDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRL-----RKKTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
++++||||+++++++.+.. ..++||||+.+|+|.+++.. ....+++..++.++.|++.||.|||++|++|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (313)
T 3brb_A 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170 (313)
T ss_dssp HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5789999999999997654 45999999999999999853 2356999999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 149 (251)
|||| |+||+++.++.++|+|||++........ ......+++.|+|
T Consensus 171 ~dik---------------------------------p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 171 RDLA---------------------------------ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CCCS---------------------------------GGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CCCC---------------------------------cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 9988 8899999999999999999976543211 1223346778999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||.+.+..++.++||||||+++|+|++ |..||.+.........+...... ..+..+++++.+++.+||..||++|||
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps 295 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDRPT 295 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--CCBTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--CCCccccHHHHHHHHHHcCCChhhCcC
Confidence 999999899999999999999999999 89999877666555444443322 235678999999999999999999999
Q ss_pred HHHHhcC
Q psy3253 229 ASEMLNH 235 (251)
Q Consensus 229 ~~evl~h 235 (251)
++|++++
T Consensus 296 ~~~l~~~ 302 (313)
T 3brb_A 296 FSVLRLQ 302 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=269.43 Aligned_cols=200 Identities=25% Similarity=0.489 Sum_probs=153.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++. .....++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlk----- 147 (289)
T 3og7_A 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK----- 147 (289)
T ss_dssp HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCc-----
Confidence 4688999999999965 5567899999999999999997666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc--cccccccccccccccccccc---c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQ---E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~ 155 (251)
|+||+++.++.++|+|||++...... ........+|+.|+|||++. +
T Consensus 148 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (289)
T 3og7_A 148 ----------------------------SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199 (289)
T ss_dssp ----------------------------GGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred ----------------------------cceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence 88999999999999999999754421 11223346799999999986 5
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC-CC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP-TK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
..++.++||||+|+++|++++|..||.+........... .. ..........+++++.+++.+||+.||++|||++|+
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 678889999999999999999999997655443332211 11 111112245689999999999999999999999999
Q ss_pred hc
Q psy3253 233 LN 234 (251)
Q Consensus 233 l~ 234 (251)
++
T Consensus 280 l~ 281 (289)
T 3og7_A 280 LA 281 (289)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=274.80 Aligned_cols=198 Identities=24% Similarity=0.468 Sum_probs=166.6
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
++ +||||+++++++.+....++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 96 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 175 (334)
T 2pvf_A 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175 (334)
T ss_dssp HHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 45 89999999999999999999999999999999997433 248999999999999999999999
Q ss_pred CCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccc
Q psy3253 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGT 144 (251)
Q Consensus 67 ~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~ 144 (251)
+|++||||| |+||+++.++.+||+|||++........ ......++
T Consensus 176 ~~ivH~Dlk---------------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 222 (334)
T 2pvf_A 176 QKCIHRDLA---------------------------------ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222 (334)
T ss_dssp TTEECSCCS---------------------------------GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCC
T ss_pred CCeeCCCCc---------------------------------cceEEEcCCCCEEEccccccccccccccccccCCCCcc
Confidence 999999988 8899999999999999999976543221 12233457
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
+.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..... ...+..+++++.+++.+||+.||
T Consensus 223 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCCh
Confidence 78999999988889999999999999999999 9999987766555444333322 22356789999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++|++++
T Consensus 301 ~~Rps~~ell~~ 312 (334)
T 2pvf_A 301 SQRPTFKQLVED 312 (334)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=270.24 Aligned_cols=199 Identities=21% Similarity=0.412 Sum_probs=163.4
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++... ...++||||+++|+|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik--- 153 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA--- 153 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc---
Confidence 3578999999999999866 67899999999999999997777889999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc---cccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++....... .......+|..|+|||.+.+
T Consensus 154 ------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 154 ------------------------------ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp ------------------------------GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred ------------------------------hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC
Confidence 889999889999999999997654332 12334457778999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------------cchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIH---------------PMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
..++.++||||+|+++|+|++|..|+.... .......+.... ....+..+++++.+++.+||+
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~ 281 (302)
T 4e5w_A 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK--RLPCPPNCPDEVYQLMRKCWE 281 (302)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC--CCCCCCCCCHHHHHHHHHHcC
Confidence 889999999999999999999998763211 011111112221 233466789999999999999
Q ss_pred cCcCccCCHHHHhc
Q psy3253 221 KNPEERATASEMLN 234 (251)
Q Consensus 221 ~~p~~Rps~~evl~ 234 (251)
.||++|||++|+++
T Consensus 282 ~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 282 FQPSNRTSFQNLIE 295 (302)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHH
Confidence 99999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=274.64 Aligned_cols=222 Identities=19% Similarity=0.279 Sum_probs=162.9
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.+++++.+++++....+.|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158 (355)
T ss_dssp SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESC
T ss_pred CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 3455999999999999999999999 567777776443 57999999999999999999999999999999966666642
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchh
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVAD 163 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 163 (251)
......... .....-..+.++.++|+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 159 ~~~~~~~~~--------------~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (355)
T 2eu9_A 159 SEFETLYNE--------------HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCD 221 (355)
T ss_dssp CCEEEEECC--------------C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred ccccccccc--------------cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccc
Confidence 110000000 0000111256778999999999754322 23456899999999999989999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCCC--------------------------------------CCC
Q psy3253 164 MWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPPP--------------------------------------SFR 202 (251)
Q Consensus 164 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~--------------------------------------~~~ 202 (251)
||||||++|+|++|..||...+.......+ ....+. ...
T Consensus 222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (355)
T 2eu9_A 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301 (355)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccc
Confidence 999999999999999999766543322111 000000 000
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 203 EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 203 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.....+.++.+||.+||+.||++|||++|+++||||+..+++
T Consensus 302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred ccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 011224578999999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=273.76 Aligned_cols=199 Identities=25% Similarity=0.390 Sum_probs=155.9
Q ss_pred CCCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR--------- 67 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------- 67 (251)
|++++||||+++++++.... .+++||||+++|+|.++++. ..+++..++.++.|++.||.|||+.
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~ 149 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEE
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccC
Confidence 56889999999999998743 47999999999999999973 4699999999999999999999999
Q ss_pred -CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccc
Q psy3253 68 -RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGT 144 (251)
Q Consensus 68 -~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~ 144 (251)
|++||||| |+||+++.++.+||+|||+++....... ......+|
T Consensus 150 ~~ivH~Dlk---------------------------------p~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 150 PAISHRDIK---------------------------------SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CEEECSCCS---------------------------------GGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCC
T ss_pred CCEEeCCCC---------------------------------hHhEEECCCCeEEEccCCcccccccccCccccccCccC
Confidence 99999988 8899999999999999999976543222 22335689
Q ss_pred ccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch----------------hhhhcCC-CCCCCCC
Q psy3253 145 PFWMAPEVIQE-----IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR----------------AIFMIPT-KPPPSFR 202 (251)
Q Consensus 145 ~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~~-~~~~~~~ 202 (251)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+.. ...+...
T Consensus 197 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (322)
T 3soc_A 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276 (322)
T ss_dssp GGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred ccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcc
Confidence 99999999976 356678999999999999999999996532211 0001111 1111110
Q ss_pred ---CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 203 ---EPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 203 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.....++++.++|.+||+.||++|||++|+++
T Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 277 DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01112355999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=285.18 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=162.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+ ...++||||+.+|+|.++++.. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk---- 307 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR---- 307 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC----
Confidence 357899999999999866 6789999999999999999643 3569999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||.+.+..+
T Consensus 308 -----------------------------p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 308 -----------------------------AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp -----------------------------GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCC
T ss_pred -----------------------------hhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCC
Confidence 8899999899999999999976543211 1223345678999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.........+.... ....+..+++.+.++|.+||+.||++|||++++++
T Consensus 359 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999 999998877666555544432 22345678999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=274.10 Aligned_cols=204 Identities=23% Similarity=0.334 Sum_probs=162.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
|++++||||+++++++.+....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk-- 166 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK-- 166 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC--
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC--
Confidence 467899999999999999999999999999999999885332 358999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 167 -------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 167 -------------------------------SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp -------------------------------STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred -------------------------------HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence 889999999999999999997543221 12233457899999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhh------------cCCCCCCC--CCCCCCCCHHHHHHHHHhhhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFM------------IPTKPPPS--FREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~ 221 (251)
..++.++|||||||++|+|++|..||........... +.....+. .......+..+.+++.+||+.
T Consensus 216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 295 (321)
T 2qkw_B 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295 (321)
T ss_dssp CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence 8999999999999999999999999965433221100 00000000 111223456789999999999
Q ss_pred CcCccCCHHHHhcChh
Q psy3253 222 NPEERATASEMLNHEF 237 (251)
Q Consensus 222 ~p~~Rps~~evl~hp~ 237 (251)
||++|||++|++++..
T Consensus 296 dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 296 SSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred CcccCcCHHHHHHHHH
Confidence 9999999999997753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.65 Aligned_cols=200 Identities=30% Similarity=0.560 Sum_probs=155.0
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
++++||||+++++++.+....++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++|||||
T Consensus 87 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~--- 163 (310)
T 2wqm_A 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK--- 163 (310)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC---
T ss_pred HhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc---
Confidence 578999999999999999999999999999999999863 35679999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++..............+++.|+|||.+.+..+
T Consensus 164 ------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 164 ------------------------------PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp ------------------------------GGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCC
T ss_pred ------------------------------HHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCC
Confidence 88999999999999999999765543333344567899999999999899
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcc--hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPM--RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++||||||+++|+|++|..||.+.... .....+.....+. .....+++++.+++.+||+.||++|||++|++++
T Consensus 214 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999654321 2222222221111 1235679999999999999999999999999853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=277.64 Aligned_cols=198 Identities=19% Similarity=0.213 Sum_probs=160.5
Q ss_pred CCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
+++ +||||+++++++.++...++||||+ +++|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk----- 132 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVK----- 132 (330)
T ss_dssp HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC-----
Confidence 345 8999999999999999999999999 899999998667889999999999999999999999999999998
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCC-----eEecccccccccCccccc-------ccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-----AKLADFGVAGQLTDTMAK-------RNTVIGTPFWM 148 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~-----~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~ 148 (251)
|+||+++.++. ++|+|||+++........ .....||+.|+
T Consensus 133 ----------------------------p~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 184 (330)
T 2izr_A 133 ----------------------------PENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184 (330)
T ss_dssp ----------------------------GGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred ----------------------------HHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcccc
Confidence 77888877766 999999999865433221 23456899999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh---hhcCCCC--CCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI---FMIPTKP--PPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
|||++.+..++.++|||||||++|+|++|..||.+....... ..+.... .+.......++ ++.+++.+||+.||
T Consensus 185 aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCT
T ss_pred ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCC
Confidence 999999999999999999999999999999999765433221 1111000 00000122344 99999999999999
Q ss_pred CccCCHHHHhc
Q psy3253 224 EERATASEMLN 234 (251)
Q Consensus 224 ~~Rps~~evl~ 234 (251)
.+||+++++++
T Consensus 264 ~~RP~~~~l~~ 274 (330)
T 2izr_A 264 FEKPDYDYLRK 274 (330)
T ss_dssp TCCCCHHHHHH
T ss_pred CCCCCHHHHHH
Confidence 99999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=275.33 Aligned_cols=198 Identities=24% Similarity=0.443 Sum_probs=163.1
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-------------KKTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-------------~~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
++ +||||+++++++.+....++||||+++|+|.+++... ...+++..+..++.|++.||.|||++|
T Consensus 105 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 45 8999999999999999999999999999999999743 346899999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPF 146 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~ 146 (251)
++||||| |+||+++.++.++|+|||++........ ......+++.
T Consensus 185 ivH~Dlk---------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T 2i1m_A 185 CIHRDVA---------------------------------ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231 (333)
T ss_dssp EECSCCS---------------------------------GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGG
T ss_pred cccCCcc---------------------------------cceEEECCCCeEEECccccccccccccceeecCCCCCCcc
Confidence 9999988 8888888888999999999976543211 2233456778
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
|+|||.+.+..++.++|||||||++|+|++ |..||.+.............. .....+..+++++.+++.+||+.||++
T Consensus 232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~ 310 (333)
T 2i1m_A 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG-YQMAQPAFAPKNIYSIMQACWALEPTH 310 (333)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhccChhh
Confidence 999999988889999999999999999998 999997655443332221111 122235567999999999999999999
Q ss_pred cCCHHHHhc
Q psy3253 226 RATASEMLN 234 (251)
Q Consensus 226 Rps~~evl~ 234 (251)
|||++|+++
T Consensus 311 Rps~~~l~~ 319 (333)
T 2i1m_A 311 RPTFQQICS 319 (333)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=268.29 Aligned_cols=199 Identities=16% Similarity=0.188 Sum_probs=161.6
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++ +|||++++++++.++...++||||+ +++|.+++...+..+++..+..++.||+.||.|||++|++|||||
T Consensus 61 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk------ 133 (298)
T 1csn_A 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK------ 133 (298)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC------
T ss_pred HHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC------
Confidence 35 7999999999999999999999999 899999998666779999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCC-----eEecccccccccCcccc-------ccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-----AKLADFGVAGQLTDTMA-------KRNTVIGTPFWMA 149 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~-----~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~a 149 (251)
|+||+++.++. ++|+|||++........ ......||+.|+|
T Consensus 134 ---------------------------p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 186 (298)
T 1csn_A 134 ---------------------------PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186 (298)
T ss_dssp ---------------------------GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred ---------------------------HHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCC
Confidence 77888866655 99999999976543321 1234568999999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc---hhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM---RAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
||++.+..++.++|||||||++|+|++|..||.+.... .....+... ..+.......+++++.+++.+||+.||+
T Consensus 187 PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 266 (298)
T 1csn_A 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFD 266 (298)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTT
T ss_pred chhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcc
Confidence 99999989999999999999999999999999764322 111111110 0011111346799999999999999999
Q ss_pred ccCCHHHHhcC
Q psy3253 225 ERATASEMLNH 235 (251)
Q Consensus 225 ~Rps~~evl~h 235 (251)
+|||++++++.
T Consensus 267 ~RP~~~~l~~~ 277 (298)
T 1csn_A 267 ATPDYDYLQGL 277 (298)
T ss_dssp CCCCHHHHHHH
T ss_pred cCCCHHHHHHH
Confidence 99999999743
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=263.98 Aligned_cols=196 Identities=27% Similarity=0.459 Sum_probs=160.0
Q ss_pred CCCCCCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+. ...++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|||||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk--- 144 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA--- 144 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS---
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCC---
Confidence 4678999999999987544 57899999999999999997443 248999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++...... .....+++.|+|||.+.+..+
T Consensus 145 ------------------------------p~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 145 ------------------------------ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp ------------------------------GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCC
T ss_pred ------------------------------cceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCC
Confidence 88999999999999999998754432 223346788999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++||||+|+++|+|++ |..||...........+..... ...+..+++++.+++.+||+.||++|||++|+++
T Consensus 192 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999998 9999987766655554444322 2345678999999999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=282.70 Aligned_cols=216 Identities=24% Similarity=0.338 Sum_probs=150.0
Q ss_pred CCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT------LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 4 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~------l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
.+||||+++++++.++...|+|||||+ |+|.+++...... ..+..+..++.||+.||.|||++||+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 389999999999999999999999995 5999999733211 123345779999999999999999999999955
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~ 153 (251)
|||+..+.. ..........++.+||+|||+++....... ......||+.|+|||++
T Consensus 145 NILl~~~~~--------------------~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 145 NILVSTSSR--------------------FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp GEEEECCHH--------------------HHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred hEEEecCcc--------------------cccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence 544431100 000000012345799999999986643321 12234689999999999
Q ss_pred cc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhh--hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 154 QE-------IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAI--FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 154 ~~-------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
.+ ..++.++||||+||++|+|++ |..||.+....... ................+++++.++|.+||+.||
T Consensus 205 ~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp SCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred ccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence 65 568899999999999999999 99999755433211 111111111111122345789999999999999
Q ss_pred CccCCHHHHhcChhhhh
Q psy3253 224 EERATASEMLNHEFIQR 240 (251)
Q Consensus 224 ~~Rps~~evl~hp~~~~ 240 (251)
++|||++|+++||||..
T Consensus 285 ~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 285 LKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp GGSCCHHHHHTSGGGSC
T ss_pred hhCCCHHHHHhCCccCC
Confidence 99999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=267.09 Aligned_cols=203 Identities=23% Similarity=0.436 Sum_probs=167.8
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+.. .++||||+.+++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik------ 148 (291)
T 1u46_A 76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA------ 148 (291)
T ss_dssp HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC------
T ss_pred HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCc------
Confidence 4679999999999997665 899999999999999998766789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCCC
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 149 ---------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (291)
T 1u46_A 149 ---------------------------ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201 (291)
T ss_dssp ---------------------------GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred ---------------------------hheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC
Confidence 8899998889999999999976543221 1223346778999999988889
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||||+++|+|++ |..||.+.+.......+.... .....+..++.++.+++.+||+.||++|||++|+++ +
T Consensus 202 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~ 278 (291)
T 1u46_A 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--F 278 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--H
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC-CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--H
Confidence 999999999999999999 999998776655554443322 123345678999999999999999999999999995 5
Q ss_pred hhhc
Q psy3253 238 IQRH 241 (251)
Q Consensus 238 ~~~~ 241 (251)
++..
T Consensus 279 l~~~ 282 (291)
T 1u46_A 279 LLEA 282 (291)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 5443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=293.89 Aligned_cols=197 Identities=25% Similarity=0.434 Sum_probs=165.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++. ....++||||+.+|+|.++++ ....+++..++.++.||+.||.|||++||+|||||
T Consensus 424 l~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLk----- 496 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA----- 496 (635)
T ss_dssp HHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS-----
T ss_pred HHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCC-----
Confidence 35689999999999996 456899999999999999997 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..
T Consensus 497 ----------------------------p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~ 548 (635)
T 4fl3_A 497 ----------------------------ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548 (635)
T ss_dssp ----------------------------GGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC
T ss_pred ----------------------------hHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC
Confidence 8899999999999999999976543221 122234567899999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|||||||++|+|++ |..||.+.+.......+...... ..+..+++++.++|.+||+.||++|||++++++
T Consensus 549 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999998 99999887776666555544332 346678999999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=265.85 Aligned_cols=204 Identities=25% Similarity=0.411 Sum_probs=165.4
Q ss_pred CCCCCCccceeeeeEee----------------CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH
Q psy3253 2 QQCDSPYVVKYYGSYFK----------------NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~----------------~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~L 64 (251)
++++||||+++++++.. ....++||||+++++|.+++... ...+++..+..++.|++.||.||
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 138 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI 138 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999998864 44589999999999999999744 36799999999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 144 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 144 (251)
|++|++||||| |+||+++.++.++|+|||++....... ......++
T Consensus 139 H~~~i~H~dlk---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 184 (284)
T 2a19_B 139 HSKKLINRDLK---------------------------------PSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGT 184 (284)
T ss_dssp HHTTEECSCCS---------------------------------GGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSC
T ss_pred HhCCeeeccCC---------------------------------HHHEEEcCCCCEEECcchhheeccccc-cccccCCc
Confidence 99999999988 889999889999999999997655432 23344688
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ....+... ..+..+++.+.++|.+||+.||+
T Consensus 185 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~ 257 (284)
T 2a19_B 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRDG-----IISDIFDKKEKTLLQKLLSKKPE 257 (284)
T ss_dssp CTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHTT-----CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhcc-----cccccCCHHHHHHHHHHccCChh
Confidence 999999999988899999999999999999999988743211 11111111 12355789999999999999999
Q ss_pred ccCCHHHHhcChhhhhccCCCC
Q psy3253 225 ERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 225 ~Rps~~evl~hp~~~~~~~~~~ 246 (251)
+|||++|++++.+.-....+..
T Consensus 258 ~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 258 DRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp GSCCHHHHHHHHHHHTC-----
T ss_pred hCcCHHHHHHHHHHHhhCCCcc
Confidence 9999999999988765544433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.35 Aligned_cols=189 Identities=28% Similarity=0.430 Sum_probs=150.6
Q ss_pred CCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
..+||||+++++++.+ ....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlk-- 144 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK-- 144 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCS--
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC--
Confidence 4589999999999987 677999999999999999997543 469999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++. ++.++|+|||++....
T Consensus 145 -------------------------------p~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------- 171 (299)
T 3m2w_A 145 -------------------------------PENLLYTSKRPNAILKLTDFGFAKETT---------------------- 171 (299)
T ss_dssp -------------------------------GGGEEESSSSTTCCEEECCCTTCEECT----------------------
T ss_pred -------------------------------HHHEEEecCCCCCcEEEeccccccccc----------------------
Confidence 77888876 6789999999985322
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCC----CCCCHHHHHHHHHhhhcCcCccCCH
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREP----DVWTPEFIDFVSRCLVKNPEERATA 229 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~ 229 (251)
+..++.++||||+||++|+|++|..||.+.............. ......+ ..+++++.+++.+||+.||++|||+
T Consensus 172 ~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~ 251 (299)
T 3m2w_A 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 251 (299)
T ss_dssp TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCH
Confidence 2346789999999999999999999997654433221111111 1111112 5679999999999999999999999
Q ss_pred HHHhcChhhhhccCCCC
Q psy3253 230 SEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 230 ~evl~hp~~~~~~~~~~ 246 (251)
+|+++||||++....+.
T Consensus 252 ~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 252 TEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp HHHHTSHHHHTGGGSCC
T ss_pred HHHhcChhhcccccCCC
Confidence 99999999987665443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=271.43 Aligned_cols=200 Identities=27% Similarity=0.460 Sum_probs=164.0
Q ss_pred CCCCCCCccceeeeeEe--eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++. +....++||||+++++|.+++......+++..++.++.|++.||.|||++|++|||||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik--- 154 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA--- 154 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS---
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC---
Confidence 35789999999999886 4567999999999999999998666789999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---ccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++........ ......++..|+|||++.+
T Consensus 155 ------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 155 ------------------------------ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp ------------------------------GGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred ------------------------------hhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc
Confidence 8899999999999999999976543221 2233456778999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch---------------hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR---------------AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
..++.++|||||||++|+|++|..||....... ....+.... ....+..+++++.+++.+||+
T Consensus 205 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~ 282 (327)
T 3lxl_A 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ--RLPAPPACPAEVHELMKLCWA 282 (327)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc--CCCCCCcccHHHHHHHHHHcC
Confidence 889999999999999999999999985432211 111111111 223466789999999999999
Q ss_pred cCcCccCCHHHHhcC
Q psy3253 221 KNPEERATASEMLNH 235 (251)
Q Consensus 221 ~~p~~Rps~~evl~h 235 (251)
.||++|||++|++++
T Consensus 283 ~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 283 PSPQDRPSFSALGPQ 297 (327)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.74 Aligned_cols=198 Identities=21% Similarity=0.251 Sum_probs=158.4
Q ss_pred CCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++++||||+++++++.. ....|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk-- 178 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK-- 178 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS--
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC--
Confidence 46799999999999987 67899999999 8999999863 3489999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCC--CeEecccccccccCcccc-------cccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG--HAKLADFGVAGQLTDTMA-------KRNTVIGTPFWM 148 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~--~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~ 148 (251)
|+||+++.++ .+||+|||+++....... ......+|+.|+
T Consensus 179 -------------------------------p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 227 (345)
T 2v62_A 179 -------------------------------AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227 (345)
T ss_dssp -------------------------------GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred -------------------------------HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence 8888887776 899999999976543211 113346889999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc-hhhhh----cCCCCCC---CCCCCCCCCHHHHHHHHHhhh
Q psy3253 149 APEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM-RAIFM----IPTKPPP---SFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 149 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~---~~~~~~~~~~~~~~li~~~l~ 220 (251)
|||++.+..++.++|||||||++|+|++|..||.+.... ..... .....+. .......+++++.++|.+||.
T Consensus 228 aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 307 (345)
T 2v62_A 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHS 307 (345)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHT
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhh
Confidence 999999988999999999999999999999999542111 11111 0001000 000122679999999999999
Q ss_pred cCcCccCCHHHHhc
Q psy3253 221 KNPEERATASEMLN 234 (251)
Q Consensus 221 ~~p~~Rps~~evl~ 234 (251)
.||++|||++|+++
T Consensus 308 ~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 308 LAYDEKPNYQALKK 321 (345)
T ss_dssp CCTTCCCCHHHHHH
T ss_pred cCcccCCCHHHHHH
Confidence 99999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=270.14 Aligned_cols=196 Identities=30% Similarity=0.521 Sum_probs=161.6
Q ss_pred CCCccceeeeeEeeCC-eEEEEEEccCCCCHHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 5 DSPYVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMRLRKKT---------------LSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~~~~~~~~---------------l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
+||||+++++++.... ..++||||+++|+|.+++...... +++..+..++.|++.||.|||++|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6999999999987654 599999999999999999743322 899999999999999999999999
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPF 146 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~ 146 (251)
++||||| |+||+++.++.++|+|||++....... .......+++.
T Consensus 169 i~H~dik---------------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 215 (316)
T 2xir_A 169 CIHRDLA---------------------------------ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 215 (316)
T ss_dssp CCCSCCS---------------------------------GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGG
T ss_pred cccccCc---------------------------------cceEEECCCCCEEECCCccccccccCccceeccCCCccee
Confidence 9999988 889999888999999999997654321 12334457888
Q ss_pred cccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 147 WMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 147 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
|+|||++.+..++.++||||+||++|+|++ |..||.+....... ..+.... ....+..+++++.+++.+||+.||+
T Consensus 216 y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~ 293 (316)
T 2xir_A 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPS 293 (316)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCc--cCCCCCCCCHHHHHHHHHHcCCChh
Confidence 999999998899999999999999999998 99999765543322 1222221 2223566899999999999999999
Q ss_pred ccCCHHHHhcC
Q psy3253 225 ERATASEMLNH 235 (251)
Q Consensus 225 ~Rps~~evl~h 235 (251)
+|||++|+++|
T Consensus 294 ~Rps~~ell~~ 304 (316)
T 2xir_A 294 QRPTFSELVEH 304 (316)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=263.94 Aligned_cols=197 Identities=26% Similarity=0.453 Sum_probs=164.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++||||+++++++. .+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|||||
T Consensus 63 ~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik----- 136 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR----- 136 (279)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC-----
Confidence 4689999999999986 456899999999999999986322 379999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++
T Consensus 137 ----------------------------p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 188 (279)
T 1qpc_A 137 ----------------------------AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188 (279)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred ----------------------------HhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCC
Confidence 8899999999999999999976543321 12233457789999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.++||||||+++|+|++ |..||.+.........+..... ...+..+++++.+++.+||+.||++|||++++++
T Consensus 189 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC--CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999 9999987766555544433322 2235678999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.90 Aligned_cols=202 Identities=23% Similarity=0.348 Sum_probs=155.7
Q ss_pred CCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q psy3253 5 DSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGS 78 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~N 78 (251)
.||||+++++++.... ..+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++ |++|||||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dik--- 159 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK--- 159 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS---
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCC---
Confidence 4899999999997654 799999999 88999999753 35699999999999999999999998 99999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecC------CCCCeEecccccccccCcccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN------TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 152 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 152 (251)
|+||+++ ..+.++|+|||++...... .....+|+.|+|||+
T Consensus 160 ------------------------------p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~ 206 (373)
T 1q8y_A 160 ------------------------------PENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEV 206 (373)
T ss_dssp ------------------------------GGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHH
T ss_pred ------------------------------hHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHH
Confidence 6666663 3346999999999765432 233467899999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch------hhhh---cCCCCC-------------------------
Q psy3253 153 IQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMR------AIFM---IPTKPP------------------------- 198 (251)
Q Consensus 153 ~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~------~~~~---~~~~~~------------------------- 198 (251)
+.+..++.++|||||||++|+|++|..||....... .... .....+
T Consensus 207 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (373)
T 1q8y_A 207 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 286 (373)
T ss_dssp HHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC
T ss_pred HhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccc
Confidence 999899999999999999999999999996543110 0000 000000
Q ss_pred -----------CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 199 -----------PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 199 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
.....+...++++.+||.+||+.||++|||++|+++||||++...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 287 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp CCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred ccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 000112234577899999999999999999999999999997543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=267.06 Aligned_cols=199 Identities=23% Similarity=0.373 Sum_probs=161.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.+....++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlk----- 157 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK----- 157 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-----
Confidence 467899999999999999999999999999999999997555679999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc-----ccccccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT-----MAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++ ++.++|+|||++...... ........+++.|+|||++.+
T Consensus 158 ----------------------------p~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 158 ----------------------------SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp ----------------------------STTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred ----------------------------hhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 7788887 578999999998654321 112233457889999999864
Q ss_pred ---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 156 ---------IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 156 ---------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
..++.++|||||||++|+|++|..||...........+.....+.. ....++.++.+++.+||..||++|
T Consensus 209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~R 287 (319)
T 2y4i_B 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQEER 287 (319)
T ss_dssp BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSSTTTS
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCChhhC
Confidence 4578899999999999999999999987766655544433332222 234578999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
||++|+++
T Consensus 288 pt~~~l~~ 295 (319)
T 2y4i_B 288 PTFTKLMD 295 (319)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.78 Aligned_cols=194 Identities=26% Similarity=0.481 Sum_probs=153.3
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK--TLSEDEIATILCDTLKGLEYLHL---RRKIHRDIKA 76 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~LH~---~~iiH~dik~ 76 (251)
++++||||+++++++.+ ..++||||+++|+|.+++..... .++...++.++.|++.||.|||+ +|++|||||
T Consensus 56 ~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlk- 132 (307)
T 2eva_A 56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK- 132 (307)
T ss_dssp HHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCS-
T ss_pred hcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCC-
Confidence 46899999999999874 47999999999999999974332 47899999999999999999999 899999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCC-eEecccccccccCccccccccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++. +||+|||++...... .....+++.|+|||++.+
T Consensus 133 --------------------------------p~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 133 --------------------------------PPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp --------------------------------GGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTC
T ss_pred --------------------------------hhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCC
Confidence 88888887776 799999999654322 223457899999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcch--hhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMR--AIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.++||||||+++|+|++|..||....... ......... ....+..+++.+.+++.+||+.||++|||++|++
T Consensus 178 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 255 (307)
T 2eva_A 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255 (307)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 899999999999999999999999997543322 111222222 2223567899999999999999999999999998
Q ss_pred cC
Q psy3253 234 NH 235 (251)
Q Consensus 234 ~h 235 (251)
++
T Consensus 256 ~~ 257 (307)
T 2eva_A 256 KI 257 (307)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.41 Aligned_cols=199 Identities=22% Similarity=0.400 Sum_probs=158.3
Q ss_pred CCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 2 QQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
++++||||+++++++.. ....++||||+.+|+|.+++.. .+..+++..++.++.|++.||.|||++|++||||
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dl 160 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 57899999999999872 3478999999999999999974 3567999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---------ccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---------KRNTVIGTP 145 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~ 145 (251)
| |+||+++.++.++|+|||.+........ ......+++
T Consensus 161 k---------------------------------p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 207 (317)
T 2buj_A 161 K---------------------------------PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207 (317)
T ss_dssp C---------------------------------GGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCG
T ss_pred C---------------------------------HHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCc
Confidence 8 8899999999999999999865432111 112234688
Q ss_pred ccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCc--chhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhh
Q psy3253 146 FWMAPEVIQEIG---YDCVADMWSLGITALEMAEGKPPYGDIHP--MRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLV 220 (251)
Q Consensus 146 ~y~aPE~~~~~~---~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 220 (251)
.|+|||.+.+.. ++.++||||||+++|+|++|..||..... ......+... ........+++++.++|.+||+
T Consensus 208 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~ 285 (317)
T 2buj_A 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ--LSIPQSPRHSSALWQLLNSMMT 285 (317)
T ss_dssp GGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC----CCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc--CCCCccccCCHHHHHHHHHHhh
Confidence 999999987543 68899999999999999999999943111 1111111111 1222345679999999999999
Q ss_pred cCcCccCCHHHHhcC
Q psy3253 221 KNPEERATASEMLNH 235 (251)
Q Consensus 221 ~~p~~Rps~~evl~h 235 (251)
.||++|||++|++++
T Consensus 286 ~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 286 VDPHQRPHIPLLLSQ 300 (317)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred cChhhCCCHHHHHHH
Confidence 999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=265.95 Aligned_cols=198 Identities=28% Similarity=0.462 Sum_probs=154.3
Q ss_pred CCCCCccceeeeeEeeC----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccc
Q psy3253 3 QCDSPYVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR--------RKI 70 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------~ii 70 (251)
.++||||+++++++... ...++||||+++|+|.++++. ..+++..+..++.|++.||.|||++ |++
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 164 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEE
Confidence 45999999999999877 789999999999999999963 4799999999999999999999998 999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----ccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----RNTVIGTPF 146 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~ 146 (251)
||||| |+||+++.++.+||+|||++......... .....||+.
T Consensus 165 H~Dik---------------------------------p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~ 211 (337)
T 3mdy_A 165 HRDLK---------------------------------SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211 (337)
T ss_dssp CSCCC---------------------------------GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGG
T ss_pred ecccc---------------------------------hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence 99988 88999999999999999999765432221 124468999
Q ss_pred cccccccccCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCcch----hhhh-c-CCCCCCCCC--
Q psy3253 147 WMAPEVIQEIGYDCV------ADMWSLGITALEMAEG----------KPPYGDIHPMR----AIFM-I-PTKPPPSFR-- 202 (251)
Q Consensus 147 y~aPE~~~~~~~~~~------~DvwslG~~l~~l~~g----------~~p~~~~~~~~----~~~~-~-~~~~~~~~~-- 202 (251)
|+|||++.+...+.. +|||||||++|+|++| ..||....... .... + .....+...
T Consensus 212 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (337)
T 3mdy_A 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291 (337)
T ss_dssp GCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred eeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccccc
Confidence 999999977665554 9999999999999999 66664332111 1111 1 111111111
Q ss_pred -CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 203 -EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 203 -~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
....+++++.+++.+||+.||++|||++|++++
T Consensus 292 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 112456779999999999999999999999965
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=286.70 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=167.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++||||+++++++.+ ...|+||||+.+|+|.++++.. ...+++.+++.++.||+.||.|||++|++|||||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk---- 390 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR---- 390 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC----
Confidence 357899999999999866 6789999999999999999643 3569999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||++.+..+
T Consensus 391 -----------------------------p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 391 -----------------------------AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp -----------------------------GGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred -----------------------------HhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCC
Confidence 8899998889999999999976543211 1223345678999999998899
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+.++|||||||++|+|++ |..||.+.........+.... ....+..++.++.+||.+||+.||++|||++++++
T Consensus 442 ~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999 999998877666555544432 22345678999999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.20 Aligned_cols=197 Identities=27% Similarity=0.466 Sum_probs=154.2
Q ss_pred CCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcc
Q psy3253 3 QCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH--------LRRKI 70 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH--------~~~ii 70 (251)
+++||||+++++++.. ....++||||+++|+|.++++ ...+++..+..++.|++.||.||| +.|++
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 135 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCee
Confidence 4799999999998754 346899999999999999995 568999999999999999999999 99999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc----ccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK----RNTVIGTPF 146 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~ 146 (251)
||||| |+||+++.++.+||+|||+++........ .....||+.
T Consensus 136 H~Dlk---------------------------------p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~ 182 (301)
T 3q4u_A 136 HRDLK---------------------------------SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182 (301)
T ss_dssp CSCCC---------------------------------GGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGG
T ss_pred cCCCC---------------------------------hHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccc
Confidence 99988 88999999999999999999654432221 223468999
Q ss_pred cccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCcc----hhhhh-cC-CCCCCCCC--
Q psy3253 147 WMAPEVIQEI------GYDCVADMWSLGITALEMAEG----------KPPYGDIHPM----RAIFM-IP-TKPPPSFR-- 202 (251)
Q Consensus 147 y~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~----~~~~~-~~-~~~~~~~~-- 202 (251)
|+|||++.+. .++.++|||||||++|+|++| ..||...... ..... .. ....+...
T Consensus 183 y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (301)
T 3q4u_A 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR 262 (301)
T ss_dssp GCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred eeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChh
Confidence 9999999775 455789999999999999999 8888543221 11111 11 11111111
Q ss_pred -CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 203 -EPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 203 -~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.....++++.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 01224577999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=265.45 Aligned_cols=198 Identities=19% Similarity=0.257 Sum_probs=157.2
Q ss_pred CCCCCccceeeeeE-eeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDSPYVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+++|++++..+..+ ..+...++||||+ +++|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk------ 132 (296)
T 4hgt_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK------ 132 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS------
T ss_pred HhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC------
Confidence 45677766665554 6778899999999 889999998667789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccc-------ccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPE 151 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE 151 (251)
|+||++ +.++.+||+|||++........ ......+|+.|+|||
T Consensus 133 ---------------------------p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 4hgt_A 133 ---------------------------PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp ---------------------------GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHH
T ss_pred ---------------------------HHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchH
Confidence 778887 6778899999999976543321 123456889999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
.+.+..++.++||||+||++|++++|..||.+...... ...+... ..+.......+++++.+++.+||+.||++|
T Consensus 186 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (296)
T 4hgt_A 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred HhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999999999975433211 1111000 000001125578999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
||++|+++
T Consensus 266 pt~~~l~~ 273 (296)
T 4hgt_A 266 PDYSYLRQ 273 (296)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=266.29 Aligned_cols=196 Identities=24% Similarity=0.438 Sum_probs=160.6
Q ss_pred CCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++++.+ ....++||||+++|+|.+++. ...+++..+..++.|++.||.|||++|++|||||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dik---- 161 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLA---- 161 (318)
T ss_dssp HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS----
T ss_pred HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc----
Confidence 46899999999999987 467899999999999999986 3459999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++.++|+|||++........ ......++..|+|||++.+.
T Consensus 162 -----------------------------p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 212 (318)
T 3lxp_A 162 -----------------------------ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212 (318)
T ss_dssp -----------------------------GGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC
T ss_pred -----------------------------hheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC
Confidence 8899999999999999999976543321 12334567789999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc---------------hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhc
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPM---------------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 221 (251)
.++.++||||+||++|+|++|..||...... .....+.... ....+..+++++.++|.+||+.
T Consensus 213 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE--RLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc--CCCCCccccHHHHHHHHHHcCC
Confidence 8999999999999999999999998643211 0111111111 2334667899999999999999
Q ss_pred CcCccCCHHHHhc
Q psy3253 222 NPEERATASEMLN 234 (251)
Q Consensus 222 ~p~~Rps~~evl~ 234 (251)
||++|||++|+++
T Consensus 291 dP~~Rps~~ell~ 303 (318)
T 3lxp_A 291 EASFRPTFENLIP 303 (318)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=289.10 Aligned_cols=198 Identities=27% Similarity=0.487 Sum_probs=165.1
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++. ++..|+||||+++|+|.++++.....+++..+..++.|++.||.|||++|++|||||
T Consensus 446 ~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDik------ 518 (656)
T 2j0j_A 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA------ 518 (656)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS------
T ss_pred HhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc------
Confidence 4689999999999984 556899999999999999998666689999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCCc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.
T Consensus 519 ---------------------------p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 571 (656)
T 2j0j_A 519 ---------------------------ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571 (656)
T ss_dssp ---------------------------GGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH
T ss_pred ---------------------------hHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc
Confidence 8899999999999999999976543321 122334567899999998889999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 161 VADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
++|||||||++|+|++ |..||.+.........+...... ..+..+++.+.++|.+||..||++|||++|+++.
T Consensus 572 ~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999997 99999877666655444333222 2356789999999999999999999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=289.49 Aligned_cols=207 Identities=27% Similarity=0.361 Sum_probs=160.6
Q ss_pred CCCCCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy3253 2 QQCDSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRD 73 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~d 73 (251)
++++||||+++++++.. +...++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.|++|||
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrD 146 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRD 146 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCC
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 46899999999999765 667899999999999999997433 2689999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCC---eEecccccccccCcccccccccccccccccc
Q psy3253 74 IKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 74 ik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|| |+||+++.++. ++|+|||.+...... .......+++.|+||
T Consensus 147 LK---------------------------------P~NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~AP 192 (676)
T 3qa8_A 147 LK---------------------------------PENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAP 192 (676)
T ss_dssp CC---------------------------------STTEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSS
T ss_pred CC---------------------------------HHHeEeecCCCceeEEEcccccccccccc-cccccccCCcccCCh
Confidence 99 66777765553 899999999765543 223445689999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh--------------hcCCC-------CCCCCCCCCCCCH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF--------------MIPTK-------PPPSFREPDVWTP 209 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~--------------~~~~~-------~~~~~~~~~~~~~ 209 (251)
|.+.+..++.++||||+||++|++++|..||.......... ....+ .+........+++
T Consensus 193 E~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~ 272 (676)
T 3qa8_A 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272 (676)
T ss_dssp CSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHH
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhH
Confidence 99999999999999999999999999999996432111100 00000 0001111233568
Q ss_pred HHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 210 EFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 210 ~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
.+.++|.+||.+||++|||++|+++||||+..+
T Consensus 273 ~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 273 KLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp HHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred HHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 899999999999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=269.84 Aligned_cols=198 Identities=23% Similarity=0.346 Sum_probs=149.2
Q ss_pred CCCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------
Q psy3253 2 QQCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR--------- 67 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~--------- 67 (251)
+.++||||+++++.+.. ....++||||+++|+|.+++.. ...++..+..++.||+.||.|||+.
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~ 139 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBC
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhcccccccc
Confidence 46899999999986542 3367999999999999999963 4558999999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--------cccc
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--------AKRN 139 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~ 139 (251)
|++||||| |+||+++.++.+||+|||+++...... ....
T Consensus 140 ~ivH~Dik---------------------------------p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~ 186 (336)
T 3g2f_A 140 AISHRDLN---------------------------------SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186 (336)
T ss_dssp CEECSSCS---------------------------------GGGEEECTTSCEEECCCTTCEECSSSSCC---------C
T ss_pred ceeecccc---------------------------------cceEEEcCCCcEEEeeccceeecccccccCccccccccc
Confidence 99999988 889999999999999999997654321 1122
Q ss_pred cccccccccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-----------------hh-c-
Q psy3253 140 TVIGTPFWMAPEVIQE-------IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI-----------------FM-I- 193 (251)
Q Consensus 140 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-----------------~~-~- 193 (251)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .. +
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T 3g2f_A 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS 266 (336)
T ss_dssp CTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT
T ss_pred cCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc
Confidence 3458999999999976 45677899999999999999997665322111000 00 0
Q ss_pred CCCCCCCC----CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 194 PTKPPPSF----REPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 194 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
.....+.+ .....+++++.++|.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 267 REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 01111111 111123457999999999999999999999953
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.53 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=159.6
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR--KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
++++||||+++++++.+....++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk---- 160 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK---- 160 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC----
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC----
Confidence 4679999999999999999999999999999999999633 3569999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--cccccccccccccccccccCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.++|+|||++........ ......+++.|+|||.+.+ .
T Consensus 161 -----------------------------p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 210 (307)
T 2nru_A 161 -----------------------------SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-E 210 (307)
T ss_dssp -----------------------------GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-E
T ss_pred -----------------------------HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-C
Confidence 8899999999999999999875543211 1233467899999998865 4
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc----CCCC--------CCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI----PTKP--------PPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
++.++||||||+++|+|++|..||...........+ .... ......+...+..+.+++.+||+.||++
T Consensus 211 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 290 (307)
T 2nru_A 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNK 290 (307)
T ss_dssp ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTT
T ss_pred CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCccc
Confidence 789999999999999999999999654432211110 0000 0001112334567899999999999999
Q ss_pred cCCHHHHhcC
Q psy3253 226 RATASEMLNH 235 (251)
Q Consensus 226 Rps~~evl~h 235 (251)
|||++|++++
T Consensus 291 Rps~~~l~~~ 300 (307)
T 2nru_A 291 RPDIKKVQQL 300 (307)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=262.51 Aligned_cols=198 Identities=19% Similarity=0.260 Sum_probs=156.3
Q ss_pred CCCCCccceeeeeE-eeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDSPYVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
+++|++++..+..+ ..+...++||||+ +++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk------ 132 (296)
T 3uzp_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK------ 132 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC------
T ss_pred HhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC------
Confidence 46677766665544 6677889999999 889999998667789999999999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCcccc-------ccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAPE 151 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE 151 (251)
|+||++ +.++.+||+|||++........ ......+++.|+|||
T Consensus 133 ---------------------------p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 185 (296)
T 3uzp_A 133 ---------------------------PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185 (296)
T ss_dssp ---------------------------GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHH
T ss_pred ---------------------------HHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChh
Confidence 777777 4678899999999976544322 123456889999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc---hhhhhcCCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPM---RAIFMIPTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
.+.+..++.++|||||||++|+|++|..||.+.... .....+... ..+.......+++++.+++.+||+.||++|
T Consensus 186 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 265 (296)
T 3uzp_A 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcC
Confidence 999989999999999999999999999999754321 111111110 000001125679999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
||++|+++
T Consensus 266 ps~~~l~~ 273 (296)
T 3uzp_A 266 PDYSYLRQ 273 (296)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.38 Aligned_cols=199 Identities=25% Similarity=0.443 Sum_probs=160.8
Q ss_pred CCCCCCCccceeeeeEeeC--CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++... ...++||||+++++|.+++......+++..+..++.|++.||.|||++|++|||||
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik--- 172 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA--- 172 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC---
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC---
Confidence 3578999999999998654 37899999999999999998666779999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc---cccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+
T Consensus 173 ------------------------------p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 173 ------------------------------TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp ------------------------------GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred ------------------------------cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC
Confidence 88999988899999999999765433211 122345677999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc----------------hhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhh
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPM----------------RAIFMIPTKPPPSFREPDVWTPEFIDFVSRCL 219 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 219 (251)
..++.++||||||+++|+|++|..||...... .....+.... ....+..+++++.++|.+||
T Consensus 223 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl 300 (326)
T 2w1i_A 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECW 300 (326)
T ss_dssp CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC--CCCCCCcccHHHHHHHHHHc
Confidence 88999999999999999999999888532110 0011111111 22335678999999999999
Q ss_pred hcCcCccCCHHHHhc
Q psy3253 220 VKNPEERATASEMLN 234 (251)
Q Consensus 220 ~~~p~~Rps~~evl~ 234 (251)
+.||++|||++|+++
T Consensus 301 ~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 301 NNNVNQRPSFRDLAL 315 (326)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.86 Aligned_cols=199 Identities=20% Similarity=0.281 Sum_probs=157.7
Q ss_pred CCCCCccce---------------eeeeEee-CCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH
Q psy3253 3 QCDSPYVVK---------------YYGSYFK-NTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLH 65 (251)
Q Consensus 3 ~l~hpniv~---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH 65 (251)
+++||||++ +++++.. +...|+||||+ +++|.+++... ...+++..++.++.||+.||.|||
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 457777776 6777766 67899999999 89999999743 368999999999999999999999
Q ss_pred hCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC--CeEecccccccccCcccc-------
Q psy3253 66 LRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG--HAKLADFGVAGQLTDTMA------- 136 (251)
Q Consensus 66 ~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~--~~kl~dfg~~~~~~~~~~------- 136 (251)
++|++||||| |+||+++.++ .++|+|||+++.......
T Consensus 177 ~~~ivH~Dik---------------------------------p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 223 (352)
T 2jii_A 177 ENEYVHGNVT---------------------------------AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223 (352)
T ss_dssp HTTCBCSCCC---------------------------------GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred hCCccCCCCC---------------------------------HHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence 9999999988 8888888887 899999999976543221
Q ss_pred cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-cchhhhh-c---CCCCC---CCCCCCCCCC
Q psy3253 137 KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIH-PMRAIFM-I---PTKPP---PSFREPDVWT 208 (251)
Q Consensus 137 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~-~~~~~~~-~---~~~~~---~~~~~~~~~~ 208 (251)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||.... ....... . ..... ........++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPS 303 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCC
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCc
Confidence 1133468899999999999899999999999999999999999996543 1111111 1 11111 0111123568
Q ss_pred HHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 209 PEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 209 ~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+++.+++.+||+.||++|||++|+++.
T Consensus 304 ~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 304 ETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 999999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.25 Aligned_cols=193 Identities=16% Similarity=0.141 Sum_probs=153.7
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL----RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
...|+||+++++++...+..|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiK--- 199 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK--- 199 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS---
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC---
Confidence 34599999999999999999999999999999999974 34679999999999999999999999999999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCC-----------CCCeEecccccccccC--ccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-----------EGHAKLADFGVAGQLT--DTMAKRNTVIGTP 145 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-----------~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~ 145 (251)
|+||+++. ++.+||+|||+++... ..........||+
T Consensus 200 ------------------------------p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 249 (365)
T 3e7e_A 200 ------------------------------PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249 (365)
T ss_dssp ------------------------------GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred ------------------------------HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence 66666655 7889999999996543 1222334456899
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
.|+|||++.+..++.++|||||||++|+|++|+.||......... +... + .....++.+.+++.+||+.+|.+
T Consensus 250 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~----~-~~~~~~~~~~~~~~~~l~~~p~~ 322 (365)
T 3e7e_A 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PEGL----F-RRLPHLDMWNEFFHVMLNIPDCH 322 (365)
T ss_dssp SCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--ECSC----C-TTCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--echh----c-cccCcHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999999999999999543222111 1111 1 01124678899999999999999
Q ss_pred cCCHHHHhcC
Q psy3253 226 RATASEMLNH 235 (251)
Q Consensus 226 Rps~~evl~h 235 (251)
|++..+.+.+
T Consensus 323 r~~~~~~l~~ 332 (365)
T 3e7e_A 323 HLPSLDLLRQ 332 (365)
T ss_dssp CCCCHHHHHH
T ss_pred cchHHHHHHH
Confidence 9655444443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.55 Aligned_cols=196 Identities=25% Similarity=0.426 Sum_probs=142.3
Q ss_pred CC-CCCccceeeeeEe--------eCCeEEEEEEccCCCCHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q psy3253 3 QC-DSPYVVKYYGSYF--------KNTDLWIVMEYCGAGSVSDIMRL--RKKTLSEDEIATILCDTLKGLEYLHLRR--K 69 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~--------~~~~~~lv~e~~~~gsL~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~LH~~~--i 69 (251)
++ +||||+++++++. ....++++|||+. |+|.+++.. ....+++..++.++.||+.||.|||++| +
T Consensus 81 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i 159 (337)
T 3ll6_A 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159 (337)
T ss_dssp HHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Confidence 44 5999999999994 3445899999995 699998863 3467999999999999999999999999 9
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc------------
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK------------ 137 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~------------ 137 (251)
+||||| |+||+++.++.++|+|||++.........
T Consensus 160 vH~Dik---------------------------------p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 206 (337)
T 3ll6_A 160 IHRDLK---------------------------------VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206 (337)
T ss_dssp BCCCCC---------------------------------GGGCEECTTSCEEBCCCTTCBCCSSCC--------------
T ss_pred EEccCC---------------------------------cccEEECCCCCEEEecCccceeccccCcccccccccccchh
Confidence 999988 88999999999999999999765432111
Q ss_pred cccccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHH
Q psy3253 138 RNTVIGTPFWMAPEVI---QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214 (251)
Q Consensus 138 ~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 214 (251)
.....+|+.|+|||++ .+..++.++|||||||++|+|++|..||.+.......... .........+..+.++
T Consensus 207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l 281 (337)
T 3ll6_A 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK-----YSIPPHDTQYTVFHSL 281 (337)
T ss_dssp -----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCCTTCCSSGGGHHH
T ss_pred hccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc-----ccCCcccccchHHHHH
Confidence 1134578899999998 5677899999999999999999999999765443322211 1222345668889999
Q ss_pred HHHhhhcCcCccCCHHHHhcChh
Q psy3253 215 VSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.+||+.||++|||++|++++-.
T Consensus 282 i~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 282 IRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=275.01 Aligned_cols=200 Identities=24% Similarity=0.408 Sum_probs=155.1
Q ss_pred CCCCCCccceeeeeEeeCC--eEEEEEEccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 2 QQCDSPYVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMRLRK--KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
++++||||+++++++.... ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|++|||||
T Consensus 62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk-- 139 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK-- 139 (396)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC--
T ss_pred HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC--
Confidence 4689999999999998654 7899999999999999996332 339999999999999999999999999999999
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceec----CCCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL----NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|+||++ +.++.+||+|||+++...... ......||+.|+|||++
T Consensus 140 -------------------------------p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 140 -------------------------------PGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMY 187 (396)
T ss_dssp -------------------------------GGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHHHH
T ss_pred -------------------------------HHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHHHh
Confidence 667766 566679999999997655432 23345689999999998
Q ss_pred cc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc----chhhhhcCCCCCC------------------CC--
Q psy3253 154 QE--------IGYDCVADMWSLGITALEMAEGKPPYGDIHP----MRAIFMIPTKPPP------------------SF-- 201 (251)
Q Consensus 154 ~~--------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~------------------~~-- 201 (251)
.+ ..++.++|||||||++|+|++|..||..... ......+....+. ..
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (396)
T 4eut_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (396)
T ss_dssp HHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCc
Confidence 64 5678899999999999999999999953221 1222222111111 00
Q ss_pred --CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 202 --REPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 202 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.....+++.+.+++.+||+.||++|||++|++++
T Consensus 268 ~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1112235678999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=259.96 Aligned_cols=198 Identities=25% Similarity=0.379 Sum_probs=155.5
Q ss_pred CCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH--------LRRKI 70 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH--------~~~ii 70 (251)
+++||||+++++++.... ..++||||+.+|+|.+++.. ..+++..+..++.|++.||.||| +.|++
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 379999999999998765 79999999999999999963 57999999999999999999999 89999
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----cccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPF 146 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~ 146 (251)
||||| |+||+++.++.++|+|||++........ ......+|+.
T Consensus 170 H~Dlk---------------------------------p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~ 216 (342)
T 1b6c_B 170 HRDLK---------------------------------SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216 (342)
T ss_dssp CSCCS---------------------------------GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGG
T ss_pred eCCCC---------------------------------HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcc
Confidence 99988 8899999999999999999976543221 1234468899
Q ss_pred cccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCcc-----hhhhhcCCC-CCCCCC--
Q psy3253 147 WMAPEVIQEI------GYDCVADMWSLGITALEMAEG----------KPPYGDIHPM-----RAIFMIPTK-PPPSFR-- 202 (251)
Q Consensus 147 y~aPE~~~~~------~~~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~-----~~~~~~~~~-~~~~~~-- 202 (251)
|+|||++.+. .++.++|||||||++|+|++| ..||...... .....+... ..+...
T Consensus 217 y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (342)
T 1b6c_B 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296 (342)
T ss_dssp GCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred cCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCccc
Confidence 9999999764 234689999999999999999 7788554221 111111111 111111
Q ss_pred -CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 203 -EPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 203 -~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.....+..+.+++.+||+.||++|||++|++++
T Consensus 297 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 011234678999999999999999999999965
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=272.67 Aligned_cols=198 Identities=18% Similarity=0.240 Sum_probs=157.7
Q ss_pred CCCC-CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.++| +++..+..++......++||||+ +++|.+++......+++..++.++.||+.||.|||++||+|||||
T Consensus 58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIK------ 130 (483)
T 3sv0_A 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK------ 130 (483)
T ss_dssp HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC------
T ss_pred HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC------
Confidence 4555 56666677777888999999999 889999998667889999999999999999999999999999998
Q ss_pred cccccccccccccccchhhhhhhhhcccCceec---CCCCCeEecccccccccCccccc-------cccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL---NTEGHAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPE 151 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~---~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE 151 (251)
|+||++ +.++.+||+|||+++........ .....||+.|+|||
T Consensus 131 ---------------------------P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 183 (483)
T 3sv0_A 131 ---------------------------PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183 (483)
T ss_dssp ---------------------------GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHH
T ss_pred ---------------------------cceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHH
Confidence 778887 57788999999999865533221 22456899999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh---hhhcCCCC--CCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 152 VIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA---IFMIPTKP--PPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 152 ~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
++.+..++.++|||||||++|+|++|..||.+...... ...+.... ......+..++.++.+++.+||+.+|++|
T Consensus 184 ~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~R 263 (483)
T 3sv0_A 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (483)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCC
T ss_pred HhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhC
Confidence 99999999999999999999999999999976543211 11111000 00001125678999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
|+++++++
T Consensus 264 Ps~~el~~ 271 (483)
T 3sv0_A 264 PDYSYLKR 271 (483)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99998864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=263.15 Aligned_cols=176 Identities=14% Similarity=0.143 Sum_probs=146.3
Q ss_pred eEEEEEEccCCCCHHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcccccccccccccc
Q psy3253 21 DLWIVMEYCGAGSVSDIMRL------RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCN 94 (251)
Q Consensus 21 ~~~lv~e~~~~gsL~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~ 94 (251)
..+++|+++ +++|.++++. .+..+++..++.++.|++.||.|||++||+|||||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK------------------- 238 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR------------------- 238 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC-------------------
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc-------------------
Confidence 478888887 5799999842 13457788999999999999999999999999988
Q ss_pred ccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccc----------ccCCCCcchhH
Q psy3253 95 VITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI----------QEIGYDCVADM 164 (251)
Q Consensus 95 ~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv 164 (251)
|+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||
T Consensus 239 --------------p~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 239 --------------PVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp --------------GGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred --------------cceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 89999999999999999998765433 233456 889999999 55568889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 165 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
|||||++|+|++|+.||...+.......+.. ....+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGGSEWIFR-------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS-------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhHHHHHh-------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999999999999977655443333322 234578999999999999999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=273.32 Aligned_cols=189 Identities=23% Similarity=0.333 Sum_probs=153.1
Q ss_pred CCCCCCCccceeeeeEeeCCe-----EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++..... .|+||||++|++|.+++. ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 467899999999999987655 799999999999998875 379999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.+ .+||+|||+++..... ....||+.|+|||++.+
T Consensus 210 ---------------------------------p~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 210 ---------------------------------PENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp ---------------------------------GGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHH
T ss_pred ---------------------------------hHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcC
Confidence 778888765 7999999999765432 34568999999999876
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
. ++.++|||||||++|+|++|.+||.+..... + + ........++.+.++|.+||+.||++||+..+.+.|
T Consensus 252 ~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----~----~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 252 G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----L----P-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----C----C-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred C-CCCceehhhhHHHHHHHHhCCCCCccccccc----c----c-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 5 4889999999999999999998886422111 0 0 100111246789999999999999999999999999
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
+|+.-
T Consensus 322 ~l~~~ 326 (681)
T 2pzi_A 322 QLTGV 326 (681)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.28 Aligned_cols=207 Identities=19% Similarity=0.218 Sum_probs=140.4
Q ss_pred CCccceeeeeEee-------------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccc
Q psy3253 6 SPYVVKYYGSYFK-------------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH-LRRKIH 71 (251)
Q Consensus 6 hpniv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~iiH 71 (251)
||||++++++|.+ ....|+||||+.+|++.+.+. +..+++..++.++.||+.||.||| ++||+|
T Consensus 108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH 185 (336)
T 2vuw_A 108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAVAEASLRFEH 185 (336)
T ss_dssp CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeE
Confidence 5555555555543 678999999999997665553 367899999999999999999999 999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceec-CCCCCeEecccccccccCcccccccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL-NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
|||||+|||+..+........ ........ .....+||+|||+++.... ....||+.|+||
T Consensus 186 rDlKp~NILl~~~~~~~~~~~--------------~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aP 246 (336)
T 2vuw_A 186 RDLHWGNVLLKKTSLKKLHYT--------------LNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDE 246 (336)
T ss_dssp SCCCGGGEEEEECSCSEEEEE--------------ETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCS
T ss_pred CCCCHHHEEEeccCCcceeee--------------ccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccCh
Confidence 999955555542210000000 00000000 1112799999999976543 234789999999
Q ss_pred cccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCC----cchhhh-hcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 151 EVIQEIGYDCVADMWSLGIT-ALEMAEGKPPYGDIH----PMRAIF-MIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~-l~~l~~g~~p~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
|++.+.. +.++||||++++ .+++++|..||.+.. ...... ............+..+++++.+||.+||+.|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 9998766 889999998777 777888999985421 001111 1111111111112346788999999999976
Q ss_pred ccCCHHHHh-cChhhh
Q psy3253 225 ERATASEML-NHEFIQ 239 (251)
Q Consensus 225 ~Rps~~evl-~hp~~~ 239 (251)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=238.18 Aligned_cols=169 Identities=14% Similarity=0.103 Sum_probs=138.2
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++++++.+++..|+||||++|++|.++++ . .....++..++.|++.||.|||++|++|||||
T Consensus 86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~--~-~~~~~~~~~i~~ql~~aL~~lH~~givH~Dik------ 156 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--T-SPSPVGAIRAMQSLAAAADAAHRAGVALSIDH------ 156 (286)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT--T-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS------
T ss_pred hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh--c-CCChHHHHHHHHHHHHHHHHHHHCCCccCCCC------
Confidence 47899999999999999999999999999999999985 2 34666788999999999999999999999988
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCV 161 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 161 (251)
|+||+++.++.++|++++ |++ +++.+
T Consensus 157 ---------------------------p~NIll~~~g~~kl~~~~--------------------~~~-------~~~~~ 182 (286)
T 3uqc_A 157 ---------------------------PSRVRVSIDGDVVLAYPA--------------------TMP-------DANPQ 182 (286)
T ss_dssp ---------------------------GGGEEEETTSCEEECSCC--------------------CCT-------TCCHH
T ss_pred ---------------------------cccEEEcCCCCEEEEecc--------------------ccC-------CCCch
Confidence 889999999999988543 222 36889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhh---hcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIF---MIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
+|||||||++|+|++|+.||.+.+...... ..... ..........+++++.++|.+||+.||++| |++|+++
T Consensus 183 ~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred hHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 999999999999999999998765543221 11111 111111235689999999999999999999 9999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=242.34 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=106.3
Q ss_pred CCCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|+++ .|+||++++++++++...||||||++|++|.+++. .++.+++. .++.||+.||.|+|++||||||||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIK---- 366 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVR---- 366 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCC----
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCc----
Confidence 3466 79999999999999999999999999999999997 56677765 478899999999999999999998
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+ .+.
T Consensus 367 -----------------------------PeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~ 416 (569)
T 4azs_A 367 -----------------------------PWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKS 416 (569)
T ss_dssp -----------------------------GGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------
T ss_pred -----------------------------hHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCC
Confidence 99999999999999999999876655455556779999999999976 456
Q ss_pred cchhHHHHHHHHHHHHhCCC
Q psy3253 160 CVADMWSLGITALEMAEGKP 179 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~ 179 (251)
.++|+||+|++++++.++..
T Consensus 417 ~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 417 WNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ------------CCCCTTHH
T ss_pred Ccccccccccchhhhccccc
Confidence 78999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.8e-24 Score=190.38 Aligned_cols=136 Identities=19% Similarity=0.240 Sum_probs=112.9
Q ss_pred CCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 2 QQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 2 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
++++||||+++..++......|+||||+++++|.+++.. ++.++.|++.||.|||++||+|||||
T Consensus 394 ~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiK------ 458 (540)
T 3en9_A 394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLT------ 458 (540)
T ss_dssp HHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCC------
T ss_pred HhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCC------
Confidence 467999999666666677778999999999999999862 66899999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-------ccccccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-------RNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++. .+||+|||+++........ .....||+.|+|||++.
T Consensus 459 ---------------------------p~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 459 ---------------------------TSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp ---------------------------TTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ---------------------------HHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence 77888877 8999999999876543221 13456899999999997
Q ss_pred c--CCCCcchhHHHHHHHHHHHHhCCCCC
Q psy3253 155 E--IGYDCVADMWSLGITALEMAEGKPPY 181 (251)
Q Consensus 155 ~--~~~~~~~DvwslG~~l~~l~~g~~p~ 181 (251)
. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 510 RFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 6 66888899999999888877766555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.7e-17 Score=136.68 Aligned_cols=89 Identities=18% Similarity=0.144 Sum_probs=71.1
Q ss_pred ceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccc
Q psy3253 10 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYC 89 (251)
Q Consensus 10 v~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~ 89 (251)
+++.+++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++|++|||||
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlk-------------- 220 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLS-------------- 220 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCS--------------
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCC--------------
Confidence 666665544 45699999999999977 32 12345799999999999999999999988
Q ss_pred cccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 90 SIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
|+||+++ ++.++|+|||+++. +..+.|||.+.
T Consensus 221 -------------------p~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 221 -------------------QYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp -------------------TTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred -------------------HHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 8899998 88999999999853 23356787764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=8.6e-14 Score=113.94 Aligned_cols=72 Identities=24% Similarity=0.367 Sum_probs=58.1
Q ss_pred eEEEEEEccCC-C----CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCCCcccccccccccccc
Q psy3253 21 DLWIVMEYCGA-G----SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLH-LRRKIHRDIKAGSGTLVYDRLDYCSIKCN 94 (251)
Q Consensus 21 ~~~lv~e~~~~-g----sL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH-~~~iiH~dik~~Ni~~~~~~~~~~~~~~~ 94 (251)
..++||||+.+ | +|.++.. ..++..+..++.|++.||.+|| +.|++|||||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk------------------- 198 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLS------------------- 198 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS-------------------
T ss_pred CCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC-------------------
Confidence 46899999942 3 7776543 1235577889999999999999 9999999988
Q ss_pred ccchhhhhhhhhcccCceecCCCCCeEeccccccccc
Q psy3253 95 VITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 95 ~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
|+||+++. .++|+|||++...
T Consensus 199 --------------p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 --------------EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp --------------TTSEEESS--SEEECCCTTCEET
T ss_pred --------------HHHEEEcC--cEEEEECcccccC
Confidence 77888877 7999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.3e-12 Score=108.10 Aligned_cols=71 Identities=18% Similarity=0.154 Sum_probs=49.6
Q ss_pred CCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 5 DSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+|+|+++++....... ..++||||++|++|.++. .......++.|++.+|.+||+.|+|||||||.|
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~N 235 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFN 235 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 3677777655432211 236999999998886542 122346788999999999999999999999444
Q ss_pred CCcc
Q psy3253 79 GTLV 82 (251)
Q Consensus 79 i~~~ 82 (251)
||+.
T Consensus 236 ILl~ 239 (397)
T 4gyi_A 236 ILIR 239 (397)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 4433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.2e-07 Score=76.96 Aligned_cols=55 Identities=13% Similarity=-0.050 Sum_probs=43.2
Q ss_pred CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 6 SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 6 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
+..+.++++++.+.+..|+||||++|.+|.+... +......++.+++.+|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhC
Confidence 5667888888888889999999999999876521 122334678899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.28 E-value=7.3e-07 Score=71.86 Aligned_cols=51 Identities=10% Similarity=0.081 Sum_probs=35.5
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
+.++++++..++..++||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCC
Confidence 566888888777899999999998884 1 1112 2245667777777777643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.9e-06 Score=73.31 Aligned_cols=58 Identities=17% Similarity=0.185 Sum_probs=44.6
Q ss_pred CCccceeeeeEeeC---CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 6 SPYVVKYYGSYFKN---TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 6 hpniv~l~~~~~~~---~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
+..+.+++.++.+. +..++||||++|.++.+. .-..++..+...++.+++..|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 34577888887665 347999999998777431 12357788888999999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.1e-06 Score=71.33 Aligned_cols=42 Identities=12% Similarity=0.068 Sum_probs=33.9
Q ss_pred EEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy3253 22 LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66 (251)
Q Consensus 22 ~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~ 66 (251)
.|+||++++|.+|.+... ..++..+...++.+++..+..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp SCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHc
Confidence 488999999988875432 357788888888999999999987
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.00 E-value=0.00016 Score=56.76 Aligned_cols=135 Identities=17% Similarity=0.193 Sum_probs=90.2
Q ss_pred CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCce
Q psy3253 33 SVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112 (251)
Q Consensus 33 sL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ni 112 (251)
||.+.++..+.++++.+++.++.|.+.+|+-+-.+.--|..| ..|..|
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i--------------------------------~~~~~i 81 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRV--------------------------------RSAAQI 81 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC--------------------------------CSGGGE
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCcee--------------------------------cCCcce
Confidence 899999989999999999999999999987763211112221 227788
Q ss_pred ecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhh
Q psy3253 113 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIF 191 (251)
Q Consensus 113 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~ 191 (251)
++..+|++...+ +.+. .....+.|||... ...+.+.=|+|||+++|..+- |-+
T Consensus 82 ~l~~dG~V~f~~-~~s~------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------ 135 (229)
T 2yle_A 82 RVWRDGAVTLAP-AADD------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------ 135 (229)
T ss_dssp EEETTSCEEECC-C------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------
T ss_pred EEecCCceeccc-cccc------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------
Confidence 899999877664 1110 1122366888764 345677889999999998754 211
Q ss_pred hcCCCCCCCCCCCCCCCHHHHHHHHHhhhc-------------------------CcCccCCHHHHhc
Q psy3253 192 MIPTKPPPSFREPDVWTPEFIDFVSRCLVK-------------------------NPEERATASEMLN 234 (251)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~-------------------------~p~~Rps~~evl~ 234 (251)
......+++.+.+||..|..- .+..|.++++|++
T Consensus 136 ---------e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 136 ---------ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ---------TTEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred ---------cccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 112456799999999999866 2467888888874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0015 Score=54.08 Aligned_cols=57 Identities=7% Similarity=-0.030 Sum_probs=38.4
Q ss_pred cceeeeeEe-eCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 9 VVKYYGSYF-KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 9 iv~l~~~~~-~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
|.+++.+.. ..+..++|||+++|.+|.+..- ..++..+...++.++...|..||+..
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~ 131 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFP 131 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 344455553 3455789999999988876322 34566677777777777777777654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0012 Score=53.34 Aligned_cols=54 Identities=13% Similarity=0.047 Sum_probs=38.3
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
|-++++++.+.+..++|||+++|.++.+.... .......+..++...|..||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTS
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCC
Confidence 55677888888899999999999888776542 1122334566777777777754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0028 Score=53.36 Aligned_cols=24 Identities=17% Similarity=0.304 Sum_probs=17.7
Q ss_pred cccCceecCCCCCeEecccccccc
Q psy3253 107 LKAGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 107 ~~~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.+.||+++....+.|+||+.+..
T Consensus 229 l~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 229 ARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CSGGGEEEETTEEEEECCGGGCEE
T ss_pred CCCCeEEEeCCcEEEEEccccccc
Confidence 448899888544468999998853
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.32 E-value=0.056 Score=44.70 Aligned_cols=21 Identities=24% Similarity=0.382 Sum_probs=16.9
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
+.||+++.++.+.++||+.+.
T Consensus 231 ~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 231 TGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp TTSEEECGGGCEEECCCTTCE
T ss_pred cccEEEeCCCcEEEEehhhcc
Confidence 777777666779999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.35 E-value=0.18 Score=41.09 Aligned_cols=21 Identities=24% Similarity=0.382 Sum_probs=16.3
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.|++ ..++.+.++||..+..
T Consensus 182 ~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 182 CENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp GGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCEE-ECCCCEEEEecccccC
Confidence 78888 5556789999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=91.54 E-value=0.16 Score=43.60 Aligned_cols=22 Identities=9% Similarity=0.191 Sum_probs=17.4
Q ss_pred cCceecCCCCCeEeccccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQL 131 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~~ 131 (251)
+.||+++.++ +.++||+.+...
T Consensus 241 ~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 241 TGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp GGGEEECSSC-EEECCCTTCEEE
T ss_pred CCcEEEeCCC-CEEEeCcccccC
Confidence 7788887666 899999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=85.73 E-value=0.83 Score=37.39 Aligned_cols=20 Identities=35% Similarity=0.479 Sum_probs=16.0
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.||+++ + .+.++||+.+..
T Consensus 204 ~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 204 AGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp GGGEEES-S-SEEECCCTTCCE
T ss_pred cccEeEc-C-CCEEEECCCCCc
Confidence 8888887 4 789999988743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=85.02 E-value=0.46 Score=39.20 Aligned_cols=23 Identities=30% Similarity=0.237 Sum_probs=16.3
Q ss_pred cCceecCCC----CCeEeccccccccc
Q psy3253 109 AGNILLNTE----GHAKLADFGVAGQL 131 (251)
Q Consensus 109 ~~nil~~~~----~~~kl~dfg~~~~~ 131 (251)
+.||+++.+ +.+.++||+.+...
T Consensus 192 ~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 192 AQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp GGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 667776553 56889999988543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.88 E-value=0.3 Score=40.05 Aligned_cols=22 Identities=23% Similarity=0.286 Sum_probs=16.2
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.||+++.+..+.++||+.+..
T Consensus 196 ~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 196 QDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGGEEEETTEEEEECCCTTCEE
T ss_pred ccCEEEeCCceEEEecchhccC
Confidence 7788877665457999988743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=80.51 E-value=1.1 Score=37.18 Aligned_cols=22 Identities=27% Similarity=0.395 Sum_probs=17.9
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.|++++.++.+.++||+.+..
T Consensus 215 ~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 215 AGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GGGEEECGGGCEEECCCSSCEE
T ss_pred cCCEEEeCCCeEEEEECCCCee
Confidence 8888888777789999987753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 251 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-07 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 9e-70
Identities = 91/250 (36%), Positives = 136/250 (54%), Gaps = 38/250 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ CD P +VK +++ +LWI++E+C G+V +M ++ L+E +I + TL
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH + IHRD+KAG NIL +G
Sbjct: 123 LNYLHDNKIIHRDLKAG---------------------------------NILFTLDGDI 149
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----EIGYDCVADMWSLGITALEMA 175
KLADFGV+ + T T+ +R++ IGTP+WMAPEV+ + YD AD+WSLGIT +EMA
Sbjct: 150 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 176 EGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
E +PP+ +++PMR + I PP+ +P W+ F DF+ +CL KN + R T S++L H
Sbjct: 210 EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269
Query: 236 EFIQRHDTDP 245
F+ P
Sbjct: 270 PFVTVDSNKP 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-64
Identities = 89/246 (36%), Positives = 137/246 (55%), Gaps = 35/246 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M++ +P +V Y SY +LW+VMEY GS++D++ + + E +IA + + L+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQA 128
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE+LH + IHRDIK+ NILL +G
Sbjct: 129 LEFLHSNQVIHRDIKSD---------------------------------NILLGMDGSV 155
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
KL DFG Q+T +KR+T++GTP+WMAPEV+ Y D+WSLGI A+EM EG+PP
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
Y + +P+RA+++I T P + P+ + F DF++RCL + E+R +A E+L H+F++
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 241 HDTDPS 246
S
Sbjct: 276 AKPLSS 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 2e-62
Identities = 90/244 (36%), Positives = 125/244 (51%), Gaps = 42/244 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ P ++Y G Y + W+VMEYC GS SD++ + KK L E EIA + L+G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YLH IHRD+KAG NILL+ G
Sbjct: 128 LAYLHSHNMIHRDVKAG---------------------------------NILLSEPGLV 154
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG---YDCVADMWSLGITALEMAEG 177
KL DFG A + N+ +GTP+WMAPEVI + YD D+WSLGIT +E+AE
Sbjct: 155 KLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
KPP +++ M A++ I P+ + W+ F +FV CL K P++R T+ +L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGH-WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
Query: 238 IQRH 241
+ R
Sbjct: 270 VLRE 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 5e-59
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
P +++ YG + T +++++EY G+V ++ + E AT + +
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANA 118
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L Y H +R IHRDIK N+LL + G
Sbjct: 119 LSYCHSKRVIHRDIKPE---------------------------------NLLLGSAGEL 145
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ADFG + + +R T+ GT ++ PE+I+ +D D+WSLG+ E GKPP
Sbjct: 146 KIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240
+ I PD T D +SR L NP +R E+L H +I
Sbjct: 204 FEANTYQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
Query: 241 H 241
+
Sbjct: 261 N 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-59
Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 78/287 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ +C+SPY+V +YG+++ + ++ I ME+ GS+ +++ + + E + + +KG
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKG 116
Query: 61 LEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
L YL + KI HRD+K NIL+N+ G
Sbjct: 117 LTYLREKHKIMHRDVKPS---------------------------------NILVNSRGE 143
Query: 120 AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
KL DFGV+GQL D+MA N+ +GT +M+PE +Q Y +D+WS+G++ +EMA G+
Sbjct: 144 IKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
Query: 180 PY--------------------------------------GDIHPMRAIFMIP---TKPP 198
P D P AIF + P
Sbjct: 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
P V++ EF DFV++CL+KNP ERA +++ H FI+R D +
Sbjct: 262 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-58
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 44/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ P +V++Y S+ + +V E +G++ ++ R K + + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQ 120
Query: 57 TLKGLEYLHLRRK--IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
LKGL++LH R IHRD+K NI +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCD---------------------------------NIFI 147
Query: 115 NTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE 173
G K+ D G+A + AK VIGTP +MAPE+ +E YD D+++ G+ LE
Sbjct: 148 TGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLE 204
Query: 174 MAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
MA + PY + I+ T V PE + + C+ +N +ER + ++L
Sbjct: 205 MATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
Query: 234 NHEFIQ 239
NH F Q
Sbjct: 265 NHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-57
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 45/248 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKK---TLSEDEIATILC 55
+++ P +V+YY T+ L+IVMEYC G ++ ++ K L E+ + ++
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 56 DTLKGLEYLHLRRK-----IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAG 110
L+ H R +HRD+K
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPA--------------------------------- 143
Query: 111 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGIT 170
N+ L+ + + KL DFG+A L + +GTP++M+PE + + Y+ +D+WSLG
Sbjct: 144 NVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203
Query: 171 ALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230
E+ PP+ I P ++ E + ++R L R +
Sbjct: 204 LYELCALMPPFTAFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSVE 261
Query: 231 EMLNHEFI 238
E+L + I
Sbjct: 262 EILENPLI 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (465), Expect = 6e-57
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 38/251 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M P +V + ++ + ++ ++ E+ G + + + +SEDE + KG
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE--G 118
L ++H +H D LK NI+ T+
Sbjct: 137 LCHMHENNYVHLD---------------------------------LKPENIMFTTKRSN 163
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
KL DFG+ L GT + APEV + DMWS+G+ + + G
Sbjct: 164 ELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 179 PPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
P+G + + + + + + DF+ + L+ +P R T + L H +
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 238 IQRHDTDPSQN 248
+ + P ++
Sbjct: 283 LTPGN-APGRD 292
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-56
Identities = 49/244 (20%), Positives = 89/244 (36%), Gaps = 37/244 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + VVK+YG + ++ +EYC G + D + + E + + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAG 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YLH HRDIK N+LL+ +
Sbjct: 116 VVYLHGIGITHRDIKPE---------------------------------NLLLDERDNL 142
Query: 121 KLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYDCVA-DMWSLGITALEMAEG 177
K++DFG+A +R N + GT ++APE+++ + D+WS GI M G
Sbjct: 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
+ P+ + + + + + LV+NP R T ++ +
Sbjct: 203 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262
Query: 238 IQRH 241
+
Sbjct: 263 YNKP 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-55
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 43/250 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ ++ + G Y L IV ++C S+ + + + ++ I T +G
Sbjct: 58 LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YLH + IHRD LK+ NI L+ +
Sbjct: 117 MDYLHAKSIIHRD---------------------------------LKSNNIFLHEDLTV 143
Query: 121 KLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQ---EIGYDCVADMWSLGITALEMA 175
K+ DFG+A + + + G+ WMAPEVI+ + Y +D+++ GI E+
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 176 EGKPPYGDIHPMRAIFMIPTK---PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232
G+ PY +I+ I + + P + ++ CL K +ER ++
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 233 LNH-EFIQRH 241
L E + R
Sbjct: 264 LASIELLARS 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 3e-55
Identities = 45/250 (18%), Positives = 92/250 (36%), Gaps = 37/250 (14%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q P ++ + ++ ++ +++E+ G + D + +SE E+ + +G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--EG 118
L+++H +H D +K NI+ T
Sbjct: 140 LKHMHEHSIVHLD---------------------------------IKPENIMCETKKAS 166
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ DFG+A +L T + APE++ DMW++G+ + G
Sbjct: 167 SVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 179 PPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
P+ + + + +PE DF+ L K P +R T + L H +
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 238 IQRHDTDPSQ 247
++ ++ +
Sbjct: 286 LKGDHSNLTS 295
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 5e-54
Identities = 71/248 (28%), Positives = 105/248 (42%), Gaps = 42/248 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ P +++ +Y NT ++V + G + D + K TLSE E I+ L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ LH +HRD+K NILL+ + +
Sbjct: 123 ICALHKLNIVHRDLKPE---------------------------------NILLDDDMNI 149
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ------EIGYDCVADMWSLGITALEM 174
KL DFG + QL K V GTP ++APE+I+ GY DMWS G+ +
Sbjct: 150 KLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208
Query: 175 AEGKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
G PP+ M + MI + E D ++ D VSR LV P++R TA E L
Sbjct: 209 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 234 NHEFIQRH 241
H F Q++
Sbjct: 269 AHPFFQQY 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-53
Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 39/243 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + D P+ VK Y ++ + L+ + Y G + +R + + E + +
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH + IHRD+K NILLN + H
Sbjct: 121 LEYLHGKGIIHRDLKPE---------------------------------NILLNEDMHI 147
Query: 121 KLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
++ DFG A L+ A+ N+ +GT +++PE++ E +D+W+LG ++ G
Sbjct: 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFI 238
PP+ + I P+ + P+ D V + LV + +R EM + +
Sbjct: 208 PPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
Query: 239 QRH 241
+ H
Sbjct: 265 KAH 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-52
Identities = 53/244 (21%), Positives = 88/244 (36%), Gaps = 37/244 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ ++ + S+ +L ++ E+ + + + L+E EI + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--EG 118
L++LH H DI+ NI+ T
Sbjct: 115 LQFLHSHNIGHFDIRPE---------------------------------NIIYQTRRSS 141
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK 178
K+ +FG A QL + P + APEV Q DMWSLG + G
Sbjct: 142 TIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
Query: 179 PPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237
P+ + I I + + E +DFV R LVK + R TASE L H +
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 238 IQRH 241
+++
Sbjct: 261 LKQK 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 2e-52
Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 33/243 (13%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ + P +V Y L+++M+ G + D + K +E + + ++ L
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDA 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YLH +HRD+K N++ L+ +
Sbjct: 120 VKYLHDLGIVHRDLKP----------------ENLL--------------YYSLDEDSKI 149
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
++DFG++ ++ D + +T GTP ++APEV+ + Y D WS+G+ A + G PP
Sbjct: 150 MISDFGLS-KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
Query: 181 YGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ D + + I + D + DF+ + K+PE+R T + L H +I
Sbjct: 209 FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
Query: 240 RHD 242
Sbjct: 269 GDT 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-49
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 42/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTL 58
M Q +V+ G + L+IV EY GS+ D +R R ++ L D + D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
+ +EYL +HRD L A N+L++ +
Sbjct: 114 EAMEYLEGNNFVHRD---------------------------------LAARNVLVSEDN 140
Query: 119 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-G 177
AK++DFG+ + + T +T W APE ++E + +D+WS GI E+ G
Sbjct: 141 VAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH-E 236
+ PY I + + PD P + + C + R + ++ E
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
Query: 237 FIQRHD 242
I+ H+
Sbjct: 256 HIKTHE 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 60/258 (23%), Positives = 95/258 (36%), Gaps = 47/258 (18%)
Query: 1 MQQCDSPYVVKYYGSY----FKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILC 55
+ P++V+ Y L IVME G + ++ R + +E E + I+
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
+ ++YLH HRD+K N+L
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPE---------------------------------NLLYT 145
Query: 116 T---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
+ KL DFG A + T T TP+++APEV+ YD DMWSLG+
Sbjct: 146 SKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204
Query: 173 EMAEGKPPYGDIHPMRAIFMIPTK-----PPPSFREPDVWTPEFIDFVSRCLVKNPEERA 227
+ G PP+ H + + T+ E + E + L P +R
Sbjct: 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264
Query: 228 TASEMLNHEFIQRHDTDP 245
T +E +NH +I + P
Sbjct: 265 TITEFMNHPWIMQSTKVP 282
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-49
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 38/245 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ P++ + ++ +L+ VMEY G + ++ + + G
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILG 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L++LH + ++RD+K NILL+ +GH
Sbjct: 116 LQFLHSKGIVYRDLKLD---------------------------------NILLDKDGHI 142
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ADFG+ + AK NT GTP ++APE++ Y+ D WS G+ EM G+ P
Sbjct: 143 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATA-SEMLNHEFIQ 239
+ I P P E D + + V+ PE+R ++ H +
Sbjct: 203 FHGQDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
Query: 240 RHDTD 244
+ +
Sbjct: 260 EINWE 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 9e-49
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 43/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D+PY+V+ G + L +VME G G + + +++ + +A +L G
Sbjct: 63 MHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL + +HRD L A N+LL +A
Sbjct: 122 MKYLEEKNFVHRD---------------------------------LAARNVLLVNRHYA 148
Query: 121 KLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG++ L R+ W APE I + +D+WS G+T E +
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE---ML 233
G+ PY + + I P PE +S C + E+R +
Sbjct: 209 GQKPYKKMKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 234 NHEFIQ 239
+
Sbjct: 267 RACYYS 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (393), Expect = 3e-46
Identities = 52/250 (20%), Positives = 97/250 (38%), Gaps = 42/250 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ D P++V ++ L +++ G + + + SE ++ + + G
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILG 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LE++H R ++RD+K NILL+ GH
Sbjct: 120 LEHMHNRFVVYRDLKPA---------------------------------NILLDEHGHV 146
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYDCVADMWSLGITALEMAEGKP 179
+++D G+A + K + +GT +MAPEV+Q+ + YD AD +SLG ++ G
Sbjct: 147 RISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204
Query: 180 PYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLN 234
P+ + + PD ++PE + L ++ R A E+
Sbjct: 205 PFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 235 HEFIQRHDTD 244
F + D
Sbjct: 265 SPFFRSLDWQ 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-46
Identities = 47/237 (19%), Positives = 89/237 (37%), Gaps = 37/237 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M +V+ YG K ++I+ EY G + + +R + ++ + D +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+EYL ++ +HRD L A N L+N +G
Sbjct: 113 MEYLESKQFLHRD---------------------------------LAARNCLVNDQGVV 139
Query: 121 KLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEGK 178
K++DFG++ + D + W PEV+ + +D+W+ G+ E+ + GK
Sbjct: 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY I P + + + + C + +ER T +L++
Sbjct: 200 MPYERFTNSETAEHIAQGLRLYR--PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-46
Identities = 52/246 (21%), Positives = 93/246 (37%), Gaps = 44/246 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
MQQ D+PY+V+ G + +VME G ++ ++ + + + + I ++ G
Sbjct: 62 MQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMG 119
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A N+LL T+ +A
Sbjct: 120 MKYLEESNFVHRD---------------------------------LAARNVLLVTQHYA 146
Query: 121 KLADFGVAGQLT---DTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG++ L + + W APE I + +D+WS G+ E +
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE---ML 233
G+ PY + M+ P E D ++ C + E R + L
Sbjct: 207 GQKPYRGMKGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
Query: 234 NHEFIQ 239
+ +
Sbjct: 265 RNYYYD 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-46
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 40/251 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ P V+ + Y TD+ +++E G + D + K++L+E+E L L G
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNG 125
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-- 118
+ YLH + H D LK NI+L
Sbjct: 126 VYYLHSLQIAHFD---------------------------------LKPENIMLLDRNVP 152
Query: 119 --HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE 176
K+ DFG+A ++ D + + GTP ++APE++ ADMWS+G+ +
Sbjct: 153 KPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 177 GKPPYGDIHPMRAIFMIPT-KPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
G P+ + + + DF+ R LVK+P++R T + L H
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 236 EFIQRHDTDPS 246
+I+ DT +
Sbjct: 272 PWIKPKDTQQA 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-45
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 37/237 (15%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M + P +V+ YG + + +V E+ G +SD +R ++ + + + + D +G
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL IHRD L A N L+
Sbjct: 114 MAYLEEACVIHRD---------------------------------LAARNCLVGENQVI 140
Query: 121 KLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEGK 178
K++DFG+ + D + W +PEV Y +D+WS G+ E+ +EGK
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
PY + + I T P + + ++ C + PE+R S +L
Sbjct: 201 IPYENRSNSEVVEDISTGFRLYK--PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 6e-44
Identities = 54/249 (21%), Positives = 97/249 (38%), Gaps = 45/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+ P++++ +G++ ++++M+Y G + + + +
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLA 116
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH + I+RD+ K NILL+ GH
Sbjct: 117 LEYLHSKDIIYRDL---------------------------------KPENILLDKNGHI 143
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ DFG A + D T+ GTP ++APEV+ Y+ D WS GI EM G P
Sbjct: 144 KITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235
+ D + M+ I P + + D +SR + ++ +R ++ NH
Sbjct: 201 FYDSNTMKTYEKILNAELR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
Query: 236 EFIQRHDTD 244
+ + +
Sbjct: 258 PWFKEVVWE 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-44
Identities = 49/239 (20%), Positives = 85/239 (35%), Gaps = 39/239 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D +++ YG + +V E GS+ D +R + ++ +G
Sbjct: 65 MHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL +R IHR L A N+LL T
Sbjct: 124 MGYLESKRFIHR---------------------------------DLAARNLLLATRDLV 150
Query: 121 KLADFGVAGQLT---DTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K+ DFG+ L D + W APE ++ + +D W G+T EM
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
G+ P+ ++ + + I K P+ + + + +C PE+R T + +
Sbjct: 211 GQEPWIGLNGSQILHKI-DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-44
Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 38/237 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M+Q D P++VK G +WI+ME C G + +++RK +L +
Sbjct: 62 MRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L YL +R +HRDI A N+L+++
Sbjct: 121 LAYLESKRFVHRDIAAR---------------------------------NVLVSSNDCV 147
Query: 121 KLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEGK 178
KL DFG++ + D+ + + WMAPE I + +D+W G+ E+ G
Sbjct: 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
Query: 179 PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
P+ + I I P P +++C +P R +E+
Sbjct: 208 KPFQGVKNNDVIGRIENGERLPM--PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 1e-43
Identities = 56/248 (22%), Positives = 92/248 (37%), Gaps = 42/248 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q D P V+ G K+T + I+ E+ GS+ +R + ++ +L G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 141 MKYLADMNYVHRD---------------------------------LAARNILVNSNLVC 167
Query: 121 KLADFGVAGQLTDTMAKRNTV-----IGTPFWMAPEVIQEIGYDCVADMWSLGITALEM- 174
K++DFG++ L D + W APE IQ + +D+WS GI E+
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
+ G+ PY D+ I I P + C K+ R +++N
Sbjct: 228 SYGERPYWDMTNQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 235 H-EFIQRH 241
+ + R+
Sbjct: 286 TLDKMIRN 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 62/275 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ P ++ ++ +++ +V ++ + I++ L+ I + TL+G
Sbjct: 54 LQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH +HRD+K N+LL+ G
Sbjct: 113 LEYLHQHWILHRDLKPN---------------------------------NLLLDENGVL 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAEGKP 179
KLADFG+A + T ++ APE++ Y DMW++G E+ P
Sbjct: 140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 180 PY---GDIHPMRAIFMIPTKPP----------------------PSFREPDVWTPEFIDF 214
D+ + IF P P + +D
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 215 VSRCLVKNPEERATASEMLNHEFIQRH--DTDPSQ 247
+ + NP R TA++ L ++ T Q
Sbjct: 260 IQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (367), Expect = 3e-43
Identities = 56/251 (22%), Positives = 103/251 (41%), Gaps = 44/251 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
+ P +V Y + T +IVMEY ++ DI+ + ++ ++ D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIAD 119
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
+ L + H IHRD+K NI+++
Sbjct: 120 ACQALNFSHQNGIIHRDVKPA---------------------------------NIMISA 146
Query: 117 EGHAKLADFGVAGQL---TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALE 173
K+ DFG+A + +++ + VIGT +++PE + D +D++SLG E
Sbjct: 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 206
Query: 174 MAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEER-ATASE 231
+ G+PP+ P+ + + P P + + + V + L KNPE R TA+E
Sbjct: 207 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266
Query: 232 MLNHEFIQRHD 242
M + ++ H+
Sbjct: 267 MR-ADLVRVHN 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-43
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 41/242 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-LSEDEIATILCDTLK 59
M+Q +V+ Y ++I+ EY GS+ D ++ L+ +++ + +
Sbjct: 62 MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ ++ R IHRD L+A NIL++
Sbjct: 121 GMAFIEERNYIHRD---------------------------------LRAANILVSDTLS 147
Query: 120 AKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D R W APE I + +D+WS GI E+ G
Sbjct: 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN--H 235
+ PY + I + PD E + C + PE+R T + +
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVR--PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
Query: 236 EF 237
+F
Sbjct: 266 DF 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-43
Identities = 48/260 (18%), Positives = 88/260 (33%), Gaps = 59/260 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK----------------- 43
Q +V G+ + ++++ EYC G + + +R +++
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 44 -----TLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITN 98
L+ +++ KG+E+L + +HRD
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD------------------------- 189
Query: 99 QIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEI 156
L A N+L+ K+ DFG+A + R WMAPE + E
Sbjct: 190 --------LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 157 GYDCVADMWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFV 215
Y +D+WS GI E+ + G PY I + + +P T E +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIM 300
Query: 216 SRCLVKNPEERATASEMLNH 235
C + +R + + +
Sbjct: 301 QSCWAFDSRKRPSFPNLTSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-42
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 42/249 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q P++ ++ + L VMEY G + + R++ +E+ + +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSA 117
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
LEYLH R ++RDIK N++L+ +GH
Sbjct: 118 LEYLHSRDVVYRDIKLE---------------------------------NLMLDKDGHI 144
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
K+ DFG+ + A T GTP ++APEV+++ Y D W LG+ EM G+ P
Sbjct: 145 KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235
+ + R +I + P +PE ++ L K+P++R + A E++ H
Sbjct: 205 FYNQDHERLFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 236 EFIQRHDTD 244
F +
Sbjct: 262 RFFLSINWQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-42
Identities = 50/244 (20%), Positives = 85/244 (34%), Gaps = 50/244 (20%)
Query: 1 MQQCDSPY--VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
+++ S + V++ + + +++E + L E+ + L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE- 117
+ + + H +HRD +K NIL++
Sbjct: 121 EAVRHCHNCGVLHRD---------------------------------IKDENILIDLNR 147
Query: 118 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-DCVADMWSLGITALEMAE 176
G KL DFG L DT+ GT + PE I+ Y A +WSLGI +M
Sbjct: 148 GELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 177 GKPPY-GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235
G P+ D +R + + E + CL P +R T E+ NH
Sbjct: 206 GDIPFEHDEEIIRGQVFFRQR----------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 236 EFIQ 239
++Q
Sbjct: 256 PWMQ 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-42
Identities = 50/245 (20%), Positives = 86/245 (35%), Gaps = 40/245 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M D+P+V + + + ++ + G + D +R K + + KG
Sbjct: 65 MASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ YL RR +HRD+ A N+L+ T H
Sbjct: 124 MNYLEDRRLVHRDLAAR---------------------------------NVLVKTPQHV 150
Query: 121 KLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AEG 177
K+ DFG+A L + WMA E I Y +D+WS G+T E+ G
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH-E 236
PY I ++ P + T + + +C + + + R E++
Sbjct: 211 SKPYDGIPASEISSILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
Query: 237 FIQRH 241
+ R
Sbjct: 269 KMARD 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-42
Identities = 54/255 (21%), Positives = 90/255 (35%), Gaps = 43/255 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLK 59
M++ +V+ Y ++IV EY GS+ D ++ K L ++ +
Sbjct: 66 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+ Y+ +HRD L+A NIL+
Sbjct: 125 GMAYVERMNYVHRD---------------------------------LRAANILVGENLV 151
Query: 120 AKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG+A + D R W APE + +D+WS GI E+ +G
Sbjct: 152 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN--H 235
+ PY + + + P D + +C K PEER T +
Sbjct: 212 RVPYPGMVNREVLDQVERGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 236 EFIQRHDTD--PSQN 248
++ + P +N
Sbjct: 270 DYFTSTEPQYQPGEN 284
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-41
Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 63/268 (23%)
Query: 1 MQQCDSPYVVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILC 55
++ + P VV+ + + T L +V E+ + + ++ + + + I ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L+GL++LH R +HRD+K NIL+
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQ---------------------------------NILVT 150
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA 175
+ G KLADFG+A ++ +V+ T ++ APEV+ + Y D+WS+G EM
Sbjct: 151 SSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209
Query: 176 EGKPPYGDIHPMRAIFMI------------------------PTKPPPSFREPDVWTPEF 211
KP + + + I P +
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 212 IDFVSRCLVKNPEERATASEMLNHEFIQ 239
D + +CL NP +R +A L+H + Q
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 1e-40
Identities = 53/266 (19%), Positives = 87/266 (32%), Gaps = 63/266 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR------------------- 41
M + D+P +VK G + ++ EY G +++ +R
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 42 ----KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVIT 97
LS E I G+ YL R+ +HRD
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD------------------------ 165
Query: 98 NQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQE 155
L N L+ K+ADFG++ + D WM PE I
Sbjct: 166 ---------LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
Query: 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214
Y +D+W+ G+ E+ G PY + I+ + + P+ E +
Sbjct: 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC--PENCPLELYNL 274
Query: 215 VSRCLVKNPEERATASEMLNHEFIQR 240
+ C K P +R + + H +QR
Sbjct: 275 MRLCWSKLPADRPSFCSI--HRILQR 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-40
Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 41/241 (17%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
M+ P V+ G ++ +V+ Y G + + +R + ++ K
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
G+++L ++ +HRD L A N +L+ +
Sbjct: 142 GMKFLASKKFVHRD---------------------------------LAARNCMLDEKFT 168
Query: 120 AKLADFGVAGQLTDTMAKRNT----VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM- 174
K+ADFG+A + D WMA E +Q + +D+WS G+ E+
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228
Query: 175 AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G PPY D++ + P+ + + +C E R + SE+++
Sbjct: 229 TRGAPPYPDVNTFDITVYLLQGRRLLQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 235 H 235
Sbjct: 287 R 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-40
Identities = 56/266 (21%), Positives = 92/266 (34%), Gaps = 60/266 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ + P +VK L++V E+ + + I + L L+G
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L + H R +HRD+ K N+L+NTEG
Sbjct: 115 LAFCHSHRVLHRDL---------------------------------KPQNLLINTEGAI 141
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA-DMWSLGITALEMAEGKP 179
KLADFG+A + + T ++ APE++ Y A D+WSLG EM +
Sbjct: 142 KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 180 PYGDIHPMRAIFMI-------------------------PTKPPPSFRE-PDVWTPEFID 213
+ + +F I P F + +
Sbjct: 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS 261
Query: 214 FVSRCLVKNPEERATASEMLNHEFIQ 239
+S+ L +P +R +A L H F Q
Sbjct: 262 LLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-40
Identities = 49/273 (17%), Positives = 77/273 (28%), Gaps = 66/273 (24%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIMRL--RKKTLSEDEIAT 52
M++ D +V+ ++ + + L +V++Y K+TL +
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
+ + L Y+H HRDIK + L D
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--------------------------- 159
Query: 113 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
KL DFG A QL + + + + Y D+WS G
Sbjct: 160 -----AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 173 EMAEGKPPYGDIHPMRAIFMI--------------------------PTKPPPSFREPDV 206
E+ G+P + + + I P +
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274
Query: 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
PE I SR L P R T E H F
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (341), Expect = 3e-39
Identities = 57/266 (21%), Positives = 94/266 (35%), Gaps = 61/266 (22%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ +VK Y L +V E+ + ++ + + L + L L G
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ Y H RR +HRD+K N+L+N EG
Sbjct: 113 IAYCHDRRVLHRDLKPQ---------------------------------NLLINREGEL 139
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDCVADMWSLGITALEMAEGKP 179
K+ADFG+A + K I T ++ AP+V+ Y D+WS+G EM G P
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 180 PYGDIHPMRAIFMI--------------------------PTKPPPSFREPDVWTPEFID 213
+ + + I +P P ID
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 214 FVSRCLVKNPEERATASEMLNHEFIQ 239
+S+ L +P +R TA + L H + +
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 6e-39
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 45/249 (18%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q + P++VK S+ N++L++VMEY G + +R R SE +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLT 153
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
EYLH I+RD+K N+L++ +G+
Sbjct: 154 FEYLHSLDLIYRDLKPE---------------------------------NLLIDQQGYI 180
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKPP 180
++ DFG A + T+ GTP +APE+I GY+ D W+LG+ EMA G PP
Sbjct: 181 QVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 181 YGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEMLNH 235
+ P++ I + P ++ + D + L + +R +++ NH
Sbjct: 238 FFADQPIQIYEKIVSGKVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
Query: 236 EFIQRHDTD 244
++ D
Sbjct: 295 KWFATTDWI 303
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-39
Identities = 48/238 (20%), Positives = 85/238 (35%), Gaps = 39/238 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
M Q +++ G K + I+ EY G++ +R + S ++ +L G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
++YL +HRD L A NIL+N+
Sbjct: 123 MKYLANMNYVHRD---------------------------------LAARNILVNSNLVC 149
Query: 121 KLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM-AE 176
K++DFG++ L D T W APE I + +D+WS GI E+
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 177 GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234
G+ PY ++ + I P + +C + R +++++
Sbjct: 210 GERPYWELSNHEVMKAINDGFRLPT--PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-39
Identities = 53/284 (18%), Positives = 95/284 (33%), Gaps = 72/284 (25%)
Query: 1 MQQCDSPYVVKYYGSY----FKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
+ + ++ + ++ + + + L+ + LS D I L
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQ 117
Query: 57 TLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT 116
L+GL+Y+H +HRD+ K N+LLNT
Sbjct: 118 ILRGLKYIHSANVLHRDL---------------------------------KPSNLLLNT 144
Query: 117 EGHAKLADFGVAGQLT---DTMAKRNTVIGTPFWMAPEVI-QEIGYDCVADMWSLGITAL 172
K+ DFG+A D + T ++ APE++ GY D+WS+G
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204
Query: 173 EMAEGKPPYGDIHPMRAIFMI----------------------------PTKPPPSFREP 204
EM +P + H + + I P R
Sbjct: 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264
Query: 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQN 248
+ +D + + L NP +R + L H +++++ DPS
Sbjct: 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY-YDPSDE 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-38
Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 52/251 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTL 45
+ P ++ G+ L++ +EY G++ D +R TL
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 46 SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLF 105
S ++ D +G++YL ++ IHRD
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRD-------------------------------- 152
Query: 106 RLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMW 165
L A NIL+ AK+ADFG++ + + K+ WMA E + Y +D+W
Sbjct: 153 -LAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 210
Query: 166 SLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
S G+ E+ + G PY + +P P E D + +C + P
Sbjct: 211 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPY 268
Query: 225 ERATASEMLNH 235
ER + +++L
Sbjct: 269 ERPSFAQILVS 279
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 5e-38
Identities = 45/236 (19%), Positives = 87/236 (36%), Gaps = 38/236 (16%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMRLRKKTLSEDEIATILCDTLK 59
M++ P +V+ G + +I+ E+ G++ D + ++ +S + +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+EYL + IHRD L A N L+
Sbjct: 127 AMEYLEKKNFIHRD---------------------------------LAARNCLVGENHL 153
Query: 120 AKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMA-EG 177
K+ADFG++ +T + W APE + + +D+W+ G+ E+A G
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 178 KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233
PY I + ++ P+ + + + C NP +R + +E+
Sbjct: 214 MSPYPGIDLSQVYELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-37
Identities = 49/262 (18%), Positives = 91/262 (34%), Gaps = 54/262 (20%)
Query: 4 CDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKT-----------------LS 46
+ +V G+ ++ EYC G + + +R ++ + L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 47 EDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFR 106
+++ + KG+ +L + IHRD+ A
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAAR----------------------------- 174
Query: 107 LKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYDCVADM 164
NILL K+ DFG+A + + + WMAPE I Y +D+
Sbjct: 175 ----NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 165 WSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
WS GI E+ P+ + F K P+ E D + C +P
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 225 ERATASEMLNHEFIQRHDTDPS 246
+R T +++ + I++ ++ +
Sbjct: 291 KRPTFKQIV--QLIEKQISEST 310
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-36
Identities = 61/262 (23%), Positives = 96/262 (36%), Gaps = 55/262 (20%)
Query: 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMR---------------LRKKT 44
+ VV G+ K L +++E+C G++S +R L K
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 45 LSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTL 104
L+ + + KG+E+L R+ IHRD
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRD------------------------------- 159
Query: 105 FRLKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162
L A NILL+ + K+ DFG+A + ++ WMAPE I + Y +
Sbjct: 160 --LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 217
Query: 163 DMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVK 221
D+WS G+ E+ PY + + R PD TPE + C
Sbjct: 218 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHG 276
Query: 222 NPEERATASEMLNH--EFIQRH 241
P +R T SE++ H +Q +
Sbjct: 277 EPSQRPTFSELVEHLGNLLQAN 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-36
Identities = 54/288 (18%), Positives = 92/288 (31%), Gaps = 77/288 (26%)
Query: 1 MQQCDSPYVVKYYGSYF--------KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIAT 52
+Q VV +++V ++C + + K + EI
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKR 121
Query: 53 ILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNI 112
++ L GL Y+H + +HRD +KA N+
Sbjct: 122 VMQMLLNGLYYIHRNKILHRD---------------------------------MKAANV 148
Query: 113 LLNTEGHAKLADFGVAGQL----TDTMAKRNTVIGTPFWMAPEVIQ-EIGYDCVADMWSL 167
L+ +G KLADFG+A + + T ++ PE++ E Y D+W
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208
Query: 168 GITALEMAEGKPPYGDIHPMRAIFMI-----------------------------PTKPP 198
G EM P + +I +
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268
Query: 199 PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246
+ V P +D + + LV +P +R + + LNH+F D PS
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW-SDPMPS 315
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 4e-36
Identities = 39/259 (15%), Positives = 75/259 (28%), Gaps = 53/259 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLK 59
+ + D +VME G S+ D+ + S + + +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGH 119
+EY+H + IHRD+ K N L+
Sbjct: 115 RIEYIHSKNFIHRDV---------------------------------KPDNFLMGLGKK 141
Query: 120 AKLA---DFGVAGQLTDT-------MAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
L DFG+A + D + + GT + + I D+ SLG
Sbjct: 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201
Query: 170 TALEMAEGKPPYGDIHPMRAIFMI-----PTKPPPSFREPDVWTPEFIDFVSRCLVKNPE 224
+ G P+ + P + EF +++ C +
Sbjct: 202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFD 261
Query: 225 ERATAS---EMLNHEFIQR 240
++ S ++ + F ++
Sbjct: 262 DKPDYSYLRQLFRNLFHRQ 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-36
Identities = 44/247 (17%), Positives = 91/247 (36%), Gaps = 47/247 (19%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKK---------TLSEDEIA 51
M++ + +VV+ G + ++ME G + +R + S ++
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 52 TILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGN 111
+ + G+ YL+ + +HRD L A N
Sbjct: 137 QMAGEIADGMAYLNANKFVHRD---------------------------------LAARN 163
Query: 112 ILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGI 169
++ + K+ DFG+ + TD K + WM+PE +++ + +D+WS G+
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223
Query: 170 TALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228
E+A + PY + + + + PD + + C NP+ R +
Sbjct: 224 VLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPS 281
Query: 229 ASEMLNH 235
E+++
Sbjct: 282 FLEIISS 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-36
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 47/251 (18%)
Query: 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYL 64
SP++V + ++ T L ++++Y G + + +++ +E E+ + + + LE+L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 145
Query: 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLAD 124
H I+RDIK NILL++ GH L D
Sbjct: 146 HKLGIIYRDIKLE---------------------------------NILLDSNGHVVLTD 172
Query: 125 FGVAGQLTDTMAKR-NTVIGTPFWMAPEVIQ--EIGYDCVADMWSLGITALEMAEGKPPY 181
FG++ + +R GT +MAP++++ + G+D D WSLG+ E+ G P+
Sbjct: 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232
Query: 182 ---GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER-----ATASEML 233
G+ + I K P + P + D + R L+K+P++R A E+
Sbjct: 233 TVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 234 NHEFIQRHDTD 244
H F Q+ + D
Sbjct: 291 EHLFFQKINWD 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 47/253 (18%), Positives = 92/253 (36%), Gaps = 53/253 (20%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTL 45
++ G+ ++ L++++EY G++ + ++ R+ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 46 SEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLF 105
S ++ + +G+EYL ++ IHRD+ A
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAAR---------------------------- 164
Query: 106 RLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYDCVAD 163
N+L+ + K+ADFG+A + + T WMAPE + + Y +D
Sbjct: 165 -----NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219
Query: 164 MWSLGITALEM-AEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKN 222
+WS G+ E+ G PY + ++ P T E + C
Sbjct: 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAV 277
Query: 223 PEERATASEMLNH 235
P +R T +++
Sbjct: 278 PSQRPTFKQLVED 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-35
Identities = 62/274 (22%), Positives = 101/274 (36%), Gaps = 74/274 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL 54
++ V+ + + TD ++VM + G + +M+ + L ED I ++
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK--HEKLGEDRIQFLV 127
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
LKGL Y+H IHRD LK GN+ +
Sbjct: 128 YQMLKGLRYIHAAGIIHRD---------------------------------LKPGNLAV 154
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDCVADMWSLGITALE 173
N + K+ DFG+A Q M + T ++ APEVI Y D+WS+G E
Sbjct: 155 NEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211
Query: 174 MAEGKPPYGDIHPM---RAIFMIPTKPPPSFREPDVW----------------------- 207
M GK + + + I + PP F +
Sbjct: 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 208 --TPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+P ++ + + LV + E+R TA E L H + +
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-34
Identities = 52/274 (18%), Positives = 89/274 (32%), Gaps = 76/274 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
++ + + K+ T LW+V +Y GS+ D L + T++ + + +
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYTVTVEGMIKLALS 108
Query: 57 TLKGLEYLHL--------RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLK 108
T GL +LH+ HRD+K+
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSK------------------------------- 137
Query: 109 AGNILLNTEGHAKLADFGVAGQLTD----TMAKRNTVIGTPFWMAPEVIQE------IGY 158
NIL+ G +AD G+A + N +GT +MAPEV+ +
Sbjct: 138 --NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195
Query: 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFRE--------------P 204
AD++++G+ E+A G + + PS E P
Sbjct: 196 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255
Query: 205 DVWTP-----EFIDFVSRCLVKNPEERATASEML 233
+ W + C N R TA +
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-32
Identities = 51/273 (18%), Positives = 85/273 (31%), Gaps = 63/273 (23%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+++ +V+ + + L +V E+C + + + L LKG
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKG 113
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
L + H R +HRD+K N+L+N G
Sbjct: 114 LGFCHSRNVLHRDLKPQ---------------------------------NLLINRNGEL 140
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDCVADMWSLGITALEMAEGKP 179
KLA+FG+A + + + T ++ P+V+ Y DMWS G E+A
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
Query: 180 PY----GDIHPMRAIFMIPTKPPPS-----------------------FREPDVWTPEFI 212
P ++ IF + P
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260
Query: 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTDP 245
D + L NP +R +A E L H + P
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDF-CPP 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 2e-32
Identities = 35/253 (13%), Positives = 73/253 (28%), Gaps = 44/253 (17%)
Query: 7 PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL 66
+ Y + +V++ G S+ D++ L + S +A L ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 67 RRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFG 126
+ ++RDIK N + G + DFG
Sbjct: 120 KSLVYRDIKP----------------DNFLI------------GRPNSKNANMIYVVDFG 151
Query: 127 VAGQLTDTMAK-------RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGKP 179
+ D + K + + GT +M+ D+ +LG + G
Sbjct: 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 211
Query: 180 PYGDIHPMRAIFMI----PTKPPPSFRE-PDVWTPEFIDFVSRCLVKNPEERATAS---E 231
P+ + K RE + EF ++ +
Sbjct: 212 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
Query: 232 MLNHEFIQRHDTD 244
+ + + + T+
Sbjct: 272 LFSKVLERLNTTE 284
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-32
Identities = 53/292 (18%), Positives = 99/292 (33%), Gaps = 84/292 (28%)
Query: 1 MQQCDSPYVVKYYGSYFKN------TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATIL 54
M+ + ++ + D+++VME A + ++ + L + ++ +L
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLL 125
Query: 55 CDTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILL 114
L G+++LH IHRD+K NI++
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPS---------------------------------NIVV 152
Query: 115 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEM 174
++ K+ DFG+A + + T ++ APEVI +GY D+WS+G EM
Sbjct: 153 KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 175 AEGKPPYGDIHP---MRAIFMIPTKPPPSF------------------------------ 201
K + + P P F
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 202 ------REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPSQ 247
+ + D +S+ LV +P +R + + L H +I DP++
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW-YDPAE 322
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 2e-31
Identities = 49/278 (17%), Positives = 91/278 (32%), Gaps = 77/278 (27%)
Query: 1 MQQCDSPYVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTL 58
P ++ +V E+ + +TL++ +I + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEIL 139
Query: 59 KGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG 118
K L+Y H +HRD+K N++++ E
Sbjct: 140 KALDYCHSMGIMHRDVKPH---------------------------------NVMIDHEH 166
Query: 119 -HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYDCVADMWSLGITALEMAE 176
+L D+G+A + + N + + ++ PE++ + YD DMWSLG M
Sbjct: 167 RKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 177 GKPPY-----------------GDIHPMRAIFMIPTKPPPSFRE---------------- 203
K P+ G I + P F +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 204 --PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
+ +PE +DF+ + L + + R TA E + H +
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-29
Identities = 49/275 (17%), Positives = 103/275 (37%), Gaps = 72/275 (26%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLW-----IVMEYCGAGSVSDIMRLRKKTLSEDEIATILC 55
++ V+ + L ++ + +++I++ + L++D + ++
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIY 128
Query: 56 DTLKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L+GL+Y+H IHRD+ K N+ +N
Sbjct: 129 QILRGLKYIHSADIIHRDL---------------------------------KPSNLAVN 155
Query: 116 TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YDCVADMWSLGITALEM 174
+ K+ DFG+A D M + T ++ APE++ Y+ D+WS+G E+
Sbjct: 156 EDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 175 AEGKPPY---GDIHPMRAIFMIPTKPP----------------------PSFREPDVW-- 207
G+ + I ++ I + P P +V+
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 208 -TPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241
P +D + + LV + ++R TA++ L H + ++
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 7e-25
Identities = 48/292 (16%), Positives = 86/292 (29%), Gaps = 86/292 (29%)
Query: 1 MQQCDSPYVVKYYGSYF----KNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCD 56
+ +++K + + +V E G ++ I + + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 57 TLKGLEYLHLRRKI-HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN 115
L GL+Y+H R I H DIK N+L+
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPE---------------------------------NVLME 160
Query: 116 TEGH-AKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITAL 172
L +A G I T + +PEV+ + C AD+WS
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220
Query: 173 EMAEGKPPY---------GDIHPMRAIFMIPTKPPP------------------------ 199
E+ G + D + I + + P
Sbjct: 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
Query: 200 ------------SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQ 239
++ E DF+S L +P +RA A ++NH +++
Sbjct: 281 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 46.7 bits (110), Expect = 4e-07
Identities = 21/176 (11%), Positives = 44/176 (25%), Gaps = 55/176 (31%)
Query: 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKG 60
+Q+ V K Y ++ME A + + + +L L+
Sbjct: 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVR--------VENPDEVLDMILEE 115
Query: 61 LEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHA 120
+ + R +H D+ +L +E
Sbjct: 116 VAKFYHRGIVHGDLSQY----------------------------------NVLVSEEGI 141
Query: 121 KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI---GYDCVADMWSLGITALE 173
+ DF + ++ + + I Y D+ S L+
Sbjct: 142 WIIDFPQSVEVGEEGWREI------LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 251 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.07 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=357.77 Aligned_cols=206 Identities=43% Similarity=0.841 Sum_probs=182.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++..|+|||||+||+|.+++.. ..+++.+++.++.||+.||+|||++||+|||||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiK----- 143 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK----- 143 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCc-----
Confidence 3578999999999999999999999999999999998763 579999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.+++.
T Consensus 144 ----------------------------p~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 195 (293)
T d1yhwa1 144 ----------------------------SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195 (293)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred ----------------------------HHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCc
Confidence 8899999999999999999987655444555667999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+||++|+|++|.+||.+.+.......+.....+....+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 196 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999988776665554444444444556778999999999999999999999999999999985
Q ss_pred c
Q psy3253 241 H 241 (251)
Q Consensus 241 ~ 241 (251)
.
T Consensus 276 ~ 276 (293)
T d1yhwa1 276 A 276 (293)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=358.00 Aligned_cols=207 Identities=43% Similarity=0.873 Sum_probs=183.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+++.+|+|||||++|+|.+++......+++.+++.++.||+.||.|||++||+|||||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiK----- 137 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK----- 137 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecC-----
Confidence 357899999999999999999999999999999999987677889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc-----c
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ-----E 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~ 155 (251)
|+||+++.++.+||+|||+|+.............||+.|+|||++. +
T Consensus 138 ----------------------------p~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 189 (288)
T d2jfla1 138 ----------------------------AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189 (288)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred ----------------------------hhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCC
Confidence 8899999999999999999976554433445567899999999983 4
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
..++.++||||+||++|+|++|.+||.+.+.......+.....+....+..+++++.+||.+||+.||++|||++|+++|
T Consensus 190 ~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 56889999999999999999999999888777766665555555555667889999999999999999999999999999
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
|||+.
T Consensus 270 p~~~~ 274 (288)
T d2jfla1 270 PFVTV 274 (288)
T ss_dssp GGGCC
T ss_pred cccCC
Confidence 99974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=349.96 Aligned_cols=203 Identities=32% Similarity=0.544 Sum_probs=179.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+++..|+|||||++|+|.+++. ....+++..++.++.||+.||+|||++||+|||||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiK----- 133 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIK----- 133 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeec-----
Confidence 357899999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++..... ......||+.|+|||++.+..++.
T Consensus 134 ----------------------------p~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~ 183 (263)
T d2j4za1 134 ----------------------------PENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDE 183 (263)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCT
T ss_pred ----------------------------cccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCc
Confidence 88999999999999999999765433 234457899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
++||||+||++|+|++|+.||.+.+.......+.... ...+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 184 ~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred hhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999998877666655544432 2345678999999999999999999999999999999986
Q ss_pred cc
Q psy3253 241 HD 242 (251)
Q Consensus 241 ~~ 242 (251)
..
T Consensus 261 ~s 262 (263)
T d2j4za1 261 NS 262 (263)
T ss_dssp HC
T ss_pred cC
Confidence 43
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=351.96 Aligned_cols=206 Identities=23% Similarity=0.393 Sum_probs=173.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+++..|+|||||++|+|.+++. ....+++.+++.++.||+.||+|||++||+|||||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiK----- 130 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK----- 130 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC-----
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCccc-----
Confidence 467899999999999999999999999999999999986 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+|+...... .......||+.|+|||++.+.++
T Consensus 131 ----------------------------p~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 131 ----------------------------PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred ----------------------------HHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC
Confidence 889999999999999999998654321 22344578999999999988776
Q ss_pred -CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 -DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 -~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|++||......................+..+++++.+||.+||+.||++|||++|+++|||
T Consensus 183 ~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 5689999999999999999999965543332222222222233334668999999999999999999999999999999
Q ss_pred hhh
Q psy3253 238 IQR 240 (251)
Q Consensus 238 ~~~ 240 (251)
|++
T Consensus 263 f~~ 265 (271)
T d1nvra_ 263 YNK 265 (271)
T ss_dssp TTC
T ss_pred hCc
Confidence 974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=348.24 Aligned_cols=208 Identities=27% Similarity=0.489 Sum_probs=180.0
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.+++.+|+|||||+||+|.+++. ..+.+++..++.++.|++.||+|||++||+|||||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK----- 135 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK----- 135 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCC-----
Confidence 357899999999999999999999999999999999987 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--ccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+|+...... .......||+.|+|||++.+..+
T Consensus 136 ----------------------------p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 187 (288)
T d1uu3a_ 136 ----------------------------PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187 (288)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC
T ss_pred ----------------------------ccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCC
Confidence 889999999999999999998664322 22334568999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHH------H
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASE------M 232 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e------v 232 (251)
+.++||||+||++|+|++|..||.+.+.......+.... ...+..+++++.+||.+||+.||++|||++| +
T Consensus 188 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i 264 (288)
T d1uu3a_ 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264 (288)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHH
T ss_pred CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHH
Confidence 999999999999999999999998877766665554442 2335678999999999999999999999998 5
Q ss_pred hcChhhhhccCCC
Q psy3253 233 LNHEFIQRHDTDP 245 (251)
Q Consensus 233 l~hp~~~~~~~~~ 245 (251)
++||||+..+|+.
T Consensus 265 ~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 265 KAHPFFESVTWEN 277 (288)
T ss_dssp HTSGGGTTCCCTT
T ss_pred HcCCccCCCCHHH
Confidence 8899999998863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=340.32 Aligned_cols=201 Identities=30% Similarity=0.541 Sum_probs=168.9
Q ss_pred CCCCCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR--KIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~--iiH~di 74 (251)
|++++|||||+++++|.+ +..+|+|||||++|+|.+++. +...+++.+++.++.||+.||.|||++| |+||||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDi 140 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 140 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCc
Confidence 578999999999999975 356899999999999999997 4568999999999999999999999998 999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecC-CCCCeEecccccccccCccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
| |+||+++ .++.+||+|||+++..... ......||+.|+|||++
T Consensus 141 K---------------------------------p~NILl~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 141 K---------------------------------CDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMY 185 (270)
T ss_dssp C---------------------------------GGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGG
T ss_pred C---------------------------------hhhceeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHh
Confidence 8 8898886 4789999999999754332 23345789999999998
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-hhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI-FMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+ +++.++||||+||++|+|++|+.||.+....... ..+..... ....+...++++.++|.+||+.||++|||++|+
T Consensus 186 ~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~el 263 (270)
T d1t4ha_ 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263 (270)
T ss_dssp GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-CcccCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 65 6999999999999999999999999765544333 33333322 222345678999999999999999999999999
Q ss_pred hcChhhh
Q psy3253 233 LNHEFIQ 239 (251)
Q Consensus 233 l~hp~~~ 239 (251)
++||||+
T Consensus 264 l~Hp~fk 270 (270)
T d1t4ha_ 264 LNHAFFQ 270 (270)
T ss_dssp HTSGGGC
T ss_pred hCCcccC
Confidence 9999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=349.57 Aligned_cols=206 Identities=29% Similarity=0.511 Sum_probs=183.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|+++..+|+|||||+||+|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlK----- 132 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK----- 132 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC-----
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccC-----
Confidence 457899999999999999999999999999999999987 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.+|.+||+|||+|+.............||+.|+|||++.+.+++.
T Consensus 133 ----------------------------P~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~ 184 (337)
T d1o6la_ 133 ----------------------------LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred ----------------------------HHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCCh
Confidence 9999999999999999999987655444555677999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~h 235 (251)
++|+||+||++|+|++|++||.+.+.......+.... ...+..+++++.+||.+||+.||++|++ ++|+++|
T Consensus 185 ~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 9999999999999999999998887766665554442 2346778999999999999999999994 9999999
Q ss_pred hhhhhccC
Q psy3253 236 EFIQRHDT 243 (251)
Q Consensus 236 p~~~~~~~ 243 (251)
|||++.+|
T Consensus 262 p~f~~i~~ 269 (337)
T d1o6la_ 262 RFFLSINW 269 (337)
T ss_dssp GGGTTCCH
T ss_pred cccccCCH
Confidence 99988765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-51 Score=345.28 Aligned_cols=206 Identities=25% Similarity=0.418 Sum_probs=166.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.+++. ....+++.++..++.||+.||.|||++||+|||||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK----- 134 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK----- 134 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEec-----
Confidence 457899999999999999999999999999999999997 56789999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecC---CCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||++. .++.+||+|||+++..... .......||+.|+|||++.+..
T Consensus 135 ----------------------------p~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~ 185 (307)
T d1a06a_ 135 ----------------------------PENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKP 185 (307)
T ss_dssp ----------------------------GGGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCC
T ss_pred ----------------------------ccceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCC
Confidence 6677763 4678999999999765433 2334457899999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++||||+||++|+|++|.+||.+.........+.... ......+..+|+++.+||.+||+.||++|||++|+++||
T Consensus 186 ~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 9999999999999999999999998877666555444332 222334567899999999999999999999999999999
Q ss_pred hhhhc
Q psy3253 237 FIQRH 241 (251)
Q Consensus 237 ~~~~~ 241 (251)
||+..
T Consensus 266 ~~~~~ 270 (307)
T d1a06a_ 266 WIAGD 270 (307)
T ss_dssp TTTSS
T ss_pred hhCCC
Confidence 99854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=341.72 Aligned_cols=203 Identities=28% Similarity=0.539 Sum_probs=165.4
Q ss_pred CCCCCCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Q psy3253 1 MQQCDSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRL---RKKTLSEDEIATILCDTLKGLEYLHLRR-----KI 70 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~LH~~~-----ii 70 (251)
|++++|||||++++++.+ ...+|+|||||++|+|.+++.. .+..+++..++.++.||+.||+|||++| |+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 678999999999999864 4568999999999999999863 3568999999999999999999999976 99
Q ss_pred ccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccc
Q psy3253 71 HRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 150 (251)
Q Consensus 71 H~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 150 (251)
||||| |+||+++.++.+||+|||+++.............||+.|+||
T Consensus 137 HrDiK---------------------------------p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~AP 183 (269)
T d2java1 137 HRDLK---------------------------------PANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183 (269)
T ss_dssp ---CC---------------------------------GGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCH
T ss_pred eCcCc---------------------------------hhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCH
Confidence 99988 899999999999999999998766544444556789999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
|++.+.+++.++|||||||++|+|++|+.||.+.+.......+....... .+..+++++.+||.+||+.||++|||++
T Consensus 184 E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~li~~~L~~dp~~Rps~~ 261 (269)
T d2java1 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPYRYSDELNEIITRMLNLKDYHRPSVE 261 (269)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--CCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999999999999999999999999998877766655554443322 3567899999999999999999999999
Q ss_pred HHhcChhh
Q psy3253 231 EMLNHEFI 238 (251)
Q Consensus 231 evl~hp~~ 238 (251)
|+++|||+
T Consensus 262 ell~hp~i 269 (269)
T d2java1 262 EILENPLI 269 (269)
T ss_dssp HHHTSTTC
T ss_pred HHHhCCcC
Confidence 99999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=349.54 Aligned_cols=209 Identities=37% Similarity=0.758 Sum_probs=173.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLR-RKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~-~iiH~dik~~Ni 79 (251)
|++++|||||+++++|.++.++|+|||||+||+|.+++. +.+.+++..++.++.|++.||.|||++ ||+|||||
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiK---- 132 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK---- 132 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCS----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccC----
Confidence 568999999999999999999999999999999999997 446799999999999999999999974 99999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+|+..... ......||+.|+|||++.+.+++
T Consensus 133 -----------------------------P~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~ 181 (322)
T d1s9ja_ 133 -----------------------------PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS 181 (322)
T ss_dssp -----------------------------GGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCC
T ss_pred -----------------------------HHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCC
Confidence 88999999999999999999765432 23456799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc------------------------------------------CCCC
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI------------------------------------------PTKP 197 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~------------------------------------------~~~~ 197 (251)
.++||||+||++|+|++|+.||.+.+........ ....
T Consensus 182 ~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T d1s9ja_ 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261 (322)
T ss_dssp TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSC
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC
Confidence 9999999999999999999999654432211100 0000
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCCCC
Q psy3253 198 PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTDPS 246 (251)
Q Consensus 198 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~~~ 246 (251)
++. .....+++++.+||.+||+.||++|||++|+|+||||++.+++..
T Consensus 262 ~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 262 PPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp CCC-CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred Ccc-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccc
Confidence 001 112346889999999999999999999999999999998887653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-51 Score=347.73 Aligned_cols=208 Identities=22% Similarity=0.399 Sum_probs=179.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++..+|+|||||+||+|.+++......+++.+++.++.||+.||+|||++||+|||||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiK----- 154 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK----- 154 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccc-----
Confidence 578999999999999999999999999999999999887556689999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecC--CCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN--TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++ .++.+||+|||+|...... .......+|+.|+|||++.+..+
T Consensus 155 ----------------------------p~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 155 ----------------------------PENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp ----------------------------GGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCB
T ss_pred ----------------------------cccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCC
Confidence 8888876 5678999999999876543 23344568999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|.+||.+.+.......+.... ......+..+++++.+||.+||+.||++|||++|+|+|||
T Consensus 206 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 999999999999999999999998877766655443322 2222345678999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|+...
T Consensus 286 ~~~~~ 290 (352)
T d1koba_ 286 LKGDH 290 (352)
T ss_dssp TSSCC
T ss_pred hCCCc
Confidence 98643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=340.39 Aligned_cols=203 Identities=42% Similarity=0.796 Sum_probs=175.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.++..+|+|||||.+|+|..++. .+..+++.+++.++.||+.||.|||++||+|||||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiK----- 142 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK----- 142 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS-----
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC-----
Confidence 578999999999999999999999999999999876654 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc---CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE---IG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~ 157 (251)
|+||+++.++.+||+|||++...... ....||+.|+|||++.+ ..
T Consensus 143 ----------------------------p~NILl~~~~~~Kl~DFG~a~~~~~~----~~~~GT~~Y~APE~~~~~~~~~ 190 (309)
T d1u5ra_ 143 ----------------------------AGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQ 190 (309)
T ss_dssp ----------------------------GGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHTTTTSCC
T ss_pred ----------------------------cceEEECCCCCEEEeecccccccCCC----CccccCccccCHHHHhccCCCC
Confidence 88999999999999999999765432 34568999999999854 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
++.++||||+||++|+|++|..||.+.........+.....+.. .+..+++++.+||.+||+.||++|||++|+|+|||
T Consensus 191 y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred cCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence 88999999999999999999999987776665554444433232 24568999999999999999999999999999999
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|++..
T Consensus 270 ~~~~~ 274 (309)
T d1u5ra_ 270 VLRER 274 (309)
T ss_dssp HHSCC
T ss_pred hcCCC
Confidence 98643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-50 Score=347.13 Aligned_cols=208 Identities=25% Similarity=0.449 Sum_probs=177.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|+.++|||||+++++|.+++.+|+|||||+||+|.+++. +...+++..++.++.||+.||.|||++|++|||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK----- 134 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK----- 134 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHHCCccceeec-----
Confidence 356799999999999999999999999999999999997 45789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+||+|||+|+..... ......||+.|+|||++.+ ..++
T Consensus 135 ----------------------------P~NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~ 184 (364)
T d1omwa3 135 ----------------------------PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYD 184 (364)
T ss_dssp ----------------------------GGGEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCC
T ss_pred ----------------------------cceeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCC
Confidence 99999999999999999999866543 3344578999999999964 5689
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC-----HHHHhc
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT-----ASEMLN 234 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~evl~ 234 (251)
.++||||+||++|+|++|+.||.+....................+..+++++.+||.+||+.||++||| ++|+++
T Consensus 185 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 999999999999999999999976544332221111122233346678999999999999999999999 799999
Q ss_pred ChhhhhccCC
Q psy3253 235 HEFIQRHDTD 244 (251)
Q Consensus 235 hp~~~~~~~~ 244 (251)
||||+..+|.
T Consensus 265 Hp~f~~i~~~ 274 (364)
T d1omwa3 265 SPFFRSLDWQ 274 (364)
T ss_dssp SGGGTTCCHH
T ss_pred CccccCCCHH
Confidence 9999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=341.42 Aligned_cols=211 Identities=27% Similarity=0.438 Sum_probs=175.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++..+|+|||||+||+|.+++.. .+.+++..++.++.|++.||+|||++||+|||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiK----- 140 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK----- 140 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccc-----
Confidence 3578999999999999999999999999999999999974 4689999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCC----CeEecccccccccCcccccccccccccccccccccccC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 156 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 156 (251)
|+||+++.++ .+|++|||++...... .......+|+.|+|||++.+.
T Consensus 141 ----------------------------p~Nill~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~ 191 (293)
T d1jksa_ 141 ----------------------------PENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYE 191 (293)
T ss_dssp ----------------------------GGGEEESCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTC
T ss_pred ----------------------------cceEEEecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCC
Confidence 7777776555 4999999999766433 233445689999999999998
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++.++||||+||++|+|++|+.||.+.+.......+..... .....+..+|+++.+||.+||+.||++|||++|+++|
T Consensus 192 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999999988776666555444322 1112235689999999999999999999999999999
Q ss_pred hhhhhccCCCC
Q psy3253 236 EFIQRHDTDPS 246 (251)
Q Consensus 236 p~~~~~~~~~~ 246 (251)
|||+..+|...
T Consensus 272 p~~~~~~~~~~ 282 (293)
T d1jksa_ 272 PWIKPKDTQQA 282 (293)
T ss_dssp TTTCC------
T ss_pred cccCCCChhHh
Confidence 99998877653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-51 Score=348.60 Aligned_cols=210 Identities=22% Similarity=0.376 Sum_probs=179.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+++.+|+|||||+||+|.+++....+.+++..++.++.||+.||+|||++|++|||||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiK----- 151 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK----- 151 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeec-----
Confidence 357899999999999999999999999999999999996556789999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecC--CCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN--TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++ .++.+||+|||+++..... .......||+.|+|||++.+.++
T Consensus 152 ----------------------------p~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~ 202 (350)
T d1koaa2 152 ----------------------------PENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 202 (350)
T ss_dssp ----------------------------GGGEEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCB
T ss_pred ----------------------------hhHeeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCC
Confidence 7788774 3578999999999876543 23344678999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|..||.+.+.......+.... .........+++++.+||.+||..||++|||++|+++|||
T Consensus 203 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 999999999999999999999998877666555443322 1122233568999999999999999999999999999999
Q ss_pred hhhccCC
Q psy3253 238 IQRHDTD 244 (251)
Q Consensus 238 ~~~~~~~ 244 (251)
|+...+.
T Consensus 283 ~~~~~~~ 289 (350)
T d1koaa2 283 LTPGNAP 289 (350)
T ss_dssp TSCTTCC
T ss_pred cCCCCCC
Confidence 9987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-50 Score=340.78 Aligned_cols=204 Identities=27% Similarity=0.544 Sum_probs=181.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.++..+|+|||||.||+|..++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiK----- 131 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK----- 131 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC-----
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccC-----
Confidence 457899999999999999999999999999999999887 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++..... .....||+.|+|||++.+.+++.
T Consensus 132 ----------------------------p~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~ 180 (316)
T d1fota_ 132 ----------------------------PENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNK 180 (316)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCT
T ss_pred ----------------------------chheeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCc
Confidence 99999999999999999999775533 23467899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|+.||.+.+.......+.... ...+..+++++.+++.+||..||++|+ |++|+++|
T Consensus 181 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999999999999998877766665554432 233567899999999999999999996 99999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||++.+|+
T Consensus 258 p~f~~i~~~ 266 (316)
T d1fota_ 258 PWFKEVVWE 266 (316)
T ss_dssp GGGSSCCHH
T ss_pred cccccCCHH
Confidence 999988765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=340.37 Aligned_cols=205 Identities=26% Similarity=0.487 Sum_probs=182.5
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
.++|||||++++++.+++.+|+|||||++|+|.++++ ....+++.+++.++.||+.||+|||++|++|||||
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDik------- 130 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK------- 130 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC-------
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc-------
Confidence 5799999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCcch
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDCVA 162 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 162 (251)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.+++.++
T Consensus 131 --------------------------p~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 184 (320)
T d1xjda_ 131 --------------------------LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 184 (320)
T ss_dssp --------------------------GGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred --------------------------ccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchh
Confidence 999999999999999999998765544455556789999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHH-HHhcChhhhhc
Q psy3253 163 DMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATAS-EMLNHEFIQRH 241 (251)
Q Consensus 163 DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~hp~~~~~ 241 (251)
||||+||++|+|++|+.||.+.+.......+....+ ..+..+++++.+||.+||+.||++|||++ |+++||||++.
T Consensus 185 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 185 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred hhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 999999999999999999988777666655544322 33567899999999999999999999995 89999999987
Q ss_pred cCC
Q psy3253 242 DTD 244 (251)
Q Consensus 242 ~~~ 244 (251)
+|+
T Consensus 262 ~~~ 264 (320)
T d1xjda_ 262 NWE 264 (320)
T ss_dssp CHH
T ss_pred CHH
Confidence 654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=339.55 Aligned_cols=204 Identities=30% Similarity=0.499 Sum_probs=181.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.+....++||||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIK----- 168 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK----- 168 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHHcCCCcEeecccccccccccccccccccccchhhhHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCC-----
Confidence 478999999999999999999999999999999999997 44689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCCCc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYDC 160 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 160 (251)
|+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.
T Consensus 169 ----------------------------P~NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~ 217 (350)
T d1rdqe_ 169 ----------------------------PENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp ----------------------------GGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCT
T ss_pred ----------------------------HHHcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCc
Confidence 99999999999999999999876532 33467899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHHHhcC
Q psy3253 161 VADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASEMLNH 235 (251)
Q Consensus 161 ~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~h 235 (251)
++||||+||++|+|++|..||.+.+.......+.... ...+..+++++.++|.+||..||++|+ |++|+++|
T Consensus 218 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred cccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 9999999999999999999998877666655554442 233567899999999999999999994 99999999
Q ss_pred hhhhhccCC
Q psy3253 236 EFIQRHDTD 244 (251)
Q Consensus 236 p~~~~~~~~ 244 (251)
|||+..+|+
T Consensus 295 p~f~~~~~~ 303 (350)
T d1rdqe_ 295 KWFATTDWI 303 (350)
T ss_dssp GGGTTCCHH
T ss_pred ccccCCCHH
Confidence 999988774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.1e-50 Score=330.39 Aligned_cols=205 Identities=35% Similarity=0.511 Sum_probs=175.8
Q ss_pred CCCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++ ||||++++++|.+++++|+|||||++|+|.++++ .++.+++.+++.++.||+.||+|||++||+|||||
T Consensus 64 ~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlk----- 137 (277)
T d1phka_ 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLK----- 137 (277)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccc-----
Confidence 3454 9999999999999999999999999999999997 45689999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-----
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE----- 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----- 155 (251)
|+||+++.++.+||+|||+++...... ......||+.|+|||.+.+
T Consensus 138 ----------------------------p~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~ 188 (277)
T d1phka_ 138 ----------------------------PENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDN 188 (277)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTT
T ss_pred ----------------------------cceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhcccccc
Confidence 899999999999999999998765432 3344568999999999853
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCC-CCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHh
Q psy3253 156 -IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKP-PPSFREPDVWTPEFIDFVSRCLVKNPEERATASEML 233 (251)
Q Consensus 156 -~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 233 (251)
..++.++||||+||++|+|++|+.||.+.+.......+.... .........+|+++.+|+.+||+.||++|||++|++
T Consensus 189 ~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 189 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp SCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 346889999999999999999999998887666554443332 222223457899999999999999999999999999
Q ss_pred cChhhhhc
Q psy3253 234 NHEFIQRH 241 (251)
Q Consensus 234 ~hp~~~~~ 241 (251)
+||||+++
T Consensus 269 ~h~~~~~~ 276 (277)
T d1phka_ 269 AHPFFQQY 276 (277)
T ss_dssp TSGGGCTT
T ss_pred cCHHHHHh
Confidence 99999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=331.54 Aligned_cols=210 Identities=24% Similarity=0.382 Sum_probs=172.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++++.|+||||+.++++..+. ..+..+++..++.++.||+.||+|||++|++|||||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiK----- 127 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK----- 127 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCC-----
Confidence 35689999999999999999999999999887665554 356789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+||+|||+++.............+|+.|+|||++.. ..++
T Consensus 128 ----------------------------p~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 179 (299)
T d1ua2a_ 128 ----------------------------PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179 (299)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCC
T ss_pred ----------------------------cceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCC
Confidence 88999999999999999999876655444455678999999999865 4579
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCC-------------CCCC---------CCCCCCHHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPP-------------PSFR---------EPDVWTPEFIDF 214 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------------~~~~---------~~~~~~~~~~~l 214 (251)
.++||||+||++|+|++|.+||.+.+.......+.. ... .... .....++++.+|
T Consensus 180 ~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 259 (299)
T d1ua2a_ 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259 (299)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHH
T ss_pred hhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHH
Confidence 999999999999999999999977655443322110 000 0000 013467899999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
|.+||+.||++|||++|+|+||||++...+
T Consensus 260 l~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 260 IQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp HHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred HHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 999999999999999999999999976543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=335.02 Aligned_cols=207 Identities=26% Similarity=0.339 Sum_probs=176.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++..+|+|||||+||+|.+++...+..+++.+++.++.||+.||+|||++||+|||||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlK----- 129 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR----- 129 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC-----
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccccc-----
Confidence 357899999999999999999999999999999999997555689999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCC--CCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++. ...++|+|||++...... .......+++.|+|||.+.+..+
T Consensus 130 ----------------------------p~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 130 ----------------------------PENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp ----------------------------GGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEE
T ss_pred ----------------------------ccceeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCC
Confidence 77887764 347999999999765433 23344568899999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCC-CCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPP-PSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++||||+||++|+|++|..||.+.+.......+..... .....+..+++++.+||.+||+.||++|||++|+++|||
T Consensus 181 ~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 9999999999999999999999988777666555443321 111123468999999999999999999999999999999
Q ss_pred hhhc
Q psy3253 238 IQRH 241 (251)
Q Consensus 238 ~~~~ 241 (251)
|++.
T Consensus 261 ~~~~ 264 (321)
T d1tkia_ 261 LKQK 264 (321)
T ss_dssp HHSC
T ss_pred hccC
Confidence 9753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=331.01 Aligned_cols=207 Identities=29% Similarity=0.424 Sum_probs=167.0
Q ss_pred CCCCccceeeeeEee----CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 4 CDSPYVVKYYGSYFK----NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 4 l~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
.+|||||+++++|.+ +..+|+|||||+||+|.+++..++ ..+++.+++.++.||+.||+|||++||+|||||
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiK--- 138 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK--- 138 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS---
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccc---
Confidence 589999999999975 467999999999999999997443 479999999999999999999999999999999
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCC---CCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT---EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++. .+.+||+|||+++..... .......||+.|+|||++.+
T Consensus 139 ------------------------------p~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 139 ------------------------------PENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp ------------------------------GGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCG
T ss_pred ------------------------------ccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcC
Confidence 77887764 457999999999766543 23345678999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC---CCCCCCC--CCCCCCHHHHHHHHHhhhcCcCccCCHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT---KPPPSFR--EPDVWTPEFIDFVSRCLVKNPEERATAS 230 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ 230 (251)
..++.++||||+||++|+|++|.+||.+.+.......+.. .....++ .+..+++++.+||.+||+.||++|||++
T Consensus 188 ~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 267 (335)
T d2ozaa1 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267 (335)
T ss_dssp GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 9999999999999999999999999965544332222111 1111111 1235789999999999999999999999
Q ss_pred HHhcChhhhhccCC
Q psy3253 231 EMLNHEFIQRHDTD 244 (251)
Q Consensus 231 evl~hp~~~~~~~~ 244 (251)
|+++||||++....
T Consensus 268 eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 268 EFMNHPWIMQSTKV 281 (335)
T ss_dssp HHHHSHHHHTTTSS
T ss_pred HHHcCHHhhCCCCC
Confidence 99999999865443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=326.02 Aligned_cols=211 Identities=26% Similarity=0.446 Sum_probs=178.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+ +..|+|||||++|+|.+++...+..+++..++.++.||+.||.|||++|++|||||
T Consensus 63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK----- 136 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA----- 136 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc-----
Confidence 357899999999999965 46899999999999999987566789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..
T Consensus 137 ----------------------------p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (285)
T d1u59a_ 137 ----------------------------ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188 (285)
T ss_dssp ----------------------------GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred ----------------------------hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC
Confidence 8899999999999999999986643221 223345788999999999889
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH---h
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM---L 233 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev---l 233 (251)
++.++|||||||++|+|+| |..||.+.........+..+..+ ..+..+++++.+||.+||+.||++|||++++ |
T Consensus 189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999998 99999887766666555554333 3467789999999999999999999999988 7
Q ss_pred cChhhhhccCCCCC
Q psy3253 234 NHEFIQRHDTDPSQ 247 (251)
Q Consensus 234 ~hp~~~~~~~~~~~ 247 (251)
+|+|+.-.....++
T Consensus 267 ~~~~~~~~~~~~~~ 280 (285)
T d1u59a_ 267 RACYYSLASKVEGH 280 (285)
T ss_dssp HHHHHHHHTTCSSC
T ss_pred HHHHHHhhhccchh
Confidence 78888755544443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=323.82 Aligned_cols=203 Identities=25% Similarity=0.440 Sum_probs=171.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+ +..++|||||++|+|.++++ ....+++..++.++.||+.||.|||++||+|||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlK----- 134 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA----- 134 (277)
T ss_dssp HHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS-----
T ss_pred HHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCc-----
Confidence 457899999999999965 45799999999999999997 56789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 135 ----------------------------p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 186 (277)
T d1xbba_ 135 ----------------------------ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186 (277)
T ss_dssp ----------------------------GGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred ----------------------------chhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC
Confidence 8899999999999999999976543221 123345788999999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH---h
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM---L 233 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev---l 233 (251)
++.++|||||||++|+|++ |++||.+.+.......+..+..+ ..+..+|+++.+||.+||+.||++|||++|+ |
T Consensus 187 ~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 9999999999999999998 89999887776666555544333 3467789999999999999999999999998 5
Q ss_pred cChhhhh
Q psy3253 234 NHEFIQR 240 (251)
Q Consensus 234 ~hp~~~~ 240 (251)
+|+|++-
T Consensus 265 ~~~~~~~ 271 (277)
T d1xbba_ 265 RNYYYDV 271 (277)
T ss_dssp HHHHHHH
T ss_pred hCHHhhc
Confidence 6777653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-48 Score=325.69 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=165.4
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+++.+++|||||++|+|.+++....+.+++.+++.++.||+.||.|||++|++|||||
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlK----- 155 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA----- 155 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccc-----
Confidence 578999999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc-----cccccccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK-----RNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++++||+|||+++........ .....+|+.|+|||.+.+
T Consensus 156 ----------------------------p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 156 ----------------------------ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp ----------------------------GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS
T ss_pred ----------------------------cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc
Confidence 99999999999999999999765432211 122346889999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++|||||||++|+|+| |.+||.+.........+..... ...+..+++++.+|+.+||+.||++|||++|+++
T Consensus 208 ~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999998 8999988877666655544432 2346678999999999999999999999999987
Q ss_pred C
Q psy3253 235 H 235 (251)
Q Consensus 235 h 235 (251)
+
T Consensus 286 ~ 286 (299)
T d1jpaa_ 286 T 286 (299)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=322.64 Aligned_cols=210 Identities=27% Similarity=0.436 Sum_probs=171.3
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-RLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~-~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||+++++|.++.++|+||||+.+ ++.+++ ......+++..++.++.||+.||+|||++||+|||||
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiK---- 129 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK---- 129 (298)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC----
T ss_pred HHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccC----
Confidence 5789999999999999999999999999976 444444 4445679999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-C
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-Y 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~ 158 (251)
|+||+++.++.+||+|||.++.............||+.|+|||.+.... +
T Consensus 130 -----------------------------peNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~ 180 (298)
T d1gz8a_ 130 -----------------------------PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180 (298)
T ss_dssp -----------------------------GGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSC
T ss_pred -----------------------------chheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCC
Confidence 8899999999999999999987665545555567899999999987655 5
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-----------------CCCCCC---C------CCCCCCHHHH
Q psy3253 159 DCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-----------------KPPPSF---R------EPDVWTPEFI 212 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~---~------~~~~~~~~~~ 212 (251)
+.++|+||+||++|+|++|+.||.+.+.......+.. ...... . ....+++++.
T Consensus 181 ~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 260 (298)
T d1gz8a_ 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 260 (298)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred CccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHH
Confidence 7899999999999999999999976654333222100 000000 0 0135678999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
+|+.+||+.||++|||++|+++||||++...+
T Consensus 261 dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 261 SLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 99999999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=322.03 Aligned_cols=208 Identities=27% Similarity=0.425 Sum_probs=171.1
Q ss_pred CCCCCccceeeeeEee-----CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy3253 3 QCDSPYVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAG 77 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~ 77 (251)
.++||||++++++|.. ....+++|||++++++..........+++..++.++.|++.||+|||++||+|||||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK-- 143 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK-- 143 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC--
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC--
Confidence 3589999999999863 346899999998877766655556789999999999999999999999999999988
Q ss_pred CCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC
Q psy3253 78 SGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 78 Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++..... .......||+.|+|||++.+.+
T Consensus 144 -------------------------------p~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~ 191 (305)
T d1blxa_ 144 -------------------------------PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS 191 (305)
T ss_dssp -------------------------------GGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCC
T ss_pred -------------------------------ccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCC
Confidence 88999999999999999998765433 3345567899999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC------------------------CCCCCCCCCCCCCCHHHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP------------------------TKPPPSFREPDVWTPEFID 213 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~ 213 (251)
++.++||||+||++|+|++|++||.+.+.......+. ....+.......+++.+.+
T Consensus 192 y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 271 (305)
T d1blxa_ 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271 (305)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHH
Confidence 9999999999999999999999997765443322210 0000111123557899999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
||.+||++||++|||++|+|+||||++.++.
T Consensus 272 li~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 272 LLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 9999999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=328.36 Aligned_cols=199 Identities=24% Similarity=0.432 Sum_probs=168.4
Q ss_pred CC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC----------------------CCCCHHHHHHHHHHHHH
Q psy3253 3 QC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK----------------------KTLSEDEIATILCDTLK 59 (251)
Q Consensus 3 ~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~----------------------~~l~~~~~~~~~~~i~~ 59 (251)
++ +|||||++++++.+.+.+|+|||||++|+|.++++.+. ..+++..++.++.||+.
T Consensus 96 ~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred HhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 45 89999999999999999999999999999999997443 24889999999999999
Q ss_pred HHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--c
Q psy3253 60 GLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--K 137 (251)
Q Consensus 60 ~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 137 (251)
||+|||++||+||||| |+||+++.++.+||+|||+|+....... .
T Consensus 176 gl~yLH~~~IiHRDlK---------------------------------p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 222 (325)
T d1rjba_ 176 GMEFLEFKSCVHRDLA---------------------------------ARNVLVTHGKVVKICDFGLARDIMSDSNYVV 222 (325)
T ss_dssp HHHHHHHTTEEETTCS---------------------------------GGGEEEETTTEEEECCCGGGSCGGGCTTSEE
T ss_pred HHHHHHhCCeeeccCc---------------------------------hhccccccCCeEEEeeccccccccCCCceee
Confidence 9999999999999988 8899999999999999999976543322 2
Q ss_pred ccccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHH
Q psy3253 138 RNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVS 216 (251)
Q Consensus 138 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 216 (251)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+.... .....+..+++++.+||.
T Consensus 223 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~-~~~~~p~~~~~~l~~li~ 301 (325)
T d1rjba_ 223 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYIIMQ 301 (325)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CCCCCCCcCCHHHHHHHH
Confidence 234567999999999999999999999999999999997 899998766554443332221 233446778999999999
Q ss_pred HhhhcCcCccCCHHHHhcC
Q psy3253 217 RCLVKNPEERATASEMLNH 235 (251)
Q Consensus 217 ~~l~~~p~~Rps~~evl~h 235 (251)
+||+.||++|||++||++|
T Consensus 302 ~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 302 SCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=319.61 Aligned_cols=201 Identities=25% Similarity=0.463 Sum_probs=163.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++. .+.+++|||||++|+|.+++...+..+++..++.++.||+.||+|||++||+|||||
T Consensus 58 l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlK----- 131 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK----- 131 (276)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccC-----
Confidence 46899999999999875 456899999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccccccccccccc---
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQE--- 155 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--- 155 (251)
|+||+++.++.+||+|||+|+...... .......||+.|+|||++.+
T Consensus 132 ----------------------------p~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 183 (276)
T d1uwha_ 132 ----------------------------SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183 (276)
T ss_dssp ----------------------------GGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred ----------------------------HHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence 899999999999999999997654321 12334568999999999964
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc-CCC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI-PTK--PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+++.++|||||||++|+|+||+.||.+.+........ ... .+.....+..+++++.+||.+||+.||++|||++|+
T Consensus 184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 263 (276)
T d1uwha_ 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 35789999999999999999999999876554433222 111 111122356789999999999999999999999999
Q ss_pred hcC
Q psy3253 233 LNH 235 (251)
Q Consensus 233 l~h 235 (251)
+++
T Consensus 264 l~~ 266 (276)
T d1uwha_ 264 LAS 266 (276)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=317.81 Aligned_cols=200 Identities=25% Similarity=0.454 Sum_probs=162.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++..++..++|||||++|+|.+++......+++..++.++.||+.||+|||+++|+|||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlK----- 128 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA----- 128 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCS-----
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccc-----
Confidence 357899999999999999999999999999999999998666789999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++
T Consensus 129 ----------------------------p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 129 ----------------------------ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp ----------------------------GGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCC
T ss_pred ----------------------------hhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCC
Confidence 8899999999999999999976543322 22334678999999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|||||||++|+|+| |.+||...........+..... ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 181 ~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC--CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999 5677766655555544444322 23466789999999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=311.20 Aligned_cols=200 Identities=23% Similarity=0.421 Sum_probs=175.8
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||+++++++.++..+++||||+++|+|.+++......+++..+..++.|++.||+|||+.||+|||||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk----- 127 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA----- 127 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCS-----
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccccccc-----
Confidence 357899999999999999999999999999999999988677889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++....... ......+|+.|+|||.+.+..++
T Consensus 128 ----------------------------~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 128 ----------------------------ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC
T ss_pred ----------------------------ceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCC
Confidence 8899999999999999999975543322 22335678899999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|||||||++|+|+| |+.||.+.+.......+..... ...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 180 ~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC--CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999998 8999988877776665655433 33467889999999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=315.36 Aligned_cols=193 Identities=26% Similarity=0.380 Sum_probs=163.1
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCccc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGA-GSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLVY 83 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~-gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~~ 83 (251)
.|||||+++++|.+++..|+||||+.+ +++.+++. .+..+++.+++.++.||+.||.|||++||+|||||
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiK-------- 137 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK-------- 137 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS--------
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCc--------
Confidence 499999999999999999999999975 58888886 45789999999999999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhcccCceecCCC-CCeEecccccccccCcccccccccccccccccccccccCCC-Ccc
Q psy3253 84 DRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-DCV 161 (251)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~ 161 (251)
|+||+++.+ +.+||+|||+++..... ......||+.|+|||++.+..+ +.+
T Consensus 138 -------------------------p~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~ 190 (273)
T d1xwsa_ 138 -------------------------DENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRS 190 (273)
T ss_dssp -------------------------GGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHH
T ss_pred -------------------------ccceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcc
Confidence 888888754 68999999999765432 2344578999999999987665 567
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 162 ADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 162 ~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||||+||++|+|++|+.||.+.+. ... . ....+..+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus 191 ~DiwSlGvilyell~g~~Pf~~~~~--i~~----~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 191 AAVWSLGILLYDMVCGDIPFEHDEE--IIR----G---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCSHHH--HHH----C---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cccccceeeehhHhhCCCCCCCchH--Hhh----c---ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999975432 111 1 122345689999999999999999999999999999999875
Q ss_pred c
Q psy3253 242 D 242 (251)
Q Consensus 242 ~ 242 (251)
.
T Consensus 262 ~ 262 (273)
T d1xwsa_ 262 L 262 (273)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=313.17 Aligned_cols=205 Identities=20% Similarity=0.344 Sum_probs=170.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||+++++|.+++..++|||||++|+|.+++... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlK---- 142 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA---- 142 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccc----
Confidence 45789999999999999999999999999999999999743 4678999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++....... ......+++.|+|||++.+..+
T Consensus 143 -----------------------------p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 143 -----------------------------ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp -----------------------------GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred -----------------------------cCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCC
Confidence 8899999999999999999986644322 2233457889999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCC-CCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChh
Q psy3253 159 DCVADMWSLGITALEMAEGKPPY-GDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEF 237 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~ 237 (251)
+.++|||||||++|+|++|..|| .+.+.......+.... ....+..+++++.+||.+||+.||++|||++|+++ +
T Consensus 194 ~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~ 269 (287)
T d1opja_ 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--A 269 (287)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--H
T ss_pred CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--H
Confidence 99999999999999999966554 5544444443333332 23346778999999999999999999999999974 5
Q ss_pred hhhcc
Q psy3253 238 IQRHD 242 (251)
Q Consensus 238 ~~~~~ 242 (251)
|+...
T Consensus 270 L~~~~ 274 (287)
T d1opja_ 270 FETMF 274 (287)
T ss_dssp HHHTT
T ss_pred HHHHH
Confidence 65543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=313.75 Aligned_cols=204 Identities=25% Similarity=0.448 Sum_probs=170.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR-KKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||++++++.+ +..++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK---- 136 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR---- 136 (272)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS----
T ss_pred HHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc----
Confidence 357899999999998854 5679999999999999987522 3469999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+|+....... ......+|+.|+|||++.+..+
T Consensus 137 -----------------------------p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 137 -----------------------------AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp -----------------------------GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred -----------------------------hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCC
Confidence 9999999999999999999987653322 2334567889999999998899
Q ss_pred CcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc--C
Q psy3253 159 DCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN--H 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~--h 235 (251)
+.++|||||||++|+|+|| .+|+...........+..... ...+..+++++.+|+.+||+.||++|||++|+++ |
T Consensus 188 ~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 9999999999999999995 556666555555544444332 2346778999999999999999999999999998 7
Q ss_pred hhhhh
Q psy3253 236 EFIQR 240 (251)
Q Consensus 236 p~~~~ 240 (251)
+||..
T Consensus 266 ~~fts 270 (272)
T d1qpca_ 266 DFFTA 270 (272)
T ss_dssp HHHHH
T ss_pred hhhhc
Confidence 88864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-46 Score=312.41 Aligned_cols=206 Identities=28% Similarity=0.428 Sum_probs=165.2
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||+++++|.++...+++|||+.++++..+. .....+++..++.++.||+.||+|||++||+|||||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiK----- 127 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK----- 127 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCC-----
Confidence 56899999999999999999999999999776555554 467889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc-CCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~ 159 (251)
|+||+++.++.+|++|||.+..............+++.|+|||.+.+ ..++
T Consensus 128 ----------------------------p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (286)
T d1ob3a_ 128 ----------------------------PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179 (286)
T ss_dssp ----------------------------GGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred ----------------------------CceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCC
Confidence 88999999999999999999876554444455568899999999965 4568
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---C-----------------------CCCCCCCCCCCCCHHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---T-----------------------KPPPSFREPDVWTPEFID 213 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~-----------------------~~~~~~~~~~~~~~~~~~ 213 (251)
.++|+||+||++|+|++|++||.+.+.......+. . ...+.......+++++.+
T Consensus 180 ~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 259 (286)
T d1ob3a_ 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (286)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred cceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence 99999999999999999999997654433222110 0 000001123557899999
Q ss_pred HHHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 214 FVSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 214 li~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
||.+||+.||++|||++|+++||||++
T Consensus 260 li~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 260 LLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=311.28 Aligned_cols=199 Identities=27% Similarity=0.494 Sum_probs=162.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++. .+.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||++|++|||||
T Consensus 62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK----- 135 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA----- 135 (273)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS-----
T ss_pred HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccc-----
Confidence 45789999999999995 567899999999999999988777889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 159 (251)
|+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++
T Consensus 136 ----------------------------p~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 136 ----------------------------ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp ----------------------------GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred ----------------------------hhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCC
Confidence 8899999999999999999976543222 23344578899999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 160 CVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
.++|||||||++|+|++ |.+||.+.........+...... +.+..+|+++.+||.+||+.||++|||++|+++|
T Consensus 188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999987 89999887777666555544332 3467889999999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=307.16 Aligned_cols=199 Identities=23% Similarity=0.380 Sum_probs=163.5
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+....++|||||.+|+|.+++......+++.++..++.||+.||.|||++||+|||||
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK----- 137 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA----- 137 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccc-----
Confidence 457899999999999999999999999999999999988777889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..
T Consensus 138 ----------------------------p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 138 ----------------------------ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred ----------------------------cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence 9999999999999999999976543221 122345788999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 158 YDCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
++.++|||||||++|+|++| .+|+...........+..+.. ...+..+++++.+||.+||+.||++|||++|+++
T Consensus 190 ~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999995 455555555555444444432 2346678999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=306.03 Aligned_cols=206 Identities=24% Similarity=0.398 Sum_probs=165.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRL-RKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||++++++.+ +..++|||||.+|+|.+++.. ....+++.+++.++.||+.||+|||++|++|||||
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK---- 140 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR---- 140 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheeccccc----
Confidence 357899999999999854 568999999999999988853 34679999999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-cccccccccccccccccccCCC
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++++||+|||+++....... ......+|+.|+|||.+....+
T Consensus 141 -----------------------------p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 191 (285)
T d1fmka3 141 -----------------------------AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191 (285)
T ss_dssp -----------------------------GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCC
T ss_pred -----------------------------ceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCC
Confidence 9999999999999999999976543322 2233567899999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCC-CCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc--C
Q psy3253 159 DCVADMWSLGITALEMAEGK-PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN--H 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~--h 235 (251)
+.++|||||||++|+|++|. +|+.+.........+..... ...+..+++++.++|.+||+.||++|||+++|++ +
T Consensus 192 ~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 99999999999999999955 55555555545544444332 2346778999999999999999999999999987 7
Q ss_pred hhhhhcc
Q psy3253 236 EFIQRHD 242 (251)
Q Consensus 236 p~~~~~~ 242 (251)
+||+...
T Consensus 270 ~~~~~~~ 276 (285)
T d1fmka3 270 DYFTSTE 276 (285)
T ss_dssp TTTSCSC
T ss_pred hhhcCCC
Confidence 8886543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=309.69 Aligned_cols=210 Identities=26% Similarity=0.341 Sum_probs=164.1
Q ss_pred CCCCCCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMR--LRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||++++++|.. ..++|+|||||+++.+..+.. .....+++.+++.++.||+.||+|||++||+||
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr 146 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 357899999999999853 345899999997654433332 245679999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCccccccccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 151 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 151 (251)
||| |+||+++.++ .+||+|||++...... .......|++.|+|||
T Consensus 147 DiK---------------------------------p~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 147 DIK---------------------------------PQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPE 192 (350)
T ss_dssp CCC---------------------------------GGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHH
T ss_pred CCC---------------------------------cceEEEecCCCceeEecccchhhccCC-cccccccccccccChH
Confidence 998 8888988765 7999999999765443 2334456899999999
Q ss_pred cccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCC-------------------CCCCC-------CCCC
Q psy3253 152 VIQE-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPT-------------------KPPPS-------FREP 204 (251)
Q Consensus 152 ~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~~~~-------~~~~ 204 (251)
.+.+ ..++.++||||+||++|+|++|.+||...+.......+.. ...+. ....
T Consensus 193 ~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (350)
T d1q5ka_ 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272 (350)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSC
T ss_pred HhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcc
Confidence 8764 5789999999999999999999999976654333222100 00000 0112
Q ss_pred CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 205 DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 205 ~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
...++++.+||.+||++||++|||++|+|+||||++....
T Consensus 273 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 4468999999999999999999999999999999976543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=308.62 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=169.1
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.++ ..++++||+.+|+|.+++......+++..++.++.||+.||.|||++||+|||||
T Consensus 65 l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlK----- 138 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA----- 138 (317)
T ss_dssp HHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC-----
T ss_pred HHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcch-----
Confidence 3578999999999999765 5788899999999999998778899999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccc--ccccccccccccccccccCCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.+||+|||+++........ .....||+.|+|||++.+..+
T Consensus 139 ----------------------------p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 190 (317)
T d1xkka_ 139 ----------------------------ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190 (317)
T ss_dssp ----------------------------GGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC
T ss_pred ----------------------------hhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC
Confidence 88999999999999999999865433222 223457899999999999999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
+.++|||||||++|+|+| |.+||.+.+.......+..+.. ...+..+++++.+|+.+||+.||++|||++|+++|.
T Consensus 191 ~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999998 8999987766655544444332 234677899999999999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=299.81 Aligned_cols=197 Identities=27% Similarity=0.451 Sum_probs=163.5
Q ss_pred CCCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRK-KTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
|++++||||+++++++.+ .+.+|+||||+++|+|.+++..+. ..+++..++.++.||+.||.|||+.+++|||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlk--- 130 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA--- 130 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS---
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccc---
Confidence 468999999999999854 466899999999999999996443 468999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCCC
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 158 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 158 (251)
|+||+++.++.++++|||+++..... .....++..|+|||.+.+..+
T Consensus 131 ------------------------------p~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 131 ------------------------------ARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp ------------------------------GGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCC
T ss_pred ------------------------------hHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCC
Confidence 89999999999999999999765432 233456889999999998999
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcC
Q psy3253 159 DCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNH 235 (251)
Q Consensus 159 ~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~h 235 (251)
+.++|||||||++|+|+| |.+||...+.......+.....+ +.+..+++++.+||.+||+.||++|||++|++++
T Consensus 178 t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999998 78999887777777666554433 3467789999999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=309.16 Aligned_cols=209 Identities=27% Similarity=0.457 Sum_probs=171.8
Q ss_pred CCCCC-CccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDS-PYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++| |||+++++++.+....+++|||+.+|+|.+++. ....+.+..++.++.||+.||+|||++|++|||||
T Consensus 83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiK----- 156 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK----- 156 (322)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC-----
T ss_pred HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCC-----
Confidence 45655 899999999999999999999999999999997 45678899999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcc-cccccccccccccccccccccC--C
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIQEI--G 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~ 157 (251)
|+||+++.++.++|+|||+++..... ........+++.|+|||.+.+. .
T Consensus 157 ----------------------------p~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~ 208 (322)
T d1vzoa_ 157 ----------------------------LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208 (322)
T ss_dssp ----------------------------GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--
T ss_pred ----------------------------ccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcC
Confidence 88999999999999999999765432 2234456789999999999653 4
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccC-----CHHH
Q psy3253 158 YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERA-----TASE 231 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e 231 (251)
++.++||||+||++|+|++|+.||.+.........+... .......+..+++++.+||.+||++||++|| |++|
T Consensus 209 ~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~e 288 (322)
T d1vzoa_ 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288 (322)
T ss_dssp -CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHH
Confidence 678999999999999999999999765444332222111 1112233567899999999999999999999 5899
Q ss_pred HhcChhhhhccCC
Q psy3253 232 MLNHEFIQRHDTD 244 (251)
Q Consensus 232 vl~hp~~~~~~~~ 244 (251)
+++||||++.+|+
T Consensus 289 il~Hpff~~i~~~ 301 (322)
T d1vzoa_ 289 IKEHLFFQKINWD 301 (322)
T ss_dssp HHTSGGGTTCCHH
T ss_pred HHcCHhhcCCCHH
Confidence 9999999987754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=298.29 Aligned_cols=207 Identities=24% Similarity=0.350 Sum_probs=169.9
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++||||++++++|.+....+++++++.+++|..++. ..+.+++..++.++.|++.||+|||++||+|||||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiK----- 128 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK----- 128 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-----
T ss_pred HHhcCcCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeeccc-----
Confidence 468999999999999999999999999999988887775 67889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccccCC-CC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YD 159 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~ 159 (251)
|+||+++.++.+||+|||.++.............+++.|.|||.+.... ++
T Consensus 129 ----------------------------P~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 180 (292)
T d1unla_ 129 ----------------------------PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_dssp ----------------------------GGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred ----------------------------CcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCC
Confidence 8899999999999999999987765544445556778899999987655 68
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCC-Ccchhhhhc---C-----------------------CCCCCCCCCCCCCCHHHH
Q psy3253 160 CVADMWSLGITALEMAEGKPPYGDI-HPMRAIFMI---P-----------------------TKPPPSFREPDVWTPEFI 212 (251)
Q Consensus 160 ~~~DvwslG~~l~~l~~g~~p~~~~-~~~~~~~~~---~-----------------------~~~~~~~~~~~~~~~~~~ 212 (251)
.++||||+||++|+|++|..||... +.......+ . ............+++++.
T Consensus 181 ~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 260 (292)
T d1unla_ 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260 (292)
T ss_dssp THHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHH
T ss_pred chhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHH
Confidence 8999999999999999999886432 222111110 0 000111122455689999
Q ss_pred HHHHHhhhcCcCccCCHHHHhcChhhhhc
Q psy3253 213 DFVSRCLVKNPEERATASEMLNHEFIQRH 241 (251)
Q Consensus 213 ~li~~~l~~~p~~Rps~~evl~hp~~~~~ 241 (251)
+||.+||+.||++|||++|+|+||||++.
T Consensus 261 dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 261 DLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=301.50 Aligned_cols=203 Identities=24% Similarity=0.445 Sum_probs=170.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
|++++|||||++++++.+ ...++|||||++|+|.+++..+...+++..++.++.||+.||.|||++||+|||||
T Consensus 65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDik----- 138 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA----- 138 (273)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC-----
T ss_pred HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeec-----
Confidence 357899999999999965 46799999999999999988777889999999999999999999999999999988
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccccccCC
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG 157 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 157 (251)
|+||+++.++.+||+|||+++....... ......++..|+|||.+.+..
T Consensus 139 ----------------------------p~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (273)
T d1u46a_ 139 ----------------------------ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190 (273)
T ss_dssp ----------------------------GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred ----------------------------HHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence 8899999999999999999987643322 122334677899999999999
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcCh
Q psy3253 158 YDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHE 236 (251)
Q Consensus 158 ~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp 236 (251)
++.++|||||||++|+|+| |..||.+.+.......+.... ...+.+..+|+++.+||.+||+.||++|||++|++ +
T Consensus 191 ~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~--~ 267 (273)
T d1u46a_ 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR--D 267 (273)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--H
T ss_pred CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC-CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH--H
Confidence 9999999999999999998 899998877776665554332 23345677899999999999999999999999997 5
Q ss_pred hhhh
Q psy3253 237 FIQR 240 (251)
Q Consensus 237 ~~~~ 240 (251)
++++
T Consensus 268 ~L~~ 271 (273)
T d1u46a_ 268 FLLE 271 (273)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 6654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=304.63 Aligned_cols=204 Identities=25% Similarity=0.426 Sum_probs=172.5
Q ss_pred CCCC-CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHH
Q psy3253 1 MQQC-DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLR---------------KKTLSEDEIATILCDTLKGLEYL 64 (251)
Q Consensus 1 l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~L 64 (251)
|+++ +|||||++++++.+++.+++||||+++|+|.++++.. ...+++..+..++.||+.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 4566 7999999999999999999999999999999999632 25799999999999999999999
Q ss_pred HhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccc
Q psy3253 65 HLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 144 (251)
Q Consensus 65 H~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 144 (251)
|++|++||||| |+||+++.++.+||+|||+++..... .......+|
T Consensus 144 H~~~iiHrDlk---------------------------------p~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt 189 (309)
T d1fvra_ 144 SQKQFIHRDLA---------------------------------ARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLP 189 (309)
T ss_dssp HHTTEECSCCS---------------------------------GGGEEECGGGCEEECCTTCEESSCEE-CCC----CC
T ss_pred hcCCccccccc---------------------------------cceEEEcCCCceEEcccccccccccc-ccccceecC
Confidence 99999999988 88999999999999999999765433 222344678
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 145 PFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK-PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 145 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
..|+|||.+.+..++.++|||||||++|+|++|. +||.+.+.......+..+.. ...+..+++++.+||.+||+.||
T Consensus 190 ~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP 267 (309)
T d1fvra_ 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKP 267 (309)
T ss_dssp TTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred CcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCCh
Confidence 8999999999999999999999999999999964 67877777776666655433 33467789999999999999999
Q ss_pred CccCCHHHHhcC--hhhhh
Q psy3253 224 EERATASEMLNH--EFIQR 240 (251)
Q Consensus 224 ~~Rps~~evl~h--p~~~~ 240 (251)
++|||++||+++ .+++.
T Consensus 268 ~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 268 YERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGSCCHHHHHHHHHHHHHS
T ss_pred hHCcCHHHHHHHHHHHHhc
Confidence 999999999987 44443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-45 Score=302.45 Aligned_cols=206 Identities=25% Similarity=0.464 Sum_probs=163.8
Q ss_pred CCCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKA 76 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~ 76 (251)
|++++|||||++++++.... ..|+|||||+|++|.+++. ..+.+++.+++.++.||+.||.|||++|++|||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK- 138 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK- 138 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS-
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc-
Confidence 35789999999999997643 3899999999999999886 45689999999999999999999999999999988
Q ss_pred CCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc---cccccccccccccccccc
Q psy3253 77 GSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 77 ~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++..+++|||.+....... .......||+.|+|||++
T Consensus 139 --------------------------------P~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 186 (277)
T d1o6ya_ 139 --------------------------------PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186 (277)
T ss_dssp --------------------------------GGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHH
T ss_pred --------------------------------CcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHH
Confidence 889999999999999999886543221 223445689999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC-CCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHH
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK-PPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEM 232 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 232 (251)
.+..++.++||||+||++|+|+||.+||.+.+........... ..+.......+|+++.++|.+||+.||++||+..+.
T Consensus 187 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~ 266 (277)
T d1o6ya_ 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266 (277)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence 9999999999999999999999999999887766555443322 222223456789999999999999999999954444
Q ss_pred hcChhhhh
Q psy3253 233 LNHEFIQR 240 (251)
Q Consensus 233 l~hp~~~~ 240 (251)
+.|+|.+-
T Consensus 267 l~~~l~r~ 274 (277)
T d1o6ya_ 267 MRADLVRV 274 (277)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 55788764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=308.34 Aligned_cols=204 Identities=27% Similarity=0.482 Sum_probs=166.6
Q ss_pred CCCCCCCccceeeeeEeeCC------eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++|||||+++++|.... ++|+||||| +.+|..+++ ...+++..++.++.||+.||.|||++||+||||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDi 147 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 147 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCccccc
Confidence 45789999999999997654 579999999 668888775 467999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.+|++|||+++..... .....+|+.|+|||++.
T Consensus 148 K---------------------------------p~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~ 191 (346)
T d1cm8a_ 148 K---------------------------------PGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVIL 191 (346)
T ss_dssp C---------------------------------GGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHH
T ss_pred C---------------------------------cchhhcccccccccccccceeccCCc---cccccccccccCHHHHc
Confidence 8 89999999999999999999766533 23456899999999987
Q ss_pred c-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---------------------------CCCCC-CCCCCCC
Q psy3253 155 E-IGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------------PTKPP-PSFREPD 205 (251)
Q Consensus 155 ~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~~ 205 (251)
+ ..++.++||||+||++|+|++|.+||.+.+........ ..... .......
T Consensus 192 ~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (346)
T d1cm8a_ 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271 (346)
T ss_dssp TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT
T ss_pred CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhcc
Confidence 6 45688999999999999999999999776543322111 00000 0111235
Q ss_pred CCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccC
Q psy3253 206 VWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDT 243 (251)
Q Consensus 206 ~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~ 243 (251)
..++++.+||.+||..||++|||++|+|+||||+....
T Consensus 272 ~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 272 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 57899999999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-44 Score=297.07 Aligned_cols=195 Identities=24% Similarity=0.483 Sum_probs=169.6
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHLRRK 69 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~~~i 69 (251)
+|||||+++++|.++...++|||||++|+|.+++..+. ..+++.+++.++.||+.||+|||+.|+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 79999999999999999999999999999999997443 358999999999999999999999999
Q ss_pred cccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccc
Q psy3253 70 IHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFW 147 (251)
Q Consensus 70 iH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 147 (251)
+||||| |+||+++.++.+||+|||+++....... ......+++.|
T Consensus 157 vHrDiK---------------------------------p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 203 (299)
T d1fgka_ 157 IHRDLA---------------------------------ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203 (299)
T ss_dssp CCSCCS---------------------------------GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGG
T ss_pred Eeeeec---------------------------------ccceeecCCCCeEeccchhhccccccccccccccCCCChhh
Confidence 999988 9999999999999999999986654322 22334578899
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCcc
Q psy3253 148 MAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEER 226 (251)
Q Consensus 148 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 226 (251)
+|||.+.+..++.++|||||||++|+|++ |.+||.+.+.......+..+.. ...+..+++++.+||.+||+.||++|
T Consensus 204 ~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1fgka_ 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQR 281 (299)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHC
Confidence 99999999999999999999999999998 7899987777666555544433 33467789999999999999999999
Q ss_pred CCHHHHhc
Q psy3253 227 ATASEMLN 234 (251)
Q Consensus 227 ps~~evl~ 234 (251)
||++||++
T Consensus 282 ps~~eil~ 289 (299)
T d1fgka_ 282 PTFKQLVE 289 (299)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=297.39 Aligned_cols=200 Identities=21% Similarity=0.388 Sum_probs=165.7
Q ss_pred CCCCCCCccceeeeeEee-CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSG 79 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni 79 (251)
|++++|||||++++++.. +...++|||||++|+|.+++......+++..++.++.|++.||.|||+.||+|||||
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK---- 157 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA---- 157 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS----
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCcc----
Confidence 468899999999999875 457999999999999999998666788899999999999999999999999999988
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----ccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.+||+|||+++....... ......||+.|+|||.+..
T Consensus 158 -----------------------------~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 158 -----------------------------ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp -----------------------------GGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred -----------------------------HHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc
Confidence 9999999999999999999986543221 2223457889999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCC-CCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 156 IGYDCVADMWSLGITALEMAEGKPPYGD-IHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 156 ~~~~~~~DvwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
..++.++||||||+++|+|++|..||.. .+.......+..+.. ...+..+++++.+||.+||+.||++|||++||++
T Consensus 209 ~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 286 (311)
T d1r0pa_ 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999997766643 333333333333322 2346678999999999999999999999999998
Q ss_pred C
Q psy3253 235 H 235 (251)
Q Consensus 235 h 235 (251)
|
T Consensus 287 ~ 287 (311)
T d1r0pa_ 287 R 287 (311)
T ss_dssp H
T ss_pred H
Confidence 8
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-44 Score=298.23 Aligned_cols=203 Identities=24% Similarity=0.400 Sum_probs=171.7
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHH
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------------------KTLSEDEIATILCDT 57 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------------------~~l~~~~~~~~~~~i 57 (251)
|++++||||+++++++.+....+++|||+.+|+|.+++.... ..+++..++.++.|+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 457899999999999999999999999999999999996432 248899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc-
Q psy3253 58 LKGLEYLHLRRKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA- 136 (251)
Q Consensus 58 ~~~l~~LH~~~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~- 136 (251)
+.||+|||++|++||||| |+||+++.++.+||+|||+++.......
T Consensus 150 ~~gl~ylH~~~ivHrDlK---------------------------------p~NILld~~~~~Kl~DFGls~~~~~~~~~ 196 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLA---------------------------------TRNCLVGENMVVKIADFGLSRNIYSADYY 196 (301)
T ss_dssp HHHHHHHHHTTCCCSCCS---------------------------------GGGEEECGGGCEEECCCSCHHHHTGGGCB
T ss_pred HHHhhhcccCCeEeeEEc---------------------------------ccceEECCCCcEEEccchhheeccCCccc
Confidence 999999999999999988 8899999999999999999975533221
Q ss_pred -cccccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHH
Q psy3253 137 -KRNTVIGTPFWMAPEVIQEIGYDCVADMWSLGITALEMAEGK-PPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDF 214 (251)
Q Consensus 137 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 214 (251)
......+++.|+|||.+.+..++.++|||||||++|+|++|. +||.+.+..+....+.....+ ..+..+++++.+|
T Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~--~~p~~~~~~~~~l 274 (301)
T d1lufa_ 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNL 274 (301)
T ss_dssp C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHH
T ss_pred cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--CCCccchHHHHHH
Confidence 223456788999999999999999999999999999999985 788888777776666555433 3467789999999
Q ss_pred HHHhhhcCcCccCCHHHHhcChhhhh
Q psy3253 215 VSRCLVKNPEERATASEMLNHEFIQR 240 (251)
Q Consensus 215 i~~~l~~~p~~Rps~~evl~hp~~~~ 240 (251)
|.+||+.||++|||+.||+ .++++
T Consensus 275 i~~cl~~~P~~RPt~~ev~--~~L~~ 298 (301)
T d1lufa_ 275 MRLCWSKLPADRPSFCSIH--RILQR 298 (301)
T ss_dssp HHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred HHHHcCCChhHCcCHHHHH--HHHHH
Confidence 9999999999999999996 45554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=296.11 Aligned_cols=207 Identities=20% Similarity=0.384 Sum_probs=176.6
Q ss_pred CCCCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy3253 1 MQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK---------KTLSEDEIATILCDTLKGLEYLHLRRKIH 71 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~LH~~~iiH 71 (251)
|++++|||||++++++..+...++|||||.+|+|.+++.... ..+++..+..++.|++.||.|||+++|+|
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 568999999999999999999999999999999999986332 34789999999999999999999999999
Q ss_pred cCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc--ccccccccccccc
Q psy3253 72 RDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMA 149 (251)
Q Consensus 72 ~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 149 (251)
|||| |+||+++.++++||+|||+++....... ......+|+.|+|
T Consensus 157 rDlk---------------------------------~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~a 203 (308)
T d1p4oa_ 157 RDLA---------------------------------ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203 (308)
T ss_dssp SCCS---------------------------------GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCC
T ss_pred ceEc---------------------------------CCceeecCCceEEEeecccceeccCCcceeeccceecccccCC
Confidence 9988 9999999999999999999976543322 2233467899999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhhcCCCCCCCCCCCCCCCHHHHHHHHHhhhcCcCccCC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFMIPTKPPPSFREPDVWTPEFIDFVSRCLVKNPEERAT 228 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 228 (251)
||.+.+..++.++|||||||++|+|+|| .+||.+.+.......+..... ...+..+++.+.++|.+||+.||++|||
T Consensus 204 Pe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPS 281 (308)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999999997 588888777666655544432 3346778999999999999999999999
Q ss_pred HHHHhc------Chhhhhcc
Q psy3253 229 ASEMLN------HEFIQRHD 242 (251)
Q Consensus 229 ~~evl~------hp~~~~~~ 242 (251)
++||++ +|+|++.+
T Consensus 282 ~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 282 FLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp HHHHHHHHGGGSCTTHHHHC
T ss_pred HHHHHHHHHHhcCCCCcCCC
Confidence 999987 78887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=301.63 Aligned_cols=208 Identities=24% Similarity=0.401 Sum_probs=161.9
Q ss_pred CCCCCCCccceeeeeEee--------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy3253 1 MQQCDSPYVVKYYGSYFK--------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHR 72 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~ 72 (251)
|++++||||+++++++.. +.+.|+||||+.++++.. .......+++..++.++.|++.||.|||++||+||
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHr 141 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 141 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCCEEec
Confidence 457899999999999854 356899999997765544 43456789999999999999999999999999999
Q ss_pred CCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc----ccccccccccccc
Q psy3253 73 DIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWM 148 (251)
Q Consensus 73 dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~ 148 (251)
||| |+||+++.++.+|++|||++....... .......||+.|+
T Consensus 142 DlK---------------------------------p~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~ 188 (318)
T d3blha1 142 DMK---------------------------------AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188 (318)
T ss_dssp CCC---------------------------------GGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGC
T ss_pred CcC---------------------------------chheeecCCCcEEeeecceeeecccccccccccccceecCHHHh
Confidence 988 889999999999999999997654321 1223346899999
Q ss_pred cccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---CCCCCCCC-CC----------------C---
Q psy3253 149 APEVIQEI-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---PTKPPPSF-RE----------------P--- 204 (251)
Q Consensus 149 aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~-~~----------------~--- 204 (251)
|||++.+. .++.++||||+||++|+|++|++||.+.+.......+ ........ .. .
T Consensus 189 aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T d3blha1 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268 (318)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCH
T ss_pred hHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccc
Confidence 99998754 6899999999999999999999999766554433221 11100000 00 0
Q ss_pred ------CCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 205 ------DVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 205 ------~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
...++++.+||.+||++||++|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred hhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 01267789999999999999999999999999998643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-44 Score=302.89 Aligned_cols=205 Identities=23% Similarity=0.376 Sum_probs=162.7
Q ss_pred CCC-CCCccceeeeeEee--CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q psy3253 2 QQC-DSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGS 78 (251)
Q Consensus 2 ~~l-~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~N 78 (251)
+++ .||||++++++|.. ...+++|||||.+++|.++. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiK--- 156 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK--- 156 (328)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS---
T ss_pred HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhccccccccc---
Confidence 455 49999999999974 45699999999999997653 579999999999999999999999999999988
Q ss_pred CCccccccccccccccccchhhhhhhhhcccCceecCCCC-CeEecccccccccCcccccccccccccccccccccccC-
Q psy3253 79 GTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI- 156 (251)
Q Consensus 79 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 156 (251)
|+||+++.++ .++|+|||++...... .......+|+.|+|||.+.+.
T Consensus 157 ------------------------------p~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 157 ------------------------------PHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp ------------------------------GGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCC
T ss_pred ------------------------------ccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCC
Confidence 8888887655 5899999999765543 234455689999999998764
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh-h---------------------------hcCCCC-C------CCC
Q psy3253 157 GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI-F---------------------------MIPTKP-P------PSF 201 (251)
Q Consensus 157 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~---------------------------~~~~~~-~------~~~ 201 (251)
.++.++||||+||++|++++|..||......... . ...... . ...
T Consensus 206 ~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (328)
T d3bqca1 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285 (328)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCT
T ss_pred CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccc
Confidence 4799999999999999999999999544321100 0 000000 0 011
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 202 REPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 202 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.....+++++.+||.+||++||++|||++|+|+||||+...|+
T Consensus 286 ~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp TTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1123468999999999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=298.61 Aligned_cols=197 Identities=29% Similarity=0.497 Sum_probs=157.9
Q ss_pred CCCCccceeeeeEeeC-CeEEEEEEccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 4 CDSPYVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMRLRK---------------KTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 4 l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
.+||||+++++++... ..+++|||||++|+|.++++... ..+++.+++.++.||+.||.|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3799999999988654 56899999999999999997432 3588999999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccc
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTP 145 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~ 145 (251)
||+||||| |+||+++.++.+||+|||+|+...... .......||+
T Consensus 154 ~ivHrDlK---------------------------------p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 154 KCIHRDLA---------------------------------ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp TCCCSCCC---------------------------------GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred CCcCCcCC---------------------------------ccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 99999988 889999999999999999997654322 2234456899
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcchhhhh-cCCCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAEG-KPPYGDIHPMRAIFM-IPTKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
.|+|||++.+..++.++|||||||++|+|++| .+||.+......... +..+. ....+..+++++.++|.+||+.||
T Consensus 201 ~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP 278 (299)
T d1ywna1 201 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEP 278 (299)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999986 567866554433322 22222 233467789999999999999999
Q ss_pred CccCCHHHHhcC
Q psy3253 224 EERATASEMLNH 235 (251)
Q Consensus 224 ~~Rps~~evl~h 235 (251)
++|||++|+++|
T Consensus 279 ~~Rpt~~eil~~ 290 (299)
T d1ywna1 279 SQRPTFSELVEH 290 (299)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=302.21 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=163.6
Q ss_pred CCCCCCCccceeeeeEeeCC-----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++||||+++++++.... ..|++ +|+.+|+|.+++.. ..+++..++.++.|++.||+|||++||+|||||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIK 136 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 136 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 45789999999999997543 34555 45558899999963 479999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc---cccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEV 152 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~ 152 (251)
|+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 137 ---------------------------------p~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 183 (345)
T d1pmea_ 137 ---------------------------------PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183 (345)
T ss_dssp ---------------------------------GGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGG
T ss_pred ---------------------------------cceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHH
Confidence 8999999999999999999976543322 2344568899999999
Q ss_pred cc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhc---------------------------CCCCCCC-CCC
Q psy3253 153 IQ-EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMI---------------------------PTKPPPS-FRE 203 (251)
Q Consensus 153 ~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------------~~~~~~~-~~~ 203 (251)
+. ...++.++||||+||++|+|++|.+||.+.+........ ....... ...
T Consensus 184 l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (345)
T d1pmea_ 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263 (345)
T ss_dssp TTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHh
Confidence 84 456788999999999999999999999765432222111 0000000 011
Q ss_pred CCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 204 PDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 204 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
...+++++.+|+.+||+.||++|||++|+|+||||+.....
T Consensus 264 ~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 264 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 34568899999999999999999999999999999965543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=299.41 Aligned_cols=206 Identities=21% Similarity=0.408 Sum_probs=160.9
Q ss_pred CCCCCCCccceeeeeEeeC-----CeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy3253 1 MQQCDSPYVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIK 75 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik 75 (251)
|++++|||||++++++... ...+++|+|+.+|+|.++++ ...+++.+++.++.||+.||+|||++||+|||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK 148 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence 3578999999999999643 23456667777999999985 4679999999999999999999999999999988
Q ss_pred CCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccccccc
Q psy3253 76 AGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 155 (251)
Q Consensus 76 ~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 155 (251)
|+||+++.++.++++|||.+..... ......|++.|+|||.+.+
T Consensus 149 ---------------------------------p~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 149 ---------------------------------PSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp ---------------------------------GGGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTT
T ss_pred ---------------------------------CccccccccccccccccchhcccCc---ccccccccccccCchhhcC
Confidence 8899999999999999999965442 3344568889999998766
Q ss_pred C-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcCCC---C-------------------CCCCC------CCCC
Q psy3253 156 I-GYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIPTK---P-------------------PPSFR------EPDV 206 (251)
Q Consensus 156 ~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------------~~~~~------~~~~ 206 (251)
. .++.++||||+||++|+|++|.+||.+.+.......+... . ..... ....
T Consensus 193 ~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (348)
T d2gfsa1 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272 (348)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence 5 4688999999999999999999999765543332221100 0 00000 1245
Q ss_pred CCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhccCC
Q psy3253 207 WTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHDTD 244 (251)
Q Consensus 207 ~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~~~ 244 (251)
.++++.+||.+||..||++|||++|+|+||||++....
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 78999999999999999999999999999999976543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=300.44 Aligned_cols=204 Identities=24% Similarity=0.413 Sum_probs=154.3
Q ss_pred CCCCCCCccceeeeeEee------CCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy3253 1 MQQCDSPYVVKYYGSYFK------NTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDI 74 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~di 74 (251)
|++++|||||+++++|.. ..++|+|||||.+ ++.+.+ ...+++..++.++.||+.||.|||++||+||||
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDl 145 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccC
Confidence 357899999999999963 4689999999976 454444 357999999999999999999999999999998
Q ss_pred CCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccccccccccccccccccccc
Q psy3253 75 KAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 154 (251)
Q Consensus 75 k~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 154 (251)
| |+||+++.++.++++|||+++..... .......+|+.|+|||++.
T Consensus 146 K---------------------------------P~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~ 191 (355)
T d2b1pa1 146 K---------------------------------PSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 191 (355)
T ss_dssp C---------------------------------GGGEEECTTCCEEECCCCC----------------CCTTCCHHHHT
T ss_pred C---------------------------------ccccccccccceeeechhhhhccccc-cccccccccccccChhhhc
Confidence 8 88999999999999999998765543 3334456899999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC----------------------CCCCCC--CC--------
Q psy3253 155 EIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP----------------------TKPPPS--FR-------- 202 (251)
Q Consensus 155 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~----------------------~~~~~~--~~-------- 202 (251)
+..+++++||||+||++|+|++|++||.+.+.......+. ...... ..
T Consensus 192 ~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (355)
T d2b1pa1 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271 (355)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGG
T ss_pred CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccc
Confidence 9999999999999999999999999997654332221110 000000 00
Q ss_pred -------CCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 203 -------EPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 203 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
.....++++.+||.+||.+||++|||++|+|+||||+...
T Consensus 272 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0011356789999999999999999999999999998743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=290.26 Aligned_cols=195 Identities=25% Similarity=0.452 Sum_probs=164.4
Q ss_pred CCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy3253 5 DSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRK-----------------KTLSEDEIATILCDTLKGLEYLHLR 67 (251)
Q Consensus 5 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~-----------------~~l~~~~~~~~~~~i~~~l~~LH~~ 67 (251)
+|||||++++++.++...++|||||++|+|.++++... ..+++..++.++.||+.||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 79999999999999999999999999999999997432 2589999999999999999999999
Q ss_pred CccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccc--cccccccccc
Q psy3253 68 RKIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTP 145 (251)
Q Consensus 68 ~iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~ 145 (251)
|++||||| |+||+++.++.++++|||.++...... .......+|+
T Consensus 165 ~ivHrDLK---------------------------------p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 165 NCIHRDLA---------------------------------ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp TCCCSCCS---------------------------------GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred Ceeecccc---------------------------------cccccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 99999988 889999999999999999998664322 2234456899
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcchhhhhcC-CCCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q psy3253 146 FWMAPEVIQEIGYDCVADMWSLGITALEMAE-GKPPYGDIHPMRAIFMIP-TKPPPSFREPDVWTPEFIDFVSRCLVKNP 223 (251)
Q Consensus 146 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p 223 (251)
.|+|||.+.+..++.++|||||||++|+|+| |.+||...........+. .+. ....+..+++++.+||.+||+.||
T Consensus 212 ~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CCCCcccccHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999998 667776655544433222 222 223356689999999999999999
Q ss_pred CccCCHHHHhc
Q psy3253 224 EERATASEMLN 234 (251)
Q Consensus 224 ~~Rps~~evl~ 234 (251)
++|||++|+++
T Consensus 290 ~~RPs~~~il~ 300 (311)
T d1t46a_ 290 LKRPTFKQIVQ 300 (311)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=283.61 Aligned_cols=199 Identities=24% Similarity=0.340 Sum_probs=152.0
Q ss_pred CCCCCCCccceeeeeEeeCC----eEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CC
Q psy3253 1 MQQCDSPYVVKYYGSYFKNT----DLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHL--------RR 68 (251)
Q Consensus 1 l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~--------~~ 68 (251)
+++++|||||++++++.+.. .+|+|||||++|+|.++++. ..+++..+..++.|++.||.|+|+ +|
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~ 128 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC
Confidence 45789999999999997643 68999999999999999973 479999999999999999999996 59
Q ss_pred ccccCCCCCCCCccccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCcccc----cccccccc
Q psy3253 69 KIHRDIKAGSGTLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMA----KRNTVIGT 144 (251)
Q Consensus 69 iiH~dik~~Ni~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~ 144 (251)
|+||||| |+||+++.++.+||+|||+++....... ......||
T Consensus 129 IvHrDlK---------------------------------p~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 129 IAHRDLK---------------------------------SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EECSCCC---------------------------------GGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSC
T ss_pred eeccccC---------------------------------ccceEEcCCCCeEEEecCccccccCCCcceeccccceecc
Confidence 9999988 9999999999999999999976543221 22345689
Q ss_pred cccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhh---------------hcCC-CCCCCCC
Q psy3253 145 PFWMAPEVIQEIG------YDCVADMWSLGITALEMAEGKPPYGDIHPMRAIF---------------MIPT-KPPPSFR 202 (251)
Q Consensus 145 ~~y~aPE~~~~~~------~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~---------------~~~~-~~~~~~~ 202 (251)
+.|+|||++.+.. ++.++|||||||++|+|+||.+||.......... .... ...+...
T Consensus 176 ~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 255 (303)
T d1vjya_ 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC
Confidence 9999999986542 5678999999999999999988874322111110 0111 1111110
Q ss_pred C---CCCCCHHHHHHHHHhhhcCcCccCCHHHHhc
Q psy3253 203 E---PDVWTPEFIDFVSRCLVKNPEERATASEMLN 234 (251)
Q Consensus 203 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 234 (251)
. .......+.+|+.+||+.||++|||++||++
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0 0112245889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-39 Score=269.18 Aligned_cols=205 Identities=18% Similarity=0.245 Sum_probs=156.2
Q ss_pred CCCCCCcc-ceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCC
Q psy3253 2 QQCDSPYV-VKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGT 80 (251)
Q Consensus 2 ~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~ 80 (251)
++++|+|+ +.+.+++.++...++||||+ +++|.+.+......+++..++.++.|++.||+|||++||+|||||
T Consensus 57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiK----- 130 (299)
T d1ckia_ 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK----- 130 (299)
T ss_dssp HHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC-----
T ss_pred HHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCC-----
Confidence 45666665 55566667888999999999 568888777677889999999999999999999999999999999
Q ss_pred ccccccccccccccccchhhhhhhhhcccCceecC---CCCCeEecccccccccCcccc-------cccccccccccccc
Q psy3253 81 LVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLN---TEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMAP 150 (251)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~---~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aP 150 (251)
|+||+++ .+..++++|||+|+....... ......||+.|+||
T Consensus 131 ----------------------------p~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 131 ----------------------------PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182 (299)
T ss_dssp ----------------------------GGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred ----------------------------HhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCH
Confidence 5566543 345699999999986543221 22345689999999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhhhhcC---CC--CCCCCCCCCCCCHHHHHHHHHhhhcCcCc
Q psy3253 151 EVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAIFMIP---TK--PPPSFREPDVWTPEFIDFVSRCLVKNPEE 225 (251)
Q Consensus 151 E~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 225 (251)
|++.+.+++.++|||||||++|+|++|..||............. .. ..+.......+|+++.+++.+||+.||++
T Consensus 183 E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~ 262 (299)
T d1ckia_ 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 262 (299)
T ss_dssp HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTC
T ss_pred HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhH
Confidence 99999999999999999999999999999997654332221110 00 00111124568999999999999999999
Q ss_pred cCCHHH---HhcChhhhh
Q psy3253 226 RATASE---MLNHEFIQR 240 (251)
Q Consensus 226 Rps~~e---vl~hp~~~~ 240 (251)
||++++ +|+|+|.+.
T Consensus 263 RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 263 KPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp CCCHHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHHc
Confidence 999875 578887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-39 Score=268.06 Aligned_cols=198 Identities=16% Similarity=0.180 Sum_probs=158.4
Q ss_pred CCC-CCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCc
Q psy3253 3 QCD-SPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTL 81 (251)
Q Consensus 3 ~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~ 81 (251)
.+. |+|++.+++++.++...++||||+ +++|.++++..+..++..++..++.|++.||+|||++||+|||||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiK------ 128 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK------ 128 (293)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC------
T ss_pred HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCC------
Confidence 454 489999999999999999999999 689999998777789999999999999999999999999999999
Q ss_pred cccccccccccccccchhhhhhhhhcccCceecCC-----CCCeEecccccccccCccc-------cccccccccccccc
Q psy3253 82 VYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNT-----EGHAKLADFGVAGQLTDTM-------AKRNTVIGTPFWMA 149 (251)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~-----~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~a 149 (251)
|+||+++. .+.++|+|||+|+...... .......||+.|+|
T Consensus 129 ---------------------------p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~a 181 (293)
T d1csna_ 129 ---------------------------PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181 (293)
T ss_dssp ---------------------------GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred ---------------------------ccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcC
Confidence 66666643 4679999999998654321 12234568999999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchhh---hhcCC--CCCCCCCCCCCCCHHHHHHHHHhhhcCcC
Q psy3253 150 PEVIQEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRAI---FMIPT--KPPPSFREPDVWTPEFIDFVSRCLVKNPE 224 (251)
Q Consensus 150 PE~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 224 (251)
||++.+..++.++||||+||++|+|++|..||.+....... ..+.. ...+.......+|+++.+++..|+..+|+
T Consensus 182 PE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~ 261 (293)
T d1csna_ 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFD 261 (293)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTT
T ss_pred HHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcc
Confidence 99999999999999999999999999999999754433221 11110 00011112356789999999999999999
Q ss_pred ccCCHHHHhc
Q psy3253 225 ERATASEMLN 234 (251)
Q Consensus 225 ~Rps~~evl~ 234 (251)
+||+.+.+.+
T Consensus 262 ~rP~y~~l~~ 271 (293)
T d1csna_ 262 ATPDYDYLQG 271 (293)
T ss_dssp CCCCHHHHHH
T ss_pred cCcCHHHHHH
Confidence 9999887754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=256.82 Aligned_cols=202 Identities=23% Similarity=0.345 Sum_probs=146.8
Q ss_pred CCCccceeeeeEee--CCeEEEEEEccCCCCHH-HHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCC
Q psy3253 5 DSPYVVKYYGSYFK--NTDLWIVMEYCGAGSVS-DIM-RLRKKTLSEDEIATILCDTLKGLEYLHL-RRKIHRDIKAGSG 79 (251)
Q Consensus 5 ~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~-~~~-~~~~~~l~~~~~~~~~~~i~~~l~~LH~-~~iiH~dik~~Ni 79 (251)
.||||+++++++.. ....+++++++..+... ... ......+++..++.++.||+.||.|||+ .||+|||||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlK---- 153 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK---- 153 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCS----
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCC----
Confidence 58999999998864 34567777776544332 322 2334688999999999999999999998 899999999
Q ss_pred CccccccccccccccccchhhhhhhhhcccCceecCCCC------CeEecccccccccCccccccccccccccccccccc
Q psy3253 80 TLVYDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEG------HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 153 (251)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 153 (251)
|+||+++.++ .++++|||.+..... ......+|+.|+|||++
T Consensus 154 -----------------------------p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~ 201 (362)
T d1q8ya_ 154 -----------------------------PENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVL 201 (362)
T ss_dssp -----------------------------GGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHH
T ss_pred -----------------------------hhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhc
Confidence 5555554433 389999999965442 33456789999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcchh------h---hhcCC------------------------CCCC-
Q psy3253 154 QEIGYDCVADMWSLGITALEMAEGKPPYGDIHPMRA------I---FMIPT------------------------KPPP- 199 (251)
Q Consensus 154 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~------~---~~~~~------------------------~~~~- 199 (251)
....++.++|+||+||++++|++|+.||........ . ..... ....
T Consensus 202 ~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
T d1q8ya_ 202 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281 (362)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccc
Confidence 999999999999999999999999999953321100 0 00000 0000
Q ss_pred -----------CCCCCCCCCHHHHHHHHHhhhcCcCccCCHHHHhcChhhhhcc
Q psy3253 200 -----------SFREPDVWTPEFIDFVSRCLVKNPEERATASEMLNHEFIQRHD 242 (251)
Q Consensus 200 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~hp~~~~~~ 242 (251)
........++++.+||.+||.+||++|||++|+|+||||++..
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred cCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0001122357799999999999999999999999999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.59 E-value=5.3e-17 Score=125.32 Aligned_cols=113 Identities=18% Similarity=0.137 Sum_probs=79.9
Q ss_pred CCCCCccceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCCCcc
Q psy3253 3 QCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRRKIHRDIKAGSGTLV 82 (251)
Q Consensus 3 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~iiH~dik~~Ni~~~ 82 (251)
++.|++++..+++.. .+++|||+++..+. .++...+..++.|++.||.|||++|++|||||
T Consensus 70 ~l~~~~v~~~~~~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiK------- 130 (191)
T d1zara2 70 KLQGLAVPKVYAWEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLS------- 130 (191)
T ss_dssp HTTTSSSCCEEEEET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCS-------
T ss_pred HccCCCcceEEEecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCC-------
Confidence 467888888776532 37999999876542 24555567899999999999999999999999
Q ss_pred ccccccccccccccchhhhhhhhhcccCceecCCCCCeEecccccccccCccccccccccccccccccc-----ccccCC
Q psy3253 83 YDRLDYCSIKCNVITNQIYKTLFRLKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE-----VIQEIG 157 (251)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~ 157 (251)
|+||+++.++ ++|+|||.+.....+.... |.... .+....
T Consensus 131 --------------------------P~NILv~~~~-~~liDFG~a~~~~~~~~~~--------~l~rd~~~~~~~f~r~ 175 (191)
T d1zara2 131 --------------------------QYNVLVSEEG-IWIIDFPQSVEVGEEGWRE--------ILERDVRNIITYFSRT 175 (191)
T ss_dssp --------------------------TTSEEEETTE-EEECCCTTCEETTSTTHHH--------HHHHHHHHHHHHHHHH
T ss_pred --------------------------hhheeeeCCC-EEEEECCCcccCCCCCcHH--------HHHHHHHHHHHHHcCC
Confidence 7777777554 8999999997654332211 11100 012356
Q ss_pred CCcchhHHHHHH
Q psy3253 158 YDCVADMWSLGI 169 (251)
Q Consensus 158 ~~~~~DvwslG~ 169 (251)
|+.++|+||+.-
T Consensus 176 y~~~~d~~s~~~ 187 (191)
T d1zara2 176 YRTEKDINSAID 187 (191)
T ss_dssp HCCCCCHHHHHH
T ss_pred CCCcccHHHHHH
Confidence 788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.49 E-value=0.0015 Score=50.40 Aligned_cols=54 Identities=13% Similarity=-0.035 Sum_probs=36.7
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIMRLRKKTLSEDEIATILCDTLKGLEYLHLRR 68 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~~~~~~~~l~~~~~~~~~~~i~~~l~~LH~~~ 68 (251)
+.+++.+..+++..++||++++|.++.+... +......++.++...+..||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~ 125 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSID 125 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSC
T ss_pred CCcEEEEEecCCceEEEEEeccccccccccc------ccccHHHHHHHHHHHHHHHhccC
Confidence 4566777778888999999999988865432 11223335666777778888654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.20 E-value=0.014 Score=44.45 Aligned_cols=26 Identities=4% Similarity=0.107 Sum_probs=20.8
Q ss_pred cceeeeeEeeCCeEEEEEEccCCCCH
Q psy3253 9 VVKYYGSYFKNTDLWIVMEYCGAGSV 34 (251)
Q Consensus 9 iv~l~~~~~~~~~~~lv~e~~~~gsL 34 (251)
+.+++.+..+++..++||++++|-++
T Consensus 68 vP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 68 CAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCceeeecccccceEEEEEeeecccc
Confidence 55667777777889999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.81 E-value=0.11 Score=42.45 Aligned_cols=21 Identities=24% Similarity=0.221 Sum_probs=16.0
Q ss_pred cCceecCCCCCeEecccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAGQ 130 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~~ 130 (251)
+.||+++.++ ++++||..+..
T Consensus 232 ~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 232 TGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp GGGEEECSSC-EEECCCTTCEE
T ss_pred CCceeEcCCc-eEEechhhccc
Confidence 7788877655 79999988743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.07 E-value=0.027 Score=44.45 Aligned_cols=21 Identities=24% Similarity=0.289 Sum_probs=17.8
Q ss_pred cCceecCCCCCeEeccccccc
Q psy3253 109 AGNILLNTEGHAKLADFGVAG 129 (251)
Q Consensus 109 ~~nil~~~~~~~kl~dfg~~~ 129 (251)
++|++++.+...-++||+.+.
T Consensus 192 ~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 192 QDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhcccccceeEecccccc
Confidence 889998887767899999885
|